PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Smith, C				Smith, C			Drug target validation: Hitting the target	NATURE			English	Article																			0	59	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					341	+		10.1038/422341a	http://dx.doi.org/10.1038/422341a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646929	Bronze			2022-12-01	WOS:000181637300045
J	Clinton, WJ				Clinton, WJ			Turning the tide on the AIDS pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									William J Clinton Presidential Fdn, New York, NY USA		Clinton, WJ (corresponding author), William J Clinton Presidential Fdn, New York, NY USA.								0	31	32	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1800	1802		10.1056/NEJMsb023052	http://dx.doi.org/10.1056/NEJMsb023052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724487				2022-12-01	WOS:000182543500010
J	Sordella, R; Jiang, W; Chen, GC; Curto, M; Settleman, J				Sordella, R; Jiang, W; Chen, GC; Curto, M; Settleman, J			Modulation of rho GTPase signaling regulates a switch between adipogenesis and myogenesis	CELL			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; AXON OUTGROWTH; P190 RHOGAP; DIFFERENTIATION; SHP-2; CELL; EXPRESSION; FAMILY; ACTIN; GENE	Mature adipocytes and myocytes are derived from a common mesenchymal precursor. While IGF-1 promotes the differentiation of both cell types, the signaling pathways that specify the distinct cell fates are largely unknown. Here, we show that the Rho GTPase and its regulator, p190-B RhoGAP, are components of a critical switch in the adipogenesis-myogenesis "decision." Cells derived from embryos lacking p190-B RhoGAP exhibit excessive Rho activity, are defective for adipogenesis, but undergo myogenesis in response to IGF-1 exposure. In vitro, activation of Rhokinase by Rho inhibits adipogenesis and is required for myogenesis. The activation state of Rho following IGF-1 signaling is determined by the tyrosine-phosphorylation status of p190-B RhoGAP and its resulting subcellular relocalization. Moreover, adjusting Rho activity is sufficient to alter the differentiation program of adipocyte and myocyte precursors. Together, these results identify the Rho GTPase as an essential modulator of IGF-1 signals that direct the adipogenesis-myogenesis cell fate decision.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.		Chen, Guang-Chao/P-1262-2019	Chen, Guang-Chao/0000-0002-4980-4718	NCI NIH HHS [CA69498] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burbelo PD, 1998, BBA-GENE STRUCT EXPR, V1443, P203, DOI 10.1016/S0167-4781(98)00207-3; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Luo LQ, 1996, PERSPECT DEV NEUROBI, V4, P199; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Settleman J, 1999, Prog Mol Subcell Biol, V22, P201; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; SUGAI M, 1992, J BIOL CHEM, V267, P2600; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; WILLIAMS IH, 1977, BIOCHEM BIOPH RES CO, V77, P175, DOI 10.1016/S0006-291X(77)80180-0; XU B, 1995, J BIOL CHEM, V270, P29825; Zhao M, 1999, MOL CELL BIOL, V19, P21	32	309	326	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					147	158		10.1016/S0092-8674(03)00271-X	http://dx.doi.org/10.1016/S0092-8674(03)00271-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705864	Bronze			2022-12-01	WOS:000182508500005
J	Neff, BD				Neff, BD			Decisions about parental care in response to perceived paternity	NATURE			English	Article							BLUEGILL SUNFISH; LEPOMIS-MACROCHIRUS; EASTERN BLUEBIRDS; INVESTMENT; BEHAVIOR; CONFIDENCE; SUCCESS; SIZE	Evolutionary ecologists are attempting to explain how parents make behavioural decisions about how much care to provide to their young(1-4). Theory predicts that when genetic relatedness to young is decreased by cuckoldry, for example, parents should reduce their care in favour of alternative broods that provide greater reproductive success(5-7). Experimental manipulation of perceived paternity has been used to test the theory(8,9), but such studies have generated mixed results(10-13). Some manipulations can fail to alter a parent's perceived paternity(14), whereas others may directly affect parental behaviour when, for instance, the manipulation involves capturing the parent(15-18). No study has demonstrated parental care adjustment in a manner uncomplicated by experimental design or life history correlates. Here I test the theory using the fact that nest-tending parental male bluegill sunfish (Lepomis macrochirus) can assess their paternity using both the visual presence of parasitic cuckolder males during spawning(19), and olfactory cues released by newly hatched eggs(20,21). By manipulating both types of cues I show that parental males dynamically adjust their parental care, favouring broods that are apparently most closely related. These results confirm the importance of genetic relatedness in parental care decision-making.	Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Neff, BD (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.			Neff, Bryan/0000-0001-8499-250X				Brown GE, 1996, REV FISH BIOL FISHER, V6, P201; BURKE T, 1989, NATURE, V338, P249, DOI 10.1038/338249a0; Cargnelli LM, 1996, CAN J FISH AQUAT SCI, V53, P360, DOI 10.1139/cjfas-53-2-360; COLEMAN RM, 1991, ETHOLOGY, V87, P177, DOI 10.1111/j.1439-0310.1991.tb00245.x; DIXON A, 1994, NATURE, V371, P698, DOI 10.1038/371698a0; DOMINEY WJ, 1980, NATURE, V284, P546, DOI 10.1038/284546a0; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105, DOI 10.1098/rspb.2001.1625; GROSS MR, 1982, Z TIERPSYCHOL, V60, P1; Hunt J, 2002, J EVOLUTION BIOL, V15, P784, DOI 10.1046/j.1420-9101.2002.00442.x; Jamieson IG, 1997, AUK, V114, P291, DOI 10.2307/4089171; Kempenaers B, 1998, ANIM BEHAV, V55, P845, DOI 10.1006/anbe.1997.0667; Kempenaers B, 1997, ANIM BEHAV, V53, P423, DOI 10.1006/anbe.1996.0377; Kokko H, 1999, ECOL LETT, V2, P247, DOI 10.1046/j.1461-0248.1999.00075.x; Kokko H, 2000, TRENDS ECOL EVOL, V15, P440, DOI 10.1016/S0169-5347(00)01985-6; Lessells C.M., 1991, P32; MacDougall-Shackleton EA, 1998, BEHAV ECOL, V9, P201, DOI 10.1093/beheco/9.2.201; Neff BD, 2002, P ROY SOC B-BIOL SCI, V269, P1435, DOI 10.1098/rspb.2002.2028; Neff BD, 2001, J HERED, V92, P111, DOI 10.1093/jhered/92.2.111; Neff BD, 2001, P ROY SOC B-BIOL SCI, V268, P1559, DOI 10.1098/rspb.2001.1678; NEFF BD, UNPUB P R SOC LOND B; NEFF BD, IN PRESS ANIM COGN; Sargent R. C., 1993, BEHAV TELEOST FISHES, P275; Sheldon BC, 2002, PHILOS T R SOC B, V357, P341, DOI 10.1098/rstb.2001.0931; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; Trivers R.L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Westneat David F., 1996, Trends in Ecology and Evolution, V11, P87, DOI 10.1016/0169-5347(96)81049-4; WESTNEAT DF, 1993, BEHAV ECOL, V4, P66, DOI 10.1093/beheco/4.1.66; Wright J., 1998, SPERM COMPETITION SE, P117, DOI 10.1016/B978-012100543-6/50029-5	28	123	126	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					716	719		10.1038/nature01528	http://dx.doi.org/10.1038/nature01528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700761				2022-12-01	WOS:000182272300040
J	Goldstein, LE; Muffat, JA; Cherny, RA; Moir, RD; Ericsson, MH; Huang, XD; Mavros, C; Coccia, JA; Faget, KY; Fitch, KA; Masters, CL; Tanzi, RE; Chylack, LT; Bush, AI				Goldstein, LE; Muffat, JA; Cherny, RA; Moir, RD; Ericsson, MH; Huang, XD; Mavros, C; Coccia, JA; Faget, KY; Fitch, KA; Masters, CL; Tanzi, RE; Chylack, LT; Bush, AI			Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease	LANCET			English	Article							ALPHA-B-CRYSTALLIN; A-BETA; OXIDATIVE STRESS; PROTEIN; PRECURSOR; BRAIN; NEUROTOXICITY; TRANSPARENCY; ACCUMULATION; PEPTIDE	Background Pathological hallmarks of Alzheimer's disease include cerebral beta-amyloid (Abeta) deposition, amyloid accumulation, and neuritic plaque formation. We aimed to investigate the hypothesis that molecular pathological findings associated with Alzheimer's disease overlap in the lens and brain. Methods We obtained postmortem specimens of eyes and brain from nine individuals with Alzheimer's disease and eight controls without the disorder, and samples of primary aqueous humour from three people without the disorder who were undergoing cataract surgery. Dissected lenses were analysed by slit-lamp stereophotomicroscopy, western blot, tryptic-digest/mass spectrometry electrospray ionisation, and anti-Abeta surface-enhanced laser desorption ionisation (SELDI) mass spectrometry, immunohistochemistry, and immunogold electron microscopy. Aqueous humour was analysed by anti-Abeta SELDI mass spectrometry. We did binding and aggregation studies to investigate Abeta-lens protein interactions. Findings We identified Abeta1-40 and Abeta1-42 in lenses from people with and without Alzheimer's disease at concentrations comparable with brain, and Abeta1-40 in primary aqueous humour at concentrations comparable with cerebrospinal fluid. Abeta accumulated in lenses from individuals with Alzheimer's disease as electron-dense deposits located exclusively in the cytoplasm of supranuclear/cleep cortical lens fibre cells (n=4). We consistently saw equatorial supranuclear cataracts in lenses from people with Alzheimer's disease (n=9) but not in controls (n = 8). These supranuclear cataracts colocalised with enhanced Abeta immunoreactivity and birefringent Congo Red staining. Synthetic Abeta bound alphaB-crystallin, an abundant cytosolic lens protein. Abeta promoted lens protein aggregation that showed protofibrils, birefringent Congo Red staining, and Abeta/alphaB-crystallin coimmunoreactivity. Interpretation Abeta is present in the cytosol of lens fibre cells of people with Alzheimer's disease. Lens Abeta might promote regionally-specific lens protein aggregation, extracerebral amyloid formation, and supranuclear cataracts.	Massachusetts Gen Hosp, Genet & Aging Res Univ, Lab Oxidat Biol, Charlestown, MA 02129 USA; Brigham & Womens Hosp, Ctr Ophthalm Res, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Ecole Normale Super, Dept Bioengn, Cachan, France; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Univ Melbourne, Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; Harvard Univ, Sch Med, Electron Microscope Facil, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Universite Paris Saclay; University of Melbourne; University of Melbourne; Harvard University; Harvard Medical School	Bush, AI (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Univ, Lab Oxidat Biol, Bldg 114,16th St, Charlestown, MA 02129 USA.		Tanzi, Rudolph/AAE-9622-2019; Bush, Ashley/Y-2457-2019; Muffat, Julien/P-2298-2014; Bush, Ashley I/A-1186-2007; Moir, Robert/M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Goldstein, Lee/0000-0001-8419-9800; Sommerville, Christine/0000-0002-9226-1691; Muffat, Julien/0000-0003-1889-7023; Moir, Robert/0000-0001-5431-3553	NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG012686, R29AG012686] Funding Source: NIH RePORTER; NIA NIH HHS [AG12686, AG005134-19] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bush A I, 2001, Novartis Found Symp, V235, P26; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; CHYLACK LT, 1984, CIBA F SYMP, V106, P3; CHYLACK LT, 1984, INVEST OPHTH VIS SCI, V25, P166; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harding JJ, 1997, ALZ DIS ASSOC DIS, V11, P123, DOI 10.1097/00002093-199709000-00002; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; LOWE J, 1992, NEUROPATH APPL NEURO, V18, P341, DOI 10.1111/j.1365-2990.1992.tb00796.x; LOWE RF, 1949, BRIT J OPHTHALMOL, V33, P131, DOI 10.1136/bjo.33.3.131; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moir RD, 1998, J BIOL CHEM, V273, P5013, DOI 10.1074/jbc.273.9.5013; Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SPECTOR A, 1984, CIBA F SYMP, V106, P48; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; VAEZY S, 1991, J MICROSC-OXFORD, V163, P85, DOI 10.1111/j.1365-2818.1991.tb03162.x	30	278	374	1	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1258	1265		10.1016/S0140-6736(03)12981-9	http://dx.doi.org/10.1016/S0140-6736(03)12981-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699953				2022-12-01	WOS:000182161600010
J	Walsh, PD; Abernethy, KA; Bermejo, M; Beyersk, R; De Wachter, P; Akou, ME; Huljbregis, B; Mambounga, DI; Toham, AK; Kilbourn, AM; Lahm, SA; Latour, S; Maisels, F; Mbina, C; Mihindou, Y; Obiang, SN; Effa, EN; Starkey, MP; Telfer, P; Thibault, M; Tutin, CEG; White, LJT; Wilkie, DS				Walsh, PD; Abernethy, KA; Bermejo, M; Beyersk, R; De Wachter, P; Akou, ME; Huljbregis, B; Mambounga, DI; Toham, AK; Kilbourn, AM; Lahm, SA; Latour, S; Maisels, F; Mbina, C; Mihindou, Y; Obiang, SN; Effa, EN; Starkey, MP; Telfer, P; Thibault, M; Tutin, CEG; White, LJT; Wilkie, DS			Catastrophic ape decline in western equatorial Africa	NATURE			English	Article							GORILLA-GORILLA; CONSERVATION; FOREST	Because rapidly expanding human populations have devastated gorilla (Gorilla gorilla) and common chimpanzee (Pan troglodytes) habitats in East and West Africa, the relatively intact forests of western equatorial Africa have been viewed as the last stronghold of African apes(1). Gabon and the Republic of Congo alone are thought to hold roughly 80% of the world's gorillas(2) and most of the common chimpanzees(1). Here we present survey results conservatively indicating that ape populations in Gabon declined by more than half between 1983 and 2000. The primary cause of the decline in ape numbers during this period was commercial hunting, facilitated by the rapid expansion of mechanized logging. Furthermore, Ebola haemorrhagic fever is currently spreading through ape populations in Gabon and Congo and now rivals hunting as a threat to apes. Gorillas and common chimpanzees should be elevated immediately to 'critically endangered' status. Without aggressive investments in law enforcement, protected area management and Ebola prevention, the next decade will see our closest relatives pushed to the brink of extinction.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08540 USA; Ctr Int Rech Med Franceville, Franceville, Gabon; Univ Stirling, Dept Biol & Mol Sci, Stirling FK9 4LA, Scotland; Univ Barcelona, Fac Biol, Dept Biol Anim Vertebrados, E-08028 Barcelona, Spain; Wildlife Conservat Soc, Bronx, NY 10460 USA; WWF, Cent Africa Reg Program Off, Libreville, Gabon; Minist Econ Forestiere Eaux Peche Charge Environm, Direct Faune & Chasse, Libreville, Gabon; Inst Rech Ecol Trop, Libreville, Gabon; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; NYU, Dept Anthropol, New York, NY 10003 USA	Princeton University; University of Stirling; University of Barcelona; Wildlife Conservation Society; World Wildlife Fund; University of Edinburgh; University of Cambridge; New York University	Walsh, PD (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Guyot Hall, Princeton, NJ 08540 USA.	pwalsh@princeton.edu	Phillips, Paul/E-7813-2013; Maisels, Fiona/E-7382-2015	Phillips, Paul/0000-0002-8749-7026; Maisels, Fiona/0000-0002-0778-0615; Abernethy, Katharine/0000-0002-0393-9342				ANGOUE C, 2000, AVENIR PEUPLES FORET, V3; Bermejo M, 1999, ORYX, V33, P323, DOI 10.1017/S0030605300030726; BLOM A, 2001, J SUST TOURISM, V8, P175; Brugiere D, 2001, J ZOOL, V255, P251, DOI 10.1017/S0952836901001315; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; CHAMBERLIN C, 1978, INT J AFR HIST STUD, V11, P429, DOI 10.2307/217312; *DIR FAUN CHASS, 1999, RAPP ACT LUTT ANT LU; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Harcourt AH, 1996, BIOL CONSERV, V75, P165, DOI 10.1016/0006-3207(95)00059-3; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; HUIJBREGTS B, IN PRESS ORYX; Kingdon J., 2003, KINGDON FIELD GUIDE; Lahm SA, 1993, ECOLOGY EC HUMAN WIL; Oates J.F., 1996, AFRICAN PRIMATES STA; POURTIER R., 1989, GABON ETAT DEVELOPPE, V2; ROBERTS L, 1998, WORLD RESOURCES, P292; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; Walsh PD, 1999, CONSERV BIOL, V13, P1194, DOI 10.1046/j.1523-1739.1999.98148.x; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI [10.1046/j.1523-1739.2000.99102.x, 10.1111/j.1523-1739.2000.99102.x]; Wilkie DS, 1999, ORYX, V33, P339, DOI 10.1017/S003060530003074X	22	393	416	0	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2003	422	6932					611	614		10.1038/nature01566	http://dx.doi.org/10.1038/nature01566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12679788				2022-12-01	WOS:000182111400041
J	Juo, ZS; Kassavetis, GA; Wang, JM; Geiduschek, EP; Sigler, PB				Juo, ZS; Kassavetis, GA; Wang, JM; Geiduschek, EP; Sigler, PB			Crystal structure of a transcription factor IIIB core interface ternary complex	NATURE			English	Article							RNA-POLYMERASE-III; TATA-BINDING PROTEIN; FACTOR TFIIIB; YEAST TFIIIB; FACTOR BRF; DNA; BOX; REFINEMENT; MODEL; NOMENCLATURE	Transcription factor IIIB ( TFIIIB), consisting of the TATA-binding protein (TBP), TFIIB-related factor (Brf1) and Bdp1, is a central component in basal and regulated transcription by RNA polymerase III1-4. TFIIIB recruits its polymerase to the promoter and subsequently has an essential role in the formation of the open initiation complex. The amino-terminal half of Brf1 shares a high degree of sequence similarity with the polymerase II general transcription factor TFIIB, but it is the carboxy-terminal half of Brf1 that contributes most of its binding affinity with TBP5-8. The principal anchoring region is located between residues 435 and 545 of yeast Brf1, comprising its homology domain II. The same region also provides the primary interface for assembling Bdp1 into the TFIIIB complex(9). We report here a 2.95 Angstrom resolution crystal structure of the ternary complex containing Brf1 homology domain II, the conserved region of TBP and 19 base pairs of U6 promoter DNA. The structure reveals the core interface for assembly of TFIIIB and demonstrates how the loosely packed Brf1 domain achieves remarkable binding specificity with the convex and lateral surfaces of TBP.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	Yale University; University of California System; University of California San Diego	Juo, ZS (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	juo@csb.yale.edu						Andrau JC, 1999, J MOL BIOL, V288, P511, DOI 10.1006/jmbi.1999.2724; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; CHAUSSIVERT N, 1995, J BIOL CHEM, V270, P15353, DOI 10.1074/jbc.270.25.15353; Colbert T, 1998, MOL CELL BIOL, V18, P1682, DOI 10.1128/MCB.18.3.1682; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Huet J, 1997, J BIOL CHEM, V272, P18341, DOI 10.1074/jbc.272.29.18341; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kassavetis GA, 1998, MOL CELL BIOL, V18, P5587, DOI 10.1128/MCB.18.9.5587; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martel LS, 2002, MOL CELL BIOL, V22, P2788, DOI 10.1128/MCB.22.8.2788-2798.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rost B, 1996, METHOD ENZYMOL, V266, P525; Ruth J, 1996, EMBO J, V15, P1941, DOI 10.1002/j.1460-2075.1996.tb00545.x; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Shen YH, 1998, MOL CELL BIOL, V18, P1692, DOI 10.1128/MCB.18.3.1692; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; WANG ZX, 1995, P NATL ACAD SCI USA, V92, P7026, DOI 10.1073/pnas.92.15.7026; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; Willis IM, 2002, GENE DEV, V16, P1337, DOI 10.1101/gad.998102; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	29	71	72	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					534	539		10.1038/nature01534	http://dx.doi.org/10.1038/nature01534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12660736				2022-12-01	WOS:000181965400041
J	Ghosh, K; Shankarkumar, U; Shetty, S; Mohanty, D				Ghosh, K; Shankarkumar, U; Shetty, S; Mohanty, D			Chronic synovitis and HLA B27 in patients with severe haemophilia	LANCET			English	Article								Chronic synovitis affects about 10% of patients with severe haemophilia in India. This disease has some features in common with ankylosing spondylitis, which has been linked to HLA B27. We therefore aimed to test whether there is an association between HLA B27 and chronic synovitis. We studied 473 patients with severe haemophilia (33 of whom had chronic synovitis), and 1175 healthy controls using a standard serological technique and the reverse line strip assay. 64% (21 of 33) of patients with haemophilia and chronic synovitis were positive for HLA B27, compared with 5% (23 of 440) of those with severe haemophilia, but not chronic synovitis (odds ratio 31.6 [95% CI 9.28-39.38], p<0.0001), and 9% (100 of 1175) of healthy controls (18.81 [9.6-27.7], p<0.0001). We conclude that there is a strong association between HLA B27 and chronic synovitis in Indian patients with severe haemophilia and screening in this population could allow treatment and prevention of the complication.	Inst Immunohaematol, Bombay 400012, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Mohanty, D (corresponding author), Inst Immunohaematol, Floor 13,New Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India.		Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565				Ghosh K, 2001, HAEMOPHILIA, V7, P273, DOI 10.1046/j.1365-2516.2001.00505.x; MACK SJ, 2000, HLA 2000 IHWG TECHNI; Rodriguez-Merchan EC, 1998, HAEMOPHILIA, V4, P506, DOI 10.1046/j.1365-2516.1998.440506.x; SENGUPTA S, 1977, LANCET, V1, P1209; SHANKARKUMAR U, 2002, BRIT J BIOMED SCI, V59, P11	5	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					933	934		10.1016/S0140-6736(03)12763-8	http://dx.doi.org/10.1016/S0140-6736(03)12763-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648975				2022-12-01	WOS:000181741600014
J	Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T				Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T			Asymmetric inheritance of oxidatively damaged proteins during cytokinesis	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DAUGHTER CELLS; MOTHER; YEAST; RESPIRATION; LONGEVITY; MUTATION; SIR2	Carbonylated proteins were visualized in single cells of the budding yeast Saccharomyces cerevisiae, revealing that they accumulate with replicative age. Furthermore, carbonylated proteins were not inherited by daughter cells during cytokinesis. Mother cells of a yeast strain lacking the sir2 gene, a life-span determinant, failed to retain oxidatively damaged proteins during cytokinesis. These findings suggest that a genetically determined, Sir2p-dependent asymmetric inheritance of oxidatively damaged proteins may contribute to free-radical defense and the fitness of newborn cells.	Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden; Chalmers Univ Technol, Dept Mol Biotechnol, S-41296 Gothenburg, Sweden; Univ Victor Segalen, CNRS, Inst Biochim & Genet Cellulaires, Bordeaux, France	University of Gothenburg; Chalmers University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Nystrom, T (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden.							Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Barker MG, 1999, FEMS MICROBIOL LETT, V177, P199, DOI 10.1016/S0378-1097(99)00308-0; Bindokas VP, 1996, J NEUROSCI, V16, P1324; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lai CY, 2002, GENETICS, V162, P73; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1111/j.1365-2958.2001.02317.x; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Nestelbacher R, 2000, EXP GERONTOL, V35, P63, DOI 10.1016/S0531-5565(99)00087-X; Park PU, 2002, METHOD ENZYMOL, V351, P468; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616	15	489	504	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1751	1753		10.1126/science.1080418	http://dx.doi.org/10.1126/science.1080418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12610228				2022-12-01	WOS:000181519500051
J	Ose, T; Watanabe, K; Mie, T; Honma, M; Watanabe, H; Yao, M; Oikawa, H; Tanaka, I				Ose, T; Watanabe, K; Mie, T; Honma, M; Watanabe, H; Yao, M; Oikawa, H; Tanaka, I			Insight into a natural Diels-Alder reaction from the structure of macrophomate synthase	NATURE			English	Article							UNUSUAL MULTISTEP TRANSFORMATION; SHAPE COMPLEMENTARITY; ENZYMATIC-ACTIVITY; REACTION-MECHANISM; 2-PYRONES; CATALYSIS; BINDING	The Diels-Alder reaction, which forms a six-membered ring from an alkene (dienophile) and a 1,3-diene, is synthetically very useful for construction of cyclic products with high regio- and stereoselectivity under mild conditions(1). It has been applied to the synthesis of complex pharmaceutical and biologically active compounds(2). Although evidence(3-7) on natural Diels-Alderases has been accumulated in the biosynthesis of secondary metabolites(8), there has been no report on the structural details of the natural Diels-Alderases. The function and catalytic mechanism of the natural Diels-Alderase are of great interest owing to the diversity of molecular skeletons in natural Diels-Alder adducts(8). Here we present the 1.70 Angstrom resolution crystal structure of the natural Diels-Alderase, fungal macrophomate synthase (MPS)(3), in complex with pyruvate. The active site of the enzyme is large and hydrophobic, contributing amino acid residues that can hydrogen-bond to the substrate 2-pyrone. These data provide information on the catalytic mechanism of MPS, and suggest that the reaction proceeds via a large-scale structural reorganization of the product.	Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Oikawa, H (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan.	hoik@chem.agr.hokudai.ac.jp; tmaka@castor.sci.hokudai.ac.jp	Watanabe, Kenji/N-2012-2015; Oikawa, Hideaki/F-9128-2012; yao, min/F-5287-2011	Watanabe, Kenji/0000-0002-0463-4831; Oikawa, Hideaki/0000-0002-6947-3397; yao, min/0000-0003-1687-5904				AFARINKIA K, 1992, TETRAHEDRON, V48, P9111, DOI 10.1016/S0040-4020(01)85607-6; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLAKE JF, 1991, J AM CHEM SOC, V113, P7430, DOI 10.1021/ja00019a055; BRAISTED AC, 1990, J AM CHEM SOC, V112, P7430, DOI 10.1021/ja00176a073; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carruthers W., 1990, CYCLOADDITION REACTI; Chen JG, 2000, CHEMBIOCHEM, V1, P255, DOI 10.1002/1439-7633(20001117)1:4<255::AID-CBIC255>3.3.CO;2-J; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Desimoni G., 1983, NATURAL PRODUCTS SYN; GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138; Heine A, 1998, SCIENCE, V279, P1934, DOI 10.1126/science.279.5358.1934; HILVERT D, 1989, J AM CHEM SOC, V111, P9261, DOI 10.1021/ja00208a037; ICHIHARA A, 1987, TETRAHEDRON, V43, P5245, DOI 10.1016/S0040-4020(01)87700-0; ICHIHARA A, 1999, COMPREHENSIVE NATURA, V1, P367; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Katayama K, 1998, BBA-PROTEIN STRUCT M, V1384, P387, DOI 10.1016/S0167-4838(98)00040-5; Oikawa H, 1998, J ORG CHEM, V63, P8748, DOI 10.1021/jo980743r; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Oikawa H, 1999, TETRAHEDRON LETT, V40, P6983, DOI 10.1016/S0040-4039(99)01441-0; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SAKURAI I, 1988, CHEM PHARM BULL, V36, P2003; SAUER J, 1980, ANGEW CHEM INT EDIT, V19, P779, DOI 10.1002/anie.198007791; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; Watanabe K, 2000, J BIOCHEM-TOKYO, V127, P467, DOI 10.1093/oxfordjournals.jbchem.a022629; Watanabe K, 2000, BIOSCI BIOTECH BIOCH, V64, P530, DOI 10.1271/bbb.64.530; Watanabe K, 2000, TETRAHEDRON LETT, V41, P1443, DOI 10.1016/S0040-4039(99)02311-4; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; YLIKAUHALUOMA JT, 1995, J AM CHEM SOC, V117, P7041, DOI 10.1021/ja00132a001	29	159	161	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					185	189		10.1038/nature01454	http://dx.doi.org/10.1038/nature01454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634789				2022-12-01	WOS:000181488900050
J	Bentley, SD; Maiwald, M; Murphy, LD; Pallen, MJ; Yeats, CA; Dover, LG; Norbertczak, HT; Besra, GS; Quail, MA; Harris, DE; von Herbay, A; Goble, A; Rutter, S; Squares, R; Squares, S; Barrell, BG; Parkhill, J; Relman, DA				Bentley, SD; Maiwald, M; Murphy, LD; Pallen, MJ; Yeats, CA; Dover, LG; Norbertczak, HT; Besra, GS; Quail, MA; Harris, DE; von Herbay, A; Goble, A; Rutter, S; Squares, R; Squares, S; Barrell, BG; Parkhill, J; Relman, DA			Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei	LANCET			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACILLUS; ORIGIN; ADHERENCE; WHIPPELII; PROTEIN; DIVERSE	Background Whipple's disease is a rare multisystem chronic infection, involving the intestinal tract as well as various other organs. The causative agent, Tropheryma whipplei, is a Gram-positive bacterium about which little is known. Our aim was to investigate the biology of this organism by generating and analysing the complete DNA sequence of its genome. Methods We isolated and propagated T whipplei strain TWO8/27 from the cerebrospinal fluid of a patient diagnosed with Whipple's disease. We generated the complete sequence of the genome by the whole genome shotgun method, and analysed it with a combination of automatic and manual bioinformatic techniques. Findings Sequencing revealed a condensed 925 938 bp genome with a lack of key biosynthetic pathways and a reduced capacity for energy metabolism. A family of large surface proteins was identified, some associated with large amounts of non-coding repetitive DNA, and an unexpected degree of sequence variation. Interpretation The genome reduction and lack of metabolic capabilities point to a host-restricted lifestyle for the organism. The sequence variation indicates both known and novel mechanisms for the elaboration and variation of surface structures, and suggests that immune evasion and host interaction play an important part in the lifestyle of this persistent bacterial pathogen.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Birmingham, Birmingham, W Midlands, England; Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany	Wellcome Trust Sanger Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Birmingham; Ruprecht Karls University Heidelberg	Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	Parkhill@sanger.ac.uk	Dover, Lynn G/F-3021-2010; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Dover, Lynn George/Q-6778-2019; Pallen, Mark J./E-7619-2011	Dover, Lynn G/0000-0002-4776-2665; Parkhill, Julian/0000-0002-7069-5958; Dover, Lynn George/0000-0002-4776-2665; Pallen, Mark/0000-0003-1807-3657; Murphy, Lee/0000-0001-6467-7449; Besra, Gurdyal/0000-0002-5605-0395; Relman, David A./0000-0001-8331-1354; Maiwald, Matthias/0000-0001-5448-8417	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK56339] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bansal AK, 2002, J BACTERIOL, V184, P2260, DOI 10.1128/JB.184.8.2260-2272.2002; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Dobbins 3rd WO, 1987, WHIPPLES DIS; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fredricks DN, 2001, J INFECT DIS, V183, P1229, DOI 10.1086/319684; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Maiwald M, 1996, INT J SYST BACTERIOL, V46, P1078, DOI 10.1099/00207713-46-4-1078; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; MAIWALD M, 2002, SLEISENGER FORDTRANS, P1854; MARTH T, 1994, CLIN IMMUNOL IMMUNOP, V72, P217, DOI 10.1006/clin.1994.1134; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; SILVA MT, 1985, J GEN MICROBIOL, V131, P1001; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	30	174	392	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					637	644		10.1016/S0140-6736(03)12597-4	http://dx.doi.org/10.1016/S0140-6736(03)12597-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606174				2022-12-01	WOS:000181129500012
J	MacDonald, TM; Wei, L				MacDonald, TM; Wei, L			Effect of ibuprofen on cardioprotective effect of aspirin	LANCET			English	Article								Treatment with ibuprofen might limit the cardioprotective effects of aspirin. We aimed to assess whether patients with known cardiovascular disease who take low-dose aspirin and ibuprofen have increased risk of cardiovascular mortality. We studied 7107 patients who were discharged after first admission for cardiovascular disease between April, 1989, and April, 1997, and who were prescribed low-dose aspirin (<325 mg/day) and survived for at least I month. Compared with those who used aspirin alone, patients taking aspirin plus ibuprofen had an increased risk of all-cause mortality (adjusted hazard ratio 1.93, 95% CI 1.30-2.87, p=0.0011) and cardiovascular mortality (1.73, 1.05-2.84, p=0.0305). Our finding lends support to the hypothesis that ibuproen may interact with the cardioprotective effects of aspirin, at least in patients with established cardiovascular disease.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland	University of Dundee	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland.			MacDonald, Thomas/0000-0001-5189-6669				Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Evans JMM, 1999, BRIT J CLIN PHARMACO, V47, P105, DOI 10.1046/j.1365-2125.1999.00853.x; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1	4	321	334	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					573	574		10.1016/S0140-6736(03)12509-3	http://dx.doi.org/10.1016/S0140-6736(03)12509-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598144				2022-12-01	WOS:000181033400012
J	Check, E				Check, E			Cancer fears cast doubts on future of gene therapy	NATURE			English	News Item																		2003, NATURE, V421, P305	1	31	38	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					678	678		10.1038/421678b	http://dx.doi.org/10.1038/421678b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610583	Bronze			2022-12-01	WOS:000180938000005
J	Abbott, A; Oyranoski, D				Abbott, A; Oyranoski, D			Biologists seek to head off future sources of infection	NATURE			English	News Item																			0	7	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					3	3		10.1038/423003b	http://dx.doi.org/10.1038/423003b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721586	Green Published, Bronze			2022-12-01	WOS:000182561600004
J	Gayle, HD				Gayle, HD			Curbing the global AIDS epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSMISSION; HIV-1		Bill & Melinda Gates Fdn, Seattle, WA USA	Bill & Melinda Gates Foundation	Gayle, HD (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA USA.							Blower S, 2001, AIDS, V15, P1309, DOI 10.1097/00002030-200107060-00014; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; de Ven PV, 1999, AIDS, V13, P2289, DOI 10.1097/00002030-199911120-00011; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; Ford K, 1996, AIDS, V10, P213, DOI 10.1097/00002030-199602000-00013; *GLOB HIV PREV WOR, 2002, GLOB MOB HIV PREV BL; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; *NAT INT COUNC, 2002, NIC PUBL ICA; *PROGR COORD BOARD, 2002, REP PROGR COORD BOAR; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *UNAIDS, 2002, REP GLOB HIV AIDS EP; WHO, 2002, SCAL ANT THER RES LI	15	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1802	1805		10.1056/NEJMsb030352	http://dx.doi.org/10.1056/NEJMsb030352			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724488				2022-12-01	WOS:000182543500011
J	Grossman, SR; Deato, ME; Brignone, C; Chan, HM; Kung, AL; Tagami, H; Nakatani, Y; Livingston, DM				Grossman, SR; Deato, ME; Brignone, C; Chan, HM; Kung, AL; Tagami, H; Nakatani, Y; Livingston, DM			Polyubiquitination of p53 by a ubiquitin ligase activity of p300	SCIENCE			English	Article							PROTEASOME-MEDIATED DEGRADATION; PROTEIN; BINDING; MDM2; COMPLEXES; PROMOTES	Rapid turnover of the tumor suppressor protein p53 requires the MDM2 ubiquitin ligase, and both interact with p300-CREB-binding protein transcriptional coactivator proteins. p53 is stabilized by the binding of p300 to the oncoprotein E1A, suggesting that p300 regulates p53 degradation. Purified p300 exhibited intrinsic ubiquitin ligase activity that was inhibited by E1A. In vitro, p300 with MDM2 catalyzed p53 polyubiquitination, whereas MDM2 catalyzed p53 monoubiquitination. E1A expression caused a decrease in polyubiquitinated but not monoubiquitinated p53 in cells. Thus, generation of the polyubiquitinated forms of p53 that are targeted for proteasome degradation requires the intrinsic ubiquitin ligase activities of MDM2 and p300.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Livingston, DM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.		Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X	NATIONAL CANCER INSTITUTE [R37CA015751, R01CA015751] Funding Source: NIH RePORTER; NCI NIH HHS [CA15751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chiou SK, 1997, J VIROL, V71, P3515, DOI 10.1128/JVI.71.5.3515-3525.1997; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Maki CG, 1996, CANCER RES, V56, P2649; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Prives C, 1999, J PATHOL, V187, P112; Querido E, 1997, J VIROL, V71, P3526, DOI 10.1128/JVI.71.5.3526-3533.1997; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Zhu QZ, 2001, CANCER RES, V61, P64; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	20	372	385	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					342	344		10.1126/science.1080386	http://dx.doi.org/10.1126/science.1080386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690203				2022-12-01	WOS:000182135400061
J	Brennecke, J; Hipfner, DR; Stark, A; Russell, RB; Cohen, SM				Brennecke, J; Hipfner, DR; Stark, A; Russell, RB; Cohen, SM			bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila	CELL			English	Article							SMALL RNAS; WINGLESS; GROWTH; EXPRESSION; SURVIVAL; ELEGANS; MYC; IDENTIFICATION; INITIATION; APOPTOSIS	Cell proliferation, cell death, and pattern formation are coordinated in animal development. Although many proteins that control cell proliferation and apoptosis have been identified, the means by which these effectors are linked to the patterning machinery remain poorly understood. Here, we report that the bantam gene of Drosophila encodes a 21 nucleotide microRNA that promotes tissue growth. bantam expression is temporally and spatially regulated in response to patterning cues. bantam microRNA simultaneously stimulates cell proliferation and prevents apoptosis. We identify the pro-apoptotic gene hid as a target for regulation by bantam miRNA, providing an explanation for bantam's anti-apoptotic activity.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl.de	Russell, Robert/GWU-6389-2022; Cohen, Stephen M/G-9930-2011; Brennecke, Julius/T-5883-2019; Brennecke, Julius/C-1626-2015; Stark, Alexander/D-1473-2012; Russell, Rob/AAH-9145-2019	Russell, Robert/0000-0002-7213-1398; Cohen, Stephen M/0000-0003-2858-9163; Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; Russell, Rob/0000-0002-1905-4717				Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baonza A, 2000, P NATL ACAD SCI USA, V97, P2609, DOI 10.1073/pnas.040576497; Baulcombe D, 2002, SCIENCE, V297, P2002, DOI 10.1126/science.1077906; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CM, 1999, DEVELOPMENT, V126, P5441; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; DURMANSCHEEL M, 2002, NATURE, V417, P299; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EVAN G, 1994, PHILOS T R SOC B, V345, P269, DOI 10.1098/rstb.1994.0105; Go MJ, 1998, DEVELOPMENT, V125, P2031; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hipfner DR, 2002, GENETICS, V161, P1527; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinscheid RK, 2000, PEPTIDES, V21, P901, DOI 10.1016/S0196-9781(00)00226-6; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yu SY, 2002, DEVELOPMENT, V129, P3269; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang J, 1998, DEVELOPMENT, V125, P3075	66	1611	1810	2	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					25	36		10.1016/S0092-8674(03)00231-9	http://dx.doi.org/10.1016/S0092-8674(03)00231-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679032	Bronze			2022-12-01	WOS:000182282900004
J	Wilf, P; Cuneo, NR; Johnson, KR; Hicks, JF; Wing, SL; Obradovich, JD				Wilf, P; Cuneo, NR; Johnson, KR; Hicks, JF; Wing, SL; Obradovich, JD			High plant diversity in Eocene South America: Evidence from Patagonia	SCIENCE			English	Article							RAIN-FOREST; CLIMATE; VEGETATION; HISTORY; HYPOTHESIS; SPECIATION; EVOLUTION; TAPHONOMY; AMAZONIA; TERTIARY	Tropical South America has the highest plant diversity of any region today, but this richness is usually characterized as a geologically recent development (Neogene or Pleistocene). From caldera-lake beds exposed at Laguna del Hunco in Patagonia, Argentina, paleolatitude similar to47degreesS, we report 102 leaf species. Radioisotopic and paleomagnetic analyses indicate that the. ora was deposited 52 million years ago, the time of the early Eocene climatic optimum, when tropical plant taxa and warm, equable climates reached middle latitudes of both hemispheres. Adjusted for sample size, observed richness exceeds that of any other Eocene leaf. ora, supporting an ancient history of high plant diversity in warm areas of South America.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; Museo Paleontol Egidio Feruglio, RA-9100 Trelew, Chubut, Argentina; Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA; Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; US Geol Survey, Lakewood, CO 80225 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; University of Pennsylvania; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey	Wilf, P (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	pwilf@geosc.psu.edu		Wilf, Peter/0000-0001-6813-1937; Wing, Scott/0000-0002-2954-8905				[Anonymous], 1994, PALAEOCLIMATES; [Anonymous], 1925, J HOPKINS U STUD GEO; [Anonymous], 1978, COURIER FORSCHUNGSIN; ARAGON E., 1997, REV ASOC GEOL ARGENT, V52, P243; ARAUJO D.S.D., 1997, CENTRES PLANT DIVERS, V3, P373; ARCHANGELSKY S, 1974, AMEGHINIANA, V11, P413; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Berry E.W., 1938, GEOLOGICAL SOC AM SP, V12, P149, DOI DOI 10.1130/SPE12-P1; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; BURNHAM RJ, 1994, US GEOLOGICAL SURVEY, V2085, P1; Burry EW, 1925, P NATL ACAD SCI USA, V11, P404, DOI 10.1073/pnas.11.7.404; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; CHRISTOPHEL DC, 1980, AUST J BOT, V28, P249, DOI 10.1071/BT9800249; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Colinvaux PA, 2001, AMAZONIANA, V16, P609; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Davies-Vollum KS, 1998, PALAIOS, V13, P28, DOI 10.2307/3515279; DUTTONG AL, 2002, PALEOCEANOGRAPHY, V17, DOI DOI 10.1029/2000PA000503; Evanoff E., 2001, P DENVER MUSEUM NA 4, V1, P1; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; GREENWOOD DR, IN PRESS GEOL SOC, V369; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; Hay WW, 1999, GEOL S AM S, P1; Herendeen PS, 2000, AM J BOT, V87, P1358, DOI 10.2307/2656727; Hill RS, 1999, AUST J BOT, V47, P639, DOI 10.1071/BT98093; HILL RS, 1994, HIST AUSTR VEGETATIO, P390; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V109, P1, DOI 10.1016/0031-0182(94)90117-1; Jaramillo CA, 2002, PALEOBIOLOGY, V28, P222, DOI 10.1666/0094-8373(2002)028<0222:ROTVTP>2.0.CO;2; Johnson KR, 2002, SCIENCE, V296, P2379, DOI 10.1126/science.1072102; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; MacGINITIE HARRY D., 1953, CARNEGIE INST WASHINGTON PUBL, V599, P1; MacGinitie HD., 1941, CARNEGIE I WASHINGTO, V534, P1; Manchester SR., 2001, PROC DENVER MUS NAT, V4, P137; Marshall L.G., 1990, Revista Geologica de Chile, V17, P57; Mazzoni M. M., 1991, REV ASOC GEOL ARGENT, V46, P150; Melchor RN, 2002, PALAIOS, V17, P16, DOI 10.1669/0883-1351(2002)017<0016:ISAPOE>2.0.CO;2; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; PASSMORE SM, 2002, GEOLOGICAL SOC AM AB, V34, P556; Petersen C.S., 1946, B DIRECCION GEN MINA, V59, P1; RAMOS VA, 2000, TECTONIC EVOLUTION S, P561; Remy R.R., 1992, US GEOL SURV B, VB1787BB, P1; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROMERO EJ, 1986, ANN MO BOT GARD, V73, P449, DOI 10.2307/2399123; ROMERO EJ, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P62; ROMERO EJ, 1976, B TORREY BOT CLUB, V103, P126, DOI 10.2307/2484888; Rull V, 1999, REV PALAEOBOT PALYNO, V107, P83, DOI 10.1016/S0034-6667(99)00014-7; SPICER RA, 1987, PALEOBIOLOGY, V13, P227; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; Villagran C, 1997, REV CHIL HIST NAT, V70, P241; Wilde V, 1998, REV PALAEOBOT PALYNO, V101, P7, DOI 10.1016/S0034-6667(97)00067-5; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; Wilf P, 2001, P NATL ACAD SCI USA, V98, P6221, DOI 10.1073/pnas.111069498; WING SL, 1993, PHILOS T ROY SOC B, V341, P243, DOI 10.1098/rstb.1993.0109; WING SL, 2000, WARM CLIMATES EARTH, P197; Wolfe J.A., 1987, US GEOL SURV B, V1597, P1; Wolfe JA, 1998, GEOL SOC AM BULL, V110, P664, DOI 10.1130/0016-7606(1998)110<0664:PEOEAO>2.3.CO;2; WOLFE JA, 1989, PALEOBIOLOGY, V15, P180, DOI 10.1017/S0094837300009350; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	68	215	229	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					122	125		10.1126/science.1080475	http://dx.doi.org/10.1126/science.1080475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677065				2022-12-01	WOS:000181988900046
J	Zicha, D; Dobbie, IM; Holt, MR; Monypenny, J; Soong, DYH; Gray, C; Dunn, GA				Zicha, D; Dobbie, IM; Holt, MR; Monypenny, J; Soong, DYH; Gray, C; Dunn, GA			Rapid actin transport during cell protrusion	SCIENCE			English	Article							FILAMENT TURNOVER; DIFFUSION; DYNAMICS	Transformed rat fibroblasts expressing two variants of green fluorescent protein, each fused to beta-actin, were used to study actin dynamics during cell protrusion. The recently developed FLAP (fluorescence localization after photobleaching) method permits the tracking of one fluorophore after localized photobleaching by using the other as a colocalized reference. Here, by visualizing the ratio of bleached to total molecules, we found that actin was delivered to protruding zones of the leading edge of the cell at speeds that exceeded 5 micrometers per second. Monte Carlo modeling confirmed that this flow cannot be explained by diffusion and may involve active transport.	Kings Coll London, Randall Ctr, London SE1 1UL, England; Canc Res UK, Light Microscopy, Lincolns Inn Fields Labs, London WC2A 3PX, England; Natl Univ Ireland, Dept Biochem, Genome Stabil Lab, Galway, Ireland	University of London; King's College London; Cancer Research UK; Ollscoil na Gaillimhe-University of Galway	Dunn, GA (corresponding author), Kings Coll London, Randall Ctr, New Hunts House,Guys Campus, London SE1 1UL, England.	graham.a.dunn@kcl.ac.uk	Zicha, Daniel/H-9310-2016	Dobbie, Ian/0000-0002-5531-5865; Zicha, Daniel/0000-0002-8808-8064; Holt, Mark/0000-0001-7775-8539	MRC [G0100152] Funding Source: UKRI; Medical Research Council [G0100152(56891), G0100152] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dunn GA, 2002, J MICROSC-OXFORD, V205, P109, DOI 10.1046/j.0022-2720.2001.001007.x; DUNN GA, 1995, J CELL SCI, V108, P1239; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	9	134	139	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2003	300	5616					142	145		10.1126/science.1082026	http://dx.doi.org/10.1126/science.1082026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677069				2022-12-01	WOS:000181988900052
J	Rogers, RR; Krause, DW; Rogers, KC				Rogers, RR; Krause, DW; Rogers, KC			Cannibalism in the Madagascan dinosaur Majungatholus atopus	NATURE			English	Article							DYNAMICS	Many lines of evidence have been brought to bear on the question of theropod feeding ecology, including functional and physiological considerations, morphological constraints, taphonomic associations, and telling - although rare - indications of direct ingestion(1-7). Tooth marks of theropods, although rarely described and generally left unassigned to a particular taxon, can provide unique clues into predator - prey interaction(8), and can also yield insights into the extent of carcass utilization(9,10). Here we describe a sample of tooth-marked dinosaur bone recovered from three well-documented localities in the Upper Cretaceous Maevarano Formation of Madagascar that provides insights into the feeding ecology of the abelisaurid theropod Majungatholus atopus(11). Intensely tooth-marked elements from multiple individuals show that Majungatholus defleshed dinosaur carcasses. Furthermore, Majungatholus clearly fed upon the remains of not only sauropods, but also conspecifics, and thus was a cannibal. Cannibalism is a common ecological strategy among extant carnivores, but until now the evidence in relation to carnivorous dinosaurs has been sparse and anecdotal.	Macalester Coll, Dept Geol, St Paul, MN 55105 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Sci Museum Minnesota, Dept Paleontol, St Paul, MN 55102 USA	Macalester College; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Rogers, RR (corresponding author), Macalester Coll, Dept Geol, 1600 Grand Ave, St Paul, MN 55105 USA.	rogers@macalester.edu						AUFFENBERG W, 1981, BEHAV ECOLOGY KOMODO, V406; BERTRAM BCR, 1975, J ZOOL, V177, P463; Buckley GA, 1999, SPEC PAP PALAEONTOL, P149; Buffetaut E., 1979, Bulletin de la Societe Geologique de France, V21, P183; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COLBERT EH, 1995, LITTLE DINOSAURS GHO, V250; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Gay Robert J., 2002, Journal of Vertebrate Paleontology, V22, p57A; Hunt Adrian P., 1994, Gaia, V10, P225; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Krause D.W., 1999, GSA TODAY, V9, P1; Maxwell WD, 1995, J VERTEBR PALEONTOL, V15, P707, DOI 10.1080/02724634.1995.10011256; POLIS GA, 1984, MAMMAL REV, V14, P187, DOI 10.1111/j.1365-2907.1984.tb00345.x; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Varricchio DJ, 2001, J PALEONTOL, V75, P401, DOI 10.1666/0022-3360(2001)075<0401:GCFACT>2.0.CO;2	26	74	77	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					515	518		10.1038/nature01532	http://dx.doi.org/10.1038/nature01532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673249				2022-12-01	WOS:000181965400036
J	Ferguson, NM; Galvani, AP; Bush, RM				Ferguson, NM; Galvani, AP; Bush, RM			Ecological and immunological determinants of influenza evolution	NATURE			English	Article							A VIRUSES; CELLULAR-IMMUNITY; HEMAGGLUTININ; INFECTION; VACCINE; FLU	In pandemic and epidemic forms, influenza causes substantial, sometimes catastrophic, morbidity and mortality. Intense selection from the host immune system drives antigenic change in influenza A and B, resulting in continuous replacement of circulating strains with new variants able to re-infect hosts immune to earlier types. This 'antigenic drift'(1) often requires a new vaccine to be formulated before each annual epidemic. However, given the high transmissibility and mutation rate of influenza, the constancy of genetic diversity within lineages over time is paradoxical. Another enigma is the replacement of existing strains during a global pandemic caused by 'antigenic shift'-the introduction of a new avian influenza A subtype into the human population(1). Here we explore ecological and immunological factors underlying these patterns using a mathematical model capturing both realistic epidemiological dynamics and viral evolution at the sequence level. By matching model output to phylogenetic patterns seen in sequence data collected through global surveillance(2), we find that short-lived strain-transcending immunity is essential to restrict viral diversity in the host population and thus to explain key aspects of drift and shift dynamics.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	Imperial College London; University of California System; University of California Berkeley; University of California System; University of California Irvine	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093				Benenson A.S., 1975, CONTROL COMMUNICABLE; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; *CDCP, 1986, MORB MORT WEEKL REP; COX N, 1993, OPTIONS CONTROL INFL, V2, P223; COX NJ, 1996, OPTIONS CONTROL INFL, V3, P591; DALY JM, 1998, TXB INFLUENZA, P168; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; FRANK AL, 1987, AM J EPIDEMIOL, V125, P576, DOI 10.1093/oxfordjournals.aje.a114571; FRANK AL, 1983, J MED VIROL, V12, P17, DOI 10.1002/jmv.1890120103; GILL PW, 1977, MED J AUSTRALIA, V2, P761, DOI 10.5694/j.1326-5377.1977.tb99276.x; GLEZEN WP, 1997, VIRAL INFECT HUMANS, P473; HOSKINS TW, 1979, LANCET, V1, P33; Layne SP, 2001, SCIENCE, V293, P1729, DOI 10.1126/science.293.5536.1729; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; MCELHANEY JE, 1995, VACCINE, V13, P6, DOI 10.1016/0264-410X(95)80003-V; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Nicholson KG, 1998, TXB INFLUENZA, P219; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Skoner DP, 1996, CLIN IMMUNOL IMMUNOP, V79, P294, DOI 10.1006/clin.1996.0082; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; YETTER RA, 1980, INFECT IMMUN, V29, P654; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	29	489	524	4	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					428	433		10.1038/nature01509	http://dx.doi.org/10.1038/nature01509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660783				2022-12-01	WOS:000181801200044
J	Martin, M; Turco, JH; Zegans, ME; Facklam, RR; Sodha, S; Elliott, JA; Pryor, JH; Beall, B; Erdman, DD; Baumgartner, YY; Sanchez, PA; Schwartzman, JD; Montero, J; Schuchat, A; Whitney, CG				Martin, M; Turco, JH; Zegans, ME; Facklam, RR; Sodha, S; Elliott, JA; Pryor, JH; Beall, B; Erdman, DD; Baumgartner, YY; Sanchez, PA; Schwartzman, JD; Montero, J; Schuchat, A; Whitney, CG			An outbreak of conjunctivitis due to atypical streptococcus pneumoniae	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIC KERATOCONJUNCTIVITIS; CARE; IDENTIFICATION; INFECTION; SEQUENCE	Background: In February 2002, clinicians at the Dartmouth College Health Service recognized an outbreak of conjunctivitis; cultures of conjunctival swabs implicated Streptococcus pneumoniae. An investigation was begun to determine the extent of the outbreak, confirm the cause, identify modes of transmission, and implement control measures. Methods: Investigators reviewed the health service's data base for diagnoses of conjunctivitis. Viral and bacterial cultures were obtained from ill students. Bile-soluble isolates that were susceptible to ethylhydrocupreine (optochin) and therefore were presumed to be pneumococci underwent serotyping, capsular staining, pulsed-field gel electrophoresis, a DNA probe, and multilocus sequence typing. A cohort study of risk factors was conducted with the use of the Internet. Control measures included distribution of alcohol-based hand gel and messages about prevention. Results: Among 5060 students, 698 (13.8 percent) received a diagnosis of conjunctivitis from January 1, 2002, through April 12, 2002, including 22 percent of first-year students. Presumed pneumococci were isolated from 43.3 percent of conjunctival swabs (110 of 254); viral cultures performed on 85 specimens were negative. DNA probes and multilocus sequence typing confirmed that the organisms were pneumococci, although the bacteria did not have the characteristic capsule. On pulsed-field gel electrophoresis, strains were found to be identical to pneumococci that caused outbreaks of conjunctivitis in other parts of the country in 1980. Analysis of survey data from 1832 students indicated that close contact with a student with conjunctivitis, wearing contact lenses, membership on a sports team, and attending parties at or living in a fraternity or sorority house were associated with conjunctivitis. The rate of diagnosis of conjunctivitis declined after the implementation of control measures and after spring break. Conclusions: This large outbreak of conjunctivitis on a college campus was caused by an atypical, unencapsulated strain of S. pneumoniae that was identical to strains that had caused outbreaks two decades earlier.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Dartmouth Coll, Hlth Serv, Hanover, NH 03755 USA; Dartmouth Hitchcock Med Ctr, Hanover, NH USA; Dartmouth Coll Sch Med, Hanover, NH 03756 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; New Hampshire Dept Hlth & Human Serv, Off Community & Publ Hlth, Concord, NH 03301 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Dartmouth College; Dartmouth College; Dartmouth College; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Whitney, CG (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,MS C23, Atlanta, GA 30333 USA.	cwhitney@cdc.gov			NATIONAL EYE INSTITUTE [K08EY013977] Funding Source: NIH RePORTER; NEI NIH HHS [1 K08 EY13977-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AUSTRIAN R, 1994, HARRISONS PRINCIPLES, V1, P607; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; BUEHLER JW, 1983, SOUTHERN MED J, V76, P587, DOI 10.1097/00007611-198305000-00014; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P553; Chapin Kimberle, 1995, P33; Elliott JA, 1998, J CLIN MICROBIOL, V36, P2115, DOI 10.1128/JCM.36.7.2115-2116.1998; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Ertugrul N, 1997, J INFECT DIS, V176, P1401, DOI 10.1086/517331; Geslin P, 1997, ADV EXP MED BIOL, V418, P383; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; *IMP COLL, 2003, MULT LOC SEQ TYP HOM; JERNIGAN JA, 1993, J INFECT DIS, V167, P1307, DOI 10.1093/infdis/167.6.1307; Leibowitz HM, 2000, NEW ENGL J MED, V343, P345, DOI 10.1056/NEJM200008033430507; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; MCMINN PC, 1991, J INFECT DIS, V164, P1113, DOI 10.1093/infdis/164.6.1113; National Committee for Clinical Laboratory Standards NCCLS, 2000, M7A5 NCCLS; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; OBRIEN TP, 2000, MANDELL DOUGLAS BENN, V1, P1251; PAPARELLO SF, 1991, MIL MED, V156, P256, DOI 10.1093/milmed/156.5.256; Parienti JJ, 2002, JAMA-J AM MED ASSOC, V288, P722, DOI 10.1001/jama.288.6.722; Parienti JJ, 2002, JAMA-J AM MED ASSOC, V288, P2688, DOI 10.1001/jama.288.21.2688-JLT1204-5-2; Pryor JH, 2002, J AM COLL HEALTH, V50, P267, DOI 10.1080/07448480209603444; Sampson JS, 1997, INFECT IMMUN, V65, P1967, DOI 10.1128/IAI.65.5.1967-1971.1997; Schinsky MF, 2000, INT J SYST EVOL MICR, V50, P575, DOI 10.1099/00207713-50-2-575; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHWARTZ B, 1989, American Journal of Ophthalmology, V107, P341; SEAL DV, 1982, BRIT J OPHTHALMOL, V66, P357, DOI 10.1136/bjo.66.6.357; SHAYEGANI M, 1982, J CLIN MICROBIOL, V16, P8, DOI 10.1128/JCM.16.1.8-14.1982; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TROTTIER S, 1991, PEDIATR INFECT DIS J, V10, P578, DOI 10.1097/00006454-199108000-00006; 2002, MMWR MORB MORTAL WKL, V51, P205; 1990, MMWR MORB MORTAL WKL, V39, P598; 2000, 50 MOST WIRED U	37	105	107	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1112	1121		10.1056/NEJMoa022521	http://dx.doi.org/10.1056/NEJMoa022521			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646668	Bronze			2022-12-01	WOS:000181628400007
J	Mukamal, KJ; Kuller, LH; Fitzpatrick, AL; Longstreth, WT; Mittleman, MA; Siscovick, DS				Mukamal, KJ; Kuller, LH; Fitzpatrick, AL; Longstreth, WT; Mittleman, MA; Siscovick, DS			Prospective-study of alcohol consumption and risk of dementia in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; TOBACCO CONSUMPTION; VASCULAR DEMENTIA; SMOKING; DRINKING; PERFORMANCE; IMPAIRMENT; BRAIN; QUESTIONNAIRE	Context Alcohol consumption has been associated with complex changes in cerebral vasculature and structure in older adults. How alcohol consumption affects the incidence of dementia is less clear. Objective To determine the prospective relationship of alcohol consumption and risk of dementia among older adults. Design, Setting, and Participants Nested case-control study of 373 cases with incident dementia and 373 controls who were among 5888 adults aged 65 years and older who participated in the Cardiovascular Health Study, a prospective, population-based cohort study in 4 US communities. The controls were frequency-matched on age, death before 1999, and their attendance of a 1998-1999 clinic. Participants in this study underwent magnetic resonance imaging (MRI) of the brain and cognitive testing between 1992 and 1994 and were followed up until 1999. Main Outcome Measures Odds of incident dementia, ascertained by detailed neurological and neuropsychological examinations according to average alcohol consumption, assessed by self-reported intake of beer, wine, and liquor at 2 visits prior to the date of the MRI. Result's Compared with abstention, the adjusted odds for dementia among those whose weekly alcohol consumption was less than 1 drink were 0.65 (95% confidence interval [CI], 0.41-1.02); 1 to 6 drinks, 0.46 (95% CI, 0.27-0.77); 7 to 13 drinks, 0.69 (95% CI, 0.37-1.31); and 14 or more drinks, 1.22 (95% CI, 0.60-2.49; P for quadratic term=.001). A trend toward greater odds of dementia associated with heavier alcohol consumption was most apparent among men and participants with an apolipoprotein E epsilon4 allele. We found generally similar relationships of alcohol use with Alzheimer disease and vascular dementia. Conclusions Compared with abstention, consumption of 1 to 6 drinks weekly is associated with a lower risk of incident dementia among older adults.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,RO-114, Boston, MA 02215 USA.	kmukamal@caregroup.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Mittleman, Murray/0000-0001-9788-7274	NHLBI NIH HHS [N01HC85082, N01HC85084, N01HC15103, N01HC85083, N01HC85081, N01HC85085, N01HC85086, N01HC85079, N01HC85080] Funding Source: Medline; NIAAA NIH HHS [K23AA00299] Funding Source: Medline; NIA NIH HHS [R01AG015928] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC085083, N01HC085084, N01HC015103, N01HC085079, N01HC085082, N01HC085086, N01HC085081, N01HC085085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA000299] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adams WL, 1996, J AM GERIATR SOC, V44, P1082, DOI 10.1111/j.1532-5415.1996.tb02943.x; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P305, DOI 10.1016/0376-8716(85)90008-0; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Bryan RN, 1997, RADIOLOGY, V202, P47, DOI 10.1148/radiology.202.1.8988191; Cervilla JA, 2000, J NEUROL NEUROSUR PS, V68, P622, DOI 10.1136/jnnp.68.5.622; Cervilla JA, 2000, BRIT J PSYCHIAT, V177, P66, DOI 10.1192/bjp.177.1.66; CHRISTIAN JC, 1995, J STUD ALCOHOL, V56, P414, DOI 10.15288/jsa.1995.56.414; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; Edelstein SL, 1998, J WOMENS HEALTH, V7, P1271, DOI 10.1089/jwh.1998.7.1271; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Elwood PC, 1999, J EPIDEMIOL COMMUN H, V53, P9, DOI 10.1136/jech.53.1.9; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fitzpatrick AL, 2002, AM J EPIDEMIOL, V155, ps53; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goodwin N, 2001, J SOUTHWEST, V43, P1; GRAVES AB, 1991, INT J EPIDEMIOL, V20, pS48, DOI 10.1093/ije/20.Supplement_2.S48; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; HEBERT LE, 1993, AM J EPIDEMIOL, V137, P881, DOI 10.1093/oxfordjournals.aje.a116749; Hendrie HC, 1996, J AM GERIATR SOC, V44, P1158, DOI 10.1111/j.1532-5415.1996.tb01364.x; HERZOG AR, 1998, NIH PUBLICATION; Jagust W, 2001, LANCET, V358, P2097, DOI 10.1016/S0140-6736(01)07230-0; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Leibovici D, 1999, INT J EPIDEMIOL, V28, P77, DOI 10.1093/ije/28.1.77; Leon J, 1998, HEALTH AFFAIR, V17, P206, DOI 10.1377/hlthaff.17.6.206; LOOMIS TA, 1958, Q J STUD ALCOHOL, V19, P30; Lopez OL, 2003, NEUROEPIDEMIOLOGY, V22, P1, DOI 10.1159/000067110; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; McDowell I, 2000, NEUROLOGY, V55, P66; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; NIXON SJ, 1998, NIH PUBLICATION; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P94; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; SCHERR PA, 1992, J AM GERIATR SOC, V40, P651, DOI 10.1111/j.1532-5415.1992.tb01954.x; Stampfer MJ, 2001, AM J EPIDEMIOL, V153, pS28; Sturmer T, 2001, EPIDEMIOLOGY, V12, P101; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Wechsler D, 1981, ADULT INTELLIGENCE S; Yue NC, 1997, RADIOLOGY, V202, P33, DOI 10.1148/radiology.202.1.8988189	57	308	320	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1405	1413		10.1001/jama.289.11.1405	http://dx.doi.org/10.1001/jama.289.11.1405			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	656PM	12636463	Bronze			2022-12-01	WOS:000181616200032
J	Wald, NJ; Huttly, WJ; Hackshaw, AK				Wald, NJ; Huttly, WJ; Hackshaw, AK			Antenatal screening for Down's syndrome with the quadruple test	LANCET			English	Article								Second trimester screening for Down's syndrome is widely practised throughout the world. We assessed the performance of antenatal serum screening for Down's syndrome with the quadruple test In 46 193 pregnancies from 14 hospitals over 5 years. Women who screened positive (risk greater than or equal to1 in 300) were offered diagnostic amniocentesis or chorionic villus sampling. Of 88 observed Down's syndrome pregnancies, 71 (81%) had a positive screening result (81% detection rate, 95% CI 72-89), and of 46 105 unaffected pregnancies, 3200 tested positive (7% false-positive rate). These results show that the quadruple test is a better method of screening for Down's syndrome than use of maternal age alone (51% detection rate, 14% false-positive rate) and is more effective than other second trimester screening tests. Therefore, we conclude that the quadruple test should be the test of choice in second trimester screening for Down's syndrome.	Barts & London Queen Mary Sch Med & Dent, Wolfson Inst Prevent Med, Dept Environm & Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Barts & London Queen Mary Sch Med & Dent, Wolfson Inst Prevent Med, Dept Environm & Prevent Med, London EC1M 6BQ, England.		Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021					Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Wald N J, 1997, J Med Screen, V4, P181; Wald NJ, 1996, PRENATAL DIAG, V16, P143, DOI 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F; Wald NJ, 1997, PRENATAL DIAG, V17, P285, DOI 10.1002/(SICI)1097-0223(199703)17:3<285::AID-PD71>3.0.CO;2-A; Wellesley D, 2002, BRIT MED J, V325, P15, DOI 10.1136/bmj.325.7354.15	5	91	99	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					835	836		10.1016/S0140-6736(03)12680-3	http://dx.doi.org/10.1016/S0140-6736(03)12680-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642052				2022-12-01	WOS:000181466600014
J	Lee, HK; Takamiya, K; Han, JS; Man, HY; Kim, CH; Rumbaugh, G; Yu, S; Ding, L; He, C; Petralia, RS; Wenthold, RJ; Gallagher, M; Huganir, RL				Lee, HK; Takamiya, K; Han, JS; Man, HY; Kim, CH; Rumbaugh, G; Yu, S; Ding, L; He, C; Petralia, RS; Wenthold, RJ; Gallagher, M; Huganir, RL			Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory	CELL			English	Article							GLUTAMATE RECEPTORS; REGULATORY PHOSPHORYLATION; SITES; POTENTIATION; SYNAPSES; REDISTRIBUTION; IDENTIFICATION; TRANSMISSION; TRAFFICKING; CONDUCTANCE	Plasticity of the nervous system is dependent on mechanisms that regulate the strength of synaptic transmission. Excitatory synapses in the brain undergo long-term potentiation (LTP) and long-term depression (LTD), cellular models of learning and memory. Protein phosphorylation is required for the induction of many forms of synaptic plasticity, including LTP and LTD. However, the critical kinase substrates that mediate plasticity have not been identified. We previously reported that phosphorylation of the GluR1 subunit of AMPA receptors, which mediate rapid excitatory transmission in the brain, is modulated during LTP and LTD. To test if GluR1 phosphorylation is necessary for plasticity and learning and memory, we generated mice with knockin mutations in the GluR1 phosphorylation sites. The phosphomutant mice show deficits in LTD and LTP and have memory defects in spatial learning tasks. These results demonstrate that phosphorylation of GluR1 is critical for LTD and LTP expression and the retention of memories.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; NIDCD, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Takamiya, Kogo/0000-0001-7240-6307; Lee, Hey-Kyoung/0000-0002-5554-983X; Han, Jung-Soo/0000-0001-8447-4518; Man, Hengye/0000-0002-3530-3066	NIMH NIH HHS [R01 MH61108-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carvalho AL, 1999, J NEUROSCI, V19, P4748; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; McDonald BJ, 2001, NEUROPHARMACOLOGY, V41, P672, DOI 10.1016/S0028-3908(01)00129-0; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; PERTRALLA RS, 1999, METHODS MOL BIOL NMD, P73; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	48	589	621	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					631	643		10.1016/S0092-8674(03)00122-3	http://dx.doi.org/10.1016/S0092-8674(03)00122-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628184	Bronze			2022-12-01	WOS:000181443600007
J	Trombetta, ES; Ebersold, M; Garrett, W; Pypaert, M; Mellman, I				Trombetta, ES; Ebersold, M; Garrett, W; Pypaert, M; Mellman, I			Activation of lysosomal function during dendritic cell maturation	SCIENCE			English	Article							II ANTIGEN PRESENTATION; IN-VIVO; INFLAMMATORY STIMULI; PLASMA-MEMBRANE; ATPASE ACTIVITY; HLA-DM; PROTEOLYSIS; COMPLEXES; ACIDIFICATION; DISSOCIATION	In response to a variety of stimuli, dendritic cells (DCs) transform from immature cells specialized for antigen capture into mature cells specialized for T cell stimulation. During maturation, the DCs acquire an enhanced capacity to form and accumulate peptide-MHC (major histocompatibility complex) class II complexes. Here we show that a key mechanism responsible for this alteration was the generalized activation of lysosomal function. In immature DCs, internalized antigens were slowly degraded and inefficiently used for peptide loading. Maturation induced activation of the vacuolar proton pump that enhanced lysosomal acidification and antigen proteolysis, facilitating efficient formation of peptide-MHC class II complexes. Lysosomal function in DCs thus appears to be specialized for the developmentally regulated processing of internalized antigens.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.			Garrett, Wendy/0000-0002-5092-0150	NIAID NIH HHS [R37-AI34098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; COHN ZA, 1969, J EXP MED, V129, P201, DOI 10.1084/jem.129.1.201; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Drakesmith H, 1998, P NATL ACAD SCI USA, V95, P14903, DOI 10.1073/pnas.95.25.14903; EHRENREICH BA, 1969, J EXP MED, V129, P227, DOI 10.1084/jem.129.1.227; FAGOTTO F, 1994, J CELL SCI, V107, P3325; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; MALLYA SK, 1992, J CELL BIOL, V117, P1211, DOI 10.1083/jcb.117.6.1211; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Vogt AB, 1999, TRENDS BIOCHEM SCI, V24, P150, DOI 10.1016/S0968-0004(99)01364-X; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	39	545	558	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1400	1403		10.1126/science.1080106	http://dx.doi.org/10.1126/science.1080106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610307				2022-12-01	WOS:000181192300054
J	McCulloh, KA; Sperry, JS; Adler, FR				McCulloh, KA; Sperry, JS; Adler, FR			Water transport in plants obeys Murray's law	NATURE			English	Article							HYDRAULIC CONDUCTANCE; STOMATAL CONDUCTANCE; GENERAL-MODEL; TRANSPIRATION	The optimal water transport system in plants should maximize hydraulic conductance (which is proportional to photosynthesis(1-5)) for a given investment in transport tissue. To investigate how this optimum may be achieved, we have performed computer simulations of the hydraulic conductance of a branched transport system. Here we show that the optimum network is not achieved by the commonly assumed pipe model of plant form(6-8), or its antecedent, da Vinci's rule(9,10). In these representations, the number and area of xylem conduits is constant at every branch rank. Instead, the optimum network has a minimum number of wide conduits at the base that feed an increasing number of narrower conduits distally. This follows from the application of Murray's law, which predicts the optimal taper of blood vessels in the cardiovascular system(11). Our measurements of plant xylem indicate that these conduits conform to the Murray's law optimum as long as they do not function additionally as supports for the plant body.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	McCulloh, KA (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mcculloh@biology.utah.edu						CANNY MJ, 1993, PHILOS T R SOC B, V341, P87, DOI 10.1098/rstb.1993.0094; da Vinci Leonardo, 1970, COURIER CORPORATION, P2; Enquist BJ, 2000, SFI S SCI C, P167; Givnish T. J., 1986, EC PLANT FORM FUNCTI, P3; GOULD SJ, 1979, P ROY SOC LOND B BIO, V205, P581, DOI DOI 10.1098/RSPB.1979.0086; Grafen A., 2002, MODERN STAT LIFE SCI; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HORN H S, 1971, P144; Horn HS, 2000, SFI S SCI C, P199; Hubbard RM, 2001, PLANT CELL ENVIRON, V24, P113, DOI 10.1046/j.1365-3040.2001.00660.x; KELLER JB, 1966, J MATH MECH, V16, P433; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Mark R, 1996, AM SCI, V84, P383; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MEINZER FC, 1995, OECOLOGIA, V101, P514, DOI 10.1007/BF00329432; MEINZER FC, 1990, PLANT CELL ENVIRON, V13, P383, DOI 10.1111/j.1365-3040.1990.tb02142.x; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Raven JA., 1977, ADV BOTANICAL RESEAR, V5, P153, DOI DOI 10.1016/S0065-2296(08)60361-4; SALIENDRA NZ, 1995, PLANTA, V196, P357, DOI 10.1007/BF00201396; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Shinozaki K., 1964, JAPANESE J ECOL, V14, P97, DOI [10.18960/seitai.14.3_97, DOI 10.18960/SEITAI.14.3_97]; Sokal RR, 2012, BIOMETRY, V4th; SPERRY JS, 1993, J EXP BOT, V44, P1075, DOI 10.1093/jxb/44.6.1075; Vogel S., 1994, LIFE MOVING FLUIDS P, V2nd ed.; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; ZIMMERMANN MH, 1983, XYLEM STRUCTURE ASCE, P15	27	299	315	8	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					939	942		10.1038/nature01444	http://dx.doi.org/10.1038/nature01444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607000				2022-12-01	WOS:000181186900048
J	Lopansri, BK; Anstey, NM; Weinberg, JB; Stoddard, GJ; Hobbs, MR; Levesque, MC; Mwaikambo, ED; Granger, DL				Lopansri, BK; Anstey, NM; Weinberg, JB; Stoddard, GJ; Hobbs, MR; Levesque, MC; Mwaikambo, ED; Granger, DL			Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production	LANCET			English	Article								Nitric oxide (NO) production and mononuclear cell NO synthase 2 (NOS2) expression are high in healthy Tanzanian children but low in those with cerebral malaria. Factors that downregulate NOS2 also diminish factors involved in cellular uptake and biosynthesis of L-arginine, the substrate for NO synthesis. We therefore postulated that L-arginine concentrations would be low in individuals with cerebral malaria. We measured concentrations of L-arginine in cryopreserved plasma samples from Tanzanian children with and without malaria. L-arginine concentrations were low in individuals with cerebral malaria (mean 46 mumol/L, SD 14), intermediate in those with uncomplicated malaria (70 mumol/L, 20), and within the normal range in healthy controls (122 mumol/L, 22; p<0.0001). Analysis by logistic regression showed that hypoargininaemia was significantly associated with cerebral malaria case-fatality. Hypoargininaemia may contribute to limited NO production in children with cerebral malaria and to severe disease.	Vet Affairs Med Ctr, Div Infect Dis, Salt Lake City, UT 84132 USA; Univ Utah, Med Ctr, Salt Lake City, UT USA; Flinders Univ No Terr Clin Sch, Darwin, NT, Australia; Menzies Sch Hlth Res, Div Infect Dis, Darwin, NT, Australia; Duke Univ, Med Ctr, Durham, NC USA; Vet Affairs Med Ctr, Div Hematol, Durham, NC USA; Univ Utah, Sch Med, Div Clin Epidemiol, Salt Lake City, UT USA; Hubert Kairuki Mem Univ, Dept Paediat, Dar Es Salaam, Tanzania	US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Flinders University South Australia; Charles Darwin University; Menzies School of Health Research; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Granger, DL (corresponding author), Vet Affairs Med Ctr, Div Infect Dis, 30 N 1900 E,Room 4B319, Salt Lake City, UT 84132 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041764] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041764] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Kamada Y, 2001, J CLIN INVEST, V108, P717, DOI 10.1172/JCI11260; Meyer J, 1997, ANAL BIOCHEM, V247, P11, DOI 10.1006/abio.1997.2008; Planche T, 2002, QJM-INT J MED, V95, P89, DOI 10.1093/qjmed/95.2.89; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	5	133	137	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					676	678		10.1016/S0140-6736(03)12564-0	http://dx.doi.org/10.1016/S0140-6736(03)12564-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606182				2022-12-01	WOS:000181129500020
J	Aas, PA; Otterlei, M; Falnes, PO; Vagbo, CB; Skorpen, F; Akbari, M; Sundheim, O; Bjoras, M; Slupphaug, G; Seeberg, E; Krokan, HE				Aas, PA; Otterlei, M; Falnes, PO; Vagbo, CB; Skorpen, F; Akbari, M; Sundheim, O; Bjoras, M; Slupphaug, G; Seeberg, E; Krokan, HE			Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA	NATURE			English	Article							ESCHERICHIA-COLI; CLONING; CONSTRUCTION; EXPRESSION; NUCLEOTIDE; VECTORS; GENE	Repair of DNA damage is essential for maintaining genome integrity, and repair deficiencies in mammals are associated with cancer, neurological disease and developmental defects(1). Alkylation damage in DNA is repaired by at least three different mechanisms, including damage reversal by oxidative demethylation of 1-methyladenine and 3-methylcytosine by Escherichia coli AlkB(2,3). By contrast, little is known about consequences and cellular handling of alkylation damage to RNA(4). Here we show that two human AlkB homologues, hABH2 and hABH3, also are oxidative DNA demethylases and that AlkB and hABH3, but not hABH2, also repair RNA. Whereas AlkB and hABH3 prefer single-stranded nucleic acids, hABH2 acts more efficiently on double-stranded DNA. In addition, AlkB and hABH3 expressed in E. coli reactivate methylated RNA bacteriophage MS2 in vivo, illustrating the biological relevance of this repair activity and establishing RNA repair as a potentially important defence mechanism in living cells. The different catalytic properties and the different subnuclear localization patterns shown by the human homologues indicate that hABH2 and hABH3 have distinct roles in the cellular response to alkylation damage.	Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway; Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; Univ Oslo, Natl Hosp, Inst Med Microbiol, N-0027 Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Krokan, HE (corresponding author), Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway.		Slupphaug, Geir/AAN-3794-2020; Vågbø, Cathrine Broberg/N-3226-2017; Bjørås, Magnar/N-9286-2017; Falnes, Pål Ø./AAA-4581-2020	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Falnes, Pal/0000-0001-8114-6025; Akbari, Mansour/0000-0002-6490-7766; Otterlei, Marit/0000-0002-5232-1186; Skorpen, Frank/0000-0001-7093-8000; Slupphaug, Geir/0000-0002-7498-3500				Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; ARAVIND L, 2001, GENOME BIOL, V2; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; BOITEUX S, 1982, BIOCHIMIE, V64, P637, DOI 10.1016/S0300-9084(82)80103-X; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Dinglay S, 2000, GENE DEV, V14, P2097; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haug T, 1996, GENOMICS, V36, P408, DOI 10.1006/geno.1996.0485; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; KAASEN I, 1986, J BACTERIOL, V168, P642, DOI 10.1128/jb.168.2.642-647.1986; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Matsugi J, 2001, BBA-GENE STRUCT EXPR, V1521, P81, DOI 10.1016/S0167-4781(01)00293-7; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SAFFHILL R, 1984, CARCINOGENESIS, V5, P691; Sambrook J., 1989, MOL CLONING LAB MANU; Singer B., 1983, MOL BIOL MUTAGENS CA; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	27	484	503	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					859	863		10.1038/nature01363	http://dx.doi.org/10.1038/nature01363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594517				2022-12-01	WOS:000181044700052
J	Langkjaer, RB; Cliften, PF; Johnston, M; Piskur, J				Langkjaer, RB; Cliften, PF; Johnston, M; Piskur, J			Yeast genome duplication was followed by asynchronous differentiation of duplicated genes	NATURE			English	Article							HEMIASCOMYCETOUS YEASTS; SACCHAROMYCES; EVOLUTION; EXPLORATION; CHROMOSOMES; REGIONS; GROWTH	Gene redundancy has been observed in yeast, plant and human genomes, and is thought to be a consequence of whole-genome duplications(1-3). Baker's yeast, Saccharomyces cerevisiae, contains several hundred duplicated genes(1). Duplication(s) could have occurred before or after a given speciation. To understand the evolution of the yeast genome, we analysed orthologues of some of these genes in several related yeast species. On the basis of the inferred phylogeny of each set of genes, we were able to deduce whether the gene duplicated and/or specialized before or after the divergence of two yeast lineages. Here we show that the gene duplications might have occurred as a single event, and that it probably took place before the Saccharomyces and Kluyveromyces lineages diverged from each other. Further evolution of each duplicated gene pair-such as specialization or differentiation of the two copies, or deletion of a single copy-has taken place independently throughout the evolution of these species.	Tech Univ Denmark, Bioctr DTU, DK-2800 Lyngby, Denmark; Washington Univ, Sch Med, Dept Genet & Genome Sequencing Ctr, St Louis, MO 63110 USA	Technical University of Denmark; Washington University (WUSTL)	Piskur, J (corresponding author), Tech Univ Denmark, Bioctr DTU, Bldg 301, DK-2800 Lyngby, Denmark.	jp@biocentrum.dtu.dk	Johnston, Mark/K-3543-2019; Johnston, Mark/R-6156-2019	Johnston, Mark/0000-0002-4932-7229; 	NIGMS NIH HHS [R01 GM063803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berbee ML, 2001, MYCOTA, V7, P229; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Koonin EV, 1997, CURR OPIN GENET DEV, V7, P757, DOI 10.1016/S0959-437X(97)80037-8; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; LALO D, 1993, CR ACAD SCI III-VIE, V316, P367; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langkjaer RB, 2000, J MOL BIOL, V304, P271, DOI 10.1006/jmbi.2000.4209; LANGKJAER RB, 2002, THESIS DTU; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MELNICK L, 1993, J MOL BIOL, V233, P372, DOI 10.1006/jmbi.1993.1518; Moller K, 2002, BIOTECHNOL BIOENG, V77, P186, DOI 10.1002/bit.10122; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Piskur J, 2001, TRENDS GENET, V17, P302, DOI 10.1016/S0168-9525(01)02308-3; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vaughan-Martini Ann, 1998, P358, DOI 10.1016/B978-044481312-1/50048-4; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WESOLOWSKILOUVE.M, 1906, NONCONVENTIONAL YEAS, P139; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099	30	114	155	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					848	852		10.1038/nature01419	http://dx.doi.org/10.1038/nature01419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594514				2022-12-01	WOS:000181044700049
J	Vinicor, F; Bowman, B; Engelgau, M				Vinicor, F; Bowman, B; Engelgau, M			Diabetes: prevention needed	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; HEALTH; PREVALENCE; MELLITUS; OBESITY; CARE; RISK		Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Vinicor, F (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA.	fxv1@cdc.gov						Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Gavin JR, 1997, DIABETES CARE, V20, P1183; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; NARAYAN V, 2002, BRIT MED J, V325, P403; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wylie G, 2002, BMJ-BRIT MED J, V324, P1190, DOI 10.1136/bmj.324.7347.1190	16	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					544	544		10.1016/S0140-6736(03)12561-5	http://dx.doi.org/10.1016/S0140-6736(03)12561-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598137				2022-12-01	WOS:000181033400005
J	Vetter, N				Vetter, N			Inappropriately delayed discharge from hospital: What do we know?	BRITISH MEDICAL JOURNAL			English	Article							APPROPRIATENESS EVALUATION PROTOCOL; CARE; HOME; BEDS		Univ Wales Coll Med, Dept Epidemiol & Stat, Cardiff CF14 4XL, S Glam, Wales; Univ Wales Coll Med, Dept Publ Hlth, Cardiff CF14 4XL, S Glam, Wales	Cardiff University; Cardiff University	Vetter, N (corresponding author), Univ Wales Coll Med, Dept Epidemiol & Stat, Heath Pk, Cardiff CF14 4XL, S Glam, Wales.							ANDERSON P, 1988, BRIT MED J, V297, P910, DOI 10.1136/bmj.297.6653.910; Chopard P, 1998, INT J EPIDEMIOL, V27, P513, DOI 10.1093/ije/27.3.513; Coast J, 1996, INT J QUAL HEALTH C, V8, P31, DOI 10.1093/intqhc/8.1.31; Epstein J, 2001, SOC WORK HEALTH CARE, V32, P43, DOI 10.1300/J010v32n04_03; FALCONE D, 1991, HEALTH SERV RES, V26, P339; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; Hermans E, 1996, SCAND J CARING SCI, V10, P81, DOI 10.1111/j.1471-6712.1996.tb00316.x; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; Hyde CJ, 2000, AGE AGEING, V29, P271, DOI 10.1093/ageing/29.3.271; LEWIS H, 1988, NEW ZEAL MED J, V101, P575; McDonagh MS, 2000, HEALTH POLICY, V53, P157, DOI 10.1016/S0168-8510(00)00092-0; Minichiello T M, 2001, Eff Clin Pract, V4, P250; Patterson CJ, 1999, CLIN REHABIL, V13, P101, DOI 10.1191/026921599677096598; STRUMWASSER I, 1990, MED CARE, V28, P95, DOI 10.1097/00005650-199002000-00001; STYRBORN K, 1993, SCAND J SOC MED, V21, P272, DOI 10.1177/140349489302100407	15	33	34	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 26	2003	326	7395					927	928		10.1136/bmj.326.7395.927	http://dx.doi.org/10.1136/bmj.326.7395.927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	673WQ	12714477	Green Published			2022-12-01	WOS:000182603600024
J	Bloomfield, FH; Oliver, MH; Hawkins, P; Campbell, M; Phillips, DJ; Gluckman, PD; Challis, JRG; Harding, JE				Bloomfield, FH; Oliver, MH; Hawkins, P; Campbell, M; Phillips, DJ; Gluckman, PD; Challis, JRG; Harding, JE			A periconceptional nutritional origin for noninfectious preterm birth	SCIENCE			English	Article									Univ Toronto, Dept Physiol, Toronto, ON, Canada; Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Monash Univ, Ctr Mol Reprod & Endocrinol, Clayton, Vic 3168, Australia	University of Toronto; University of Auckland; Monash University	Bloomfield, FH (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	f.bloomfield@auckland.ac.nz	Phillips, David/A-5007-2009; Challis, John RG/E-7419-2014; Bloomfield, Frank/A-1374-2008; Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Oliver, Mark/0000-0002-0359-2297; Bloomfield, Frank/0000-0001-6424-6577				Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Fadalti M, 2000, ANN NY ACAD SCI, V900, P89; FALL CM, COMMUNICATION; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; LIGGINS GC, 1972, PEDIATRICS, V50, P515	6	202	203	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					606	606		10.1126/science.1080803	http://dx.doi.org/10.1126/science.1080803			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714735				2022-12-01	WOS:000182453700031
J	Fujita, N; Jaye, DL; Kajita, M; Geigerman, C; Moreno, CS; Wade, PA				Fujita, N; Jaye, DL; Kajita, M; Geigerman, C; Moreno, CS; Wade, PA			MTA3, a Mi-2/NuRD complex subunit, an invasive growth pathway in breast	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR SNAIL; CELL-CELL-ADHESION; HISTONE DEACETYLASE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; E-CADHERIN; MAMMARY ADENOCARCINOMA; EPITHELIAL-CELLS; DNA METHYLATION	Estrogen receptor is a key regulator of proliferation and differentiation in mammary epithelia and represents a crucial prognostic indicator and therapeutic target in breast cancer. Mechanistically, estrogen receptor induces changes in gene expression through direct gene activation and also through the biological functions of target loci. Here, we identify the product of human MTA3 as an estrogen-dependent component of the Mi-2/NuRD transcriptional corepressor in breast epithelial cells and demonstrate that MTA3 constitutes a key component of an estrogen-dependent pathway regulating growth and differentiation. The absence of estrogen receptor or of MTA3 leads to aberrant expression of the transcriptional repressor Snail, a master regulator of epithelial to mesenchymal transitions. Aberrant Snail expression results in loss of expression of the cell adhesion molecule E-cadherin, an event associated with changes in epithelial architecture and invasive growth. These results establish a mechanistic link between estrogen receptor status and invasive growth of breast cancers.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Wade, PA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Whitehead Biomed Res Bldg,Room 142,615 Michael St, Atlanta, GA 30322 USA.		Moreno, Carlos S/B-3863-2009; Wade, Paul A/D-2374-2019; Larue, Lionel/I-6532-2016	Moreno, Carlos S/0000-0002-5582-0028; Wade, Paul A/0000-0002-6042-357X; jaye, david/0000-0001-7977-6909	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K22HD001238] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K22CA096560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060647] Funding Source: NIH RePORTER; NCI NIH HHS [K22-CA96560-01] Funding Source: Medline; NICHD NIH HHS [5K22HD01238] Funding Source: Medline; NIDDK NIH HHS [DK60647] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; IMHOF BA, 1983, CELL, V35, P667, DOI 10.1016/0092-8674(83)90099-5; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lapidus RG, 1998, J MAMMARY GLAND BIOL, V3, P85, DOI 10.1023/A:1018778403001; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MASOOD S, 1992, DIAGN CYTOPATHOL, V8, P475, DOI 10.1002/dc.2840080508; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; McDonnell DP, 2002, AM J CARDIOL, V90, p35F, DOI 10.1016/S0002-9149(01)02221-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; REDDEL RR, 1984, EUR J CANCER CLIN ON, V20, P1419, DOI 10.1016/0277-5379(84)90062-2; Solari F, 1999, DEVELOPMENT, V126, P2483; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.0.CO;2-4; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	47	413	446	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					207	219		10.1016/S0092-8674(03)00234-4	http://dx.doi.org/10.1016/S0092-8674(03)00234-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705869	Bronze			2022-12-01	WOS:000182508500010
J	Gould, WS				Gould, WS			The "magic" word	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2003	289	15					1899	1900		10.1001/jama.289.15.1899	http://dx.doi.org/10.1001/jama.289.15.1899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667VC	12697774				2022-12-01	WOS:000182253900001
J	Snyder, M; Gerstein, M				Snyder, M; Gerstein, M			Genomics - Defining genes in the genomics era	SCIENCE			English	Editorial Material							PROTEIN-CODING GENES; SACCHAROMYCES-CEREVISIAE GENOME; YEAST GENOME; TRANSCRIPTIONAL ACTIVITY; TOTAL NUMBER; PSEUDOGENES; EVOLUTION; DNA		Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.			Snyder, Michael/0000-0003-0784-7987				Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Coelho PSR, 2000, CURR OPIN MICROBIOL, V3, P309, DOI 10.1016/S1369-5274(00)00095-3; Coelho PSR, 2002, GENE DEV, V16, P2755, DOI 10.1101/gad.1035002; Das M, 2001, GENOMICS, V77, P71, DOI 10.1006/geno.2001.6620; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; FALK R, 1986, STUD HIST PHILOS SCI, V17, P133, DOI 10.1016/0039-3681(86)90024-5; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Harrison PM, 2002, NUCLEIC ACIDS RES, V30, P1083, DOI 10.1093/nar/30.5.1083; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kowalczuk M, 1999, YEAST, V15, P1031, DOI 10.1002/(SICI)1097-0061(199908)15:11<1031::AID-YEA431>3.0.CO;2-G; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu HP, 1996, GENETICS, V144, P967; Mackiewicz P, 2002, YEAST, V19, P619, DOI 10.1002/yea.865; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Morange M, 2001, MISUNDERSTOOD GENE; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhang CT, 2000, NUCLEIC ACIDS RES, V28, P2804, DOI 10.1093/nar/28.14.2804; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	29	89	106	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					258	260		10.1126/science.1084354	http://dx.doi.org/10.1126/science.1084354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690176				2022-12-01	WOS:000182135400032
J	Anselmi, M; Avanzini, F; Moreira, JM; Montalvo, G; Armani, D; Prandi, R; Marquez, M; Caicedo, C; Colombo, F; Tognoni, G				Anselmi, M; Avanzini, F; Moreira, JM; Montalvo, G; Armani, D; Prandi, R; Marquez, M; Caicedo, C; Colombo, F; Tognoni, G			Treatment and control of arterial hypertension in a rural community in Ecuador	LANCET			English	Article								Cardiovascular diseases are widespread in developing countries, but little is known about cardiovascular risk profiles in rural communities. To assess the importance of arterial hypertension in a rural district of Ecuador, we screened 4284 of the 8876 adults who lived in the area. 1542 (36%) individuals had hypertension, only four (0.3%) of whom were well controlled by treatment. We monitored all deaths for 2.5 years, and noted that cardiovascular diseases were the primary cause of death in the adult population. Furthermore, of the individuals who died of a cardiovascular disease, four out of five had a history of hypertension. Our findings indicate that in this rural area of Ecuador the high prevalence of uncontrolled hypertension is a major cause of total mortality.	Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; CECOMET, Esmeraldas, Ecuador; Minist Salud Publ, Borbon, Ecuador; Osped S Cuore, Ctr Malattie Trop, Verona, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Avanzini, F (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.	avanzini@marionegri.it		Avanzini, Fausto/0000-0002-4029-2891				CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Ordunez P, 2001, Rev Panam Salud Publica, V10, P226, DOI 10.1590/S1020-49892001001000002; Reddy KS, 1998, CIRCULATION, V97, P596; [No title captured]	5	22	23	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2003	361	9364					1186	1187		10.1016/S0140-6736(03)12918-2	http://dx.doi.org/10.1016/S0140-6736(03)12918-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686043				2022-12-01	WOS:000182094600014
J	Juurlink, DN; Mamdani, M; Kopp, A; Laupacis, A; Redelmeier, DA				Juurlink, DN; Mamdani, M; Kopp, A; Laupacis, A; Redelmeier, DA			Drug-drug interactions among elderly patients hospitalized for drug toxicity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual North American Congress of Clinical Toxicology	SEP 24-29, 2002	PALM SPRINGS, CA				CONVERTING ENZYME-INHIBITORS; DIGOXIN TOXICITY; P-GLYCOPROTEIN; CISAPRIDE; CLARITHROMYCIN; HYPERKALEMIA; ASSOCIATION; EVENTS; CYP2C9; SULFAMETHOXAZOLE	Context Drug-drug interactions are a preventable cause of morbidity and mortality, yet their consequences in the community are not well characterized. Objective To determine whether elderly patients admitted to hospital with specific drug toxicities were likely to have been,prescribed an interacting drug in the week prior to admission. Design Three population-based, nested case-control studies. Setting Ontario, Canada, from January 1, 1994, to December 31, 2000. Patients All Ontario residents aged 66 years or older treated with glyburide, digoxin, or an angiotensin-converting enzyme (ACE) inhibitor. Case patients were those admitted to hospital for drug-related toxicity. Prescription records of cases were compared with those of controls (matched on age, sex, use of the same medication, and presence or absence of renal disease) for receipt of interacting medications (co-trimoxazole with glyburide, clarithromycin with digoxin, and potassium-sparing diuretics with ACE inhibitors). Main Outcome Measure Odds ratio for association between hospital admission for drug toxicity (hypoglycemia, digoxin toxicity, or hyperkalemia, respectively) and use of an interacting medication in the preceding-week, adjusted for diagnoses, receipt of other medications, the number of prescription drugs, and the number of hospital admissions in the year preceding the index date. Results During the 7-year study period, 909 elderly patients receiving glyburide were admitted with a diagnosis of hypoglycemia. In the primary analysis, those patients admitted for hypoglycemia were more than 6 times as likely to have been treated with co-trimoxazole in the previous week (adjusted odds ratio, 6.6; 95% confidence interval, 4.5-9.7). Patients admitted with digoxin toxicity (n=1051) were about 12 times more likely to have been treated with clarithromycin (adjusted odds ratio, 11.7; 95% confidence interval, 7.5-18.2) in the previous week, and patients treated with ACE inhibitors admitted with a diagnosis of hyperkalemia (n=523) were about 20 times more likely to have been treated with a potassium-sparing diuretic (adjusted odds ratio, 20.3; 95% confidence interval, 13.4-30.7) in the previous week. No increased risk of drug toxicity was found for drugs with similar indications but no known interactions (amoxicillin, cefuroxime, and indapamide, respectively). Conclusions Many hospital admissions of elderly patients for drug toxicity occur after administration of a drug known to cause drug-drug interactions. Many of these interactions could have been avoided.	Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Clin Epidemiol & Healthcare Res Program, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Pharm, Toronto, ON M4N 3M5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, G Wing 106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.juurlink@ices.on.ca						Ahuja TS, 2000, AM J NEPHROL, V20, P268, DOI 10.1159/000013599; Alvarez-Requejo A, 1998, EUR J CLIN PHARMACOL, V54, P483, DOI 10.1007/s002280050498; [Anonymous], 1982, EPIDEMIOLOGIC RES; Atkin PA, 1999, DRUG AGING, V14, P141, DOI 10.2165/00002512-199914020-00005; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; BRIAN WR, 2000, METABOLIC DRUG INTER, P529; Brown BA, 1997, CLIN INFECT DIS, V24, P92, DOI 10.1093/clinids/24.1.92; Cavuto NJ, 1996, JAMA-J AM MED ASSOC, V275, P1086, DOI 10.1001/jama.275.14.1086; CHRISTENSEN LK, 1969, ACTA DIABETOLOGICA S, V1, P116; Crighton EJ, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-7; Del Fiol G, 2000, J AM MED INFORM ASSN, P171; DUSSUSKE LM, 1999, CLIN THER, V21, P281; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Glassman PA, 2002, MED CARE, V40, P1161, DOI 10.1097/00005650-200212000-00004; Gooderham MJ, 1999, ANN PHARMACOTHER, V33, P796, DOI 10.1345/aph.18330; Guerriero SE, 1997, PHARMACOTHERAPY, V17, P1035; Guzey C, 2002, DRUG SAFETY, V25, P553; Halkin H, 2001, CLIN PHARMACOL THER, V69, P260, DOI 10.1067/mcp.2001.114228; Hansten P D, 2001, J Am Pharm Assoc (Wash), V41, P161; Hazlet T K, 2001, J Am Pharm Assoc (Wash), V41, P200; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Jha AK, 2001, PHARMACOEPIDEM DR S, V10, P113, DOI 10.1002/pds.568; JOHNSON JF, 1990, DICP ANN PHARMAC, V24, P250, DOI 10.1177/106002809002400307; Jones JK, 2001, JAMA-J AM MED ASSOC, V286, P1607, DOI 10.1001/jama.286.13.1607; KIFOR I, 1991, ENDOCRINOLOGY, V129, P823, DOI 10.1210/endo-129-2-823; Kirchheiner J, 2002, CLIN PHARMACOL THER, V71, P286, DOI 10.1067/mcp.2002.122476; Koren G, 1998, VET HUM TOXICOL, V40, P45; Langdorf MI, 2000, ACAD EMERG MED, V7, P1321, DOI 10.1111/j.1553-2712.2000.tb00483.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lehmann DF, 2000, J CLIN PHARMACOL, V40, P939, DOI 10.1177/00912700022009675; Mamdani MM, 2000, CAN MED ASSOC J, V162, P1421; Mamdani MM, 2000, AM J MED, V108, P418, DOI 10.1016/S0002-9343(99)00452-0; Michalets EL, 2000, CLIN PHARMACOKINET, V39, P49, DOI 10.2165/00003088-200039010-00004; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; Moride Y, 1997, BRIT J CLIN PHARMACO, V43, P177, DOI 10.1046/j.1365-2125.1997.05417.x; Niemi M, 2002, CLIN PHARMACOL THER, V72, P326, DOI 10.1067/mcp.2002.127495; Peterson J F, 2001, J Am Pharm Assoc (Wash), V41, P159; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Potasman I, 1980, Harefuah, V98, P78; *PRACT MAN INF COR, 2003, INT CLASS DIS; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Roberts RL, 2002, NEW ZEAL MED J, V115, P137; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Rosholm JU, 1998, DAN MED BULL, V45, P210; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Schlesselman J.J., 1982, CASE CONTROL STUDIES; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Seymour RM, 1998, DRUG AGING, V12, P485, DOI 10.2165/00002512-199812060-00006; Shaoul R, 2002, PEDIATRICS, V109, P1118, DOI 10.1542/peds.109.6.1118; Shapiro LE, 1999, CAN MED ASSOC J, V161, P1266; Statistics Canada, 2010, POP AG GROUP; Tamblyn RM, 1996, CAN MED ASSOC J, V154, P1177; Wakasugi H, 1998, CLIN PHARMACOL THER, V64, P123, DOI 10.1016/S0009-9236(98)90030-3; Weideman RA, 1999, AM J HEALTH-SYST PH, V56, P1524, DOI 10.1093/ajhp/56.15.1524; Wen X, 2002, DRUG METAB DISPOS, V30, P631, DOI 10.1124/dmd.30.6.631; Wynn Richard L., 1993, General Dentistry, V41, P27; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416; Wysowski DK, 2001, AM J GASTROENTEROL, V96, P1698, DOI 10.1016/S0002-9270(01)02490-X; ZECHNICH AD, 1994, WESTERN J MED, V160, P321	65	493	512	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1652	1658		10.1001/jama.289.13.1652	http://dx.doi.org/10.1001/jama.289.13.1652			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	662JX	12672733	Green Published			2022-12-01	WOS:000181944500028
J	Chapman, S; Reeve, E; Rajaratnam, G; Neary, R				Chapman, S; Reeve, E; Rajaratnam, G; Neary, R			Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care	BRITISH MEDICAL JOURNAL			English	Article							MS		Univ Keele, Dept Med Management, Keele ST5 5BG, Staffs, England; N Stoke Primary Care Trust, Stoke On Trent ST4 4LX, Staffs, England; S Stoke Primary Care Trust, Stoke On Trent ST4 4LX, Staffs, England; N Staffordshire Hosp NHS Trust, Cent Pathol Lab, Stoke On Trent ST4 7PA, Staffs, England	Keele University; University Hospital of North Staffordshire NHS Trust	Chapman, S (corresponding author), Univ Keele, Dept Med Management, Keele ST5 5BG, Staffs, England.	s.r.chapman@keele.ac.uk						BELLINGHAM C, 2001, PHARM J, V267, P672; *DEP HLTH, 2001, NAT SERV FRAM COR HE; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; Little R, 2002, BRIT MED J, V324, P316; Mayor S, 2001, BRIT MED J, V323, P1087, DOI 10.1136/bmj.323.7321.1087; *N STAFF HLTH AUTH, 2001, HLTH WELL BEING IMPR; *N STAFF HLTH AUTH, 2000, CLOS GAP HLTH IN N S; RICHARDS RG, GUARANTEED OUTCOMES; *STAND MED ADV COM, 1997, USE STAT; Taylor D, 2001, BRIT MED J, V323, P1379, DOI 10.1136/bmj.323.7326.1379; Wood D, 1998, HEART, V80, pS1	11	29	31	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 29	2003	326	7391					707	709		10.1136/bmj.326.7391.707	http://dx.doi.org/10.1136/bmj.326.7391.707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663WL	12663411	Green Published			2022-12-01	WOS:000182029500029
J	Nash, D; Magder, L; Lustberg, M; Sherwin, RW; Rubin, RJ; Kaufmann, RB; Silbergeld, EK				Nash, D; Magder, L; Lustberg, M; Sherwin, RW; Rubin, RJ; Kaufmann, RB; Silbergeld, EK			Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; BONE-MINERAL CONTENT; 3RD NATIONAL-HEALTH; MIDDLE-AGED WOMEN; CARDIOVASCULAR-DISEASE; UNITED-STATES; POPULATION; EXPOSURE; RISK; OSTEOPOROSIS	Context Lead exposures have been shown to be associated with increased blood pressure and risk of hypertension in older men. In perimenopausal women, skeletal lead stores are an important source of endogenous lead exposure due to increased bone demineralization. Objective To examine the relationship of blood lead level with blood pressure and hypertension prevalence in a population-based sample of perimenopausal and postmenopausal women in the United States. Design, Setting, and Participants Cross-sectional sample of 2165 women aged 40 to 59 years, who participated in a household interview and physical examination, from the Third National Health and Nutrition Examination Survey conducted from 1988 to 1994. Main Outcome Measures Associations of blood lead with blood pressure and hypertension, with age, race and ethnicity, cigarette smoking status, body mass index, alcohol use, and kidney function as covariates. Results A change in blood lead levels from the lowest (quartile 1: range, 0.5-1.6 mug/dL) to the highest (quartile 4: range, 4.0-31.1 mug/dL) was associated with small statistically significant adjusted changes in systolic and diastolic blood pressures. Women in quartile 4 had increased risks of diastolic (>90 mm Hg) hypertension (adjusted odds ratio [OR], 3.4; 95% confidence interval [CI], 1.3-8.7), as well as moderately increased risks for general hypertension (adjusted OR, 1.4; 95% CI, 0.92-2.0) and systolic (>140 mm Hg) hypertension (adjusted OR, 1.5; 95% CI, 0.72-3.2). This association was strongest in postmenopausal women in whom adjusted ORs for diastolic hypertension increased with increasing quartile of blood lead level compared with quartile 1 (adjusted OR, 4.6; 95% CI, 1.1-19.2 for quartile 2; adjusted OR, 5.9; 95% CI, 1.5-23.1 for quartile 3; adjusted OR, 8.1; 95% CI, 2.6-24.7 for quartile 4). Conclusions At levels well below the current US occupational exposure limit guidelines (40 mug/dL); blood lead level is positively associated with both systolic and diastolic blood pressure and risks of both systolic and diastolic hypertension among women aged 40 to 59 years. The relationship between blood lead level and systolic and diastolic hypertension is most pronounced in postmenopausal women. These results provide support for continued efforts to reduce lead levels in the general population, especially women.	New York City Dept Hlth & Mental Hyg, HIV AIDS Surveillance & Epidemiol Program, New York, NY 10013 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; University System of Maryland; University of Maryland Baltimore; Tulane University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Nash, D (corresponding author), New York City Dept Hlth & Mental Hyg, HIV AIDS Surveillance & Epidemiol Program, 346 Broadway,Room 706, New York, NY 10013 USA.		Nash, Denis/AFI-7485-2022; Lustberg, Mark/AAO-9924-2020	Nash, Denis/0000-0002-3280-5386	ATSDR CDC HHS [TS-288-14/14] Funding Source: Medline	ATSDR CDC HHS		BATUMAN V, 1983, NEW ENGL J MED, V309, P17, DOI 10.1056/NEJM198307073090104; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cake KM, 1996, AM J IND MED, V29, P440, DOI 10.1002/(SICI)1097-0274(199605)29:5<440::AID-AJIM2>3.0.CO;2-Q; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; ELWOOD PC, 1988, ENVIRON HEALTH PERSP, V78, P119, DOI 10.2307/3430511; ELWOOD PC, 1988, AM J EPIDEMIOL, V127, P942, DOI 10.1093/oxfordjournals.aje.a114897; EZZATI T, 1992, PUBLICATION PHS; GRANDJEAN P, 1992, SCAND J CLIN LAB INV, V52, P321, DOI 10.3109/00365519209088366; GRANDJEAN P, 1989, AM J EPIDEMIOL, V129, P732, DOI 10.1093/oxfordjournals.aje.a115188; GULSON BL, 1995, J LAB CLIN MED, V125, P703; Gulson BL, 1997, J LAB CLIN MED, V130, P51, DOI 10.1016/S0022-2143(97)90058-5; HARLAN WR, 1985, JAMA-J AM MED ASSOC, V253, P530, DOI 10.1001/jama.253.4.530; HARLAN WR, 1988, ENVIRON HEALTH PERSP, V78, P9; HEANEY RP, 1978, J LAB CLIN MED, V92, P964; HENSE HW, 1993, EPIDEMIOLOGY, V4, P173, DOI 10.1097/00001648-199303000-00014; HENSE HW, 1994, EPIDEMIOLOGY, V5, P120, DOI 10.1097/00001648-199401000-00018; HERTZPICCIOTTO I, 1993, EPIDEMIOL REV, V15, P352, DOI 10.1093/oxfordjournals.epirev.a036125; Hu FB, 2002, AM J CARDIOL, V90, p26F, DOI 10.1016/S0002-9149(01)02219-6; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Hu H, 1996, JAMA-J AM MED ASSOC, V275, P1171, DOI 10.1001/jama.275.15.1171; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; KNIGHT EM, 1994, J NUTR, V124, pS943, DOI 10.1093/jn/124.suppl_6.943S; KOPP SJ, 1988, ENVIRON HEALTH PERSP, V78, P91, DOI 10.2307/3430507; Korrick SA, 1999, AM J PUBLIC HEALTH, V89, P330, DOI 10.2105/AJPH.89.3.330; KROLNER B, 1982, CLIN SCI, V62, P329, DOI 10.1042/cs0620329; LAGERKVIST BJ, 1993, SCAND J WORK ENV HEA, V19, P50; LINDQUIST O, 1981, SCAND J CLIN LAB INV, V41, P215, DOI 10.3109/00365518109092037; LINDSAY R, 1976, LANCET, V1, P1038; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091, DOI 10.1093/oxfordjournals.aje.a116574; MULDOON SB, 1994, AM J EPIDEMIOL, V139, P599, DOI 10.1093/oxfordjournals.aje.a117049; MULDOON SB, 1997, SOC EP RES JUN CALG; Nash D, 1998, AM J EPIDEMIOL, V147, pS93; NERI LC, 1988, ENVIRON HEALTH PERSP, V78, P123, DOI 10.2307/3430512; NORDIN BEC, 1983, OSTEOPOROTIC SYNDROM; NOWACK R, 1993, EUR J CLIN INVEST, V23, P433, DOI 10.1111/j.1365-2362.1993.tb00787.x; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; PIRKLE JL, 1985, AM J EPIDEMIOL, V121, P246, DOI 10.1093/oxfordjournals.aje.a113995; POCOCK SJ, 1988, ENVIRON HEALTH PERSP, V78, P23, DOI 10.2307/3430494; Proctor SP, 1996, INT J EPIDEMIOL, V25, P528, DOI 10.1093/ije/25.3.528; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; SCHWARTZ J, 1995, ARCH ENVIRON HEALTH, V50, P31, DOI 10.1080/00039896.1995.9955010; SCHWARTZ J, 1991, ENVIRON HEALTH PERSP, V91, P71, DOI 10.2307/3430985; SCHWARTZ J, 1988, ENVIRON HEALTH PERSP, V78, P15, DOI 10.2307/3430493; SHARP DS, 1987, MED TOXICOL ADV DRUG, V2, P210, DOI 10.1007/BF03259865; SHARP DS, 1990, AM J EPIDEMIOL, V131, P845, DOI 10.1093/oxfordjournals.aje.a115575; SHARP DS, 1989, ARCH ENVIRON HEALTH, V44, P18, DOI 10.1080/00039896.1989.9935867; SHARP DS, 1988, ENVIRON HEALTH PERSP, V78, P131, DOI 10.2307/3430514; Silbergeld E., 1995, FUNDAM APPL TOXICOL, V25, P167; SILBERGELD E, 2001, PROGR ENV SCI, V1, P53; SILBERGELD EK, 1988, ENVIRON RES, V47, P79, DOI 10.1016/S0013-9351(88)80023-9; Smith DR, 1996, ENVIRON HEALTH PERSP, V104, P60, DOI 10.2307/3432761; STAESSEN J, 1991, J HUM HYPERTENS, V5, P485; Staessen J, 1995, Verh K Acad Geneeskd Belg, V57, P527; Staessen JA, 1998, J HUM HYPERTENS, V12, P587, DOI 10.1038/sj.jhh.1000670; Staessen JA, 1996, JAMA-J AM MED ASSOC, V275, P1563, DOI 10.1001/jama.275.20.1563; SYMANSKI E, 1995, AM J EPIDEMIOL, V141, P1047, DOI 10.1093/oxfordjournals.aje.a117369; VANDER AJ, 1988, ENVIRON HEALTH PERSP, V78, P77, DOI 10.2307/3430505; Webber CE, 1995, ENVIRON HEALTH PERSP, V103, P1150, DOI 10.2307/3432612; West WL, 1994, J NUTR, V124, P981	62	180	182	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2003	289	12					1523	1532		10.1001/jama.289.12.1523	http://dx.doi.org/10.1001/jama.289.12.1523			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659XE	12672769	Bronze			2022-12-01	WOS:000181803100030
J	Spies, M; Herndon, DN; Rosenblatt, J; Sanford, AP; Wolf, SE				Spies, M; Herndon, DN; Rosenblatt, J; Sanford, AP; Wolf, SE			Prediction of mortality from catastrophic burns in children	LANCET			English	Article; Proceedings Paper	33rd Annual Meeting of the American-Burn-Association	APR 18-21, 2001	BOSTON, MASSACHUSETTS	Amer Burn Assoc			80-PERCENT; OUTCOMES; TBSA	Background We previously developed a model to predict survival in massive paediatric burns (>80% total body surface area [TBSA]). This model included not only demographic variables, but also variables obtained throughout the hospital course. We aimed to prospectively validate our model for accuracy of outcome prediction. Methods We admitted 33 paediatric burn patients with burns greater than 80% TBSA. We recorded age, burn size, inhalation injury, resuscitation, packed-cell volume at admission, base deficit, serum osmolarity, sepsis, inotropic support, platelet count, creatinine, and ventilator dependency. We entered these data into our previous models. Results 20 male and 13 female children with mean age 7.6 (SD 1) years with TBSA burns of 88% (SD 1; full thickness 86% [SD 1]) were admitted. Mortality was 39.4% (13 of 30). When all variables were integrated into our final model, we predicted outcome with 97% accuracy. When we used a model based only on demographic characteristics of age, burn size, and presence of inhalation injury, outcome was correctly predicted in only 51% of patients. Conclusions We show prospectively that mortality in severely burned children can be reliably estimated at a burn centre, and that outcome cannot be reliably predicted on the basis of demographic and injury characteristics alone. These data suggest that all severely burned children should be given a course of treatment before consideration of treatment futility.	Shriners Hosp Children, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Surg, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Wolf, SE (corresponding author), Shriners Hosp Children, 815 Market St, Galveston, TX 77550 USA.		Herndon, David/AAC-3354-2020	Wolf, Steven/0000-0003-2972-3440				BAUX S, 1989, BURNS, V15, P239, DOI 10.1016/0305-4179(89)90039-9; Blakeney P, 1998, J TRAUMA, V44, P625, DOI 10.1097/00005373-199804000-00011; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Meyers-Paal R, 2000, J BURN CARE REHABIL, V21, P43, DOI 10.1097/00004630-200021010-00009; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Saffle Jeffrey R., 1995, Journal of Burn Care and Rehabilitation, V16, P219, DOI 10.1097/00004630-199505000-00002; SMITH DL, 1994, J TRAUMA, V37, P655, DOI 10.1097/00005373-199410000-00021; TOBIASEN J, 1982, SURG GYNECOL OBSTET, V154, P711; Wolf SE, 1997, ANN SURG, V225, P554, DOI 10.1097/00000658-199705000-00012	10	44	46	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					989	994		10.1016/S0140-6736(03)12824-3	http://dx.doi.org/10.1016/S0140-6736(03)12824-3			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660055				2022-12-01	WOS:000181699700008
J	Nong, Y; Huang, YQ; Ju, W; Kalia, LV; Ahmadian, G; Wang, YT; Salter, MW				Nong, Y; Huang, YQ; Ju, W; Kalia, LV; Ahmadian, G; Wang, YT; Salter, MW			Glycine binding primes NMDA receptor internalization	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC VESICLE ENDOCYTOSIS; D-ASPARTATE RECEPTOR; ACID; SITE; AMPA; TRANSMISSION; HIPPOCAMPUS; ANTAGONISTS; ACTIVATION	NMDA (N-methyl-D-aspartate) receptors (NMDARs) are a principal subtype of excitatory ligand-gated ion channel with prominent roles in physiological and disease processes in the central nervous system(1). Recognition that glycine potentiates NMDAR-mediated currents(2) as well as being a requisite co-agonist of the NMDAR subtype of 'glutamate' receptor(3) profoundly changed our understanding of chemical synaptic communication in the central nervous system. The binding of both glycine and glutamate is necessary to cause opening of the NMDAR conductance pore(1). Although binding of either agonist alone is insufficient to cause current flow through the channel, we report here that stimulation of the glycine site initiates signalling through the NMDAR complex, priming the receptors for clathrin-dependent endocytosis. Glycine binding alone does not cause the receptor to be endocytosed; this requires both glycine and glutamate site activation of NMDARs. The priming effect of glycine is mimicked by the NMDAR glycine site agonist D-serine, and is blocked by competitive glycine site antagonists. Synaptic as well as extrasynaptic NMDARs are primed for internalization by glycine site stimulation. Our results demonstrate transmembrane signal transduction through activating the glycine site of NMDARs, and elucidate a model for modulating cell-cell communication in the central nervous system.	Univ Toronto, Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pathobiol & Lab Med, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Med, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of British Columbia	Salter, MW (corresponding author), Univ Toronto, Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada.		Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Kalia, Lorraine/0000-0002-9384-1305				BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Danysz W, 1998, PHARMACOL REV, V50, P597; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FOSTER AC, 1992, MOL PHARMACOL, V41, P914; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; HANSFORD C. G., 1961, SYDOWIA ANN MYCOLOGICI SER II SUPPL, V2, P1; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kittler JT, 2000, J NEUROSCI, V20, P7972; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mugnaini M, 1998, J RECEPT SIGNAL TR R, V18, P91, DOI 10.3109/10799899809047739; Mugnaini M, 2000, EUR J PHARMACOL, V391, P233, DOI 10.1016/S0014-2999(00)00101-1; Popik P, 1995, EUR J PHARM-MOLEC PH, V291, P221, DOI 10.1016/0922-4106(95)90061-6; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; SALITURO FG, 1992, J MED CHEM, V35, P1791, DOI 10.1021/jm00088a014; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8	29	327	339	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					302	307		10.1038/nature01497	http://dx.doi.org/10.1038/nature01497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646920				2022-12-01	WOS:000181637300038
J	Hari, P; Raivonen, M; Vesala, T; Munger, JW; Pilegaard, K; Kulmala, M				Hari, P; Raivonen, M; Vesala, T; Munger, JW; Pilegaard, K; Kulmala, M			Atmospheric science - Ultraviolet light and leaf emission of NOx	NATURE			English	Article							FLUX; CHEMISTRY		Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Riso Natl Lab, Plant Res Dept, DK-4000 Roskilde, Denmark	University of Helsinki; University of Helsinki; Harvard University; Technical University of Denmark	Hari, P (corresponding author), Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland.		Pilegaard, Kim/I-7137-2013; Munger, J William/H-4502-2013; Pilegaard, Kim/H-9026-2019; Vesala, Timo/C-3795-2017; Kulmala, Markku T/I-7671-2016	Pilegaard, Kim/0000-0002-5169-5717; Munger, J William/0000-0002-1042-8452; Pilegaard, Kim/0000-0002-5169-5717; Vesala, Timo/0000-0002-4852-7464; Kulmala, Markku T/0000-0003-3464-7825; Raivonen, Maarit/0000-0002-8987-4972				Altimir N, 2002, ATMOS ENVIRON, V36, P19, DOI 10.1016/S1352-2310(01)00478-2; CONRAD R, 1994, BIOGEOCHEMISTRY, V27, P155, DOI 10.1007/BF00000582; ESALA T, 1998, TRENDS HEAT MASS MOM, V4, P17; Hari P, 1999, PLANT CELL ENVIRON, V22, P1297, DOI 10.1046/j.1365-3040.1999.00478.x; Hereid DP, 2001, ATMOS ENVIRON, V35, P975, DOI 10.1016/S1352-2310(00)00342-3; Honrath RE, 2000, J GEOPHYS RES-ATMOS, V105, P24183, DOI 10.1029/2000JD900361; Lerdau MT, 2000, SCIENCE, V289, P2291, DOI 10.1126/science.289.5488.2291; RONDON A, 1994, TELLUS B, V46, P339, DOI 10.1034/j.1600-0889.1994.t01-4-00001.x; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Sparks JP, 2001, OECOLOGIA, V127, P214, DOI 10.1007/s004420000594; Wildt J, 1997, J GEOPHYS RES-ATMOS, V102, P5919, DOI 10.1029/96JD02968	11	42	46	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					134	134		10.1038/422134a	http://dx.doi.org/10.1038/422134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634774	Bronze			2022-12-01	WOS:000181488900033
J	Knight, J				Knight, J			NASA seeks inspiration from microscopic views of life	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					878	878		10.1038/421878b	http://dx.doi.org/10.1038/421878b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606959	Bronze			2022-12-01	WOS:000181186900005
J	Sugita, Y; Suzuki, Y				Sugita, Y; Suzuki, Y			Audiovisual perception - Implicit estimation of sound-arrival time	NATURE			English	Editorial Material									Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3004201, Japan; Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Tohoku University	Sugita, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Teragu Hakusan 1497-1, Tsukuba, Ibaraki 3004201, Japan.							McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669	3	141	142	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					911	911		10.1038/421911a	http://dx.doi.org/10.1038/421911a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606990				2022-12-01	WOS:000181186900037
J	Hinrichs, KU; Hmelo, LR; Sylva, SP				Hinrichs, KU; Hmelo, LR; Sylva, SP			Molecular fossil record of elevated methane levels in late pleistocene coastal waters	SCIENCE			English	Article							SANTA-BARBARA BASIN; MARINE-SEDIMENTS; SUBDUCTION ZONE; GAS HYDRATE; OXIDATION; DISSOCIATION; PALEOCENE; LIPIDS; OCEAN; SEEPS	Accumulating evidence suggests that methane has been released episodically from hydrates trapped in sea floor sediments during many intervals of rapid climate warming. Here we show that sediments from the Santa Barbara Basin deposited during warm intervals in the last glacial period contain molecular fossils that are diagnostic of aerobic and anaerobic methanotrophs. Sediment intervals with high abundances of these compounds indicate episodes of vigorous methanotrophic activity in methane-laden water masses. Signals for anaerobic methanotrophy in 44, 100-year-old sediment are evidence for particularly intense methane emissions and suggest that the basin's methane cycle can profoundly affect oxygen budgets in the water column.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hinrichs, KU (corresponding author), Univ Bremen, DFG Res Ctr Ocean Margins, POB 330 440, D-28334 Bremen, Germany.	khinrichs@uni-bremen.de	Sylva, Sean/D-4400-2014; Hinrichs, Kai-Uwe/C-7675-2009	Sylva, Sean/0000-0002-4727-440X; Hinrichs, Kai-Uwe/0000-0002-0739-9291				Behl R. J., 1995, P OCEAN DRILL PROGRA, V146, P295; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Bohrmann G, 1998, GEOLOGY, V26, P647, DOI 10.1130/0091-7613(1998)026<0647:ACFTCS>2.3.CO;2; Clark JF, 2000, J GEOPHYS RES-OCEANS, V105, P11509, DOI 10.1029/2000JC000259; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Dickens GR, 2000, B SOC GEOL FR, V171, P37; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HEESCHEN K, 2002, GEOL SOC AM ABSTR, V34, P35231; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hinrichs KU, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000286; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; Hinrichs KU, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; HINRICHS KU, UNPUB; Kennett J. P., 2003, METHANE HYDRATES QUA; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kuwabara JS, 1999, GEOCHIM COSMOCHIM AC, V63, P2199, DOI 10.1016/S0016-7037(99)00084-8; LANGWORTHY TA, 1986, SYST APPL MICROBIOL, V7, P253; Pancost RD, 2001, ORG GEOCHEM, V32, P695, DOI 10.1016/S0146-6380(01)00015-8; REEBURGH WS, 1991, DEEP-SEA RES, V38, pS1189; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Schimmelmann A, 1991, GLOBAL BIOGEOCHEM CY, V5, P173, DOI 10.1029/91GB00382; Stott LD, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000196; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; VANGEEN A, 1995, PALEOCEANOGRAPHY, V10, P159, DOI 10.1029/94PA03352; WAKEHAM SG, IN PRESS GEOCHIM COS; WARD BB, 1987, NATURE, V327, P226, DOI 10.1038/327226a0; WEFER G, 1994, NATURE, V369, P282, DOI 10.1038/369282a0	30	83	95	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1214	1217		10.1126/science.1079601	http://dx.doi.org/10.1126/science.1079601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595688				2022-12-01	WOS:000181065500035
J	Krasilnikov, AS; Yang, XJ; Pan, T; Mondragon, A				Krasilnikov, AS; Yang, XJ; Pan, T; Mondragon, A			Crystal structure of the specificity domain of ribonuclease P	NATURE			English	Article							SUBTILIS RNASE-P; IN-VITRO SELECTION; PRE-TRANSFER-RNA; MACROMOLECULAR STRUCTURES; TERTIARY INTERACTIONS; RIBOZYME; RECOGNITION; EVOLUTION; SUBSTRATE; SUBUNIT	RNase P is the only endonuclease responsible for processing the 5' end of transfer RNA by cleaving a precursor and leading to tRNA maturation(1,2). It contains an RNA component and a protein component and has been identified in all organisms. It was one of the first catalytic RNAs identified(3) nd the first that acts as a multiple-turnover enzyme in vivo. RNase P and the ribosome are so far the only two ribozymes known to be conserved in all kingdoms of life. The RNA component of bacterial RNase P can catalyse pre-tRNA cleavage in the absence of the RNase P protein in vitro and consists of two domains: a specificity domain and a catalytic domain(4,5). Here we report a 3.15-Angstrom resolution crystal structure of the 154-nucleotide specificity domain of Bacillus subtilis RNase P. The structure reveals the architecture of this domain, the interactions that maintain the overall fold of the molecule, a large non-helical but well-structured module that is conserved in all RNase P RNA, and the regions that are involved in interactions with the substrate.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu						Altman S., 1999, RNA WORLD, P351; Barrera A, 2002, BIOCHEMISTRY-US, V41, P12986, DOI 10.1021/bi020416k; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen JL, 1997, RNA, V3, P557; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; NOLAN JM, 1993, SCIENCE, V261, P762, DOI 10.1126/science.7688143; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; PAN T, 1995, BIOCHEMISTRY-US, V34, P8458, DOI 10.1021/bi00026a029; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Qin H, 2001, BIOCHEMISTRY-US, V40, P11202, DOI 10.1021/bi010076n; TANNER MA, 1995, RNA, V1, P349	29	188	201	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					760	764		10.1038/nature01386	http://dx.doi.org/10.1038/nature01386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610630				2022-12-01	WOS:000180938000048
J	Reynolds, SJ; Bartlett, JG; Quinn, TC; Beyrer, C; Bollinger, RC				Reynolds, SJ; Bartlett, JG; Quinn, TC; Beyrer, C; Bollinger, RC			Antiretroviral therapy where resources are limited	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUG-RESISTANCE; POOR SETTINGS; COTE-DIVOIRE; HIV; ADULTS; TUBERCULOSIS; INFECTION; SURVIVAL; ABIDJAN; AFRICA		Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Reynolds, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.		safaiee, malihe/C-5045-2018; Zolfigol, Mohammad Ali/AAH-9281-2020; Habibi, Davood/AAH-3062-2020	Habibi, Davood/0000-0002-2386-8502; Bollinger, Robert/0000-0002-6798-6834; Reynolds, Steven/0000-0002-5403-2759	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, Z01AI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adje C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bell JC, 1999, AIDS, V13, P1549, DOI 10.1097/00002030-199908200-00016; Brenner B, 2000, INT J ANTIMICROB AG, V16, P429, DOI 10.1016/S0924-8579(00)00270-3; *BRIT HIV ASS, 2002, GUID TREATM HIV INF; Casseb J, 1999, AIDS PATIENT CARE ST, V13, P213, DOI 10.1089/apc.1999.13.213; *DEP HLTH HUM SERV, 2002, GUID US ANT AG HIV I; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; *GLOB FUND FIGHT A, 2002, PROP COMP APPR FUND; Kam KM, 1998, CLIN IMMUNOL IMMUNOP, V89, P11, DOI 10.1006/clin.1998.4570; Kannangai R, 2000, J CLIN VIROL, V17, P101, DOI 10.1016/S1386-6532(00)00080-9; Kebba A, 2002, AIDS RES HUM RETROV, V18, P1181, DOI 10.1089/08892220260387922; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Mbewu A, 2001, B WORLD HEALTH ORGAN, V79, P1152; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Vergne L, 2002, J ACQ IMMUN DEF SYND, V29, P165, DOI 10.1097/00042560-200202010-00009; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2002, SCAL ANT THER RES LI; *WHO UNAIDS, 2000, WHO UNAIDS HAIL CONS; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	25	24	25	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1806	1809		10.1056/NEJMsb035366	http://dx.doi.org/10.1056/NEJMsb035366			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724489	Bronze			2022-12-01	WOS:000182543500012
J	Shedlock, DJ; Shen, H				Shedlock, DJ; Shen, H			Requirement for CD4 T cell help in generating functional CD8 T cell memory	SCIENCE			English	Article							CD4-DEFICIENT MICE; VIRAL-INFECTION; VIRUS CHALLENGE; RESPONSES; IMMUNIZATION; LYMPHOCYTES	Although primary CD8 responses to acute infections are independent of CD4 help, it is unknown whether a similar situation applies to secondary responses. We show that depletion of CD4 cells during the recall response has minimal effect, whereas depletion during the priming phase leads to reduced responses by memory CD8 cells to reinfection. Memory CD8 cells generated in CD4(+/+) mice responded normally when transferred into CD4(-/-) hosts, whereas memory CD8 cells generated in CD4(-/-) mice mounted defective recall responses in CD4(-/-) adoptive hosts. These results demonstrate a previously undescribed role for CD4 help in the development of functional CD8 memory.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Shen, H (corresponding author), Univ Penn, Sch Med, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.			Shedlock, Devon/0000-0003-1018-7510	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045025] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45025, AI07632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belz GT, 2000, P NATL ACAD SCI USA, V97, P2725, DOI 10.1073/pnas.040575197; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Liu HY, 2002, J IMMUNOL, V168, P3477, DOI 10.4049/jimmunol.168.7.3477; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; WHITTON JL, 1993, J VIROL, V67, P348, DOI 10.1128/JVI.67.1.348-352.1993; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	20	1156	1204	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					337	339		10.1126/science.1082305	http://dx.doi.org/10.1126/science.1082305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690201				2022-12-01	WOS:000182135400059
J	Li, XY; Qian, Q; Fu, ZM; Wang, YH; Xiong, GS; Zeng, DL; Wang, XQ; Liu, XF; Teng, S; Hiroshi, F; Yuan, M; Luo, D; Han, B; Li, JY				Li, XY; Qian, Q; Fu, ZM; Wang, YH; Xiong, GS; Zeng, DL; Wang, XQ; Liu, XF; Teng, S; Hiroshi, F; Yuan, M; Luo, D; Han, B; Li, JY			Control of tillering in rice	NATURE			English	Article							CELL-DIVISION; SIGNAL-TRANSDUCTION; ARABIDOPSIS ROOT; GENE ENCODES; PATHWAY; FAMILY; GRAS; EVOLUTION; PROTEIN; MEMBER	Tillering in rice (Oryza sativa L.) is an important agronomic trait for grain production, and also a model system for the study of branching in monocotyledonous plants. Rice tiller is a specialized grain-bearing branch that is formed on the unelongated basal internode and grows independently of the mother stem (culm) by means of its own adventitious roots(1). Rice tillering occurs in a two-stage process: the formation of an axillary bud at each leaf axil and its subsequent outgrowth(2). Although the morphology and histology(2,3) and some mutants of rice tillering(4) have been well described, the molecular mechanism of rice tillering remains to be elucidated. Here we report the isolation and characterization of MONOCULM 1 (MOC1), a gene that is important in the control of rice tillering. The moc1 mutant plants have only a main culm without any tillers owing to a defect in the formation of tiller buds. MOC1 encodes a putative GRAS family nuclear protein that is expressed mainly in the axillary buds and functions to initiate axillary buds and to promote their outgrowth.	Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Chinese Acad Agr Sci, China Natl Rice Res Inst, Hangzhou 310006, Zhejiang, Peoples R China; China Agr Univ, Beijing 100094, Peoples R China; Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; Chinese Acad Sci, Natl Ctr Gene Res, Shanghai 200233, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; China Agricultural University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.		Li, Jiayang/AAG-4377-2020; qian, qian/AAH-8708-2021	Li, Xueyong/0000-0002-8955-0345				[Anonymous], 1995, RICE GENET NEWSLETT; Bolle C, 2000, GENE DEV, V14, P1269; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; FOBERT PR, 1994, EMBO J, V13, P616, DOI 10.1002/j.1460-2075.1994.tb06299.x; Hanada K, 1993, SCI RICE PLANT, V1, P222; Hanada K., 1995, SCI RICE PLANT PHYSL, V2, P61; Harushima Y, 1998, GENETICS, V148, P479; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu YX, 2000, PLANT J, V24, P693, DOI 10.1046/j.1365-313x.2000.00915.x; Hubbard L, 2002, GENETICS, V162, P1927; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; KATAYAMA TUKUDA, 1931, JOUR IMP AGRIC EXP STA [TOKYO] [NOJI SHIKEN JO IHO], V1, P327; Li YH, 1979, MORPHOLOGY ANATOMY G, P138; Lukens L, 2001, MOL BIOL EVOL, V18, P627, DOI 10.1093/oxfordjournals.molbev.a003843; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Richards DE, 2000, BIOESSAYS, V22, P573, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;573::AID-BIES10&gt;3.0.CO;2-H; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Smith HMS, 1997, PLANT PHYSIOL, V114, P411, DOI 10.1104/pp.114.2.411; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895	29	731	981	27	428	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					618	621		10.1038/nature01518	http://dx.doi.org/10.1038/nature01518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687001				2022-12-01	WOS:000182111400043
J	Schadt, EE; Monks, SA; Drake, TA; Lusis, AJ; Che, N; Colinayo, V; Ruff, TG; Milligan, SB; Lamb, JR; Cavet, G; Linsley, PS; Mao, M; Stoughton, RB; Friend, SH				Schadt, EE; Monks, SA; Drake, TA; Lusis, AJ; Che, N; Colinayo, V; Ruff, TG; Milligan, SB; Lamb, JR; Cavet, G; Linsley, PS; Mao, M; Stoughton, RB; Friend, SH			Genetics of gene expression surveyed in maize, mouse and man	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; MODEL; SUSCEPTIBILITY; IDENTIFICATION; DISSECTION; DENSITY; LINKAGE; MICE	Treating messenger RNA transcript abundances as quantitative traits and mapping gene expression quantitative trait loci for these traits has been pursued in gene-specific ways. Transcript abundances often serve as a surrogate for classical quantitative traits in that the levels of expression are significantly correlated with the classical traits across members of a segregating population. The correlation structure between transcript abundances and classical traits has been used to identify susceptibility loci for complex diseases such as diabetes' and allergic asthma(2). One study recently completed the first comprehensive dissection of transcriptional regulation in budding yeast(3), giving a detailed glimpse of a genome-wide survey of the genetics of gene expression. Unlike classical quantitative traits, which often represent gross clinical measurements that may be far removed from the biological processes giving rise to them, the genetic linkages associated with transcript abundance affords a closer look at cellular biochemical processes. Here we describe comprehensive genetic screens of mouse, plant and human transcriptomes by considering gene expression values as quantitative traits. We identify a gene expression pattern strongly associated with obesity in a murine cross, and observe two distinct obesity subtypes. Furthermore, we find that these obesity subtypes are under the control of different loci.	Rosetta Inpharmat LLC, Kirkland, WA 98034 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Monsanto Co, St Louis, MO 63167 USA; Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA	Merck & Company; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Monsanto; Merck & Company	Schadt, EE (corresponding author), Rosetta Inpharmat LLC, 12040 115th Ave NE, Kirkland, WA 98034 USA.	eric_schadt@merck.com; stephen_friend@merck.com	Califano, Andrea/F-7239-2012					AMOS CI, 1994, AM J HUM GENET, V54, P535; BASTEN CA, 1999, QTL CARTOGRAPHER USE; Borecki I B, 1994, Obes Res, V2, P213; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Byrne PF, 1996, P NATL ACAD SCI USA, V93, P8820, DOI 10.1073/pnas.93.17.8820; CAUSSE M, 1995, MOL BREEDING, V1, P259, DOI 10.1007/BF02277426; Claudio L, 1997, FUND APPL TOXICOL, V35, P84, DOI 10.1006/faat.1996.2265; DAMERVAL C, 1994, GENETICS, V137, P289; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Drake TA, 2001, PHYSIOL GENOMICS, V5, P205, DOI 10.1152/physiolgenomics.2001.5.4.205; Eaves IA, 2002, GENOME RES, V12, P232, DOI 10.1101/gr.214102. Article published online before print in January 2002; Fisch RD, 1996, GENETICS, V143, P571; Huang YH, 2002, NUCLEIC ACIDS RES, V30, P186, DOI 10.1093/nar/30.1.186; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; LINCOLN SE, 1993, MAPMAKERQTL USERS MA; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Swift LL, 2001, J LIPID RES, V42, P218; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; TOSATIO G, 1991, CURR PROTOC IMMUNOL, V1; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yan L, 1998, DNA CELL BIOL, V17, P659, DOI 10.1089/dna.1998.17.659	25	1088	1152	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					297	302		10.1038/nature01434	http://dx.doi.org/10.1038/nature01434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646919				2022-12-01	WOS:000181637300037
J	Moller, JE; Connolly, HM; Rubin, J; Seward, JB; Modesto, K; Pellikka, PA				Moller, JE; Connolly, HM; Rubin, J; Seward, JB; Modesto, K; Pellikka, PA			Factors associated with progression of carcinoid heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRICUSPID REGURGITATION; NEUROENDOCRINE TUMORS; SOMATOSTATIN ANALOG; ENDOCRINE TUMORS; PHASE-II; SEROTONIN; OCTREOTIDE; EFFICACY; ECHOCARDIOGRAPHY; ABNORMALITIES	Background: By releasing vasoactive substances into the circulation, carcinoid tumors can cause right-sided valvular heart disease. Factors associated with the progression of carcinoid heart disease are poorly understood. We conducted a retrospective study to identify such factors. Methods: Our sample included 71 patients with the carcinoid syndrome who underwent serial echocardiographic studies performed more than one year apart and 32 patients referred directly for surgical intervention after an initial echocardiographic evaluation. A score for carcinoid heart disease was determined on the basis of an assessment of valvular anatomy and function and the function of the right ventricle. An increase of more than 25 percent in the score between studies was considered suggestive of disease progression. Tumor progression was assessed on the basis of abdominal computed tomographic scans and changes in the level of urinary 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of serotonin. Results: Of the patients with serial echocardiographic studies, 25 (35 percent) had an increase of more than 25 percent in the cardiac score. As compared with patients whose score changed by 25 percent or less, these patients had higher urinary peak 5-HIAA levels (median, 265 mg per 24 hours [interquartile range, 209 to 593] vs. 189 mg per 24 hours [interquartile range, 75 to 286]; P=0.004) and were more likely to have biochemical progression (10 of 25 patients vs. 9 of 46, P=0.05) and to have received chemotherapy (13 of 25 vs. 10 of 46, P=0.009). Logistic-regression analysis showed that a higher peak urinary 5-HIAA level and previous chemotherapy were predictors of an increase in the cardiac score that exceeded 25 percent (odds ratio for each increase in 5-HIAA of 25 mg per 24 hours, 1.08 [95 percent confidence interval, 1.03 to 1.13]; P=0.009); odds ratio associated with chemotherapy, 3.65 [95 percent confidence interval, 1.74 to 7.48]; P=0.001). Conclusions: Serotonin is related to the progression of carcinoid heart disease, and the risk of progressive heart disease is higher in patients who receive chemotherapy than in those who do not.	Mayo Clin & Mayo Fdn, Echocardiog Lab, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Med Oncol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Pellikka, PA (corresponding author), Mayo Clin & Mayo Fdn, Echocardiog Lab, Div Cardiovasc Dis, Gonda 6-138 NW,200 1st St SW, Rochester, MN 55905 USA.		Pellikka, Patricia A/N-5387-2014	Pellikka, Patricia A/0000-0001-6800-3521; Moller, Jacob Eifer/0000-0003-2873-5845				Ansell SM, 2001, CANCER-AM CANCER SOC, V91, P1543, DOI 10.1002/1097-0142(20010415)91:8<1543::AID-CNCR1163>3.0.CO;2-N; Caplin ME, 1998, LANCET, V352, P799, DOI 10.1016/S0140-6736(98)02286-7; CUBEDDU LX, 1992, BRIT J CANCER, V66, P198, DOI 10.1038/bjc.1992.242; CUBEDDU LX, 1990, NEW ENGL J MED, V322, P810, DOI 10.1056/NEJM199003223221204; Denney WD, 1998, J AM COLL CARDIOL, V32, P1017, DOI 10.1016/S0735-1097(98)00354-4; DiBartolomeo M, 1996, CANCER-AM CANCER SOC, V77, P402, DOI 10.1002/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4; Eriksson BK, 1998, CANCER, V83, P2293, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E; KUBOTA A, 1994, J CLIN INVEST, V93, P1321, DOI 10.1172/JCI117090; Kulke MH, 1999, NEW ENGL J MED, V340, P858, DOI 10.1056/NEJM199903183401107; KVOLS LK, 1986, NEW ENGL J MED, V315, P663, DOI 10.1056/NEJM198609113151102; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; LUNDIN L, 1988, CIRCULATION, V77, P264, DOI 10.1161/01.CIR.77.2.264; Modlin IM, 1997, CANCER-AM CANCER SOC, V79, P813, DOI 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2; OBERG K, 1987, ACTA ONCOL, V26, P429; Oberg K, 2001, ANN ONCOL, V12, pS111, DOI 10.1093/annonc/12.suppl_2.S111; PELLIKKA PA, 1993, CIRCULATION, V87, P1188, DOI 10.1161/01.CIR.87.4.1188; PENNESTRI F, 1984, AM J CARDIOL, V54, P363, DOI 10.1016/0002-9149(84)90198-X; Rajamannan NM, 2001, J HEART VALVE DIS, V10, P827; Rivera J M, 1994, J Am Soc Echocardiogr, V7, P480; ROBIOLIO PA, 1995, CIRCULATION, V92, P790, DOI 10.1161/01.CIR.92.4.790; Roy A, 2000, J HEART VALVE DIS, V9, P256; Rubin J, 1999, J CLIN ONCOL, V17, P600, DOI 10.1200/JCO.1999.17.2.600; RUSZNIEWSKI P, 1993, CANCER, V71, P2624, DOI 10.1002/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; SUZUKI Y, 1986, AM J CARDIOL, V57, P811, DOI 10.1016/0002-9149(86)90619-3	25	194	198	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2003	348	11					1005	1015		10.1056/NEJMoa021451	http://dx.doi.org/10.1056/NEJMoa021451			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653YT	12637610				2022-12-01	WOS:000181465200005
J	Ruta, V; Jiang, YX; Lee, A; Chen, JY; MacKinnon, R				Ruta, V; Jiang, YX; Lee, A; Chen, JY; MacKinnon, R			Functional analysis of an archaebacterial voltage-dependent K+ channel	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; GATING MODIFIER; ION CHANNELS; WILD-TYPE; CHARYBDOTOXIN; ACTIVATION; PEPTIDE; INACTIVATION; HANATOXIN; SEQUENCE	All living organisms use ion channels to regulate the transport of ions across cellular membranes'. Certain ion channels are classed as voltage-dependent because they have a voltage-sensing structure that induces their pores to open in response to changes in the cell membrane voltage. Until recently, the voltage-dependent K+, Ca2+ and Na+ channels were regarded as a unique development of eukaryotic cells, adapted to accomplish specialized electrical signalling, as exemplified in neurons. Here we present the functional characterization of a voltage-dependent K+ (K-V) channel from a hyperthermophilic archaebacterium from an oceanic thermal vent. This channel possesses all the functional attributes of classical neuronal K-V channels. The conservation of function reflects structural conservation in the voltage sensor as revealed by specific, high-affinity interactions with tarantula venom toxins, which evolved to inhibit eukaryotic K-V channels.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	30	205	216	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					180	185		10.1038/nature01473	http://dx.doi.org/10.1038/nature01473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12629550				2022-12-01	WOS:000181488900049
J	Fan, ZS; Beresford, PJ; Oh, DY; Zhang, D; Lieberman, J				Fan, ZS; Beresford, PJ; Oh, DY; Zhang, D; Lieberman, J			Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor	CELL			English	Article							DIPHOSPHATE KINASE; HISTONE ACETYLATION; CELL-DEATH; FRAGMENTATION; REPAIR; CLEAVAGE; TARGET; TRANSCRIPTION; NUCLEASE; GENE	Granzyme A (GzmA) induces a caspase-independent cell death pathway characterized by single-stranded DNA nicks and other features of apoptosis. A GzmA-activated DNase (GAAD) is in an ER associated complex containing pp32 and the GzmA substrates SET, HMG-2, and Ape1. We show that GAAD is NM23-H1, a nucleoside diphosphate kinase implicated in suppression of tumor metastasis, and its specific inhibitor (IGAAD) is SET. NM23-H1 binds to SET and is released from inhibition by GzmA cleavage of SET. After GzmA loading or CTL attack, SET and NM23-H1 translocate to the nucleus and SET is degraded, allowing NM23-H1 to nick chromosomal DNA. GzmA-treated cells with silenced NM23-H1 expression are resistant to GzmA-mediated DNA damage and cytolysis, while cells over-expressing NM23-H1 are more sensitive.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015	ZHANG, DONG/0000-0002-1068-8334	NIAID NIH HHS [AI45587] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045587, R56AI045587] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Jans DA, 1999, J BIOL CHEM, V274, P3953, DOI 10.1074/jbc.274.7.3953; KOKILEVA L, 1994, INT ARCH ALLERGY IMM, V105, P339, DOI 10.1159/000236779; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Krystosek A, 1999, HISTOCHEM CELL BIOL, V111, P265, DOI 10.1007/s004180050357; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LAGARKOVA MA, 1995, J BIOL CHEM, V270, P20239, DOI 10.1074/jbc.270.35.20239; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P213; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Monteiro ANA, 2000, TRENDS BIOCHEM SCI, V25, P469, DOI 10.1016/S0968-0004(00)01632-7; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; Postel EH, 2002, BIOCHEMISTRY-US, V41, P6330, DOI 10.1021/bi025606+; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Postel EH, 2000, P NATL ACAD SCI USA, V97, P14194, DOI 10.1073/pnas.97.26.14194; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; Toh SY, 1998, BIOCHEM BIOPH RES CO, V250, P598, DOI 10.1006/bbrc.1998.9369; WEAVER VM, 1993, BIOCHEM CELL BIOL, V71, P488, DOI 10.1139/o93-071; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	50	436	470	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					659	672		10.1016/S0092-8674(03)00150-8	http://dx.doi.org/10.1016/S0092-8674(03)00150-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628186	Bronze			2022-12-01	WOS:000181443600009
J	Olesen, AW; Basso, O				Olesen, AW; Basso, O			Risk of recurrence of prolonged pregnancy	BRITISH MEDICAL JOURNAL			English	Article							POSTTERM		Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University	Olesen, AW (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark.		Basso, Olga/E-5384-2010	Basso, Olga/0000-0001-9298-4921; Olesen, Annette Wind/0000-0002-0586-4815				Campbell MK, 1997, OBSTET GYNECOL, V89, P543; Mackie J. L., 1974, CEMENT UNIVERSE STUD; Olsen J, 1997, EPIDEMIOLOGY, V8, P6, DOI 10.1097/00001648-199701000-00001; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Stornes I, 1996, Ugeskr Laeger, V158, P422	5	33	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					476	476		10.1136/bmj.326.7387.476	http://dx.doi.org/10.1136/bmj.326.7387.476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609943	Green Published, Bronze			2022-12-01	WOS:000181421400017
J	Moreno, MA				Moreno, MA			The cross-cover resident	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					956	957		10.1001/jama.289.8.956	http://dx.doi.org/10.1001/jama.289.8.956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597732				2022-12-01	WOS:000181129800001
J	Sehgal, AR				Sehgal, AR			Impact of quality improvement efforts on race and sex disparities in hemodialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALBUMIN CONCENTRATION; ETHNIC DISPARITIES; OF-LIFE; HEALTH; PREDICTORS; CARE; INEQUALITY; MORTALITY; SURVIVAL; DIALYSIS	Context By improving the process of care, quality improvement efforts have the potential to reduce race and sex disparities. However, little is known about whether reductions actually occur. National quality improvement activities targeting hemodialysis patients provide an opportunity to examine this issue. Objective To determine the effect of quality improvement efforts on race and sex disparities among hemodialysis patients. Design, Setting, and Subjects Longitudinal study of 58700 randomly selected hemodialysis patients from throughout the United States in 1993 through 2000. Intervention Medicare-funded quality improvement project involving monitoring of patient outcomes, feedback of performance data, and education of clinicians at dialysis centers. Main Outcome Measures Changes in hemodialysis dose (Kt/V), anemia management (hemoglobin level), and nutritional status (albumin level). Results The proportion of all patients with an adequate hemodialysis dose increased 2-fold. In 1993, 46% of white patients and 36% of black patients received an adequate hemodialysis dose compared with 2000 when the proportions were 87% and 84%, respectively. Thus, the gap between white and black patients decreased from 10% to 3% (P<.001). The gap between female and male patients decreased from 23% to 9% over the same period (P=.008). The proportion of all patients with adequate hemoglobin levels increased 3-fold. The proportion of all patients with adequate albumin levels remained unchanged. Race and sex disparities in anemia management and nutritional status did not change significantly. Conclusions Quality improvement efforts have a variable impact on race and sex disparities in health outcomes. Further work is needed to determine how quality improvement methods can be targeted to reduce health disparities.	Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA; Case Western Reserve Univ, Metrohlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Biomed Eth, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sehgal, AR (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	axs81@po.cwru.edu			NIDDK NIH HHS [DK54178, DK51472] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051472, P50DK054178] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; [Anonymous], 1997, Am J Kidney Dis, V30, pS15; [Anonymous], 1997, Am J Kidney Dis, V30, pS192; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bierman A S, 2001, J Am Med Womens Assoc (1972), V56, P155; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272, DOI 10.1016/S0272-6386(12)80984-X; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Hakim RM, 2001, HDB DIALYSIS, V3rd, P236; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; *HLTH CAR FIN ADM, 1994, ANN REP END STAG REN; IGLEHART JK, 1993, NEW ENGL J MED, V328, P366, DOI 10.1056/NEJM199302043280528; Kaysen GA, 1997, AM J KIDNEY DIS, V29, P658, DOI 10.1016/S0272-6386(97)90117-7; KEPPEL KG, 2002, HLTH PEOPLE 2000 STA, V23, P1; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Leon JB, 2001, AM J NEPHROL, V21, P200, DOI 10.1159/000046248; Leon JB, 2001, J RENAL NUTR, V11, P9, DOI 10.1016/S1051-2276(01)79890-1; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; McClellan WM, 1999, AM J KIDNEY DIS, V34, P1075, DOI 10.1016/S0272-6386(99)70013-2; McClellan WM, 1998, AM J KIDNEY DIS, V31, P584, DOI 10.1053/ajkd.1998.v31.pm9531173; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS1, DOI DOI 10.1053/KD.2000.6671; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; SCHOENBACH VJ, 2002, AM PUBL HLTH ASS ANN; Sehgal A R, 1998, J Ren Nutr, V8, P179, DOI 10.1016/S1051-2276(98)90016-4; Sehgal AR, 2002, JAMA-J AM MED ASSOC, V287, P1961, DOI 10.1001/jama.287.15.1961; Sehgal AR, 2001, AM J KIDNEY DIS, V37, P1223, DOI 10.1053/ajkd.2001.24526; Smith JL, 2001, MED CARE, V39, P910, DOI 10.1097/00005650-200109000-00002; Stamler R, 1987, HYPERTENSION, V9, P641; *US DEPT HHS, 1998, 1998 ANN REP END STA; *US DEPT HHS, 1996, 1995 ANN REP END STA; *US DEPT HHS, 1999, 1999 ANN REP END STA; *US DEPT HHS, 1997, 1997 ANN REP END STA; *US DEPT HHS, 2000, 2000 ANN REP END STA; *US DEPT HHS, 1997, 1996 ANN REP END STA; *US DHHS, 2001, 2001 ANN REP END STA; *USRDS, 2002, 2002 ANN DAT REP; Williams DR, 2000, HEALTH CARE FINANC R, V21, P75	40	143	145	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					996	1000		10.1001/jama.289.8.996	http://dx.doi.org/10.1001/jama.289.8.996			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597751	Bronze			2022-12-01	WOS:000181129800025
J	Catteruccia, F; Godfray, HCJ; Crisanti, A				Catteruccia, F; Godfray, HCJ; Crisanti, A			Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes	SCIENCE			English	Article							GERMLINE TRANSFORMATION; MALARIA; VECTOR	Genetic modification of mosquitoes offers exciting possibilities for controlling malaria, but success will depend on how transformation affects the fitness of modified insects. The expression of an exogenous gene, the mutations caused by its insertion, and inbreeding while transformed lines are established can all lead to reductions in fitness. Factors influencing fitness were investigated in cage experiments with four lines of transgenic Anopheles stephensi, a vector species of human malaria. The results indicate direct costs of the introduced transgene in at least three out of the four lines, as well as an apparent cost of the inbreeding involved in making transgenic homozygotes.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Perugia, I-06100 Perugia, Italy	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, SAF Bldg,S Kensington Campus, London SW7 2AZ, England.	acrs@ic.ac.uk		Catteruccia, Flaminia/0000-0003-3295-6683; Crisanti, Andrea/0000-0002-2406-4426	Biotechnology and Biological Sciences Research Council [S19551] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Arca B, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P483; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Hartl D.L., 1997, PRINCIPLES POPULATIO; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nolan T, 2002, J BIOL CHEM, V277, P8759, DOI 10.1074/jbc.C100766200; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117	14	156	165	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1225	1227		10.1126/science.1081453	http://dx.doi.org/10.1126/science.1081453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595691				2022-12-01	WOS:000181065500038
J	Bates, SH; Stearns, WH; Dundon, TA; Schubert, M; Tso, AWK; Wang, YP; Banks, AS; Lavery, HJ; Haq, AK; Maratos-Flier, E; Neel, BG; Schwartz, MW; Myers, MG				Bates, SH; Stearns, WH; Dundon, TA; Schubert, M; Tso, AWK; Wang, YP; Banks, AS; Lavery, HJ; Haq, AK; Maratos-Flier, E; Neel, BG; Schwartz, MW; Myers, MG			STAT3 signalling is required for leptin regulation of energy balance but not reproduction	NATURE			English	Article							HYPOTHALAMIC NEURONS; CYTOKINE RECEPTORS; NEUROPEPTIDE-Y; POMC NEURONS; FEMALE MICE; EARLY-ONSET; OB-R; ACTIVATION; OBESITY; MOUSE	Secretion of leptin from adipocytes communicates body energy status to the brain by activating the leptin receptor long form (LRb). LRb regulates energy homeostasis and neuroendocrine function; the absence of LRb in db/db mice results in obesity, impaired growth, infertility and diabetes(1-4). Tyr 1138 of LRb mediates activation of the transcription factor STAT3 during leptin action(5-8). To investigate the contribution of STAT3 signalling to leptin action in vivo, we replaced the gene encoding the leptin receptor (lepr) in mice with an allele coding for a replacement of Tyr 1138 in LRb with a serine residue (lepr(S1138)) that specifically disrupts the LRb-STAT3 signal. Here we show that, like db/db mice, lepr(S1138) homozygotes (s/s) are hyperphagic and obese. However, whereas db/db mice are infertile, short and diabetic, s/s mice are fertile, long and less hyperglycaemic. Furthermore, hypothalamic expression of neuropeptide Y (NPY) is elevated in db/db mice but not s/s mice, whereas the hypothalamic melanocortin system is suppressed in both db/db and s/s mice. LRb-STAT3 signalling thus mediates the effects of leptin on melanocortin production and body energy homeostasis, whereas distinct LRb signals regulate NPY and the control of fertility, growth and glucose homeostasis.	Beth Israel Deaconess Med Ctr, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98122 USA	Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harborview Medical Center; University of Washington; University of Washington Seattle	Myers, MG (corresponding author), Beth Israel Deaconess Med Ctr, Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.		Schwartz, Michael W/H-9950-2012; Banks, Alexander/B-4832-2012; Schubert, Markus/F-5150-2010	Banks, Alexander/0000-0003-1787-6925; 				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; CATZEFLIS C, 1993, ENDOCRINOLOGY, V132, P224, DOI 10.1210/en.132.1.224; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Malik NM, 2001, ENDOCRINOLOGY, V142, P5198, DOI 10.1210/en.142.12.5198; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065	25	762	793	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					856	859		10.1038/nature01388	http://dx.doi.org/10.1038/nature01388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594516				2022-12-01	WOS:000181044700051
J	Genty, D; Blamart, D; Ouahdi, R; Gilmour, M; Baker, A; Jouzel, J; Van-Exter, S				Genty, D; Blamart, D; Ouahdi, R; Gilmour, M; Baker, A; Jouzel, J; Van-Exter, S			Precise dating of Dansgaard-Oeschger climate oscillations in western Europe from stalagmite data	NATURE			English	Article							LAST GLACIAL PERIOD; GREENLAND ICE-CORE; OXYGEN-ISOTOPE; SPELEOTHEMS; CAVE; RECORDS; PAST; TEMPERATURE; INSTABILITY; ANTARCTICA	The signature of Dansgaard-Oeschger events-millennial-scale abrupt climate oscillations during the last glacial period-is well established in ice cores and marine records(1-3). But the effects of such events in continental settings are not as clear, and their absolute chronology is uncertain beyond the limit of C-14 dating and annual layer counting for marine records and ice cores, respectively. Here we present carbon and oxygen isotope records from a stalagmite collected in southwest France which have been precisely dated using U-234/Th-230 ratios. We find rapid climate oscillations coincident with the established Dansgaard-Oeschger events between 83,000 and 32,000 years ago in both isotope records. The oxygen isotope signature is similar to a record from Soreq cave, Israel(4), and deep-sea records(5,6), indicating the large spatial scale of the climate oscillations. The signal in the carbon isotopes gives evidence of drastic and rapid vegetation changes in western Europe, an important site in human cultural evolution. We also find evidence for a long phase of extremely cold climate in southwest France between 61.2 6 +/- 0.6 and 67.4 +/- 0.9 kyr ago.	CEA, CNRS, UMR 1572, IPSL Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Open Univ, Dept Earth Sci, Uranium Series Facil, Milton Keynes MK7 6AA, Bucks, England; Univ Newcastle Upon Tyne, Ctr Land Use & Water Resouces Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Montpellier 2, Lab Hydrosci, CNRS,UMR 5569, IRD, F-34095 Montpellier 5, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Open University - UK; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Genty, D (corresponding author), CEA, CNRS, UMR 1572, IPSL Lab Sci Climat & Environm, Bat 709,Lorme Merisiers CEA Saclay, F-91191 Gif Sur Yvette, France.		Baker, Andy/O-5362-2019	Baker, Andy/0000-0002-1552-6166				Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; BAKER A, 1993, NATURE, V364, P518, DOI 10.1038/364518a0; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cayre O, 1999, PALEOCEANOGRAPHY, V14, P384, DOI 10.1029/1998PA900027; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dennis PF, 2001, GEOCHIM COSMOCHIM AC, V65, P871, DOI 10.1016/S0016-7037(00)00576-7; Dorale JA, 1998, SCIENCE, V282, P1871, DOI 10.1126/science.282.5395.1871; Genty D, 1996, J SEDIMENT RES, V66, P275; Genty D, 2001, GEOCHIM COSMOCHIM AC, V65, P3443, DOI 10.1016/S0016-7037(01)00697-4; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; GUIOT J, 1993, PALAEOGEOGR PALAEOCL, V103, P73, DOI 10.1016/0031-0182(93)90053-L; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Labeyrie L, 2000, SCIENCE, V290, P1905, DOI 10.1126/science.290.5498.1905; Lang C, 1999, SCIENCE, V286, P934, DOI 10.1126/science.286.5441.934; Mook W.G., 1980, HDB ENV ISOTOPE GEOC, P49, DOI DOI 10.1016/B978-0-444-41780-0.50008-0; ONEIL JR, 1969, J CHEM PHYS, V51, P5547, DOI 10.1063/1.1671982; ROZANSKI K, 1985, CHEM GEOL, V52, P349, DOI 10.1016/0168-9622(85)90045-4; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Stringer C, 2001, NATURE, V413, P791, DOI 10.1038/35101688; Urbanc J., 1985, ACTA CARSOLOGICA, V13, P99; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yiou F, 1997, J GEOPHYS RES-OCEANS, V102, P26783, DOI 10.1029/97JC01265	30	456	501	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					833	837		10.1038/nature01391	http://dx.doi.org/10.1038/nature01391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594510				2022-12-01	WOS:000181044700045
J	Cho, HS; Mason, K; Ramyar, KX; Stanley, AM; Gabelli, SB; Denney, DW; Leahy, DJ				Cho, HS; Mason, K; Ramyar, KX; Stanley, AM; Gabelli, SB; Denney, DW; Leahy, DJ			Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab	NATURE			English	Article							ERBB SIGNALING NETWORK; BREAST-CANCER; TRASTUZUMAB HERCEPTIN; MOLECULAR REPLACEMENT; MONOCLONAL-ANTIBODY; RECEPTORS; ONCOGENE; PROGRAM; DOMAIN; CELLS	HER2 (also known as Neu, ErbB2) is a member of the epidermal growth factor receptor (EGFR; also known as ErbB) family of receptor tyrosine kinases, which in humans includes HER1 (EGFR, ERBB1), HER2, HER3 (ERBB3) and HER4 (ERBB4)(1). ErbB receptors are essential mediators of cell proliferation and differentiation in the developing embryo and in adult tissues(2), and their inappropriate activation is associated with the development and severity of many cancers(3). Overexpression of HER2 is found in 20-30% of human breast cancers, and correlates with more aggressive tumours and a poorer prognosis(4). Anticancer therapies targeting ErbB receptors have shown promise, and a monoclonal antibody against HER2, Herceptin (also known as trastuzumab), is currently in use as a treatment for breast cancer(5). Here we report crystal structures of the entire extracellular regions of rat HER2 at 2.4 Angstrom and human HER2 complexed with the Herceptin antigen-binding fragment (Fab) at 2.5 Angstrom. These structures reveal a fixed conformation for HER2 that resembles a ligand-activated state, and show HER2 poised to interact with other ErbB receptors in the absence of direct ligand binding. Herceptin binds to the juxtamembrane region of HER2, identifying this site as a target for anticancer therapies.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Genitope Corp, Redwood City, CA 94063 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.		Gabelli, Sandra B/A-3705-2008; Mieszkowska, Magdalena/O-6753-2017	Gabelli, Sandra B/0000-0003-1205-5204; 				Banfield MJ, 1997, PROTEINS, V29, P161, DOI 10.1002/(SICI)1097-0134(199710)29:2<161::AID-PROT4>3.0.CO;2-G; Berezov A, 2002, J BIOL CHEM, V277, P28330, DOI 10.1074/jbc.M202880200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke CL, 1997, ONCOGENE, V14, P687, DOI 10.1038/sj.onc.1200873; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.bi.56.070187.004313; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; DENNEY DW, 1998, Patent No. 5776746; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FERGUSON KM, IN PRESS MOL CELL; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Molina MA, 2001, CANCER RES, V61, P4744; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Tang CK, 1998, HORMONES SIGNALING, P113; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	30	1119	1289	5	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					756	760		10.1038/nature01392	http://dx.doi.org/10.1038/nature01392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610629				2022-12-01	WOS:000180938000047
J	Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; Churakova, T; Zurawski, S; Wiekowski, M; Lira, SA; Gorman, D; Kastelein, RA; Sedgwick, JD				Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; Churakova, T; Zurawski, S; Wiekowski, M; Lira, SA; Gorman, D; Kastelein, RA; Sedgwick, JD			Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; IFN-GAMMA; ENCEPHALOMYELITIS; EXPRESSION; DISEASE; IL-12; MICE; ANTIBODIES; RESPONSES; IL-23	Interleukin-12 (IL-12) is a heterodimeric molecule composed of p35 and p40 subunits. Analyses in vitro have defined IL-12 as an important factor for the differentiation of naive T cells into T-helper type 1 CD4(+) lymphocytes secreting interferon-gamma (refs 1, 2). Similarly, numerous studies(3-7) have concluded that IL-12 is essential for T-cell-dependent immune and inflammatory responses in vivo, primarily through the use of IL-12 p40 gene-targeted mice and neutralizing antibodies against p40. The cytokine IL-23, which comprises the p40 subunit of IL-12 but a different p19 subunit(8), is produced predominantly by macrophages and dendritic cells, and shows activity on memory T cells. Evidence from studies of IL-23 receptor expression(9) and IL-23 overexpression in transgenic mice(10) suggest, however, that IL-23 may also affect macrophage function directly. Here we show, by using gene-targeted mice lacking only IL-23 and cytokine replacement studies, that the perceived central role for IL-12 in autoimmune inflammation, specifically in the brain, has been misinterpreted and that IL-23, and not IL-12, is the critical factor in this response. In addition, we show that IL-23, unlike IL-12, acts more broadly as an end-stage effector cytokine through direct actions on macrophages.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Genom, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Prot & Antibody Technol, Palo Alto, CA 94304 USA; Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Schering Plough Corporation	Cua, DJ (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, 901 Calif Ave, Palo Alto, CA 94304 USA.							Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Caspi NR, 1998, CLIN IMMUNOL IMMUNOP, V88, P4, DOI 10.1006/clin.1998.4540; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Constantinescu CS, 1998, J IMMUNOL, V161, P5097; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; FRUCHT DM, 2002, SCI STKE, V114; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; ISSAZADEH S, 1995, J NEUROIMMUNOL, V61, P205, DOI 10.1016/0165-5728(95)00100-G; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Leonard JP, 1996, ANN NY ACAD SCI, V795, P216, DOI 10.1111/j.1749-6632.1996.tb52671.x; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Matthys P, 2001, TRENDS IMMUNOL, V22, P367, DOI 10.1016/S1471-4906(01)01937-8; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Piccotti JR, 1998, J IMMUNOL, V160, P1132; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Willenborg DO, 1996, J IMMUNOL, V157, P3223	29	2154	2377	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					744	748		10.1038/nature01355	http://dx.doi.org/10.1038/nature01355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610626				2022-12-01	WOS:000180938000044
J	Mougeot, F; Redpath, SM; Leckie, F; Hudson, PJ				Mougeot, F; Redpath, SM; Leckie, F; Hudson, PJ			The effect of aggressiveness on the population dynamics of a territorial bird	NATURE			English	Article							HOST-PARASITE SYSTEM; RED GROUSE; TRICHOSTRONGYLUS-TENUIS; CYCLES; KIN; PREDATION; DENSITY; FLUCTUATIONS; PREVENTION; STABILITY	A central issue in ecology lies in identifying the importance of resources, natural enemies and behaviour in the regulation of animal populations. Much of the debate on this subject has focused on animals that show cyclic fluctuations in abundance(1-7). However, there is still disagreement about the role of extrinsic (food, parasites or predators) and intrinsic (behaviour) factors in causing cycles(2,8-10). Recent studies have examined the impact of natural enemies(1,3,4,7), although spatial patterns resulting from restricted dispersal or recruitment are increasingly recognized as having the potential to influence unstable population dynamics(5,6,11-13). We tested the hypothesis that population cycles in a territorial bird, red grouse Lagopus lagopus scoticus, are caused by delayed density-dependent changes in the aggressiveness and spacing behaviour of males. Here we show that increasing aggressiveness experimentally for a short period in autumn reduced recruitment and subsequent breeding density by 50%, and changed population trajectories from increasing to declining. Intrinsic processes can therefore have fundamental effects on population dynamics.	CEH Banchory, Banchory AB31 4BW, Aberdeen, Scotland; Univ Stirling, Dept Biol & Mol Sci, Stirling FK9 4LA, Scotland	UK Centre for Ecology & Hydrology (UKCEH); University of Stirling	Mougeot, F (corresponding author), CEH Banchory, Hills Brathens, Banchory AB31 4BW, Aberdeen, Scotland.		Mougeot, Francois/B-1894-2009; Hudson, Peter/AAB-8080-2020; Mougeot, Francois/Y-9569-2019; Redpath, Stephen/B-4640-2012	Mougeot, Francois/0000-0002-5819-6275; Hudson, Peter/0000-0003-0468-3403; Mougeot, Francois/0000-0002-5819-6275; Redpath, Stephen/0000-0001-5399-9477				Berryman AA, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P3; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; CHARNOV EL, 1980, OECOLOGIA, V45, P1, DOI 10.1007/BF00346698; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fox A, 2001, ECOL LETT, V4, P139, DOI 10.1046/j.1461-0248.2001.00207.x; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hudson P. J., 1985, Ecology and genetics of host-parasite interactions. International symposium, Keele University, 12-13 July 1984, P77; Hudson PJ, 1997, WILDLIFE BIOL, V3, P79, DOI 10.2981/wlb.1997.010; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Hudson PJ, 2002, PHILOS T R SOC B, V357, P1259, DOI 10.1098/rstb.2002.1126; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; Matthiopoulos J, 2000, ECOL MODEL, V127, P53, DOI 10.1016/S0304-3800(99)00199-4; Moss R, 2001, ADV ECOL RES, V32, P53, DOI 10.1016/S0065-2504(01)32011-1; Moss R, 1996, ECOLOGY, V77, P1512, DOI 10.2307/2265548; MOSS R, 1994, P ROY SOC B-BIOL SCI, V258, P175, DOI 10.1098/rspb.1994.0159; Mountford M.D., 1990, P78; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1423, DOI 10.1098/rspb.1996.0208; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; Turchin P, 1999, SCIENCE, V285, P1068, DOI 10.1126/science.285.5430.1068; WATSON A, 1994, J ANIM ECOL, V63, P39, DOI 10.2307/5581	27	88	92	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					737	739		10.1038/nature01395	http://dx.doi.org/10.1038/nature01395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610624				2022-12-01	WOS:000180938000042
J	Rodger, A; Jaffar, S; Paynter, S; Hayward, A; Carless, J; Maguire, H				Rodger, A; Jaffar, S; Paynter, S; Hayward, A; Carless, J; Maguire, H			Delay in the diagnosis of pulmonary tuberculosis, London, 1998-2000: analysis of surveillance data	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England; UCL Royal Free & Univ Coll Med Sch, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England; Ctr Communicable Dis Surveillance, London Reg Unit, London W2 3QR, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Rodger, A (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	alison.rodger@lshtm.ac.uk	Hayward, Andrew C/C-3268-2013; Paynter, Stuart/F-7916-2010	Hayward, Andrew C/0000-0002-3549-6232; Jaffar, Shabbar/0000-0002-9615-1588				Chin DP, 2000, JAMA-J AM MED ASSOC, V283, P2968, DOI 10.1001/jama.283.22.2968; Rodrigo T, 2001, INT J TUBERC LUNG D, V5, P432; Wares DF, 1999, J PUBLIC HEALTH MED, V21, P355, DOI 10.1093/pubmed/21.3.355; WRIGHT A, 2001, COMMUNICABLE DIS SUR; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	5	47	49	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 26	2003	326	7395					909	910		10.1136/bmj.326.7395.909	http://dx.doi.org/10.1136/bmj.326.7395.909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673WQ	12714470	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000182603600016
J	Saveliev, A; Everett, C; Sharpe, T; Webster, Z; Festenstein, R				Saveliev, A; Everett, C; Sharpe, T; Webster, Z; Festenstein, R			DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing	NATURE			English	Article							MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; TRANSGENIC MICE; HISTONE H3; HETEROCHROMATIN PROTEIN-1; CTG REPEAT; HIGH-LEVEL; LYSINE 9; IN-VIVO; EXPANSION	Gene repression is crucial to the maintenance of differentiated cell types in multicellular organisms, whereas aberrant silencing can lead to disease. The organization of DNA into chromatin and heterochromatin(1) is implicated in gene silencing. In chromatin, DNA wraps around histones, creating nucleosomes. Further condensation of chromatin, associated with large blocks of repetitive DNA sequences, is known as heterochromatin. Position effect variegation (PEV) occurs when a gene is located abnormally close to heterochromatin, silencing the affected gene in a proportion of cells(1). Here we show that the relatively short triplet-repeat expansions found inmyotonic dystrophy and Friedreich's ataxia confer variegation of expression on a linked transgene in mice. Silencing was correlated with a decrease in promoter accessibility and was enhanced by the classical PEV modifier heterochromatin protein 1 ( HP1). Notably, triplet-repeat-associated variegation was not restricted to classical heterochromatic regions but occurred irrespective of chromosomal location. Because the phenomenon described here shares important features with PEV, the mechanisms underlying heterochromatin-mediated silencing might have a role in gene regulation at many sites throughout the mammalian genome and modulate the extent of gene silencing and hence severity in several triplet-repeat diseases.	Univ London Imperial Coll Sci Technol & Med, Sch Med, CSC Gene Control Mechanisms & Dis Grp, Fac Med, London W12 0NN, England; MRC, Ctr Clin Sci, Transgen & Embryon Stem Cell Lab, London W12 0NN, England; Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Neurogenet, London WC1N 3BG, England	Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Festenstein, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, CSC Gene Control Mechanisms & Dis Grp, Fac Med, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.			Saveliev, Alexander/0000-0003-0840-4774				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAKE RA, 1990, EMBO J, V9, P3129, DOI 10.1002/j.1460-2075.1990.tb07510.x; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	30	200	212	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					909	913		10.1038/nature01596	http://dx.doi.org/10.1038/nature01596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712207				2022-12-01	WOS:000182432600059
J	Chaudhuri, J; Tian, M; Khuong, C; Chua, K; Pinaud, E; Alt, FW				Chaudhuri, J; Tian, M; Khuong, C; Chua, K; Pinaud, E; Alt, FW			Transcription-targeted DNA deamination by the AID antibody diversification enzyme	NATURE			English	Article							IMMUNOGLOBULIN SWITCH REGIONS; SOMATIC HYPERMUTATION; MECHANISM; RECOMBINATION; SEQUENCES; COMPLEX; REPAIR	Activation-induced cytidine deaminase (AID), which is specific to B lymphocytes, is required for class switch recombination (CSR)-a process mediating isotype switching of immunoglobulin-and somatic hypermutation-the introduction of many point mutations into the immunoglobulin variable region genes(1,2). It has been suggested that AID may function as an RNA-editing enzyme(3) or as a cytidine deaminase on DNA(4),(5). However, the precise enzymatic activity of AID has not been assessed in previous studies. Similarly, although transcription of the target immunoglobulin locus sequences is required for both CSR and somatic hypermutation, the precise role of transcription has remained speculative(6-9). Here we use two different assays to demonstrate that AID can deaminate specifically cytidines on single-stranded (ss) DNA but not double-stranded (ds) DNA substrates in vitro. However, dsDNA can be deaminated by AID in vitro when the reaction is coupled to transcription. Moreover, a synthetic dsDNA sequence, which targets CSR in vivo in a manner dependent on transcriptional orientation(10), was deaminated by AID in vitro with the same transcriptional-orientation-dependence as observed for endogenous CSR. We conclude that transcription targets the DNA deamination activity of AID to dsDNA by generating secondary structures that provide ssDNA substrates.	Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	PINAUD, Eric/O-8443-2016	PINAUD, Eric/0000-0001-7405-9273				Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; PAPAVASILIOU FN, 2002, CELL S1, V109, P35; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; RAMIRO AR, IN PRESS NATURE IMMU; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365; SHINKUTA R, IN PRESS NATURE IMMU; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Storb U, 1998, IMMUNOL REV, V162, P153; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; YU K, IN PRESS NATURE IMMU	31	574	584	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					726	730		10.1038/nature01574	http://dx.doi.org/10.1038/nature01574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12692563				2022-12-01	WOS:000182272300043
J	Clarke, T				Clarke, T			Infection risk puts the brakes on Canada's biomedical research	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					652	652		10.1038/422652b	http://dx.doi.org/10.1038/422652b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700726	Bronze			2022-12-01	WOS:000182272300009
J	Minto, CL; Liao, LM; Woodhouse, CRJ; Ransley, PG; Creighton, SM				Minto, CL; Liao, LM; Woodhouse, CRJ; Ransley, PG; Creighton, SM			The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study	LANCET			English	Article							FEMINIZING GENITOPLASTY; GENDER ASSIGNMENT; HERMAPHRODITISM; RECONSTRUCTION; MANAGEMENT	Background The effects on sexual function of surgical removal of parts of the clitoris are unknown. For infants with intersex conditions and ambiguous genitalia being raised female, this surgery is often undertaken in early childhood. Our aim was to assess the effects of surgery on sexual outcome in this population. Method We did a cross-sectional study to which we recruited 39 adults who had intersex conditions with ambiguous genitalia who were living as female from clinical (n=15) and peer-support (n=24) settings. We obtained data by use of a postal questionnaire, incorporating a validated sexual function assessment inventory. We also obtained hospital notes of 36 respondents who did not want to remain anonymous, and did genital examinations of 19 women. We assessed sexual problems in relation to surgical history and compared the results for our population to those of a healthy control group. Findings Of the 39 individuals enrolled, 28 had been sexually active and all had sexual difficulties. The 18 women who had undergone clitoral surgery had higher rates of non-sensuality (78%) and of inability to achieve orgasm (39%) than did the ten who had not had surgery (20% [p=0.002] and 0% [p=0.03], respectively). Interpretation Sexual function could be compromised by clitoral surgery. Debate on the ethics of the use of this surgery in children should be promoted and further multicentre research is needed to ensure representative samples and comprehensive outcome assessment. Meanwhile, parents and patients who consent to clitoral surgery should be fully informed of the potential risks to sexual function.	UCL Hosp NHS Trust, Elizabeth Garrett Anderson Hosp, Dept Obstet & Gynaecol, London WC1E 6DH, England; UCL Hosp NHS Trust, Middlesex Hosp, Inst Urol, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Creighton, SM (corresponding author), UCL Hosp NHS Trust, Elizabeth Garrett Anderson Hosp, Dept Obstet & Gynaecol, Huntley St, London WC1E 6DH, England.	sarah.creighton@uclh.org						Baskin LS, 1999, J UROLOGY, V162, P1015, DOI 10.1016/S0022-5347(01)68052-2; Blackless M, 2000, AM J HUM BIOL, V12, P151, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F; Costa EMF, 1997, FERTIL STERIL, V67, P229; Creighton S, 2001, BMJ-BRIT MED J, V323, P1264, DOI 10.1136/bmj.323.7324.1264; DITTMANN RW, 1992, PSYCHONEUROENDOCRINO, V17, P153, DOI 10.1016/0306-4530(92)90054-B; Glassberg KI, 1999, J UROLOGY, V161, P1308, DOI 10.1016/S0022-5347(01)61676-8; GOLOMBOK S, 1984, BR J SEX MED, V11, P171; Golombok S., 1994, GENDER DEV; GONZALEZ R, 1990, J UROLOGY, V143, P776, DOI 10.1016/S0022-5347(17)40091-7; HAMPSON JL, 1961, SEX INTERNAL SECRETI, P1401; HINDERER UT, 1989, PLAST RECONSTR SURG, V84, P325, DOI 10.1097/00006534-198908000-00022; Jones Howard Wilbur, 1958, HERMAPHRODITISM GENI; May B, 1996, J Health Psychol, V1, P479, DOI 10.1177/135910539600100406; Meyer-Bahlburg HFL, 1999, J CLIN ENDOCR METAB, V84, P3455, DOI 10.1210/jc.84.10.3455; MINTO CL, IN PRESS FERTIL STER; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P301; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P284; NEWMAN K, 1992, J PEDIATR SURG, V27, P180, DOI 10.1016/0022-3468(92)90308-T; O'Connell HE, 1998, J UROLOGY, V159, P1892, DOI 10.1016/S0022-5347(01)63188-4; Passerini-Glazel G, 1999, J UROLOGY, V161, P1592, DOI 10.1016/S0022-5347(05)68987-2; RAJFER J, 1982, J UROLOGY, V128, P341, DOI 10.1016/S0022-5347(17)52916-X; Rink RC, 1998, WORLD J UROL, V16, P212, DOI 10.1007/s003450050055; RUST J, 1985, BRIT J CLIN PSYCHOL, V24, P63, DOI 10.1111/j.2044-8260.1985.tb01314.x; RUST J, 1986, INTERPERSONAL DIFFIC, P51; Slijper FME, 1998, ARCH SEX BEHAV, V27, P125, DOI 10.1023/A:1018670129611; Von Prader A, 1954, HELV PEDIAT ACTA, V9, P231; Young Hugh, 1937, GENITAL ABNORMALITIE; Zucker Kenneth J, 2002, J Pediatr Adolesc Gynecol, V15, P3, DOI 10.1016/S1083-3188(01)00133-4	28	185	198	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2003	361	9365					1252	1257		10.1016/S0140-6736(03)12980-7	http://dx.doi.org/10.1016/S0140-6736(03)12980-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699952				2022-12-01	WOS:000182161600009
J	Knapp, S				Knapp, S			Dynamic diversity	NATURE			English	Article									Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.		Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945				DALY HE, 2002, WORLD BANK ANN REV 2, P15; ORiordan T., 2002, BIODIVERSITY SUSTAIN; Orr DW, 2002, CONSERV BIOL, V16, P1457; Raven PH, 2002, SCIENCE, V297, P954, DOI 10.1126/science.297.5583.954; Rees WE, 2003, NATURE, V421, P898, DOI 10.1038/421898a; *ROYAL SOC WORK GR, 2003, MEAS BIOD	6	11	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					475	475		10.1038/422475a	http://dx.doi.org/10.1038/422475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673231				2022-12-01	WOS:000181965400020
J	Xiao, Y; Patolsky, F; Katz, E; Hainfeld, JF; Willner, I				Xiao, Y; Patolsky, F; Katz, E; Hainfeld, JF; Willner, I			"Plugging into enzymes": Nanowiring of redox enzymes by a gold nanoparticle	SCIENCE			English	Article							GLUCOSE-OXIDASE; ELECTRON-TRANSFER; RECONSTITUTION; INTEGRATION; BIOSENSORS; MONOLAYER; SUPPORTS; POLYMER; SYSTEMS; SURFACE	The reconstitution of an apo-flavoenzyme, apo-glucose oxidase, on a 1.4-nanometer gold nanocrystal functionalized with the cofactor flavin adenine dinucleotide and integrated into a conductive film yields a bioelectrocatalytic system with exceptional electrical contact with the electrode support. The electron transfer turnover rate of the reconstituted bioelectrocatalyst is similar to5000 per second, compared with the rate at which molecular oxygen, the natural cosubstrate of the enzyme, accepts electrons (similar to700 per second). The gold nanoparticle acts as an electron relay or "electrical nanoplug" for the alignment of the enzyme on the conductive support and for the electrical wiring of its redox-active center.	Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; Brookhaven Natl Lab, Dept Biol, Upton, NY 11873 USA	Hebrew University of Jerusalem; United States Department of Energy (DOE); Brookhaven National Laboratory	Willner, I (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.		Xiao, Yi/L-6606-2016; patolsky, Fernando/AAD-1188-2021	Xiao, Yi/0000-0001-7278-9811; patolsky, Fernando/0000-0002-1382-5357				Armstrong FA, 2000, ELECTROCHIM ACTA, V45, P2623, DOI 10.1016/S0013-4686(00)00342-X; BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001; Bard A. J., 1980, ELECTROCHEMICAL METH, DOI 10.1021/ed060pa25; BOURDILLON C, 1993, J AM CHEM SOC, V115, P12264, DOI 10.1021/ja00079a005; DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Kranz C, 1998, ELECTROANAL, V10, P546, DOI 10.1002/(SICI)1521-4109(199807)10:8<546::AID-ELAN546>3.3.CO;2-R; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; Raitman OA, 2002, J AM CHEM SOC, V124, P6487, DOI 10.1021/ja012680r; Rajagopalan R, 1996, J PHYS CHEM-US, V100, P3719, DOI 10.1021/jp952160g; SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048; WILLNER I, 1992, BIOELECTROCH BIOENER, V29, P29, DOI 10.1016/0302-4598(92)80051-H; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E; Zayats M, 2002, J AM CHEM SOC, V124, P2120, DOI 10.1021/ja025503e	19	1098	1124	8	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1877	1881		10.1126/science.1080664	http://dx.doi.org/10.1126/science.1080664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649477				2022-12-01	WOS:000181669700041
J	Kerner, M; Hohenberg, H; Ertl, S; Reckermann, M; Spitzy, A				Kerner, M; Hohenberg, H; Ertl, S; Reckermann, M; Spitzy, A			Self-organization of dissolved organic matter to micelle-like microparticles in river water	NATURE			English	Article							PARTICLES; COLLOIDS; CARBON; ACID	In aquatic systems, the concept of the 'microbial loop' is invoked to describe the conversion of dissolved organic matter to particulate organic matter by bacteria(1). This process mediates the transfer of energy and matter from dissolved organic matter to higher trophic levels, and therefore controls (together with primary production) the productivity of aquatic systems. Here we report experiments on laboratory incubations of sterile filtered river water in which we find that up to 25% of the dissolved organic carbon (DOC) aggregates abiotically to particles of diameter 0.4-0.8 micrometres, at rates similar to bacterial growth. Diffusion drives aggregation of low- to high-molecular-mass DOC and further to larger micelle-like microparticles. The chemical composition of these microparticles suggests their potential use as food by planktonic bacterivores. This pathway is apparent from differences in the stable carbon isotope compositions of picoplankton and the microparticles. A large fraction of dissolved organic matter might therefore be channelled through microparticles directly to higher trophic levels-bypassing the microbial loop-suggesting that current concepts of carbon conversion in aquatic systems require revision.	Univ Hamburg, Inst Hydrobiol & Fishery Sci, D-22765 Hamburg, Germany; Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Univ Kiel, Res & Technol Ctr Westcoast, D-25761 Busum, Hafentorn, Germany	University of Hamburg; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University of Kiel	Kerner, M (corresponding author), Univ Hamburg, Inst Hydrobiol & Fishery Sci, Zeiseweg 9, D-22765 Hamburg, Germany.							AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bianchi A, 1996, APPL ENVIRON MICROB, V62, P174, DOI 10.1128/AEM.62.1.174-177.1996; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ducklow Hugh W., 1993, P261; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; GREENSPAN P, 1985, J LIPID RES, V26, P781; HARRIS JR, 1997, NEGATIVE STAINING CR, P12; Hertkorn N, 2002, J ENVIRON QUAL, V31, P375, DOI 10.2134/jeq2002.0375; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; HUBER SA, 1991, ANAL CHEM, V63, P2122, DOI 10.1021/ac00019a011; Hullar MAJ, 1996, APPL ENVIRON MICROB, V62, P2489, DOI 10.1128/AEM.62.7.2489-2493.1996; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; Kerner M, 2001, MICROBIAL ECOL, V41, P69; LEPPARD GG, 1995, SCI TOTAL ENVIRON, V165, P103, DOI 10.1016/0048-9697(95)04546-D; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Nanny MA, 2001, ENVIRON SCI TECHNOL, V35, P379, DOI 10.1021/es0012927; Niedergesass R., 1995, WASSERWIRTSCHAFT WAS, V7, P22; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; POLLARD TD, 2002, CELL BIOL, P277; Posch T, 1996, AQUAT MICROB ECOL, V10, P45, DOI 10.3354/ame010045; RAIMBAULT P, 1991, LIMNOL OCEANOGR, V36, P405, DOI 10.4319/lo.1991.36.2.0405; RILEY GA, 1963, LIMNOL OCEANOGR, V8, P372, DOI 10.4319/lo.1963.8.4.0372; Santschi PH, 1998, LIMNOL OCEANOGR, V43, P896, DOI 10.4319/lo.1998.43.5.0896; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Volke F, 1997, CHEM PHYS LIPIDS, V85, P115, DOI 10.1016/S0009-3084(96)02649-7	25	117	126	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					150	154		10.1038/nature01469	http://dx.doi.org/10.1038/nature01469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634782				2022-12-01	WOS:000181488900041
J	Vidal-Madjar, A; des Etangs, AL; Desert, JM; Ballester, GE; Ferlet, R; Hebrand, G; Mayor, M				Vidal-Madjar, A; des Etangs, AL; Desert, JM; Ballester, GE; Ferlet, R; Hebrand, G; Mayor, M			An extended upper atmosphere around the extrasolar planet HD209458b	NATURE			English	Article							LYMAN-ALPHA; 51 PEGASI; SEARCH; TRANSITS	The planet in the system HD209458 is the first one for which repeated transits across the stellar disk have been observed(1,2). Together with radial velocity measurements', this has led to a determination of the planet's radius and mass, confirming it to be a gas giant. But despite numerous searches for an atmospheric signature(4-6), only the dense lower atmosphere of HD209458b has been observed, through the detection of neutral sodium absorption(7). Here we report the detection of atomic hydrogen absorption in the stellar Lyman alpha line during three transits of HD209458b. An absorption of 15 +/- 4% (1sigma) is observed. Comparison with models shows that this absorption should take place beyond the Roche limit and therefore can be understood in terms of escaping hydrogen atoms.	UPMC, CNRS, Inst Astrophys Paris, F-75014 Paris, France; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Observ Geneva, CH-1290 Sauverny, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Arizona; University of Geneva	Vidal-Madjar, A (corresponding author), UPMC, CNRS, Inst Astrophys Paris, 98bis Blvd Arago, F-75014 Paris, France.	alfred@iap.fr	Lecavelier des Etangs, Alain/GLU-6503-2022	Lecavelier des Etangs, Alain/0000-0002-5637-5253				Bundy KA, 2000, PUBL ASTRON SOC PAC, V112, P1421, DOI 10.1086/317706; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; CUMMING A, 2002, ASTROPH0209199; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; Lemaire P, 2002, ESA SPEC PUBL, V508, P219; Mazeh T, 2000, ASTROPHYS J, V532, pL55, DOI 10.1086/312558; Moutou C, 2001, ASTRON ASTROPHYS, V371, P260, DOI 10.1051/0004-6361:20010406; PACZYNSKI B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; PRINZ DK, 1974, ASTROPHYS J, V187, P369, DOI 10.1086/152641; Rauer H, 2000, ASTRON ASTROPHYS, V355, P573; VIDALMADJAR A, 1975, SOL PHYS, V40, P69, DOI 10.1007/BF00183153	13	843	847	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					143	146		10.1038/nature01448	http://dx.doi.org/10.1038/nature01448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634780				2022-12-01	WOS:000181488900039
J	Klein, RG				Klein, RG			Whither the Neanderthals?	SCIENCE			English	Editorial Material							EVOLUTION; DNA		Stanford Univ, Program Human Biol, Stanford, CA 94305 USA	Stanford University	Klein, RG (corresponding author), Stanford Univ, Program Human Biol, Stanford, CA 94305 USA.		Klein, Richard G/B-5910-2009	Klein, Richard/0000-0002-6180-2168				Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; HUBLIN JJ, 1995, CR ACAD SCI II A, V321, P931; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Mellars P., 1996, NEANDERTHAL LEGACY, DOI [10.1515/9781400843602, DOI 10.1515/9781400843602]; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; SANTALUCA AP, 1978, J HUM EVOL, V7, P619, DOI 10.1016/S0047-2484(78)80047-5; Smith NP, 1999, COMPUT SCI ENG, V1, P96; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Trinkaus E., 1993, NEANDERTALS CHANGING; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685	17	113	116	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1525	1527		10.1126/science.1082025	http://dx.doi.org/10.1126/science.1082025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624250				2022-12-01	WOS:000181367900020
J	Baba, H; Aziz, F; Kaifu, Y; Suwa, G; Kono, RT; Jacob, T				Baba, H; Aziz, F; Kaifu, Y; Suwa, G; Kono, RT; Jacob, T			Homo erectus calvarium from the Pleistocene of Java	SCIENCE			English	Article							RELATIVE BRAIN SIZE; CRANIAL VARIATION; ARCHITECTURE; EVOLUTION; REMAINS; SAPIENS; BASE	A Homo erectus calvarium [Sambungmacan 4 (Sm 4)] was recovered from Pleistocene sediments at Sambungmacan in central Java. Micro-computed tomography analysis shows a modern human-like cranial base flexion associated with a low platycephatic vault, implying that the evolution of human cranial globularity was independent of cranial base flexion. The overall morphology of Sm 4 is intermediate between that of earlier and later Javanese Homo erectus; apparent morphological specializations are more strongly expressed in the latter. This supports the hypothesis that later Pleistocene Javanese populations were substantially isolated and made minimal contributions to the ancestry of modern humans.	Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan; Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Geol Res & Dev Ctr, Lab Vertebrate Paleontol, Bandung 40122, Indonesia; Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; Gadjah Mada Univ, Lab Bio & Palaeomanthropol, Yogyakarta 55002, Indonesia	University of Tokyo; University of Tokyo; Gadjah Mada University	Baba, H (corresponding author), Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan.	baba@kahaku.go.jp		Kaifu, Yousuke/0000-0003-0483-104X				Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; Anton SC, 2002, J HUM EVOL, V43, P555, DOI 10.1006/jhev.2002.0577; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; BHAT M, 1985, ANGLE ORTHOD, V55, P269; Bookstein F, 1999, ANAT RECORD, V257, P217, DOI 10.1002/(SICI)1097-0185(19991215)257:6<217::AID-AR7>3.0.CO;2-W; Delson E, 2001, ANAT RECORD, V262, P380, DOI 10.1002/ar.1048; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Hawks J, 2000, J HUM EVOL, V39, P1, DOI 10.1006/jhev.1999.0384; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOLLOWAY R, 1999, HDB HUMAN SYMBOLIC E, P74; Hyodo M, 2002, J HUM EVOL, V43, P27, DOI 10.1006/jhev.2002.0555; Jacob T., 1981, HOMO ERECTUS PAPERS, P87; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Matsu'ura S, 2000, CURR ANTHROPOL, V41, P297, DOI 10.1086/300136; McCarthy RC, 2001, J HUM EVOL, V40, P41, DOI 10.1006/jhev.2000.0446; Rightmire, 1990, EVOLUTION HOMO ERECT; ROSS C, 1995, AM J PHYS ANTHROPOL, V98, P575, DOI 10.1002/ajpa.1330980413; Santa Luca A.P., 1980, NGANDONG FOSSIL HOMI; Seidler H, 1997, J HUM EVOL, V33, P691, DOI 10.1006/jhev.1997.0163; Spoor F, 2000, AM J PHYS ANTHROPOL, P288; Spoor F, 1997, S AFR J SCI, V93, P182; Spoor F, 1999, NATURE, V397, P572, DOI 10.1038/17505; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; van den Bergh G.D., 1996, B INDO PACIFIC PREHI, V14, P7, DOI [10.7152/bippa.v14i0.11583, DOI 10.7152/BIPPA.V14I0.11583]; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Weidenreich F., 1951, ANTHROPOLOGICAL PAPE, V43, P205; Wolpoff M. H., 1999, PALEOANTHROPOLOGY	31	74	78	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1384	1388		10.1126/science.1081676	http://dx.doi.org/10.1126/science.1081676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610302				2022-12-01	WOS:000181192300049
J	Schmitt, JP; Kamisago, M; Asahi, M; Li, GH; Ahmad, F; Mende, U; Kranias, EG; MacLennan, DH; Seidman, JG; Seidman, CE				Schmitt, JP; Kamisago, M; Asahi, M; Li, GH; Ahmad, F; Mende, U; Kranias, EG; MacLennan, DH; Seidman, JG; Seidman, CE			Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban	SCIENCE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; CALCIUM; CONTRACTILITY; CA2+; PHOSPHORYLATION; CA2+-ATPASES; EXPRESSION; DOMAIN	Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLNR9C mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLNR9C did not directly inhibit SERCA2a. Rather, PLNR9C trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Cincinnati, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Toronto; University System of Ohio; University of Cincinnati	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.		Schmitt, Joachim/GQP-7068-2022	Ahmad, Ferhaan/0000-0003-2877-4641				Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Ausubel F. M., 1994, CURRENT PROTOCOLS MO; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Frank K, 2000, ANN MED, V32, P572, DOI 10.3109/07853890008998837; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Solaro RJ, 1999, NAT MED, V5, P1353, DOI 10.1038/70916; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1992, J BIOL CHEM, V267, P14490; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	22	438	460	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1410	1413		10.1126/science.1081578	http://dx.doi.org/10.1126/science.1081578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610310				2022-12-01	WOS:000181192300057
J	Hannonen, M; Sundstrom, L				Hannonen, M; Sundstrom, L			Sociobiology - Worker nepotism among polygynous ants	NATURE			English	Editorial Material							REPRODUCTIVE-SKEW; EVOLUTION; INSECT		Univ Helsinki, Dept Systemat & Ecol, FIN-00014 Helsinki, Finland	University of Helsinki	Hannonen, M (corresponding author), Univ Helsinki, Dept Systemat & Ecol, POB 65, FIN-00014 Helsinki, Finland.	liselotte.sundstrom@helsinki.fi	Sundstrom, Liselotte/G-5080-2010	Sundstrom, Liselotte/0000-0002-6176-8940				COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hannonen M, 2002, ETHOLOGY, V108, P961, DOI 10.1046/j.1439-0310.2002.00829.x; KELLER L, 1993, SCIENCE, V260, P1107, DOI 10.1126/science.260.5111.1107; Keller L, 1999, MG BEH ECOL, P153; PAGE RE, 1989, NATURE, V338, P576, DOI 10.1038/338576a0; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197	10	73	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					910	910		10.1038/421910a	http://dx.doi.org/10.1038/421910a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606988				2022-12-01	WOS:000181186900036
J	Foy, E; Li, K; Wang, CF; Sumpter, R; Ikeda, M; Lemon, SM; Gale, M				Foy, E; Li, K; Wang, CF; Sumpter, R; Ikeda, M; Lemon, SM; Gale, M			Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease	SCIENCE			English	Article							IRF-3; PHOSPHORYLATION; TRANSACTIVATION; LOCALIZATION; INFECTION; DISTINCT; THERAPY; KINASE; PKR	Persistent infections with hepatitis C virus (HCV) are likely to depend on viral inhibition of host defenses. We show that the HCV NS3/4A serine protease blocks the phosphorylation and effector action of interferon regulatory factor -3 (IRF-3), a key cellular antiviral signaling molecule. Disruption of NS3/4A protease function by mutation or a ketoamide peptidomimetic inhibitor relieved this blockade and restored IRF-3 phosphorylation after cellular challenge with an unrelated virus. Furthermore, dominant-negative or constitutively active IRF-3 mutants, respectively, enhanced or suppressed HCV RNA replication in hepatoma cells. Thus, the NS3/4A protease represents a dual therapeutic target, the inhibition of which may both block viral replication and restore IRF-3 control of HCV infection.	Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston	Gale, M (corresponding author), Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA.	Michael.Gale@UTSouthwestern.edu	Sumpter, Jr., Rhea/N-8152-2018; IKEDA, Masanori/B-2279-2011	Gale, Michael/0000-0002-6332-7436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048235, U19AI040035] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI48235, U19-AI40035] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; De Francesco R, 2000, CURR TOP MICROBIOL, V242, P149; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Fredericksen B, 2002, VIRAL IMMUNOL, V15, P29, DOI 10.1089/088282402317340215; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; LEMON SM, UNPUB; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; McHutchison JG, 2002, HEPATOLOGY, V36, pS245, DOI 10.1053/jhep.2002.36795; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Reed KE, 1998, CURR STUD HEMATOL BL, P1; Reich NC, 2002, J INTERF CYTOK RES, V22, P103, DOI 10.1089/107999002753452719; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHERING CORP CORVAS, 2002, Patent No. 0208244; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhu NL, 2001, VIROLOGY, V283, P178, DOI 10.1006/viro.2001.0896	28	636	691	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1145	1148		10.1126/science.1082604	http://dx.doi.org/10.1126/science.1082604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12702807	Green Submitted			2022-12-01	WOS:000182886500046
J	Morillon, A; O'Sullivan, J; Azad, A; Proudfoot, N; Mellor, J				Morillon, A; O'Sullivan, J; Azad, A; Proudfoot, N; Mellor, J			Regulation of elongating RNA polymerase II by forkhead transcription factors in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; ENVIRONMENTAL-CHANGES; PROCESSING FACTORS; TERMINAL DOMAIN; GENE-EXPRESSION; INITIATION; PROMOTER; KINASE; FKH1P	The elongation phase of transcription by RNA polymerase II (RNAPII) is highly regulated and tightly linked to pre-messenger RNA (pre-mRNA) processing. Recent studies have implicated an early elongation checkpoint that facilitates the link to pre-mRNA processing. Here we show that the yeast forkhead transcription factors, Fkh1p and Fkh2p, associate with the coding regions of active genes and influence, in opposing ways, transcriptional elongation and termination. These events are coordinated with serine-5 and -2 phosphorylation of the heptad repeat of the carboxy-terminal domain (CTD) of RNAPII. Our results suggest that, in addition to their documented promoter function, Fkh1p and Fkh2p coordinate early transcription elongation and pre-mRNA processing. This may reflect a general feature of gene regulation in eukaryotes.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Mellor, J (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.		O'Sullivan, Justin/HDO-1639-2022; Pillay, Nischalan/F-9536-2012; Morillon, Antonin/M-4751-2017	O'Sullivan, Justin/0000-0003-2927-450X; Morillon, Antonin/0000-0002-0575-5264; Proudfoot, Nicholas/0000-0001-8646-3222				Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	27	56	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					492	495		10.1126/science.1081379	http://dx.doi.org/10.1126/science.1081379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702877				2022-12-01	WOS:000182295900042
J	Plath, K; Fang, J; Mlynarczyk-Evans, SK; Cao, R; Worringer, KA; Wang, HB; de la Cruz, CC; Otte, AP; Panning, B; Zhang, Y				Plath, K; Fang, J; Mlynarczyk-Evans, SK; Cao, R; Worringer, KA; Wang, HB; de la Cruz, CC; Otte, AP; Panning, B; Zhang, Y			Role of histone H3 lysine 27 methylation in X inactivation	SCIENCE			English	Article							METHYLTRANSFERASE ACTIVITY; CHROMOSOME INACTIVATION; PROTEINS; ENHANCER; COMPLEX	The Polycomb group (PcG) protein Eed is implicated in regulation of imprinted X-chromosome inactivation in extraembryonic cells but not of random X inactivation in embryonic cells. The Drosophila homolog of the Eed-Ezh2 PcG protein complex achieves gene silencing through methylation of histone H3 on lysine 27 (H3-K27), which suggests a role for H3-K27 methylation in imprinted X inactivation. Here we demonstrate that transient recruitment of the Eed-Ezh2 complex to the inactive X chromosome (Xi) occurs during initiation of X inactivation in both extraembryonic and embryonic cells and is accompanied by H3-K27 methylation. Recruitment of the complex and methylation on the Xi depend on Xist RNA but are independent of its silencing function. Together, our results suggest a role for Eed-Ezh2-mediated H3-K27 methylation during initiation of both imprinted and random X inactivation and demonstrate that H3-K27 methylation is not sufficient for silencing of the Xi.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ Amsterdam, Bioctr Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam	Panning, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	bpanning@biochem.ucsf.edu; yi_zhang@med.unc.edu		Plath, Kathrin/0000-0001-7796-3372; Wang, Hengbin/0000-0003-2414-0609; Worringer, Kathleen/0000-0001-7807-2344; Zhang, Yi/0000-0002-2789-0811; Fang, Jia/0000-0001-8583-1652	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063671] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063671] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Brockdorff N, 2002, TRENDS GENET, V18, P352, DOI 10.1016/S0168-9525(02)02717-8; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CAO R, UNPUB; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; PANNING B, UNPUB; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; PLATH K, UNPUB; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; WORRINGER KA, UNPUB; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	21	906	961	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					131	135		10.1126/science.1084274	http://dx.doi.org/10.1126/science.1084274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12649488				2022-12-01	WOS:000181988900049
J	Schultz, CH; Koenig, KL; Lewis, RJ				Schultz, CH; Koenig, KL; Lewis, RJ			Implications of hospital evacuation after the Northridge, California, earthquake	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND: On January 17, 1994, an earthquake with a moment magnitude (total energy release) of 6.7 occurred in Northridge, California, leading to the evacuation of patients from several hospitals. We examined the reasons for and methods of evacuation and the emergency-management strategies used. The experience in California may have implications for hospital strategies for responding to any major disaster, including an act of terrorism. METHODS: From September 1995 to September 1996, we surveyed all acute care hospitals in Los Angeles County that reported having evacuated patients after the Northridge earthquake. Physicians, nurses, hospital administrators, and staff on duty at the hospitals during the evacuation responded to a 58-item structured questionnaire. RESULTS: Eight of 91 acute care hospitals (9 percent) were evacuated. Six hospitals evacuated patients within 24 hours (the immediate-evacuation group), four completely and two partially. All six cited nonstructural damage such as water damage and loss of electrical power as a major reason for evacuation. Five hospitals evacuated the most seriously ill patients first, and one hospital evacuated the healthiest patients first. All hospitals used available equipment to transport patients (blankets, backboards, and gurneys) rather than specialized devices. No deaths resulted from evacuation. One hospital evacuated patients after 3 days and another after 14 days because of structural damage, even though initial inspections had shown no damage (the delayed-evacuation group). Both hospitals required demolition. Some hospitals identified destinations for their evacuated patients independently, whereas others sought the assistance of the Los Angeles County Emergency Operations Center; the two strategies were equally effective. CONCLUSIONS: After even a moderate earthquake, hospitals are at risk for both immediate nonstructural damage that may force them to evacuate patients and the delayed discovery of structural damage resulting in permanent closure. Evacuation of large numbers of inpatients from multiple hospitals can be accomplished quickly and safely with the use of available resources and personnel.	Univ Calif Irvine, Irvine Med Ctr, Emergency Dept, Orange, CA 92668 USA; Univ Calif Irvine, Coll Med, Irvine, CA 92717 USA; George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; Dept Vet Affairs, Vet Hlth Adm, Hlth Sci & Emergency Management Strateg Healthcar, Washington, DC USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Schultz, CH (corresponding author), Univ Calif Irvine, Irvine Med Ctr, Emergency Dept, Rte 128,101 City Dr, Orange, CA 92668 USA.	schultzc@uci.edu						ARNOLD C, 1983, HOSP SAN FERNANDO EA; BLASER M J, 1985, Journal of Emergency Medicine, V3, P387, DOI 10.1016/0736-4679(85)90323-3; Chavez C W, 1996, J Emerg Med, V14, P445, DOI 10.1016/0736-4679(96)00083-2; De Lorenzo R A, 1996, Prehosp Disaster Med, V11, P270; FISHER HL, 1986, MIL MED, V151, P154, DOI 10.1093/milmed/151.3.154; Gretenkort Peter, 2002, Prehosp Disaster Med, V17, P42; JONES L, 1994, SCIENCE, V266, P389, DOI 10.1126/science.266.5184.398; KOBAYASHI H, 1996, JPN J DISASTER MED, V1, P73; *OFF STAT HLTH PLA, 2001, SUMM HOSP SEISM PERF; Schultz CH, 1996, NEW ENGL J MED, V334, P438, DOI 10.1056/NEJM199602153340706; Tanaka H, 1998, J Emerg Med, V16, P439, DOI 10.1016/S0736-4679(98)00014-6; TSUBOI S, 1996, JPN J DISASTER MED, V1, P36; Ukai T, 1997, RENAL FAILURE, V19, P633, DOI 10.3109/08860229709109029; *US ARM SOLD BIOL, 2002, MASS CAS CAR STRAT B	14	105	105	2	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2003	348	14					1349	1355		10.1056/NEJMsa021807	http://dx.doi.org/10.1056/NEJMsa021807			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662LW	12672863				2022-12-01	WOS:000181949100007
J	Vermeer, SE; Prins, ND; den Heijer, T; Hofman, A; Koudstaal, PJ; Breteler, MMB				Vermeer, SE; Prins, ND; den Heijer, T; Hofman, A; Koudstaal, PJ; Breteler, MMB			Silent brain infarcts and the risk of dementia and cognitive decline	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER LESIONS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; NEUROFIBRILLARY TANGLES; CLINICAL DETERMINANTS; VASCULAR DEMENTIA; ELDERLY-PEOPLE; PREVALENCE; EXPRESSION	BACKGROUND: Silent brain infarcts are frequently seen on magnetic resonance imaging (MRI) in healthy elderly people and may be associated with dementia and cognitive decline. METHODS: We studied the association between silent brain infarcts and the risk of dementia and cognitive decline in 1015 participants of the prospective, population-based Rotterdam Scan Study, who were 60 to 90 years of age and free of dementia and stroke at base line. Participants underwent neuropsychological testing and cerebral MRI at base line in 1995 to 1996 and again in 1999 to 2000 and were monitored for dementia throughout the study period. We performed Cox proportional-hazards and multiple linear-regression analyses, adjusted for age, sex, and level of education and for the presence or absence of subcortical atrophy and white-matter lesions. RESULTS: During 3697 person-years of follow-up (mean per person, 3.6 years), dementia developed in 30 of the 1015 participants. The presence of silent brain infarcts at base line more than doubled the risk of dementia (hazard ratio, 2.26; 95 percent confidence interval, 1.09 to 4.70). The presence of silent brain infarcts on the base-line MRI was associated with worse performance on neuropsychological tests and a steeper decline in global cognitive function. Silent thalamic infarcts were associated with a decline in memory performance, and nonthalamic infarcts with a decline in psychomotor speed. When participants with silent brain infarcts at base line were subdivided into those with and those without additional infarcts at follow-up, the decline in cognitive function was restricted to those with additional silent infarcts. CONCLUSIONS: Elderly people with silent brain infarcts have an increased risk of dementia and a steeper decline in cognitive function than those without such lesions.	Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Breteler, MMB (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	m.breteler@erasmusmc.nl	Breteler, Monique M.B./J-5058-2014; Zito, Giancarlo/F-9008-2010	Breteler, Monique M.B./0000-0002-0626-9305; Prins, Niels/0000-0002-6297-7592				American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837, DOI 10.1212/WNL.38.6.837; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P1335; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; de Groot JC, 2000, ANN NEUROL, V47, P145; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; de la Monte SM, 2000, NEUROBIOL AGING, V21, P309, DOI 10.1016/S0197-4580(99)00108-6; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Desmond DW, 2000, NEUROLOGY, V54, P1124, DOI 10.1212/WNL.54.5.1124; Esiri MM, 2001, LANCET, V357, P169; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Heyman A, 1998, NEUROLOGY, V51, P159, DOI 10.1212/WNL.51.1.159; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; HOFMAN A, 1983, NEW ENGL J MED, V309, P1248; Howard G, 1998, STROKE, V29, P913, DOI 10.1161/01.STR.29.5.913; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Petrovitch H, 2000, NEUROBIOL AGING, V21, P57, DOI 10.1016/S0197-4580(00)82479-3; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; Small SA, 1999, NEUROLOGY, V52, P1392, DOI 10.1212/WNL.52.7.1392; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; SPARKS DL, 1995, J NEUROL SCI, V131, P162, DOI 10.1016/0022-510X(95)00105-B; TATEMICHI TK, 1992, ANN NEUROL, V32, P162, DOI 10.1002/ana.410320207; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111	33	1617	1692	2	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2003	348	13					1215	1222		10.1056/NEJMoa022066	http://dx.doi.org/10.1056/NEJMoa022066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659RG	12660385	Bronze, Green Published			2022-12-01	WOS:000181790800003
J	Nagar, B; Hantschel, O; Young, MA; Scheffzek, K; Veach, D; Bornmann, V; Clarkson, B; Superti-Furga, G; Kuriyan, J				Nagar, B; Hantschel, O; Young, MA; Scheffzek, K; Veach, D; Bornmann, V; Clarkson, B; Superti-Furga, G; Kuriyan, J			Structural basis for the autoinhibition of c-Abl tyrosine kinase	CELL			English	Article							CRYSTAL-STRUCTURE; SRC FAMILY; BCR-ABL; CELLULAR FUNCTIONS; DIFFRACTION DATA; DOMAIN; INHIBITORS; MECHANISM; PHOSPHORYLATION; ACTIVATION	c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The details of this mechanism have been elusive because c-Abl lacks a phosphotyrosine residue that triggers the assembly of the autoinhibited form of the closely related Src kinases by internally engaging the SH2 domain. Crystal structures of c-Abl show that the N-terminal myristoyl modification of c-Abl 1b binds to the kinase domain and induces conformational changes that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl forms an assembly that is strikingly similar to that of inactive Src kinases but with specific differences that explain the differential ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the catalytic activity of Abl, but not that of c-Src.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Memorial Sloan Kettering Cancer Center	Kuriyan, J (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	superti@embl-heidelberg.de; kudyan@uclink.berkeley.edu	Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Hantschel, Oliver D/H-4705-2013; Nagar, Bhushan/C-1297-2010; Young, Matthew/D-2033-2011; Young, Matthew/AAE-2632-2020; Hantschel, Oliver/M-7016-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Hantschel, Oliver D/0000-0001-8569-8169; Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; Hantschel, Oliver/0000-0001-8569-8169; Veach, Darren/0000-0002-8201-622X	NCI NIH HHS [P30 CA008748, P01 CA064593] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA064593, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Brasher BB, 2001, ONCOGENE, V20, P7744, DOI 10.1038/sj.onc.1204978; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano WL., 2002, PYMOL USERS MANUAL D; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koegl M, 1995, ONCOGENE, V11, P2317; Kraker AJ, 2000, BIOCHEM PHARMACOL, V60, P885, DOI 10.1016/S0006-2952(00)00405-6; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; MULLER AJ, 1993, P NATL ACAD SCI USA, V90, P3457, DOI 10.1073/pnas.90.8.3457; Nagar B, 2002, CANCER RES, V62, P4236; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sawyers CL, 2002, CANCER CELL, V1, P13, DOI 10.1016/S1535-6108(02)00022-3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wisniewski D, 2002, CANCER RES, V62, P4244; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4	38	628	664	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					859	871		10.1016/S0092-8674(03)00194-6	http://dx.doi.org/10.1016/S0092-8674(03)00194-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654251	Bronze			2022-12-01	WOS:000181818500012
J	Sniderman, AD; Furberg, CD; Keech, A; van Lennep, JER; Frohlich, J; Jungner, I; Walldius, G				Sniderman, AD; Furberg, CD; Keech, A; van Lennep, JER; Frohlich, J; Jungner, I; Walldius, G			Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment	LANCET			English	Editorial Material							HEART-DISEASE; A-I; LIPOPROTEIN CHOLESTEROL; B REPLACE; FOLLOW-UP; PREVENTION; PREDICTION; PROFILE; EVENTS		McGill Univ, McGill Univ Hlth Ctr, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ, Canada; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Leiden Univ, Med Ctr, Leiden, Netherlands; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; St Gorans Univ Hosp, CALAB Res, Stockholm, Sweden; Karolinska Inst, Karolinska Hosp, Clin Epidemiol Unit, S-10401 Stockholm, Sweden; AstraZeneca, Molndal, Sweden; Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden	McGill University; Wake Forest University; Wake Forest Baptist Medical Center; University of Sydney; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Saint Goran's Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Karolinska Institutet	Sniderman, AD (corresponding author), Royal Victoria Hosp, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	allan.sniderman@muhc.mcgill.ca						Ballantyne CM, 2001, AM J CARDIOL, V88, P265, DOI 10.1016/S0002-9149(01)01638-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Durrington PN, 2002, CLIN CHEM, V48, P401; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Miremadi S, 2002, CLIN CHEM, V48, P484; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Simes RJ, 2002, CIRCULATION, V105, P1162, DOI 10.1161/hc1002.105136; Sniderman AD, 2001, ANN INTERN MED, V135, P447, DOI 10.7326/0003-4819-135-6-200109180-00014; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2	17	357	370	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					777	780		10.1016/S0140-6736(03)12663-3	http://dx.doi.org/10.1016/S0140-6736(03)12663-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620753				2022-12-01	WOS:000181232000023
J	Fowler, KB; Stagno, S; Pass, RF				Fowler, KB; Stagno, S; Pass, RF			Maternal immunity and prevention of congenital cytomegalovirus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAY-CARE; VIRUS INFECTION; INFANTS BORN; MOTHERS; TRANSMISSION; POPULATION; PREGNANCY; WORKERS; WOMEN	Context Vaccine development to prevent congenital cytomegalovinus (CMV) infection has been impeded by the uncertainty over whether maternal immunity protects the fetus. Objective To determine whether the presence of maternal antibodies to CMV significantly reduces the risk of congenital CMV infection in future pregnancies. Design, Setting, and Participants Cohort study of 3461 multiparous women from a population with a high rate of congenital CMV infection who delivered newborns screened for congenital CMV infection between 1993 and 1998, and whose cord serum specimen from a previous delivery could be retrieved and tested for antibody to CMV. Main Outcome Measure Congenital CMV infection according to maternal immune status, age, race, parity, and socioeconomic status. Results Of 604 newborns born to initially seronegative mothers, congenital CMV infection occurred in 18 (3.0%). In contrast, of 2857 newborns born to immune mothers, congenital CMV infection occurred in 29 (1.0%) Two factors, preconception maternal immunity (adjusted risk ratio, 0.31; 95% confidence interval, 0.17-0.58) and maternal age of 25 years or older (adjusted risk ratio, 0.19; 95% confidence interval, 0.07-0.49), were highly protective against congenital CMV infection. No other factors were associated with a reduction in the risk of congenital CMV infection. Conclusion Naturally acquired immunity results in a 69% reduction in the risk of congenital CMV infection in future pregnancies.	Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama, Dept Epidemiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Maternal & Child Hlth, Birmingham, AL 35233 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fowler, KB (corresponding author), Univ Alabama, Dept Pediat, 1600 7th Ave S,CHB 306, Birmingham, AL 35233 USA.			Pass, Robert/0000-0003-2029-0247	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043681] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000032] Funding Source: Medline; NIAID NIH HHS [P01 AI43681, P01 AI043681] Funding Source: Medline; PHS HHS [M01 R00032] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADLER SP, 1989, NEW ENGL J MED, V321, P1290, DOI 10.1056/NEJM198911093211903; Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; CHANDLER SH, 1985, J INFECT DIS, V152, P249, DOI 10.1093/infdis/152.2.249; FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; HICKS T, 1993, J PEDIATR-US, V123, P779, DOI 10.1016/S0022-3476(05)80859-5; MURPH JR, 1991, JAMA-J AM MED ASSOC, V265, P603, DOI 10.1001/jama.265.5.603; Mussi-Pinhata MM, 1998, J PEDIATR-US, V132, P285, DOI 10.1016/S0022-3476(98)70446-9; PASS RF, 1990, PEDIATR INFECT DIS J, V9, P465, DOI 10.1097/00006454-199007000-00003; Pass RF, 1996, INFECT AGENT DIS, V5, P240; PREECE PM, 1986, J EPIDEMIOL COMMUN H, V40, P205, DOI 10.1136/jech.40.3.205; SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536; SOHN Y M, 1992, Journal of Korean Medical Science, V7, P47; SOHN YM, 1991, J INFECT DIS, V163, P460, DOI 10.1093/infdis/163.3.460; STAGNO C, 1995, INFECT DIS FETUS NEW, P312; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STAGNO S, 1977, NEW ENGL J MED, V296, P1254, DOI 10.1056/NEJM197706022962203; STRATTON K, 2001, VACCINES 21 CENTURY, P476	22	295	307	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1008	1011		10.1001/jama.289.8.1008	http://dx.doi.org/10.1001/jama.289.8.1008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597753	Bronze			2022-12-01	WOS:000181129800027
J	Lokkegaard, E; Pedersen, AT; Heitmann, BL; Jovanovic, Z; Keiding, N; Hundrup, YA; Obel, EB; Ottesen, B				Lokkegaard, E; Pedersen, AT; Heitmann, BL; Jovanovic, Z; Keiding, N; Hundrup, YA; Obel, EB; Ottesen, B			Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; PLASMA-LIPIDS; RISK FACTOR; PREVENTION; NONUSERS; COHORT; NIDDM	Objective To investigate the risk of ischaemic heart disease and myocardial infarction among women using hormone replacement therapy, especially the potential modifying effect of cardiovascular risk factors. Design Prospective observational study. Setting Denmark. Participants 19 898 nurses aged 45 and over completing a questionnaire on lifestyle and use of hormone replacement therapy in 1993. Main outcome measures All cases of death and incident cases of ischaemic heart disease and myocardial infarction until the end of 1998. Results Current users of hormone replacement therapy smoked more, consumed more alcohol, had lower self rated health, but were slimmer and had a lower prevalence of diabetes than never users. In current users compared with never users, hormone replacement therapy had no protective effect on ischaemic heart disease (hazard ratio 1.2, 0.9 to 1.7) or myocardial infarction (1.0, 0.6 to 1.7), whereas current users with diabetes had an increased risk of death (3.2, 1.4 to 7.5), ischaemic heart disease (4.2, 1.4 to 12.5), and myocardial infarction (9.2, 2.0 to 41.4) compared with never users with diabetes. Conclusion Hormone replacement therapy showed no protective effect on ischaemic heart disease, but there was a significantly increased risk of death from all causes and ischaemic heart disease among women with diabetes.	Hvidovre Univ Hosp, Dept Obstet & Gynaecol, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Rigshosp, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Dept Biostat, DK-2100 Copenhagen, Denmark; Natl Inst Publ Hlth, Danish Nurse Study, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-1399 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Lokkegaard, E (corresponding author), Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	loekkegaard@dadlnet.dk	Andersen, Zorana Jovanovic/P-4983-2014	Andersen, Zorana Jovanovic/0000-0003-4138-9828; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Lokkegaard, Ellen/0000-0003-4149-5663				Andersson B, 1997, J CLIN ENDOCR METAB, V82, P638, DOI 10.1210/jc.82.2.638; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Brussaard HE, 1997, DIABETOLOGIA, V40, P843, DOI 10.1007/s001250050758; Cornu C, 2000, MATURITAS, V37, P95, DOI 10.1016/S0378-5122(00)00164-X; FALKEBORN M, 1992, BRIT J OBSTET GYNAEC, V99, P821, DOI 10.1111/j.1471-0528.1992.tb14414.x; Friday KE, 2001, J CLIN ENDOCR METAB, V86, P48, DOI 10.1210/jc.86.1.48; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRADY J, 2002, JAMA-J AM MED ASSOC, V288, P49; Grodstein F, 1999, EPIDEMIOLOGY, V10, P476, DOI 10.1097/00001648-199909000-00003; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hundrup YA, 2000, ACTA OBSTET GYN SCAN, V79, P194, DOI 10.1080/j.1600-0412.2000.079003194.x; Hundrup YA, 2002, SCAND J PUBLIC HEALT, V30, P47, DOI 10.1080/140349401753481583; Koh KK, 2001, J AM COLL CARDIOL, V38, P1409, DOI 10.1016/S0735-1097(01)01566-2; Manwaring P, 2000, MATURITAS, V34, P239, DOI 10.1016/S0378-5122(99)00112-7; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Rodstrom K, 1999, BMJ-BRIT MED J, V319, P890, DOI 10.1136/bmj.319.7214.890; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Troisi RJ, 2000, OBSTET GYNECOL, V96, P665, DOI 10.1097/00006250-200011000-00005	25	32	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					426	428A		10.1136/bmj.326.7386.426	http://dx.doi.org/10.1136/bmj.326.7386.426			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595383	Bronze, Green Published			2022-12-01	WOS:000181318000020
J	Ikeda, H; Heinke, B; Ruscheweyh, R; Sandkuhler, J				Ikeda, H; Heinke, B; Ruscheweyh, R; Sandkuhler, J			Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia	SCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSTANCE-P RECEPTOR; DORSAL HORN; T-TYPE; NEUROPATHIC PAIN; CALCIUM CHANNELS; RAT; INVOLVEMENT; EXPRESSION; MEMORY	Inflammation, trauma, or nerve injury may cause enduring hyperalgesia, an enhanced sensitivity to painful stimuli. Neurons in lamina I of the spinal dorsal horn that express the neurokinin 1 receptor for substance P mediate this abnormal pain sensitivity by an unknown cellular mechanism. We report that in these, but not in other nociceptive lamina I cells, neurokinin 1 receptor-activated signal transduction pathways and activation of low-threshold (T-type) voltage-gated calcium channels synergistically facilitate activity- and calcium-dependent long-term potentiation at synapses from nociceptive nerve fibers. Thereby, memory traces of painful events are retained.	Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; Univ Vienna, Sch Med, Brain Res Inst, A-1090 Vienna, Austria	Ruprecht Karls University Heidelberg; University of Vienna	Sandkuhler, J (corresponding author), Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany.		Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X				Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DUGGAN AW, 1988, BRAIN RES, V451, P261, DOI 10.1016/0006-8993(88)90771-8; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Honore P, 1999, J NEUROSCI, V19, P7670, DOI 10.1523/JNEUROSCI.19-17-07670.1999; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Khasabov SG, 2002, J NEUROSCI, V22, P9086; KLEIN T, 2003, IN PRESS PROGR PAIN, V24; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Matthews EA, 2001, EUR J PHARMACOL, V415, P141, DOI 10.1016/S0014-2999(01)00812-3; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Talley EM, 1999, J NEUROSCI, V19, P1895; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Tolle TR, 1996, PROG BRAIN RES, V110, P193; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	24	416	439	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1237	1240		10.1126/science.1080659	http://dx.doi.org/10.1126/science.1080659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595694				2022-12-01	WOS:000181065500042
J	Janssen, EM; Lemmens, EE; Wolfe, T; Christen, U; von Herrath, MG; Schoenberger, SP				Janssen, EM; Lemmens, EE; Wolfe, T; Christen, U; von Herrath, MG; Schoenberger, SP			CD4(+) T cells are required for secondary expansion and memory in CD8(+) T lymphocytes	NATURE			English	Article							HELPER; DIFFERENTIATION; RESPONSES; GENERATION; INDUCTION; INVIVO; MICE; CTL	A long-standing paradox in cellular immunology concerns the conditional requirement for CD4(+) T-helper (T-H) cells in the priming of cytotoxic CD8(+) T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4(+) T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T-H cells(1-4). A clearer understanding of the contribution of T-H cells to CTL development has been hampered by the fact that most T-H-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T-H-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T-H-dependent and T-H-independent CTLs and find in both cases that CD4(+) T cells are dispensable for primary expansion of CD8(+) T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T-H cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8(+) T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Christen, Urs/A-7338-2009	Christen, Urs/0000-0003-4165-7976; janssen, edith/0000-0001-7881-6307				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; DI RF, 1996, J EXP MED, V183, P2153; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Oehen S, 1998, J IMMUNOL, V161, P5338; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730	27	1253	1302	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					852	856		10.1038/nature01441	http://dx.doi.org/10.1038/nature01441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594515				2022-12-01	WOS:000181044700050
J	Ueda, H; Howson, JMM; Esposito, L; Heward, J; Snook, H; Chamberlain, G; Rainbow, DB; Hunter, KMD; Smith, AN; Di Genova, G; Herr, MH; Dahlman, I; Payne, F; Smyth, D; Lowe, C; Twells, RCJ; Howlett, S; Healy, B; Nutland, S; Rance, HE; Everett, V; Smink, LJ; Lam, AC; Cordell, HJ; Walker, NM; Bordin, C; Hulme, J; Motzo, C; Cucca, F; Hess, JF; Metzker, ML; Rogers, J; Gregory, S; Allahabadia, A; Nithiyananthan, R; Tuomilehto-Wolf, E; Tuomilehto, J; Bingley, P; Gillespie, KM; Undlien, DE; Ronningen, KS; Guja, C; Ionescu-Tirgoviste, C; Savage, DA; Maxwell, AP; Carson, DJ; Patterson, CC; Franklyn, JA; Clayton, DG; Peterson, LB; Wicker, LS; Todd, JA; Gough, SCL				Ueda, H; Howson, JMM; Esposito, L; Heward, J; Snook, H; Chamberlain, G; Rainbow, DB; Hunter, KMD; Smith, AN; Di Genova, G; Herr, MH; Dahlman, I; Payne, F; Smyth, D; Lowe, C; Twells, RCJ; Howlett, S; Healy, B; Nutland, S; Rance, HE; Everett, V; Smink, LJ; Lam, AC; Cordell, HJ; Walker, NM; Bordin, C; Hulme, J; Motzo, C; Cucca, F; Hess, JF; Metzker, ML; Rogers, J; Gregory, S; Allahabadia, A; Nithiyananthan, R; Tuomilehto-Wolf, E; Tuomilehto, J; Bingley, P; Gillespie, KM; Undlien, DE; Ronningen, KS; Guja, C; Ionescu-Tirgoviste, C; Savage, DA; Maxwell, AP; Carson, DJ; Patterson, CC; Franklyn, JA; Clayton, DG; Peterson, LB; Wicker, LS; Todd, JA; Gough, SCL			Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease	NATURE			English	Article							DEPENDENT DIABETES-MELLITUS; SOLUBLE FORM; CHROMOSOME 2Q33; GRAVES-DISEASE; CD28; POLYMORPHISM; REGION; EPIDEMIOLOGY; LYMPHOCYTES; REQUIRES	Genes and mechanisms involved in common complex diseases, such as the autoimmune disorders that affect approximately 5% of the population, remain obscure. Here we identify polymorphisms of the cytotoxic T lymphocyte antigen 4 gene (CTLA4)-which encodes a vital negative regulatory molecule of the immune system-as candidates for primary determinants of risk of the common autoimmune disorders Graves' disease, autoimmune hypothyroidism and type 1 diabetes. In humans, disease susceptibility was mapped to a non-coding 6.1 kb 30 region of CTLA4, the common allelic variation of which was correlated with lower messenger RNA levels of the soluble alternative splice form of CTLA4. In the mouse model of type 1 diabetes, susceptibility was also associated with variation in CTLA-4 gene splicing with reduced production of a splice form encoding a molecule lacking the CD80/CD86 ligand-binding domain. Genetic mapping of variants conferring a small disease risk can identify pathways in complex disorders, as exemplified by our discovery of inherited, quantitative alterations of CTLA4 contributing to autoimmune tissue destruction.	Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England; Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, Cagliari, Italy; Merck Res Labs, W Point, PA 19486 USA; Wellsome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Helsinki, Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Univ Bristol, Div Med, Diabet & Metab Unit, Bristol BS10 5NG, Avon, England; Univ Oslo, Ulleval Univ Hosp, Inst Med Genet, Oslo, Norway; Rikshosp Univ Hosp, Inst Immunol, Oslo, Norway; Univ Oslo, Norwegian Inst Publ Hlth, Div Epidemiol, Lab Mol Epidemiol, Oslo, Norway; Inst Diabet Nutr & Metab Dis N Paulescu, Diabet Clin, Bucharest, Romania; Queens Univ Belfast, Belfast City Hosp, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland; Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AB, Antrim, North Ireland; Queens Univ Belfast, Dept Child Hlth, Belfast BT12 6BJ, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA	University of Cambridge; University of Birmingham; University of Cagliari; Merck & Company; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Bristol; University of Oslo; University of Oslo; National Hospital Norway; Norwegian Institute of Public Health (NIPH); University of Oslo; Belfast City Hospital; Queens University Belfast; Belfast City Hospital; Queens University Belfast; Queens University Belfast; Merck & Company	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.		Wicker, Linda S/F-7384-2010; Guja, Cristian/K-2334-2019; Nithiyananthan, Ratnasingam/ABD-7859-2020; Todd, John A/A-3542-2010; Payne, Felicity/GKF-2573-2022	Todd, John A/0000-0003-2740-8148; Payne, Felicity/0000-0003-4228-581X; Howson, Joanna/0000-0001-7618-0050; Walker, Neil/0000-0001-9796-7688; Gregory, Simon/0000-0002-7805-1743; Cordell, Heather/0000-0002-1879-5572; smyth, deborah/0000-0002-6330-2669; Maxwell, Alexander P./0000-0002-6110-7253; Dahlman, Ingrid/0000-0003-3819-5977; CUCCA, Francesco/0000-0002-7414-1995				Allahabadia A, 2001, LANCET, V358, P984, DOI 10.1016/S0140-6736(01)06125-6; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; CLAYTON D, 2001, HDB STAT GENETICS, P519; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hanawa H, 2002, BLOOD, V99, P2138, DOI 10.1182/blood.V99.6.2138; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Howard TD, 2002, J ALLERGY CLIN IMMUN, V110, P743, DOI 10.1067/mai.2002.128723; Huang DR, 2000, J NEUROIMMUNOL, V105, P69, DOI 10.1016/S0165-5728(00)00191-0; Kaijzel EL, 2001, GENES IMMUN, V2, P135, DOI 10.1038/sj.gene.6363747; Kaufman KA, 1999, MOL HUM REPROD, V5, P84, DOI 10.1093/molehr/5.1.84; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Lamhamedi-Cherradi SE, 2001, DIABETES, V50, P2874, DOI 10.2337/diabetes.50.12.2874; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Lesage S, 2001, J EXP MED, V194, pF31, DOI 10.1084/jem.194.5.F31; Lin H, 1998, J EXP MED, V188, P199, DOI 10.1084/jem.188.1.199; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Magistrelli G, 1999, BIOCHEM BIOPH RES CO, V259, P34, DOI 10.1006/bbrc.1999.0725; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.3.CO;2-P; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Manzotti CN, 2002, EUR J IMMUNOL, V32, P2888, DOI 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F; Marron MP, 2000, DIABETES, V49, P492, DOI 10.2337/diabetes.49.3.492; Maurer M, 2002, IMMUNOGENETICS, V54, P1, DOI 10.1007/s00251-002-0429-9; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Olivier M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf052; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Sakaguchi S, 2003, J EXP MED, V197, P397, DOI 10.1084/jem.20030012; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; TUOMILEHTO J, 1992, DIABETOLOGIA, V35, P70, DOI 10.1007/BF00400854; Zheng ZM, 1999, J VIROL, V73, P29, DOI 10.1128/JVI.73.1.29-36.1999	46	1689	1772	1	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					506	511		10.1038/nature01621	http://dx.doi.org/10.1038/nature01621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12724780	Green Published, Bronze			2022-12-01	WOS:000183162900035
J	O'Brien, TG; Kinnaird, MF				O'Brien, TG; Kinnaird, MF			Caffeine and conservation	SCIENCE			English	Editorial Material									Wildlife Conservat Soc, Bogor, Indonesia	Wildlife Conservation Society - Indonesia	O'Brien, TG (corresponding author), Wildlife Conservat Soc, Jalan Pangrango 8, Bogor, Indonesia.							Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; RODEN C, 1999, COFFEE; Vandermeer J., 1995, BREAKFAST BIODIVERSI; VANDERNEER J, 2003, TROPICAL AGROECOSYST; Ward J., 1996, COFFEE CONSERVATION; 2001, LAMPUNG FIGURES; 2002, JAKARTA POST    0926, P13	8	67	67	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					587	587		10.1126/science.1082328	http://dx.doi.org/10.1126/science.1082328			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714727				2022-12-01	WOS:000182453700023
J	Melton, L				Melton, L			Crime busters	NATURE			English	Article																			0	22	23	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					917	917		10.1038/422917b	http://dx.doi.org/10.1038/422917b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712209	Bronze			2022-12-01	WOS:000182432600061
J	Hasbun, R; Vikram, HR; Barakat, LA; Buenconsejo, J; Quagliarello, VJ				Hasbun, R; Vikram, HR; Barakat, LA; Buenconsejo, J; Quagliarello, VJ			Complicated left-sided native valve endocarditis in adults - Risk classification for mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-DEATH-INDEX; INFECTIVE ENDOCARDITIS; BACTERIAL-ENDOCARDITIS; VITAL STATUS; SURGERY; MANAGEMENT; DIAGNOSIS	Context Complicated left-sided native valve endocarditis causes significant morbidity and mortality in adults. Lack of valid data regarding estimation of prognosis makes management of this condition difficult. Objective To derive and externally validate a prognostic classification system for adults with complicated left-sided native valve endocarditis. Design, Setting, and Patients Retrospective observational cohort study conducted from January 1990 to January 2000 at 7 Connecticut hospitals among 513 patients older than 16,years who experienced complicated left-sided native valve endocarditis and who were divided into derivation (n=259) and validation (n=254) cohorts. Main Outcome Measure All-cause mortality at 6 months after baseline. Results In the derivation and validation cohorts, the 6-month mortality rates were 25% and 26%, respectively. Five baseline features were independently associated with 6-month mortality (comorbidity [P=.03], abnormal mental status [P=.02], moderate to severe congestive heart failure [P=.01], bacterial etiology other than viridans streptococci [P<.001 except Staphylococus aureus, P=.004], and medical therapy without valve surgery [P=.002]) and were used to create a prognostic classification system. In the derivation cohort, patients were classified into 4 groups with increasing risk for 6-month mortality: 5%, 15%, 31%, and 59% (P<.001). In the validation cohort, a similar risk among the 4 groups was observed: 7%, 19%, 32%, and 69% (P<.001). Conclusions Adults with complicated left-sided native valve endocarditis can be accurately risk stratified using baseline features into 4 groups of prognostic severity. This prognostic classification system might be useful for facilitating management decisions.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Griffin Hosp, Derby, CT USA; Hosp St Raphael, Infect Dis Sect, New Haven, CT USA; Tulane Univ, Sch Med, Infect Dis Sect, New Orleans, LA 70112 USA	Yale University; Yale University; Hospital Saint Raphael; Tulane University	Hasbun, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208022,800 LCI, New Haven, CT 06520 USA.							Alexiou C, 2000, ANN THORAC SURG, V69, P1448, DOI 10.1016/S0003-4975(00)01139-5; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; Bishara J, 2001, CLIN INFECT DIS, V33, P1636, DOI 10.1086/323785; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; CARPENTER JL, 1991, REV INFECT DIS, V13, P127; CATES JE, 1951, Q J MED, V20, P93; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; CROFT CH, 1983, AM J CARDIOL, V51, P1650, DOI 10.1016/0002-9149(83)90203-5; DINUBILE MJ, 1982, ANN INTERN MED, V96, P650, DOI 10.7326/0003-4819-96-5-650; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR, V2nd; GRIFFIN FM, 1972, ANN INTERN MED, V76, P23, DOI 10.7326/0003-4819-76-1-23; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; KARALIS DG, 1991, AM J MED, V90, P193; KIMOSE HH, 1990, SCAND J THORAC CARD, V24, P111, DOI 10.3109/14017439009098053; Lash TL, 2001, EPIDEMIOLOGY, V12, P259, DOI 10.1097/00001648-200103000-00021; MCANULTY JH, 1979, JAMA-J AM MED ASSOC, V242, P77, DOI 10.1001/jama.242.1.77; MIDDLEMOST S, 1991, J AM COLL CARDIOL, V18, P663, DOI 10.1016/0735-1097(91)90785-8; MUGGE A, 1993, INFECT DIS CLIN N AM, V7, P877; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002; PRUITT AA, 1978, MEDICINE, V57, P329, DOI 10.1097/00005792-197807000-00004; RICHARDSON JV, 1978, CIRCULATION, V58, P589, DOI 10.1161/01.CIR.58.4.589; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; WALLACE AG, 1965, CIRCULATION, V31, P450, DOI 10.1161/01.CIR.31.3.450; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270; WILSON WR, 1982, MAYO CLIN PROC, V57, P162; WILSON WR, 1978, CIRCULATION, V58, P585, DOI 10.1161/01.CIR.58.4.585; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	33	236	246	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2003	289	15					1933	1940		10.1001/jama.289.15.1933	http://dx.doi.org/10.1001/jama.289.15.1933			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667VC	12697795				2022-12-01	WOS:000182253900025
J	Warren, SM; Brunet, LJ; Harland, RM; Economides, AN; Longaker, MT				Warren, SM; Brunet, LJ; Harland, RM; Economides, AN; Longaker, MT			The BMP antagonist noggin regulates cranial suture fusion	NATURE			English	Article							IN-VITRO; BONE-FORMATION; EXPRESSION; PROTEIN; BIOLOGY; GROWTH; VIVO; OSTEOBLASTS; MECHANISMS; MUTATIONS	During skull development, the cranial connective tissue framework undergoes intramembranous ossification to form skull bones (calvaria). As the calvarial bones advance to envelop the brain, fibrous sutures form between the calvarial plates(1). Expansion of the brain is coupled with calvarial growth through a series of tissue interactions within the cranial suture complex(2). Craniosynostosis, or premature cranial suture fusion, results in an abnormal skull shape, blindness and mental retardation(3). Recent studies have demonstrated that gain-of-function mutations in fibroblast growth factor receptors (fgfr) are associated with syndromic forms of craniosynostosis(4,5). Noggin, an antagonist of bone morphogenetic proteins (BMPs), is required for embryonic neural tube, somites and skeleton patterning(6-8). Here we show that noggin is expressed postnatally in the suture mesenchyme of patent, but not fusing, cranial sutures, and that noggin expression is suppressed by FGF2 and syndromic fgfr signalling. Since noggin misexpression prevents cranial suture fusion in vitro and in vivo, we suggest that syndromic fgfr-mediated craniosynostoses may be the result of inappropriate downregulation of noggin expression.	Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Stanford University; University of California System; University of California Berkeley; Regeneron	Longaker, MT (corresponding author), Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA.			Economides, Aris/0000-0002-6508-8942				Albrecht U, 1997, MOL CELLULAR METHODS, P23; Bradley JP, 1996, CLEFT PALATE-CRAN J, V33, P150, DOI 10.1597/1545-1569(1996)033<0150:SICSBV>2.3.CO;2; Bradley JP, 1996, PLAST RECONSTR SURG, V98, P1039, DOI 10.1097/00006534-199611000-00018; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; COHEN MM, 1995, AM J MED GENET, V56, P334, DOI 10.1002/ajmg.1320560327; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Greenwald JA, 2001, AM J PATHOL, V158, P441, DOI 10.1016/S0002-9440(10)63987-9; Greenwald JA, 2000, J BONE MINER RES, V15, P2413, DOI 10.1359/jbmr.2000.15.12.2413; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; McCarthy JG, 1990, PLASTIC SURG, P3013; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Minabe-Saegusa C, 1998, DEV GROWTH DIFFER, V40, P343; Moore R, 2002, DEV BIOL, V243, P99, DOI 10.1006/dbio.2001.0533; Opperman LA, 1997, J BONE MINER RES, V12, P301, DOI 10.1359/jbmr.1997.12.3.301; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Roth DA, 1997, J BONE MINER RES, V12, P311, DOI 10.1359/jbmr.1997.12.3.311; Slavkin HC, 1979, DEV CRANIOFACIAL BIO; THILANDER B, 1995, ACTA ODONTOL SCAND, V53, P144, DOI 10.3109/00016359509005964; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Warren SM, 2001, PLAST RECONSTR SURG, V107, P523, DOI 10.1097/00006534-200102000-00034; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	28	259	272	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					625	629		10.1038/nature01545	http://dx.doi.org/10.1038/nature01545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687003				2022-12-01	WOS:000182111400045
J	Schefuss, E; Schouten, S; Jansen, JHF; Damste, JSS				Schefuss, E; Schouten, S; Jansen, JHF; Damste, JSS			African vegetation controlled by tropical sea surface temperatures in the mid-Pleistocene period	NATURE			English	Article							MIDPLEISTOCENE CLIMATE TRANSITION; ATMOSPHERIC CO2; LATE MIOCENE; C-4 GRASSES; ATLANTIC; PAST; EXPANSION; PLANTS; MODEL; CYCLE	The dominant forcing factors for past large-scale changes in vegetation are widely debated. Changes in the distribution of C-4 plants-adapted to warm, dry conditions and low atmospheric CO2 concentrations(1)-have been attributed to marked changes in environmental conditions, but the relative impacts of changes in aridity, temperature(2,3) and CO2 concentration(4,5) are not well understood. Here, we present a record of African C-4 plant abundance between 1.2 and 0.45 million years ago, derived from compound-specific carbon isotope analyses of wind-transported terrigenous plant waxes. We find that large-scale changes in African vegetation are linked closely to sea surface temperatures in the tropical Atlantic Ocean. We conclude that, in the mid-Pleistocene, changes in atmospheric moisture content-driven by tropical sea surface temperature changes and the strength of the African monsoon-controlled aridity on the African continent, and hence large-scale vegetation changes.	Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Schefuss, E (corresponding author), Royal Netherlands Inst Sea Res, POB 59, NL-1790 AB Den Burg, Netherlands.		Schefuß, Enno/A-7101-2015; Damste, Jaap S Sinninghe/F-6128-2011	Schefuß, Enno/0000-0002-5960-930X; Damste, Jaap S Sinninghe/0000-0002-8683-1854				BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; COLLISTER JW, 1994, ORG GEOCHEM, V21, P619, DOI 10.1016/0146-6380(94)90008-6; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FONTAINE B, 1993, INT J CLIMATOL, V13, P271, DOI 10.1002/joc.3370130304; Ganopolski A, 1998, NATURE, V391, P351, DOI 10.1038/34839; Huang Y, 2001, SCIENCE, V293, P1647, DOI 10.1126/science.1060143; JANSEN JHF, 2001, P OC DRILL PROGR SCI, V175; Katz EJ, 1982, J MAR RES, V40, P307; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; McIntyre A, 1989, PALEOCEANOGRAPHY, V4, P19, DOI 10.1029/PA004i001p00019; Mudelsee M, 1997, EARTH PLANET SC LETT, V151, P117, DOI 10.1016/S0012-821X(97)00114-3; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Partridge TC, 1997, QUATERNARY SCI REV, V16, P1125, DOI 10.1016/S0277-3791(97)00005-X; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; PHILANDER SGH, 1986, J GEOPHYS RES-OCEANS, V91, P14192, DOI 10.1029/JC091iC12p14192; PRELL WL, 1987, J GEOPHYS RES-ATMOS, V92, P8411, DOI 10.1029/JD092iD07p08411; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; Sage RF, 2001, PLANT BIOLOGY, V3, P202, DOI 10.1055/s-2001-15206; SCHEFUSS E, IN PRESS GEOCHIM COS; SCHNEIDER RR, 1995, PALEOCEANOGRAPHY, V10, P197, DOI 10.1029/94PA03308; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Shackleton NJ., 1976, GEOLOGICAL SOC AM ME, P449, DOI DOI 10.1130/MEM145-P449; Wyputta U, 1999, PALAEOGEOGR PALAEOCL, V146, P53, DOI 10.1016/S0031-0182(98)00142-4	30	169	181	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					418	421		10.1038/nature01500	http://dx.doi.org/10.1038/nature01500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660780				2022-12-01	WOS:000181801200041
J	Blankenburg, F; Taskin, B; Ruben, J; Moosmann, M; Ritter, P; Curio, G; Villringer, A				Blankenburg, F; Taskin, B; Ruben, J; Moosmann, M; Ritter, P; Curio, G; Villringer, A			Imperceptible stimuli and sensory processing impediment	SCIENCE			English	Article							SOMATOSENSORY CORTEX; BLOOD-FLOW		Humboldt Univ, Charite, Dept Neurol, D-10117 Berlin, Germany; Free Univ Berlin, Benjamin Franklin Hosp, Dept Neurol, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blankenburg, F (corresponding author), Humboldt Univ, Charite, Dept Neurol, Schumannstr 20-21, D-10117 Berlin, Germany.		Ritter, Petra/B-6953-2008	Ritter, Petra/0000-0002-4643-4782; Villringer, Arno/0000-0003-2604-2404; Curio, Gabriel/0000-0002-3377-7735				DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; LIBET B, 1967, SCIENCE, V158, P1597, DOI 10.1126/science.158.3808.1597; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802	8	77	77	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1864	1864		10.1126/science.1080806	http://dx.doi.org/10.1126/science.1080806			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649475				2022-12-01	WOS:000181669700036
J	Campion, EW				Campion, EW			A death at Duke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	28	28	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1083	1084		10.1056/NEJMp030033	http://dx.doi.org/10.1056/NEJMp030033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646664				2022-12-01	WOS:000181628400003
J	Duncan, RR; Greaves, J; Wiegand, UK; Matskovich, I; Bodammer, G; Apps, DK; Shipston, MJ; Chow, RH				Duncan, RR; Greaves, J; Wiegand, UK; Matskovich, I; Bodammer, G; Apps, DK; Shipston, MJ; Chow, RH			Functional and spatial segregation of secretory vesicle pools according to vesicle age	NATURE			English	Article							ADRENAL CHROMAFFIN CELLS; EXOCYTOSIS; GRANULES; CALCIUM; BARIUM; SYNAPTOTAGMINS; BIOSYNTHESIS; MICROSCOPY; TRANSPORT; DYNAMICS	Synaptic terminals and neuroendocrine cells are packed with secretory vesicles, only a few of which are docked at the plasma membrane and readily releasable. The remainder are thought to constitute a large cytoplasmic reserve pool awaiting recruitment into the readily releasable pool (RRP) for exocytosis'. How vesicles are prioritized in recruitment is still unknown: the choice could be random, or else the oldest or the newest ones might be favoured. Here we show, using a fluorescent cargo protein(2) that changes colour with time(3), that vesicles in bovine adrenal chromaffin cells segregate into distinct populations, based on age. Newly assembled vesicles are immobile (morphologically docked) at the plasma membrane shortly after biogenesis, whereas older vesicles are mobile and located deeper in the cell. Different secretagogues selectively release vesicles from the RRP or, surprisingly, selectively from the deeper cytoplasmic pool. Thus, far from being equal, vesicles are segregated functionally and spatially according to age.	Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; Univ Edinburgh, Membrane Biol Grp, Edinburgh EH8 9XD, Midlothian, Scotland	University of Southern California; University of Edinburgh	Chow, RH (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.		Chow, Robert/B-8155-2013; Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Greaves, Jennifer/0000-0001-8445-789X; Duncan, Rory/0000-0003-0693-910X				Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; CHEN TT, 1989, ENDOCRINOLOGY, V125, P1904, DOI 10.1210/endo-125-4-1904; CORCORAN JJ, 1984, J BIOL CHEM, V259, P6208; Cuchillo-Ibanez I, 1999, FEBS LETT, V459, P22, DOI 10.1016/S0014-5793(99)01115-1; Duncan RR, 1999, BIOCHEM J, V342, P497, DOI 10.1042/0264-6021:3420497; FREESTONE S, 1989, BRIT J CLIN PHARMACO, V27, P13, DOI 10.1111/j.1365-2125.1989.tb05329.x; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; HELDMAN E, 1989, J BIOL CHEM, V264, P7914; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lundstrom K, 2001, HISTOCHEM CELL BIOL, V115, P83, DOI 10.1007/s004180000223; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; NGUYEN TT, 1988, FEBS LETT, V231, P393, DOI 10.1016/0014-5793(88)80857-3; Ogawa T, 1999, AM J PHYSIOL-HEART C, V276, pH1977, DOI 10.1152/ajpheart.1999.276.6.H1977; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PHILLIPS JH, 1982, NEUROSCIENCE, V7, P1595, DOI 10.1016/0306-4522(82)90017-3; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Seward EP, 1996, J NEUROSCI, V16, P1370; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; TERBUSH DR, 1992, J NEUROCHEM, V58, P680, DOI 10.1111/j.1471-4159.1992.tb09771.x; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Winkler H, 1998, CELL MOL NEUROBIOL, V18, P193, DOI 10.1023/A:1022516919932	27	174	178	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					176	180		10.1038/nature01389	http://dx.doi.org/10.1038/nature01389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634788				2022-12-01	WOS:000181488900048
J	Hakin-Smith, V; Jellinek, DA; Levy, D; Carroll, T; Teo, M; Timperley, WR; McKay, MJ; Reddel, RR; Royds, JA				Hakin-Smith, V; Jellinek, DA; Levy, D; Carroll, T; Teo, M; Timperley, WR; McKay, MJ; Reddel, RR; Royds, JA			Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme	LANCET			English	Article							MECHANISM	Despite advances In the molecular pathogenesis of giloblastoma multiforme, no reliable prognostic markers have been Identified. We analysed telomerase activity and telomere lengths In giloblastoma multiformes from 77 patients. 19 patients (25%) had tumours with the alternative-lengthening-of-telomere (ALT) phenotype. Median survival for patients with this phenotype was 542 days (95% CI 114-970) compared with 247 days (224-270) for glioblastoma multiformes with normal telomeres (p=0.0003). Cox's regression analysis showed that this association is independent of age. In patients with non-ALT tumours, telomerase activity did not affect survival (median 287 [199-375] vs 236 [230-242] days, p=0.275). We conclude that ALT Is a prognostic Indicator for patients with glioblastoma multiforme.	Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England; Royal Hallamshire Hosp, Dept Neuropathol, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Dept Neurosurg, Sheffield S10 2JF, S Yorkshire, England; Weston Pk Hosp, Sheffield, S Yorkshire, England; Peter MacCallum Canc Inst, Div Res, Melbourne, Vic 3000, Australia; Childrens Med Res Inst, Sydney, NSW, Australia	University of Sheffield; University of Sheffield; University of Sheffield; Weston Park Hospital; Peter Maccallum Cancer Center; Children's Medical Research Institute - Australia; University of Sydney	Royds, JA (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin, New Zealand.		Reddel, Roger R/A-6635-2014; Teo, Mario/AAE-5804-2020; McKay, Michael/ABA-9029-2021	Reddel, Roger R/0000-0002-6302-6107; Teo, Mario/0000-0002-0051-3303; 				Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Bryant JE, 1997, BIOTECHNIQUES, V23, P476, DOI 10.2144/97233st05; Carroll T, 1999, J PATHOL, V188, P395; Latif AZB, 1998, J NEUROL NEUROSUR PS, V64, P747, DOI 10.1136/jnnp.64.6.747; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599	5	213	223	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					836	838		10.1016/S0140-6736(03)12681-5	http://dx.doi.org/10.1016/S0140-6736(03)12681-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642053				2022-12-01	WOS:000181466600015
J	Depege, N; Bellafiore, S; Rochaix, JD				Depege, N; Bellafiore, S; Rochaix, JD			Role of chloroplast protein kinase Stt7 in LHCII phosphorylation and state transition in Chlamydomonas	SCIENCE			English	Article							LIGHT ENERGY-DISTRIBUTION; REINHARDTII; PHOTOSYNTHESIS; MUTANTS; POLYPEPTIDE; ACTIVATION; SUBUNIT	Photosynthetic organisms adapt to changes in light quality by redistributing light excitation energy between two photosystems through state transition. This reorganization of antenna systems leads to an enhanced photosynthetic yield. Using a genetic approach in Chlamydomonas reinhardtii to dissect the signal transduction pathway of state transition, we identified a chloroplast thylakoid-associated serine-threonine protein kinase, Stt7, that has homologs in land plants. Stt7 is required for the phosphorylation of the major light-harvesting protein (LHCII) and for state transition.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-david.rochaix@molbio.unige.ch	Bellafiore, stephane/J-4756-2014; Rochaix, Jean-David/ABC-5243-2020; Bellafiore, stephane/AFS-1835-2022	Bellafiore, stephane/0000-0002-4394-0866; Bellafiore, stephane/0000-0002-4394-0866; Fargeix, Nathalie/0000-0003-4591-1791				ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; DEPEGE N, UNPUB; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; PURTON S, 1994, PLANT MOL BIOL, V24, P533, DOI 10.1007/BF00024121; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	19	392	411	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1572	1575		10.1126/science.1081397	http://dx.doi.org/10.1126/science.1081397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624266				2022-12-01	WOS:000181367900037
J	Vanhamme, L; Paturiaux-Hanocq, F; Poelvoorde, P; Nolan, DP; Lins, L; Van den Abbeele, J; Pays, A; Tebabi, P; Van Xong, H; Jacquet, A; Moguilevsky, N; Dieu, M; Kane, JP; De Baetselier, P; Brasseur, R; Pays, E				Vanhamme, L; Paturiaux-Hanocq, F; Poelvoorde, P; Nolan, DP; Lins, L; Van den Abbeele, J; Pays, A; Tebabi, P; Van Xong, H; Jacquet, A; Moguilevsky, N; Dieu, M; Kane, JP; De Baetselier, P; Brasseur, R; Pays, E			Apolipoprotein L-I is the trypanosome lytic factor of human serum	NATURE			English	Article							HAPTOGLOBIN-RELATED PROTEIN; L GENE-CLUSTER; BRUCEI; EXPRESSION; IDENTIFICATION; GLYCOPROTEIN; RHODESIENSE; ENDOCYTOSIS; RESISTANCE; CLONING	Human sleeping sickness in east Africa is caused by the parasite Trypanosoma brucei rhodesiense. The basis of this pathology is the resistance of these parasites to lysis by normal human serum (NHS)(1,2). Resistance to NHS is conferred by a gene that encodes a truncated form of the variant surface glycoprotein termed serum resistance associated protein (SRA)(3,4). We show that SRA is a lysosomal protein, and that the amino-terminal alpha-helix of SRA is responsible for resistance to NHS. This domain interacts strongly with a carboxy-terminal alpha-helix of the human-specific serum protein apolipoprotein L-I (apoL-I). Depleting NHS of apoL-I, by incubation with SRA or anti-apoL-I, led to the complete loss of trypanolytic activity. Addition of native or recombinant apoL-I either to apoL-I-depleted NHS or to fetal calf serum induced lysis of NHS-sensitive, but not NHS-resistant, trypanosomes. Confocal microscopy demonstrated that apoL-I is taken up through the endocytic pathway into the lysosome. We propose that apoL-I is the trypanosome lytic factor of NHS, and that SRA confers resistance to lysis by interaction with apoL-I in the lysosome.	Univ Brussels, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Univ Gembloux, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium; Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; Free Univ Brussels, Cellular Immunol Lab, B-1640 Rhode St Genese, Belgium; Univ Brussels, IBMM, Lab Appl Genet, B-6041 Brussels, Belgium; Univ Namur, Unit Cellular Biochem & Biol, B-5000 Namur, Belgium; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Universite Libre de Bruxelles; University of Liege; Institute of Tropical Medicine (ITM); University of Namur; University of California System; University of California San Francisco	Pays, E (corresponding author), Univ Brussels, IBMM, Mol Parasitol Lab, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	Jacquet, Alain/GQI-0546-2022; Jacquet, Alain/T-8611-2019; De Baetselier, Patrick/D-3866-2014; LINS, LAURENCE/Y-1661-2019	Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; LINS, LAURENCE/0000-0001-7772-6748; Dieu, Marc/0000-0002-3902-542X; Van Den Abbeele, Jan/0000-0002-4533-4480; Nolan, Derek/0000-0002-3742-4304				BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; BRASSEUR R, 1994, J MOL GRAPHICS, V12, P212; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; DOTHI CD, 1991, MOL BIOCHEM PARASIT, V48, P199; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; GUEX N, 1997, ELECTROPHORESIS, V18, P14; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Hatada S, 2002, MOL BIOCHEM PARASIT, V119, P291, DOI 10.1016/S0166-6851(01)00420-0; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lins L, 2001, PROTEINS, V44, P435, DOI 10.1002/prot.1109; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	21	350	364	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					83	87		10.1038/nature01461	http://dx.doi.org/10.1038/nature01461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621437				2022-12-01	WOS:000181343100042
J	Nath, U; Crawford, BCW; Carpenter, R; Coen, E				Nath, U; Crawford, BCW; Carpenter, R; Coen, E			Genetic control of surface curvature	SCIENCE			English	Article							LEAF DEVELOPMENT; GROWTH; ARABIDOPSIS; ANTIRRHINUM; EXPRESSION; ASYMMETRY; PATTERNS; DIVISION; TOBACCO; PLANTS	Although curvature of biological surfaces has been considered from mathematical and biophysical perspectives, its molecular and developmental basis is unclear. We have studied the cin mutant of Antirrhinum, which has crinkly rather than flat leaves. Leaves of cin display excess growth in marginal regions, resulting in a gradual introduction of negative curvature during development. This reflects a change in the shape and the progression of a cell-cycle arrest front moving from the leaf tip toward the base. CIN encodes a TCP protein and is expressed downstream of the arrest front. We propose that CIN promotes zero curvature (flatness) by making cells more sensitive to an arrest signal, particularly in marginal regions.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk						Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; BALL P, 2002, NATURE SCI UPDATE; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; DOONAN JH, COMMUNICATION; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; FOBERT PR, 1994, EMBO J, V13, P616, DOI 10.1002/j.1460-2075.1994.tb06299.x; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gaudin V, 2000, PLANT PHYSIOL, V122, P1137, DOI 10.1104/pp.122.4.1137; Green PB, 1999, AM J BOT, V86, P1059, DOI 10.2307/2656967; Green PB, 1996, ANN BOT-LONDON, V78, P269, DOI 10.1006/anbo.1996.0121; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; KRSEK P., 1998, MATH SURFACES 8, P1; Lawrence A.D, UNPUB; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; MARDER M, IN PRESS COND MAT; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1985, PLANTA, V165, P158, DOI 10.1007/BF00395038; PYKE KA, 1991, J EXP BOT, V42, P1407, DOI 10.1093/jxb/42.11.1407; Stubbe H, 1966, GENETIK ZYTOLOGIE AN; SYLVESTER AW, 1990, DEVELOPMENT, V110, P985; TODD PH, 1985, J THEOR BIOL, V113, P63, DOI 10.1016/S0022-5193(85)80075-8; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; WOLF SD, 1986, AM J BOT, V73, P832, DOI 10.2307/2444294	27	524	568	11	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1404	1407		10.1126/science.1079354	http://dx.doi.org/10.1126/science.1079354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610308				2022-12-01	WOS:000181192300055
J	Gaunt, MW; Yeo, M; Frame, IA; Stothard, JR; Carrasco, HJ; Taylor, MC; Mena, SS; Veazey, P; Miles, GAJ; Acosta, N; de Arias, AR; Miles, MA				Gaunt, MW; Yeo, M; Frame, IA; Stothard, JR; Carrasco, HJ; Taylor, MC; Mena, SS; Veazey, P; Miles, GAJ; Acosta, N; de Arias, AR; Miles, MA			Mechanism of genetic exchange in American trypanosomes	NATURE			English	Article							CRUZI; IDENTIFICATION; EVOLUTION; LINEAGES; STRAINS	The kinetoplastid Protozoa are responsible for devastating diseases(1). In the Americas, Trypanosoma cruzi is the agent of Chagas' disease-a widespread disease transmissible from animals to humans (zoonosis)-which is transmitted by exposure to infected faeces of blood-sucking triatomine bugs(2). The presence of genetic exchange in T. cruzi and in Leishmania is much debated(3,4). Here, by producing hybrid clones, we show that T. cruzi has an extant capacity for genetic exchange. The mechanism is unusual and distinct from that proposed for the African trypanosome, Trypanosoma brucei(5). Two biological clones(6) of T. cruzi were transfected to carry different drug-resistance markers(7,8), and were passaged together through the entire life cycle. Six double-drug-resistant progeny clones, recovered from the mammalian stage of the life cycle, show fusion of parental genotypes, loss of alleles, homologous recombination, and uniparental inheritance of kinetoplast maxicircle DNA. There are strong genetic parallels between these experimental hybrids and the genotypes among natural isolates of T. cruzi. In this instance, aneuploidy through nuclear hybridization results in recombination across far greater genetic distances than mendelian genetic exchange. This mechanism also parallels genome duplication(9,10).	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Cent Univ Venezuela, Fac Med, Caracas, Venezuela; Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Trop Med, Asuncion, Paraguay	University of London; London School of Hygiene & Tropical Medicine; Natural History Museum London; University of Central Venezuela; Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion	Miles, MA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		Stothard, John Russell/AAK-4829-2021; Carrasco, Hernan Jose/AAU-6492-2020	Stothard, John Russell/0000-0002-9370-3420; Carrasco, Hernan Jose/0000-0001-7500-0927; Acosta, Nidia/0000-0003-2652-354X; Taylor, Martin/0000-0003-4147-0693; Rojas de Arias, Antonieta/0000-0002-6207-1870				Bingle LEH, 2001, MICROBIOL-SGM, V147, P3231, DOI 10.1099/00221287-147-12-3231; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Carrasco HJ, 1996, AM J TROP MED HYG, V54, P418, DOI 10.4269/ajtmh.1996.54.418; Chamnanpunt J, 2001, P NATL ACAD SCI USA, V98, P14530, DOI 10.1073/pnas.251464498; Cook GC, 2003, MANSONS TROPICAL DIS; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; DOPAZO J, 1993, P NATL ACAD SCI USA, V90, P10320, DOI 10.1073/pnas.90.21.10320; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; GIBSON WC, 1996, MOL BIOCHEM PARASIT, V64, P241; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kelly JM, 1997, ADV PARASIT, V39, P227, DOI 10.1016/S0065-308X(08)60047-0; Knight J, 2002, NATURE, V417, P374, DOI 10.1038/417374a; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Mendonca MBA, 2002, PARASITOLOGY, V124, P177, DOI 10.1017/S0031182001001172; MILES MA, 1981, LANCET, V1, P1338; MILES MA, 1992, PROTOCOLS MOL PARASI, P15; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Robello C, 2000, GENE, V246, P331, DOI 10.1016/S0378-1119(00)00074-3; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Stothard JR, 1999, MEM I OSWALDO CRUZ, V94, P189, DOI 10.1590/S0074-02761999000700027; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200	30	276	283	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					936	939		10.1038/nature01438	http://dx.doi.org/10.1038/nature01438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606999				2022-12-01	WOS:000181186900047
J	Busch, MP; Kleinman, SH; Nemo, GJ				Busch, MP; Kleinman, SH; Nemo, GJ			Current and emerging infectious risks of blood transfusions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; SAFETY; CONTAMINATION; BACK; NAT		Blood Ctr Pacific, San Francisco, CA 94118 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Blood Syst Inc, Scottsdale, AZ USA; Westat Corp, Rockville, MD USA; Univ British Columbia, Victoria, BC, Canada; NHLBI, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; Vitalant; Westat; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Busch, MP (corresponding author), Blood Ctr Pacific, 270 Masonic Ave, San Francisco, CA 94118 USA.	mpbusch@itsa.ucsf.edu			DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097077] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HB-97077] Funding Source: Medline; PHS HHS [47114-97081, 47114-97080, 47114-97079, 47114-77078, 47114-97082] Funding Source: Medline	DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AuBuchon JP, 1997, TRANSFUSION, V37, P1211, DOI 10.1046/j.1537-2995.1997.37111298088055.x; Blajchman Morris A., 2001, Transfusion Medicine Reviews, V15, P108, DOI 10.1053/tm.2001.22614; Busch M, 1999, VOX SANG, V77, P67, DOI 10.1159/000031079; Busch MP, 2000, TRANSFUSION, V40, P1157, DOI 10.1046/j.1537-2995.2000.40101157.x; Busch MP, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P33; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P879; Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787; CHAMBERLAND ME, 2001, AIDS REV, V3, P24; DELWART EL, IN PRESS TRANSFUSION; *DEP HLTH, CREUTZF J DIS CJD BO; Dodd RY, 2002, TRANSFUSION, V42, P509, DOI 10.1046/j.1537-2995.2002.00143.x; JACKSON BR, IN PRESS TRANSFUSION; Jacobs MR, 2001, TRANSFUSION, V41, P1331, DOI 10.1046/j.1537-2995.2001.41111331.x; Klein HG, 2000, JAMA-J AM MED ASSOC, V284, P238, DOI 10.1001/jama.284.2.238; Kleinman S, 2001, TRANSFUS MED REV, V15, P201, DOI 10.1053/tmrv.2001.24589; Kleinman SH, 2000, BEST PRACT RES CL HA, V13, P631, DOI 10.1053/beha.2000.0104; Kleinman SH, 2001, TRANSFUSION, V41, P1081, DOI 10.1046/j.1537-2995.2001.41091081.x; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Leiby DA, 1997, J INFECT DIS, V176, P1047, DOI 10.1086/516534; Leiby DA, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P55; Mungai M, 2001, NEW ENGL J MED, V344, P1973, DOI 10.1056/NEJM200106283442603; Popovsky MA, 2000, CURR OPIN HEMATOL, V7, P402, DOI 10.1097/00062752-200011000-00014; Schmidt I, 2001, VOX SANG, V81, P228, DOI 10.1046/j.1423-0410.2001.00120.x; Sibinga CTS, 2000, TRANSFUS MED REV, V14, P269, DOI 10.1053/tm.2000.7396; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Turner ML, 2000, TRANSFUS MED REV, V14, P216, DOI 10.1053/tm.2000.7357; Weinberg PD, 2002, ANN INTERN MED, V136, P312, DOI 10.7326/0003-4819-136-4-200202190-00011	28	206	217	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					959	962		10.1001/jama.289.8.959	http://dx.doi.org/10.1001/jama.289.8.959			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597733				2022-12-01	WOS:000181129800002
J	Wisborg, K; Kesmodel, L; Bech, BH; Hedegaard, M; Henriksen, TB				Wisborg, K; Kesmodel, L; Bech, BH; Hedegaard, M; Henriksen, TB			Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life: prospective study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; CAFFEINE INTAKE; FETAL GROWTH; BIRTH; RISK; REPRODUCTION; POPULATION; EXPOSURE; TOBACCO	Objective To study the association between coffee consumption during pregnancy and the risk of stillbirth and infant death in the first year of life. Design Prospective follow up study. Setting Aarhus University Hospital, Denmark, 1989-96. Participants 18 478 singleton pregnancies in women with valid information about coffee consumption during pregnancy. Main outcome measures Stillbirth (delivery of a dead fetus at greater than or equal to 28 weeks' gestation) and infant death (death of a liveborn infant during the first year of life). Results Pregnant women who drank eight or more cups of coffee per day during pregnancy had an increased risk of stillbirth compared with women who did not drink coffee (odds ratio=3.0,95% confidence interval 1.5 to 5.9). After adjustment for smoking habits and alcohol intake during pregnancy, the relative risk of stillbirth decreased slightly. Adjustment for parity, maternal age, marital status, years of education, occupational status, and body mass index did not substantially change the estimates of association. There was no significant association between coffee consumption and death in the first year of life after adjustment for smoking habits during pregnancy. Conclusion Drinking coffee during pregnancy is associated with an increased risk of stillbirth but not with infant death.	Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark; Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus, Denmark; Aarhus Univ, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Wisborg, K (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark.		Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687				BUNKER ML, 1979, J AM DIET ASSOC, V74, P28; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GILBERT SG, 1988, J PHARMACOL EXP THER, V245, P1048; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Juel K, 1999, DAN MED BULL, V46, P354; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; WATKINSON B, 1985, NEUROBEH TOXICOL TER, V7, P9; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322	16	58	62	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					420	422		10.1136/bmj.326.7386.420	http://dx.doi.org/10.1136/bmj.326.7386.420			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595379	Bronze, Green Published			2022-12-01	WOS:000181318000016
J	Aizenberg, J; Muller, DA; Grazul, JL; Hamann, DR				Aizenberg, J; Muller, DA; Grazul, JL; Hamann, DR			Direct fabrication of large micropatterned single crystals	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; AMORPHOUS CALCIUM-CARBONATE; BIOMIMETIC SYNTHESIS; CRYSTALLIZATION; PRECURSOR; GROWTH; TRANSFORMATION; FILMS; PHASE	Micropatterning of single crystals for technological applications is a complex, multistep process. Nature provides alternative fabrication strategies, when crystals with exquisite micro-ornamentation directly develop within preorganized frameworks. We report a bio-inspired approach to growing large micropatterned single crystals. Micropatterned templates organically modified to induce the formation of metastable amorphous calcium carbonate were imprinted with calcite nucleation sites. The template-directed deposition and crystallization of the amorphous phase resulted in the fabrication of millimeter-sized single calcite crystals with sub-10-mum patterns and controlled crystallographic orientation. We suggest that in addition to regulating the shape, micropatterned frameworks act as sites for stress and impurity release during the amorphous-to-crystalline transition. The proposed mechanisms may have direct biological relevance and broad implications in materials synthesis.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Mat Sim Res, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Aizenberg, J (corresponding author), Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA.		Muller, David/A-7745-2010; Sanguansri, Luz/B-6630-2011	Muller, David/0000-0003-4129-0473; Sanguansri, Luz/0000-0003-1908-7604				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; ALPER M, 1991, MAT SYNTHESIS BASED; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; Beniash E, 1999, J STRUCT BIOL, V125, P50, DOI 10.1006/jsbi.1998.4081; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Fendler JH, 1996, CHEM MATER, V8, P1616, DOI 10.1021/cm960116n; GONIS A, 2000, NUCLEATION GROWTH PR; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; Loste E, 2001, CHEM COMMUN, P901, DOI 10.1039/b101563j; Lowenstam H.A., 1989, BIOMINERALISATION; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Merten H.L., 1980, Patent version, Patent No. [4237147, 4,237,147, 431,002]; Pedersen TPL, 2001, APPL PHYS LETT, V79, P3597, DOI 10.1063/1.1415419; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Sawada K, 1997, PURE APPL CHEM, V69, P921, DOI 10.1351/pac199769050921; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Vere A. W., 1988, CRYSTAL GROWTH PRINC; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108	30	425	441	15	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1205	1208		10.1126/science.1079204	http://dx.doi.org/10.1126/science.1079204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595685				2022-12-01	WOS:000181065500032
J	Kriebel, PW; Barr, VA; Parent, CA				Kriebel, PW; Barr, VA; Parent, CA			Adenylyl cyclase localization regulates streaming during chemotaxis	CELL			English	Article							DEPENDENT PROTEIN-KINASE; MYOSIN HEAVY-CHAIN; DICTYOSTELIUM-DISCOIDEUM; CHEMOATTRACTANT RECEPTOR; MEDIATED ACTIVATION; CELL POLARITY; NEUTROPHIL CHEMOTAXIS; LIVING CELLS; CAMP; MORPHOGENESIS	We studied the role of the adenylyl cyclase ACA in Dictyostelium discoideum chemotaxis and streaming. In this process, cells orient themselves in a head to tail fashion as they are migrating to form aggregates. We show that cells lacking ACA are capable of moving up a chemoattractant gradient, but are unable to stream. Imaging of ACA-YFP reveals plasma membrane labeling highly enriched at the uropod of polarized cells. This localization requires the actin cytoskeleton but is independent of the regulator CRAC and the effector PKA. A constitutively active mutant of ACA shows dramatically reduced uropod enrichment and has severe streaming defects. We propose that the asymmetric distribution of ACA provides a compartment from which cAMP is secreted to locally act as a chemoattractant, thereby providing a unique mechanism to amplify chemical gradients. This could represent a general mechanism that cells use to amplify chemotactic responses.	NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37 Room 1E24, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [ZIABC010418, Z01BC010418] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; BRICKEY DA, 1990, MOL CELL BIOCHEM, V97, P17; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; HARVATH L, 1991, J IMMUNOL, V146, P224; HAUERT AB, 2002, INT J BIOCHEM CELL B, V34, P1467; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Parent CA, 1996, J BIOL CHEM, V271, P18333, DOI 10.1074/jbc.271.31.18333; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHELDEN E, 1995, J CELL SCI, V108, P1105; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; VANMENTSCOHEN M, 1989, J BIOL CHEM, V264, P8717; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	45	119	121	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					549	560		10.1016/S0092-8674(03)00081-3	http://dx.doi.org/10.1016/S0092-8674(03)00081-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600317	Bronze			2022-12-01	WOS:000181252600012
J	Liakopoulos, D; Kusch, J; Grava, S; Vogel, J; Barral, Y				Liakopoulos, D; Kusch, J; Grava, S; Vogel, J; Barral, Y			Asymmetric loading of Kar9 onto spindle poles and microtubules ensures proper spindle alignment	CELL			English	Article							CYCLIN-DEPENDENT KINASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYTOPLASMIC MICROTUBULES; NUCLEAR MIGRATION; MITOTIC SPINDLE; PROTEIN COMPLEX; CELL-CYCLE; ORIENTATION; PHOSPHORYLATION	Spindle alignment is the process in which the two spindle poles are directed toward preselected and opposite cell ends. In budding yeast, the APC-related molecule Kar9 is required for proper alignment of the spindle with the mother-bud axis. We find that Kar9 localizes to the prospective daughter cell spindle pole. Kar9 is transferred from the pole to cytoplasmic microtubules, which are then guided in a myosin-dependent manner to the bud. Clb4/Cdc28 kinase phosphorylates Kar9 and accumulates on the pole destined to the mother cell. Mutations that block phosphorylation at Cdc28 consensus sites result in localization of Kar9 to both poles and target them both to the bud. Thus, Clb4/Cdc28 prevents Kar9 loading on the mother bound pole. In turn, asymmetric distribution of Kar9 ensures that only one pole orients toward the bud. Our results indicate that Cdk1-dependent spindle asymmetry ensures proper alignment of the mitotic spindle with the cell division axis.	ETH Honggerberg, HPM, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; McGill Univ, Montreal, PQ H3A 1B1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; McGill University	Barral, Y (corresponding author), ETH Honggerberg, HPM, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.			Barral, Yves/0000-0002-0989-3373				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Dikovskaya D, 2001, TRENDS CELL BIOL, V11, P378, DOI 10.1016/S0962-8924(01)02069-4; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Guthrie C, 1991, GUIDE YEAST GENETICS; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehberg M, 2002, MOL BIOL CELL, V13, P2301, DOI 10.1091/mbc.E02-01-0054; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Segal M, 1998, J CELL BIOL, V143, P135, DOI 10.1083/jcb.143.1.135; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; SIKORSKI RS, 1989, GENETICS, V122, P19; SU LK, 1995, CANCER RES, V55, P2972; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Trzepacz C, 1997, J BIOL CHEM, V272, P21681, DOI 10.1074/jbc.272.35.21681; TYERS M, 1991, COLD SH Q B, V56, P21; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	38	206	207	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					561	574		10.1016/S0092-8674(03)00119-3	http://dx.doi.org/10.1016/S0092-8674(03)00119-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600318	Bronze			2022-12-01	WOS:000181252600013
J	Annas, GJ				Annas, GJ			The right to health and the nevirapine case in South Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Baleta A, 2002, LANCET, V360, P467, DOI 10.1016/S0140-6736(02)09697-6; Barnard D, 2002, KENNEDY INST ETHIC J, V12, P159, DOI 10.1353/ken.2002.0008; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Farmer P, 2001, NEW ENGL J MED, V345, P208, DOI 10.1056/NEJM200107193450310; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; INNOCENTI NG, 2002, FINANCIAL TIMES 1018, P29; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; MANDELA N, 2002, 14 INT AIDS C BARC S; Mann JM., 1999, HLTH HUMAN RIGHTS RE, P216; MCGREAL C, 2002, GUARDIAN LONDON 1101, P2; Ngwena C, 2000, Health Hum Rights, V5, P26, DOI 10.2307/4065221; STEINER HJ, 2000, INT HUMAN RIGHTS CON, P1395; SWARNS RL, 2002, NY TIMES        0331, P4; Tarantola Daniel, 1998, Health Hum Rights, V3, P60, DOI 10.2307/4065285; Torres Mary Ann, 2002, Chic J Int Law, V3, P105; *UN EC SOC COUNC C, 2000, GEN COMM 14 RIGHT HI	16	25	25	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					750	754		10.1056/NEJMlim022737	http://dx.doi.org/10.1056/NEJMlim022737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594322	Green Published			2022-12-01	WOS:000181014400013
J	Tsang, KW; Ho, PL; Ooi, GC; Yee, WK; Wang, T; Chan-Yeung, M; Lam, WK; Seto, WH; Yam, LY; Cheung, TM; Wong, PC; Lam, B; Ip, MS; Chan, J; Yuen, KY; Lai, KN				Tsang, KW; Ho, PL; Ooi, GC; Yee, WK; Wang, T; Chan-Yeung, M; Lam, WK; Seto, WH; Yam, LY; Cheung, TM; Wong, PC; Lam, B; Ip, MS; Chan, J; Yuen, KY; Lai, KN			A cluster of cases of severe acute respiratory syndrome in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORGANIZING PNEUMONIA; CT FINDINGS	BACKGROUND Information on the clinical features of the severe acute respiratory syndrome (SARS) will be of value to physicians caring for patients suspected of having this disorder. METHODS We abstracted data on the clinical presentation and course of disease in 10 epidemiologically linked Chinese patients (5 men and 5 women 38 to 72 years old) in whom SARS was diagnosed between February 22, 2003, and March 22, 2003, at our hospitals in Hong Kong, China. RESULTS Exposure between the source patient and subsequent patients ranged from minimal to that between patient and health care provider. The incubation period ranged from 2 to 11 days. All patients presented with fever (temperature, >38 degreesC for over 24 hours), and most presented with rigor, dry cough, dyspnea, malaise, headache, and hypoxemia. Physical examination of the chest revealed crackles and percussion dullness. Lymphopenia was observed in nine patients, and most patients had mildly elevated aminotransferase levels but normal serum creatinine levels. Serial chest radiographs showed progressive air-space disease. Two patients died of progressive respiratory failure; histologic analysis of their lungs showed diffuse alveolar damage. There was no evidence of infection by Mycoplasma pneumoniae, Chlamydia pneumoniae, or Legionella pneumophila. All patients received corticosteroid and ribavirin therapy a mean (+/-SD) of 9.6+/-5.42 days after the onset of symptoms, and eight were treated earlier with a combination of beta-lactams and macrolide for 4+/-1.9 days, with no clinical or radiologic efficacy. CONCLUSIONS SARS appears to be infectious in origin. Fever followed by rapidly progressive respiratory compromise is the key complex of signs and symptoms from which the syndrome derives its name. The microbiologic origins of SARS remain unclear. .	Univ Hong Kong, Dept Clin Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Kwong Wah Hospital; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong	Lai, KN (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China.		何栢良, Pak-Leung HO/C-4310-2009; Lai, Kar Neng/C-4300-2009; Yuen, Kwok Yung/C-4465-2009; Ip, Mary Sau Man/C-4284-2009	何栢良, Pak-Leung HO/0000-0002-8811-1308; Yuen, Kwok-yung/0000-0002-2083-1552; Seto, Wing Hong/0000-0002-1139-9200; Ip, Mary Sau Man/0000-0002-8692-6933				*CDCP, 2003, SEV AC RESP SYNDR SA; HAWKER J, 2001, COMMUNICABLE DIS CON, P152; JACKSON LA, 2000, MANDELL DOUGLAS BENN, V2, P2007; LEE KS, 1994, AM J ROENTGENOL, V162, P543, DOI 10.2214/ajr.162.3.8109493; MULLER NL, 1990, AM J ROENTGENOL, V154, P983; PRIMACK SL, 1993, RADIOLOGY, V188, P817, DOI 10.1148/radiology.188.3.8351354; *WHO, 2003, AC RESP SYNDR CHIN U; *WHO, 2003, CASE DEF SURV SEV AC	8	730	847	1	82	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1977	1985		10.1056/NEJMoa030666	http://dx.doi.org/10.1056/NEJMoa030666			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12671062	Bronze			2022-12-01	WOS:000182823400006
J	Jiang, YX; Ruta, V; Chen, JY; Lee, A; MacKinnon, R				Jiang, YX; Ruta, V; Chen, JY; Lee, A; MacKinnon, R			The principle of gating charge movement in a voltage-dependent K+ channel	NATURE			English	Article							SHAKER POTASSIUM CHANNEL; TRANSMEMBRANE MOVEMENT; ESCHERICHIA-COLI; ION CHANNELS; S4 SEGMENT; WILD-TYPE; ACTIVATION; SENSOR; MUTANT; SITE	The steep dependence of channel opening on membrane voltage allows voltage-dependent K+ channels to turn on almost like a switch. Opening is driven by the movement of gating charges that originate from arginine residues on helical S4 segments of the protein. Each S4 segment forms half of a 'voltage-sensor paddle' on the channel's outer perimeter. Here we show that the voltage-sensor paddles are positioned inside the membrane, near the intracellular surface, when the channel is closed, and that the paddles move a large distance across the membrane from inside to outside when the channel opens. KvAP channels were reconstituted into planar lipid membranes and studied using monoclonal Fab fragments, a voltage-sensor toxin, and avidin binding to tethered biotin. Our findings lead us to conclude that the voltage-sensor paddles operate somewhat like hydrophobic cations attached to levers, enabling the membrane electric field to open and close the pore.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Aziz QH, 2002, J BIOL CHEM, V277, P42719, DOI 10.1074/jbc.M207258200; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Laine M, 2002, BIOPHYS J, V82, p231A; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Papazian DM, 2002, NOVART FDN SYMP, V245, P178; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; QIU XQ, 1994, J BIOL CHEM, V269, P7483; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	33	656	685	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					42	48		10.1038/nature01581	http://dx.doi.org/10.1038/nature01581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721619				2022-12-01	WOS:000182561600033
J	Giasson, BI; Forman, MS; Higuchi, M; Golbe, LI; Graves, CL; Kotzbauer, PT; Trojanowski, JQ; Lee, VMY				Giasson, BI; Forman, MS; Higuchi, M; Golbe, LI; Graves, CL; Kotzbauer, PT; Trojanowski, JQ; Lee, VMY			Initiation and synergistic fibrillization of tau and alpha-synuclein	SCIENCE			English	Article							PROTEIN-TAU; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; FILAMENTS; MUTANT; PHOSPHORYLATION; LOCALIZATION; DEMENTIA; RESIDUES; MISSENSE	Alpha-synuclein (alpha-syn) and tau polymerize into amyloid fibrils and form intraneuronal filamentous inclusions characteristic of neurodegenerative diseases. We demonstrate that alpha-syn induces fibrillization of tau and that coincubation of tau and alpha-syn synergistically promotes fibrillization of both proteins. The in vivo relevance of these findings is grounded in the co-occurrence of alpha-syn and tau filamentous amyloid inclusions in humans, in single transgenic mice that express A53T human alpha-syn in neurons, and in oligodendrocytes of bigenic mice that express wild-type human alpha-syn plus P301L mutant tau. This suggests that interactions between alpha-syn and tau can promote their fibrillization and drive the formation of pathological inclusions in human neurodegenerative diseases.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, 3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu						Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; CRYSTAL A, UNPUB; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 1998, BIOCHEM SOC T, V26, P463, DOI 10.1042/bst0260463; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; HANSEN L, 1990, NEUROLOGY, V40, P1; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	29	639	665	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					636	640		10.1126/science.1082324	http://dx.doi.org/10.1126/science.1082324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714745				2022-12-01	WOS:000182453700041
J	Reches, M; Gazit, E				Reches, M; Gazit, E			Casting metal nanowires within discrete self-assembled peptide nanotubes	SCIENCE			English	Article							AMYLOID FIBRIL FORMATION; PI-STACKING; PENTAPEPTIDE; MODEL	Tubular nanostructures are suggested to have a wide range of applications in nanotechnology. We report our observation of the self-assembly of a very short peptide, the Alzheimer's beta-amyloid diphenylalanine structural motif, into discrete and stiff nanotubes. Reduction of ionic silver within the nanotubes, followed by enzymatic degradation of the peptide backbone, resulted in the production of discrete nanowires with a long persistence length. The same dipeptide building block, made of D-phenylalanine, resulted in the production of enzymatically stable nanotubes.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Gazit, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il	Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019; Gazit, Ehud/C-3715-2011; Reches, Meital/B-2348-2013	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Reches, Meital/0000-0001-5652-9868				Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Claessens CG, 1997, J PHYS ORG CHEM, V10, P254, DOI 10.1002/(SICI)1099-1395(199705)10:5<254::AID-POC875>3.0.CO;2-3; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; ENUSTUN BV, 1963, J AM CHEM SOC, V85, P3317, DOI 10.1021/ja00904a001; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2002, ANGEW CHEM INT EDIT, V41, P257, DOI 10.1002/1521-3773(20020118)41:2<257::AID-ANIE257>3.0.CO;2-M; Gazit E, 2002, CURR MED CHEM, V9, P1725; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Gorbitz CH, 2001, CHEM-EUR J, V7, P5153, DOI 10.1002/1521-3765(20011203)7:23<5153::AID-CHEM5153>3.0.CO;2-N; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s; Henglein A, 1999, J PHYS CHEM B, V103, P9533, DOI 10.1021/jp9925334; Matsui H, 2000, J PHYS CHEM B, V104, P3383, DOI 10.1021/jp994117p; Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Shetty AS, 1996, J AM CHEM SOC, V118, P1019, DOI 10.1021/ja9528893; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5	29	1984	2042	20	872	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					625	627		10.1126/science.1082387	http://dx.doi.org/10.1126/science.1082387			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714741				2022-12-01	WOS:000182453700037
J	Sun, JC; Bevan, MJ				Sun, JC; Bevan, MJ			Defective CD8 T cell memory following acute infection without CD4 T cell help	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; LISTERIA INFECTION; MICE; RESPONSES; LYMPHOCYTES; RESISTANCE	The CD8(+) cytotoxic T cell response to pathogens is thought to be CD4(+) helper T cell independent because infectious agents provide their own inflammatory signals. Mice that lack CD4(+) T cells mount a primary CD8 response to Listeria monocytogenes equal to that of wild-type mice and rapidly clear the infection. However, protective memory to a challenge is gradually lost in the former animals. Memory CD8(+) T cells from normal mice can respond rapidly, but memory CD8(+) T cells that are generated without CD4 help are defective in their ability to respond to secondary encounters with antigen. The results highlight a previously undescribed role for CD4 help in promoting protective CD8 memory development.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.		Nogueira, Raquel Tayar/F-6475-2019	Nogueira, Raquel Tayar/0000-0002-0581-763X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019335, R01AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335-19, R01 AI019335, AI 19335] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; CARDIN RD, 1996, J EXP MED, V184, P8056; Edelson BT, 1999, J IMMUNOL, V163, P4087; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Liu HY, 2002, J IMMUNOL, V168, P3477, DOI 10.4049/jimmunol.168.7.3477; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Zajac AJ, 1998, CURR OPIN IMMUNOL, V10, P444, DOI 10.1016/S0952-7915(98)80119-2; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	25	997	1032	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					339	342		10.1126/science.1083317	http://dx.doi.org/10.1126/science.1083317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690202	Green Accepted			2022-12-01	WOS:000182135400060
J	Yoder, CF; Konopliv, AS; Yuan, DN; Standish, EM; Folkner, WM				Yoder, CF; Konopliv, AS; Yuan, DN; Standish, EM; Folkner, WM			Fluid core size of mars from detection of the solar tide	SCIENCE			English	Article							INTERIOR STRUCTURE; GRAVITY-FIELD; MODEL; PATHFINDER; TRACKING	The solar tidal deformation of Mars, measured by its k(2) potential Love number, has been obtained from an analysis of Mars Global Surveyor radio tracking. The observed k(2) of 0.153 +/- 0.017 is large enough to rule out a solid iron core and so indicates that at least the outer part of the core is liquid. The inferred core radius is between 1520 and 1840 kilometers and is independent of many interior properties, although partial melt of the mantle is one factor that could reduce core size. Ice-cap mass changes can be deduced from the seasonal variations in air pressure and the odd gravity harmonic J(3), given knowledge of cap mass distribution with latitude. The south cap seasonal mass change is about 30 to 40% larger than that of the north cap.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Yoder, CF (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Charles.F.Yoder@jpl.nasa.gov; Alex.Konopliv@jpl.nasa.gov						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; DICKEY JO, 1994, SCIENCE, V265, P482, DOI 10.1126/science.265.5171.482; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Groten E, 1996, ASTRON J, V111, P1388, DOI 10.1086/117885; Haberle RM, 1999, J GEOPHYS RES-PLANET, V104, P8957, DOI 10.1029/1998JE900040; JUSTUS CJ, 1996, 108513 NASA; Konopliv AS, 1996, GEOPHYS RES LETT, V23, P1857, DOI 10.1029/96GL01589; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Ray RD, 1996, NATURE, V381, P595, DOI 10.1038/381595a0; REASENBERG RD, 1977, J GEOPHYS RES, V82, P369, DOI 10.1029/JB082i002p00369; Smith DE, 1999, J GEOPHYS RES-PLANET, V104, P1885, DOI 10.1029/1998JE900024; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; Turcotte DL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001594; WAHR J, 1995, HDB PHYSICAL CONSTAN, V1, P40; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0; Yoder CF, 1997, J GEOPHYS RES-PLANET, V102, P4065, DOI 10.1029/96JE03642; YODER CF, 1995, ICARUS, V117, P250, DOI 10.1006/icar.1995.1156; YODER CF, 1995, HDB PHYSICAL CONSTAN, V1, P1; Yuan DN, 2001, J GEOPHYS RES-PLANET, V106, P23377, DOI 10.1029/2000JE001302; Zharkov VN, 2000, PHYS EARTH PLANET IN, V117, P407, DOI 10.1016/S0031-9201(99)00110-7; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	22	226	234	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					299	303		10.1126/science.1079645	http://dx.doi.org/10.1126/science.1079645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12624177				2022-12-01	WOS:000182135400048
J	Wiznitzer, M; Findling, RL				Wiznitzer, M; Findling, RL			Why do psychiatric drug research in children?	LANCET			English	Editorial Material							OBSESSIVE-COMPULSIVE DISORDER; MOOD DISORDERS; PSYCHOPHARMACOLOGY; ADOLESCENTS; PERSPECTIVE; DEPRESSION		Univ Hosp Cleveland, Dept Pediat, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Psychiat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University	Wiznitzer, M (corresponding author), Univ Hosp Cleveland, Dept Pediat, Cleveland, OH 44106 USA.							Carrey N, 2001, CAN J PSYCHIAT, V46, P810, DOI 10.1177/070674370104600904; HAZELL P, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002317; Hyman SE, 2001, BIOL PSYCHIAT, V49, P962, DOI 10.1016/S0006-3223(01)01128-3; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kaufman J, 2001, BIOL PSYCHIAT, V49, P980, DOI 10.1016/S0006-3223(01)01127-1; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; March JS, 2001, J CLIN CHILD PSYCHOL, V30, P8, DOI 10.1207/S15374424JCCP3001_3; Michael KD, 2002, CLIN PSYCHOL REV, V22, P247, DOI 10.1016/S0272-7358(01)00089-7; Piacentini J, 2000, PSYCHIAT CLIN N AM, V23, P519, DOI 10.1016/S0193-953X(05)70178-7; *US FDA, 2003, FDA APPR PROZ PED US; Vitiello B, 2001, PEDIATRICS, V108, P983, DOI 10.1542/peds.108.4.983; Weintrob N, 2002, ARCH PEDIAT ADOL MED, V156, P696, DOI 10.1001/archpedi.156.7.696; Zito JM, 2003, ARCH PEDIAT ADOL MED, V157, P17, DOI 10.1001/archpedi.157.1.17	13	17	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1147	1148		10.1016/S0140-6736(03)12967-4	http://dx.doi.org/10.1016/S0140-6736(03)12967-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZF	12686034				2022-12-01	WOS:000182094600005
J	Spehr, M; Gisselmann, G; Poplawski, A; Riffell, JA; Wetzel, CH; Zimmer, RK; Hatt, H				Spehr, M; Gisselmann, G; Poplawski, A; Riffell, JA; Wetzel, CH; Zimmer, RK; Hatt, H			Identification of a testicular odorant receptor mediating human sperm chemotaxis	SCIENCE			English	Article							FUNCTIONAL EXPRESSION; OLFACTORY RECEPTORS; HUMAN SPERMATOZOA; ADENYLYL-CYCLASE; GERM-CELLS; PROGESTERONE; CHANNEL; SYSTEM	Although it has been known for some time that olfactory receptors (ORs) reside in spermatozoa, the function of these ORs is unknown. Here, we identified, cloned, and functionally expressed a previously undescribed human testicular OR, hOR17-4. With the use of raticifluorometric imaging, Ca2+ signals were induced by a small subset of applied chemical stimuli, establishing the molecular receptive fields for the recombinantly expressed receptor in human embryonic kidney (HEK) 293 cells and the native receptor in human spermatozoa. Bourgeonal was a powerful agonist for both recombinant and native receptor types, as well as a strong chemoattractant in subsequent behavioral bioassays. In contrast, undecanal was a potent OR antagonist to bourgeonal and related compounds. Taken together, these results indicate that hOR17-4 functions in human sperm chemotaxis and may be a critical component of the fertilization process.	Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany; Univ Calif Los Angeles, Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	Ruhr University Bochum; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hatt, H (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, 150 Univ St, D-44780 Bochum, Germany.		Wetzel, Christian H/N-9880-2017; Wetzel, Christian/F-1366-2018; Wetzel, Christian/C-2501-2009; Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011	Wetzel, Christian H/0000-0002-5762-0003; Wetzel, Christian/0000-0002-5762-0003; Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196				Baldi E, 2002, J REPROD IMMUNOL, V53, P121, DOI 10.1016/S0165-0378(01)00089-4; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Garcia MA, 1999, BIOL REPROD, V60, P102, DOI 10.1095/biolreprod60.1.102; Gautier-Courteille C, 1998, ENDOCRINOLOGY, V139, P2588, DOI 10.1210/en.139.5.2588; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Kobori H, 2000, BIOL REPROD, V63, P113, DOI 10.1095/biolreprod63.1.113; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Wellerdieck C, 1997, CHEM SENSES, V22, P467, DOI 10.1093/chemse/22.4.467; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0	19	553	580	6	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2054	2058		10.1126/science.1080376	http://dx.doi.org/10.1126/science.1080376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663925				2022-12-01	WOS:000181834200051
J	Betschinger, J; Mechtler, K; Knoblich, JA				Betschinger, J; Mechtler, K; Knoblich, JA			The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl	NATURE			English	Article							II HEAVY-CHAIN; TUMOR-SUPPRESSOR PROTEIN; DROSOPHILA NEUROBLASTS; PLASMA-MEMBRANE; PROSPERO; POLARITY; BAZOOKA; MYOSIN; LOCALIZATION; MITOSIS	To generate different cell types, some cells can segregate protein determinants into one of their two daughter cells during mitosis. In Drosophila neuroblasts, the Par protein complex localizes apically(1-5) and directs localization of the cell fate determinants Prospero(6-8) and Numb(9) and the adaptor proteins Miranda(10,11) and Pon(12) to the basal cell cortex, to ensure their segregation into the basal daughter cell. The Par protein complex has a conserved function in establishing cell polarity(13) but how it directs proteins to the opposite side is unknown. We show here that a principal function of this complex is to phosphorylate the cytoskeletal protein Lethal (2) giant larvae (Lgl; also known as L(2)gl). Phosphorylation by Drosophila atypical protein kinase C (aPKC), a member of the Par protein complex, releases Lgl from its association with membranes and the actin cytoskeleton. Genetic and biochemical experiments show that Lgl phosphorylation prevents the localization of cell fate determinants to the apical cell cortex. Lgl promotes cortical localization of Miranda(14,15),, and we propose that phosphorylation of Lgl by aPKC at the apical neuroblast cortex restricts Lgl activity and Miranda localization to the opposite, basal side of the cell.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Mechtler, Karl/AAF-2717-2019; Knoblich, Juergen A/C-2974-2015	Mechtler, Karl/0000-0002-3392-9946; Knoblich, Juergen A/0000-0002-6751-3404; Betschinger, Joerg/0000-0002-2627-8479				BRAND AH, 1993, DEVELOPMENT, V118, P401; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kagami M, 1998, GENETICS, V149, P1717; Kalmes A, 1996, J CELL SCI, V109, P1359; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schulze KL, 1996, GENETICS, V144, P1713; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1994, J CELL BIOL, V127, P1345, DOI 10.1083/jcb.127.5.1345; STRAND D, 1995, ONCOGENE, V11, P291; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	30	446	456	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					326	330		10.1038/nature01486	http://dx.doi.org/10.1038/nature01486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12629552				2022-12-01	WOS:000181637300043
J	Hoag, H				Hoag, H			Tougher rules aim to prevent gene flow into crops	NATURE			English	News Item																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					103	103		10.1038/422103b	http://dx.doi.org/10.1038/422103b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634744	Bronze			2022-12-01	WOS:000181488900008
J	Susser, E; Terry, MB				Susser, E; Terry, MB			A conception-to-death cohort	LANCET			English	Editorial Material							SCHIZOPHRENIA		Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Epidemiol Brain Disorders, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Susser, E (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.	ess8@columbia.edu		Terry, Mary Beth/0000-0002-4106-5033				Barker DJP, 1992, FETAL INFANT ORIGINS; Broman S., 1984, HDB LONGITUDINAL RES, V1, P185; Delongchamp RR, 1997, RADIAT RES, V147, P385, DOI 10.2307/3579348; Eaton WW, 2002, ANN EPIDEMIOL, V12, P445, DOI 10.1016/S1047-2797(01)00314-3; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Kuh D, 1997, LIFE COURSE APPROACH; Susser E, 1999, PSYCHIAT ANN, V29, P161, DOI 10.3928/0048-5713-19990301-13; Susser E, 1998, AM J EPIDEMIOL, V147, P213; Terry MB, 2001, INT J EPIDEMIOL, V30, P95, DOI 10.1093/ije/30.1.95; VANDENBERG BJ, 1984, HDB LONGITUDINAL RES, V1, P166; Wadsworth M. E. J., 1991, IMPRINT TIME CHILDHO; Wyatt RJ, 2000, SCHIZOPHRENIA BULL, V26, P255, DOI 10.1093/oxfordjournals.schbul.a033450	12	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2003	361	9360					797	798		10.1016/S0140-6736(03)12721-3	http://dx.doi.org/10.1016/S0140-6736(03)12721-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642043				2022-12-01	WOS:000181466600005
J	Margarit, SM; Sondermann, H; Hall, BE; Nagar, B; Hoelz, A; Pirruccello, M; Bar-Sagi, D; Kuriyan, J				Margarit, SM; Sondermann, H; Hall, BE; Nagar, B; Hoelz, A; Pirruccello, M; Bar-Sagi, D; Kuriyan, J			Structural evidence for feedback activation by Ras-GTP of the Ras-specific nucleotide exchange factor SOS	CELL			English	Article							SIGNAL-TRANSDUCTION; GENE-PRODUCT; BINDING; SWITCH	Growth factor receptors activate Ras by recruiting the nucleotide exchange factor son of sevenless (SOS) to the cell membrane, thereby triggering the production of GTP-loaded Ras. Crystallographic analyses of Ras bound to the catalytic module of SOS have led to the unexpected discovery of a highly conserved Ras binding site on SOS that is located distal to the active site and is specific for Ras-GTP. The crystal structures suggest that Ras-GTP stabilizes the active site of SOS allosterically, and we show that Ras-GTP forms ternary complexes with SOScat in solution and increases significantly the rate of SOScat-stimulated nucleotide release from Ras. These results demonstrate the existence of a positive feedback mechanism for the spatial and temporal regulation of Ras.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Rockefeller Univ, New York, NY 10021 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rockefeller University	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	barsagi@pharm.sunysb.edu; kuriyan@uclink.berkeley.edu	Hoelz, Andre/AAB-6978-2021; Nagar, Bhushan/C-1297-2010	Pirruccello-Straub, Michelle/0000-0002-7996-857X; Bar-Sagi, Dafna/0000-0003-2597-8948				Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARSAGI D, 1994, TRENDS ENDOCRIN MET, V5, P165, DOI 10.1016/1043-2760(94)90014-0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang C, 2000, EMBO J, V19, P3283, DOI 10.1093/emboj/19.13.3283; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; LAI SHY, 1993, COMPUT IND ENG, V25, P13, DOI 10.1016/0360-8352(93)90209-G; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MARGARIT SM, 2002, THESIS STATE U NEW Y; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wyatt PJ, 1997, INSTRUM SCI TECHNOL, V25, P1, DOI 10.1080/10739149709351443	32	325	359	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					685	695		10.1016/S0092-8674(03)00149-1	http://dx.doi.org/10.1016/S0092-8674(03)00149-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628188	Bronze			2022-12-01	WOS:000181443600011
J	Wang, YC; Shirogane, T; Liu, D; Harper, JW; Elledge, SJ				Wang, YC; Shirogane, T; Liu, D; Harper, JW; Elledge, SJ			Exit from exit: Resetting the cell cycle through Amn1 inhibition of G protein signaling	CELL			English	Article							SPINDLE POLE BODIES; SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; BUDDING YEAST; TRANSCRIPTION FACTOR; PHOSPHATASE CDC14; KINASE COMPLEX; TEM1 GTPASE; CHECKPOINT; MITOSIS	In S. cerevisiae cells undergoing anaphase, a ras-related GTPase, Tem1, is located on the spindle pole body that enters the daughter cell and activates a signal transduction pathway, MEN, to allow mitotic exit. MEN activation must be reversed after mitotic exit to reset the cell cycle in G1. We find that daughter cells activate an Antagonist of MEN pathway (AMEN) in part through induction of the Amn1 protein that binds directly to Tem1 and prevents its association with its target kinase Cdc15. Failure of Amn1 function results in defects of both the spindle assembly and nuclear orientation checkpoints and delays turning off Cdc14 in G1. Thus Amn1 is part of a daughter-specific switch that helps cells exit from mitotic exit and reset the cell cycle.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Wang, Yanchang/0000-0001-6782-0570; Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM054137, R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG00183] Funding Source: Medline; NIGMS NIH HHS [GM54137, GM44664] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Asakawa K, 2001, GENETICS, V157, P1437; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Geymonat M, 2002, J BIOL CHEM, V277, P28439, DOI 10.1074/jbc.M202540200; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lee SE, 2001, J CELL SCI, V114, P2345; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LIU HP, 1992, GENETICS, V132, P665; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(00)00002-2; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Ro HS, 2002, P NATL ACAD SCI USA, V99, P5436, DOI 10.1073/pnas.062059999; ROSE M, 1995, YEAST, V11, P865, DOI 10.1002/yea.320110908; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9	42	66	70	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					697	709		10.1016/S0092-8674(03)00121-1	http://dx.doi.org/10.1016/S0092-8674(03)00121-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628189	Bronze			2022-12-01	WOS:000181443600012
J	Yajnik, V; Paulding, C; Sordella, R; McClatchey, AI; Saito, M; Wahrer, DCR; Reynolds, P; Bell, DW; Lake, R; van den Heuvel, S; Settleman, J; Haber, DA				Yajnik, V; Paulding, C; Sordella, R; McClatchey, AI; Saito, M; Wahrer, DCR; Reynolds, P; Bell, DW; Lake, R; van den Heuvel, S; Settleman, J; Haber, DA			DOCK4, a GTPase activator, is disrupted during tumorigenesis	CELL			English	Article							REPRESENTATIONAL DIFFERENCE ANALYSIS; TUMOR-SUPPRESSOR GENE; E-CADHERIN; LYMPHOCYTE MIGRATION; BINDING-PROTEIN; PROSTATE-CANCER; CELL-MIGRATION; FREQUENT LOSS; ADHESION; COMPLEX	We used representational difference analysis to identify homozygous genomic deletions selected during tumor progression in the mouse NF2 and TP53 tumor model. We describe a deletion targeting DOCK4, a member of the CDM gene family encoding regulators of small GTPases. DOCK4 specifically activates Rap GTPase, enhancing the formation of adherens junctions. DOCK4 mutations are present in a subset of human cancer cell lines; a recurrent missense mutant identified in human prostate and ovarian cancers encodes a protein that is defective in Rap1 activation. The engulfment defect of C. elegans mutants lacking the CDM gene ced-5 is rescued by wild-type DOCK4, but not by the mutant allele. Expression of wild-type, but not mutant, DOCK4 in mouse osteosarcoma cells with a deletion of the endogenous gene suppresses growth in soft agar and tumor invasion in vivo. DOCK4 therefore encodes a CDM family member that regulates intercellular junctions and is disrupted during tumorigenesis.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Med Sch, Gastrointestinal Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.		van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; Reynolds, Paul/0000-0001-8738-1245	NATIONAL CANCER INSTITUTE [R37CA058596, R01CA058596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063081] Funding Source: NIH RePORTER; NCI NIH HHS [CA58596] Funding Source: Medline; NIDDK NIH HHS [5T32DK07191] Funding Source: Medline; NIGMS NIH HHS [GM63081] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang H, 2000, GENOMICS, V66, P226, DOI 10.1006/geno.2000.6198; LISITSYN N, 1995, METHOD ENZYMOL, V254, P291; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LISITSYN NA, 1994, COLD SPRING HARB SYM, V59, P585, DOI 10.1101/SQB.1994.059.01.066; LISITSYN NA, 1995, TRENDS GENET, V11, P303, DOI 10.1016/S0168-9525(00)89087-3; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 1998, CURR OPIN GENET DEV, V8, P304, DOI 10.1016/S0959-437X(98)80086-5; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Perego C, 2002, J CELL SCI, V115, P3331; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; SEKIDO Y, 1995, CANCER RES, V55, P1227; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; TAKAHASHI S, 1995, CANCER RES, V55, P4114; Thomas DM, 1996, J BONE MINER RES, V11, P1312; Thomas NA, 2001, NAT GENET, V29, P379, DOI 10.1038/ng784; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	59	185	192	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					673	684		10.1016/S0092-8674(03)00155-7	http://dx.doi.org/10.1016/S0092-8674(03)00155-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628187	Bronze			2022-12-01	WOS:000181443600010
J	Tang, FS; Kauffman, EJ; Novak, JL; Nau, JJ; Catlett, NL; Weisman, LS				Tang, FS; Kauffman, EJ; Novak, JL; Nau, JJ; Catlett, NL; Weisman, LS			Regulated degradation of a class V myosin receptor directs movement of the yeast vacuole	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; CELL-CYCLE; ACTIN; INHERITANCE; MYO2P; LOCALIZATION; PROTEIN; COMPLEX; MOTOR	Normal cellular function requires that organelles be positioned in specific locations. The direction in which molecular motors move organelles is based in part on the polarity of microtubules and actin filaments(1-3). However, this alone does not determine the intracellular destination of organelles. For example, the yeast class V myosin, Myo2p, moves several organelles to distinct locations during the cell cycle(4-8). Thus the movement of each type of Myo2p cargo must be regulated uniquely. Here we report a regulatory mechanism that specifically provides directionality to vacuole movement. The vacuole-specific Myo2p receptor, Vac17p, has a key function in this process. Vac17p binds simultaneously to Myo2p and to Vac8p, a vacuolar membrane protein. The transport complex, Myo2p-Vac17p-Vac8p, moves the vacuole to the bud, and is then disrupted through the degradation of Vac17p. The vacuole is ultimately deposited near the centre of the bud. Removal of a PEST sequence (a potential signal for rapid protein degradation) within Vac17p causes its stabilization and the subsequent 'backward' movement of vacuoles, which mistargets them to the neck between the mother cell and the bud. Thus the regulated disruption of this transport complex places the vacuole in its proper location. This may be a general mechanism whereby organelles are deposited at their terminal destination.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Weisman, LS (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.							Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Catlett NL, 2000, CURR OPIN CELL BIOL, V12, P509, DOI 10.1016/S0955-0674(00)00124-1; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; deMesquita DSG, 1996, EUR J CELL BIOL, V71, P237; DEMESQUITA DSG, 1991, J GEN MICROBIOL, V137, P2447, DOI 10.1099/00221287-137-10-2447; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; ISHIKAWA K, IN PRESS J CELL BIOL; James P, 1996, GENETICS, V144, P1425; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reck-Peterson SL, 1999, MOL BIOL CELL, V10, P1001, DOI 10.1091/mbc.10.4.1001; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang ZQ, 1998, CHINESE CHEM LETT, V9, P261; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	29	93	96	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					87	92		10.1038/nature01453	http://dx.doi.org/10.1038/nature01453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594460				2022-12-01	WOS:000181343100043
J	Elia, AEH; Cantley, LC; Yaffe, MB				Elia, AEH; Cantley, LC; Yaffe, MB			Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates	SCIENCE			English	Article							MAMMALIAN POLO KINASE; CELL-CYCLE; PROTEIN; SPECIFICITY; EXTRACTS; CLONING; PEPTIDE; SRC	We have developed a proteomic approach for identifying phosphopeptide binding domains that modulate kinase-dependent signaling pathways. An immobilized library of partially degenerate phosphopeptides biased toward a particular protein kinase phosphorylation motif is used to isolate phospho-binding domains that bind to proteins phosphorylated by that kinase. Applying this approach to cyclin-dependent kinases (Cdks), we identified the polo-box domain (PBD) of the mitotic kinase polo-like kinase 1 (Plk1) as a specific phosphoserine (pSer) or phosphothreonine (pThr) binding domain and determined its optimal binding motif. This motif is present in known Plk1 substrates such as Cdc25, and an optimal phosphopeptide containing the motif disrupted PBD-substrate binding and localization of the PBD to centrosomes. This finding reveals how Plk1 can localize to specific sites within cells in response to Cdk phosphorylation at those sites and provides a structural mechanism for targeting the Plk1 kinase domain to its substrates.	MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA; Beth Israel Deaconess Hosp, Div Signal Transduct, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56203, R01 GM056203, GM52981] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 1999, P NATL ACAD SCI USA, V96, P14360, DOI 10.1073/pnas.96.25.14360; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pawson T, 2000, GENE DEV, V14, P1027; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	22	558	570	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1228	1231		10.1126/science.1079079	http://dx.doi.org/10.1126/science.1079079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595692				2022-12-01	WOS:000181065500039
J	Willert, K; Brown, JD; Danenberg, E; Duncan, AW; Weissman, IL; Reya, T; Yates, JR; Nusse, R				Willert, K; Brown, JD; Danenberg, E; Duncan, AW; Weissman, IL; Reya, T; Yates, JR; Nusse, R			Wnt proteins are lipid-modified and can act as stem cell growth factors	NATURE			English	Article							SIGNALING PATHWAY; C-ELEGANS; DROSOPHILA; WINGLESS; IDENTIFICATION; EXPRESSION; CANCER; FORM	Wnt signalling is involved in numerous events in animal development(1), including the proliferation of stem cells(2) and the specification of the neural crest(3). Wnt proteins are potentially important reagents in expanding specific cell types, but in contrast to other developmental signalling molecules such as hedgehog proteins and the bone morphogenetic proteins, Wnt proteins have never been isolated in an active form. Although Wnt proteins are secreted from cells(4-7), secretion is usually inefficient(8) and previous attempts to characterize Wnt proteins have been hampered by their high degree of insolubility. Here we have isolated active Wnt molecules, including the product of the mouse Wnt3a gene. By mass spectrometry, we found the proteins to be palmitoylated on a conserved cysteine. Enzymatic removal of the palmitate or site-directed and natural mutations of the modified cysteine result in loss of activity, and indicate that the lipid is important for signalling. The purified Wnt3a protein induces self-renewal of haematopoietic stem cells, signifying its potential use in tissue engineering.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Duke University; Stanford University; Scripps Research Institute	Nusse, R (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.			Duncan, Andrew/0000-0003-4962-4191; Danenberg, Esther/0000-0002-1799-4457				BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADLEY RS, 1995, MOL CELL BIOL, V15, P4616; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Maloof JN, 1999, DEVELOPMENT, V126, P37; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Polakis P, 2000, GENE DEV, V14, P1837; REYA T, 2003, NATURE          0427; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Shibamoto S, 1998, GENES CELLS, V3, P659; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200	30	1669	1823	3	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					448	452		10.1038/nature01611	http://dx.doi.org/10.1038/nature01611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12717451				2022-12-01	WOS:000183012000044
J	Lessard, J; Sauvageau, G				Lessard, J; Sauvageau, G			Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW CELLS; ACUTE MYELOGENOUS LEUKEMIA; POLYCOMB-GROUP GENES; HEMATOPOIETIC-CELL; EXPRESSION; HOXA9; T(7-11)(P15-P15); TRANSFORMATION; OVEREXPRESSION	An emerging concept in the field of cancer biology is that a rare population of 'tumour stem cells' exists among the heterogeneous group of cells that constitute a tumour. This concept, best described with human leukaemia, indicates that stem cell function ( whether normal or neoplastic) might be defined by a common set of critical genes. Here we show that the Polycomb group gene Bmi-1 has a key role in regulating the proliferative activity of normal stem and progenitor cells. Most importantly, we provide evidence that the proliferative potential of leukaemic stem and progenitor cells lacking Bmi-1 is compromised because they eventually undergo proliferation arrest and show signs of differentiation and apoptosis, leading to transplant failure of the leukaemia. Complementation studies showed that Bmi-1 completely rescues these proliferative defects. These studies therefore indicate that Bmi-1 has an essential role in regulating the proliferative activity of both normal and leukaemic stem cells.	Clin Res Inst Montreal, Lab Mol Genet Hemopoiet Stem Cells, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Hosp Maisonneuve Rosemont, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Hosp Maisonneuve Rosemont, Div Hematol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Clin Res Inst Montreal, Lab Mol Genet Hemopoiet Stem Cells, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	sauvagg@ircm.qc.ca		Sauvageau, Guy/0000-0002-4333-7266				Appelbaum F R, 2001, Hematology Am Soc Hematol Educ Program, P62; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Dimri GP, 2002, CANCER RES, V62, P4736; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Krosl J, 1998, ONCOGENE, V16, P3403, DOI 10.1038/sj.onc.1201883; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weber HO, 2002, ONCOGENE, V21, P3207, DOI 10.1038/sj.onc.1205429	24	1177	1298	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					255	260		10.1038/nature01572	http://dx.doi.org/10.1038/nature01572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12714970				2022-12-01	WOS:000182853100034
J	Liu, YF; Hong, X; Kappler, J; Jiang, L; Zhang, RG; Xu, LG; Pan, CH; Martin, WE; Murphy, RC; Shu, HB; Dai, SD; Zhang, GY				Liu, YF; Hong, X; Kappler, J; Jiang, L; Zhang, RG; Xu, LG; Pan, CH; Martin, WE; Murphy, RC; Shu, HB; Dai, SD; Zhang, GY			Ligand-receptor binding revealed by the TNF family member TALL-1	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; B-CELL MATURATION; CRYSTAL-STRUCTURE; AUTOIMMUNE-DISEASE; LYMPHOCYTE STIMULATOR; BAFF; TACI; BLYS; APRIL; BCMA	The tumour necrosis factor (TNF) ligand TALL-1 and its cognate receptors, BCMA, TACI and BAFF-R, were recently identified as members of the TNF superfamily, which are essential factors contributing to B-cell maturation. The functional, soluble fragment of TALL-1 (sTALL-1) forms a virus-like assembly for its proper function. Here we determine the crystal structures of sTALL-1 complexed with the extracellular domains of BCMA and BAFF-R at 2.6 and 2.5 Angstrom, respectively. The single cysteine-rich domain of BCMA and BAFF-R both have saddle-like architectures, which sit on the horseback-like surface formed by four coil regions on each individual sTALL-1 monomer. Three novel structural modules, D2, X2 and N, were revealed from the current structures. Sequence alignments, structural modelling and mutagenesis revealed that one disulphide bridge in BAFF-R is critical for determining the binding specificity of the extracellular domain eBAFF-R to TALL-1 instead of APRIL, a closely related ligand of TALL-1, which was confirmed by binding experiments in vitro.	Univ Colorado, Hlth Sci Ctr, Sch Med, Natl Jewish Med & Res Ctr,Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pharmacol,Biomol Struct Program, Denver, CO 80206 USA; Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China; Argonne Natl Lab, Struct Biol Sect, Argonne, IL 60439 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Peking University; United States Department of Energy (DOE); Argonne National Laboratory	Zhang, GY (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Natl Jewish Med & Res Ctr,Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	zhangg@njc.org		Xu, Liangguo/0000-0003-1991-2889				BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, TRENDS IMMUNOL, V23, P113, DOI 10.1016/S1471-4906(01)02159-7; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roschke V, 2002, J IMMUNOL, V169, P4314, DOI 10.4049/jimmunol.169.8.4314; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Ware CF, 2000, J EXP MED, V192, pF35, DOI 10.1084/jem.192.11.F35; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	45	103	122	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					49	56		10.1038/nature01543	http://dx.doi.org/10.1038/nature01543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721620				2022-12-01	WOS:000182561600034
J	Prochaska, JX; Howk, JC; Wolfe, AM				Prochaska, JX; Howk, JC; Wolfe, AM			The elemental abundance pattern in a galaxy at z=2.626	NATURE			English	Article							LYMAN-BREAK GALAXIES; LY-ALPHA SYSTEMS; NUCLEOSYNTHESIS; ABSORPTION; EVOLUTION; RATIOS; STARS	The discovery of metal-poor stars(1,2) (where metal is any element more massive than helium) has enabled astronomers to probe the chemical enrichment history of the Milky Way(3,4). More recently, element abundances in gas inside high-redshift galaxies has been probed through the absorption lines imprinted on the spectra of background quasars(5-8), but these have typically yielded measurements of only a few elements. Furthermore, interpretation of these abundances is complicated by the fact that differential incorporation of metals into dust can produce an abundance pattern similar to that expected from nucleosynthesis by massive stars(9). Here we report the observation of over 25 elements in a galaxy at redshift z = 2.626. With these data, we can examine nucleosynthetic processes independent of the uncertainty arising from depletion. We find that the galaxy was enriched mainly by massive stars (M > 15 solar masses) and propose that it is the progenitor of a massive elliptical galaxy. The detailed abundance patterns suggest that boron is produced through processes that act independently of metallicity, and may require alternative mechanisms for the nucleosynthesis of germanium.	Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Diego; University of California System; University of California San Diego	Prochaska, JX (corresponding author), Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA.		Howk, Jay/D-2577-2013	Prochaska, J. Xavier/0000-0002-7738-6875; Howk, J. Christopher/0000-0002-2591-3792				BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; CASSE M, 1995, NATURE, V373, P318, DOI 10.1038/373318a0; CHAMBERLAIN JW, 1951, ASTROPHYS J, V114, P52, DOI 10.1086/145451; Fields BD, 1999, ASTROPHYS J, V516, P797, DOI 10.1086/307145; HELFER HL, 1959, ASTROPHYS J, V129, P700, DOI 10.1086/146668; Hoffman RD, 1996, ASTROPHYS J, V460, P478, DOI 10.1086/176986; JURA M, 1978, ASTROPHYS J, V219, P861, DOI 10.1086/155847; Lu LM, 1996, ASTROPHYS J SUPPL S, V107, P475, DOI 10.1086/192373; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Molaro P, 2000, ASTROPHYS J, V541, P54, DOI 10.1086/309439; Pettini M, 2001, ASTROPHYS J, V554, P981, DOI 10.1086/321403; Pettini M, 2000, ASTROPHYS J, V532, P65, DOI 10.1086/308562; Pettini M, 2000, ASTROPHYS J, V528, P96, DOI 10.1086/308176; Prochaska JX, 2002, ASTROPHYS J, V566, P68, DOI 10.1086/338080; PROCHASKA JX, UNPUB ASTROPHYS J SU; Saglia RP, 2002, ASTROPHYS J, V579, pL13, DOI 10.1086/344742; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; Schramm DN, 1998, REV MOD PHYS, V70, P303, DOI 10.1103/RevModPhys.70.303; Sheinis AI, 2002, PUBL ASTRON SOC PAC, V114, P851, DOI 10.1086/341706; TINSLEY BM, 1979, ASTROPHYS J, V229, P1046, DOI 10.1086/157039; Trager SC, 2000, ASTRON J, V119, P1645, DOI 10.1086/301299; Vladilo G, 2002, ASTRON ASTROPHYS, V391, P407, DOI 10.1051/0004-6361:20020822; VOGT SS, 1994, SPIE, V2198, P362; WHEELER JC, 1989, ANNU REV ASTRON ASTR, V27, P279; White RL, 2000, ASTROPHYS J SUPPL S, V126, P133, DOI 10.1086/313300; WOLFE AM, 1986, ASTROPHYS J SUPPL S, V61, P249, DOI 10.1086/191114; WOLFE AM, UNPUB ASTROPHYS J; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1990, ASTROPHYS J, V356, P272, DOI 10.1086/168839	30	72	72	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					57	59		10.1038/nature01524	http://dx.doi.org/10.1038/nature01524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721621	Green Submitted			2022-12-01	WOS:000182561600035
J	Melton, L				Melton, L			On the trail of SNPs	NATURE			English	Article									Novartis Fdn, London, England	Novartis	Melton, L (corresponding author), Novartis Fdn, London, England.								0	22	23	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					917	923		10.1038/422917a	http://dx.doi.org/10.1038/422917a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712209	Bronze			2022-12-01	WOS:000182432600060
J	Hu, FB; Li, TY; Colditz, GA; Willett, WC; Manson, JE				Hu, FB; Li, TY; Colditz, GA; Willett, WC; Manson, JE			Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; UNITED-STATES; MEN; WEIGHT; CHILDREN; HEALTH	Context Current public health campaigns to reduce obesity and type 2 diabetes have largely focused on increasing exercise, but have paid little attention to the reduction of sedentary behaviors. Objective To examine the-relationship between various sedentary behaviors, especially prolonged television (TV) watching, and risk of obesity and type 2 diabetes in women. Design, Setting, and Participants Prospective cohort study conducted from 1992 to 1998 among women from 11 states in the Nurses' Health Study. The obesity analysis included 50277 women who had a body mass index (BMI) of less than 30 and were free from diagnosed cardiovascular disease, diabetes, or cancer and completed questions on physical activity and sedentary behaviors at baseline. The diabetes analysis included 68497 women who at baseline were free from diagnosed diabetes mellitus, cardiovascular disease, or cancer. Main Outcome Measures Onset of obesity and type 2 diabetes mellitus. Results During 6 years of follow-up, 3757 (7.5%) of 50277 women who had a BMI of less than 30 in 1992 became obese (13MI greater than or equal to30). Overall, we documented 1515 new cases of type 2 diabetes. Time spent watching TV was positively associated with risk of obesity and type 2 diabetes. In the multivariate analyses adjusting for age, smoking, exercise levels, dietary factors, and other covariates, each 2-h/d increment in TV watching was associated with a 23% (95% confidence interval [CI], 17%-30%) increase in obesity and a 14% (95% CI, 5%-23%) increase in risk of diabetes; each 2-h/d increment in sitting at work was associated with a 5% (95% CI, 0%-10%) increase in obesity and a 7% (95% CI, 0%-1.6%) increase in diabetes. In contrast, standing or walking around at home (2 h/d) was associated with a 9% (95% CI, 6%-12%) reduction in obesity and a 12% (95% CI, 7%-16%) reduction in diabetes. Each 1 hour per day of brisk walking was associated with a 24% (95% CI, 19%-29%) reduction in obesity and a 34% (95% CI, 27%-41%) reduction in diabetes We estimated that in our cohort, 30% (95% CI, 24%-36%) of new cases of obesity and 43% (95% CI, 32%-52%) of new cases of diabetes could be prevented by adopting a relatively active lifestyle (<10 h/wk of TV watching and &GE;30 min/d of brisk walking). Conclusions Independent of exercise levels, sedentary behaviors, especially TV watching, were associated with significantly elevated risk of obesity and type 2 diabetes, whereas even light to moderate activity was associated with substantially lower risk. This study emphasize's the importance of reducing prolonged TV watching and other sedentary behaviors for preventing obesity and diabetes.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Channing Labs, Boston, MA USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009; Hu, Frank/C-1919-2013	Colditz, Graham/0000-0002-7307-0291; 	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Ching PLYH, 1996, AM J PUBLIC HEALTH, V86, P25, DOI 10.2105/AJPH.86.1.25; Coakley EH, 1998, INT J OBESITY, V22, P89, DOI 10.1038/sj.ijo.0800549; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DIETZ WH, 1985, PEDIATRICS, V75, P807; FALCIGLIA GA, 1980, J NUTR EDUC, V12, P196; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P1235, DOI 10.1111/j.1532-5415.1994.tb06503.x; HARRIS M, 1979, DIABETES, V28, P1039; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Lank N H, 1992, J Community Health, V17, P377, DOI 10.1007/BF01323999; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; *NIELS MED RES, 1998, NIELS REP TEL; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; TUCKER LA, 1989, AM J PUBLIC HEALTH, V79, P516, DOI 10.2105/AJPH.79.4.516; TUCKER LA, 1991, AM J PUBLIC HEALTH, V81, P908, DOI 10.2105/AJPH.81.7.908; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P668; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	34	1161	1201	7	162	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2003	289	14					1785	1791		10.1001/jama.289.14.1785	http://dx.doi.org/10.1001/jama.289.14.1785			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZJ	12684356	Bronze			2022-12-01	WOS:000182094900023
J	Berg, L; Riise, GC; Cosman, D; Bergstrom, T; Olofsson, S; Karre, W; Carbone, E				Berg, L; Riise, GC; Cosman, D; Bergstrom, T; Olofsson, S; Karre, W; Carbone, E			LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients	LANCET			English	Article							INHIBITORY RECEPTOR; CELLS	Human cytomegalovirus infection is a major cause of morbidity after lung transplantation. LIR-1 (leucocyte immunoglobulin-like receptor-1) is an inhibitory cell surface receptor that has high affinity for an MHC class I homologue (UL18) encoded by human cytomegalovirus. We aimed to investigate whether reactivation of human cytomegalovirus affects the expression of LIR-1. We measured LIR-1 expression on peripheral blood lymphocytes from 13 lung-transplant recipients and established human cytomegalovirus load using PCR. Eight patients developed cytomegalovirus disease. The percentage of cells expressing LIR-1 increased in the patients who developed cytomegalovirus disease several weeks before viral DNA was detectable by PCR. Measurement of LIR-1 expression might allow early identification of cytomegalovirus disease in lung-transplant patients.	Karolinska Inst, Microbiol & Tumourbiol Ctr, S-17177 Stockholm, Sweden; Univ Gothenburg, Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden; Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Virol, Gothenburg, Sweden; Amgen Corp, Mol Biol, Seattle, WA USA; Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy	Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Magna Graecia University of Catanzaro	Carbone, E (corresponding author), Karolinska Inst, Microbiol & Tumourbiol Ctr, Box 280, S-17177 Stockholm, Sweden.	ennio.carbone@mtc.ki.se		carbone, ennio/0000-0002-2275-8803; Berg, Louise/0000-0001-6538-2837; Bergstrom, Tomas/0000-0002-9257-6757				Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; LJUNGMAN P, 1993, BONE MARROW TRANSPL, V12, P399; Riise GC, 2000, CHEST, V118, P1653, DOI 10.1378/chest.118.6.1653; Wang LL, 2000, J IMMUNOL, V164, P5215, DOI 10.4049/jimmunol.164.10.5215	5	55	56	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2003	361	9363					1099	1101		10.1016/S0140-6736(03)12855-3	http://dx.doi.org/10.1016/S0140-6736(03)12855-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672315				2022-12-01	WOS:000181865200013
J	Takasugi, N; Tomita, T; Hayashi, I; Tsuruoka, M; Niimura, M; Takahashi, Y; Thinakaran, G; Iwatsubo, T				Takasugi, N; Tomita, T; Hayashi, I; Tsuruoka, M; Niimura, M; Takahashi, Y; Thinakaran, G; Iwatsubo, T			The role of presenilin cofactors in the gamma-secretase complex	NATURE			English	Article							AMYLOID-BETA-PROTEIN; INTRAMEMBRANE PROTEOLYSIS; PRECURSOR PROTEIN; NICASTRIN; NOTCH; CLEAVAGE; CELLS; APH-1; APP; STABILIZATION	Mutations in presenilin genes account for the majority of the cases of the familial form of Alzheimer's disease (FAD). Presenilin is essential for gamma-secretase activity, a proteolytic activity involved in intramembrane cleavage of Notch and beta-amyloid precursor protein (betaAPP)(1,2). Cleavage of betaAPP by FAD mutant presenilin results in the overproduction of highly amyloidogenic amyloid beta42 peptides(3-6). gamma-Secretase activity requires the formation of a stable, high-molecular-mass protein complex(7-11) that, in addition to the endoproteolysed fragmented form of presenilin, contains essential cofactors including nicastrin(12-14), APH-1 (refs 15-18) and PEN-2 ( refs 16, 19). However, the role of each protein in complex formation and the generation of enzymatic activity is unclear. Here we show that Drosophila APH-1 (Aph-1) increases the stability of Drosophila presenilin (Psn) holoprotein in the complex. Depletion of PEN-2 by RNA interference prevents endoproteolysis of presenilin and promotes stabilization of the holoprotein in both Drosophila and mammalian cells, including primary neurons. Co-expression of Drosophila Pen-2 with Aph-1 and nicastrin increases the formation of Psn fragments as well as gamma-secretase activity. Thus, APH-1 stabilizes the presenilin holoprotein in the complex, whereas PEN-2 is required for endoproteolytic processing of presenilin and conferring gamma-secretase activity to the complex.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Tokyo; University of Chicago	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; TAKASUGI, NOBUMASA/0000-0002-6059-2082				Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	28	742	779	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					438	441		10.1038/nature01506	http://dx.doi.org/10.1038/nature01506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660785				2022-12-01	WOS:000181801200046
J	Fiorillo, CD; Tobler, PN; Schultz, W				Fiorillo, CD; Tobler, PN; Schultz, W			Discrete coding of reward probability and uncertainty by dopamine neurons	SCIENCE			English	Article							RESPONSES; STIMULI; SIGNAL	Uncertainty is critical in the measure of information and in assessing the accuracy of predictions. It is determined by probability P, being maximal. at P = 0.5 and decreasing at higher and lower probabilities. Using distinct stimuli to indicate the probability of reward, we found that the phasic activation of dopamine neurons varied monotonically across the full range of probabilities, supporting past claims that this response codes the discrepancy between predicted and actual reward. In contrast, a previously unobserved response co-varied with uncertainty and consisted of a gradual increase in activity until the potential time of reward. The coding of uncertainty suggests a possible role for dopamine signals in attention-based learning and risk-taking behavior.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Fribourg; University of Cambridge	Fiorillo, CD (corresponding author), Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland.	cdf28@cam.ac.uk	Fiorillo, Christopher Dante/C-1718-2011	Tobler, Philippe/0000-0002-4915-9448; Fiorillo, Christopher/0000-0002-7232-9505	Wellcome Trust [095495] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Dickinson A., 1980, CONT ANIMAL LEARNING; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIORILLO CD, UNPUB; Gallistel C.R., 1990, ORG LEARNING; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; KAYE H, 1984, J EXP PSYCHOL ANIM B, V10, P90, DOI 10.1037/0097-7403.10.1.90; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PEARCE JM, 1987, INTRO ANIMAL COGNITI; Rao R. P., 2002, PROBABILISTIC MODELS; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	23	1310	1330	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1898	1902		10.1126/science.1077349	http://dx.doi.org/10.1126/science.1077349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649484	Green Submitted			2022-12-01	WOS:000181669700048
J	Rehling, P; Model, K; Brandner, K; Kovermann, P; Sickmann, A; Meyer, HE; Kuhlbrandt, W; Wagner, R; Truscott, KN; Pfanner, N				Rehling, P; Model, K; Brandner, K; Kovermann, P; Sickmann, A; Meyer, HE; Kuhlbrandt, W; Wagner, R; Truscott, KN; Pfanner, N			Protein insertion into the mitochondrial inner membrane by a twin-pore translocase	SCIENCE			English	Article							OUTER-MEMBRANE; INTERMEMBRANE SPACE; IMPORT RECEPTORS; ADP/ATP CARRIER; COMPLEX; CHANNEL; PREPROTEINS; BIOGENESIS; MACHINERY; FAMILY	The mitochondrial inner membrane imports numerous proteins that span it multiple times using the membrane potential Deltapsi as the only external energy source. We purified the protein insertion complex (TIM22 complex), a twin-pore translocase that mediated the insertion of precursor proteins in a three-step process. After the precursor is tethered to the translocase without losing energy from the Deltapsi, two energy-requiring steps were needed. First, Deltapsi acted on the precursor protein and promoted its docking in the translocase complex. Then, Deltapsi and an internal signal peptide together induced rapid gating transitions in one pore and closing of the other pore and drove membrane insertion to completion. Thus, protein insertion was driven by the coordinated action of a twin-pore complex in two voltage-dependent steps.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Max Planck Inst Biophys, Abt Strukturbiol, D-60528 Frankfurt, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Osnabruck, Fachbereich Biol Chem, D-49034 Osnabruck, Germany; Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	University of Freiburg; Max Planck Society; University of Freiburg; University Osnabruck; Ruhr University Bochum	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Truscott, Kaye/D-3362-2012; Pfanner, Nikolaus/AAV-7878-2021; Kovermann, Peter/AAF-4411-2020; Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Kovermann, Peter/0000-0001-5296-4918; Kuhlbrandt, Werner/0000-0002-2013-4810; Truscott, Kaye/0000-0002-5352-9835				Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I; Geissler A, 2000, MOL BIOL CELL, V11, P3977, DOI 10.1091/mbc.11.11.3977; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Kaldi K, 1998, EMBO J, V17, P1569, DOI 10.1093/emboj/17.6.1569; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; Zara V, 2001, J MOL BIOL, V310, P965, DOI 10.1006/jmbi.2001.4833	23	232	244	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1747	1751		10.1126/science.1080945	http://dx.doi.org/10.1126/science.1080945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637749				2022-12-01	WOS:000181519500050
J	Aligne, CA; Moss, ME; Auinger, P; Weitzman, M				Aligne, CA; Moss, ME; Auinger, P; Weitzman, M			Association of pediatric dental caries with passive smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; ENVIRONMENTAL TOBACCO-SMOKE; 3RD NATIONAL-HEALTH; CHILDRENS ORAL HEALTH; BLOOD LEAD LEVELS; UNITED-STATES; PRESCHOOL-CHILDREN; PARENTAL SMOKING; COTININE LEVELS; US POPULATION	Context Dental decay is the most common chronic disease of children and it disproportionately affects those living in poverty, but the reasons for this are not clear. Passive smoking may be a modifiable, risk factor for dental caries. Objective To examine the relationship between dental caries and serum cotinine levels. Design, Setting, and Participants Cross-sectional data from the Third National Health and Nutrition Examination Survey (1988-1994) of 3531 children aged 4 to 11 years, who had had both dental examinations and a serum cotinine level measurement. Main Outcome Measures Passive smoking defined as serum cotinine levels of 0.2 to 10 ng/mL and caries defined as decayed (unfilled) or filled tooth surfaces. Results Twenty-five percent of the children had at least 1 unfilled decayed tooth surface and 33% had at least 1 filled surface. Fifty-three percent had cotinine levels consistent with passive smoking. Elevated cotinine level was significantly associated with both decayed (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.5-2.9) and filled (OR, 1.4; 95% CI, 1.1-1.8) tooth surfaces in deciduous but not in permanent teeth. This relationship persisted after adjusting forage, sex, race, family income, geographic region, frequency of dental visits, and blood lead level. For dental caries in deciduous teeth, the adjusted OR was 1.8 (95% CI, 1.2-2.7) for the risk of decayed surfaces and 1.4 (95% CI, 1.1-2.0) for filled surfaces. We estimated the population attributable risk-from passive smoking to be 27% for decayed and 14% for filled tooth surfaces. Conclusions There is an association between environmental tobacco smoke and risk of caries among children. Reduction of passive smoking is important not only for the prevention of many medical problems, but also for the promotion of children's dental health.	Pediathink, Rochester, NY USA; Eastman Sch Dent, Rochester, NY USA; Amer Acad Pediat, Ctr Child Hlth Res, Elk Grove Village, IL 60007 USA; Univ Rochester, Sch Med, Dept Community & Prevent Med, Rochester, NY USA; Univ Rochester, Sch Med, Dept Pediat, Rochester, NY 14642 USA	University of Rochester; American Academy of Pediatrics; University of Rochester; University of Rochester	Aligne, CA (corresponding author), 620 Pk Ave,Box 135, Rochester, NY 14607 USA.		Moss, Mark E/AAF-1697-2020; Moss, Mark E/Q-3014-2019	Moss, Mark E/0000-0003-0105-0416; 				ADAIR SM, 1999, PEDIAT DENT; Aligne CA, 1997, ARCH PEDIAT ADOL MED, V151, P648, DOI 10.1001/archpedi.1997.02170440010002; Arbes SJ, 2001, AM J PUBLIC HEALTH, V91, P253, DOI 10.2105/AJPH.91.2.253; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Brown LJ, 2000, J AM DENT ASSOC, V131, P223, DOI 10.14219/jada.archive.2000.0151; Brunelle J A, 1990, J Dent Res, V69 Spec No, P723; BRUNELLE JA, 1982, J DENT RES, V61, P1346; *CDC, 1992, MMWR-MORBID MORTAL W, V41, P372; CDC (Centers for Disease Control and Prevention), 2001, NAT REP HUM EXP ENV; CHARLTON A, 1994, J FAM PRACTICE, V38, P267; DiFranza JR, 1996, PEDIATRICS, V97, P560; DOLL R, 1992, BMJ-BRIT MED J, V305, P1521, DOI 10.1136/bmj.305.6868.1521; Drury TF, 1996, J DENT RES, V75, P620, DOI 10.1177/002203459607502S02; EDELSTEIN BL, 1995, PUBLIC HEALTH REP, V110, P522; Edelstein BL, 2002, AMBUL PEDIATR, V2, P141, DOI 10.1367/1539-4409(2002)002<0141:DIOHAA>2.0.CO;2; Edwards K, 1999, HUM EXP TOXICOL, V18, P233, DOI 10.1191/096032799678839978; Ettinger R L, 1999, Dent Clin North Am, V43, P679; Hopper JA, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e47; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; KIDD EAM, 1997, ESSENTIALS DENT CARI; LINDEMEYER RG, 1981, J AM DENT ASSOC, V103, P719, DOI 10.14219/jada.archive.1981.0372; MANDEL ID, 1987, J DENT RES, V66, P623, DOI 10.1177/00220345870660S203; Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409; Mannino DM, 2001, CHEST, V120, P718, DOI 10.1378/chest.120.3.718; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; Mouradian WE, 2000, JAMA-J AM MED ASSOC, V284, P2625, DOI 10.1001/jama.284.20.2625; Nelson E, 1999, HUM EXP TOXICOL, V18, P252, DOI 10.1191/096032799678840002; *NIH, 1999, SMOK TOB CONTR MON N, V10; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; RONCHETTI R, 1994, EUR RESPIR J, V7, P472, DOI 10.1183/09031936.94.07030472; Schafer TE, 2000, PEDIATR CLIN N AM, V47, P1021, DOI 10.1016/S0031-3955(05)70256-X; SCHYDLOWER M, 1994, PEDIATRICS, V93, P866; Seow WK, 1998, COMMUNITY DENT ORAL, V26, P8, DOI 10.1111/j.1600-0528.1998.tb02090.x; Shah BV, 1997, SOFTWARE STAT ANAL C; Stamm J. W., 1991, RISK MARKERS ORAL DI, V1, P132; Strauss RS, 2001, PEDIATRICS, V107, P540, DOI 10.1542/peds.107.3.540; Tinanoff N, 2000, J PUBLIC HEALTH DENT, V60, P197, DOI 10.1111/j.1752-7325.2000.tb03328.x; Tinanoff Norman, 1997, Pediatric Dentistry, V19, P12; VAANANEN MK, 1994, SCAND J DENT RES, V102, P103; Vargas CM, 1998, J AM DENT ASSOC, V129, P1229, DOI 10.14219/jada.archive.1998.0420; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Weaver VM, 1996, CANCER EPIDEM BIOMAR, V5, P135; Weitzman M, 2001, AMBUL PEDIATR, V1, P162, DOI 10.1367/1539-4409(2001)001<0162:ACSOHN>2.0.CO;2; Williams SA, 2000, CARIES RES, V34, P117, DOI 10.1159/000016578; Winn DM, 1996, J DENT RES, V75, P642, DOI 10.1177/002203459607502S04; WOOD RA, 2001, PRIMARY PEDIAT CARE, P1318; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; CENSUS 2000 SUPPLEME; ORAL HLTH AM REPORT; 1997, MMWR MORB MORTAL WKL, V46, P1038	50	154	159	2	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1258	1264		10.1001/jama.289.10.1258	http://dx.doi.org/10.1001/jama.289.10.1258			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633187	Bronze			2022-12-01	WOS:000181466500027
J	Chilcott, J; McCabe, C; Tappenden, P; O'Hagan, A; Cooper, NJ; Abrams, K; Claxton, K				Chilcott, J; McCabe, C; Tappenden, P; O'Hagan, A; Cooper, NJ; Abrams, K; Claxton, K		Cost Effectiveness Multiple Sclero	Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. Design Modelling cost effectiveness. Setting UK NHS. Participants Patients with relapsing remitting multiple sclerosis and secondary progressive multiple sclerosis. Main outcome measures Cost per quality adjusted life year gained. Results The base case cost per quality adjusted life year gained by using any of the four treatments ranged from pound42 000 ($66 469; (sic) 61 630) to pound98 000 based on efficacy information in the public domain. Uncertainty analysis suggests that the probability of any of these therapies having a cost effectiveness better than pound20 000 is below 20%. The key determinants of cost effectiveness were the time horizon, the progression of patients after stopping treatment, differential discount rates, and the price of the treatments. Conclusions Cost effectiveness varied markedly between the interventions. Uncertainty around point estimates was substantial. This uncertainty could be reduced by conducting research on the true magnitude of the effect of these drugs, the progression of patients after stopping treatment, the costs of care, and the quality of life of the patients. Price was the key modifiable determinant of the cost effectiveness of these treatments.	Univ Sheffield, Sch Hlth & Related Res Rapid Rev Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Dept Probabil & Stat, Ctr Bayesian Stat Hlth Econ, Sheffield S3 7RH, S Yorkshire, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ York, Dept Econ & Related Studies, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of Sheffield; University of Sheffield; University of Leicester; University of York - UK	McCabe, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res Rapid Rev Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.		Tappenden, Paul/B-4557-2009; McCabe, Christopher/E-2051-2016; O'Hagan, Anthony/B-2992-2016; Abrams, Keith/AAA-2557-2020; Chilcott, Jim/B-4474-2009	O'Hagan, Anthony/0000-0002-7994-0702; Abrams, Keith/0000-0002-7557-1567	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		*ASS BRIT NEUR, 2001, GUID TREATM INT BET; *ASS BRIT NEUR, 2001, GUID US BET INT GLAT; *BRIT MED ASS, 2001, BRIT NAT FORM, P422; Brown MG, 2000, INT J TECHNOL ASSESS, V16, P751, DOI 10.1017/S026646230010203X; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EBERS G, 2001, LONDON ONTARIO COHOR; Forbes RB, 1999, BMJ-BRIT MED J, V319, P1529, DOI 10.1136/bmj.319.7224.1529; Kendrick M, 2000, PHARMACOECONOMICS, V18, P45, DOI 10.2165/00019053-200018010-00005; Kobelt G, 2000, SCANDINAVIAN WORKING; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; *MULT SCL RES TRUS, 2001, QUAL LIF PEOPL MULT; *NAT I CLIN EXC, 2002, BET INT GLAT AC TREA; *NAT I CLIN EXC, TECHN APPR COMM M 13; National Grid, 2002, FULL GUID US BET INT, P1; Noseworthy J, 2003, LANCET, V361, P350, DOI 10.1016/S0140-6736(03)12354-9; PARKIN D, 1998, HLTH TECHNOL ASSESS, V4, pR1; PATZOLD U, 1982, ACTA NEUROL SCAND, V65, P248, DOI 10.1111/j.1600-0404.1982.tb03084.x; PROSSER L, 2000, COST EFFECTIVENESS T; RICE GPA, 2001, COCHRANE LIB; RICHARDS RG, 2002, HLTH TECHNOL ASSESS, V6, pR1; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	21	108	108	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					522	525		10.1136/bmj.326.7388.522	http://dx.doi.org/10.1136/bmj.326.7388.522			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623909	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000181548400014
J	Lim, LP; Glasner, ME; Yekta, S; Burge, CB; Bartel, DP				Lim, LP; Glasner, ME; Yekta, S; Burge, CB; Bartel, DP			Vertebrate MicroRNA genes	SCIENCE			English	Article							IDENTIFICATION; RNAS		MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Lim, LP (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Burge, Christopher B./AAH-2177-2020	Glasner, Margaret/0000-0003-1818-1965				Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LIM LP, IN PRESS GENES DEV; Moss EG, 2002, CURR BIOL, V12, pR688, DOI 10.1016/S0960-9822(02)01206-X	6	939	1236	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1540	1540		10.1126/science.1080372	http://dx.doi.org/10.1126/science.1080372			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624257				2022-12-01	WOS:000181367900027
J	Juengst, ET; Binstock, RH; Mehlman, MJ; Post, SG				Juengst, ET; Binstock, RH; Mehlman, MJ; Post, SG			Aging - Antiaging research and the need for public dialogue	SCIENCE			English	Editorial Material							POLICY		Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Case Western Reserve University	Juengst, ET (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.			Juengst, Eric/0000-0002-8374-5774	NATIONAL INSTITUTE ON AGING [R01AG020916] Funding Source: NIH RePORTER; NIA NIH HHS [1R01-AGHG20916-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], QUEST IMMORTALITY SC; [Anonymous], 2000, MORAL CHALLENGE ALZH; BINSTOCK RH, IN PRESS GERONTOLOGI; BONNICKSEN AL, 2002, CRAFTING CLONING POL; Butler R, 2001, GENERATIONS, V25, P63; Butler RN, 2002, J GERONTOL A-BIOL, V57, pB333, DOI 10.1093/gerona/57.9.B333; Cohen Gene., 2000, CREATIVE AGE AWAKENI; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; de Grey ADNJ, 2002, BIOESSAYS, V24, P667, DOI 10.1002/bies.10113; de Grey ADNJ, 2000, BIOGERONTOLOGY, V1, P369, DOI 10.1023/A:1026547023576; Fisher A, 2002, J GERONTOL A-BIOL, V57, pM636, DOI 10.1093/gerona/57.10.M636; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Garland MJ, 1999, PUBLIC UNDERST SCI, V8, P241, DOI 10.1088/0963-6625/8/3/308; GRUMAN G, 1966, T AM PHILOS SOC, V56; Hackler C, 2001, GENERATIONS, V25, P15; Hayflick L, 2001, GENERATIONS, V25, P20; Juengst ET, 2002, J ANTI-AGING MED, V5, P73, DOI 10.1089/109454502317629318; Kass L R, 2001, First Things, P17; Kirkland JL, 2002, CLIN GERIATR MED, V18, P383, DOI 10.1016/S0749-0690(02)00023-X; Lane MA, 2002, SCI AM, V287, P36, DOI 10.1038/scientificamerican0802-36; MASORO EJ, 2001, J GERONTOL A, V56; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Moody H. R., 1995, WORLD GROWING OLD CO, P9; Moody HR, 2001, GENERATIONS, V25, P33; *NAT I AG, 2001, ACT PLAN AG RES STRA; Olshansky SJ, 2002, SCI AM, V286, P92, DOI 10.1038/scientificamerican0602-92; Olshansky SJ, 2002, J GERONTOL A-BIOL, V57, pB292, DOI 10.1093/gerona/57.8.B292; SELTZER M, 1995, IMPACT INCREASED LIF; WALTERS L, 1991, HUM GENE THER, V2, P115, DOI 10.1089/hum.1991.2.2-115; WATSON J, 1992, GENE MAPPING USING L, pR15	30	38	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1323	1323		10.1126/science.1083135	http://dx.doi.org/10.1126/science.1083135			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610284				2022-12-01	WOS:000181192300029
J	Krause, TG; Hviid, A; Koch, A; Friborg, J; Hjuler, T; Wohlfahrt, J; Olsen, OR; Kristensen, B; Melbye, M				Krause, TG; Hviid, A; Koch, A; Friborg, J; Hjuler, T; Wohlfahrt, J; Olsen, OR; Kristensen, B; Melbye, M			BCG vaccination and risk of atopy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; SENSITIZATION; CHILDHOOD	Context It has been suggested that BCG vaccination may protect against development of allergic diseases, particularly when given just after birth. BCG vaccination was given routinely to all infants in Greenland until 1990, when it was withdrawn from the vaccination program.,Whether this resulted in an increased prevalence of atopy in children born after the stop of BCG vaccination is unknown. Objective To determine whether BCG vaccination and age at BCG vaccination are associated with development of atopy. Design, Setting, and Participants Cross-sectional study among schoolchildren aged 8 to 16 years in 4 towns on the northwest coast of Greenland. Participants had a blood sample drawn and information on BCG vaccination was obtained during 2 periods, November 1998 and November 2001. A total of 1686 children (79% of available children) participated, 1575 of whom had complete information on vaccination status. Atopy was defined as a positive test result in an assay that tests for IgE specific against the most common inhalant allergens in serum. Main Outcome Measures Odds ratio (OR) of atopy in BCG-vaccinated compared with unvaccinated children and OR according to age at vaccination. Results The risk of atopy was the same in BCG-vaccinated compared with unvaccinated children after adjustment for confounders (OR, 1.03; 95% confidence interval, 0.72-1.48). The risk of atopy in BCG-vaccinated children was not associated with age at vaccination (P=.17). Conclusions BCG vaccination administered to infants is not associated with reduced risk of development of atopy.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Sisimiut Hosp, Sisimiut, Greenland; Pharmacia, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Pfizer	Krause, TG (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	tgv@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785; Hjuler, Thomas/0000-0002-3860-0306; Friborg, Jeppe/0000-0001-5423-0627; Koch, Anders/0000-0001-9205-1048				Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; Alm JS, 2002, GENES IMMUN, V3, P71, DOI 10.1038/sj.gene.6363834; *AT, 1991, STAT HLTH GREENL REP; Gruber C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e36; Gruber C, 2002, PEDIAT ALLERG IMM-UK, V13, P177, DOI 10.1034/j.1399-3038.2002.01006.x; Gruber C, 2001, PEDIAT ALLERG IMM-UK, V12, P296, DOI 10.1034/j.1399-3038.2001.1r046.x; Krause TG, 2002, CLIN EXP ALLERGY, V32, P367, DOI 10.1046/j.1365-2222.2002.01316.x; Marchant A, 1999, J IMMUNOL, V163, P2249; MARTINEZ FD, 1994, THORAX, V49, P1189, DOI 10.1136/thx.49.12.1189; Pershagen G, 2000, PEDIATR ALLERGY IMMU, V11, P26, DOI 10.1034/j.1399-3038.2000.00507.x; ROMANUS V, 1992, TUBERCLE LUNG DIS, V73, P150, DOI 10.1016/0962-8479(92)90149-E; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Strannegard IL, 1998, ALLERGY, V53, P249, DOI 10.1111/j.1398-9995.1998.tb03884.x	14	44	45	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1012	1015		10.1001/jama.289.8.1012	http://dx.doi.org/10.1001/jama.289.8.1012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597754	Bronze			2022-12-01	WOS:000181129800028
J	Bray, D				Bray, D			Molecular prodigality	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bray, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nakada K, 2002, DIFFERENTIATION, V70, P92, DOI 10.1046/j.1432-0436.2002.700204.x; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Wolfram S., 2002, NEW KIND SCI	11	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1189	1190		10.1126/science.1080010	http://dx.doi.org/10.1126/science.1080010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595679				2022-12-01	WOS:000181065500025
J	Montcouquiol, M; Rachel, RA; Lanford, PJ; Copeland, NG; Jenkins, NA; Kelley, MW				Montcouquiol, M; Rachel, RA; Lanford, PJ; Copeland, NG; Jenkins, NA; Kelley, MW			Identification of Vangl2 and Scrb1 as planar polarity genes in mammals	NATURE			English	Article							NEURAL-TUBE DEFECTS; DROSOPHILA TISSUE POLARITY; CELL FATE; MOUSE; STRABISMUS; CIRCLETAIL; MUTANT; LOCALIZATION; EXTENSION; MUTATION	In mammals, an example of planar cell polarity (PCP) is the uniform orientation of the hair cell stereociliary bundles within the cochlea. The PCP pathway of Drosophila(1-4) refers to a conserved signalling pathway that regulates the coordinated orientation of cells or structures within the plane of an epithelium. Here we show that a mutation in Vangl2, a mammalian homologue of the Drosophila PCP gene Strabismus/Van Gogh, results in significant disruptions in the polarization of stereociliary bundles in mouse cochlea as a result of defects in the direction of movement and/or anchoring of the kinocilium within each hair cell. Similar, but less severe, defects are observed in animals containing a mutation in the LAP protein family gene Scrb1 (homologous with Drosophila scribble). Polarization defects in animals heterozygous for Vangl2 and Scrb1 are comparable with Vangl2 homozygotes, demonstrating genetic interactions between these genes in the regulation of PCP in mammals. These results demonstrate a role for the PCP pathway in planar polarization in mammals, and identify Scrb1 as a PCP gene.	NIDCD, Sect Dev Neurosci, NIH, Rockville, MD 20850 USA; NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Maryland, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park	Montcouquiol, M (corresponding author), NIDCD, Sect Dev Neurosci, NIH, Rockville, MD 20850 USA.	montcouq@nidcd.nih.gov	montcouquiol, mireille/L-6199-2017	montcouquiol, mireille/0000-0001-8739-6519	DIVISION OF BASIC SCIENCES - NCI [Z01BC010394, Z01BC010556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000059, Z01DC000059] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Chen P, 2002, DEVELOPMENT, V129, P2495; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Mueller KL, 2002, J NEUROSCI, V22, P9368; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rachel RA, 2002, GENESIS, V33, P55, DOI 10.1002/gene.10088; Rachel RA, 2000, GENESIS, V27, P32, DOI 10.1002/1526-968X(200005)27:1<32::AID-GENE50>3.0.CO;2-T; Rubel EW, 1978, HDB SENSORY PHYSL, VIX, P135, DOI [10.1007/978-3-642-66880-7_5, DOI 10.1007/978-3-642-66880-7_5]; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Taylor J, 1998, GENETICS, V150, P199; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu DK, 1996, J NEUROSCI, V16, P6454	25	539	555	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					173	177		10.1038/nature01618	http://dx.doi.org/10.1038/nature01618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12724779				2022-12-01	WOS:000182699600047
J	Moore, J				Moore, J			Stealth ship sets sail for a quiet life fishing for data	NATURE			English	News Item																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					7	7		10.1038/423007b	http://dx.doi.org/10.1038/423007b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721594	Bronze			2022-12-01	WOS:000182561600012
J	Butler, D				Butler, D			Agent Orange health investigation stuck at square one	NATURE			English	News Item																		2003, NATURE, V422, P649; 2002, NATURE, V416, P252	2	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					793	793		10.1038/422793b	http://dx.doi.org/10.1038/422793b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712159	Bronze			2022-12-01	WOS:000182432600011
J	Counter, CM; Press, W; Compton, CC				Counter, CM; Press, W; Compton, CC			Telomere shortening in cultured autografts of patients with burns	LANCET			English	Article							CELLS	In extensive third-degree burns, donor sites for conventional split thickness skin grafts are limited. In such cases, cultured epithelial (keratinocyte) grafts are prepared from small samples of the patient's own skin and expanded In tissue culture, a process that may incur very many cell divisions. Telomeres shorten with each cell division, and are markers of cellular proliferative history. We therefore measured telomere length In healed cultured epithelial autografts from four patients with burns, and noted that their telomeres were shorter than those in non-cultured skin from the same Individuals, and than those in skin of healthy donors older than 80 years. Such great loss of telomeric DNA suggests that engrafted cells might have a shortened lifespan, which could have negative repercussions on the long-term viability of these grafts.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA; Harvard Inst Med, Harvard Gene Therapy Initiat, Boston, MA USA; McGill Univ, Dept Pathol, Montreal, PQ H3A 2T5, Canada	Duke University; Harvard University; Harvard Medical School; McGill University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA.			Counter, Christopher M/0000-0003-0748-3079	NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NCI NIH HHS [CA82481] Funding Source: Medline; PHS HHS [R01-35242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021	5	23	24	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1345	1346		10.1016/S0140-6736(03)13042-5	http://dx.doi.org/10.1016/S0140-6736(03)13042-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711471				2022-12-01	WOS:000182346100013
J	Morrison-Griffiths, S; Walley, TJ; Park, BK; Breckenridge, AM; Pirmohamed, M				Morrison-Griffiths, S; Walley, TJ; Park, BK; Breckenridge, AM; Pirmohamed, M			Reporting of adverse drug reactions by nurses	LANCET			English	Article								Schemes for spontaneous reporting of adverse drug reactions are Important to post-marketing safety surveillance worldwide. In the UK, doctors, dentists, coroners, and pharmacists are allowed to report through the yellow card scheme, but nurses were not until October, 2002. We used a similar programme to assess the role of community and hospital nurses in reporting of adverse drug reactions. The proportion and quality of reports received from nurses was similar to that of those received from doctors: we received reports from one in seven nurses eligible to report, compared with one In eight doctors; 137 of 1.77 nurse reports and 676 of 984 doctor reports were judged to be appropriate according to regulatory authority criteria (95% CI for difference between proportions 1.4-15.0, z=2.3, p=0.02). Our findings suggest that nurses, who form the largest proportion of healthcare staff in the UK, can play a valuable part in improvement of pharmacovigilance.	Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England	University of Liverpool	Pirmohamed, M (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Ashton St, Liverpool L69 3GE, Merseyside, England.		Pirmohamed, Munir/H-6004-2011	Pirmohamed, Munir/0000-0002-7534-7266; Morrison-Griffiths, Sally/0000-0002-0250-9076				HALL M, 1995, BRIT J CLIN PHARMACO, V40, P173, DOI 10.1111/j.1365-2125.1995.tb05774.x; Morrison-Griffiths S, 1998, Nurs Times, V94, P52; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; RAWLINS MD, 1995, J ROY COLL PHYS LOND, V29, P41; *UK DEP HLTH, EXT IND NURS PRESCR	5	51	54	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1347	1348		10.1016/S0140-6736(03)13043-7	http://dx.doi.org/10.1016/S0140-6736(03)13043-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711472				2022-12-01	WOS:000182346100014
J	Wolfe, SM				Wolfe, SM			Ephedra - Scientific evidence versus money/politics	SCIENCE			English	Editorial Material							ALKALOIDS		Publ Citizens Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizens Hlth Res Grp, Washington, DC 20009 USA.							CRABTREE P, 2003, SAN DIEGO UNION 0123, pC1; EVANS D, 2002, BLOOMBERG NEWS  0411; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523; HEATH M, COMMUNICATION; ROAN S, 2002, LOS ANGELES TIM 1209, pF1; Weintraub A, 2002, BUS WEEK, P40; WEISSKOPF M, 2000, TIME            0522, pR20; Willman D., 2001, LOS ANGELES TIM 0311, pA1	9	9	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					437	437		10.1126/science.1081910	http://dx.doi.org/10.1126/science.1081910			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702860				2022-12-01	WOS:000182295900021
J	Lodwig, EM; Hosie, AHF; Bordes, A; Findlay, K; Allaway, D; Karunakaran, R; Downie, JA; Poole, PS				Lodwig, EM; Hosie, AHF; Bordes, A; Findlay, K; Allaway, D; Karunakaran, R; Downie, JA; Poole, PS			Amino-acid cycling drives nitrogen fixation in the legume - Rhizobium symbiosis	NATURE			English	Article							PEA ROOT-NODULES; PERIBACTEROID MEMBRANE; TRANSPORT MUTANTS; LEGUMINOSARUM; METABOLISM; IDENTIFICATION; BACTEROIDS; PERMEASE; SHUTTLE; CARBON	The biological reduction of atmospheric N-2 to ammonium (nitrogen fixation) provides about 65% of the biosphere's available nitrogen. Most of this ammonium is contributed by legume rhizobia symbioses(1), which are initiated by the infection of legume hosts by bacteria (rhizobia), resulting in formation of root nodules. Within the nodules, rhizobia are found as bacteroids, which perform the nitrogen fixation: to do this, they obtain sources of carbon and energy from the plant, in the form of dicarboxylic acids(2,3). It has been thought that, in return, bacteroids simply provide the plant with ammonium. But here we show that a more complex amino-acid cycle is essential for symbiotic nitrogen fixation by Rhizobium in pea nodules. The plant provides amino acids to the bacteroids, enabling them to shut down their ammonium assimilation. In return, bacteroids act like plant organelles to cycle amino acids back to the plant for asparagine synthesis. The mutual dependence of this exchange prevents the symbiosis being dominated by the plant, and provides a selective pressure for the evolution of mutualism.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	University of Reading; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Poole, PS (corresponding author), Univ Reading, Sch Anim & Microbial Sci, POB 228, Reading RG6 6AJ, Berks, England.		Downie, Allan/I-3487-2012; Hosie, Arthur/J-9615-2012	Hosie, Arthur/0000-0002-1327-7901; Allaway, David/0000-0003-4602-8933; Downie, Allan/0000-0003-1011-4960; Ramakrishnan, Karunakaran/0000-0002-6450-1299; Findlay, Kim/0000-0002-1556-0532; Lodwig, Emma/0000-0001-6941-7996				Allaway D, 2000, MOL MICROBIOL, V36, P508, DOI 10.1046/j.1365-2958.2000.01884.x; APPELS MA, 1991, PLANT PHYSIOL, V95, P740, DOI 10.1104/pp.95.3.740; BERINGER JE, 1977, J GEN MICROBIOL, V98, P339, DOI 10.1099/00221287-98-2-339; Craig J, 1999, PLANT J, V17, P353, DOI 10.1046/j.1365-313X.1999.00382.x; FINAN TM, 1983, J BACTERIOL, V154, P1403, DOI 10.1128/JB.154.3.1403-1413.1983; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Hosie AHF, 2001, MOL MICROBIOL, V40, P1449, DOI 10.1046/j.1365-2958.2001.02497.x; INDIVERI C, 1987, J BIOL CHEM, V262, P15979; Kahn M. L., 1985, Nitrogen fixation research progress. Proceedings of the 6th International Symposium on Nitrogen Fixation, Corvallis, OR, USA, August 4-10. 1985., P193; Mouritzen P, 1997, PLANT PHYSIOL, V115, P519, DOI 10.1104/pp.115.2.519; NEWTON WE, 2000, NITROGEN FIXATION MO, P3; Parsons R, 1996, J EXP BOT, V47, P421, DOI 10.1093/jxb/47.3.421; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Poole P, 2000, ADV MICROB PHYSIOL, V43, P117, DOI 10.1016/S0065-2911(00)43004-3; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; ROSENDAHL L, 1992, J PLANT PHYSIOL, V139, P635, DOI 10.1016/S0176-1617(11)80385-8; Rosendahl L, 2001, PLANT SOIL, V230, P31, DOI 10.1023/A:1004628217418; Saalbach G, 2002, PROTEOMICS, V2, P325, DOI 10.1002/1615-9861(200203)2:3<325::AID-PROT325>3.0.CO;2-W; Udvardi M. K., 1988, Molecular Plant-Microbe Interactions, V1, P250, DOI 10.1094/MPMI-1-250; UDVARDI MK, 1988, FEBS LETT, V231, P36, DOI 10.1016/0014-5793(88)80697-5; Vance CP, 2000, PROKARYOTIC NITROGEN FIXATION, P589; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; WATSON RJ, 1993, J BACTERIOL, V175, P1919, DOI 10.1128/JB.175.7.1919-1928.1993	24	331	356	11	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					722	726		10.1038/nature01527	http://dx.doi.org/10.1038/nature01527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700763				2022-12-01	WOS:000182272300042
J	Davis, N; Pohlman, A; Gehlbach, B; Kress, JP; McAtee, J; Herlitz, J; Hall, J				Davis, N; Pohlman, A; Gehlbach, B; Kress, JP; McAtee, J; Herlitz, J; Hall, J			Improving the process of informed consent in the critically ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFUSION ASSESSMENT METHOD; UNIT CAM-ICU; DELIRIUM	Context Invasive procedures are often performed emergently in the intensive care unit (ICU), and patients or their proxies may not be available to provide informed consent. Little is known about the effectiveness of intensivists in obtaining informed consent. Objectives To describe the nature of informed consent in the ICU and to determine if simple interventions could enhance the process. Design, Setting, and Patients Prospective study of 2 cohorts of consecutively admitted patients (N=270) in a 16-bed ICU at a university hospital. All patients admitted to the ICU during the baseline period from November 1, 2001, to December 31, 2001, and during the intervention period from March 1, 2002, to April 30, 2002, were included. Intervention A hospital-approved universal consent form for 8 commonly performed procedures (arterial catheter, central venous catheter, pulmonary artery catheter, or peripherally inserted central catheter placement; lumbar puncture; thoracentesis; paracentesis; and intubation/mechanical ventilation) was administered to patients or proxies. Handouts describing each procedure were available in the ICU waiting area. Physicians and nurses were introduced to the universal consent form during orientation to the ICU. Main Outcome Measures Incidence of informed consent for invasive procedures at baseline and after intervention; whether the patient or proxy provided informed consent; and understanding by the consenter of the procedure as determined by the responses on a questionnaire. Results Fifty-three percent of procedures (155/292) were performed after consent had been obtained during the baseline period compared with 90% (308/340) during the intervention period (absolute difference, 37.4%; P<.001). During baseline, the majority (71.6%; 111/155) of consents were provided by proxies. This was also the case during the intervention period in which 65.6% (202/308) of consents were provided by proxies (absolute difference, 6.0%; P=.23). Comprehension by consenters of indications for and risks of the procedures was high and not different between the 2 periods (P=.75). Conclusions Invasive procedures are frequent in the ICU and consent for them is often obtained by proxy. Providing a universal consent form to patients, proxies, and health care clinicians significantly increased the frequency with which consent was obtained without compromising comprehension of the process by the consenter.	Univ Chicago Hosp & Clin, Pritzker Sch Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Univ Chicago Hosp & Clin, Off Risk Management, Chicago, IL 60637 USA	University of Chicago; University of Illinois System; University of Chicago; University of Illinois System	Hall, J (corresponding author), Univ Chicago Hosp & Clin, Pritzker Sch Med, Pulm & Crit Care Med Sect, MC 6076,5841 S Maryland Ave, Chicago, IL 60637 USA.			Gehlbach, Brian/0000-0003-3160-1741	PHS HHS [K236M63906] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; *CRIT CAR ASS AM T, 2002, PRIM CRIT CAR PAT TH; Dyson M, 1999, J CLIN NURS, V8, P284, DOI 10.1046/j.1365-2702.1999.00265.x; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; ETHELLS E, 1996, CMAJ, V155, P177; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levine R J, 1991, Law Med Health Care, V19, P207; Shelly MP, 1999, INTENS CARE MED, V25, P137, DOI 10.1007/s001340050805; SULMASY DP, 1994, AM J MED, V96, P432, DOI 10.1016/0002-9343(94)90170-8; *U CHIC, 2001, U CHIC HOSP POL PROC	13	51	52	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2003	289	15					1963	1968		10.1001/jama.289.15.1963	http://dx.doi.org/10.1001/jama.289.15.1963			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667VC	12697799	Bronze			2022-12-01	WOS:000182253900029
J	Osterhaus, A; Fouchier, R				Osterhaus, A; Fouchier, R			Human metapneumovirus in the community	LANCET			English	Editorial Material							CHILDREN		Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Osterhaus, A (corresponding author), Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869				Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Nissen MD, 2002, MED J AUSTRALIA, V176, P188, DOI 10.5694/j.1326-5377.2002.tb04354.x; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098	8	90	98	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					890	891		10.1016/S0140-6736(03)12785-7	http://dx.doi.org/10.1016/S0140-6736(03)12785-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648965				2022-12-01	WOS:000181741600004
J	Williams, BF; French, JK; White, HD				Williams, BF; French, JK; White, HD		HERO-2 Consent Substudy Investigat	Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; COMPETENCE	Background Anxiety, fear, pain, and treatment with morphine might compromise the ability of patients to comprehend information about, and give informed consent for, participation in clinical trials. We aimed to assess whether patients with acute myocardial infarction could understand written and verbal information and whether they were competent to give autonomous informed consent to participate in a clinical trial. Methods We prospectively studied 399 patients with acute myocardial infarction in 16 hospitals in New Zealand and Australia who were eligible for participation in the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. We assessed readability of patient information sheets, patients' educational status, their views of the consent process, comprehension of verbal and written information, and competence to give consent. Findings The patient information sheet needed a year 13 (age 18) educational level for comprehension, although only 75 of 345 patients (22%) had been educated beyond secondary school. Only 63 of 346 (18%) read the patient. information sheet before giving or refusing consent to participate. Patients who gave consent were more likely to report good or partial comprehension of the information provided than were those who refused consent (272 [89%] vs 14 [70%], respectively; p=0.009). In an assessment of competence to make an autonomous decision, 75 of 145 (52%) were ranked at the lowest grade and 26 (18%) were not competent to consent. Interpretation Although the consent process for HERO-2 met regulatory requirements for clinical trials, it was inappropriate for the needs of most patients. The patients' comprehension of the information provided and their competence to autonomously give consent was less than optimum.	Green Lane Hosp, Cardiovasc Res Unit, Auckland 1030, New Zealand		Williams, BF (corresponding author), Green Lane Hosp, Cardiovasc Res Unit, CCU Res Suite,Private Bag 92189, Auckland 1030, New Zealand.	barbaraw@adhb.govt.nz						Agard A, 2001, HEART, V86, P632, DOI 10.1136/heart.86.6.632; [Anonymous], 1990, LANCET, V336, P65; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1986, HIST THEORY INFORM C; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Colaizzi P.F., 1978, PSYCHOL RES PHENOMEN; DeLuca S A, 1995, J Cardiovasc Nurs, V9, P54; *EUR PARL, 2001, OFFICIAL J L, V121, P34; Flesch R., 1974, ART READABLE WRITING; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; HOLMBERG S, 1990, AM J CARDIOL, V65, P401; Kucia AM, 2000, AM HEART J, V140, P94, DOI 10.1067/mhj.2000.106625; KUTNER JS, 1991, CHEST, V100, P1404, DOI 10.1378/chest.100.5.1404; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; OCKENE IS, 1991, CLIN RES, V39, P13; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Seedhouse D, 1998, ETHICS HEART HLTH CA; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; US Dept of Health and Human Services (HHS) Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM), ICH HARM TRIP GUID G; VEHEGGEN FW, 1998, PATIENT EDUC COUNS, V35, P111; White HD, 2001, LANCET, V358, P1855; Williams BF, 1997, NEW ZEAL MED J, V110, P298; Williams C, 1992, INTRO NEW TREATMENTS, P49; WILLIAMS CJ, 1994, EUR J CANCER, V30A, P907, DOI 10.1016/0959-8049(94)90111-2; *WORLD MED ASS DEC, 2000, P 52 WORLD MED ASS G; 1949, NUREMBERG CODE TRIAL, P181	28	97	98	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2003	361	9361					918	922		10.1016/S0140-6736(03)12773-0	http://dx.doi.org/10.1016/S0140-6736(03)12773-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648970				2022-12-01	WOS:000181741600009
J	Cui, HM; Cruz-Correa, M; Giardiello, FM; Hutcheon, DF; Kafonek, DR; Brandenburg, S; Wu, YQ; He, XB; Powe, NR; Feinberg, AP				Cui, HM; Cruz-Correa, M; Giardiello, FM; Hutcheon, DF; Kafonek, DR; Brandenburg, S; Wu, YQ; He, XB; Powe, NR; Feinberg, AP			Loss of IGF2 imprinting: A potential marker of colorectal cancer risk	SCIENCE			English	Article							GROWTH-FACTOR-II; CELL-LINE; STIMULATION	Loss of imprinting (LOI), an epigenetic alteration affecting the insulin-like growth factor II gene (IGF2), is found in normal colonic mucosa of about 30% of colorectal cancer (CRC) patients, but it is found in only 10% of healthy individuals. In a pilot study to investigate the utility of LOI as a marker of CRC risk, we evaluated 172 patients at a colonoscopy clinic. The adjusted odds ratio for LOI in lymphocytes was 5.15 for patients with a positive family history [95% confidence interval (95% CI), 1.70 to 16.96; probability P = 0.002], 3.46 for patients with adenomas (95% CI, 1.14 to 11.37; P = 0.026), and 21.7 for patients with CRC (95% CI, 3.48 to 153.6; P = 0.0005). LOI can be assayed with a DNA-based blood test, and it may be a valuable predictive marker of an individual's risk for CRC.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 1064 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Feinberg, Andrew/AAY-7666-2020; Cui, Hengmi/A-2598-2008	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [K07CA092445, R01CA065145] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA092445, R01 CA65145] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2002, CANCER RES, V62, P6442; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEINBERG AP, 2002, METABOLIC MOL BASES, pCH18; GELATO MC, 1990, J CLIN ENDOCR METAB, V71, P1168, DOI 10.1210/jcem-71-5-1168; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; LAHM H, 1992, BRIT J CANCER, V65, P341, DOI 10.1038/bjc.1992.69; LAMONERIE T, 1995, INT J CANCER, V61, P587, DOI 10.1002/ijc.2910610425; Markey Kristina, 2002, Curr Gastroenterol Rep, V4, P404, DOI 10.1007/s11894-002-0011-5; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; POMMIER GJ, 1992, CANCER RES, V52, P3182; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; YEE D, 1988, CANCER RES, V48, P6691	17	580	627	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1753	1755		10.1126/science.1080902	http://dx.doi.org/10.1126/science.1080902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637750				2022-12-01	WOS:000181519500052
J	Lack, G; Fox, D; Northstone, K; Golding, J				Lack, G; Fox, D; Northstone, K; Golding, J		Avon Longitudinal Study Parents Ch	Factors associated with the development of peanut allergy in childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATOPIC-DERMATITIS; FOOD HYPERSENSITIVITY; CHILDREN; SENSITIZATION; SKIN; FORMULAS; INFANTS; PROTEIN; ANTIGEN; SOY	Background: The prevalence of peanut allergy appears to have increased in recent decades. Other than a family history of peanut allergy and the presence of atopy, there are no known risk factors. Methods: We used data from the Avon Longitudinal Study of Parents and Children, a geographically defined cohort study of 13,971 preschool children, to identify those with a convincing history of peanut allergy and the subgroup that reacted to a double-blind peanut challenge. We first prospectively collected data on the whole cohort and then collected detailed information retrospectively by interview from the parents of children with peanut reactions and of children from two groups of controls (a random sample from the cohort and a group of children whose mothers had a history of eczema and who had had eczema themselves in the first six months of life). Results: Forty-nine children had a history of peanut allergy; peanut allergy was confirmed by peanut challenge in 23 of 36 children tested. There was no evidence of prenatal sensitization from the maternal diet, and peanut-specific IgE was not detectable in the cord blood. Peanut allergy was independently associated with intake of soy milk or soy formula (odds ratio, 2.6; 95 percent confidence interval, 1.3 to 5.2), rash over joints and skin creases (odds ratio, 2.6; 95 percent confidence interval, 1.4 to 5.0), and oozing, crusted rash (odds ratio, 5.2; 95 percent confidence interval, 2.7 to 10.2). Analysis of interview data showed a significant independent relation of peanut allergy with the use of skin preparations containing peanut oil (odds ratio, 6.8; 95 percent confidence interval, 1.4 to 32.9). Conclusions: Sensitization to peanut protein may occur in children through the application of peanut oil to inflamed skin. The association with soy protein could arise from cross-sensitization through common epitopes. Confirmation of these risk factors in future studies could lead to new strategies to prevent sensitization in infants who are at risk for subsequent peanut allergy.	Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Paediat Allergy & Immunol, London W2 1NY, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Bristol, Avon, England	Imperial College London; University of Bristol	Lack, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Paediat Allergy & Immunol, Ground Floor,Salton House,Praed St, London W2 1NY, England.		Northstone, Kate/A-8165-2011	Northstone, Kate/0000-0002-0602-1983; Golding, Jean/0000-0003-2826-3307; Lack, Gideon/0000-0001-7350-4021				ASSEM ESK, 1990, BRIT MED J, V300, P1377, DOI 10.1136/bmj.300.6736.1377; BARNETT D, 1987, J ALLERGY CLIN IMMUN, V79, P433, DOI 10.1016/0091-6749(87)90359-9; BERNHISELBROADBENT J, 1989, J ALLERGY CLIN IMMUN, V83, P435, DOI 10.1016/0091-6749(89)90130-9; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; BOCK SA, 1978, J ALLERGY CLIN IMMUN, V62, P327, DOI 10.1016/0091-6749(78)90132-X; BURKS AW, 1989, ALLERGY PROC, V10, P265, DOI 10.2500/108854189778960045; CARSWELL F, 1986, LANCET, V2, P13, DOI 10.1016/S0140-6736(86)92560-2; CHANDRA RK, 1991, ANN ALLERGY, V67, P129; DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 1996, BRIT MED J, V313, P1046; Legendre C, 1997, NEW ENGL J MED, V337, P822, DOI 10.1056/NEJM199709183371204; Lever LR, 1996, BRIT MED J, V313, P299, DOI 10.1136/bmj.313.7052.299; Moneret-Vautrin D A, 1994, Pediatr Allergy Immunol, V5, P184, DOI 10.1111/j.1399-3038.1994.tb00236.x; Moneret-Vautrin DA, 1998, CLIN EXP ALLERGY, V28, P1113, DOI 10.1046/j.1365-2222.1998.00370.x; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Oldaeus G, 1997, ARCH DIS CHILD, V77, P4, DOI 10.1136/adc.77.1.4; Olszewski A, 1998, CLIN EXP ALLERGY, V28, P850, DOI 10.1046/j.1365-2222.1998.00325.x; RENZ H, 1993, J IMMUNOL, V151, P7206; SALOGA J, 1994, AM J RESP CRIT CARE, V149, P65, DOI 10.1164/ajrccm.149.1.8111600; Sampson HA, 1998, J ALLERGY CLIN IMMUN, V101, pS240; SAMPSON HA, 1985, J PEDIATR-US, V107, P669, DOI 10.1016/S0022-3476(85)80390-5; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sicherer SH, 2000, ALLERGY, V55, P515, DOI 10.1034/j.1398-9995.2000.00119.x; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; *U BRIST, 2003, ALSPAC; van Reijsen FC, 1998, J ALLERGY CLIN IMMUN, V101, P207, DOI 10.1016/S0091-6749(98)70410-5; ZIMMERMAN B, 1989, J ALLERGY CLIN IMMUN, V83, P764, DOI 10.1016/0091-6749(89)90012-2	29	644	657	2	68	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2003	348	11					977	985		10.1056/NEJMoa013536	http://dx.doi.org/10.1056/NEJMoa013536			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653YT	12637607				2022-12-01	WOS:000181465200002
J	Cowan, F; Rutherford, M; Groenendaal, F; Eken, P; Mercuri, E; Bydder, GM; Meiners, LC; Dubowitz, LMS; de Vries, LS				Cowan, F; Rutherford, M; Groenendaal, F; Eken, P; Mercuri, E; Bydder, GM; Meiners, LC; Dubowitz, LMS; de Vries, LS			Origin and timing of brain lesions in term infants with neonatal encephalopathy	LANCET			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CEREBRAL INFARCTION; ASPHYXIA; CHILDREN; PALSY	Background The role of intrapartum asphyxia in neonatal encephalopathy and seizures in term infants is not clear, and antenatal factors are being implicated in the causal pathway for these disorders. However, there is no evidence that brain damage occurs before birth. We aimed to test the hypothesis that neonatal encephalopathy, early neonatal seizures, or both result from early antenatal insults. Methods We used brain MRI or post-mortem examination in 351 fullterm infants with neonatal encephalopathy, early seizures, or both to distinguish between lesions acquired antenatally and those that developed in the intrapartum and early post-partum period. We excluded infants with major congenital malformations or obvious chromosomal disorders. Infants were divided into two groups: those with neonatal encephalopathy (with or without seizures), and evidence of perinatal asphyxia (group 1); and those without other evidence of encephalopathy, but who presented with seizures within 3 days of birth (group 2). Findings Brain images showed evidence of an acute insult without established injury or atrophy in 197 (80%) of infants in group 1, MRI showed evidence of established injury in only 2 infants (<1%), although tiny foci of established white matter gliosis, in addition to acute injury, were seen in three of 21 on post-mortem examination. In group 2, acute focal damage was noted in 62 (69%) of infants. Two (3%) also had evidence of antenatal injury. Interpretation Although our results cannot exclude the possibility that antenatal or genetic factors might predispose some infants to perinatal brain injury, our data strongly suggest that events in the immediate perinatal period are most important in neonatal brain injury.	Hammersmith Hosp, Imperial Coll, Fac Med, Dept Paediat, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Fac Med, Dept Neonatal Med, London W12 0NN, England; Univ Med Ctr, Wilhelmina Childrens Hosp, Utrecht, Netherlands; Catholic Univ, Dept Paediat Neurol, Rome, Italy	Imperial College London; Imperial College London; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cowan, F (corresponding author), Hammersmith Hosp, Imperial Coll, Fac Med, Dept Paediat, London W12 0NN, England.	f.cowan@imperial.ac.uk	Groenendaal, Floris/P-6872-2019; de Vries, Linda S/AAB-6454-2021	Groenendaal, Floris/0000-0002-9284-1637; 				ALNAKEB L, 1999, EUR J PAED NEUROL, V29, P124; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; BADAWI N, 1998, ANTEPARTUM RISK FACT, P1549; BADAWI N, 1998, INTRAPARTUM RISK FAC, P1554; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; *CHILD GROWTH FDN, 1996, BOYS GIRLS 4 IN ON G; COWAN EM, 1994, NEUROPEDIATRICS, V25, P172, DOI 10.1055/s-2008-1073018; Cowan F, 2000, Semin Neonatol, V5, P127, DOI 10.1053/siny.2000.0011; COWAN F, 2003, DEV MED CHILD NE S93, V45, P24; Draper ES, 2002, ARCH DIS CHILD-FETAL, V87, P176; EKEN P, 1994, NEUROPEDIATRICS, V25, P301, DOI 10.1055/s-2008-1073044; Felix JF, 2000, DEV MED CHILD NEUROL, V42, P803; GAFFNEY G, 1994, ARCH DIS CHILD-FETAL, V70, pF195, DOI 10.1136/fn.70.3.F195; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; HELLER G, 2000, EARLY NEONATAL MORTA, P274; HOPE PL, 1984, LANCET, V2, P366; Jouvet P, 1999, AM J NEURORADIOL, V20, P1343; LOW JA, 1989, AM J OBSTET GYNECOL, V160, P608, DOI 10.1016/S0002-9378(89)80040-7; MERCURI E, 1995, ARCH DIS CHILD-FETAL, V73, pF67, DOI 10.1136/fn.73.2.F67; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Mercuri E, 2002, NEUROPEDIATRICS, V33, P150, DOI 10.1055/s-2002-33412; Mercuri E, 2001, PEDIATRICS, V107, P1400, DOI 10.1542/peds.107.6.1400; NELSON KB, 1991, AM J DIS CHILD, V145, P1325, DOI 10.1001/archpedi.1991.02160110117034; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Rutherford M, 1996, ARCH DIS CHILD-FETAL, V75, pF145, DOI 10.1136/fn.75.3.F145; RUTHERFORD MA, 1995, NEUROPEDIATRICS, V26, P183, DOI 10.1055/s-2007-979751; Rutherford MA, 1998, PEDIATRICS, V102, P323, DOI 10.1542/peds.102.2.323; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; SQUIER M, 1991, NEUROPATH APPL NEURO, V17, P29, DOI 10.1111/j.1365-2990.1991.tb00691.x; YUDKIN PL, 1994, BRIT J OBSTET GYNAEC, V101, P774, DOI 10.1111/j.1471-0528.1994.tb11945.x	33	406	418	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					736	742		10.1016/S0140-6736(03)12658-X	http://dx.doi.org/10.1016/S0140-6736(03)12658-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620738				2022-12-01	WOS:000181232000009
J	Gunturkun, O				Gunturkun, O			Adult persistence of head-turning asymmetry	NATURE			English	Article							FUNCTIONAL LATERALITIES; PRETERM INFANTS; POSITION		Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany	Ruhr University Bochum	Gunturkun, O (corresponding author), Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany.			Gunturkun, Onur/0000-0003-4173-5233				Casey MB, 2000, DEV PSYCHOBIOL, V37, P13, DOI 10.1002/1098-2302(200007)37:1<13::AID-DEV3>3.0.CO;2-M; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Coryell J.F., 1978, INFANT BEHAV DEV, V1, P245, DOI DOI 10.1016/S0163-6383(78)80036-8; GENTRY V, 1995, J GEN PSYCHOL, V122, P37, DOI 10.1080/00221309.1995.9921220; KONISHI Y, 1986, DEV MED CHILD NEUROL, V28, P450; KONISHI Y, 1987, DEV MED CHILD NEUROL, V29, P751; Michel GF, 2002, DEV PSYCHOBIOL, V40, P1; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Reiss M, 1997, PERCEPT MOTOR SKILL, V85, P569, DOI 10.2466/PMS.85.6.569-574; Rogers L.J., 2002, COMP VERTEBRATE LATE; Skiba M, 2002, BEHAV BRAIN RES, V134, P149, DOI 10.1016/S0166-4328(01)00463-6; VERVERS IAP, 1994, EARLY HUM DEV, V39, P83, DOI 10.1016/0378-3782(94)90157-0	12	89	89	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					711	711		10.1038/421711a	http://dx.doi.org/10.1038/421711a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	644UP	12610611	Bronze			2022-12-01	WOS:000180938000029
J	Griffith, CA; Owen, T; Geballe, TR; Rayner, J; Rannou, P				Griffith, CA; Owen, T; Geballe, TR; Rayner, J; Rannou, P			Evidence for the exposure of water ice on Titan's surface	SCIENCE			English	Article							5 MU-M; CARBON-MONOXIDE; JOVIAN PLANETS; ATMOSPHERE; AEROSOLS; METHANE; CLOUDS; SPECTROPHOTOMETRY; SPECTRUM; IMAGES	The smoggy stratosphere of Saturn's largest moon, Titan, veils its surface from view, except at narrow wavelengths centered at 0.83, 0.94, 1.07, 1.28, 1.58, 2.0, 2.9, and 5.0 micrometers. We derived a spectrum of Titan's surface within these "windows" and detected features characteristic of water ice. Therefore, despite the hundreds of meters of organic liquids and solids hypothesized to exist on Titan's surface, its icy bedrock lies extensively exposed.	Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Gemini Observ, Hilo, HI 96720 USA; Univ Paris 06, Paris, France	University of Arizona; University of Hawaii System; UDICE-French Research Universities; Sorbonne Universite	Griffith, CA (corresponding author), Univ Arizona, Dept Planetary Sci, 1629 E Univ Blvd, Tucson, AZ 85721 USA.		RANNOU, Pascal/I-9059-2012	RANNOU, pascal/0000-0003-0836-723X				Combes M, 1997, ICARUS, V129, P482, DOI 10.1006/icar.1997.5772; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; CRUIKSHANK DP, 1991, ICARUS, V94, P345, DOI 10.1016/0019-1035(91)90233-J; FLASAR FM, 1983, SCIENCE, V221, P55, DOI 10.1126/science.221.4605.55; Gibbard SG, 1999, ICARUS, V139, P189, DOI 10.1006/icar.1999.6095; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; GRIFFITH CA, 1993, NATURE, V364, P511, DOI 10.1038/364511a0; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Grundy WM, 2002, ICARUS, V155, P486, DOI 10.1006/icar.2001.6726; Hidayat T, 1998, ICARUS, V133, P109, DOI 10.1006/icar.1998.5908; HUSSON N, 1991, GEISA DATA BANK 1991; KARKOSCHKA E, 1994, ICARUS, V111, P174, DOI 10.1006/icar.1994.1139; Karkoschka E, 1998, ICARUS, V133, P134, DOI 10.1006/icar.1998.5913; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LEMMON MT, 1993, ICARUS, V103, P329, DOI 10.1006/icar.1993.1074; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; LUTZ BL, 1983, SCIENCE, V220, P1374, DOI 10.1126/science.220.4604.1374; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; MCCORD TB, COMMUNICATION; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; Noll KS, 1996, ICARUS, V124, P625, DOI 10.1006/icar.1996.0236; RAGES K, 1983, J GEOPHYS RES-SPACE, V88, P8721, DOI 10.1029/JA088iA11p08721; Rannou P, 1997, J GEOPHYS RES-PLANET, V102, P10997, DOI 10.1029/97JE00719; Rannou P, 1995, ICARUS, V118, P355, DOI 10.1006/icar.1995.1196; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; RICHARDSON J, UNPUB; ROUSH TL, 2002, C 33 LUN PLAN I HOUS; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; TOMASKO MG, 1982, ICARUS, V51, P65, DOI 10.1016/0019-1035(82)90030-6; TOMASKO MG, 1997, ESA SP PUBL, V1177, P109; TOON OB, 1992, ICARUS, V95, P24, DOI 10.1016/0019-1035(92)90188-D; WEST RA, 1991, ICARUS, V90, P330, DOI 10.1016/0019-1035(91)90113-8; WEST RA, 1983, J GEOPHYS RES-SPACE, V88, P8699, DOI 10.1029/JA088iA11p08699; YELLE RV, 1997, ESA SP PUBL, V1177, P243; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	40	116	117	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					628	630		10.1126/science.1081897	http://dx.doi.org/10.1126/science.1081897			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714742				2022-12-01	WOS:000182453700038
J	Umeda, H; Nomoto, K				Umeda, H; Nomoto, K			First-generation black-hole-forming supernovae and the metal abundance pattern of a very iron-poor star	NATURE			English	Article							II SUPERNOVAE; 1ST STARS; NUCLEOSYNTHESIS; EVOLUTION; PECULIAR	It has been proposed(1) theoretically that the first generation of stars in the Universe (population III) would be as massive as 100 solar masses (100 M.), because of inefficient cooling(2-4) of the precursor gas clouds. Recently, the most iron-deficient (but still carbon-rich) low-mass star-HE0107-5240-was discovered(5). If this is a population III star that gained its metals (elements heavier than helium) after its formation, it would challenge the theoretical picture of the formation of the first stars. Here we report that the patterns of elemental abundance in HE0107-5240 (and other extremely metal-poor stars) are in good accord with the nucleosynthesis that occurs in stars with masses of 20-130 M. when they become supernovae if, during the explosions, the ejecta undergo substantial mixing and fall-back to form massive black holes. Such supernovae have been observed(7). The abundance patterns are not, however, consistent with enrichment by supernovae from stars in the range 130-300 M. We accordingly infer that the first-generation supernovae came mostly from explosions of similar to20-130 M. stars; some of these produced iron-poor but carbon- and oxygen-rich ejecta. Low-mass second-generation stars, like HE0107-5240, could form because the carbon and oxygen provided pathways for the gas to cool.	Univ Tokyo, Dept Astron, Sch Sci, Tokyo 1130033, Japan	University of Tokyo	Nomoto, K (corresponding author), Univ Tokyo, Dept Astron, Sch Sci, Tokyo 1130033, Japan.	nomoto@astron.s.u-tokyo.ac.jp						Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Aoki W, 2002, ASTROPHYS J, V567, P1166, DOI 10.1086/338756; AUDOUZE J, 1995, ASTROPHYS J, V451, pL49, DOI 10.1086/309687; Blake LAJ, 2001, NUCL PHYS A, V688, p502C; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Depagne E, 2002, ASTRON ASTROPHYS, V390, P187, DOI 10.1051/0004-6361:20020687; Fujimoto MY, 2000, ASTROPHYS J, V529, pL25, DOI 10.1086/312453; HACHISU I, 1990, ASTROPHYS J, V358, pL57, DOI 10.1086/185779; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Kifonidis K, 2000, ASTROPHYS J, V531, pL123, DOI 10.1086/312541; MAEDA K, UNPUB ASTROPHYS J; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Nakamura F, 1999, ASTROPHYS J, V515, P239, DOI 10.1086/307020; NOMOTO K, 2002, ASTROPH0209064; NOMOTO K, IN PRESS MASSIVE STA; Norris JE, 2001, ASTROPHYS J, V561, P1034, DOI 10.1086/323429; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; RYAN SG, IN PRESS CNO UNIVERS; RYAN SG, 2002, ASTROPH0211608; Sackmann IJ, 1999, ASTROPHYS J, V510, P217, DOI 10.1086/306545; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Shigeyama T, 1998, ASTROPHYS J, V507, pL135, DOI 10.1086/311699; Siess L, 2002, ASTROPHYS J, V570, P329, DOI 10.1086/339733; Turatto M, 1998, ASTROPHYS J, V498, pL129, DOI 10.1086/311324; Umeda H, 2002, ASTROPHYS J, V565, P385, DOI 10.1086/323946; YOSHII Y, 1981, ASTRON ASTROPHYS, V97, P280; Zampieri L, 2003, MON NOT R ASTRON SOC, V338, P711, DOI 10.1046/j.1365-8711.2003.06082.x	27	326	330	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					871	873		10.1038/nature01571	http://dx.doi.org/10.1038/nature01571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712199	Green Submitted			2022-12-01	WOS:000182432600048
J	Ng, J; O'Grady, G; Pettit, T; Frith, R				Ng, J; O'Grady, G; Pettit, T; Frith, R			Nitrous oxide use in first-year students at Auckland University	LANCET			English	Article								In a recent Lancet Case report, a patient presented with subacute combined degeneration of the spinal cord after recreational use of nitrous oxide (N2O). There is very little information about use of this substance as a recreational drug. In a questionnaire-based study, we surveyed 1782 students in their first year at the University of Auckland, New Zealand. 1360 (76%) questionnaires were completed and consistent. 780 (57%) students were aware of recreational use of N2O, 158 (12%) used the substance recreationally, and 39 (3%) inhaled It at least monthly. Users were most likely to be white and to be men. Our results show a high frequency of recreational N2O use in first-year students at Auckland University. Although this study does not accurately reflect use of this substance in the wider community, the high prevalence suggests that presentations of subacute myelopathy in an otherwise fit young person should prompt an enquiry about use of N2O.	Auckland Hosp, Dept Neurol, Auckland 1001, New Zealand	Auckland City Hospital	Frith, R (corresponding author), Auckland Hosp, Dept Neurol, Auckland 1001, New Zealand.							DEACON R, 1978, LANCET, V2, P1023, DOI 10.1016/S0140-6736(78)92341-3; Ng J, 2002, LANCET, V360, P384, DOI 10.1016/S0140-6736(02)09611-3; *STAT NZ, 1998, GUID COLL COMM INF, P7	3	41	43	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1349	1350		10.1016/S0140-6736(03)13045-0	http://dx.doi.org/10.1016/S0140-6736(03)13045-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711474				2022-12-01	WOS:000182346100016
J	Biezeveld, MH; Kuipers, IM; Geisser, J; Lam, J; Ottenkamp, JJ; Hack, CE; Kuijpers, TW				Biezeveld, MH; Kuipers, IM; Geisser, J; Lam, J; Ottenkamp, JJ; Hack, CE; Kuijpers, TW			Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease	LANCET			English	Article								Kawasaki disease is an acute vasculitis of possible infectious cause, which in particular affects the coronary arteries. Young children rely mostly on their innate immune system for protection against invading microorganisms, of which mannose-binding lectin is an important component. We aimed to investigate the possible role of the gene for this molecule (MBL) in white Dutch patients with Kawasaki disease. In 90 patients, frequency of mutations in the MBL gene was higher than in healthy children. In children younger than I year, those with mutations were at higher risk of development of coronary artery lesions than were those without (odds ratio 15-7, 95% CI 1.4-176.5, p=0.026). Our findings suggest that the innate immune system contributes differently to pathophysiology of Kawasaki disease at various ages.	Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Netherlands Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands; Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam	Kuijpers, TW (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Levi, Marcel/AAZ-8559-2020					KAWASAKI T, 1974, PEDIATRICS, V54, P271; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Rowley AH, 1999, PEDIATR CLIN N AM, V46, P313, DOI 10.1016/S0031-3955(05)70120-6; Turner M W, 2000, Rev Immunogenet, V2, P305; Zhang T, 2002, ACTA PAEDIATR, V91, P517, DOI 10.1080/080352502753711623	5	53	55	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1268	1270		10.1016/S0140-6736(03)12985-6	http://dx.doi.org/10.1016/S0140-6736(03)12985-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699957				2022-12-01	WOS:000182161600013
J	van Walraven, C; Mamdani, M; Cohn, A; Katib, Y; Walker, M; Rodger, MA				van Walraven, C; Mamdani, M; Cohn, A; Katib, Y; Walker, M; Rodger, MA			Risk of subsequent thromboembolism for patients wit pre-eclampsia	BRITISH MEDICAL JOURNAL			English	Article							THROMBOPHILIA; PREECLAMPSIA		Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4N 3N5, Canada; Univ Ottawa, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Ottawa	van Walraven, C (corresponding author), Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada.			Rodger, Marc/0000-0001-8166-3487				Grandone E, 1997, THROMB HAEMOSTASIS, V77, P1052; Gris JC, 1997, THROMB HAEMOSTASIS, V77, P1096; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; REDMAN CWG, 1990, NEW ENGL J MED, V323, P478, DOI 10.1056/NEJM199008163230710; Rodeghiero F, 1997, THROMB HAEMOSTASIS, V78, P636	5	35	35	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 12	2003	326	7393					791	792		10.1136/bmj.326.7393.791	http://dx.doi.org/10.1136/bmj.326.7393.791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BE	12689975	Green Published, Bronze			2022-12-01	WOS:000182386700017
J	Messenger, S; Keller, LP; Stadermann, FJ; Walker, RM; Zinner, E				Messenger, S; Keller, LP; Stadermann, FJ; Walker, RM; Zinner, E			Samples of stars beyond the solar system: Silicate grains in interplanetary dust	SCIENCE			English	Article							ISOTOPIC COMPOSITION; OXYGEN ISOTOPES; PRESOLAR; CORUNDUM; NUCLEOSYNTHESIS; IDENTIFICATION; ORIGINS; AL2O3	We have identified six circumstellar silicate grains within interplanetary dust particles (IDPs). Their extrasolar origins are demonstrated by their extremely anomalous oxygen isotopic compositions. Three O-17-rich grains appear to originate from red giant or asymptotic giant branch stars. One O-16-rich grain may be from a metal-poor star. Two O-16-poor grains have unknown stellar sources. One of the grains is forsterite, and two are amorphous silicate "GEMS" (glass with embedded metal and sulfides), which is consistent with astronomical identifications of crystalline and amorphous silicates in the outflows of evolved stars. These observations suggest cometary origins of these IDPs and underscore the perplexing absence of silicates among circumstellar dust grains from meteorites.	Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Washington University (WUSTL); Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Messenger, S (corresponding author), Washington Univ, Space Sci Lab, St Louis, MO 63130 USA.							ALEXANDER CMO, 2001, LUNAR PLANET SCI, V32, P2191; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bradley J, 1996, ASTR SOC P, V104, P275; Bradley J. P., 1988, METEORITES EARLY SOL, P861; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 1983, NATURE, V301, P473, DOI 10.1038/301473a0; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Choi BG, 1999, ASTROPHYS J, V522, pL133, DOI 10.1086/312239; ENGRAND C, 1999, LUNAR PLANET SCI, V30, pA1690; ESAT TM, 1979, SCIENCE, V206, P190, DOI 10.1126/science.206.4415.190; Harker DE, 2002, ASTROPHYS J, V565, pL109, DOI 10.1086/339363; HUSS GR, 1994, ASTROPHYS J, V430, pL81, DOI 10.1086/187443; HUTCHEON ID, 1994, ASTROPHYS J, V425, pL97, DOI 10.1086/187319; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; Kemper F, 2001, ASTRON ASTROPHYS, V369, P132, DOI 10.1051/0004-6361:20010086; KRESTINA N, 2002, LUNAR PLANET SCI, V33, pA1425; Li A, 2001, ASTROPHYS J, V550, pL213, DOI 10.1086/319640; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; MCKEEGAN KD, 1987, THESIS WASHINGTON U; Messenger S, 2000, METEORIT PLANET SCI, V35, pA109; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2002, METEORIT PLANET SCI, V37, P1491, DOI 10.1111/j.1945-5100.2002.tb00806.x; Messenger S, 1997, AIP CONF PROC, P545, DOI 10.1063/1.53336; MOLSTER FJ, 2002, LUNAR PLANET SCI, V33, pA1471; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; NITTLER LR, 2003, LUNAR PLANET SCI, V34; Sandford S. A., 1987, Fundamentals of Cosmic Physics, V12, P1; STADERMANN FJ, 1991, THESIS U HEIDELBERG; WASSERBURG GJ, 1995, ASTROPHYS J, V447, pL37, DOI 10.1086/309555; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; Waters LBFM, 2000, ASTR SOC P, V196, P3; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147; ZINNER E, UNPUB	34	321	327	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					105	108		10.1126/science.1080576	http://dx.doi.org/10.1126/science.1080576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12610229				2022-12-01	WOS:000181988900041
J	Steinbrook, R				Steinbrook, R			How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LUNG INJURY; CONTROLLED CLINICAL-TRIAL; MECHANICAL VENTILATION; METAANALYSIS; STRATEGY											Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Anzueto A, 1996, NEW ENGL J MED, V334, P1417, DOI 10.1056/NEJM199605303342201; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brower RG, 2002, AM J RESP CRIT CARE, V166, P1515, DOI 10.1164/ajrccm.166.11.340; CAROME MA, 2002, COMMUNICATION   1007; CAROME MA, 2002, COMMUNICATION   0828; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Eichacker PQ, 2003, AM J RESP CRIT CARE, V167, P798; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; MARTIN TR, 2002, COMMUNICATION   1212; MARTIN TR, 2003, COMMUNICATION   0106; MEYER RJ, 2002, COMMUNICATION   0208; Oba Y, 2000, NEW ENGL J MED, V343, P813; Rubenfeld G, 2001, AM J RESP CRIT CARE, V163, pA295; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; SEEMAN BT, 2002, FEDS DEMAND DATA LUN; SEEMAN BT, 2002, SAFETY WARNINGS HALT; SHARAV VN, 2002, COMMUNICATION   0729; Stewart TE, 2002, AM J RESP CRIT CARE, V166, P1421, DOI 10.1164/rccm.2210002; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; TANSEY B, 2002, SAN FRANCISCO C 0728, pA1; Thompson BT, 2001, CHEST, V120, P1622, DOI 10.1378/chest.120.5.1622; Tobin MJ, 2000, NEW ENGL J MED, V342, P1360, DOI 10.1056/NEJM200005043421808; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEIL CJ, 2002, COMMUNICATION   1007; WEINERT CR, IN PRESS AM J RESP C	30	59	59	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2003	348	14					1393	1401		10.1056/NEJMhpr030349	http://dx.doi.org/10.1056/NEJMhpr030349			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662LW	12672870				2022-12-01	WOS:000181949100015
J	Green, MJ; Botkin, JR				Green, MJ; Botkin, JR			"Genetic exceptionalism" in medicine: Clarifying the differences between genetic and nongenetic tests	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; HEALTH-INSURANCE; FAMILY-HISTORY; PRIVACY ACT; DISEASE; DISCRIMINATION; INFORMATION; DIAGNOSIS; POLICY	Predictive genetic tests are now available for assessing susceptibility to a variety of conditions, including breast and colon cancer, hemochromatosis, and Alzheimer and Huntington disease. Much controversy surrounds the application of these tests, stemming from their similarities to and differences from other tests commonly used in asymptomatic persons. Some have argued that genetic tests are unique and therefore justify special consideration with regard to informed consent and privacy. This paper examines the arguments for such "genetic exceptionalism" and concludes that no clear, significant distinctions between genetic and non-genetic tests justify a different approach to testing by clinicians. Nevertheless, with many genetic tests, the results may cause stigmatization, family discord, and psychological distress. Regardless of whether a test is genetic, when this combination of characteristics is present and when health care providers are not specifically trained to interpret results, testing should be performed with particular caution and the highest standards of informed consent and privacy protection should be applied.	Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA; Univ Utah, Sch Med, Salt Lake City, UT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Utah System of Higher Education; University of Utah	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities, H134,Rm 1743,500 Univ Dr, Hershey, PA 17033 USA.		Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749	NCI NIH HHS [R01CA84770, 5R03 CA70838] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084770, R03CA070838] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen GE, 1997, GENETICA, V99, P77, DOI 10.1023/A:1018396529332; ALONZO AA, 1995, SOC SCI MED, V41, P303, DOI 10.1016/0277-9536(94)00384-6; Annas GJ, 1995, J LAW MED ETHICS, V23, P360, DOI 10.1111/j.1748-720X.1995.tb01378.x; Beckwith J, 1998, J LAW MED ETHICS, V26, P205, DOI 10.1111/j.1748-720X.1998.tb01421.x; Bernhardt Barbara A, 1997, J Genet Couns, V6, P207, DOI 10.1023/A:1025668320403; Bernstein T, 1994, RADON RENTAL HOUSING; Biesecker B B, 1997, Semin Oncol Nurs, V13, P129, DOI 10.1016/S0749-2081(97)80010-1; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLOOM JR, 1981, AM J PUBLIC HEALTH, V71, P1228, DOI 10.2105/AJPH.71.11.1228; BOLGER A, 2000, FINANCIAL TIMES 1013; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; Capron Alexander Morgan, 1990, Emory Law J, V39, P665; CHESNEY MA, 1994, PSYCHIAT CLIN N AM, V17, P163; CODORI AM, 1994, AM J MED GENET, V54, P167, DOI 10.1002/ajmg.1320540303; COHEN MM, 1994, AM J HUM GENET, V55, pR1; Collins FS, 1996, NEW ENGL J MED, V334, P186, DOI 10.1056/NEJM199601183340311; COLLINS FS, 1994, JAMA-J AM MED ASSOC, V271, P785, DOI 10.1001/jama.1994.03510340075038; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Vries BBA, 1998, J MED GENET, V35, P579, DOI 10.1136/jmg.35.7.579; de Vries BBA, 1999, J MED GENET, V36, P467; Dodek DY, 1997, CAN MED ASSOC J, V156, P847; Elsas LJ, 2000, POSTGRAD MED, V107, P191, DOI 10.3810/pgm.2000.04.1000; Flinter FA, 2001, BRIT MED J, V322, P1008, DOI 10.1136/bmj.322.7293.1008; FOST N, 1993, AM J DIS CHILD, V147, P1190, DOI 10.1001/archpedi.1993.02160350064009; FOST N, 1992, FASEB J, V6, P2813, DOI 10.1096/fasebj.6.10.1634044; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; GELLER G, 1995, NAT GENET, V11, P364, DOI 10.1038/ng1295-364; Geller G, 1993, Arch Fam Med, V2, P1119, DOI 10.1001/archfami.2.11.1119; Geller Lisa N, 1996, Sci Eng Ethics, V2, P71, DOI 10.1007/BF02639319; GOSTIN L, 1991, AM J LAW MED, V17, P109; Gould S.J., 1981, MISMEASURE MAN; Guazzo E, 1997, GERIATRICS, V52, P25; Hall MA, 2000, AM J HUM GENET, V66, P293, DOI 10.1086/302714; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; HOFMAN KJ, 1993, ACAD MED, V68, P625, DOI 10.1097/00001888-199308000-00013; HOLM S, 1999, GENETIC INFORMATION; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; JOHNSTON ME, 1984, J CHRON DIS, V37, P417, DOI 10.1016/0021-9681(84)90025-0; Juengst Eric T, 1995, Genome Sci Technol, V1, P21, DOI 10.1089/gst.1995.1.21; KASH KM, 1992, J NATL CANCER I, V84, P24, DOI 10.1093/jnci/84.1.24; Keller EF., 1992, SCI SOCIAL ISSUES HU, P281; Kevles D., 1985, NAME EUGENICS; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; Lerman C, 1994, J Natl Cancer Inst Monogr, P171; Lifton R. J., 1986, NAZI DOCTORS MED KIL; LO B, 1989, ANN INTERN MED, V110, P727; MACDONALD LA, 1984, J CHRON DIS, V37, P933, DOI 10.1016/0021-9681(84)90070-5; Markel H, 1997, Health Matrix Clevel, V7, P49; MARKEL H, 1992, AM J MED, V93, P209, DOI 10.1016/0002-9343(92)90052-D; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; MCEWEN JE, 1992, AM J HUM GENET, V51, P785; MCGINISS MJ, 1997, EMORY RIMOINS PRINCI, P537; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOSSEY JM, 1981, CLIN INVEST MED, V4, P201; MURRAY TH, 1997, GENETIC SECRETS PROT, P60; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; Nelkin D, 1995, DNS MYSTIQUE GENE CU; *NIH, 2000, ENH OV GEN TESTS REC, P20; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; OSTRER H, 1993, AM J HUM GENET, V52, P565; POKORSKI RJ, 1989, PRINCIPLES INSURANCE, P45; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755; Rothenberg KH, 1995, J LAW MED ETHICS, V23, P312, DOI 10.1111/j.1748-720X.1995.tb01373.x; Rothstein Mark A, 1992, Houst Law Rev, V29, P23; Schulman J D, 1996, Cancer J Sci Am, V2, P244; SCRIVER CR, 1995, METABOLIC MOL BASES, P1052; Secretary's Advisory Committee on Genetic Testing, 2000, ENH OV GEN TESTS REC, P15; SIEGLER M, 1982, NEW ENGL J MED, V307, P1518, DOI 10.1056/NEJM198212093072411; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Troy ESF, 1997, J LAW MED ETHICS, V25, P256, DOI 10.1111/j.1748-720X.1997.tb01408.x; UBEL PA, 1995, AM J MED, V99, P190, DOI 10.1016/S0002-9343(99)80139-9; WALDHOLZ M, 1997, CURING CANC STORY ME; Wertz D C, 1997, J Contemp Health Law Policy, V13, P299; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; Wilfond BS, 1997, J LAW MED ETHICS, V25, P243, DOI 10.1111/j.1748-720X.1997.tb01406.x; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	82	146	147	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2003	138	7					571	575		10.7326/0003-4819-138-7-200304010-00013	http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BV	12667027				2022-12-01	WOS:000181872100006
J	Floto, RA; Smith, KGC				Floto, RA; Smith, KGC			The vagus nerve, macrophages, and nicotine	LANCET			English	Editorial Material							STIMULATION; SMOKING; LUNG		Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Floto, RA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	arf27@cam.ac.uk		Smith, Kenneth/0000-0003-3829-4326				Baughman RP, 2001, SARCOIDOSIS VASC DIF, V18, P70; BAUR X, 1992, RESPIRATION, V59, P211; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Camarena A, 2001, AM J RESP CRIT CARE, V163, P1528, DOI 10.1164/ajrccm.163.7.2004023; CORMIER Y, 1988, AM REV RESPIR DIS, V137, P1104, DOI 10.1164/ajrccm/137.5.1104; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; HANCE AJ, 1986, ANN NY ACAD SCI, V465, P643, DOI 10.1111/j.1749-6632.1986.tb18541.x; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Mori H, 2002, NEUROSCI LETT, V320, P21, DOI 10.1016/S0304-3940(02)00012-5; Son YS, 2002, NEUROSCI LETT, V319, P45, DOI 10.1016/S0304-3940(01)02538-1; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x	15	31	33	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2003	361	9363					1069	1070		10.1016/S0140-6736(03)12902-9	http://dx.doi.org/10.1016/S0140-6736(03)12902-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672307				2022-12-01	WOS:000181865200005
J	Lum, L; Yao, SQ; Mozer, B; Rovescalli, A; Von Kessler, D; Nirenberg, M; Beachy, PA				Lum, L; Yao, SQ; Mozer, B; Rovescalli, A; Von Kessler, D; Nirenberg, M; Beachy, PA			Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells	SCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DOUBLE-STRANDED-RNA; CUBITUS INTERRUPTUS; TRANSCRIPTIONAL REGULATION; TOUT-VELU; WINGLESS; GENE; PROTEIN; INTERFERENCE; SUPPRESSOR	Classical genetic screens can be limited by the selectivity of mutational targeting, the complexities of anatomically based phenotypic analysis, or difficulties in subsequent gene identification. Focusing on signaling response to the secreted morphogen Hedgehog (Hh), we used RNA interference (RNAi) and a quantitative cultured cell assay to systematically screen functional roles of all kinases and phosphatases, and subsequently 43% of predicted Drosophila genes. Two gene products reported to function in Wingless (Wg) signaling were identified as Hh pathway components: a cell surface protein (Daily-like protein) required for Hh signal reception, and casein kinase 1alpha, a candidate tumor suppressor that regulates basal activities of both Hh and Wg pathways. This type of cultured cell-based functional genomics approach may be useful in the systematic analysis of other biological processes.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000009, Z01HL000009] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baeg GH, 2001, DEVELOPMENT, V128, P87; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BROWN S, 1995, AM J HUM GENET, V57, P859; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Campbell GL, 2000, DEVELOPMENT, V127, P4095; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FORBES AJ, 1993, DEVELOPMENT, P115; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Paine-Saunders S, 1999, GENOMICS, V57, P455, DOI 10.1006/geno.1999.5793; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PREAT T, 1992, GENETICS, V132, P725; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; VEEMON MT, IN PRESS CURR BIOL; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733	37	422	442	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2039	2045		10.1126/science.1081403	http://dx.doi.org/10.1126/science.1081403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663920				2022-12-01	WOS:000181834200046
J	Tamas, G; Lorincz, A; Simon, A; Szabadics, J				Tamas, G; Lorincz, A; Simon, A; Szabadics, J			Identified sources and targets of slow inhibition in the neocortex	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; POSTSYNAPTIC POTENTIALS; INTERNATIONAL-UNION; PHYSIOLOGICAL-ROLE; GABA(B) RECEPTORS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; RAT NEOCORTEX; INTERNEURONS; HIPPOCAMPUS	There are two types of inhibitory postsynaptic potentials in the cerebral cortex. Fast inhibition is mediated by ionotropic gamma-aminobutyric acid type A (GABA(A)) receptors, and slow inhibition is due to metabotropic GABA(B) receptors. Several neuron classes elicit inhibitory postsynaptic potentials through GABA(A) receptors, but possible distinct sources of slow inhibition remain unknown. We identified a class of GABAergic interneurons, the neurogliaform cells, that, in contrast to other GABA-releasing cells, elicited combined GABA(A) and GABA(B) receptor-mediated responses with single action potentials and that predominantly targeted the dendritic spines of pyramidal neurons. Slow inhibition evoked by a distinct interneuron in spatially restricted postsynaptic compartments could locally and selectively modulate cortical excitability.	Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary	Szeged University	Tamas, G (corresponding author), Univ Szeged, Dept Comparat Physiol, Kozep Fasor 52, H-6726 Szeged, Hungary.		Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001; Szabadics, Janos/0000-0002-4968-2562				Banks MI, 1998, J NEUROSCI, V18, P1305; Barnard EA, 1998, PHARMACOL REV, V50, P291; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cajal S. R., 1904, TEXTURA SYSTEMA NERV, V2; DESTEXHE A, 1995, P NATL ACAD SCI USA, V92, P9515, DOI 10.1073/pnas.92.21.9515; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hestrin S, 1996, J NEUROSCI, V16, P5290; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JONES EG, 1975, J COMP NEUROL, V160, P205, DOI 10.1002/cne.901600204; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; KISVARDAY ZF, 1990, BRAIN, V113, P793, DOI 10.1093/brain/113.3.793; KRNJEVIC K, 1967, EXP BRAIN RES, V3, P320, DOI 10.1007/BF00237558; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Li JL, 2001, NEUROSCI LETT, V315, P93, DOI 10.1016/S0304-3940(01)02321-7; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; MILES R, 1996, NEURON, V16, P816; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Thomson AM, 1999, NEUROSCIENCE, V92, P1193, DOI 10.1016/S0306-4522(99)00021-4; VALVERDE F, 1971, International Journal of Neuroscience, V1, P181, DOI 10.3109/00207457109146970	35	252	257	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1902	1905		10.1126/science.1082053	http://dx.doi.org/10.1126/science.1082053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649485				2022-12-01	WOS:000181669700049
J	Walden, H; Podgorski, MS; Schulman, BA				Walden, H; Podgorski, MS; Schulman, BA			Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8	NATURE			English	Article							PROTEIN MODIFICATION PATHWAY; MECHANISM; COMPLEX; SYSTEM; CONJUGATION; SITE; FAMILY; LIGASE; SMT3P	Post-translational modification by ubiquitin-like proteins (Ublps) is an essential cellular regulatory mechanism(1-3). The Ublp NEDD8 regulates cell division, signalling and embryogenesis(4-6). Ublps are conjugated to their targets by the sequential action of E1, E2 and often E3 enzymes(3). Each Ublp has a dedicated E1, or activating enzyme, that initiates its conjugation cascade(1,3,7-10). First, E1 associates with the Ublp and catalyses adenylation of the carboxy terminus of the Ublp. Second, E1 forms a thioester between its catalytic cysteine and the Ublp. Next, E1 is loaded with a second Ublp molecule, adenylating the C terminus of this second Ublp while still carrying the first thioester-bound LTblp. Last, E1 binds E2 and promotes Ublp transfer to the catalytic cysteine of E2. We report here the structure and mutational analysis of human APPBP1-UBA3, the heterodimeric E1 enzyme for NEDD8 (ref. 11). Each E1 activity is specified by a domain: an adenylation domain resembling bacterial adenylating enzymes 12, an E1-specific domain organized around the catalytic cysteine, and a domain involved in E2 recognition resembling ubiquitin. The domains are arranged around two clefts that coordinate protein and nucleotide binding so that each of E1's reactions drives the next, in an assembly-line fashion.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	Brenda.schulman@stjude.org						Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HATFIELD PM, 1990, J BIOL CHEM, V265, P15813; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WHITEHEAD GW, 1983, B AM MATH SOC, V8, P1, DOI 10.1090/S0273-0979-1983-15072-3	30	169	175	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					330	334		10.1038/nature01456	http://dx.doi.org/10.1038/nature01456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646924				2022-12-01	WOS:000181637300044
J	Heath, DD; Heath, JW; Bryden, CA; Johnson, RM; Fox, CW				Heath, DD; Heath, JW; Bryden, CA; Johnson, RM; Fox, CW			Rapid evolution of egg size in captive salmon	SCIENCE			English	Article							OFFSPRING SIZE; PACIFIC SALMON; CHINOOK SALMON; NUMBER; SELECTION; POPULATIONS; RECOVERY; FITNESS; LIFE	Captive breeding and release programs, widely used to supplement populations of declining species, minimize juvenile mortality to achieve rapid population growth. However, raising animals in benign environments may promote traits that are adaptive in captivity but maladaptive in nature. In chinook salmon, hatchery rearing relaxes natural selection favoring large eggs, allowing fecundity selection to drive exceptionally rapid evolution of small eggs. Trends toward small eggs are also evident in natural populations heavily supplemented by hatcheries, but not in minimally supplemented populations. Unintentional selection in captivity can lead to rapid changes in critical life-history traits that may reduce the success of supplementation or reintroduction programs.	Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada; Yellow Isl Aquaculture Ltd, Campbell River, BC V9W 6K9, Canada; AXYS Environm Consulting Ltd, Sidney, BC V8L 3S8, Canada; Univ No British Columbia, Coll Sci & Management, Prince George, BC V2N 4Z9, Canada; Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Windsor; University of Windsor; University of Northern British Columbia; University of Kentucky	Heath, DD (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	dheath@uwindsor.ca	Fox, Charles W/I-5274-2012	Fox, Charles W/0000-0002-7545-7967				ALLENDORF FW, 1993, CONSERV BIOL, V7, P416, DOI 10.1046/j.1523-1739.1993.07020416.x; Duchesne P, 2002, CONSERV GENET, V3, P47; EBENHARD T, 1995, TRENDS ECOL EVOL, V10, P438, DOI 10.1016/S0169-5347(00)89176-4; Einum S, 2002, P ROY SOC B-BIOL SCI, V269, P2325, DOI 10.1098/rspb.2002.2150; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Gippoliti S, 1997, CONSERV BIOL, V11, P806, DOI 10.1046/j.1523-1739.1997.96342.x; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heath DD, 2002, CAN J FISH AQUAT SCI, V59, P77, DOI 10.1139/F01-192; Heath DD, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P178; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hendry AP, 2001, AM NAT, V157, P387, DOI 10.1086/319316; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LLOYD DG, 1987, AM NAT, V129, P800, DOI 10.1086/284676; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PHILIPPART JC, 1995, BIOL CONSERV, V72, P281, DOI 10.1016/0006-3207(94)00090-D; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; Roff D.A., 2012, EVOLUTIONARY QUANTIT; Roff Derek A., 1992; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Wang JL, 2001, CONSERV BIOL, V15, P1619, DOI 10.1046/j.1523-1739.2001.00173.x; WAPLES RS, 1994, CONSERV BIOL, V8, P884, DOI 10.1046/j.1523-1739.1994.08030863-12.x; WINKLER DW, 1987, AM NAT, V129, P708, DOI 10.1086/284667	28	245	256	0	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1738	1740		10.1126/science.1079707	http://dx.doi.org/10.1126/science.1079707			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637746				2022-12-01	WOS:000181519500047
J	Treiner, E; Duban, L; Bahram, S; Radosavljevic, M; Wanner, V; Tilloy, F; Affaticati, P; Gilfillan, S; Lantz, O				Treiner, E; Duban, L; Bahram, S; Radosavljevic, M; Wanner, V; Tilloy, F; Affaticati, P; Gilfillan, S; Lantz, O			Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1	NATURE			English	Article							MHC CLASS-I; POSITIVE SELECTION; HEMATOPOIETIC-CELLS; MUTANT MICE; MU-CHAIN; GENE; MOUSE; GENERATION; EXPRESSION; BINDING	The evolutionary conservation of T lymphocyte subsets bearing T-cell receptors (TCRs) using invariant alpha-chains is indicative of unique functions. CD1d-restricted natural killer T (NK-T) cells that express an invariant Valpha14 TCRalpha chain have been implicated in microbial and tumour responses, as well as in auto-immunity(1,2) Here we show that T cells that express the canonical hValpha7.2-Jalpha33 or mValpha19-Jalpha33 TCR rearrangement' are preferentially located in the gut lamina propria of humans and mice, respectively, and are therefore genuine mucosal-associated invariant T (MAIT) cells. Selection and/or expansion of this population requires B lymphocytes, as MAIT cells are absent in B-cell-deficient patients and mice. In addition, we show that MAIT cells are selected and/or restricted by MR1, a monomorphic major histocompatibility complex class I-related molecule that is markedly conserved in diverse mammalian species'. MAIT cells are not present in germfree mice, indicating that commensal flora is required for their expansion in the gut lamina propria. This indicates that MAIT cells are probably involved in the host response at the site of pathogen entry, and may regulate intestinal B-cell activity.	Inst Curie, Immunol Lab, F-75005 Paris, France; Inst Curie, INSERM, U520, F-75005 Paris, France; Ctr Rech Immunol & Hematol, CReS, INSERM, F-67085 Strasbourg, France; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Washington University (WUSTL)	Lantz, O (corresponding author), Inst Curie, Immunol Lab, F-75005 Paris, France.		Bahram, Seiamak/GZA-7150-2022; Lantz, Olivier J/J-4960-2012	Lantz, Olivier J/0000-0003-3161-7719; Radosavljevic, Mirjana/0000-0003-3925-0640; Bahram, Seiamak/0000-0002-6928-9952				Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Bahram S, 2000, Adv Immunol, V76, P1; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BENVENISTE J, 1971, J IMMUNOL, V107, P1656; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lee N, 1998, J IMMUNOL, V160, P4951; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Riegert P, 1998, J IMMUNOL, V161, P4066; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Tourne S, 1996, P NATL ACAD SCI USA, V93, P1464, DOI 10.1073/pnas.93.4.1464; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; Ugolini S, 2001, NAT IMMUNOL, V2, P198, DOI 10.1038/85246; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3	30	731	754	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					164	169		10.1038/nature01433	http://dx.doi.org/10.1038/nature01433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634786				2022-12-01	WOS:000181488900045
J	Gurwitz, JH; Field, TS; Harrold, LR; Rothschild, J; Debellis, K; Seger, AC; Cadoret, C; Garber, L; Kelleher, M; Bates, DW				Gurwitz, JH; Field, TS; Harrold, LR; Rothschild, J; Debellis, K; Seger, AC; Cadoret, C; Garber, L; Kelleher, M; Bates, DW			Incidence and preventability of adverse drug events among older persons in the ambulatory setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICATION ERRORS; ELDERLY PATIENTS; UNITED-STATES; MEDICINE; QUALITY; PRESCRIPTION; POPULATION; DEATHS; SAFETY; COSTS	Context Adverse drug events, especially those that may be preventable, are among the most serious concerns about medication use in older persons cared for in the ambulatory clinical setting. Objective To assess the incidence and preventability of adverse drug events among older persons in the ambulatory clinical setting. Design, Setting, and Patients Cohort study of all Medicare enrollees (30 397 person-years of observation) cared for by a multispecialty group practice during a 12-month study period (July 1, 1999, through June 30, 2000), in which possible drug-related incidents occurring in the ambulatory clinical setting were detected using multiple methods, including reports from health care providers; review of hospital discharge summaries; review of emergency department notes; computer-generated signals; automated free-text review of electronic clinic notes; and review of administrative incident reports concerning medication errors. Main Outcome Measures Number of adverse drug events, severity of the events (classified as significant, serious, life-threatening, or fatal), and whether the events were preventable. Results There were 1523 identified adverse drug events, of which 27.6% (421) were considered preventable. The overall rate of adverse drug events was 50.1 per 1000 person-years, with a rate of 13.8 preventable adverse drug events per 1000 person-years. Of the adverse drug events, 578 (38.0%) were categorized as serious, life-threatening, or fatal; 244 (42.2%) of these more severe events were deemed preventable compared with 177 (18.7%) of the 945 significant adverse drug events. Errors associated with preventable adverse drug events occurred most often at the stages of prescribing (n = 246, 58.4%) and monitoring (n = 256, 60.8%), and errors involving patient adherence (n = 89, 21.1%) also were common. Cardiovascular medications (24.5%), followed by diuretics (22.1%), nonopioid analgesics (15.4%), hypoglytemics (10.9%), and anticoagulants (10.2%) were the most common medication categories associated with preventable adverse drug events. Electrolyte/renal (26.6%), gastrointestinal tract (21.1%), hemorrhagic (15.9%), metabolic/endocrine (13.8%), and neuropsychiatric (8.6%) events were the most common types of preventable adverse drug events. Conclusions Adverse drug events are common and often preventable among older persons in the ambulatory Clinical setting. More serious adverse drug events are more likely to be preventable. Prevention strategies should target the prescribing and monitoring stages of. pharmaceutical care. Interventions focused on improving patient adherence with prescribed regimens and monitoring of prescribed medications also may be beneficial.	Meyers Primary Care Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Partners Healthcare Syst, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Gurwitz, JH (corresponding author), Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA.	jgurwitz@meyersprimary.org		Cadoret, Cynthia/0000-0001-6713-2823	NATIONAL INSTITUTE ON AGING [R01AG015979] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Applegate WB, 2002, JAMA-J AM MED ASSOC, V288, P495, DOI 10.1001/jama.288.4.495; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; *CTR MED MED SERV, MED MAN CAR CONTR PL; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; Hanlon JT, 2000, PHARMACOTHERAPY, V20, P575, DOI 10.1592/phco.20.6.575.35163; Hanlon JT, 2002, J AM GERIATR SOC, V50, P26, DOI 10.1046/j.1532-5415.2002.50004.x; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Honigman B, 2001, INT J MED INFORM, V61, P21, DOI 10.1016/S1386-5056(00)00131-3; Honigman B, 2001, J AM MED INFORM ASSN, V8, P254, DOI 10.1136/jamia.2001.0080254; KATZ JN, 1992, ARTHRITIS RHEUM-US, V35, P1257, DOI 10.1002/art.1780351103; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kaushal R, 2001, ARCH PEDIAT ADOL MED, V155, P1002, DOI 10.1001/archpedi.155.9.1002; Knight EL, 2001, ANN INTERN MED, V135, P703, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00009; Kohn L, 2000, ERR IS HUMAN BUILDIN; KOZAK LJ, 2002, ADV DATA VITAL HLTH, V13; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *LEAPFR GROUP, 2002, PAT SAF SURV RES SUM; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Matchar DB, 2002, AM J MED, V113, P42, DOI 10.1016/S0002-9343(02)01131-2; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; *NAT CTR HLTH STAT, POP AG SEX RAC NAT S; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Rosner B., 1995, FUNDAMENTALS BIOSTAT; Sackett D, 1991, CLIN EPIDEMIOLOGY BA; SHOJANIA K, 2001, AHRQ PUBLICATION; Sox H C Jr, 2000, Eff Clin Pract, V3, P277; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; WALTON RT, 2001, COCHRANE DB SYST REV, V1; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	45	1078	1113	1	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1107	1116		10.1001/jama.289.9.1107	http://dx.doi.org/10.1001/jama.289.9.1107			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622580	Bronze			2022-12-01	WOS:000181289400026
J	Spodick, DH				Spodick, DH			Acute pericarditis - Current concepts and practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIAC-TAMPONADE; DIAGNOSIS; FREQUENCY; ETIOLOGY; DISEASE		Univ Massachusetts, Sch Med, Cardiovasc Med Fellowship Program, St Vincent Hosp, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Spodick, DH (corresponding author), Worcester Med Ctr, Div Cardiovasc, 20 Worcester Ctr Blvd, Worcester, MA 01608 USA.							BRUCE MA, 1980, J ELECTROCARDIOL, V13, P61, DOI 10.1016/S0022-0736(80)80011-2; FOWLER NO, 1991, JAMA-J AM MED ASSOC, V266, P99, DOI 10.1001/jama.266.1.99; FRIEDMAN PL, 1981, NEW ENGL J MED, V305, P1171, DOI 10.1056/NEJM198111123052002; LEE KS, 1993, CLEV CLIN J MED, V60, P336, DOI 10.3949/ccjm.60.4.336; Lieng LH, 1996, J AM COLL CARDIOL, V27, p32A; MAISCH B, 1994, CURR OPIN CARDIOL, V9, P379, DOI 10.1097/00001573-199405000-00017; Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6; Myers RBH, 1999, AM HEART J, V138, P219, DOI 10.1016/S0002-8703(99)70105-5; PERMANYER G, 1988, ENFERMEDADES PERICAR, P5; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; REDDY PS, 1990, AM J CARDIOL, V66, P1487, DOI 10.1016/0002-9149(90)90540-H; REYDEL B, 1990, AM HEART J, V119, P1160, DOI 10.1016/S0002-8703(05)80248-0; Spodick DH, 1997, AM J CARDIOL, V80, P102, DOI 10.1016/S0002-9149(97)00296-8; SPODICK DH, 1984, AM J CARDIOL, V53, P842, DOI 10.1016/0002-9149(84)90416-8; SPODICK DH, 1973, CIRCULATION, V48, P575, DOI 10.1161/01.CIR.48.3.575; Spodick DH, 1997, PERICARDIUM COMPREHE; Spodick DH, 2001, HEART DIS, P823; SPODICK DH, 2002, EVALUATION PATIENT H, P339; SWAMI A, IN PRESS CLIN CARDIO; ZAYAS R, 1995, AM J CARDIOL, V75, P378, DOI 10.1016/S0002-9149(99)80558-X	20	117	121	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1150	1153		10.1001/jama.289.9.1150	http://dx.doi.org/10.1001/jama.289.9.1150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622586				2022-12-01	WOS:000181289400032
J	Bose, A; Coen, P; Tully, J; Viner, R; Booy, R				Bose, A; Coen, P; Tully, J; Viner, R; Booy, R			Effectiveness of meningococcal C conjugate vaccine in teenagers in England	LANCET			English	Article							EFFICACY	Meningococcal C conjugate vaccine was introduced into clinical practice in the UK before phase 3 trials had been undertaken. We therefore did a case-control study,in teenagers to assess vaccine effectiveness. All cases (n=31) enrolled had laboratory confirmed meningococcal C disease. We also enrolled between one and three controls (n=65) per case, matched by age, sex, and general practitioner. Three patients and 23 controls had been vaccinated. The protective effectiveness of the vaccine, estimated by conditional logistic regression, was 93% (95% CI 39-99), which is similar to screening method estimates. The estimated protective effectiveness varied little when potential confounding risk factors were taken into account. Our findings indicate that the vaccine is highly protective against invasive meningococcal C disease.	Royal London Hosp, Acad Dept Child Hlth, London E1 1BB, England; Inst Child Hlth, London, England; UCL Hosp, Adolescent Res Unit, London, England; Great Ormond St Hosp Sick Children, London, England	Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Booy, R (corresponding author), Royal London Hosp, Acad Dept Child Hlth, London E1 1BB, England.	R.Booy@qmul.ac.uk	Booy, Robert/D-4188-2011; Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247; Tully, Joanna/0000-0002-3918-6063				MARYKRAUSE M, 1993, REV EPIDEMIOL SANTE, V41, P155; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Simondon F, 1999, INT J EPIDEMIOL, V28, P113, DOI 10.1093/ije/28.1.113; TULLY J, ARCH DIS CHILD S, V82, pA5	5	33	35	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					675	676		10.1016/S0140-6736(03)12563-9	http://dx.doi.org/10.1016/S0140-6736(03)12563-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606181				2022-12-01	WOS:000181129500019
J	Henry, G; Li, W; Garner, W; Woodley, DT				Henry, G; Li, W; Garner, W; Woodley, DT			Migration of human keratinocytes in plasma and serum and wound re-epithelialisation	LANCET			English	Article								When skin is wounded, human keratinocytes at the wound edge stop differentiating and start migrating to resurface the wound. How this change takes place is unclear. Because keratinocytes at the wound edge are for the first time surrounded by serum rather than plasma, serum could contain some migration-promoting factor or factors that is absent in plasma. We did standard computer-assisted in-vitro migration assays of human keratinocytes in the presence of either human plasma or serum. We also did a semiquantitative western blot analysis to determine if p38 mitogen-activated protein kinase (p38MAPK) was activated by either serum or plasma. Our results showed that keratinocytes migrating on collagen in the presence of serum produced migration indices in the range of 28, whereas those in the presence of plasma were about 12-the same level as control assays without either serum or plasma. We also showed that induced keratinocyte polarisation, activation of p38MAPK, and production of matrix metalloprotease 9 are possible mechanisms for promotion of re-epithelialisation of skin wounds by human serum.	Univ So Calif, Keck Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Surg, Div Plast Surg, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Woodley, DT (corresponding author), Univ So Calif, Keck Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90033 USA.				NIAMS NIH HHS [R01 AR46538] Funding Source: Medline; NIGMS NIH HHS [R01 GM/AR66193] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066193] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Johansson N, 2000, J CELL SCI, V113, P227; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Woodley DT, 1996, MOL CELLULAR BIOL WO, P339	5	38	39	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					574	576		10.1016/S0140-6736(03)12510-X	http://dx.doi.org/10.1016/S0140-6736(03)12510-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598145				2022-12-01	WOS:000181033400013
J	Park, IK; Qian, DL; Kiel, M; Becker, MW; Pihalja, M; Weissman, IL; Morrison, SJ; Clarke, MF				Park, IK; Qian, DL; Kiel, M; Becker, MW; Pihalja, M; Weissman, IL; Morrison, SJ; Clarke, MF			Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells	NATURE			English	Article							GENE-EXPRESSION; POLYCOMB; MICE; DEFECTS; REGULATOR; DELETION; LOCUS; MDM2; P53	A central issue in stem cell biology is to understand the mechanisms that regulate the self-renewal of haematopoietic stem cells (HSCs), which are required for haematopoiesis to persist for the lifetime of the animal(1). We found that adult and fetal mouse and adult human HSCs express the proto-oncogene Bmi-1. The number of HSCs in the fetal liver of Bmi-1(-/-) mice(2) was normal. In postnatal Bmi-1(-/-) mice, the number of HSCs was markedly reduced. Transplanted fetal liver and bone marrow cells obtained from Bmi-1(-/-) mice were able to contribute only transiently to haematopoiesis. There was no detectable self-renewal of adult HSCs, indicating a cell autonomous defect in Bmi-1(-/-) mice. A gene expression analysis revealed that the expression of stem cell associated genes(3), cell survival genes, transcription factors, and genes modulating proliferation including p16(Ink4a) and p19(Arf) was altered in bone marrow cells of the Bmi-1(-/-) mice. Expression of p16(Ink4a) and p19(Arf) in normal HSCs resulted in proliferative arrest and p53-dependent cell death, respectively. Our results indicate that Bmi-1 is essential for the generation of self-renewing adult HSCs.	Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Clarke, MF (corresponding author), Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA.		Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Becker, Michael/0000-0001-9890-8815				Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; COTTA C, 2001, RETROVIRAL TRANSDUCT, P243; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Fisher RC, 1999, BLOOD, V94, P1283, DOI 10.1182/blood.V94.4.1283.416k16_1283_1290; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; LESSARD J, 2003, NATURE          0420; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; QUELLE DE, 1995, CELL, V83, P993; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	30	1484	1603	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					302	305		10.1038/nature01587	http://dx.doi.org/10.1038/nature01587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12714971	Green Published			2022-12-01	WOS:000182853100046
J	Poutanen, SM; Low, DE; Henry, B; Finkelstein, S; Rose, D; Green, K; Tellier, R; Draker, R; Adachi, D; Ayers, M; Chan, AK; Skowronski, DM; Salit, I; Simor, AE; Slutsky, AS; Doyle, PW; Krajden, M; Petric, M; Brunham, RC; McGeer, AJ				Poutanen, SM; Low, DE; Henry, B; Finkelstein, S; Rose, D; Green, K; Tellier, R; Draker, R; Adachi, D; Ayers, M; Chan, AK; Skowronski, DM; Salit, I; Simor, AE; Slutsky, AS; Doyle, PW; Krajden, M; Petric, M; Brunham, RC; McGeer, AJ		Natl Microbiology Lab Canada; Canadian Severe Acute Respiratory	Identification of severe acute respiratory syndrome in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN METAPNEUMOVIRUS; MECHANICAL VENTILATION; CORONAVIRUS; INFECTIONS; RIBAVIRIN; CHILDREN; TRIAL	BACKGROUND Severe acute respiratory syndrome (SARS) is a condition of unknown cause that has recently been recognized in patients in Asia, North America, and Europe. This report summarizes the initial epidemiologic findings, clinical description, and diagnostic findings that followed the identification of SARS in Canada. METHODS SARS was first identified in Canada in early March 2003. We collected epidemiologic, clinical, and diagnostic data from each of the first 10 cases prospectively as they were identified. Specimens from all cases were sent to local, provincial, national, and international laboratories for studies to identify an etiologic agent. RESULTS The patients ranged from 24 to 78 years old; 60 percent were men. Transmission occurred only after close contact. The most common presenting symptoms were fever (in 100 percent of cases) and malaise (in 70 percent), followed by nonproductive cough (in 100 percent) and dyspnea (in 80 percent) associated with infiltrates on chest radiography (in 100 percent). Lymphopenia (in 89 percent of those for whom data were available), elevated lactate dehydrogenase levels (in 80 percent), elevated aspartate aminotransferase levels (in 78 percent), and elevated creatinine kinase levels (in 56 percent) were common. Empirical therapy most commonly included antibiotics, oseltamivir, and intravenous ribavirin. Mechanical ventilation was required in five patients. Three patients died, and five have had clinical improvement. The results of laboratory investigations were negative or not clinically significant except for the amplification of human metapneumovirus from respiratory specimens from five of nine patients and the isolation and amplification of a novel coronavirus from five of nine patients. In four cases both pathogens were isolated. CONCLUSIONS SARS is a condition associated with substantial morbidity and mortality. It appears to be of viral origin, with patterns suggesting droplet or contact transmission. The role of human metapneumovirus, a novel coronavirus, or both requires further investigation.	Toronto Med Labs, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; City Toronto Publ Hlth Dept, Toronto, ON, Canada; Scarborough Gen Hosp, Toronto, ON, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; British Columbia Ctr Dis Control, Epidemiol Serv, Vancouver, BC, Canada; British Columbia Ctr Dis Control, Lab Serv, Vancouver, BC, Canada; Univ Hlth Network, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Vancouver Hosp & Hlth Sci Ctr, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; Scarborough Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of British Columbia; University of British Columbia	McGeer, AJ (corresponding author), Toronto Med Labs, 600 Univ Ave,Rm 1460, Toronto, ON M5G 1X5, Canada.		Low, Donald/B-1726-2012; McGeer, Allison/AAB-6885-2020; Poutanen, Susan M/F-9640-2012; mcgeer, allison/H-7747-2014; Slutsky, Arthur S/A-6013-2008; Poutanen, Susan M./N-8066-2019; Slutsky, Arthur/M-3325-2019; Draker, Ryan/GQP-7335-2022	McGeer, Allison/0000-0001-5647-6137; Poutanen, Susan M/0000-0003-4747-2550; mcgeer, allison/0000-0001-5647-6137; Slutsky, Arthur S/0000-0002-6063-3876; Poutanen, Susan M./0000-0003-4747-2550; 				[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Crotty S, 2001, NAT MED, V7, P255; Falsey AR, 1997, J AM GERIATR SOC, V45, P706, DOI 10.1111/j.1532-5415.1997.tb01474.x; Farr BM, 2000, RESP MED, V94, P954, DOI 10.1053/rmed.2000.0865; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Nissen MD, 2002, MED J AUSTRALIA, V176, P188, DOI 10.5694/j.1326-5377.2002.tb04354.x; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; SIDWELL RW, 1987, ANTIMICROB AGENTS CH, V31, P1130, DOI 10.1128/AAC.31.7.1130; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; TRUYEN U, 1995, VET MICROBIOL, V43, P103, DOI 10.1016/0378-1135(95)92531-F; Vabret A, 1998, PRESSE MED, V27, P1813; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEISS RC, 1989, VET MICROBIOL, V20, P255, DOI 10.1016/0378-1135(89)90049-7; 2003, MMWR MORB MORTAL WKL, V52, P241	23	782	922	0	54	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1995	2005		10.1056/NEJMoa030634	http://dx.doi.org/10.1056/NEJMoa030634			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12671061	Green Published, Bronze			2022-12-01	WOS:000182823400008
J	Raffle, AE; Alden, B; Quinn, M; Babb, PJ; Brett, MT				Raffle, AE; Alden, B; Quinn, M; Babb, PJ; Brett, MT			Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; PROGRESSION; MORTALITY; CYTOLOGY; CONSENT; ENGLAND; TRENDS; WOMEN	Objective To determine the frequency of different outcomes in women participating in cervical screening. Design Analysis of screening records from 348 419 women, and modelling of cases of cervical cancer and deaths with and without screening. Setting Cervical screening programme in Bristol. Results For every 10 000 women screened from 1976 to 1996,1564 had abnormal cytology, 818 were investigated, and 543 had abnormal histology. One hundred and seventy six had persistent abnormality for two years or more. In the absence of screening 80 women would be expected to develop cancer of the cervix by 2011, of whom 25 would die. With screening 10 of these deaths would be avoided. Comparison of cumulative abnormality rates with numbers expected to develop cancer in the absence of screening suggests that at least 80% of high grade dyskaryosis and of high grade dysplasia would not progress to cancer. The lifetime risk of having abnormal cytology detected could be as high as 40% for women born since 1960. Conclusions Screening is labour and resource intensive. It involves treatment for many women not destined to develop invasive cancer. The increased intervention rate for cervical abnormality in England is due to change in practice, not a cohort effect, and is probably the reason for the marked fall in incidence and mortality during the 1990s. For other cancers there is scope for major iatrogenic harm from screening because of invasive tests and treatments.	Avon Hlth Author, Bristol BS2 8EE, Avon, England; Off Natl Stat, Natl Canc Intelligence Ctr, London SW1V 2QQ, England; Southmead Gen Hosp, Dept Cellular Pathol, Bristol BS10 5NB, Avon, England	Southmead Hospital	Raffle, AE (corresponding author), Avon Hlth Author, King Sq House, Bristol BS2 8EE, Avon, England.							Anderson CM, 1999, CYTOPATHOLOGY, V10, P221, DOI 10.1046/j.1365-2303.1999.00198.x; Bos AB, 1997, BRIT J CANCER, V75, P124, DOI 10.1038/bjc.1997.20; Dillner J, 2000, J CLIN VIROL, V19, P7, DOI 10.1016/S1386-6532(00)00126-8; EVANS DMD, 1986, J CLIN PATHOL, V39, P933, DOI 10.1136/jcp.39.9.933; Foster P, 1998, J MED ETHICS, V24, P151, DOI 10.1136/jme.24.3.151; Frable WJ, 1998, ACTA CYTOL, V42, P76, DOI 10.1159/000331537; Furber SE, 1997, AUST NZ J OBSTET GYN, V37, P107, DOI 10.1111/j.1479-828X.1997.tb02230.x; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; MARTEAU TM, 1990, BRIT J OBSTET GYNAEC, V97, P859, DOI 10.1111/j.1471-0528.1990.tb02586.x; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Quinn M, 2001, CANC TRENDS ENGLAND; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Raffle AE, 1999, LANCET, V354, P431, DOI 10.1016/S0140-6736(05)75855-4; RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0; Sasieni P, 1999, BRIT MED J, V318, P1244; Slater D, 1998, LANCET, V351, P1130, DOI 10.1016/S0140-6736(05)79410-1; Slater DN, 2000, CYTOPATHOLOGY, V11, P166, DOI 10.1046/j.1365-2303.2000.00248.x; *UK NAT SCREEN COM, 2000, 2 REP	20	87	88	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 26	2003	326	7395					901	904A		10.1136/bmj.326.7395.901	http://dx.doi.org/10.1136/bmj.326.7395.901			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673WQ	12714468	Green Published, Bronze			2022-12-01	WOS:000182603600014
J	Jonsson, KB; Zahradnik, R; Larsson, T; White, KE; Sugimoto, T; Imanishi, Y; Yamamoto, T; Hampson, G; Koshiyama, H; Ljunggren, O; Oba, K; Yang, IM; Miyauchi, A; Econs, MJ; Lavigne, J; Juppner, H				Jonsson, KB; Zahradnik, R; Larsson, T; White, KE; Sugimoto, T; Imanishi, Y; Yamamoto, T; Hampson, G; Koshiyama, H; Ljunggren, O; Oba, K; Yang, IM; Miyauchi, A; Econs, MJ; Lavigne, J; Juppner, H			Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INDUCED OSTEOMALACIA; RICKETS; FGF-23; GENE	Background: Mutations in fibroblast growth factor 23 (FGF-23) cause autosomal dominant hypophosphatemic rickets. Clinical and laboratory findings in this disorder are similar to those in oncogenic osteomalacia, in which tumors abundantly express FGF-23 messenger RNA, and to those in X-linked hypophosphatemia, which is caused by inactivating mutations in a phosphate-regulating endopeptidase called PHEX. Recombinant FGF-23 induces phosphaturia and hypophosphatemia in vivo, suggesting that it has a role in phosphate regulation. To determine whether FGF-23 circulates in healthy persons and whether it is elevated in those with oncogenic osteomalacia or X-linked hypophosphatemia, an immunometric assay was developed to measure it. Methods: Using affinity-purified, polyclonal antibodies against [Tyr223]FGF-23(206-222)amide and [Tyr224]FGF-23(225-244)amide, we developed a two-site enzyme-linked immunosorbent assay that detects equivalently recombinant human FGF-23, the mutant form in which glutamine is substituted for arginine at position 179 (R179Q), and synthetic human FGF-23(207-244)amide. Plasma or serum samples from 147 healthy adults (mean [+/-SD] age, 48.4+/-19.6 years) and 26 healthy children (mean age, 10.9+/-5.5 years) and from 17 patients with oncogenic osteomalacia (mean age, 43.0+/-13.3 years) and 21 patients with X-linked hypophosphatemia (mean age, 34.9+/-17.2 years) were studied. Results: Mean FGF-23 concentrations in the healthy adults and children were 55+/-50 and 69+/-36 reference units (RU) per milliliter, respectively. Four patients with oncogenic osteomalacia had concentrations ranging from 426 to 7970 RU per milliliter, which normalized after tumor resection. FGF-23 concentrations were 481+/-528 RU per milliliter in those with suspected oncogenic osteomalacia and 353+/-510 RU per milliliter (range, 31 to 2335) in those with X-linked hypophosphatemia. Conclusions: FGF-23 is readily detectable in the plasma or serum of healthy persons and can be markedly elevated in those with oncogenic osteomalacia or X-linked hypophosphatemia, suggesting that this growth factor has a role in phosphate homeostasis. FGF-23 measurements might improve the management of phosphate-wasting disorders.	Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, MassGen Hosp Children, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; Uppsala Univ, Dept Med Sci, Uppsala, Sweden; Immutopics, San Clemente, CA USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Endocrinol & Metab, Kobe, Hyogo 657, Japan; Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; Minoh City Hosp, Dept Pediat, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan; St Thomas Hosp, Dept Chem Pathol, London, England; Hyogo Kenritsu Amagasaki Hosp, Dept Med, Div Endocrinol & Metab, Amagasaki, Hyogo, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; Aso Iizuka Hosp, Fukuoka, Japan; Kuyunghee Univ, Dept Internal Med, Seoul, South Korea; Natl Hyogo Chuo Hosp, Sanda, Hyogo, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Uppsala University; Uppsala University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Kobe University; Osaka Metropolitan University; Osaka University; Guy's & St Thomas' NHS Foundation Trust; Kyushu University; Kyung Hee University	Juppner, H (corresponding author), Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Wellman 5, Boston, MA 02114 USA.		Miyauchi, Akimitsu/GYU-7403-2022; Koshiyama, Hiroyuki/H-3877-2011; , kenneth/GPF-8006-2022	Econs, Michael/0000-0003-0940-1911	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042228, R29AR042228, K24AR002095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046718, R37DK046718, R01DK063934] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR42228, K24-AR02095] Funding Source: Medline; NIDDK NIH HHS [DK46718, DK063934-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Holm IA, 1997, AM J HUM GENET, V60, P790; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; SABBAGH Y, PHEX LOCUS DATA BASE; Seufert J, 2001, NEW ENGL J MED, V345, P1883, DOI 10.1056/NEJMoa010839; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2001, J BONE MINER RES, V16, pS151; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yang In Myung, 1997, Korean Journal of Internal Medicine (English Edition), V12, P89	15	641	672	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1656	1663		10.1056/NEJMoa020881	http://dx.doi.org/10.1056/NEJMoa020881			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711740				2022-12-01	WOS:000182416300005
J	Wang, YX; Lee, CH; Tiep, S; Yu, RT; Ham, JY; Kang, HJ; Evans, RM				Wang, YX; Lee, CH; Tiep, S; Yu, RT; Ham, JY; Kang, HJ; Evans, RM			Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity	CELL			English	Article							INSULIN-RESISTANCE; PPAR-GAMMA; ADAPTIVE THERMOGENESIS; CHOLESTEROL EFFLUX; NUCLEAR RECEPTORS; LEPTIN RECEPTOR; ADIPOSE-TISSUE; DB/DB MICE; MACROPHAGES; MECHANISMS	In contrast to the well-established roles of PPARgamma and PPARalpha in lipid metabolism, little is known for PPARdelta in this process. We show here that targeted activation of PPARdelta in adipose tissue specifically induces expression of genes required for fatty acid oxidation and energy dissipation, which in turn leads to improved lipid profiles and reduced adiposity. Importantly, these animals are completely resistant to both high-fat diet-induced and genetically predisposed (Lepr(db/db)) obesity. As predicted, acute treatment of Lepr(db/db) mice with a PPARdelta agonist depletes lipid accumulation. In parallel, PPARdelta-deficient mice challenged with high-fat diet show reduced energy uncoupling and are prone to obesity. In vitro, activation of PPARdelta in adipocytes and skeletal muscle cells promotes fatty acid oxidation and utilization. Our findings suggest that PPARdelta serves as a widespread regulator of fat burning and identify PPARdelta as a potential target in treatment of obesity and its associated disorders.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Seoul Natl Univ, Sch Earth & Environm Sci, Oceanog Program, Marine Biotechnol Lab, Seoul 151747, South Korea	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Seoul National University (SNU)	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627				Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	35	1053	1138	1	95	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					159	170		10.1016/S0092-8674(03)00269-1	http://dx.doi.org/10.1016/S0092-8674(03)00269-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705865	Bronze			2022-12-01	WOS:000182508500006
J	De Deyn, GB; Raaijmakers, CE; Zoomer, HR; Berg, MP; de Ruiter, PC; Verhoef, HA; Bezemer, TM; van der Putten, WH				De Deyn, GB; Raaijmakers, CE; Zoomer, HR; Berg, MP; de Ruiter, PC; Verhoef, HA; Bezemer, TM; van der Putten, WH			Soil invertebrate fauna enhances grassland succession and diversity	NATURE			English	Article							PLANT; COMMUNITY; HERBIVORY; FEEDBACK; MYCORRHIZAE; DYNAMICS; MOSAICS; BIOTA	One of the most important areas in ecology is to elucidate the factors that drive succession in ecosystems and thus influence the diversity of species in natural vegetation. Significant mechanisms in this process are known to be resource limitation(1-3) and the effects of aboveground vertebrate herbivores(4,5). More recently, symbiotic and pathogenic soil microbes have been shown to exert a profound effect on the composition of vegetation(6-9) and changes therein(10,11). However, the influence of invertebrate soil fauna on succession has so far received little attention(12,13). Here we report that invertebrate soil fauna might enhance both secondary succession and local plant species diversity. Soil fauna from a series of secondary grassland succession stages selectively suppress early successional dominant(14) plant species, thereby enhancing the relative abundance of subordinate(14) species and also that of species from later succession stages. Soil fauna from the mid-succession stage had the strongest effect. Our results clearly show that soil fauna strongly affects the composition of natural vegetation and we suggest that this knowledge might improve the restoration and conservation of plant species diversity.	Netherlands Inst Ecol, NIOO, KNAW, Ctr Terr Ecol,Dept Multitrop Interact, NL-6666 ZG Heteren, Netherlands; Vrije Univ Amsterdam, Inst Ecol Sci, Dept Anim Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Utrecht, Copernicus Res Inst Sustainable Dev & Innovat, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; Utrecht University	De Deyn, GB (corresponding author), Netherlands Inst Ecol, NIOO, KNAW, Ctr Terr Ecol,Dept Multitrop Interact, POB 40, NL-6666 ZG Heteren, Netherlands.	g.dedeyn@nioo.knaw.nl	De Deyn, Gerlinde/F-7080-2017; De Deyn, Gerlinde B/C-1593-2009; Bezemer, Martijn/A-4068-2009; De Deyn, Gerlinde/AFI-8702-2022; van der Putten, Wim H/C-3707-2011	De Deyn, Gerlinde/0000-0003-4823-6912; De Deyn, Gerlinde B/0000-0003-4823-6912; Bezemer, Martijn/0000-0002-2878-3479; De Deyn, Gerlinde/0000-0003-4823-6912; van der Putten, Wim H/0000-0002-9341-4442; Berg, Matty P./0000-0001-8442-8503				ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Blomqvist MM, 2000, OIKOS, V90, P582, DOI 10.1034/j.1600-0706.2000.900316.x; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; BROWN VK, 1992, VEGETATIO, V101, P3, DOI 10.1007/BF00031910; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Clements, 1916, PLANT SUCCESSION ANA; Crawley MJ, 1997, PLANT ECOL; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; MARRS RH, 1993, ADV ECOL RES, V24, P241, DOI 10.1016/S0065-2504(08)60044-6; Olff H, 2000, OECOLOGIA, V125, P45, DOI 10.1007/PL00008890; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oostenbrink M., 1960, NEMATOLOGY, P85; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; PETERS JH, 1988, CANCER LETT, V39, P287, DOI 10.1016/0304-3835(88)90072-9; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tilman D., 1982, Monographs in Population Biology, pi; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VANDERPUTTEN WH, 1993, NATURE, V362, P53; VANSTRAALEN NM, 1982, PEDOBIOLOGIA, V24, P197; Wardle DA, 1997, OIKOS, V80, P470, DOI 10.2307/3546620; YEATES GW, 1993, J NEMATOL, V25, P315	27	407	431	18	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					711	713		10.1038/nature01548	http://dx.doi.org/10.1038/nature01548			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700759				2022-12-01	WOS:000182272300038
J	Han, AD; Pan, F; Stroud, JC; Youn, HD; Liu, JO; Chen, L				Han, AD; Pan, F; Stroud, JC; Youn, HD; Liu, JO; Chen, L			Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2	NATURE			English	Article							HISTONE DEACETYLASES; CRYSTAL-STRUCTURE; TERNARY COMPLEX; FACTOR MEF2; MADS-BOX; ACTIVATION; DNA; APOPTOSIS; DIFFERENTIATION; CALCINEURIN	The myocyte enhancer factor-2 (MEF2) family of transcription factors has important roles in the development and function of T cells, neuronal cells and muscle cells(1-3). MEF2 is capable of repressing or activating transcription by association with a variety of co-repressors or co-activators in a calcium-dependent manner(1,4,5). Transcriptional repression by MEF2 has attracted particular attention because of its potential role in hypertrophic responses of cardiomyocytes(6). Several MEF2 co-repressors, such as Cabin1/Cain and class II histone deacetylases (HDACs), have been identified(7-12). However, the molecular mechanism of their recruitment to specific promoters by MEF2 remains largely unknown. Here we report a crystal structure of the MADS-box/MEF2S domain of human MEF2B bound to a motif of the transcriptional co-repressor Cabin1 and DNA at 2.2 Angstrom resolution. The crystal structure reveals a stably folded MEF2S domain on the surface of the MADS box. Cabin1 adopts an amphipathic alpha-helix to bind a hydrophobic groove on the MEF2S domain, forming a triple-helical interaction. Our studies of the ternary Cabin1/MEF2/DNA complex show a general mechanism by which MEF2 recruits transcriptional co-repressor Cabin1 and class II HDACs to specific DNA sites.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins University	Chen, L (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.		Youn, Hong-Duk/J-2774-2012; Stroud, James C/B-3230-2012; chen, Lin/A-3392-2008	Stroud, James C/0000-0003-0850-4812; chen, Lin/0000-0003-4798-6199	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049905] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL076334] Funding Source: Medline; NIAID NIH HHS [R21 AI049905] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; Huang K, 2000, EMBO J, V19, P2615, DOI 10.1093/emboj/19.11.2615; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	30	81	93	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					730	734		10.1038/nature01555	http://dx.doi.org/10.1038/nature01555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700764				2022-12-01	WOS:000182272300044
J	Edwards, IR				Edwards, IR			Withdrawing drugs: nefazodone, the start of the latest saga	LANCET			English	Editorial Material									Uppsala Monitoring Ctr, S-75320 Uppsala, Sweden		Edwards, IR (corresponding author), Uppsala Monitoring Ctr, S-75320 Uppsala, Sweden.							Abraham J, 2003, DRUG SAFETY, V26, P135, DOI 10.2165/00002018-200326030-00001; BISCARINI L, 2000, MEYLERS SIDE EFFECTS, P266; Edwards IR, 1997, DRUG SAFETY, V17, P216, DOI 10.2165/00002018-199717040-00002; Graham DJ, 2001, JAMA-J AM MED ASSOC, V286, P831, DOI 10.1001/jama.286.7.831; *PUBL CIT, 2003, HRG PUBL, V1657; *PUBL CIT, 2003, PUBL CIT CALLS FDA B; SANJAY AP, 2003, LANCET, V361, P1136; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; van Grootheest ACK, 2002, DRUG SAFETY, V25, P1051, DOI 10.2165/00002018-200225150-00001	9	11	13	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1240	1240		10.1016/S0140-6736(03)13030-9	http://dx.doi.org/10.1016/S0140-6736(03)13030-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699949				2022-12-01	WOS:000182161600006
J	Moore, B; Zhou, L; Rolland, F; Hall, Q; Cheng, WH; Liu, YX; Hwang, I; Jones, T; Sheen, J				Moore, B; Zhou, L; Rolland, F; Hall, Q; Cheng, WH; Liu, YX; Hwang, I; Jones, T; Sheen, J			Role of the Arabidopsis glucose sensor HXK1 in nutrient, light, and hormonal signaling	SCIENCE			English	Article							GENE-EXPRESSION; HEXOKINASE	Glucose modulates many vital processes in photosynthetic plants. Analyses of Arabidopsis glucose insensitive2 (gin2) mutants de. ne the physiological functions of a specific hexokinase (HXK1) in the plant glucose-signaling network. HXK1 coordinates intrinsic signals with extrinsic light intensity. HXK1 mutants lacking catalytic activity still support various signaling functions in gene expression, cell proliferation, root and in florescence growth, and leaf expansion and senescence, thus demonstrating the uncoupling of glucose signaling from glucose metabolism. The gin2 mutants are also insensitive to auxin and hypersensitive to cytokinin. Plants use HXK as a glucose sensor to interrelate nutrient, light, and hormone signaling networks for controlling growth and development in response to the changing environment.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu	Cheng, Wan-Hsing/ABH-1421-2020	Cheng, Wan-Hsing/0000-0003-4924-7429; Rolland, Filip/0000-0003-2601-0752				Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Kraakman LS, 1999, BIOCHEM J, V343, P159, DOI 10.1042/0264-6021:3430159; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MA H, 1989, MOL CELL BIOL, V9, P5630, DOI 10.1128/MCB.9.12.5630; Pego JV, 2000, TRENDS PLANT SCI, V5, P531, DOI 10.1016/S1360-1385(00)01783-0; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; SHEEN J, UNPUB; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	26	827	887	14	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					332	336		10.1126/science.1080585	http://dx.doi.org/10.1126/science.1080585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690200				2022-12-01	WOS:000182135400058
J	Strausberg, RL; Schreiber, SL				Strausberg, RL; Schreiber, SL			From knowing to controlling: A path from Genomics to drugs using small molecule probes	SCIENCE			English	Article							STOCK SOLUTION APPROACH; CHEMICAL GENETICS; ONE-BEAD	The National Cancer Institute Initiative in Chemical Genetics is designed to encourage the development of small molecular probes. The probes are useful for activating or inactivating protein functions, thereby providing resources that help discern the functions of gene products in normal and disease cells, as well as in tissues. This initiative includes "ChemBank," a suite of informatics tools and databases aimed at promoting the development and use of chemical genetics by scientists worldwide. The information generated with such tools should provide a critical link from genomic discovery to drug development.	NCI, Canc Genom Off, Bethesda, MD 20892 USA; Harvard Univ, Dept Chem & Biol Chem, Howard Hughes Med Inst, Cambridge, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Harvard University; Howard Hughes Medical Institute	Strausberg, RL (corresponding author), NCI, Canc Genom Off, 31 Ctr Dr, Bethesda, MD 20892 USA.							Blackwell HE, 2001, CHEM BIOL, V8, P1167, DOI 10.1016/S1074-5521(01)00085-0; Clemons PA, 2001, CHEM BIOL, V8, P1183, DOI 10.1016/S1074-5521(01)00086-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Shuey DJ, 2002, DRUG DISCOV TODAY, V7, P1040, DOI 10.1016/S1359-6446(02)02474-1; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9	9	229	237	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					294	295		10.1126/science.1083395	http://dx.doi.org/10.1126/science.1083395			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690189	Green Published			2022-12-01	WOS:000182135400045
J	Decosas, J				Decosas, J			HIV prevention and treatment in South Africa: affordable and desirable	LANCET			English	Editorial Material									Plan Ghana, Plan W Africa Reg Off, Accra, Ghana		Decosas, J (corresponding author), Plan Ghana, Plan W Africa Reg Off, PMB Osu Main PO, Accra, Ghana.							*ACT SOC S AFR, 2002, AIDS DEM MOD ACT SOC; FASSIN D, 2003, BRIT MED J, V320, P495; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; GEFFEN N, 2003, 28 CSSR U CAP TOWN; *HLTH SYST TRUST, 2002, INT FIND PMTCT PIL S; Meda N, 2002, AIDS, V16, P2323, DOI 10.1097/00002030-200211220-00013; World Health Organization, 2002, WORLD HLTH REPORT 20	7	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1146	1147		10.1016/S0140-6736(03)12966-2	http://dx.doi.org/10.1016/S0140-6736(03)12966-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686033				2022-12-01	WOS:000182094600004
J	Liu, QL; D'Silva, P; Walter, W; Marszalek, J; Craig, EA				Liu, QL; D'Silva, P; Walter, W; Marszalek, J; Craig, EA			Regulated cycling of mitochondrial Hsp70 at the protein import channel	SCIENCE			English	Article							MATRIX; MOTOR; ATP; DISSOCIATION; SSC1	Hsp70 of the mitochondrial matrix (mtHsp70) provides a critical driving force for the import of proteins into mitochondria. Tim44, a peripheral inner-membrane protein, tethers it to the import channel. Here, regulated interactions were found to maximize occupancy of the active, adenosine 5'-triphosphate (ATP)-bound mtHsp70 at the channel through its intrinsic high affinity for Tim44, as well as through release of adenosine diphosphate (ADP)-bound mtHsp70 from Tim44 by the cofactor Mge1. A model peptide substrate rapidly released mtHsp70 from Tim44, even in the absence of ATP hydrolysis. In vivo, the analogous interaction of translocating polypeptide would release mtHsp70 from the channel. Consistent with the ratchet model of translocation, subsequent hydrolysis of ATP would trap the polypeptide, driving import by preventing its movement back toward the cytosol.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Grad Program Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	ecraig@wisc.edu	D'Silva, Patrick/L-6653-2019	Marszalek, Jaroslaw/0000-0002-6978-1189	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM27870] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Dekker PJT, 1997, J MOL BIOL, V270, P321, DOI 10.1006/jmbi.1997.1131; Horst M, 1996, PROTEIN SCI, V5, P759; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; Schneider HC, 1996, EMBO J, V15, P5796, DOI 10.1002/j.1460-2075.1996.tb00966.x; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; VOISINE C, UNPUB; VONAHSEN O, 1995, J BIOL CHEM, V270, P29848; Weiss C, 1999, P NATL ACAD SCI USA, V96, P8890, DOI 10.1073/pnas.96.16.8890	20	137	139	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					139	141		10.1126/science.1083379	http://dx.doi.org/10.1126/science.1083379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677068				2022-12-01	WOS:000181988900051
J	Straight, AF; Cheung, A; Limouze, J; Chen, I; Westwood, NJ; Sellers, JR; Mitchison, TJ				Straight, AF; Cheung, A; Limouze, J; Chen, I; Westwood, NJ; Sellers, JR; Mitchison, TJ			Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor	SCIENCE			English	Article							CONTRACTILE RING; PROTEIN-KINASE; MAMMALIAN-CELLS; MITOTIC SPINDLE; CLEAVAGE; LOCALIZATION; MICROTUBULES; PROTEOLYSIS; ANTIBODY; MIDZONE	Completion of cell division during cytokinesis requires temporally and spatially regulated communication from the microtubule cytoskeleton to the actin cytoskeleton and the cell membrane. We identified a specific inhibitor of nonmuscle myosin II, blebbistatin, that inhibited contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly. Using blebbistatin and other drugs, we showed that exit from the cytokinetic phase of the cell cycle depends on ubiquitin-mediated proteolysis. Continuous signals from microtubules are required to maintain the position of the cleavage furrow, and these signals control the localization of myosin II independently of other furrow components.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ St Andrews, Sch Chem, St Andrews KY16 9AJ, Fife, Scotland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; University of St Andrews	Straight, AF (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 250 Longwood Ave, Boston, MA 02115 USA.	aaron_straight@hms.harvard.edu		Straight, Aaron/0000-0001-5885-7881; Chen, Irene/0000-0001-6040-7927; Westwood, Nicholas/0000-0003-0630-0138	NIGMS NIH HHS [GM23928, GM62566] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062566, R01GM023928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Cimini D, 1998, CHROMOSOMA, V107, P479, DOI 10.1007/s004120050332; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Fabbro D, 1999, PHARMACOL THERAPEUT, V82, P293, DOI 10.1016/S0163-7258(99)00005-4; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; FUJIWARA K, 1976, J CELL BIOL, V71, P848, DOI 10.1083/jcb.71.3.848; Gatti M, 2000, MICROSC RES TECHNIQ, V49, P202, DOI 10.1002/(SICI)1097-0029(20000415)49:2<202::AID-JEMT13>3.0.CO;2-8; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; HENRI JF, 2001, Patent No. 0155116; HENRI JF, 2001, Patent No. 0121596; HIRANO A, 1974, EXP CELL RES, V89, P111, DOI 10.1016/0014-4827(74)90193-1; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Rappaport R., 1996, DEV CELL BIOL SERIES, V32; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Shuster CB, 2002, CURR BIOL, V12, P854, DOI 10.1016/S0960-9822(02)00838-2; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981	32	1083	1111	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1743	1747		10.1126/science.1081412	http://dx.doi.org/10.1126/science.1081412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637748				2022-12-01	WOS:000181519500049
J	Walsh, JME; Terdiman, JP				Walsh, JME; Terdiman, JP			Colorectal cancer screening - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS ANALYSIS; OCCULT BLOOD-TEST; COLON-CANCER; FLEXIBLE SIGMOIDOSCOPY; AVERAGE-RISK; CONTROLLED-TRIAL; COLONOSCOPY; PARTICIPATION; GUIDELINES; ADHERENCE	Screening for colorectal cancer reduces mortality in individuals aged 50 years or older. A number of screening tests, including fecal occult blood tests, sigmoidoscopy, double-contrast barium enema, and colonoscopy, are recommended by professional organizations for colorectal cancer screening, yet the rates of colorectal cancer screening remain low. Questions regarding the quality of evidence for each screening test, whether screening for individuals at higher risk should be modified, the availability of the tests, and cost-effectiveness are addressed. Many potential barriers to colorectal cancer screening exist for the patient and the physician. Strategies to increase compliance for colorectal cancer screening are proposed.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walsh, JME (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, Campus Box 1793,1635 Divisadero Suite 600, San Francisco, CA 94115 USA.	Jwalsh@medicine.ucsf.edu						Anderson ML, 2000, AM J GASTROENTEROL, V95, P3418, DOI 10.1111/j.1572-0241.2000.03356.x; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82822-X; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Beeker C, 2000, J COMMUN HEALTH, V25, P263, DOI 10.1023/A:1005104406934; Bejes C, 1992, Fam Pract Res J, V12, P83; Bell CM, 1998, JAMA-J AM MED ASSOC, V279, P1015, DOI 10.1001/jama.279.13.1015; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Bini EJ, 1999, ARCH INTERN MED, V159, P2022, DOI 10.1001/archinte.159.17.2022; Brenes GA, 2000, PREV MED, V31, P410, DOI 10.1006/pmed.2000.0729; Burke CA, 2001, AM J GASTROENTEROL, V96, P3175; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; DiPalma AM, 1998, SOUTHERN MED J, V91, P342, DOI 10.1097/00007611-199804000-00005; Dominitz JA, 1997, AM J GASTROENTEROL, V92, P2171; EISNER MS, 1991, ARCH INTERN MED, V151, P2180, DOI 10.1001/archinte.151.11.2180; Ellerbeck EF, 2001, J GEN INTERN MED, V16, P697, DOI 10.1046/j.1525-1497.2001.01224.x; ELWOOD TW, 1978, AM J PUBLIC HEALTH, V68, P135, DOI 10.2105/AJPH.68.2.135; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; HARDCASTLE JD, 1986, CANCER-AM CANCER SOC, V58, P397, DOI 10.1002/1097-0142(19860715)58:2<397::AID-CNCR2820580235>3.0.CO;2-X; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; HARDCASTLE JD, 1983, LANCET, V2, P1; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P961, DOI 10.1093/oxfordjournals.aje.a117744; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; KELLY RB, 1992, MED CARE, V30, P1029, DOI 10.1097/00005650-199211000-00006; Khandker RK, 2000, INT J TECHNOL ASSESS, V16, P799, DOI 10.1017/S0266462300102077; KING J, 1992, AUST NZ J SURG, V62, P714, DOI 10.1111/j.1445-2197.1992.tb07068.x; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LALLEMAND RC, 1984, BRIT MED J, V288, P31, DOI 10.1136/bmj.288.6410.31; LEE C Y, 1991, Yonsei Medical Journal, V32, P131; LEE FI, 1983, BRIT J CANCER, V48, P843, DOI 10.1038/bjc.1983.275; Lemon S, 2001, AM J PUBLIC HEALTH, V91, P1264, DOI 10.2105/AJPH.91.8.1264; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Ling BS, 2001, J GEN INTERN MED, V16, P822, DOI 10.1046/j.1525-1497.2001.10337.x; Lipkus IM, 1996, J COMMUN HEALTH, V21, P409, DOI 10.1007/BF01702602; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANT D, 1992, BRIT J GEN PRACT, V42, P18; MYERS RE, 1994, PREV MED, V23, P142, DOI 10.1006/pmed.1994.1020; MYERS RE, 1991, MED CARE, V29, P1039, DOI 10.1097/00005650-199110000-00009; NEALE AV, 1989, J OCCUP ENVIRON MED, V31, P1007, DOI 10.1097/00043764-198912000-00015; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Ness RM, 2000, AM J GASTROENTEROL, V95, P1800; NICHOLS S, 1986, BRIT MED J, V293, P107, DOI 10.1136/bmj.293.6539.107; Olynyk JK, 1996, MED J AUSTRALIA, V165, P74, DOI 10.5694/j.1326-5377.1996.tb124851.x; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; PLASKON PP, 1995, SOC WORK HEALTH CARE, V21, P59, DOI 10.1300/J010v21n04_04; PYE G, 1988, J EPIDEMIOL COMMUN H, V42, P66, DOI 10.1136/jech.42.1.66; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Schroy PC, 1999, GASTROENTEROLOGY, V117, P304, DOI 10.1053/gast.1999.0029900304; SLATER PE, 1985, J CLIN GASTROENTEROL, V7, P51, DOI 10.1097/00004836-198502000-00007; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; Sonnenberg A, 2002, ARCH INTERN MED, V162, P163, DOI 10.1001/archinte.162.2.163; SONTAG SJ, 1983, AM J SURG, V145, P89, DOI 10.1016/0002-9610(83)90172-1; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; STRUEWING JP, 1991, AM J PREV MED, V7, P75, DOI 10.1016/S0749-3797(18)30941-3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; THOMPSON RS, 1986, MED CARE, V24, P904, DOI 10.1097/00005650-198610000-00004; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; VERNON SW, 1990, J OCCUP ENVIRON MED, V32, P46, DOI 10.1097/00043764-199001000-00013; Vernon SW, 1992, HEALTH VALUES, V16, P3; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Wagner JL, 1996, PREVENTION EARLY DET, P321; Walsh JME, 2002, PREV MED, V35, P209, DOI 10.1006/pmed.2002.1059; WEINRICH SP, 1993, GERONTOLOGIST, V33, P491, DOI 10.1093/geront/33.4.491; Weitzman ER, 2001, PREV MED, V32, P502, DOI 10.1006/pmed.2001.0838; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yamamoto M, 2000, HEPATO-GASTROENTEROL, V47, P396; 2000, MMWR MORB MORTAL WKL, V50, P162	78	95	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1297	1302		10.1001/jama.289.10.1297	http://dx.doi.org/10.1001/jama.289.10.1297			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633192	Bronze			2022-12-01	WOS:000181466500032
J	Shen, K; Bargmann, CI				Shen, K; Bargmann, CI			The immunoglobulin superfamily protein SYG-1 determines the location of specific synapses in C-elegans	CELL			English	Article							EGG-LAYING SYSTEM; CAENORHABDITIS-ELEGANS; MYOBLAST FUSION; ADHESION MOLECULE; VULVAL INDUCTION; SEX MYOBLASTS; MOTOR NEURONS; CELL LINEAGE; GENE; DROSOPHILA	During nervous system development, neurons form reproducible synapses onto specific targets. Here, we analyze the development of stereotyped synapses of the C. elegans HSNL neuron in vivo. Postsynaptic neurons and muscles were not required for accurate synaptic vesicle clustering in HSNL. Instead, vulval epithelial cells that contact HSNL act as synaptic guidepost cells that direct HSNL presynaptic vesicles to adjacent regions. The mutant syg-1(ky652) has defects in synapse formation that resemble those in animals that lack vulval epithelial cells: HSNL synaptic vesicles fail to accumulate at normal synaptic locations and form ectopic anterior clusters. syg-1 encodes an immunoglobulin superfamily protein that acts in the presynaptic HSNL axon. SYG-1 protein is localized to the site of future synapses, where it initiates synapse formation and localizes synaptic connections in response to the epithelial signal. SYG-1 is related to Drosophila IrreC and vertebrate NEPH1 proteins, which mediate cell-cell recognition in diverse developmental contexts.	Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, Box 0452, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Artero RD, 2001, DEVELOPMENT, V128, P4251; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bour BA, 2000, GENE DEV, V14, P1498; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; CASH S, 1992, J NEUROSCI, V12, P2051; CLARK SG, 1993, CELL, V74, P43, DOI 10.1016/0092-8674(93)90293-Y; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fournier-Thibault C, 1999, J NEUROSCI, V19, P1382; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HENRIKSON CK, 1974, J NEUROCYTOL, V6, P659; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Hobert O, 1998, J NEUROSCI, V18, P2084; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; LI C, 1990, NEURON, V4, P681, DOI 10.1016/0896-6273(90)90195-L; Mello C, 1995, METHOD CELL BIOL, V48, P451; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; POURQUIE O, 1992, J NEUROSCI, V12, P1548; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	56	218	224	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					619	630		10.1016/S0092-8674(03)00113-2	http://dx.doi.org/10.1016/S0092-8674(03)00113-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628183	Bronze			2022-12-01	WOS:000181443600006
J	Oda, Y; Hosokawa, N; Wada, I; Nagata, K				Oda, Y; Hosokawa, N; Wada, I; Nagata, K			EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin	SCIENCE			English	Article							MANNOSIDASE-LIKE PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; QUALITY-CONTROL; CALRETICULIN; YEAST	Terminally misfolded proteins in the endoplasmic reticulum (ER) are retro-translocated to the cytoplasm and degraded by proteasomes through a mechanism known as ER-associated degradation (ERAD). EDEM, a postulated Man8B-binding protein, accelerates the degradation of misfolded proteins in the ER. Here, EDEM was shown to interact with calnexin, but not with calreticulin, through its transmembrane region. Both binding of substrates to calnexin and their release from calnexin were required for ERAD to occur. Overexpression of EDEM accelerated ERAD by promoting the release of terminally misfolded proteins from calnexin. Thus, EDEM appeared to function in the ERAD pathway by accepting substrates from calnexin.	Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan; Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan	Kyoto University; Japan Science & Technology Agency (JST); Sapporo Medical University	Nagata, K (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan.			Wada, Ikuo/0000-0001-5668-6994				Braakman I, 2001, EMBO REP, V2, P666, DOI 10.1093/embo-reports/kve162; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; CARBRAL CM, 2002, MOL BIOL CELL, V13, P2639; CARBRAL CM, 2001, TRENDS BIOCHEM SCI, V26, P619; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Danilczyk UG, 2000, J BIOL CHEM, V275, P13089, DOI 10.1074/jbc.275.17.13089; ELLGARD L, 2001, CURR OPIN CELL BIOL, V11, P120; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; ODA Y, UNPUB; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	27	360	375	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1394	1397		10.1126/science.1079181	http://dx.doi.org/10.1126/science.1079181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610305				2022-12-01	WOS:000181192300052
J	McCulloch, M; Fallon, S; Wyndham, T; Hendy, E; Lough, J; Barnes, D				McCulloch, M; Fallon, S; Wyndham, T; Hendy, E; Lough, J; Barnes, D			Coral record of increased sediment flux to the inner Great Barrier Reef since European settlement	NATURE			English	Article							PHASE-SHIFTS; MASSIVE CORALS; PERSPECTIVES; IMPACTS; ISSUES; BANDS; WATER	The effect of European settlement on water quality in the Great Barrier Reef of Australia is a long-standing and controversial issue(1-6). Erosion and sediment transport in river catchments in this region have increased substantially since European settlement(6-10), but the magnitude of these changes remains uncertain(1-10). Here we report analyses of Ba/Ca ratios in long-lived Porites coral from Havannah Reef-a site on the inner Great Barrier Reef that is influenced by flood plumes from the Burdekin river-to establish a record of sediment fluxes from about 1750 to 1998. We find that, in the early part of the record, suspended sediment from river floods reached the inner reef area only occasionally, whereas after about 1870-following the beginning of European settlement-a five- to tenfold increase in the delivery of sediments is recorded with the highest fluxes occurring during the drought-breaking floods. We conclude that, since European settlement, land-use practices such as clearing and overstocking have led to major degradation of the semi-arid river catchments, resulting in substantially increased sediment loads entering the inner Great Barrier Reef.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian National University; Australian Institute of Marine Science	McCulloch, M (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	Malcom.McCulloch@anu.edu.au	Fallon, Stewart J/G-6645-2011; Lough, Janice M/L-1682-2013; Hendy, Erica J/H-4488-2016; McCulloch, Malcolm T/C-3651-2009	Fallon, Stewart J/0000-0002-8064-5903; Lough, Janice M/0000-0002-3789-1009; Hendy, Erica J/0000-0001-5949-4349; McCulloch, Malcolm T/0000-0003-1538-1558				ALIBERT C, IN PRESS GEOCHIM COS; Ash A. J., 1997, Rangeland Journal, V19, P123, DOI 10.1071/RJ9970123; Barnes DJ, 2001, CORAL REEFS, V19, P221, DOI 10.1007/PL00006958; BELL PR, 1991, MAR POLLUT BULL, V23, P89, DOI 10.1016/0025-326X(91)90655-C; BELPERIO AP, 1983, BMR J AUST GEOL GEOP, V8, P179; Devlin M., 2001, GREAT BARRIER REEF M; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Fallon SJ, 2002, GEOCHIM COSMOCHIM AC, V66, P45, DOI 10.1016/S0016-7037(01)00715-3; Furnas M, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P37; Haynes D, 2000, MAR POLLUT BULL, V41, P428, DOI 10.1016/S0025-326X(00)00150-8; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; HOLMES JM, 1963, AUSTR OPEN N; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; Larcombe P, 1999, CORAL REEFS, V18, P163, DOI 10.1007/s003380050174; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; LI YH, 1979, EARTH PLANET SC LETT, V43, P343, DOI 10.1016/0012-821X(79)90089-X; LOUGH JM, IN PRESS HOLOCENE RE; McCook LJ, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P113; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; Moore WS, 1999, MAR CHEM, V65, P111, DOI 10.1016/S0304-4203(99)00014-6; Moss AJ, 1993, PRELIMINARY ASSESSME; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Prosser IP, 2001, MAR FRESHWATER RES, V52, P81, DOI 10.1071/MF00033; SHEN GT, 1990, GLOBAL ECOLOGICAL CO, P255, DOI DOI 10.1016/S0422-9894(08)70038-2; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SMITH SV, 1981, PAC SCI, V35, P279; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245	30	528	547	2	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					727	730		10.1038/nature01361	http://dx.doi.org/10.1038/nature01361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610621				2022-12-01	WOS:000180938000039
J	Abbott, A				Abbott, A			Human fatality adds fresh impetus to fight against bird flu	NATURE			English	News Item																		2003, NATURE, V422, P247	1	10	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					5	5		10.1038/423005b	http://dx.doi.org/10.1038/423005b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721589	Bronze			2022-12-01	WOS:000182561600007
J	Chacron, MJ; Doiron, B; Maler, L; Longtin, A; Bastian, J				Chacron, MJ; Doiron, B; Maler, L; Longtin, A; Bastian, J			Non-classical receptive field mediates switch in a sensory neuron's frequency tuning	NATURE			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; GYMNOTIFORM FISH; SPIKE TRAINS; SIGNALS; REPRESENTATION; COMMUNICATION; ORGANIZATION; MECHANISMS; AFFERENTS	Animals have developed stereotyped communication calls to which specific sensory neurons are well tuned(1,2). These communication calls must be discriminated from environmental signals such as those produced by prey. Sensory systems might have evolved neural circuitry to encode both categories. In weakly electric fish, prey and communication signals differ in their spatial extent and frequency content(3,4). Here we show that stimuli of different spatial extents mimicking prey and communication signals cause a switch in the frequency tuning and spike-timing precision of electrosensory pyramidal neurons, resulting in the selective and optimal encoding of both stimulus categories. As in other sensory systems(5), pyramidal neurons respond only to stimuli located within a restricted region of space known as the classical receptive field (CRF)(6). In some systems, stimulation outside the CRF but within a non-classical receptive field (nCRF) can modulate the neural response to CRF stimulation even though nCRF stimulation alone fails to elicit responses(7,8). We show that pyramidal neurons possess a nCRF and that it can modulate the response to CRF stimuli to induce this neurobiological switch in frequency tuning.	Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Ottawa; University of Ottawa; University of Oklahoma System; University of Oklahoma - Norman	Chacron, MJ (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.		Longtin, Andre/D-2443-2009	Chacron, Maurice/0000-0002-3032-452X				BASTCHELET E, 1981, CIRCULAR STAT BIOL; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1981, J COMP PHYSIOL, V144, P465, DOI 10.1007/BF01326832; Berman NJ, 1999, J EXP BIOL, V202, P1243; Bialek W., 1996, SPIKES EXPLORING NEU; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; CARR CE, 1982, J COMP NEUROL, V211, P139, DOI 10.1002/cne.902110204; Crampton William G. R., 1998, Anais da Academia Brasileira de Ciencias, V70, P805; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gabbiani F, 1996, NETWORK-COMP NEURAL, V7, P61, DOI 10.1080/0954898X.1996.11978655; HEILIGENBERG W, 1982, J COMP PHYSIOL, V148, P287, DOI 10.1007/BF00679013; Heiligenberg W., 1991, NEURAL NETS ELECT FI; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MALER L, 1994, J COMP NEUROL, V345, P224, DOI 10.1002/cne.903450206; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; METZNER W, 1991, J COMP PHYSIOL A, V169, P135, DOI 10.1007/BF00215861; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; Nelson ME, 1999, J EXP BIOL, V202, P1195; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; Zhang H, 1999, J COMP PHYSIOL A, V184, P85, DOI 10.1007/s003590050308; ZUPANC GKH, 1993, CAN J ZOOL, V71, P2301, DOI 10.1139/z93-323	30	143	144	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					77	81		10.1038/nature01590	http://dx.doi.org/10.1038/nature01590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721628				2022-12-01	WOS:000182561600042
J	Hoag, H				Hoag, H			Atlantic cod meet icy death	NATURE			English	News Item																		Marsh R, 1999, FISH OCEANOGR, V8, P39, DOI 10.1046/j.1365-2419.1999.00092.x	1	18	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					792	792		10.1038/422792b	http://dx.doi.org/10.1038/422792b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712158	Bronze			2022-12-01	WOS:000182432600009
J	Vassilopoulos, G; Wang, PR; Russell, DW				Vassilopoulos, G; Wang, PR; Russell, DW			Transplanted bone marrow regenerates liver by cell fusion	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; FOAMY VIRUS VECTORS; FUMARYLACETOACETATE HYDROLASE; HEPATIC-DYSFUNCTION; KUPFFER CELLS; MOUSE-LIVER; ORIGIN; HEPATOCYTES; PHENOTYPE; KINETICS	Results from several experimental systems suggest that cells from one tissue type can form other tissue types after transplantation. This could be due to the presence of multipotential or several types of adult stem cells in donor tissues, or alternatively, to fusion of donor and recipient cells. In a model of tyrosinaemia type I, mice with mutations in the fumarylacetoacetate hydrolase gene (Fah(-/-)) regain normal liver function after transplantation of Fah(+/+) bone marrow cells, and form regenerating liver nodules with normal histology that express Fah(1). Here we show that these hepatic nodules contain more mutant than wild-type Fah alleles, and that their hepatocytes express both donor and host genes, consistent with polyploid genome formation by fusion of host and donor cells. Using bone marrow cells marked with integrated foamy virus vectors that express green fluorescent protein, we identify common proviral junctions in hepatic nodules and haematopoietic cells. We also show that the haematopoietic donor genome adopts a more hepatocyte-specific expression profile after cell fusion, as the wild-type Fah gene was activated and the pan-haematopoietic CD45 marker was no longer expressed.	Univ Washington, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.		Vassilopoulos, George/AAK-8069-2020					ARIAS IM, 1994, LIVER; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BOHM N, 1981, HISTOCHEMISTRY, V72, P55, DOI 10.1007/BF00496779; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; GALE RP, 1978, SCIENCE, V201, P937, DOI 10.1126/science.356266; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; GROMPE M, 1992, BIOCHEM MED METAB B, V48, P26, DOI 10.1016/0885-4505(92)90044-Y; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Josephson NC, 2002, P NATL ACAD SCI USA, V99, P8295, DOI 10.1073/pnas.122131099; KERBEL RS, 1983, MOL CELL BIOL, V3, P523, DOI 10.1128/MCB.3.4.523; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P592, DOI 10.1073/pnas.58.2.592; PARADIS K, 1990, J PEDIATR GASTR NUTR, V11, P525, DOI 10.1097/00005176-199011000-00014; PARWARESCH MR, 1986, VIRCHOWS ARCH B, V51, P89, DOI 10.1007/BF02899019; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Vassilopoulos G, 2001, BLOOD, V98, P604, DOI 10.1182/blood.V98.3.604; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; WIENER F, 1974, P NATL ACAD SCI USA, V71, P148, DOI 10.1073/pnas.71.1.148; WIENER F, 1972, NATURE-NEW BIOL, V238, P155, DOI 10.1038/newbio238155a0; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; ZAKIM D, 1990, HEPATOLOGY	26	1002	1093	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					901	904		10.1038/nature01539	http://dx.doi.org/10.1038/nature01539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12665833				2022-12-01	WOS:000182432600057
J	Schroder, R				Schroder, R			The genes orthodenticle and hunchback substitute for bicoid in the beetle Tribolium	NATURE			English	Article							DROSOPHILA EMBRYO; AXIS FORMATION; EXPRESSION; ANTERIOR; SEGMENTATION; INSECTS; RNA; PROTEIN; ELEGANS; PATTERN	In Drosophila, the morphogen Bicoid organizes anterior patterning in a concentration-dependent manner by activating the transcription of target genes such as orthodenticle (otd)(1) and hunchback (hb), and by repressing the translation of caudal(2),(3). Homologues of the bicoid gene have not been isolated in any organism apart from the higher Dipterans(4-7). In fact, head and thorax formation in other insects is poorly understood. To elucidate this process in a short-germband insect, I analysed the function of the conserved genes orthodenticle-1 (otd-1) and hb in the flour beetle Tribolium castaneum. Here I show that, in contrast to Drosophila, Tribolium otd-1 messenger RNA is maternally inherited by the embryo. Reduction of Tribolium otd-1 levels by RNA interference (RNAi) results in headless embryos. This shows that otd-1 is required for anterior patterning in Tribolium. As in Drosophila, Tribolium hb specifies posterior gnathal and thoracic segments. The head, thorax and the anterior abdomen fail to develop in otd-1/hb double-RNAi embryos. This phenotype is similar to that of strong bicoid mutants in Drosophila. I propose that otd-1 and hb are part of an ancestral anterior patterning system.	Univ Tubingen, Interfak Inst Zellbiol, Abt Genet Tiere, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schroder, R (corresponding author), Univ Tubingen, Interfak Inst Zellbiol, Abt Genet Tiere, Morgenstelle 28, D-72076 Tubingen, Germany.			Schroder, Reinhard/0000-0002-3483-1916				Brown S, 2001, CURR BIOL, V11, pR43, DOI 10.1016/S0960-9822(01)00007-0; Brown SJ, 1999, EVOL DEV, V1, P11, DOI 10.1046/j.1525-142x.1999.99013.x; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; COHEN S, 1991, TRENDS GENET, V7, P267; Dearden P, 1999, CURR BIOL, V9, pR591, DOI 10.1016/S0960-9822(99)80381-9; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Falciani F, 1996, P NATL ACAD SCI USA, V93, P8479, DOI 10.1073/pnas.93.16.8479; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Gao Q, 1998, DEVELOPMENT, V125, P4185; Isaacs HV, 1999, EVOL DEV, V1, P143, DOI 10.1046/j.1525-142x.1999.99020.x; Lall S, 2003, CURR BIOL, V13, P224, DOI 10.1016/S0960-9822(03)00045-9; Lall S, 2001, ANNU REV GENET, V35, P407, DOI 10.1146/annurev.genet.35.102401.090832; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Li YB, 1996, DEV GENES EVOL, V206, P35, DOI 10.1007/s004270050028; Niessing D, 2000, MOL CELL, V5, P395, DOI 10.1016/S1097-2765(00)80434-7; Patel NH, 2001, DEVELOPMENT, V128, P3459; Pultz MA, 1999, DEVELOPMENT, V126, P701; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; SCHRODER R, 1993, ROUX ARCH DEV BIOL, V203, P34, DOI 10.1007/BF00539888; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SOMMER R, 1991, DEVELOPMENT, V113, P419; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; STJOHNSTON D, 1992, CELL, V68, P201; TAUTZ D, 1994, DEVELOPMENT, P193; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Wolff C, 1995, DEVELOPMENT, V121, P4227	30	140	147	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					621	625		10.1038/nature01536	http://dx.doi.org/10.1038/nature01536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687002				2022-12-01	WOS:000182111400044
J	Dutzler, R; Campbell, EB; MacKinnon, R				Dutzler, R; Campbell, EB; MacKinnon, R			Gating the selectivity filter in ClC chloride channels	SCIENCE			English	Article							TORPEDO ELECTROPLAX; MOLECULAR-BASIS; K+ CHANNEL; CONDUCTION; MECHANISM; RECEPTOR; CLONING; ANION	ClC channels conduct chloride (Cl-) ions across cell membranes and thereby govern the electrical activity of muscle cells and certain neurons, the transport of fluid and electrolytes across epithelia, and the acidification of intracellular vesicles. The structural basis of ClC channel gating was studied. Crystal structures of wild-type and mutant Escherichia coli ClC channels bound to a monoclonal Fab fragment reveal three Cl- binding sites within the 15-angstrom neck of an hourglass-shaped pore. The Cl- binding site nearest the extracellular solution can be occupied either by a Cl- ion or by a glutamate carboxyl group. Mutations of this glutamate residue in Torpedo ray ClC channels alter gating in electrophysiological assays. These findings reveal a form of gating in which the glutamate carboxyl group closes the pore by mimicking a Cl- ion.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu						Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Harlow E., 1989, ANTIBODIES LAB MANUA; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Miller C., 1980, Annals of the New York Academy of Sciences, V341, P534, DOI 10.1111/j.1749-6632.1980.tb47197.x; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	619	640	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					108	112		10.1126/science.1082708	http://dx.doi.org/10.1126/science.1082708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12649487				2022-12-01	WOS:000181988900042
J	Faivre, B; Gregoire, A; Preault, M; Cezilly, F; Sorci, G				Faivre, B; Gregoire, A; Preault, M; Cezilly, F; Sorci, G			Immune activation rapidly mirrored in a secondary sexual trait	SCIENCE			English	Article							CAROTENOIDS		Univ Bourgogne, CNRS, UMR Biogeosci 5561, Equipe Ecol Evolut, F-21000 Dijon, France; Univ Paris 06, CNRS, UMR 7103, Lab Parasitol Evolut, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Faivre, B (corresponding author), Univ Bourgogne, CNRS, UMR Biogeosci 5561, Equipe Ecol Evolut, 6 Blvd Gabriel, F-21000 Dijon, France.	bfaivre@u-bourgogne.fr	Gregoire, Arnaud/B-6321-2008	Gregoire, Arnaud/0000-0001-6103-355X; Sorci, Gabriele/0000-0002-0799-3995				Andersson Malte, 1994; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bright A, 2002, ANIM BEHAV, V64, P207, DOI 10.1006/anbe.2002.3042; Faivre B, 2001, ANIM BEHAV, V61, P969, DOI 10.1006/anbe.2000.1669; JYONOUCHI H, 1994, NUTR CANCER, V21, P47, DOI 10.1080/01635589409514303; Mortensen A, 1997, FEBS LETT, V418, P91, DOI 10.1016/S0014-5793(97)01355-0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0	7	333	339	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					103	103		10.1126/science.1081802	http://dx.doi.org/10.1126/science.1081802			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677062				2022-12-01	WOS:000181988900040
J	Strauss, SH				Strauss, SH			Genetic technologies - Genomics, genetic engineering, and domestication of crops	SCIENCE			English	Editorial Material							TOLERANCE; BIOLOGY		Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA	Oregon State University	Strauss, SH (corresponding author), Oregon State Univ, Dept Forest Sci, Peavy Hall 154, Corvallis, OR 97331 USA.	Steve.Strauss@orst.edu						[Anonymous], 1982, AM HERITAGE DICT, VThird; Bennetzen J, 2002, SCIENCE, V296, P60, DOI 10.1126/science.1071402; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; DUVICK D, 2001, COMMUNICATION; HANCOCK J, COMMUNICATION; KAUFMAN M, 2001, WASHINGTON POST 0301, pA17; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; *NAT RES COUNC, 2002, ENV EFF TRANSG PLANT; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yeo A, 1998, J EXP BOT, V49, P915, DOI 10.1093/jexbot/49.323.915; 2002, FED REG, V68, P50578	12	51	53	3	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2003	300	5616					61	62		10.1126/science.1079514	http://dx.doi.org/10.1126/science.1079514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677045				2022-12-01	WOS:000181988900023
J	Schober, SE; Sinks, TH; Jones, RL; Bolger, PM; McDowell, M; Osterloh, J; Garrett, ES; Canady, RA; Dillon, CF; Sun, Y; Joseph, CB; Mahaffey, KR				Schober, SE; Sinks, TH; Jones, RL; Bolger, PM; McDowell, M; Osterloh, J; Garrett, ES; Canady, RA; Dillon, CF; Sun, Y; Joseph, CB; Mahaffey, KR			Blood mercury levels in US children and women of childbearing age, 1999-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHYLMERCURY EXPOSURE; FISH CONSUMPTION; POPULATION; DISEASE; HAIR	Context Humans are exposed to methylmercury, a well-established neurotoxin, through fish consumption. The fetus is most sensitive to the adverse effects of, exposure. The extent of exposure to methylmercury in US women of reproductive age is not known. Objective To describe the distribution of blood mercury levels in US children and women of childbearing age and the association with sociodemographic characteristics and fish consumption. Design and Setting The 1999-2000 data from, the National Health and Nutrition Examination Survey, a cross-sectional survey of the noninstitutionalized US population. Participants In 1999-2000,1250 children aged 1 to 5 years and 2314 women aged 16 to 49 years were selected to participate in the survey. Household interviews, physical examinations, and blood mercury levels assessments were performed on 705 children (56% response rate) and 1709 women (74% response rate). Main Outcome Measure Blood concentration of total mercury. Results Blood mercury levels were approximately 3-fold higher in women compared with children. The geometric mean concentration of total blood mercury was 0.34 mug/L (95% confidence interval [CI], 0.30-0.39 mug/L) in children and 1.02 mug/L (95% Cl, 0.85-1.20 mug/L) in women. Geometric mean mercury levels were almost 4-fold higher among women who ate 3 or more servings of fish in the past 30 days compared with women who ate no fish in that period (1.94 mug/L vs 0.51 mug/L; P<.001). Conclusions Measures of mercury exposure in women of childbearing age and young children generally fall below levels of concern. However, approximately 8% of women had concentrations higher than the US Environmental Protection Agency's recommended reference dose (5.8 &mu;g/L), below which exposures are considered to be without adverse effects. Women who are pregnant or who intend to become pregnant should follow federal and state advisories on consumption of fish.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA; Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Pascagoula, MS USA; Orkand Corp, Falls Church, VA USA; US EPA, Off Sci Coordinat & Policy, Off Prevent Pesticides & Tox Subst, Washington, DC 20460 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; United States Environmental Protection Agency	Schober, SE (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4210, Hyattsville, MD 20782 USA.	sschober@cdc.gov						ABERG B, 1969, ARCH ENVIRON HEALTH, V19, P478, DOI 10.1080/00039896.1969.10666872; Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC UPD; BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; Bellanger T M, 2000, J La State Med Soc, V152, P64; BRUNE D, 1991, SCI TOTAL ENVIRON, V100, P235, DOI 10.1016/0048-9697(91)90380-W; Burge P, 1994, J Ark Med Soc, V90, P542; *CDCP, 2 NAT REP HUM EXP EN; Chen HP, 1998, ATOM SPECTROSC, V19, P176; *CTR FOOD SAF APPL, IMP MESS PREGN WOM W; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Elinder C.G., 1994, BIOL MONITORING META; *FOOD STAND AG, 2003, AG UPD ADV PREGN BRE; Gerstenberger SL, 1997, J TOXICOL-CLIN TOXIC, V35, P377, DOI 10.3109/15563659709043370; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Hall RA, 1978, SSRF721 NOAA NMFS; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kjellstrom T, 1989, 3642 NAT SWED ENV PR; KNOBELOCH LM, 1995, ENVIRON HEALTH PERSP, V103, P604, DOI 10.2307/3432438; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Mahaffey KR, 1999, PUBLIC HEALTH REP, V114, P397, DOI 10.1093/phr/114.5.397; Miettinen J. -K., 1973, MERCURY MERCURIALS M, P233; National Academy of Sciences, 2000, TOX EFF METH; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Seifert B, 2000, J EXPO ANAL ENV EPID, V10, P552, DOI 10.1038/sj.jea.7500111; SHERLOCK J, 1984, HUM TOXICOL, V3, P117, DOI 10.1177/096032718400300205; Stern AH, 2001, ARCH ENVIRON HEALTH, V56, P4, DOI 10.1080/00039890109604048; Toffleson L, 1986, ENV HLTH PERSPECT, V68, P203; Tsubaki T, 1977, MINAMATA DIS; *US EPA, 1997, MERC STUD REP C, V1; *US EPA, 2002, FISH ADV; *WHO, 1990, WHO ENV HLTH CRIT, V101; CANADA FOOD INSPECTI	35	220	227	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1667	1674		10.1001/jama.289.13.1667	http://dx.doi.org/10.1001/jama.289.13.1667			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672735	Bronze			2022-12-01	WOS:000181944500030
J	Tran, SD; Pillemer, SR; Dutra, A; Barrett, AJ; Brownstein, MJ; Key, S; Pak, E; Leakan, RA; Kingman, A; Yamada, KM; Baum, BJ; Mezey, E				Tran, SD; Pillemer, SR; Dutra, A; Barrett, AJ; Brownstein, MJ; Key, S; Pak, E; Leakan, RA; Kingman, A; Yamada, KM; Baum, BJ; Mezey, E			Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study	LANCET			English	Article							HEMATOPOIETIC STEM-CELLS; OSTEOGENESIS IMPERFECTA; MESENCHYMAL CELLS; TRANSPLANTS; CHILDREN; FUSION	Background Adult bone marrow-derived (BMD) cells could be used to repair damaged organs and tissues, but the intrinsic plasticity of these cells has been questioned by results of in-vitro studies suggesting that such cells might fuse with other cells giving the appearance of differentiation. We aimed to determine whether fusion events are important in vivo. Methods To test whether BMD cells can colonise an epithelial tissue and differentiate there without fusion, we did in-situ hybridisation with Y and X chromosome probes labelled with 35-sulphur or digoxigenin, or labelled fluorescently. We did immunohistochemistry with anticytokeratin 13 along with fluorescence in-situ hybridisation to identify Y-chromosome positive buccal epithelial cells in cheek scrapings obtained from five females who had received either a bone-marrow transplant or an allogeneic mobilised peripheral-blood progenitor-cell transplant (enriched in CD34+ cells) from male donors. Findings When examined 4-6 years after male-to-female marrow-cell transplantation, all female recipients had Y-chromosome-positive buccal cells (0.8-12.7%). In more than 9700 cells studied, we detected only one XXXY-positive cell (0.01%) and one XXY cell (0.01%), both of which could have arisen when an XY cell fused with an XX cell. Interpretation Male BMD cells migrate into the cheek and differentiate into epithelial cells, an occurrence that does not depend on fusion of BMD cells to recipient cells. This finding might be an example of transdifferentiation of haemopoietic or stromal progenitor cells. Plasticity of BMD cells could be useful in regenerative medicine.	NIDCR, NIH, Gene Therapy & Therapeut Branch, Bethesda, MD 20892 USA; NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD USA; NIDCR, Biostat Core, NIH, Bethesda, MD USA; NHGRI, Cytogenet Core, NIH, Bethesda, MD 20892 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NIMH, Genet Lab, NIH, Bethesda, MD 20892 USA; NINDS, Basic Neurosci Programme, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tran, SD (corresponding author), NIDCR, NIH, Gene Therapy & Therapeut Branch, 10 Ctr Dr,Room 1N113,MSC 1190, Bethesda, MD 20892 USA.	stran@dir.nidcr.nih.gov	Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691; Yamada, Kenneth/0000-0003-1512-6805	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002342, Z01HL002342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000525, Z01DE000336, ZIADE000336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002996] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abkowitz JL, 2002, NEW ENGL J MED, V346, P770, DOI 10.1056/NEJM200203073461012; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Brouard M, 2002, NEW ENGL J MED, V347, P218; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; Fogt F, 2002, HEPATOLOGY, V36, P173, DOI 10.1053/jhep.2002.33994; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; *LAB CELL MOL REC, 2003, SECT NEUR GEN EXPR; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wells WA, 2002, J CELL BIOL, V157, P15, DOI 10.1083/jcb.200203037; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	18	133	144	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 29	2003	361	9363					1084	1088		10.1016/S0140-6736(03)12894-2	http://dx.doi.org/10.1016/S0140-6736(03)12894-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672312				2022-12-01	WOS:000181865200010
J	Watkins, DN; Berman, DM; Burkholder, SG; Wang, BL; Beachy, PA; Baylin, SB				Watkins, DN; Berman, DM; Burkholder, SG; Wang, BL; Beachy, PA; Baylin, SB			Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer	NATURE			English	Article							SONIC HEDGEHOG; CYCLOPAMINE; INHIBITION; GROWTH; SHH; MEDULLOBLASTOMA; DIFFERENTIATION; MORPHOGENESIS; CEREBELLUM; MUTANTS	Embryonic signalling pathways regulate progenitor cell fates in mammalian epithelial development and cancer(1,2). Prompted by the requirement for sonic hedgehog (Shh) signalling in lung development(3,4), we investigated a role for this pathway in regeneration and carcinogenesis of airway epithelium. Here we demonstrate extensive activation of the hedgehog (Hh) pathway within the airway epithelium during repair of acute airway injury. This mode of Hh signalling is characterized by the elaboration and reception of the Shh signal within the epithelial compartment, and immediately precedes neuroendocrine differentiation. We reveal a similar pattern of Hh signalling in airway development during normal differentiation of pulmonary neuroendocrine precursor cells, and in a subset of small-cell lung cancer (SCLC), a highly aggressive and frequently lethal human tumour with primitive neuroendocrine features. These tumours maintain their malignant phenotype in vitro and in vivo through ligand-dependent Hh pathway activation. We propose that some types of SCLC might recapitulate a critical, Hh-regulated event in airway epithelial differentiation. This requirement for Hh pathway activation identifies a common lethal malignancy that may respond to pharmacological blockade of the Hh signalling pathway.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Watkins, DN (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.		Watkins, David N/I-6113-2013	berman, david/0000-0001-5985-3698				Bellusci S, 1997, DEVELOPMENT, V124, P53; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hogan B., 2014, MANIPULATING MOUSE E; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Johnson DH, 1999, CHEST, V116, p525S, DOI 10.1378/chest.116.suppl_3.525S; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lee J, 1997, DEVELOPMENT, V124, P2537; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park HL, 2000, DEVELOPMENT, V127, P1593; Peake JL, 2000, AM J PATHOL, V156, P279, DOI 10.1016/S0002-9440(10)64728-1; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	30	876	973	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					313	317		10.1038/nature01493	http://dx.doi.org/10.1038/nature01493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12629553				2022-12-01	WOS:000181637300040
J	Meneghini, MD; Wu, M; Madhani, HD				Meneghini, MD; Wu, M; Madhani, HD			Conserved histone variant H2A.Z protects euchromatin from the ectopic spread of silent heterochromatin	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; GENE-EXPRESSION; ACTIVE GENES; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; YEAST; CHROMATIN; H3; METHYLATION	Boundary elements hinder the spread of heterochromatin, yet these sites do not fully account for the preservation of adjacent euchromatin. Histone variant H2A.Z (Htz1 in yeast) replaces conventional H2A in many nucleosomes. Microarray analysis revealed that HTZ1-activated genes cluster near telomeres. The reduced expression of most of these genes in htz1Delta cells was reversed by the deletion of SIR2 (sir2Delta) suggesting that H2A.Z antagonizes telomeric silencing. Other Htz1-activated genes flank the silent HMR mating-type locus. Their requirement for Htz1 can be bypassed by sir2Delta or by a deletion encompassing the silencing nucleation sites in HMR. In htz1Delta cells, Sir2 and Sir3 spread into flanking euchromatic regions, producing changes in histone H4 acetylation and H3 4-methylation indicative of ectopic heterochromatin formation. Htz1 is enriched in these euchromatic regions and acts synergistically with a boundary element to prevent the spread of heterochromatin. Thus, euchromatin and heterochromatin each contains components that antagonize switching to the opposite chromatin state.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Madhani, Hiten/0000-0001-7400-6657				Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1998, GENETICS, V149, P1205; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	53	480	496	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					725	736		10.1016/S0092-8674(03)00123-5	http://dx.doi.org/10.1016/S0092-8674(03)00123-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628191	Bronze			2022-12-01	WOS:000181443600014
J	White, AR; Enever, P; Tayebi, M; Mushens, R; Linehan, J; Brandner, S; Anstee, D; Collinge, J; Hawke, S				White, AR; Enever, P; Tayebi, M; Mushens, R; Linehan, J; Brandner, S; Anstee, D; Collinge, J; Hawke, S			Monoclonal antibodies inhibit prion replication and delay the development of prion disease	NATURE			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE AGENT; INCUBATION PERIOD; MICE LACKING; VARIANT CJD; CONGO RED; PROTEIN; PRP; ACCUMULATION	Prion diseases such as Creutzfeldt-Jakob disease (CJD) are fatal, neuro-degenerative disorders with no known therapy. A proportion of the UK population has been exposed to a bovine spongiform encephalopathy-like prion strain(1-3) and are at risk of developing variant CJD(4). A hallmark of prion disease is the transformation of normal cellular prion protein (PrP(C)) into an infectious disease-associated isoform(5), PrP(Sc). Recent in vitro studies indicate that anti-PrP monoclonal antibodies with little or no affinity for PrP(Sc) can prevent the incorporation of PrP(C) into propagating prions(6,7). We therefore investigated in a murine scrapie model whether anti-PrP monoclonal antibodies show similar inhibitory effects on prion replication in vivo. We found that peripheral PrP(Sc) levels and prion infectivity were markedly reduced, even when the antibodies were first administered at the point of near maximal accumulation of PrP(Sc) in the spleen. Furthermore, animals in which the treatment was continued remained healthy for over 300 days after equivalent untreated animals had succumbed to the disease. These findings indicate that immunotherapeutic strategies for human prion diseases are worth pursuing.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci & Psychol Med, Dept Neurogenet,CNS Infect & Immun Grp, London W2 1PG, England; Natl Blood Serv, IBGRL, Bristol BS10 5ND, Avon, England; UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	Imperial College London; University of London; University College London; University of London; University College London	Hawke, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci & Psychol Med, Dept Neurogenet,CNS Infect & Immun Grp, Norfolk Pl, London W2 1PG, England.	s.hawke@imperial.ac.uk	TAYEBI, MOURAD/F-7404-2010; Brandner, Sebastian/J-4562-2014; White, Anthony/P-5596-2016	Brandner, Sebastian/0000-0002-9821-0342; White, Anthony/0000-0003-1802-9891; TAYEBI, MOURAD/0000-0001-8664-6918				ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; AVENT ND, 1988, BIOCHEM J, V256, P1043, DOI 10.1042/bj2561043; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beringue V, 2000, J VIROL, V74, P5432, DOI 10.1128/JVI.74.12.5432-5440.2000; BERINGUE V, UNPUB BRAIN; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Brown P, 2002, NEUROLOGY, V58, P1720, DOI 10.1212/WNL.58.12.1720; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; MCKENZIE D, 1994, J VIROL, V68, P7534, DOI 10.1128/JVI.68.11.7534-7536.1994; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Souan L, 2001, EUR J IMMUNOL, V31, P2338, DOI 10.1002/1521-4141(200108)31:8&lt;2338::AID-IMMU2338&gt;3.0.CO;2-V; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Westaway D, 2002, TRENDS BIOCHEM SCI, V27, P301, DOI 10.1016/S0968-0004(02)02106-0; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	30	382	410	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					80	83		10.1038/nature01457	http://dx.doi.org/10.1038/nature01457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621436				2022-12-01	WOS:000181343100041
J	Hamm, CE; Merkel, R; Springer, O; Jurkojc, P; Maier, C; Prechtel, K; Smetacek V				Hamm, CE; Merkel, R; Springer, O; Jurkojc, P; Maier, C; Prechtel, K; Smetacek, V			Architecture and material properties of diatom shells provide effective mechanical protection	NATURE			English	Article							ZOOPLANKTON; MORPHOLOGY; FRUSTULE; SILICA; CYCLE; BONE	Diatoms are the major contributors to phytoplankton blooms in lakes and in the sea and hence are central in aquatic ecosystems and the global carbon cycle(1). All free-living diatoms differ from other phytoplankton groups in having silicified cell walls in the form of two 'shells' (the frustule) of manifold shape and intricate architecture(2) whose function and role, if any, in contributing to the evolutionary success of diatoms is under debate(3-5). We explored the defence potential of the frustules as armour against predators by measuring their strength. Real and virtual loading tests (using calibrated glass microneedles and finite element analysis) were performed on centric and pennate diatom cells. Here we show that the frustules are remarkably strong by virtue of their architecture and the material properties of the diatom silica. We conclude that diatom frustules have evolved as mechanical protection for the cells because exceptional force is required to break them. The evolutionary arms race between diatoms and their specialized predators will have had considerable influence in structuring pelagic food webs and biogeochemical cycles.	Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Tech Univ Munich, Dept Phys, Biophys Grp E22, D-85748 Garching, Germany; Forschungszentrum Julich, Res Ctr, Inst Thin Films & Interfaces, D-52425 Julich, Germany; Hsch bramen Univ Appl Sci, D-28199 Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Technical University of Munich; Helmholtz Association; Research Center Julich; Bremen University of Applied Sciences	Hamm, CE (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.	chamm@awi-bremerhaven.de	Merkel, Rudolf/G-3647-2013	Merkel, Rudolf/0000-0003-3178-3282; Hamm, Christian/0000-0002-5121-9542				ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0; ATKINSON A, 1995, ICES J MAR SCI, V52, P385, DOI 10.1016/1054-3139(95)80054-9; BURKHARDT B, 1984, DIATOMS 1 SHELLS NAT; Cifuentes AO, 1992, FINITE ELEM ANAL DES, V12, P313, DOI DOI 10.1016/0168-874X(92)90040-J; Crawford SA, 2001, J PHYCOL, V37, P543, DOI 10.1046/j.1529-8817.2001.037004543.x; Ehrenberg CG, 1838, INFUSIONSTHIERCHEN V; Fortin D., 2000, J AM DENT ASSOC, V131, p26S, DOI DOI 10.14219/JADA.ARCHIVE.2000.0399; FOWLER SW, 1983, DEEP-SEA RES, V30, P963, DOI 10.1016/0198-0149(83)90051-1; Gersonde R., 1990, P OCEAN DRILLING PRO, V113, P365, DOI DOI 10.2973/0DP.PR0C.SR.113.127.1990; HAECKEL Ernst, 2004, KUNSTFORMEN NATUR; Hale MS, 2001, AQUAT MICROB ECOL, V24, P287, DOI 10.3354/ame024287; Jacobson DM, 1999, J EUKARYOT MICROBIOL, V46, P376, DOI 10.1111/j.1550-7408.1999.tb04616.x; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; Round F.E., 1990, DIATOMS BIOL MORPHOL; Round F. E., 1972, NOVA HEDWIGIA, V23, P291; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SMETACEK V, 1981, MAR BIOL, V63, P1, DOI 10.1007/BF00394657; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; STEUCEK G, 1989, BEITR 1 INT S SOND 2, P194; Suh HL, 1996, HYDROBIOLOGIA, V321, P235, DOI 10.1007/BF00143753; SULLIVAN BK, 1975, MAR BIOL, V30, P175, DOI 10.1007/BF00391591; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; TILMAN D, 1976, LIMNOL OCEANOGR, V21, P409; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Weis-Fogh T., 1977, SCALE EFFECTS ANIMAL, P511; WILLEMS G, 1992, DENT MATER, V8, P310, DOI 10.1016/0109-5641(92)90106-M	27	634	661	10	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					841	843		10.1038/nature01416	http://dx.doi.org/10.1038/nature01416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594512	Green Published			2022-12-01	WOS:000181044700047
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Cdc42 regulates GSK-3 beta and adenomatous polyposis coli to control cell polarity	NATURE			English	Article							BETA-CATENIN; XENOPUS EMBRYOS; PROTEIN EB1; C-ELEGANS; KINASE; PHOSPHORYLATION; MICROTUBULES; COMPLEX; BINDING; ACTIVATION	Cell polarity is a fundamental property of all cells. In higher eukaryotes, the small GTPase Cdc42, acting through a Par6-atypical protein kinase C (aPKC) complex, is required to establish cellular asymmetry during epithelial morphogenesis, asymmetric cell division and directed cell migration(1-5). However, little is known about what lies downstream of this complex. Here we show, through the use of primary rat astrocytes in a cell migration assay, that Par6-PKCzeta interacts directly with and regulates glycogen synthase kinase-3beta (GSK-3beta) to promote polarization of the centrosome and to control the direction of cell protrusion. Cdc42-dependent phosphorylation of GSK-3beta induces the interaction of adenomatous polyposis coli (Apc) protein with the plus ends of microtubules. The association of Apc with microtubules is essential for cell polarization. We conclude that Cdc42 regulates cell polarity through the spatial regulation of GSK-3beta and Apc. This role for Apc may contribute to its tumour-suppressor activity. occurs specifically at the leading edge of migrating cells, and	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Canc Res UK Oncogene & Signal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Barth AIM, 2002, J CELL SCI, V115, P1583; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Lucas FR, 1998, J CELL SCI, V111, P1351; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SU LK, 1995, CANCER RES, V55, P2972; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Wagner U, 1996, J CELL SCI, V109, P1537; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	28	682	706	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					753	756		10.1038/nature01423	http://dx.doi.org/10.1038/nature01423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610628				2022-12-01	WOS:000180938000046
J	Sweeney, A; Jiggins, C; Johnsen, S				Sweeney, A; Jiggins, C; Johnsen, S			Insect communication: Polarized light as a butterfly mating signal	NATURE			English	Article							COLOR		Duke Univ, Dept Biol, Durham, NC 27708 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Duke University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Edinburgh	Sweeney, A (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.		Jiggins, Chris D/B-9960-2008; Jiggins, Chris/T-4296-2019	Jiggins, Chris D/0000-0002-7809-062X; Jiggins, Chris/0000-0002-7809-062X				[Anonymous], 2002, AQUACULTURE, V235, P13, DOI [10.1016/j.aquaculture.2003.11.035, DOI 10.1016/J.AQUACULTURE.2003.11.035, DOI 10.1016/S1369-7021(02)00929-X]; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Estrada C, 2002, ECOL ENTOMOL, V27, P448, DOI 10.1046/j.1365-2311.2002.00434.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kelber A, 1999, NATURE, V402, P251, DOI 10.1038/46204; Kemp DJ, 2002, TRENDS ECOL EVOL, V17, P298, DOI 10.1016/S0169-5347(02)02516-8; Kinoshita M, 1997, NATURWISSENSCHAFTEN, V84, P199, DOI 10.1007/s001140050377; Shashar N, 1998, BIOTROPICA, V30, P275, DOI 10.1111/j.1744-7429.1998.tb00061.x; Shashar N, 2000, VISION RES, V40, P71, DOI 10.1016/S0042-6989(99)00158-3; Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561; Vukusic P, 2002, P ROY SOC B-BIOL SCI, V269, P7, DOI 10.1098/rspb.2001.1836	12	188	197	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					31	32		10.1038/423031a	http://dx.doi.org/10.1038/423031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721616				2022-12-01	WOS:000182561600030
J	McGill, BJ				McGill, BJ			A test of the unified neutral theory of biodiversity	NATURE			English	Article							RAIN-FOREST; ABUNDANCE; COMMUNITIES; DIVERSITY; PATTERNS	One of the fundamental questions of ecology is what controls biodiversity. Recent theory suggests that biodiversity is controlled predominantly by neutral drift of species abundances(1-4). This theory has generated considerable controversy(5-12), because it claims that many mechanisms that have long been studied by ecologists (such as niches) have little involvement in structuring communities. The theory predicts that the species abundance distribution within a community should follow a zero-sum multinomial distribution (ZSM), but this has not, so far, been rigorously tested. Specifically, it remains to be shown that the ZSM fits the data significantly better than reasonable null models. Here I test whether the ZSM fits several empirical data sets better than the lognormal distribution. It does not. Not only does the ZSM fail to fit empirical data better than the lognormal distribution 95% of the time, it also fails to fit empirical data better even a majority of the time. This means that there is no evidence that the ZSM predicts abundances better than the much more parsimonious null hypothesis.	Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	University of Arizona	McGill, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	mail@brianmcgill.org	McGill, Brian J/A-3476-2008	McGill, Brian J/0000-0002-0850-1913				Abrams PA, 2001, NATURE, V412, P858, DOI 10.1038/35091120; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; de Mazancourt C, 2001, SCIENCE, V293, P1772; Dewdney AK, 2000, BIOL BULL-US, V198, P152, DOI 10.2307/1542811; Enquist BJ, 2002, SCIENCE, V295, P1835; Gaston KJ, 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Grimmett G, 1992, PROBABILITY RANDOM P; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Hilborn Ray, 1997, V28; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; HUBBELL SP, 1975, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; Kimura M., 1983, NEUTRAL THEORY MOL E; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Levine JM, 2002, TRENDS ECOL EVOL, V17, P99; May R.M., 1975, P81; MCGILL BJ, IN PRESS OIKOS; PIELOU E C, 1969, P286; PRICE J, 1995, SUMMER ATLAS N AM BI; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Robbins C. S., 1986, BREEDING BIRD SURVEY; SAUER JR, 2001, N AM BREEDINB BIRD S; Terborgh J, 1996, ECOLOGY, V77, P561, DOI 10.2307/2265630; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; Yu DW, 1998, ECOL LETT, V1, P193; Yu DW, 2002, TRENDS ECOL EVOL, V17, P353, DOI 10.1016/S0169-5347(02)02575-2	28	346	373	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					881	885		10.1038/nature01583	http://dx.doi.org/10.1038/nature01583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12692564				2022-12-01	WOS:000182432600052
J	Kusminsky, RE				Kusminsky, RE			One more time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2003	289	16					2037	2038		10.1001/jama.289.16.2037	http://dx.doi.org/10.1001/jama.289.16.2037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669WW	12709445				2022-12-01	WOS:000182374300001
J	Wilson, BJ; Watson, MS; Prescott, GJ; Sunderland, S; Campbell, DM; Hannaford, P; Smith, WCS				Wilson, BJ; Watson, MS; Prescott, GJ; Sunderland, S; Campbell, DM; Hannaford, P; Smith, WCS			Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY DEATHS; HEART-DISEASE; FOLLOW-UP; HEALTH; WOMEN; PREECLAMPSIA; ECLAMPSIA; PROGNOSIS; MOTHERS; RECALL	Objective To examine the association between hypertensive diseases of pregnancy (gestational hypertension and pre-eclampsia) and the development of circulatory diseases in later life. Design Cohort study of women who had pre-eclampsia during their first singleton pregnancy. Two comparison groups were matched for age and year of delivery, one with gestational hypertension and one with no history of raised blood pressure. Setting Maternity services. in the Grampian region of Scotland. Participants Women selected from the Aberdeen maternity and neonatal databank who were resident in Aberdeen and who delivered a first, live singleton from 1951 to 1970. Main outcome measures Current vital and cardiovascular health status ascertained through postal questionnaire survey, clinical examination, linkage to hospital discharge, and mortality data. Results There were significant positive associations between pre-eclampsia/eclampsia or gestational hypertension and later hypertension in all measures. The adjusted relative risks varied from 1.13-3.72 for gestational hypertension and 1.40-3.98 for pre-eclampsia or eclampsia. The adjusted incident rate ratio for death from stroke for the pre-eclampsia/eclampsia group was 3.59 (95% confidence interval 1.04 to 12.4). Conclusions Hypertensive diseases of pregnancy seem to be associated in later life with diseases related to hypertension. If greater awareness of this association leads to earlier diagnosis and improved management, there may be scope for reducing a proportion of the morbidity and mortality from such diseases.	Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB9 1FX, Scotland; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB9 1FX, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Smith, WCS (corresponding author), Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland.		Hannaford, Philip C/B-7867-2012	Prescott, Gordon/0000-0002-9156-2361				ADAMS EM, 1961, LANCET, V2, P1373; BERAL V, 1985, J EPIDEMIOL COMMUN H, V39, P343, DOI 10.1136/jech.39.4.343; CAMPBELL DM, 2000, HDB HYPERTENSION, V20; CARELTON H, 1988, AM J OBSTET GYNECOL, V159, P156; CARLETON H, 1988, AM J OBSTET GYNECOL, V159, P156, DOI 10.1016/0002-9378(88)90513-3; DUFFUS GM, 1968, LANCET, V1, P994; GIBSON GB, 1959, BRIT MED J, V2, P159, DOI 10.1136/bmj.2.5145.159; HAKIM RB, 1992, AM J EPIDEMIOL, V136, P566, DOI 10.1093/oxfordjournals.aje.a116534; Hall MH, 1992, EFFECTS SMOKING FETU, P81; Hannaford P, 1997, HEART, V77, P154, DOI 10.1136/hrt.77.2.154; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; KOTCHEN JM, 1982, AM J EPIDEMIOL, V115, P861, DOI 10.1093/oxfordjournals.aje.a113373; LINDEBERG S, 1988, ACTA OBSTET GYN SCAN, V67, P605, DOI 10.3109/00016348809004272; *NAT HIGH BLOOD PR, REP HIGH BLOOD PRESS; NEUGEBAUER R, 1990, J CLIN EPIDEMIOL, V43, P1337, DOI 10.1016/0895-4356(90)90100-4; *OFF POP CENS SURV, 1992, MORT STAT DH2, V19; PLESS CE, 1995, ARCH PEDIAT ADOL MED, V149, P553, DOI 10.1001/archpedi.1995.02170180083016; SAMPHIER ML, 1981, PROSPECTIVE LONGITUD; SELVAGGI L, 1988, INT J GYNECOL OBSTET, V27, P45, DOI 10.1016/0020-7292(88)90086-0; SIBAI BM, 1992, AM J OBSTET GYNECOL, V166, P1757, DOI 10.1016/0002-9378(92)91566-S; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; SINGH MM, 1974, J OBSTET GYN BR COMM, V81, P903; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; SMITH WCS, 1989, SCOT MED J, V34, P550, DOI 10.1177/003693308903400603; SMITH WCS, 1990, BRIT HEART J, V64, P295; Svensson A, 1983, J Hypertens Suppl, V1, P94; Todd G. F., 1969, STAT SMOKING UK; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Womersley J, 1996, J PUBLIC HEALTH MED, V18, P465, DOI 10.1093/oxfordjournals.pubmed.a024546; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1	31	460	504	1	67	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					845	849		10.1136/bmj.326.7394.845	http://dx.doi.org/10.1136/bmj.326.7394.845			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702615	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000182386800015
J	Canfield, RL; Henderson, CR; Cory-Slechta, DA; Cox, C; Jusko, TA; Lanphear, BP				Canfield, RL; Henderson, CR; Cory-Slechta, DA; Cox, C; Jusko, TA; Lanphear, BP			Intellectual impairment in children with blood lead concentrations below 10 mu g per deciliter	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	21st Annual Meeting of the Behavioral-Toxicology-Society	APR 20-22, 2002	RES TRIANGLE PK, NORTH CAROLINA	Behav Toxicol Soc			PORT-PIRIE COHORT; ENVIRONMENTAL LEAD; COGNITIVE FUNCTION; NEUROPSYCHOLOGICAL DEVELOPMENT; PRESCHOOL-CHILDREN; PRIMARY PREVENTION; BONE LEAD; EXPOSURE; INTELLIGENCE; LEVEL	BACKGROUND: Despite dramatic declines in children's blood lead concentrations and a lowering of the Centers for Disease Control and Prevention's level of concern to 10 microg per deciliter (0.483 micromol per liter), little is known about children's neurobehavioral functioning at lead concentrations below this level. METHODS: We measured blood lead concentrations in 172 children at 6, 12, 18, 24, 36, 48, and 60 months of age and administered the Stanford-Binet Intelligence Scale at the ages of 3 and 5 years. The relation between IQ and blood lead concentration was estimated with the use of linear and nonlinear mixed models, with adjustment for maternal IQ, quality of the home environment, and other potential confounders. RESULTS: The blood lead concentration was inversely and significantly associated with IQ. In the linear model, each increase of 10 microg per deciliter in the lifetime average blood lead concentration was associated with a 4.6-point decrease in IQ (P=0.004), whereas for the subsample of 101 children whose maximal lead concentrations remained below 10 microg per deciliter, the change in IQ associated with a given change in lead concentration was greater. When estimated in a nonlinear model with the full sample, IQ declined by 7.4 points as lifetime average blood lead concentrations increased from 1 to 10 microg per deciliter. CONCLUSIONS: Blood lead concentrations, even those below 10 microg per deciliter, are inversely associated with children's IQ scores at three and five years of age, and associated declines in IQ are greater at these concentrations than at higher concentrations. These findings suggest that more U.S. children may be adversely affected by environmental lead than previously estimated.	Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA; Cornell Univ, Coll Human Ecol, Dept Human Dev, Ithaca, NY USA; Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY USA; Univ Rochester, Sch Med, Dept Biostat & Computat Biol, Rochester, NY USA; NICHHD, Div Epidemiol Stat & Prevent, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Childrens Hosp, Med Ctr, Cincinnati Childrens Environm Hlth Ctr, Cincinnati, OH 45229 USA	Cornell University; Cornell University; University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center	Canfield, RL (corresponding author), Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R01ES008388] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES008388, P30 ES001247, ES01247, R01 ES08388] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bae DS, 2001, TOXICOL SCI, V63, P132, DOI 10.1093/toxsci/63.1.132; BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; BELLINGER D, 1994, PEDIATR ANN, V23, P600, DOI 10.3928/0090-4481-19941101-08; BELLINGER D, 1991, PEDIATRICS, V87, P219; BELLINGER D, 1994, PEDIATRICS, V93, pA28; BELLINGER DC, 1983, J PEDIATR-US, V102, P523, DOI 10.1016/S0022-3476(83)80178-4; BELLINGER DC, 1992, PEDIATRICS, V90, P855; BUCK SF, 1960, J ROY STAT SOC B, V22, P302; Caldwell B.M., 1984, HOME OBSERVATION MEA; *CDC, 1991, PREV LEAD POIS YOUNG; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; CORYSLECHTA DA, 1995, ANNU REV PHARMACOL, V35, P391, DOI 10.1146/annurev.pa.35.040195.002135; DIETRICH KN, 1993, NEUROTOXICOL TERATOL, V15, P37, DOI 10.1016/0892-0362(93)90043-N; Dietrich KN, 2001, NEUROTOXICOL TERATOL, V23, P511, DOI 10.1016/S0892-0362(01)00184-2; FULTON M, 1987, LANCET, V1, P1221; HENDERSON CR, 1982, BIOMETRICS, V38, P623, DOI 10.2307/2530044; International Programme on Chemical Safety, 1995, ENV HLTH CRIT, V165; *JM SATTL, 1992, ASS CHILDR; Langford IH, 1998, J ROY STAT SOC A STA, V161, P121, DOI 10.1111/1467-985X.00094; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 1999, PEDIATRICS, V103, P772, DOI 10.1542/peds.103.4.772; Lanphear BP, 1998, SCIENCE, V281, P1617, DOI 10.1126/science.281.5383.1617; Lanphear BP, 1998, SCIENCE, V282, P51; Lanphear BP, 1996, AM J PUBLIC HEALTH, V86, P1416, DOI 10.2105/AJPH.86.10.1416; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Marsden PA, 2003, NEW ENGL J MED, V348, P345, DOI 10.1056/NEJMe020164; MCCROWELL KL, 1994, J PSYCHOEDUC ASSESS, V12, P126, DOI 10.1177/073428299401200202; MCMICHAEL AJ, 1992, NEUROTOXICOL TERATOL, V14, P321, DOI 10.1016/0892-0362(92)90038-C; MCMICHAEL AJ, 1988, NEW ENGL J MED, V319, P468, DOI 10.1056/NEJM198808253190803; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; NEEDLEMAN HL, 1990, JAMA-J AM MED ASSOC, V263, P673, DOI 10.1001/jama.263.5.673; Needleman HL, 1996, JAMA-J AM MED ASSOC, V275, P363, DOI 10.1001/jama.275.5.363; PEOPLES CE, 1995, INTELLIGENCE, V21, P69, DOI 10.1016/0160-2896(95)90039-X; POCOCK SJ, 1994, BRIT MED J, V309, P1189, DOI 10.1136/bmj.309.6963.1189; RICE DC, 1993, NEUROTOXICOLOGY, V14, P167; Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902; Rosen JF, 2001, NEW ENGL J MED, V344, P1470, DOI 10.1056/NEJM200105103441910; Ruppert D., 2003, SEMIPARAMETRIC REGRE; SCHWARTZ J, 1995, ARCH ENVIRON HEALTH, V50, P31, DOI 10.1080/00039896.1995.9955010; SCHWARTZ J, 1994, ENVIRON RES, V65, P42, DOI 10.1006/enrs.1994.1020; SCHWARTZ J, 1993, NEUROTOXICOLOGY, V14, P237; Searle S.R., 1971, LINEAR MODELS; Segal N., 1985, HDB INTELLIGENCE THE, P391; Stone B. M., 2003, ARCH CLIN NEUROPSYCH, V613, P1; THORNDIKE RL, 1986, STANFORDBINET INTELL; Tong S, 1998, JAMA-J AM MED ASSOC, V280, P1915, DOI 10.1001/jama.280.22.1915; Tong S, 1996, BRIT MED J, V313, P198; Tong SL, 1996, BRIT MED J, V312, P1569, DOI 10.1136/bmj.312.7046.1569; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Wasserman GA, 1997, ENVIRON HEALTH PERSP, V105, P956, DOI 10.1289/ehp.97105956; Wasserman GA, 2000, NEUROTOXICOL TERATOL, V22, P811, DOI 10.1016/S0892-0362(00)00106-9; Wasserman GA, 1998, AM J PUBLIC HEALTH, V88, P481, DOI 10.2105/AJPH.88.3.481; WINNEKE G, 1994, NEUROTOXICOLOGY, V15, P705	53	1479	1545	3	133	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1517	1526		10.1056/NEJMoa022848	http://dx.doi.org/10.1056/NEJMoa022848			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700371	Green Accepted, Bronze			2022-12-01	WOS:000182248900002
J	Shi, YJ; Sawada, J; Sui, GC; Affar, EB; Whetstine, JR; Lan, F; Ogawa, H; Luke, MPS; Nakatani, Y; Shi, Y				Shi, YJ; Sawada, J; Sui, GC; Affar, EB; Whetstine, JR; Lan, F; Ogawa, H; Luke, MPS; Nakatani, Y; Shi, Y			Coordinated histone modifications mediated by a CtBP co-repressor complex	NATURE			English	Article							COREPRESSOR; PROTEIN; TRANSCRIPTION; TRANSFORMATION; METHYLATION; EXPRESSION; FAMILY; GENES	The transcriptional co-repressor CtBP (C-terminal binding protein) is implicated in tumorigenesis because it is targeted by the adenovirus E1A protein during oncogenic transformation(1). Genetic studies have also identified a crucial function for CtBP in animal development(2). CtBP is recruited to DNA by transcription factors that contain a PXDLS motif(3,4), but the detailed molecular events after the recruitment of CtBP to DNA and the mechanism of CtBP function in tumorigenesis are largely unknown. Here we report the identification of a CtBP complex that contains the essential components for both gene targeting and coordinated histone modifications, allowing for the effective repression of genes targeted by CtBP. Inhibiting the expression of CtBP and its associated histone-modifying activities by RNA-mediated interference resulted in alterations of histone modifications at the promoter of the tumour invasion suppressor gene E-cadherin and increased promoter activity in a reporter assay. These findings identify a molecular mechanism by which CtBP mediates transcriptional repression and provide insight into CtBP participation in oncogenesis.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Ogawa, Hidesato/M-3778-2019; Ogawa, Hidesato/A-2079-2016	Ogawa, Hidesato/0000-0001-9740-9010; Sui, Guangchao/0000-0002-8164-5585				Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chinnadurai G, 2003, BIOESSAYS, V25, P9, DOI 10.1002/bies.10212; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	24	607	636	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					735	738		10.1038/nature01550	http://dx.doi.org/10.1038/nature01550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700765				2022-12-01	WOS:000182272300045
J	Skelly, M; Hoffman, J; Fabbri, M; Holzman, RS; Clarkson, AB; Merali, S				Skelly, M; Hoffman, J; Fabbri, M; Holzman, RS; Clarkson, AB; Merali, S			S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia	LANCET			English	Article								Pneumocystis carinii is unable to synthesise S-adenosylmethionine and thus scavenges this intermediate. We aimed to test whether measurement of concentrations of this metabolic intermediate in plasma could provide a new method for rapid diagnosis of Pneumocystis carinii pneumonia (PCP). We measured S-adenosylmethionine plasma concentrations in 12 healthy controls, 16 patients with confirmed or suspected PCP, and 36 patients with other infections. Median concentration in healthy controls was 106 nmol/L (range 86-128), but the protein was undetectable in eight patients with histologically proven and seven with suspected PCP, and was 8 nmol/L in another confirmed case (p<0.0001). In 36 patients with other infections, S-adenosylmethionine concentrations were much the same as in controls: IS had bacterial pneumonia, two tuberculosis, five cryptococcal meningitis, three had other infections, and eight had asymptomatic HIV-1 infection. After treatment for PCP, S-adenosylmethionine concentrations rose rapidly in all but one patient who died of the disease. Measurement of plasma S-adenosylmethlonine concentrations could prove useful for diagnosis of PCP and assessment of patients' response to treatment.	NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA; NYU, Bellevue Hosp Ctr, Dept Med, New York, NY 10016 USA	New York University; Bellevue Hospital Center; New York University	Merali, S (corresponding author), NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA.							Barry S M, 2001, HIV Med, V2, P123, DOI 10.1046/j.1468-1293.2001.00062.x; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Merali S, 1999, P NATL ACAD SCI USA, V96, P2402, DOI 10.1073/pnas.96.5.2402	5	43	45	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1267	1268		10.1016/S0140-6736(03)12984-4	http://dx.doi.org/10.1016/S0140-6736(03)12984-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699956				2022-12-01	WOS:000182161600012
J	Yin, YX; Liu, YX; Jin, YJ; Hall, EJ; Barrett, JC				Yin, YX; Liu, YX; Jin, YJ; Hall, EJ; Barrett, JC			PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression	NATURE			English	Article							OXIDATIVE STRESS; DNA-BINDING; ACTIVATION; DEFICIENCY; DOMAIN; P21	p53 has a role in many cellular processes through the transcriptional regulation of target genes(1,2). PAC1 ( phosphatase of activated cells 1; also known as dual specificity phosphatase 2, DUSP2) is a dual threonine/tyrosine phosphatase that specifically dephosphorylates and inactivates mitogen-activated protein (MAP) kinases(3,4). Here we show that during apoptosis, p53 activates transcription of PAC1 by binding to a palindromic site in the PAC1 promoter. PAC1 transcription is induced in response to serum deprivation and oxidative stress, which results in p53-dependent apoptosis, but not in response to gamma-irradiation, which causes cell cycle arrest(5,6). Reduction of PAC1 transcription using small interfering RNA inhibits p53-mediated apoptosis, whereas overexpression of PAC1 increases susceptibility to apoptosis and suppresses tumour formation. Moreover, activation of p53 significantly inhibits MAP kinase activity. We conclude that, under specific stress conditions, p53 regulates transcription of PAC1 through a new p53-binding site, and that PAC1 is necessary and sufficient for p53-mediated apoptosis. Identification of a palindromic motif as a p53-binding site may reveal a novel mechanism whereby p53 regulates its target genes.	Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA; NCI, Lab Biosyst & Canc, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yin, YX (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, 630 W 168th St, New York, NY 10032 USA.	yy151@columbia.edu			DIVISION OF BASIC SCIENCES - NCI [Z01BC010417] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOORD OS, 1991, NUCLEIC ACIDS RES, V19, P5191, DOI 10.1093/nar/19.19.5191; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maiyar AC, 1996, J BIOL CHEM, V271, P12414, DOI 10.1074/jbc.271.21.12414; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SUIT G, 2002, P NATL ACAD SCI USA, V99, P5515; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Yin YX, 1999, MOL CARCINOGEN, V24, P15, DOI 10.1002/(SICI)1098-2744(199901)24:1<15::AID-MC3>3.3.CO;2-P; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; Zhao RB, 2000, GENE DEV, V14, P981	21	117	122	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					527	531		10.1038/nature01519	http://dx.doi.org/10.1038/nature01519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673251				2022-12-01	WOS:000181965400039
J	Morris, DG; Huang, XZ; Kaminski, N; Wang, YN; Shapiro, SD; Dolganov, G; Glick, A; Sheppard, D				Morris, DG; Huang, XZ; Kaminski, N; Wang, YN; Shapiro, SD; Dolganov, G; Glick, A; Sheppard, D			Loss of integrin alpha v beta 6-mediated TGF-beta activation causes Mmp12-dependent emphysema	NATURE			English	Article							MACROPHAGE METALLOELASTASE; CYTOPLASMIC DOMAIN; LUNG INFLAMMATION; FOCAL CONTACTS; EXPRESSION; MICE; SUBUNIT; REVEALS; LOCALIZATION; INHIBITION	Integrins are heterodimeric cell-surface proteins that regulate cell growth, migration and survival. We have shown previously that the epithelial-restricted integrin alphavbeta6 has another critical function; that is, it binds and activates latent transforming growth factor-beta (TGF-beta)(1,2). Through a global analysis of pulmonary gene expression in the lungs of mice lacking this integrin (Itgb6 null mice) we have identified a marked induction of macrophage metalloelastase (Mmp12)-a metalloproteinase that preferentially degrades elastin and has been implicated in the chronic lung disease emphysema(3). Here we report that Itgb6-null mice develop age-related emphysema that is completely abrogated either by transgenic expression of versions of the beta6 integrin subunit that support TGF-beta activation, or by the loss of Mmp12. Furthermore, we show that the effects of Itgb6 deletion are overcome by simultaneous transgenic expression of active TGF-beta1. We have uncovered a pathway in which the loss of integrin-mediated activation of latent TGF-beta causes age-dependent pulmonary emphysema through alterations of macrophage Mmp12 expression. Furthermore, we show that a functional alteration in the TGF-beta activation pathway affects susceptibility to this disease.	Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Pittsburgh, Dept Med, Div Pulm & Crit Care Med, Pittsburgh, PA 15261 USA; Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med Sect, Boston, MA 02115 USA; NCI, Cellular Carcinogenesis & Tumor Promot Lab, Bethesda, MD 20892 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sheppard, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA.			Kaminski, Naftali/0000-0001-5917-4601				AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Clark JC, 2001, AM J PHYSIOL-LUNG C, V280, pL705, DOI 10.1152/ajplung.2001.280.4.L705; CONE RI, 1994, CELL ADHES COMMUN, V2, P101, DOI 10.3109/15419069409004430; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Feinberg MW, 2000, J BIOL CHEM, V275, P25766, DOI 10.1074/jbc.M002664200; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HUANG XZ, 1995, AM J RESP CELL MOL, V13, P245, DOI 10.1165/ajrcmb.13.2.7626292; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Huang XZ, 1998, AM J RESP CELL MOL, V19, P636, DOI 10.1165/ajrcmb.19.4.3293; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; WIKENHEISER KA, 1992, CANCER RES, V52, P5342; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	27	373	393	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					169	173		10.1038/nature01413	http://dx.doi.org/10.1038/nature01413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634787				2022-12-01	WOS:000181488900046
J	Conway, G; Toenniessen, G				Conway, G; Toenniessen, G			Science for African food security	SCIENCE			English	Editorial Material							SOIL		Rockefeller Fdn, Food Secur Theme, New York, NY 10018 USA		Conway, G (corresponding author), Rockefeller Fdn, Food Secur Theme, New York, NY 10018 USA.							Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; [Anonymous], 2001, STAT FOOD INS WORLD; Banziger M, 2001, EUPHYTICA, V122, P503, DOI 10.1023/A:1017510928038; Conway G, 1999, DOUBLY GREEN REVOLUT; CONWAY G, 1997, FEEDING WORLD POPULA, P249; Delgado C.L., 1998, 107 IFPRI; DeVries J, 2001, SECURING HARVEST BIO; HENNO J, 1999, ESTIMATING RATES NUT; Herren Hans R., 1996, V15, P136; ININDA J, 2000, COORDINATED ECOSYSTE; Kanampiu F, 2002, PLANT CELL TISS ORG, V69, P105, DOI 10.1023/A:1015241509808; LANGAT M, 2000, MBILI UPDATE TESTING; Legg JP, 1999, CROP PROT, V18, P627, DOI 10.1016/S0261-2194(99)00062-9; Mwangi WM, 1997, NUTR CYCL AGROECOSYS, V47, P135; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; SEWARD PD, 1998, METHODS DEV INFRASTR; Wambugu F, 2001, BENEFITS BIOTECHNOLO; World Bank, 1986, POVERTY HUNGER ISSUE; *WORLD FOOD PROGR, 2002, WFP GLOB FOOD AID SH	21	44	46	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1187	1188		10.1126/science.1081978	http://dx.doi.org/10.1126/science.1081978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595678				2022-12-01	WOS:000181065500024
J	Eriksson, M; Brown, WT; Gordon, LB; Glynn, MW; Singer, J; Scott, L; Erdos, MR; Robbins, CM; Moses, TY; Berglund, P; Dutra, A; Pak, E; Durkin, S; Csoka, AB; Boehnke, M; Glover, TW; Collins, FS				Eriksson, M; Brown, WT; Gordon, LB; Glynn, MW; Singer, J; Scott, L; Erdos, MR; Robbins, CM; Moses, TY; Berglund, P; Dutra, A; Pak, E; Durkin, S; Csoka, AB; Boehnke, M; Glover, TW; Collins, FS			Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome	NATURE			English	Article							NUCLEAR-ENVELOPE; UNIPARENTAL DISOMY; CHROMOSOME-1; HOMOZYGOSITY; PATIENT; LMNA	Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by features reminiscent of marked premature ageing(1,2). Here, we present evidence of mutations in lamin A (LMNA) as the cause of this disorder. The HGPS gene was initially localized to chromosome 1q by observing two cases of uniparental isodisomy of 1q - the inheritance of both copies of this material from one parent - and one case with a 6-megabase paternal interstitial deletion. Sequencing of LMNA, located in this interval and previously implicated in several other heritable disorders(3,4), revealed that 18 out of 20 classical cases of HGPS harboured an identical de novo ( that is, newly arisen and not inherited) single-base substitution, G608G( GGC > GGT), within exon 11. One additional case was identified with a different substitution within the same codon. Both of these mutations result in activation of a cryptic splice site within exon 11, resulting in production of a protein product that deletes 50 amino acids near the carboxy terminus. Immunofluorescence of HGPS fibroblasts with antibodies directed against lamin A revealed that many cells show visible abnormalities of the nuclear membrane. The discovery of the molecular basis of this disease may shed light on the general phenomenon of human ageing.	NHGRI, NIH, Bethesda, MD 20892 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institute for Basic Research in Developmental Disabilities; Tufts University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Brown University	Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	fc23a@nih.gov	Gordon, Leslie B./AAJ-5793-2021; Brown, William/GXN-2777-2022		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; BROWN WT, 1979, MECH AGEING DEV, V9, P325; BROWN WT, 1992, AM J CLIN NUTR, V55, P1222; BROWN WT, 1990, GENETIC EFFECTS AGIN, V2, P521; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; EGGERT M, 1993, EUR J BIOCHEM, V213, P659, DOI 10.1111/j.1432-1033.1993.tb17806.x; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Gelb BD, 1998, AM J HUM GENET, V62, P848, DOI 10.1086/301795; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; HENNEKES H, 1994, J CELL SCI, V107, P1019; KHALIFA MM, 1989, CLIN GENET, V35, P125; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIN F, 1993, J BIOL CHEM, V268, P16321; Luengo WD, 2002, AM J MED GENET, V113, P298, DOI 10.1002/ajmg.10753; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SINENSKY M, 1994, J CELL SCI, V107, P61; SMITH AS, 1993, AM J NEURORADIOL, V14, P441; SMITH CAB, 1953, J R STAT SOC B, V15, P153; Speckman, 2000, AM J HUM GENET, V67, P775; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TREVASMACIEL A, 1988, AM J MED GENET, V31, P483	28	1473	1532	4	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					293	298		10.1038/nature01629	http://dx.doi.org/10.1038/nature01629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12714972	Green Published			2022-12-01	WOS:000182853100044
J	Wood, ZA; Poole, LB; Karplus, PA				Wood, ZA; Poole, LB; Karplus, PA			Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling	SCIENCE			English	Article							2-CYS PEROXIREDOXIN; MAMMALIAN PEROXIREDOXIN; THIOREDOXIN PEROXIDASE; ALKYL-HYDROPEROXIDE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; THIOL PEROXIDASE; SITE CYSTEINE; I EXPRESSION; NADH OXIDASE	Eukaryotic 2-Cys peroxiredoxins (2-Cys Prxs) not only act as antioxidants, but also appear to regulate hydrogen peroxide-mediated signal transduction. We show that bacterial 2-Cys Prxs are much less sensitive to oxidative inactivation than are eukaryotic 2-Cys Prxs. By identifying two sequence motifs unique to the sensitive 2-Cys Prxs and comparing the crystal structure of a bacterial 2-Cys Prx at 2.2 angstrom resolution with other Prx structures, we define the structural origins of sensitivity. We suggest this adaptation allows 2-Cys Prxs to act as floodgates, keeping resting levels of hydrogen peroxide low, while permitting higher levels during signal transduction.	Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97333 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Oregon State University; Wake Forest University; Wake Forest Baptist Medical Center	Karplus, PA (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97333 USA.	karplusp@ucs.orst.edu		Karplus, Paul/0000-0001-8725-6292	NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [R01 GM050389-10, R01 GM050389, GM50389] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chung YM, 2001, ANTICANCER RES, V21, P1129; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/0300-5127:0290345; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; NIIMURA Y, 1995, J BIOL CHEM, V270, P25645, DOI 10.1074/jbc.270.43.25645; Noh DY, 2001, ANTICANCER RES, V21, P2085; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Park SH, 2000, CLIN CANCER RES, V6, P4915; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	40	1081	1131	6	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					650	653		10.1126/science.1080405	http://dx.doi.org/10.1126/science.1080405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714747				2022-12-01	WOS:000182453700045
J	Barkai, G; Arbuzova, S; Berkenstadt, M; Heifetz, S; Cuckle, H				Barkai, G; Arbuzova, S; Berkenstadt, M; Heifetz, S; Cuckle, H			Frequency of Down's syndrome and neural-tube defects in the same family	LANCET			English	Article							MATERNAL RISK-FACTORS; METHYLENETETRAHYDROFOLATE REDUCTASE; FOLIC-ACID; PLASMA HOMOCYSTEINE; FOLATE METABOLISM; SPINA-BIFIDA; PREGNANCY; GENE; POLYMORPHISM; MUTATION	Background There is evidence that some mothers of infants with Down's syndrome have abnormal metabolism of folate and methyl, as well as mutations in folate genes, which are features that are also seen in neural-tube defects (NTD). We therefore investigated whether Down's syndrome and NTD arise more often in the same family than would be expected from the incidence of each disorder considered separately. Methods We studied two series of families using information obtained from medical records about maternal age, pregnancy outcome, congenital malformations, and karyotype: the first, 493 families from Israel who were at high risk of NTD (445 with a history of NTD and 48 with isolated hydrocephalus); and the second, 516 families from the Ukraine at high risk of Down's syndrome. Findings In the families at risk of NTD, there were a total of 11 pregnancies affected by Down's syndrome in 1492 at-risk pregnancies (compared with 1.87 expected on the basis of maternal age), which was a significant increase (p<0.00001). In the families at risk of Down's syndrome, there were seven NTD pregnancies in 1847 at risk, compared with 1.37 expected (p<0.001). Interpretation In this study, we provide direct evidence of a link between Down's syndrome and NTD. Folate supplementation before conception has the potential to reduce the frequency of Down's syndrome.	Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, IL-52621 Tel Aviv, Israel; Interreg Medicogenet Ctr, Donetsk, Ukraine; Univ Leeds, Leeds, W Yorkshire, England	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Leeds	Barkai, G (corresponding author), Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel.		Arbuzova, Svetlana/W-5491-2018	Arbuzova, Svetlana/0000-0002-5846-1067				Arbuzova S, 2001, CLIN GENET, V60, P456, DOI 10.1034/j.1399-0004.2001.600609.x; ARBUZOVA S, 1998, DOWNS SYNDROME RES P, V5, P26; Ashfield-Watt PAL, 2002, AM J CLIN NUTR, V76, P180, DOI 10.1093/ajcn/76.1.180; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Chadefaux-Vekemans B, 2002, PEDIATR RES, V51, P766, DOI 10.1203/01.PDR.0000017484.64723.43; Cuckle H, 1999, PRENATAL DIAG, V19, P1177, DOI 10.1002/(SICI)1097-0223(199912)19:12<1177::AID-PD714>3.0.CO;2-N; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Fenech M, 2001, MUTAT RES-FUND MOL M, V480, P51, DOI 10.1016/S0027-5107(01)00168-3; Hassold T, 2000, CLIN GENET, V57, P95, DOI 10.1034/j.1399-0004.2000.570201.x; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; James SJ, 1999, AM J CLIN NUTR, V70, P495; KIRKE PN, 1993, Q J MED, V86, P703; Little J., 1992, EPIDEMIOLOGY CONTROL, P604; NANCE WE, 1969, NATURE, V224, P373, DOI 10.1038/224373a0; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Petersen MB, 2001, AM J HUM GENET, V69, P323; Posey DL, 1996, LANCET, V347, P686, DOI 10.1016/S0140-6736(96)91236-2; PRYTKOV AN, 1978, GENETIKA+, V14, P1461; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Stuppia L, 2002, EUR J HUM GENET, V10, P388, DOI 10.1038/sj.ejhg.5200819; vanderPut NMJ, 1997, QJM-INT J MED, V90, P505, DOI 10.1093/qjmed/90.8.505; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; WALD N, 1991, LANCET, V338, P131; Wald NJ, 2001, LANCET, V358, P2069, DOI 10.1016/S0140-6736(01)07104-5; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Zittoun J, 1998, METABOLISM, V47, P1413, DOI 10.1016/S0026-0495(98)90315-8	29	60	68	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1331	1335		10.1016/S0140-6736(03)13080-2	http://dx.doi.org/10.1016/S0140-6736(03)13080-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711468				2022-12-01	WOS:000182346100010
J	El-Hashemite, N; Zhang, HB; Henske, EP; Kwiatkowski, DJ				El-Hashemite, N; Zhang, HB; Henske, EP; Kwiatkowski, DJ			Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma	LANCET			English	Article							CELL-GROWTH; PROLIFERATION	Mutations that inactivate either TSC1 or TSC2 cause tuberous sclerosis. We have used immunoblotting and immunohistochemical analysis to see whether there is phosphorylation of p70 S6 kinase, and the ribosomal S6 protein in anglomyolipomas occurring in tuberous sclerosis. Hamartin (encoded by TSC1) and S6K was expressed in all samples. Tuberin (TSC2) was weak or absent in angiomyolipomas, but present in healthy kidney, whereas, phosphorylated p70 S6 kinase and p56 were present only in angiomyolipomas. Our results indicate activation of a mammalian target of rapamycin metabolic pathway in tuberous sclerosis lesions, which contributes to their growth. We suggest that treatment with rapamycin and its analogues could benefit such patients.	Brigham & Womens Hosp, Dept Med, Div Haematol, Boston, MA 02115 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Harvard University; Brigham & Women's Hospital; Fox Chase Cancer Center	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Haematol, 75 Francis St, Boston, MA 02115 USA.							Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4	5	150	156	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1348	1349		10.1016/S0140-6736(03)13044-9	http://dx.doi.org/10.1016/S0140-6736(03)13044-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711473				2022-12-01	WOS:000182346100015
J	Boshoff, HIM; Reed, MB; Barry, CE; Mizrahi, V				Boshoff, HIM; Reed, MB; Barry, CE; Mizrahi, V			DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis	CELL			English	Article							IRRADIATED ESCHERICHIA-COLI; POL-II; REPLICATION RESTART; DAMAGE INDUCTION; MUTATION-RATES; ERROR-PRONE; EXPRESSION; SMEGMATIS; REPAIR; GENES	The presence of multiple copies of the major replicative DNA polymerase (DnaE) in some organisms, including important pathogens and symbionts, has remained an unresolved enigma. We postulated that one copy might participate in error-prone DNA repair synthesis. We found that UV irradiation of Mycobacterium tuberculosis results in increased mutation frequency in the surviving fraction. We identified dnaE2 as a gene that is upregulated in vitro by several DNA damaging agents, as well as during infection of mice. Loss of this protein reduces both survival of the bacillus after UV irradiation and the virulence of the organism in mice. Our data suggest that DnaE2, and not a member of the Y family of error-prone DNA polymerases, is the primary mediator of survival through inducible mutagenesis and can contribute directly to the emergence of drug resistance in vivo. These results may indicate a potential new target for therapeutic intervention.	NIAID, TB Res Sect, Host Def Lab, NIH, Rockville, MD 20852 USA; Univ Witwatersrand, Sch Pathol, MRC, NHLS,WITS Mol Mycobacteriol Res Unit, Johannesburg, South Africa; Natl Hlth Lab Serv, Johannesburg, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Health Laboratory Service; University of Witwatersrand; National Health Laboratory Service	Barry, CE (corresponding author), NIAID, TB Res Sect, Host Def Lab, NIH, Twinbrook 2,12441 Parklawn Dr, Rockville, MD 20852 USA.	clifton-barry@nih.gov; mizrahiv@pathology.wits.ac.za	Barry, Clifton E/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000734, Z01AI000783] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Borden A, 2002, J BACTERIOL, V184, P2674, DOI 10.1128/JB.184.10.2674-2681.2002; Boshoff HIM, 2001, SCAND J INFECT DIS, V33, P101, DOI 10.1080/003655401753382567; Boshoff HIM, 2000, J BACTERIOL, V182, P5479, DOI 10.1128/JB.182.19.5479-5485.2000; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Courcelle J, 2001, GENETICS, V158, P41; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Durbach SI, 1997, MOL MICROBIOL, V26, P643, DOI 10.1046/j.1365-2958.1997.5731934.x; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frischkorn K, 1998, MOL MICROBIOL, V29, P1203, DOI 10.1046/j.1365-2958.1998.01003.x; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Huang YP, 1999, J MOL EVOL, V48, P756, DOI 10.1007/PL00006520; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Karunakaran P, 2000, J BACTERIOL, V182, P3331, DOI 10.1128/JB.182.12.3331-3335.2000; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Luria SE, 1943, GENETICS, V28, P491; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Maor-Shoshani A, 2000, P NATL ACAD SCI USA, V97, P565, DOI 10.1073/pnas.97.2.565; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mdluli K, 1996, J INFECT DIS, V174, P1085, DOI 10.1093/infdis/174.5.1085; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Mizrahi V, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P159; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P3298, DOI 10.1128/AAC.44.12.3298-3301.2000; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; OGAORA P, 1997, MED PRIN PRACT, V6, P91; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Schoolnik GK, 2001, METHOD ENZYMOL, V336, P3, DOI 10.1016/S0076-6879(01)36573-4; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sung HM, 2003, J BACTERIOL, V185, P2153, DOI 10.1128/JB.185.7.2153-2160.2003; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833	48	309	326	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					183	193		10.1016/S0092-8674(03)00270-8	http://dx.doi.org/10.1016/S0092-8674(03)00270-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705867	Bronze			2022-12-01	WOS:000182508500008
J	Eden, A; Gaudet, F; Waghmare, A; Jaenisch, R				Eden, A; Gaudet, F; Waghmare, A; Jaenisch, R			Chromosomal instability and tumors promoted by DNA hypomethylation	SCIENCE			English	Article									MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Max Delbruck Ctr Mol Med, Berlin, Germany; Univ Munich, Dept Biol, Munich, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Waghmare, Alpana/0000-0003-2268-9470	NATIONAL CANCER INSTITUTE [R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [CA87869] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; FEINBERG AP, 1998, CANCER RES, V48, P1149; KENDAL WS, 1988, CANCER RES, V48, P1060; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X	6	984	1038	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2003	300	5618					455	455		10.1126/science.1083557	http://dx.doi.org/10.1126/science.1083557			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702868				2022-12-01	WOS:000182295900029
J	Magurran, AE; Henderson, PA				Magurran, AE; Henderson, PA			Explaining the excess of rare species in natural species abundance distributions	NATURE			English	Article							LOWER SEVERN ESTUARY; POPULATION STABILITY; DYNAMICS	The observation that a few species in ecological communities are exceptionally abundant, whereas most are rare, prompted the development of species abundance models(1-3). Nevertheless, despite the large literature on the commonness and rarity of species inspired by these pioneering studies, some widespread empirical patterns of species abundance resist easy explanation(4). Notable among these is the observation(5) that in large assemblages there are more rare species than the log normal model predicts(6,7). Here we use a long-term (21-year) data set, from an estuarine fish community, to show how an ecological community can be separated into two components. Core species, which are persistent, abundant and biologically associated with estuarine habitats, are log normally distributed. Occasional species occur infrequently in the record, are typically low in abundance and have different habitat requirements; they follow a log series distribution. These distributions are overlaid, producing the negative skew that characterizes real data sets.	Univ St Andrews, Sch Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; Pisces Conservat Ltd, Lymington SO41 8GN, Hants, England	University of St Andrews	Magurran, AE (corresponding author), Univ St Andrews, Sch Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland.	aem1@st-andrews.ac.uk	Magurran, Anne E/D-7463-2013; Henderson, Peter Alan/Q-5145-2019	Henderson, Peter Alan/0000-0002-7461-1758; Magurran, Anne/0000-0002-0036-2795				Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Brown JH, 2001, EVOLUTION, V55, P2137; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gaston K.J., 2000, MACROECOLOGY; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; HENDERSON PA, 1990, J FISH BIOL, V37, P605; HENDERSON PA, 1994, NETH J SEA RES, V32, P321, DOI 10.1016/0077-7579(94)90009-4; Henderson PA, 1999, J FISH BIOL, V54, P1161, DOI 10.1111/j.1095-8649.1999.tb02046.x; Henderson PA, 1997, J FISH BIOL, V50, P280, DOI 10.1006/jfbi.1996.0291; Henderson PA, 1998, J SEA RES, V40, P131, DOI 10.1016/S1385-1101(98)00020-3; HENDERSON PA, 1991, NETH J SEA RES, V27, P337, DOI 10.1016/0077-7579(91)90036-Z; Hubbell Stephen P., 2001, V32, pi; Krebs C.J., 1999, ECOLOGICAL METHODOLO, DOI DOI 10.4404/HYSTRIX-21.2-4458; LYTHGOE J, 1971, FISHES SEA; Magurran A.E., 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0; May R.M., 1975, P81; Motomura I., 1932, JPN J ZOOL, V44, P379; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Rodrigues ASL, 2000, P ROY SOC B-BIOL SCI, V267, P897, DOI 10.1098/rspb.2000.1087; Southwood R, 2000, ECOLOGICAL METHODS; Southwood TRE, 1996, PHILOS T R SOC B, V351, P1113, DOI 10.1098/rstb.1996.0097; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; TURNPENNY AWH, 1981, CEGB PUBLICATION; WHEELER A, 1969, FISHES BRIT ISLES	25	607	647	9	218	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					714	716		10.1038/nature01547	http://dx.doi.org/10.1038/nature01547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700760				2022-12-01	WOS:000182272300039
J	Martin, GS; Mannino, DM; Eaton, S; Moss, M				Martin, GS; Mannino, DM; Eaton, S; Moss, M			The epidemiology of sepsis in the United States from 1979 through 2000	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATORY RESPONSE SYNDROME; GRAM-NEGATIVE SEPSIS; SEPTIC SHOCK; NATURAL-HISTORY; SIRS; POLYMORPHISM; MORTALITY; SUSCEPTIBILITY; DEFINITIONS	BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.	Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Martin, GS (corresponding author), Emory Univ, Grady Mem Hosp, Dept Med, Div Pulm Allergy & Crit Care, 69 Jesse Hill Jr Dr SE,Rm 2D-004, Atlanta, GA 30303 USA.	greg_martin@emory.org	Martin, Greg/B-4085-2009	Martin, Greg/0000-0002-9684-7593; Mannino, David/0000-0003-3646-7828; NOIRI, Eisei/0000-0002-9515-7582	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL067739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011660] Funding Source: NIH RePORTER; NCRR NIH HHS [L30 RR020488, L30 RR020488-02] Funding Source: Medline; NHLBI NIH HHS [HL K23-67739, K23 HL067739, K23 HL067739-05] Funding Source: Medline; NIAAA NIH HHS [AA R01-11660] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abel SJC, 1998, THORAX, V53, P292, DOI 10.1136/thx.53.4.292; Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039; ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P1222, DOI 10.1001/jama.270.10.1222; ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P2055; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Alberti C, 2002, INTENS CARE MED, V28, P525, DOI 10.1007/s00134-002-1284-8; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bieler GS, 1997, ANAL SURVEY DATA USI; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P31; CHALFIN DB, 1993, JAMA-J AM MED ASSOC, V269, P249, DOI 10.1001/jama.269.2.249; Eaton S, 2002, AM J RESP CRIT CARE, V165, pA471; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; HOYERT DL, 2001, NATL VITAL STAT REPO, V8; HSIA DC, 1990, NEW ENGL J MED, V322, P1540; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Hubacek JA, 2001, CRIT CARE MED, V29, P557, DOI 10.1097/00003246-200103000-00015; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; KIEFT H, 1993, ARCH INTERN MED, V153, P2241, DOI 10.1001/archinte.153.19.2241; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; *NAT CTR HLTH STAT, 2002, NAT HOSP DISCH SURV; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; PITTET D, 1995, INTENS CARE MED, V21, P302, DOI 10.1007/BF01705408; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; SALVO I, 1995, INTENS CARE MED, V21, pS244, DOI 10.1007/BF01740762; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; Wenzel RP, 2001, CRIT CARE MED, V29, P1472, DOI 10.1097/00003246-200107000-00028; Wenzel RP, 2000, NEW ENGL J MED, V343, P1961, DOI 10.1056/NEJM200012283432610; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	49	4299	4769	6	254	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1546	1554		10.1056/NEJMoa022139	http://dx.doi.org/10.1056/NEJMoa022139			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700374	Green Published			2022-12-01	WOS:000182248900005
J	Sharma, L; Dunlop, DD; Song, J; Hayes, KW				Sharma, L; Dunlop, DD; Song, J; Hayes, KW			Quadriceps strength and osteoarthritis progression in maligned and lax knees	ANNALS OF INTERNAL MEDICINE			English	Article							EXERCISE; DISABILITY; RISK; PAIN; HIP	Background: Quadriceps muscle strengthening is a common goal in the management of knee osteoarthritis. In healthy knees, strength protects against new osteoarthritis. In arthritic knees, greater strength may protect joints and thereby delay osteoarthritis progression. Alternatively, in certain joint environments, such as malalignment or laxity, greater strength may, translate into damaging joint reaction forces. The relationship between quadriceps strength and progression of knee osteoarthritis may differ according to these factors. Objective: To determine whether greater quadriceps strength is associated with greater probability of tibiofemoral osteoarthritis progression in malaligned knees and in high-laxity knees. Design: Prospective, longitudinal cohort study. Setting: Academic medical center. Participants: 237 persons with primary knee osteoarthritis, definite tiblofemoral osteophytes, and at least some difficulty with knee-requiring activity. Two hundred thirty completed the 18-month evaluation. The current study primarily involved those without advanced osteoarthritis in either knee (n = 171). Measurements: Quadriceps strength, knee laxity and alignment, and osteoarthritis progression. Results: The predicted probability of tibiofemoral progression was 0.153 (95% Cl, 0.100 to 0.228) in high-strength knees and 0.098 (Cl, 0.061 to 0.155) in low-strength knees. In malaligned knees, high strength was associated with a significant increase (P = 0.03) in the likelihood of progression (predicted probability, 0.406 [Cl, 0.226 to 0.615] vs. 0.187 [Cl, 0.081 to 0.375] in high-strength vs. low-strength knees). Strength was also associated with increased likelihood of progression in high-laxity knees (P = 0.003 when high laxity was defined as greater than or equal to6.75 degrees). The probability of patellofemoral progression did not differ between high- and low-strength knees in the full sample or within subsets. Conclusions: Greater quadriceps strength at baseline was associated with increased likelihood of tibiofemoral osteoarthritis progression in malaligned knees and lax knees. Subset-specific approaches beyond strengthening exercises should be developed to enhance joint-protective muscle activity.	Northwestern Univ, Sch Med, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Sharma, L (corresponding author), Northwestern Univ, Sch Med, Feinberg Sch Med, Div Rheumatol, 300 E Super Ave,Tarry Bldg 3-715, Chicago, IL 60611 USA.			Sharma, Leena/0000-0002-5571-1622	NCRR NIH HHS [RR-00048] Funding Source: Medline; NIAMS NIH HHS [AR-30692] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR030692] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Baker K, 2000, CURR OPIN RHEUMATOL, V12, P456, DOI 10.1097/00002281-200009000-00020; BRAGE ME, 1994, CLIN ORTHOPAEDICS, V304, P184; Brandt KD, 1999, J RHEUMATOL, V26, P2431; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; Chaisson CE, 1999, ARTHRITIS RHEUM-US, V42, P33, DOI 10.1002/1529-0131(199901)42:1<33::AID-ANR4>3.0.CO;2-I; CHAO EYS, 1994, ORTHOP CLIN N AM, V25, P379; Dieppe P, 1995, OSTEOARTHRITIC DISOR, P481; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FISHER NM, 1991, ARCH PHYS MED REHAB, V72, P365; Gerber L.H., 2001, OSTEOARTHRITIS DIAGN, P413; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HSU RWW, 1990, CLIN ORTHOP RELAT R, V255, P215; KANNUS P, 1989, AM J SPORT MED, V17, P83, DOI 10.1177/036354658901700114; KANNUS P, 1988, CLIN ORTHOP RELAT R, V226, P103; LANKHORST GJ, 1985, SCAND J REHABIL MED, V17, P167; MARKOLF KL, 1981, J BONE JOINT SURG AM, V63, P570, DOI 10.2106/00004623-198163040-00007; MARKS R, 1994, J THEOR BIOL, V170, P283, DOI 10.1006/jtbi.1994.1189; MCALINDON TE, 1993, ANN RHEUM DIS, V52, P258, DOI 10.1136/ard.52.4.258; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Rejeski WJ, 1996, J GERONTOL B-PSYCHOL, V51, pP24, DOI 10.1093/geronb/51B.1.P24; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Sharma L, 1999, ARTHRITIS RHEUM-US, V42, P25, DOI 10.1002/1529-0131(199901)42:1<25::AID-ANR3>3.0.CO;2-G; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Solomonow M, 1994, KNEE, P107; TETSWORTH K, 1994, ORTHOP CLIN N AM, V25, P367; Van Baar ME, 1999, ARTHRITIS RHEUM-US, V42, P1361, DOI 10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9; van Baar ME, 1998, J RHEUMATOL, V25, P125; Wada M, 1996, BRIT J RHEUMATOL, V35, P560; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; WOO SL, 2001, OSTEOARTHRITIS DIAGN, P145	35	222	225	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					613	619		10.7326/0003-4819-138-8-200304150-00006	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693882	Green Submitted			2022-12-01	WOS:000182173800001
J	Yoshikawa, S; McKinnon, RD; Kokel, M; Thomas, JB				Yoshikawa, S; McKinnon, RD; Kokel, M; Thomas, JB			Wnt-mediated axon guidance via the Drosophila derailed receptor	NATURE			English	Article							TYROSINE KINASE FAMILY; ROBO RECEPTORS; CNS MIDLINE; COMMISSURAL AXONS; VENTRAL ECTODERM; WINGLESS GENE; EXPRESSION; PROTEIN; RYK; DIFFERENTIATION	In nervous systems with bilateral symmetry, many neurons project axons across the midline to the opposite side. In each segment of the Drosophila embryonic nervous system, axons that display this projection pattern choose one of two distinct tracts: the anterior or posterior commissure. Commissure choice is controlled by Derailed, an atypical receptor tyrosine kinase expressed on axons projecting in the anterior commissure. Here we show that Derailed keeps these axons out of the posterior commissure by acting as a receptor for Wnt5, a member of the Wnt family of secreted signalling molecules. Our results reveal an unexpected role in axon guidance for a Wnt family member, and show that the Derailed receptor is an essential component of Wnt signalling in these guidance events.	Salk Inst Biol Studies, Mol Neurobiol Lab, San Diego, CA 92186 USA; Robert Wood Johnson Med Sch, Dept Surg, Piscataway, NJ 08854 USA; Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol, Piscataway, NJ 08854 USA	Salk Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Thomas, JB (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, POB 85800, San Diego, CA 92186 USA.		McKinnon, Randall D/B-4699-2010	McKinnon, Randall/0000-0002-7539-9613				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dittrich R, 1997, DEVELOPMENT, V124, P2515; EISENBERG LM, 1992, DEV BIOL, V154, P73, DOI 10.1016/0012-1606(92)90049-M; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Gieseler K, 1999, MECH DEVELOP, V85, P123, DOI 10.1016/S0925-4773(99)00097-0; Golembo M, 1996, DEVELOPMENT, V122, P3363; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Katso RM, 1999, MOL CELL BIOL, V19, P6427; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moreau-Fauvarque C, 2002, NEUROREPORT, V13, P2309, DOI 10.1097/00001756-200212030-00028; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RUSSELL J, 1992, DEVELOPMENT, V115, P475; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yoshikawa S, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0002.2001	50	326	331	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					583	588		10.1038/nature01522	http://dx.doi.org/10.1038/nature01522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12660735				2022-12-01	WOS:000182111400033
J	Barbosa-Cesnik, C; Schwartz, K; Foxman, B				Barbosa-Cesnik, C; Schwartz, K; Foxman, B			Lactation mastitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-FEEDING WOMEN; PUERPERAL MASTITIS; STAPHYLOCOCCUS-AUREUS; PROSPECTIVE COHORT; RISK-FACTORS; INFLAMMATION; MANAGEMENT; POSTPARTUM		Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Mol & Clin Epidemiol Infect Dis, Ann Arbor, MI 48109 USA; Wayne State Univ, Dept Family Med, Detroit, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University	Barbosa-Cesnik, C (corresponding author), Univ Michigan, Dept Epidemiol, 109 Observ St, Ann Arbor, MI 48109 USA.	cibele@umich.edu	Dahlen, Hannah/V-1034-2019	Dahlen, Hannah/0000-0002-4450-3078; Foxman, Betsy/0000-0001-6682-238X				Amir L H, 1999, J Hum Lact, V15, P221, DOI 10.1177/089033449901500312; Bedinghaus JM, 1997, PRIMARY CARE, V24, P147; BRODRIBB W, 1991, BREASTFEEDING MANAGE; Buescher ES, 2001, CELL IMMUNOL, V210, P87, DOI 10.1006/cimm.2001.1813; Castro M, 1999, J NURSE-MIDWIFERY, V44, P280, DOI 10.1016/S0091-2182(99)00040-3; DEVEREUX WP, 1970, AM J OBSTET GYNECOL, V108, P78, DOI 10.1016/0002-9378(70)90208-5; DIXON JM, 1988, BRIT MED J, V297, P1517, DOI 10.1136/bmj.297.6662.1517; EIDELMAN AI, 1979, OBSTET GYNECOL, V53, P550; EVANS M, 1995, BREASTFEED REV, V3, P65; Fetherston C, 2001, Breastfeed Rev, V9, P5; Fetherston C, 1997, Breastfeed Rev, V5, P13; Fetherston C, 1998, J Hum Lact, V14, P101, DOI 10.1177/089033449801400209; Fetherston C, 1997, Breastfeed Rev, V5, P5; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; Fujiwara Y, 2001, Kansenshogaku Zasshi, V75, P898; Hager WD, 1992, INFECT PROTOCOLS OBS, P27; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; JONSSON S, 1994, ANN CHIR GYNAECOL FE, V83, P84; KAUFMANN R, 1991, SOC SCI MED, V33, P701, DOI 10.1016/0277-9536(91)90024-7; Kinlay JR, 1998, MED J AUSTRALIA, V169, P310, DOI 10.5694/j.1326-5377.1998.tb140282.x; Kinlay JR, 2001, AUST NZ J PUBL HEAL, V25, P115, DOI 10.1111/j.1753-6405.2001.tb01831.x; Marchant DJ, 2002, OBSTET GYN CLIN N AM, V29, P89, DOI 10.1016/S0889-8545(03)00054-8; MARSHALL BR, 1975, JAMA-J AM MED ASSOC, V233, P1377, DOI 10.1001/jama.233.13.1377; MCLACHLAN Z, 1993, BREASTFEEDING REV, V2, P316; NIEBYL JR, 1978, J REPROD MED, V20, P97; OGLE KS, 1978, J FAM PRACTICE, V26, P139; OLSEN CG, 1990, AM FAM PHYSICIAN, V41, P1509; Osterman K L, 2000, J Hum Lact, V16, P297, DOI 10.1177/089033440001600405; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Riordan J M, 1990, J Hum Lact, V6, P53, DOI 10.1177/089033449000600213; Ryan AS, 2002, PEDIATRICS, V110, P1103, DOI 10.1542/peds.110.6.1103; Schwartz K, 2002, J FAM PRACTICE, V51, P439; Shellshear M, 1981, Aust J Physiother, V27, P15, DOI 10.1016/S0004-9514(14)60742-X; THOMSEN AC, 1984, AM J OBSTET GYNECOL, V149, P492, DOI 10.1016/0002-9378(84)90022-X; THOMSEN AC, 1983, AM J OBSTET GYNECOL, V146, P938, DOI 10.1016/0002-9378(83)90969-9; Vogel A, 1999, BIRTH-ISS PERINAT C, V26, P218, DOI 10.1046/j.1523-536x.1999.00218.x; World Health Organization, 2000, MAST CAUS MAN	38	72	77	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1609	1612		10.1001/jama.289.13.1609	http://dx.doi.org/10.1001/jama.289.13.1609			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672715				2022-12-01	WOS:000181944500001
J	Beroud, C; Karliova, M; Bonnefont, JP; Benachi, A; Munnich, A; Dumez, Y; Lacour, B; Paterlini-Brechot, P				Beroud, C; Karliova, M; Bonnefont, JP; Benachi, A; Munnich, A; Dumez, Y; Lacour, B; Paterlini-Brechot, P			Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells	LANCET			English	Article							MATERNAL BLOOD	Spinal muscular atrophy (SMA) has a prevalence of one in 6000 births and a one in 40 heterozygote frequency. We aimed to develop a routine test for non-invasive prenatal diagnosis. We tested blood with ISET (isolation by size of epithelial tumour or trophoblastic cells) in 12 pregnant women whose babies were at risk of SMA. Using genetic analysis of fetal cells, we identified SMA In all nine Isolated from the three mothers carrying an affected child. There was no mutation in any of the 26 fetal cells isolated from the nine women with an unaffected child. Our results show that non-invasive detection of genetic diseases by the analysis of maternal blood is feasible.	Hop Necker Enfants Malad, Lab Biochim A, Paris, France; Hop Necker Enfants Malad, Serv Matern, Paris, France; Hop Necker Enfants Malad, Med Genet Lab, Paris, France; Hop Necker Enfants Malad, Lab Biochim B, Paris, France; Fac Med Necker Enfants Malad, INSERM, U370, F-75730 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Paterlini-Brechot, P (corresponding author), Hop Necker Enfants Malad, Lab Biochim A, Paris, France.		BEROUD, Christophe/A-8381-2008	BEROUD, Christophe/0000-0003-2986-8738; BONNEFONT, Jean-Paul/0000-0002-4235-1197; Paterlini- Brechot, Patrizia/0000-0001-7981-6325				Bianchi DW, 1999, BRIT J HAEMATOL, V105, P574, DOI 10.1046/j.1365-2141.1999.01383.x; Chan V, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60535-1; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Saugier-Veber P, 2001, J MED GENET, V38, P240, DOI 10.1136/jmg.38.4.240; Vona G, 2002, AM J PATHOL, V160, P51, DOI 10.1016/S0002-9440(10)64348-9	5	31	56	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					1013	1014		10.1016/S0140-6736(03)12798-5	http://dx.doi.org/10.1016/S0140-6736(03)12798-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660061				2022-12-01	WOS:000181699700014
J	Wilczak, N; de Vos, RAI; De Keyser, J				Wilczak, N; de Vos, RAI; De Keyser, J			Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis	LANCET			English	Article							PROGRAMMED CELL-DEATH; FACTOR-I; ALS; SYSTEM; MUSCLE; CORDS; NERVE	Background Insulin-like growth factor-I (IGF-I) is a potent survival factor for motor neurons and is being investigated as possible therapeutic agent for amyotrophic lateral sclerosis. However, very little information is available on the components of the IGF-I system in this disease. Insulinlike growth factor binding proteins (IGFBPs) play an important part in regulating the bioavailability of IGF-I. Methods We investigated the components of the IGF-I system in spinal cord sections of ten patients with amyotrophic lateral sclerosis and in ten controls without neurological disease. IGF-I was studied by western immunoblotting. IGFBPs and IGF-I receptors were investigated by immunohistochemistry and Western immunoblotting. Findings Total IGF-I in ventral horn homogenates did not differ between patients and controls. However, free IGF-I was 53% lower in patients than in controls. Compared with controls, immunoreactivity in the spinal motor neurons of patients with amyotrophic lateral sclerosis was 64% higher for IGFBP2, 46% higher for IGFBP5, and 33% higher for IGFBP6, with upregulation of IGF-I receptors. Immunoreactivity for IGFBPs1, 3, and 4 did not differ between patients and controls. Interpretation In the ventral horns of patients, free IGF-I is reduced, which could be because of specific increases in IGFBPs 2, 5, and 6 in spinal motor neurons. This abnormality might have an important role in the processes leading to motor neuron death, and should be taken into account when developing treatments aimed to stimulate IGF-I receptors in motor neurons.	Acad Ziekenhuis Groningen, Dept Neurol, Groningen, Netherlands; Oost Nederland, Dept Pathol, Enschede, Netherlands	University of Groningen	De Keyser, J (corresponding author), Univ Groningen Hosp, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.		Wilczak, Nadine/G-4422-2011; De Keyser, Jacques/D-3725-2013	De Keyser, Jacques/0000-0002-3394-7757				ADEM A, 1994, MOL NEUROBIOL, V9, P225, DOI 10.1007/BF02816121; Babajko S, 1997, J ENDOCRINOL, V152, P221, DOI 10.1677/joe.0.1520221; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; BRAUNSTEIN GD, 1987, J NEUROL NEUROSUR PS, V50, P792, DOI 10.1136/jnnp.50.6.792; Brooke MH, 1996, NEUROLOGY, V47, pS108, DOI 10.1212/WNL.47.4_Suppl_2.108S; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chou SM, 1998, J NEUROL SCI, V160, pS73, DOI 10.1016/S0022-510X(98)00202-0; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; D'Costa AP, 1998, J NEUROBIOL, V36, P379; DENYS EH, 1988, MUSCLE NERVE, V11, P1000; Dore S, 1996, MOL BRAIN RES, V41, P128, DOI 10.1016/0169-328X(96)00081-2; FESTOFF BW, 1995, J NEUROL SCI, V129, P114, DOI 10.1016/0022-510X(95)00080-L; Gustafsson T, 1999, J ENDOCRINOL, V161, P245, DOI 10.1677/joe.0.1610245; Hammarberg H, 1998, J COMP NEUROL, V400, P57; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KERKHOFF H, 1994, ACTA NEUROPATHOL, V87, P411, DOI 10.1007/BF00313611; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; LEWIS ME, 1993, EXP NEUROL, V124, P73, DOI 10.1006/exnr.1993.1177; Loddick SA, 1998, P NATL ACAD SCI USA, V95, P1894, DOI 10.1073/pnas.95.4.1894; Meins M, 2001, J NEUROSCI, V21, P8830, DOI 10.1523/JNEUROSCI.21-22-08830.2001; NEUHOFF V, 1979, H-S Z PHYSIOL CHEM, V360, P1657, DOI 10.1515/bchm2.1979.360.2.1657; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sueoka N, 2000, AM J RESP CELL MOL, V23, P297, DOI 10.1165/ajrcmb.23.3.4013; Sueoka N, 2000, ONCOGENE, V19, P4432, DOI 10.1038/sj.onc.1203813; Torres-Aleman I, 1998, NEUROLOGY, V50, P772, DOI 10.1212/WNL.50.3.772; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035	27	71	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					1007	1011		10.1016/S0140-6736(03)12828-0	http://dx.doi.org/10.1016/S0140-6736(03)12828-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660059				2022-12-01	WOS:000181699700012
J	Grueber, WB; Jan, LY; Jan, YN				Grueber, WB; Jan, LY; Jan, YN			Different levels of the homeodomain protein cut regulate distinct dendrite branching patterns of Drosophila multidendritic neurons	CELL			English	Article							SENSORY ORGAN IDENTITY; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE-COMPLEX; DNA-BINDING; BICOID PROTEIN; MOTOR-NEURON; EXPRESSION; LOCUS; SPECIFICATION; TRANSFORMATION	Functionally similar neurons can share common dendrite morphology, but how different neurons are directed into similar forms is not understood. Here, we show in embryonic and larval development that the level of Cut immunoreactivity in individual dendritic arborization (da) sensory neurons correlates with distinct patterns of terminal dendrites: high Cut in neurons with extensive unbranched terminal protrusions (dendritic spikes), medium levels in neurons with expansive and complex arbors, and low or nondetectable Cut in neurons with simple dendrites. Loss of Cut reduced dendrite growth and class-specific terminal branching, whereas overexpression of Cut or a mammalian homolog in lower-level neurons resulted in transformations toward the branch morphology of high-Cut neurons. Thus, different levels of a homeoprotein can regulate distinct patterns of dendrite branching.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Dept Biochem, 533 Parnassus Ave,Room U226, San Francisco, CA 94143 USA.	ynjan@itsa.ucsf.edu		Jan, Lily/0000-0003-3938-8498; Grueber, Wesley/0000-0001-6751-256X; Jan, Yuh Nung/0000-0003-1367-6299	NINDS NIH HHS [1 F32 NS43027-01A1, 1R01 NS 40929-0, T32 NS007067-23] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, T32NS007067, F32NS043027] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; ANDRES V, 1992, DEVELOPMENT, V116, P321; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Beck JC, 2000, J NEUROSCI METH, V98, P155, DOI 10.1016/S0165-0270(00)00200-4; BLOCHLINGER K, 1993, DEVELOPMENT, V117, P441; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Brewster R, 2001, MECH DEVELOP, V105, P57, DOI 10.1016/S0925-4773(01)00375-6; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; JACK JW, 1985, CELL, V42, P869, DOI 10.1016/0092-8674(85)90283-1; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; KOESTER SE, 1992, J NEUROSCI, V12, P1382; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LIU S, 1991, GENETICS, V127, P151; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Ludlow C, 1996, DEV BIOL, V178, P149, DOI 10.1006/dbio.1996.0205; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Merritt DJ, 1997, MICROSC RES TECHNIQ, V39, P492, DOI 10.1002/(SICI)1097-0029(19971215)39:6<492::AID-JEMT4>3.0.CO;2-G; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Quaggin SE, 1996, J BIOL CHEM, V271, P22624, DOI 10.1074/jbc.271.37.22624; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; YOON SO, 1994, J BIOL CHEM, V269, P18453; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	47	223	228	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 21	2003	112	6					805	818		10.1016/S0092-8674(03)00160-0	http://dx.doi.org/10.1016/S0092-8674(03)00160-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654247	Bronze			2022-12-01	WOS:000181818500008
J	Whitfield, J				Whitfield, J			Alien-hunters get scope to search	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					249	249		10.1038/422249b	http://dx.doi.org/10.1038/422249b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646886	Bronze			2022-12-01	WOS:000181637300010
J	Kaniecki, R				Kaniecki, R			Headache assessment and management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TENSION-TYPE HEADACHE; AMERICAN MIGRAINE; UNITED-STATES; SUMATRIPTAN; POPULATION; EPIDEMIOLOGY; PREVALENCE; MEDICATION		Univ Pittsburgh, Dept Neurol, Headache Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaniecki, R (corresponding author), Univ Pittsburgh, Dept Neurol, Headache Ctr, 120 Lytton Ave,Suite 300, Pittsburgh, PA 15213 USA.	kanieckirg@msx.upmc.edu						*AM AC NEUR, 2003, AAN ENC KIT HEAD; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Barbanti P, 2002, CEPHALALGIA, V22, P256, DOI 10.1046/j.1468-2982.2002.00358.x; Bigal ME, 2000, HEADACHE, V40, P241, DOI 10.1046/j.1526-4610.2000.00035.x; Cady RK, 2000, CLIN THER, V22, P1035, DOI 10.1016/S0149-2918(00)80083-1; CARP H, 1994, ANESTH ANALG, V79, P180; DOWSON A, 2002, CEPHALALGIA, V22, P590; FRISHBERG BM, 2003, EVIDENCE BASED GUIDE; Halpern MT, 2002, HEADACHE, V42, P984, DOI 10.1046/j.1526-4610.2002.02228.x; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Jensen Rigmor, 2001, Curr Treat Options Neurol, V3, P169, DOI 10.1007/s11940-001-0052-3; Kaniecki RG, 2002, NEUROLOGY, V58, pS15, DOI 10.1212/WNL.58.9_suppl_6.S15; Kaniecki RG, 2001, HEADACHE, V41, P862, DOI 10.1046/j.1526-4610.2001.01157.x; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Lipton RB, 2000, JAMA-J AM MED ASSOC, V284, P2599, DOI 10.1001/jama.284.20.2599; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; MAIZELS M, 2002, HEADACHE, V42, P416; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; ROSENBERG J, 1995, NEUROLOGY, V45, P1411; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; SCHREIBER C, 2002, ANN SCI M AM HEAD SO; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Sheftell FD, 2002, HEADACHE, V42, P58, DOI 10.1046/j.1526-4610.2002.02015.x; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Snow V, 2002, ANN INTERN MED, V137, P840, DOI 10.7326/0003-4819-137-10-200211190-00014; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Wiest FC, 2002, JAMA-J AM MED ASSOC, V288, P2609, DOI 10.1001/jama.288.20.2609	28	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1430	1433		10.1001/jama.289.11.1430	http://dx.doi.org/10.1001/jama.289.11.1430			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636467				2022-12-01	WOS:000181616200036
J	Langmore, NE; Hunt, S; Kilner, RM				Langmore, NE; Hunt, S; Kilner, RM			Escalation of a coevolutionary arms race through host rejection of brood parasitic young	NATURE			English	Article							CUCULUS-CANORUS; REED WARBLERS; CUCKOO; DISCRIMINATION; CONSTRAINTS; EVOLUTION; MODEL; EGGS	Cuckoo nestlings that evict all other young from the nest soon after hatching impose a high reproductive cost on their hosts(1). In defence, hosts have coevolved strategies to prevent brood parasitism. Puzzlingly, they do not extend beyond the egg stage(2-5). Thus, hosts adept at recognizing foreign eggs remain vulnerable to exploitation by cuckoo nestlings(6,7). Here we show that the breach of host egg defences by cuckoos creates a new stage in the coevolutionary cycle. We found that defences used during the egg-laying period by host superb fairy-wrens (Malurus cyaneus) are easily evaded by the Horsfield's bronze-cuckoo (Chrysococcyx basalis), a specialist fairy-wren brood parasite. However, although hosts never deserted their own broods, they later abandoned 40% of nests containing a lone Horsfield's bronze-cuckoo nestling, and 100% of nests with a lone shining bronze-cuckoo nestling (Chrysococcyx lucidus), an occasional fairy-wren brood parasite. Our experiments demonstrate that host discrimination against evictor-cuckoo nestlings is possible, and suggest that it has selected for the evolution of nestling mimicry in bronze-cuckoos.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Australian National University; University of Bristol; University of Cambridge	Langmore, NE (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	naomi.langmore@anu.edu.au	Kilner, Rebecca/B-2867-2012; Langmore, Naomi E/C-9302-2009	Kilner, Rebecca/0000-0003-1159-0758; 				BIBBY CJ, 1978, BIRD STUDY, V25, P207, DOI 10.1080/00063657809476599; BROOKE MD, 1988, NATURE, V335, P630; BROOKER MG, 1989, IBIS, V131, P528, DOI 10.1111/j.1474-919X.1989.tb04789.x; BROOKER MG, 1989, AUSTR ZOOLOGICAL REV, V2, P1; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; DAVIDSON LS, 1989, J MACROECON, V11, P1, DOI 10.1016/0164-0704(89)90014-1; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Fraga RM, 1998, OX ORN SER, V9, P173; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kruger O, 2002, P ROY SOC B-BIOL SCI, V269, P375, DOI 10.1098/rspb.2001.1887; Lichtenstein G, 2001, ANIM BEHAV, V61, P401, DOI 10.1006/anbe.2000.1595; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; Lotem A, 1998, OX ORN SER, V9, P223; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; MASON P, 1986, EVOLUTION, V40, P1207, DOI 10.1111/j.1558-5646.1986.tb05745.x; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; MULDER RA, 1992, EVOLUTIONARY ECOLOGY; NIAS RC, 1987, COOPERATIVE BREEDING; OGILVIE MA, 1992, HDB BIRDS EUROPE MID, V6, P193; Payne RB, 1998, OX ORN SER, V9, P152; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; Rowley I., 1997, FAIRY WRENS GRASSWRE; Rowley Ian, 1965, Emu, V64, P251; TIDEMANN SC, 1983, BEHAV ECOLOGY TREE C	27	249	264	2	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					157	160		10.1038/nature01460	http://dx.doi.org/10.1038/nature01460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634784				2022-12-01	WOS:000181488900043
J	Falush, D; Wirth, T; Linz, B; Pritchard, JK; Stephens, M; Kidd, M; Blaser, MJ; Graham, DY; Vacher, S; Perez-Perez, GI; Yamaoka, Y; Megraud, F; Otto, K; Reichard, U; Katzowitsch, E; Wang, XY; Achtman, M; Suerbaum, S				Falush, D; Wirth, T; Linz, B; Pritchard, JK; Stephens, M; Kidd, M; Blaser, MJ; Graham, DY; Vacher, S; Perez-Perez, GI; Yamaoka, Y; Megraud, F; Otto, K; Reichard, U; Katzowitsch, E; Wang, XY; Achtman, M; Suerbaum, S			Traces of human migrations in Helicobacter pylori populations	SCIENCE			English	Article							GENETIC-STRUCTURE; ASIAN GENOTYPES; RECOMBINATION; STRAINS; MARKERS	Helicobacter pylori, a chronic gastric pathogen of human beings, can be divided into seven populations and subpopulations with distinct geographical distributions. These modern populations derive their gene pools from ancestral populations that arose in Africa, Central Asia, and East Asia. Subsequent spread can be attributed to human migratory fluxes such as the prehistoric colonization of Polynesia and the Americas, the neolithic introduction of farming to Europe, the Bantu expansion within Africa, and the stave trade.	Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Univ Bordeaux 2, F-33076 Bordeaux, France; Univ Wurzburg, Inst Hyg & Mikrobiol, D-97080 Wurzburg, Germany	Max Planck Society; University of Chicago; University of Washington; University of Washington Seattle; Yale University; New York University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); UDICE-French Research Universities; Universite de Bordeaux; University of Wurzburg	Achtman, M (corresponding author), Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany.	achtman@mpiib-berlin.mpg.de	Graham, David/AAL-2165-2021; Wirth, Thierry/B-4915-2008; Perez, Guillermo Perez/AAJ-3761-2020	Wirth, Thierry/0000-0002-7371-0172; Achtman, Mark/0000-0001-6815-0070; Perez Perez, Guillermo/0000-0002-0131-5798; Yamaoka, Yoshio/0000-0002-1222-5819	NIGMS NIH HHS [R02GM63270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; FALUSH D, UNPUB; Feldman RA, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P29; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Graham DY, 2000, HELICOBACTER, V5, pS3; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; LI WH, 1991, GENETICS, V129, P513; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; Pritchard JK, 2000, GENETICS, V155, P945; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0	25	700	734	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1582	1585		10.1126/science.1080857	http://dx.doi.org/10.1126/science.1080857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624269				2022-12-01	WOS:000181367900040
J	Carr, A; Emery, S; Law, I; Puls, R; Lundgren, JD; Powderly, WG; Carr, B; Cooper, DA; Grinspoon, S; Ioannidis, J; Lewis, R; Law, M; Lichtenstein, K; Murray, J; Pizzuti, D; Rozenbaum, W; Schambelan, M; Moore, A; Miller, J				Carr, A; Emery, S; Law, I; Puls, R; Lundgren, JD; Powderly, WG; Carr, B; Cooper, DA; Grinspoon, S; Ioannidis, J; Lewis, R; Law, M; Lichtenstein, K; Murray, J; Pizzuti, D; Rozenbaum, W; Schambelan, M; Moore, A; Miller, J		HIV Lipodystrophy Case Definition	An objective case definition of lipodystrophy in HIV-infected adults: a case-control study	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS INFECTION; PREADIPOCYTE DIFFERENTIATION; METABOLIC ABNORMALITIES; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; RISK; PREVALENCE	Background Lipodystrophy (peripheral lipoatrophy, central fat accumulation, and lipomatosis) is a common and disfiguring problem in adult patients with HIV-1 infection on antiretrovirals. However, an objective, validated definition of the disorder does not exist. We aimed to develop an objective, sensitive, specific, and broadly applicable case definition of HIV lipodystrophy. Methods In a case-control study, 1081 consecutive, HIV-infected, adult outpatients (261 [15%] women) without active AIDS were recruited from 32 sites worldwide. We classed patients with at least one moderate or severe subjective lipodystrophic feature, identified by lipodystrophy-specific physical examination and patient questionnaire, and apparent to both doctor and patient as cases (n=417). We classed patients with no such feature as controls (n=371), and patients without a clear diagnosis as non-assigned. We used objective clinical, metabolic, and body composition measurements to construct a logistic regression model with a subset of randomly selected cases and controls. The model was validated in the remaining patients. Findings A model including age, sex, duration of HIV infection, HIV disease stage, waist to hip ratio, anion gap, serum HDL cholesterol concentration, trunk to peripheral fat ratio, percentage leg fat, and intra-abdominal to extra-abdominal fat ratio had 79% (95% CI 70-85) sensitivity and 80% (95% Cl 71-87) specificity for diagnosis of lipodystrophy. Models that incorporated only clinical, or only clinical and metabolic variables had lower sensitivity and specificity than the inclusive model. Models for lipoatrophy, fat accumulation, and lipomatosis could not be developed since pure phenotypes occurred in fewer than 10% of patients with clinical diagnoses of these disorders. Interpretation Our objective case definition of HIV-associated lipodystrophy should improve assessment of lipodystrophy prevalence, risk factors, and pathogenesis; prevention and treatment approaches; and assist in diagnosis.	St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Hvidovre Univ Hosp, Copenhagen, Denmark; Washington Univ, Sch Med, St Louis, MO USA; Forum Collaborat HIV Res, Baltimore, MD USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Ioannina, GR-45110 Ioannina, Greece; Agouron Pharmaceut, San Diego, CA USA; HIV Outpatient Study Ctr Dis Control & Prevent, Denver, CO USA; US FDA, US Dept HHS, Washington, DC 20204 USA; Bristol Myers Squibb Co, Princeton, NJ USA; Hop Rothschild, F-75571 Paris, France; Agence Natl Res SIDA, Paris, France; Univ Calif San Francisco, San Francisco, CA 94143 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute; University of Copenhagen; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; University of Ioannina; Pfizer; US Food & Drug Administration (FDA); Bristol-Myers Squibb; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco	Carr, A (corresponding author), St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia.	acarr@stvincents.com.au	Lundgren, Jens/AAE-6876-2019; Ioannidis, John P. A./G-9836-2011; Puls, Rebekah/A-3992-2013; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Law, Matthew/0000-0002-3540-8837; Rozenbaum, Willy/0000-0003-1975-3566; Lundgren, Jens/0000-0001-8901-7850; Powderly, William/0000-0001-7808-3086				Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belloso WH, 2003, JAIDS-J ACQ IMM DEF, V32, P104, DOI 10.1097/00126334-200301010-00015; Caron M, 2001, DIABETES, V50, P1378, DOI 10.2337/diabetes.50.6.1378; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 2002, LANCET, V360, P81, DOI 10.1016/S0140-6736(02)09341-8; Dowell P, 2000, J BIOL CHEM, V275, P41325, DOI 10.1074/jbc.M006474200; Duran S, 2001, AIDS, V15, P2441, DOI 10.1097/00002030-200112070-00012; Egger M, 2001, AIDS, V15, pS193, DOI 10.1097/00002030-200100005-00023; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grunfeld C., 2002, 14 INT AIDS C BARC S; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hyams KC, 1998, EPIDEMIOL REV, V20, P148, DOI 10.1093/oxfordjournals.epirev.a017977; KINGSLEY L, 2001, 8 C RETR OPP INF CHI; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Marcos MA, 2001, LANCET, V357, P1499, DOI 10.1016/S0140-6736(00)04658-4; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; *NAT CHOL ED PROGR, FRAM CARD RISK EQ; Roche R, 2002, AIDS, V16, P13, DOI 10.1097/00002030-200201040-00003; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thiebaut R, 2000, CLIN INFECT DIS, V31, P1482, DOI 10.1086/317477; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; Yarasheski KE, 1999, J ACQ IMMUN DEF SYND, V21, P209, DOI 10.1097/00126334-199907010-00005	32	337	347	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					726	735		10.1016/S0140-6736(03)12656-6	http://dx.doi.org/10.1016/S0140-6736(03)12656-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620736				2022-12-01	WOS:000181232000007
J	Ong, ACM; Wheatley, DN				Ong, ACM; Wheatley, DN			Polycystic kidney disease - the ciliary connection	LANCET			English	Review							TRANSGENIC MICE; GENE HOMOLOG; C-ELEGANS	Context "Cystic degeneration" of the kidneys was first described pathologically in 1841 and "polycystic kidneys" as a clinical syndrome in 1888. The heritable nature in some families was noted in 1899, and autosomal dominant and, recessive patterns of inheritance of polycystic kidney disease (PKD) were later recognised. Autosomal dominant PKD is one, of the most common human genetic diseases and results, from mutations in PKD1 or PKD2. These genes encode two proteins, polycystin-1 and polycystin-2. Starting point Primary cilia are cellular organelles previously,thought by some to be vestigial. New findings from several, species, including algae, nematodes, and mice, implicate, defects in structure or function of primary cilia as a possible common mechanism central to the development of some forms of recessive PKD. Two recent reports propose a causal link between ciliary dysfunction and autosomal dominant PKD. B Yoder and colleagues (J Am Soc Nephrol 2002; 13:, 2508-16) show that polycystin-1 and polycystin-2 are localised to primary cilia in cultured renal epithelial cells. S Nauli and colleagues (Nat Genet 2003; 33: 129-37) show that polycystin-1 and polycystin-2 function as flow-sensitive mechanosensors in the same signal-transduction pathway. Where next? Cystic epithelial cells show many altered cellular properties, including changes in proliferation, apoptosis, adhesion, differentiation, polarity, extracellular matrix synthesis, and fluid transport. The next important steps in PKD research will be to define the physiological roles: of primary renal cilia and how defects in ciliary structure and function lead to the development of a cystic phenotype in: different forms of PKD.	Univ Sheffield, Div Clin Sci N, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England; Univ Aberdeen, Dept Cell Pathol, Aberdeen, Scotland	University of Sheffield; University of Aberdeen	Ong, ACM (corresponding author), Univ Sheffield, Div Clin Sci N, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; ARCHER FL, 1971, J ANAT, V109, P277; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; SCHAFFNER DL, 1993, AM J PATHOL, V142, P1051; Streets AJ, 2002, J AM SOC NEPHROL, V13, p46A; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zimmerman KW, 1898, ARCH MIKROSK ANAT, V52, P552, DOI [10.1007/BF02975837, DOI 10.1007/BF02975837]	28	103	107	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					774	776		10.1016/S0140-6736(03)12662-1	http://dx.doi.org/10.1016/S0140-6736(03)12662-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620752				2022-12-01	WOS:000181232000022
J	Bridle, KR; Frazer, DM; Wilkins, SJ; Dixon, JL; Purdie, DM; Crawford, DHG; Subramaniam, VN; Powell, LW; Anderson, GJ; Ramm, GA				Bridle, KR; Frazer, DM; Wilkins, SJ; Dixon, JL; Purdie, DM; Crawford, DHG; Subramaniam, VN; Powell, LW; Anderson, GJ; Ramm, GA			Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis	LANCET			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; GENE; OVERLOAD; PROTEIN; EXPRESSION; MUTATIONS; CLONING; SLC11A3	Background The mechanisms responsible for disturbed iron homoeostasis in hereditary haemochromatosis are poorly understood. However, results of some studies indicate a link between hepcidin, a liver-derived peptide, and intestinal iron absorption, suggesting that this molecule could play a part in hepatic iron overload. To investigate this possible association, we studied the hepatic expression of the gene for hepcidin (HAMP) and a gene important in iron transport (IREG1) in patients with haemochromatosis, in normal controls, and in Hfe-knockout mice. Methods We extracted total RNA from the liver tissue of 27 patients with HFE-associated haemochromatosis, seven transplant donors (controls), and Hfe-knockout mice. HAMP and IREG1 mRNA concentrations were examined by ribonuclease protection assays and expressed relative to the housekeeping gene GAPD. Findings There was a significant decrease in HAMP expression in untreated patients compared with controls (5.4-fold, 95% CI 3.3-7.5; p<0.0001) despite significantly increased iron loading. Similarly, we noted a decrease in Hamp expression in iron-loaded Hfe-knockout mice. Hepatic IREG1 expression was greatly upregulated in patients with haemochromatosis (1.8-fold, 95% CI 1.5-2.2; p=0.002). There was a significant correlation between hepatic iron concentration and expression of HAMP (r=0.59, p=0.02) and IREG1 (r=0.67, p=0.007) in untreated patients. Interpretation Lack of HAMP upregulation in HFE-associated haemochromatosis despite significant hepatic iron loading indicates that HFE plays an important part in the regulation of hepcidin expression in response to iron overload. Our results imply that the liver is important in the pathophysiology of HFE-associated haemochromatosis. Furthermore, the increase in hepatic IREG1 expression in haemochromatosis suggests that IREG1 could function to facilitate the removal of excess iron from the liver.	Royal Brisbane Hosp, Queensland Inst Med Res, Lab Iron Metab, Iron Metab Grp, Herston, Qld 4029, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Hepat Fibrosis Grp, Herston, Qld 4029, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Membrane Transport Grp, Herston, Qld 4029, Australia; Univ Queensland, Dept Med, St Lucia, Qld 4067, Australia; Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Anderson, GJ (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Lab Iron Metab, Iron Metab Grp, Herston, Qld 4029, Australia.		Bridle, Kim/F-6266-2010; Anderson, Gregory J/G-4148-2013; Ramm, Grant A/G-2669-2013; Crawford, Darrell HG/F-2157-2010; Frazer, David M/L-3570-2014; Subramaniam, V. Nathan/A-1901-2010	Bridle, Kim/0000-0002-7090-1387; Anderson, Gregory J/0000-0002-8814-5866; Ramm, Grant A/0000-0001-7058-6201; Frazer, David M/0000-0003-4098-1379; Subramaniam, V. Nathan/0000-0002-4583-7790; Crawford, Darrell/0000-0001-8480-5954	NIDDK NIH HHS [R01 DK57648-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057648] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDERSON GJ, 2002, MOL CELLULAR IRON TR, P559; BASSETT ML, 1984, SEMIN LIVER DIS, V4, P217, DOI 10.1055/s-2008-1041772; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; Cardoso EM, 2002, BLOOD, V100, P4239, DOI 10.1182/blood-2002-05-1565; Crawford D, 2002, HEPATOLOGY, V36, p194A; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; Jouanolle AM, 1997, HUM GENET, V100, P544, DOI 10.1007/s004390050549; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MCLAREN GD, 1991, J LAB CLIN MED, V117, P390; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI13468; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; NIEDERAU C, 1994, BAIL CL HAE, V7, P881, DOI 10.1016/S0950-3536(05)80129-5; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; OLYNYK JK, 1994, POSTGRAD MED, V96, P151, DOI 10.1080/00325481.1994.11945914; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POWELL LW, 1980, GASTROENTEROLOGY, V78, P374; Stuart, 1977, ADV THEORY STAT; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260	30	484	499	2	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					669	673		10.1016/S0140-6736(03)12602-5	http://dx.doi.org/10.1016/S0140-6736(03)12602-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606179				2022-12-01	WOS:000181129500017
J	Drosten, C; Gunther, S; Preiser, W; van der Werf, S; Brodt, HR; Becker, S; Rabenau, H; Panning, M; Kolesnikova, L; Fouchier, RAM; Berger, A; Burguiere, AM; Cinatl, J; Eickmann, M; Escriou, N; Grywna, K; Kramme, S; Manuguerra, JC; Muller, S; Rickerts, V; Sturmer, M; Vieth, S; Klenk, HD; Osterhaus, ADME; Schmitz, H; Doerr, HW				Drosten, C; Gunther, S; Preiser, W; van der Werf, S; Brodt, HR; Becker, S; Rabenau, H; Panning, M; Kolesnikova, L; Fouchier, RAM; Berger, A; Burguiere, AM; Cinatl, J; Eickmann, M; Escriou, N; Grywna, K; Kramme, S; Manuguerra, JC; Muller, S; Rickerts, V; Sturmer, M; Vieth, S; Klenk, HD; Osterhaus, ADME; Schmitz, H; Doerr, HW			Identification of a novel coronavirus in patients with severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LASSA VIRUS; FEVER	BACKGROUND The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS The novel coronavirus might have a role in causing SARS.	Bernhard Nocht Inst Trop Med, Dept Virol, Natl Reference Ctr Trop Infect Dis, D-20359 Hamburg, Germany; Goethe Univ Frankfurt, Inst Med Virol, D-6000 Frankfurt, Germany; Goethe Univ Frankfurt, Med Clin 3, D-6000 Frankfurt, Germany; Univ Marburg, Inst Virol, D-3550 Marburg, Germany; Inst Pasteur, Natl Influenza Ctr No France, Paris, France; Erasmus Univ, Inst Virol, Rotterdam, Netherlands	Bernhard Nocht Institut fur Tropenmedizin; Goethe University Frankfurt; Goethe University Frankfurt; Philipps University Marburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Erasmus University Rotterdam	Drosten, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Natl Reference Ctr Trop Infect Dis, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	drosten@bni-hamburg.de	Fouchier, Ron A/A-1911-2014; Preiser, Wolfgang/J-4875-2016; Becker, Stefanie/AEM-2050-2022; Becker, Stephan/A-1065-2010; Escriou, Nicolas/A-2392-2016; Panning, Marcus/I-7889-2016	Fouchier, Ron A/0000-0001-8095-2869; Preiser, Wolfgang/0000-0002-0254-7910; Becker, Stephan/0000-0002-2794-5659; Escriou, Nicolas/0000-0002-1224-6839; Vieth, Simon/0000-0002-2765-1589; Sturmer, Martin/0000-0003-4300-9315; Gunther, Stephan/0000-0002-6562-0230; Osterhaus, Albert/0000-0002-6074-1172; van der WERF, Sylvie/0000-0002-1148-4456				[Anonymous], 2003, Wkly Epidemiol Rec, V78, P73; [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; Cho KO, 2001, AM J VET RES, V62, P1436, DOI 10.2460/ajvr.2001.62.1436; Cossart Y, 1998, LANCET, V352, P164, DOI 10.1016/S0140-6736(05)77802-8; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Felsenstein J, 2000, PHYLIP PHYLOGENY INF; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Kew MC, 1996, LANCET, V348, pSII10; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, 2003, CUM NUMB REP CAS SEV	13	2983	3370	10	433	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1967	1976		10.1056/NEJMoa030747	http://dx.doi.org/10.1056/NEJMoa030747			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12690091	Green Published, Bronze			2022-12-01	WOS:000182823400005
J	Carpenter, SJ; Erickson, JM; Holland, FD				Carpenter, SJ; Erickson, JM; Holland, FD			Migration of a Late Cretaceous fish	NATURE			English	Article							UNITED-STATES; OTOLITHS; CLIMATE	Late Cretaceous sediments from the Western Interior of North America yield exceptionally well preserved fossils(1,2) that serve as proxies for the rapidly changing climate preceding the Cretaceous/ Tertiary boundary (about 67-65 Myr ago)(3,4). Here we reconstruct the ontogenetic history of a Maastrichtian-age fish, Vorhisia vulpes(5), by using the carbon, oxygen and strontium isotope ratios of four aragonite otoliths collected from the Fox Hills Formation of South Dakota. Individuals of V. vulpes spawned in brackish water (about 70-80% seawater) and during their first year migrated to open marine waters of the Western Interior Seaway, where they remained for 3 years before returning to the estuary, presumably to spawn and die. The mean delta(18)O from the marine growth phase of V. vulpes yields a seawater temperature of 18 degreesC, which is consistent with leaf physiognomy and general-circulation-model temperature estimates for the Western Interior during the latest Maastrichtian(4,6,7).	Univ Iowa, Dept Geosci, Paul H Nelson Stable Isotope Lab, Iowa City, IA 52242 USA; Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; St Lawrence Univ, Dept Geol, Canton, NY 13617 USA; Univ N Dakota, Dept Geol & Geol Engn, Grand Forks, ND 58202 USA	University of Iowa; University of Iowa; Saint Lawrence University; University of North Dakota Grand Forks	Carpenter, SJ (corresponding author), Univ Iowa, Dept Geosci, Paul H Nelson Stable Isotope Lab, Iowa City, IA 52242 USA.	scott-j-carpenter@uiowa.edu						Andrus CFT, 2002, SCIENCE, V295, P1508, DOI 10.1126/science.1062004; Barrera E, 1999, GEOL S AM S, P245; BARRON EJ, 1993, PHILOS T R SOC B, V341, P307, DOI 10.1098/rstb.1993.0116; CARPENTER SJ, 1988, J SEDIMENT PETROL, V58, P706; CARPENTER SJ, 2002, GEOL SOC AM ABSTR, P31; Dettman DL, 2000, GEOLOGY, V28, P243, DOI 10.1130/0091-7613(2000)028<0243:OIEFHA>2.3.CO;2; Erickson J.M., 1999, N DAKOTA ACAD SCI P, V53, P124; Erickson J.M., 1992, N DAKOTA GEOLOGICAL, V76, P199; Frizzell D.L., 1965, COPEIA, V1965, P178, DOI DOI 10.2307/1440721; Healey MC, 1987, COMMON STRATEGIES AN, VI, P298; HUDDLESTON R W, 1983, Proceedings of the Biological Society of Washington, V96, P658; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; MCARTHUR JM, 1994, PALAEOGEOGR PALAEOCL, V108, P95, DOI 10.1016/0031-0182(94)90024-8; McCormick S.D., 1987, AM FISH SOC S, V1, P211; Nolf Dirk, 1996, P433; Patterson WP, 1999, GEOLOGY, V27, P199, DOI 10.1130/0091-7613(1999)027<0199:OICFOP>2.3.CO;2; PATTERSON WP, 1993, CLIMATE CHANGE CONTI, P191; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Randall R, 1987, AM FISHERIES SOC S, P27; Schwarcz HP, 1998, CAN J FISH AQUAT SCI, V55, P1798, DOI 10.1139/cjfas-55-8-1798; SHACKLETON NJ, 1975, INIT REP DSDP, V74, P761; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; URSIN E, 1979, S ZOOL SOC LOND, V44, P63; WAAGE KM, 1968, YALE U B, V27; Weidman CR, 2000, FISH RES, V46, P327, DOI 10.1016/S0165-7836(00)00157-0; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; Wurster CM, 2001, PALAEOGEOGR PALAEOCL, V170, P81, DOI 10.1016/S0031-0182(01)00229-2; WURSTER CM, IN PRESS PALEOBIOLOG	29	52	56	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					70	74		10.1038/nature01575	http://dx.doi.org/10.1038/nature01575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721626				2022-12-01	WOS:000182561600040
J	Temeles, EJ; Kress, WJ				Temeles, EJ; Kress, WJ			Adaptation in a plant-hummingbird association	SCIENCE			English	Article							AGE-SEX CLASSES; RUFOUS HUMMINGBIRDS; DIMORPHISM; BEHAVIOR	Sexual dimorphism in bill morphology and body size of the Caribbean purple-throated carib hummingbird is associated with a reversal in. oral dimorphism of its Heliconia food plants. This hummingbird is the sole pollinator of H. caribaea and H. bihai, with flowers of the former corresponding to the short, straight bills of males, the larger sex, and flowers of the latter corresponding to the long, curved bills of females. On St. Lucia, H. bihai compensates for the rarity of H. caribaea by evolving a second color morph with flowers that match the bills of males, whereas on Dominica, H. caribaea evolves a second color morph with flowers that match the bills of females. The nectar rewards of all Heliconia morphs are consistent with each sex's choice of the morph that corresponds to its bill morphology and energy requirements, supporting the hypothesis that feeding preferences have driven their coadaptation.	Amherst Coll, Dept Biol, Amherst, MA 01002 USA; Smithsonian Inst, Natl Museum Nat Hist, US Natl Herbarium, MRC166, Washington, DC 20013 USA	Amherst College; Smithsonian Institution; Smithsonian National Museum of Natural History	Temeles, EJ (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.		Temeles, Ethan J./AAD-7366-2021					Bleiweiss R, 1999, P ROY SOC B-BIOL SCI, V266, P2491, DOI 10.1098/rspb.1999.0951; CARPENTER FL, 1993, BEHAV ECOL SOCIOBIOL, V33, P297; CARPENTER FL, 1993, BEHAV ECOL SOCIOBIOL, V33, P305; Colwell RK, 2000, AM NAT, V156, P495, DOI 10.1086/303406; Darwin C., 1859, ORIGIN SPECIES MEANS; Faegri K, 1966, PRINCIPLES POLLINATI; FEINSINGER P, 1982, ECOLOGY, V63, P1574, DOI 10.2307/1938881; FEINSINGER P, 1976, ECOL MONOGR, V46, P257, DOI 10.2307/1942255; Reznick David, 1996, P243; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; TEMELES EJ, 1993, OECOLOGIA, V94, P87, DOI 10.1007/BF00317307; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Wallace Alfred R., 1871, CONTRIBUTIONS THEORY; WOLF LL, 1971, ECOLOGY, V52, P980, DOI 10.2307/1933803; WOLF LL, 1975, AUK, V92, P511, DOI 10.2307/4084604	16	136	139	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					630	633		10.1126/science.1080003	http://dx.doi.org/10.1126/science.1080003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714743				2022-12-01	WOS:000182453700039
J	Brent, AE; Schweitzer, R; Tabin, CJ				Brent, AE; Schweitzer, R; Tabin, CJ			A somitic compartment of tendon progenitors	CELL			English	Article							GENE-EXPRESSION; CHICK; SCLERAXIS; ORIGIN; CHONDROGENESIS; MESODERM; MUSCLES; PATTERN; EMBRYO; FATE	We demonstrate that the tendons associated with the axial skeleton derive from a heretofore unappreciated, fourth compartment of the somites. Scleraxis (Scx), a bHLH transcription factor, marks this somitic tendon progenitor population at its inception, and is continuously expressed through differentiation into the mature tendons. Two earlier-formed somitic compartments, the sclerotome and myotome, interact to establish this fourth Scx-positive compartment. The tendon progenitors are induced at the sclerotome's edge, at the expense of skeletogenic Pax1 positive cells and in response to FGF signaling in the adjacent myotome. The tendon primordia thus form in a location abutting the two tissues that the mature tendons must ultimately connect. Tendon progenitor formation may reveal a general mechanism for the specification of other somitic subcompartments.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Harvard University; Harvard Medical School; Oregon Health & Science University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@rascal.med.harvard.edu	Schweitzer, Ronen/AAY-2127-2020	Schweitzer, Ronen/0000-0002-7425-5028	NIDDK NIH HHS [P01 DK56246] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; BERESFORD B, 1983, J EMBRYOL EXP MORPH, V77, P99; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHEVALLIER A, 1979, J EMBRYOL EXP MORPH, V49, P73; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Dockter JL, 1998, DEVELOPMENT, V125, P2113; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Fraidenraich D, 2000, DEV BIOL, V225, P392, DOI 10.1006/dbio.2000.9839; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang RJ, 2000, ANAT EMBRYOL, V202, P195, DOI 10.1007/s004290000110; Huang RJ, 2000, DEVELOPMENT, V127, P527; HURLE JM, 1990, CELL DIFFER DEV, V30, P97, DOI 10.1016/0922-3371(90)90078-B; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Kahane N, 2001, DEVELOPMENT, V128, P2187; Kiefer JC, 2001, DEV BIOL, V232, P77, DOI 10.1006/dbio.2000.0114; KIENY M, 1979, J EMBRYOL EXP MORPH, V49, P153; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; MARCELLE C, 1994, DEVELOPMENT, V120, P683; Monsoro-Burq AH, 2000, CURR TOP DEV BIOL, V48, P43; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; ORDAHL CP, 1993, MOL BASIS MORPHOGENE, P165; Peters H, 1999, DEVELOPMENT, V126, P5399; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; SEARLS RL, 1969, J EXP ZOOL, V170, P365, DOI 10.1002/jez.1401700313; Shellswell G., 1977, VERTEBRATE LIMB SOMI, P71; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; Stolte D, 2002, ANAT EMBRYOL, V205, P1, DOI 10.1007/s00429-002-0227-z; UENO H, 1992, J BIOL CHEM, V267, P1470; Williams BA, 1997, DEVELOPMENT, V124, P4983	36	392	409	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					235	248		10.1016/S0092-8674(03)00268-X	http://dx.doi.org/10.1016/S0092-8674(03)00268-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705871	Bronze			2022-12-01	WOS:000182508500012
J	Kayed, R; Head, E; Thompson, JL; McIntire, TM; Milton, SC; Cotman, CW; Glabe, CG				Kayed, R; Head, E; Thompson, JL; McIntire, TM; Milton, SC; Cotman, CW; Glabe, CG			Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ALZHEIMERS-DISEASE; IN-VITRO; BETA; PEPTIDE; FIBRILS; PROTOFIBRILS; DETERMINANT; POTENT	Soluble oligomers are common to most amyloids and may represent the primary toxic species of amyloids, like the Abeta peptide in Alzheimer's disease (AD). Here we show that all of the soluble oligomers tested display a common conformation-dependent structure that is unique to soluble oligomers regardless of sequence. The in vitro toxicity of soluble oligomers is inhibited by oligomer-specific antibody. Soluble oligomers have a unique distribution in human AD brain that is distinct from fibrillar amyloid. These results indicate that different types of soluble amyloid oligomers have a common structure and suggest they share a common mechanism of toxicity.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Glabe, CG (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.				NIA NIH HHS [AG00538, AG16573] Funding Source: Medline; NINDS NIH HHS [NS31230] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; El-Agnaf OMA, 2001, J MOL BIOL, V310, P157, DOI 10.1006/jmbi.2001.4743; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9	18	3292	3456	6	670	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					486	489		10.1126/science.1079469	http://dx.doi.org/10.1126/science.1079469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702875				2022-12-01	WOS:000182295900040
J	Muller, B; Hartmann, B; Pyrowolakis, G; Affolter, M; Basler, K				Muller, B; Hartmann, B; Pyrowolakis, G; Affolter, M; Basler, K			Conversion of an extracellular Dpp/BMP morphogen gradient into an inverse transcriptional gradient	CELL			English	Article							DROSOPHILA WING DEVELOPMENT; SIGNAL-TRANSDUCTION; IMAGINAL DISCS; BINDING-SITES; DPP TARGETS; BRINKER; GENE; REPRESSION; SCHNURRI; ENCODES	Morphogen gradients control body pattern by differentially regulating cellular behavior. Here, we analyze the molecular events underlying the primary response to the Dpp/BMP morphogen in Drosophila. Throughout development, Dpp transduction causes the graded transcriptional downregulation of the brinker (brk) gene. We first provide significance for the brk expression gradient by showing that different Brk levels repress distinct combinations of wing genes expressed at different distances from Dpp-secreting cells. We then dissect the brk regulatory region and identify two separable elements with opposite properties, a constitutive enhancer and a Dpp morphogen-regulated silencer. Furthermore, we present genetic and biochemical evidence that the brk silencer serves as a direct target for a protein complex consisting of the Smad homologs Mad/Medea and the zinc finger protein Schnurri. Together, our results provide the molecular framework for a mechanism by which the extracellular Dpp/BMP morphogen establishes a finely tuned, graded read-out of transcriptional repression.	Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Basel; University of Zurich	Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Mueller, Bruno/E-9888-2017	Mueller, Bruno/0000-0003-2664-7219; Basler, Konrad/0000-0003-3534-1529; Affolter, Markus/0000-0002-5171-0016				Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; HOCH M, 1993, CURR OPIN GENET DEV, V3, P566, DOI 10.1016/0959-437X(93)90092-4; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Morgan T.H., 1897, ROUX ARCH DEV BIOL, V5, P570; Muller B, 2000, DEVELOPMENT, V127, P2999; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; SEGALAT L, 1994, MECH DEVELOP, V47, P241, DOI 10.1016/0925-4773(94)90042-6; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Torres-Vazquez J, 2000, DEV BIOL, V227, P388, DOI 10.1006/dbio.2000.9900; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WOLPERT L, 1989, DEVELOPMENT, V107, P3	49	143	145	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					221	233		10.1016/S0092-8674(03)00241-1	http://dx.doi.org/10.1016/S0092-8674(03)00241-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705870	Green Accepted, Bronze			2022-12-01	WOS:000182508500011
J	Song, JB; Wu, LL; Chen, Z; Kohanski, RA; Pick, L				Song, JB; Wu, LL; Chen, Z; Kohanski, RA; Pick, L			Axons guided by insulin receptor in Drosophila visual system	SCIENCE			English	Article							ADAPTER PROTEIN; EMBRYONIC-DEVELOPMENT; GUIDANCE; GROWTH; HOMOLOG; MEMORY; DOMAIN; BRAIN; PHOSPHORYLATION; SPECIFICITY	Insulin receptors are abundant in the central nervous system, but their roles remain elusive. Here we show that the insulin receptor functions in axon guidance. The Drosophila insulin receptor (DInR) is required for photoreceptor-cell (R-cell) axons to find their way from the retina to the brain during development of the visual system. DInR functions as a guidance receptor for the adapter protein Dock/Nck. This function is independent of Chico, the Drosophila insulin receptor substrate (IRS) homolog.	Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA	Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University	Pick, L (corresponding author), Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, 1 Gustave Levy Pl, New York, NY 10029 USA.							Ausubel FM, 1992, CURRENT PROTOCOLS MO; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; KOHANSKI RA, UNPUB; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; PETRUZZELLI L, 1985, J BIOL CHEM, V260, P6072; PETRUZZELLI L, 1986, P NATL ACAD SCI USA, V83, P4710, DOI 10.1073/pnas.83.13.4710; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277; Yenush L, 1996, MOL CELL BIOL, V16, P2509; Zaia A, 2000, MECH AGEING DEV, V113, P227, DOI 10.1016/S0047-6374(99)00118-9; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	33	122	125	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					502	505		10.1126/science.1081203	http://dx.doi.org/10.1126/science.1081203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702880				2022-12-01	WOS:000182295900045
J	Casolino, M; Bidoli, V; Morselli, A; Narici, L; DePascale, MP; Picozza, P; Reali, E; Sparvoli, R; Mazzenga, G; Ricci, M; Spillantini, P; Boezio, M; Bonvicini, V; Vacchi, A; Zampa, N; Castellini, G; Sannita, WG; Carlson, P; Galper, A; Korotkov, M; Popov, A; Vavilov, N; Avdeev, S; Fugelsang, C				Casolino, M; Bidoli, V; Morselli, A; Narici, L; DePascale, MP; Picozza, P; Reali, E; Sparvoli, R; Mazzenga, G; Ricci, M; Spillantini, P; Boezio, M; Bonvicini, V; Vacchi, A; Zampa, N; Castellini, G; Sannita, WG; Carlson, P; Galper, A; Korotkov, M; Popov, A; Vavilov, N; Avdeev, S; Fugelsang, C			Space travel - Dual origins of light flashes seen in space	NATURE			English	Article							STATION		Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; Ist Nazl Fis Nucl, LNF, Rome, Italy; Univ Florence, Dept Phys, I-50121 Florence, Italy; Univ Trieste, Dept Phys, I-34127 Trieste, Italy; CNR, IROE, I-50127 Florence, Italy; Univ Genoa, DISMR, Genoa, Italy; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; Royal Inst Technol, Stockholm, Sweden; Moscow State Engn Phys Inst, Moscow, Russia; Russian Space Corp Energia Korolin, Moscow, Russia; European Astronaut Ctr, Cologne, Germany	University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); University of Genoa; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Royal Institute of Technology; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Roscosmos; United Rocket & Space Corporation; S.P. Korolev Rocket & Space Corporation - Energia; European Space Agency	Casolino, M (corresponding author), Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy.	casolino@roma2.infn.it	Vacchi, Andrea G/C-1291-2010; Casolino, Marco/ABI-1081-2020; Galper, Arkady M/M-9610-2015; Boezio, Mirko/ABC-4188-2020; Morselli, Aldo/G-6769-2011; Sparvoli, Roberta/H-8024-2018; Castellini, Guido/C-6716-2018	Vacchi, Andrea G/0000-0003-3855-5856; Boezio, Mirko/0000-0002-8015-2981; Morselli, Aldo/0000-0002-7704-9553; Sparvoli, Roberta/0000-0002-6314-6117; Bonvicini, Valter/0000-0003-1826-5843; Castellini, Guido/0000-0002-0177-0643; casolino, marco/0000-0001-6067-5104; Picozza, Piergiorgio/0000-0002-7986-3321				Avdeev S, 2002, ACTA ASTRONAUT, V50, P511, DOI 10.1016/S0094-5765(01)00190-4; Bidoli V, 2001, J PHYS G NUCL PARTIC, V27, P2051, DOI 10.1088/0954-3899/27/10/307; BUDINGER TF, 1977, SP412 NASA, P193; CHARMAN WN, 1971, NATURE, V230, P522, DOI 10.1038/230522a0; Hoffman RA, 1977, SP377 NASA, P127; HORNECK G, 1992, NUCL TRACKS RAD MEAS, V20, P185; MCNULTY PJ, 1978, SCIENCE, V201, P341, DOI 10.1126/science.663660; PINSKY LS, 1974, SCIENCE, V183, P957, DOI 10.1126/science.183.4128.957; TOBIAS C A, 1952, J Aviat Med, V23, P345	9	72	73	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					680	680		10.1038/422680a	http://dx.doi.org/10.1038/422680a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700751	Bronze			2022-12-01	WOS:000182272300030
J	Siddiqui, A; Kerb, R; Weale, ME; Brinkmann, U; Smith, A; Goldstein, DB; Wood, NW; Sisodiya, SM				Siddiqui, A; Kerb, R; Weale, ME; Brinkmann, U; Smith, A; Goldstein, DB; Wood, NW; Sisodiya, SM			Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GENOMIC DIVERSITY; P-GLYCOPROTEIN; MDR1 GENE; REFRACTORY EPILEPSY; EXPRESSION; BRAIN; CELLS	BACKGROUND: One third of patients with epilepsy have drug-resistant epilepsy, which is associated with an increased risk of death and debilitating psychosocial consequences. Because this form is resistant to multiple antiepileptic drugs, the mode of resistance must be nonspecific, involving drug-efflux transporters such as ATP-binding cassette sub-family B member 1 (ABCB1, also known as MDR1 and P-glycoprotein 170). We hypothesized that the CC genotype at the ABCB1 C3435T polymorphism, which is associated with increased expression of the protein, influences the response to antiepileptic-drug treatment. METHODS: ABCB1 3435 was genotyped in 315 patients with epilepsy, classified as drug-resistant in 200 and drug-responsive in 115, and 200 control subjects without epilepsy. Recently devised methods were used to control for population stratification, and linkage disequilibrium was calculated across the gene. RESULTS: As compared with patients with drug-responsive epilepsy, patients with drug-resistant epilepsy were more likely to have the CC genotype at ABCB1 3435 than the TT genotype (odds ratio, 2.66; 95 percent confidence interval, 1.32 to 5.38; P=0.006). There was no genetic stratification between the two groups of patients. The polymorphism fell within an extensive block of linkage disequilibrium spanning much or all of the gene, implying that the polymorphism may not itself be causal but rather may be linked with the causal variant. CONCLUSIONS: These pharmacogenomic results identify a genetic factor associated with resistance to antiepileptic drugs.	UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; UCL, Inst Neurol, Dept Mol Pathogenesis, London WC1N 3BG, England; UCL, Dept Biol, London WC1N 3BG, England; Epidauros Biotechnol, Pharmacogenet Lab, Bernried, Germany; Natl Neurol Inst, Singapore, Singapore	University of London; University College London; University of London; University College London; University of London; University College London	Sisodiya, SM (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.	s.sisodiya@ion.ucl.ac.uk	Weale, Michael E/F-2587-2010; Wood, Nicholas W/C-2505-2009; Brinkmann, Ulrich/AAF-8216-2019; Goldstein, David/AAY-8125-2020	Weale, Michael E/0000-0003-4593-1186; Wood, Nicholas W/0000-0002-9500-3348; Brinkmann, Ulrich/0000-0002-5558-0212; 				Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Casetta I, 1999, ACTA NEUROL SCAND, V99, P329, DOI 10.1111/j.1600-0404.1999.tb07360.x; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gelisse P, 2001, J NEUROL NEUROSUR PS, V70, P240, DOI 10.1136/jnnp.70.2.240; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Kerb R., 2001, Pharmacogenomics Journal, V1, P204; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Lazarowski A, 1999, PEDIATR NEUROL, V21, P731, DOI 10.1016/S0887-8994(99)00074-0; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Llorente L, 2000, JOINT BONE SPINE, V67, P30; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; MacDonald BK, 2001, ANN NEUROL, V50, P830; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.3.CO;2-L; MACDONALD BK, 2001, ANN NEUROL, V49, P547; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Roy-Engel AM, 2001, GENETICS, V159, P279; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Sisodiya SM, 1999, NEUROREPORT, V10, P3437, DOI 10.1097/00001756-199911080-00032; Sisodiya SM, 2001, LANCET, V357, P42, DOI 10.1016/S0140-6736(00)03573-X; Tai HL, 2000, CURR OPIN MOL THER, V2, P459; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Weir B.S., 1996, GENETIC DATA ANAL	34	509	556	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2003	348	15					1442	1448		10.1056/NEJMoa021986	http://dx.doi.org/10.1056/NEJMoa021986			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665CU	12686700	Green Published			2022-12-01	WOS:000182102700004
J	Buesseler, KO; Boyd, PW				Buesseler, KO; Boyd, PW			Will ocean fertilization work?	SCIENCE			English	Editorial Material							IRON FERTILIZATION; SOUTHERN-OCEAN; PHYTOPLANKTON; BLOOM		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Otago, Dept Chem, Natl Inst Water & Atmospher Res, Ctr Phys & Chem Oceanog, Dunedin 9001, New Zealand	Woods Hole Oceanographic Institution; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu; p.boyd@niwa.co.nz	Boyd, Philip W/J-7624-2014	Boyd, Philip W/0000-0001-7850-1911				Abbott MR, 2001, DEEP-SEA RES PT II, V48, P3891, DOI 10.1016/S0967-0645(01)00073-X; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BUESSELER KO, 2002, EOS S, V83; Charette MA, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000069; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; COALE K, 2002, EOS S, V83; Feely R.A., 2001, OCEANOGRAPHY, V14, P18, DOI DOI 10.5670/0CEAN0G.2001.03; Johnson KS, 2002, SCIENCE, V296, P467; Lawrence MG, 2002, SCIENCE, V297, P1993; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; MARKELS M, 2000, 220 ACS ANN M S CO2; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Nodder SD, 2001, GEOPHYS RES LETT, V28, P2409, DOI 10.1029/2001GL013008; SCHLERMEIER Q, 2003, NATURE, V421, P109; Smetacek V., 2001, US JGOFS NEWS, V11, P11; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P	17	79	81	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					67	68		10.1126/science.1082959	http://dx.doi.org/10.1126/science.1082959			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677048				2022-12-01	WOS:000181988900026
J	Valle, M; Gillet, R; Kaur, S; Henne, A; Ramakrishnan, V; Frank, J				Valle, M; Gillet, R; Kaur, S; Henne, A; Ramakrishnan, V; Frank, J			Visualizing tmRNA entry into a stalled ribosome	SCIENCE			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; PROTEIN S1; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; MESSENGER-RNA; SMPB SYSTEM; EF-TU; BINDING; GTP	Bacterial ribosomes stalled on defective messenger RNAs (mRNAs) are rescued by tmRNA, an similar to300-nucleotide-long molecule that functions as both transfer RNA (tRNA) and mRNA. Translation then switches from the defective message to a short open reading frame on tmRNA that tags the defective nascent peptide chain for degradation. However, the mechanism by which tmRNA can enter and move through the ribosome is unknown. We present a cryo-electron microscopy study at similar to13 to 15 angstroms of the entry of tmRNA into the ribosome. The structure reveals how tmRNA could move through the ribosome despite its complicated topology and also suggests roles for proteins S1 and SmpB in the function of tmRNA.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Albany, NY 12201 USA; Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	MRC Laboratory Molecular Biology; Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk; joachim@wadsworth.org	Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Ramakrishnan, V/0000-0002-4699-2194	NIGMS NIH HHS [GM55440, GM29169, GM 44973] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R37GM029169, R01GM029169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; Bordeau V, 2002, BIOCHIMIE, V84, P723, DOI 10.1016/S0300-9084(02)01442-6; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1997, RNA, V3, P89; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Knudsen B, 2001, NUCLEIC ACIDS RES, V29, P171, DOI 10.1093/nar/29.1.171; LAUGHREA M, 1977, J MOL BIOL, V112, P399, DOI 10.1016/S0022-2836(77)80189-7; Lee S, 2001, RNA, V7, P999, DOI 10.1017/S1355838201010342; Nameki N, 2000, FEBS LETT, V470, P345, DOI 10.1016/S0014-5793(00)01349-1; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Stagg SM, 2001, J MOL BIOL, V309, P727, DOI 10.1006/jmbi.2001.4632; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Williams KP, 1996, RNA, V2, P1306; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612; Wower J, 2002, BIOCHEMISTRY-US, V41, P8826, DOI 10.1021/bi0201365; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zvereva MI, 2001, J BIOL CHEM, V276, P47702, DOI 10.1074/jbc.M106786200; Zwieb C, 1999, NUCLEIC ACIDS RES, V27, P2063, DOI 10.1093/nar/27.10.2063	38	121	128	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					127	130		10.1126/science.1081798	http://dx.doi.org/10.1126/science.1081798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677067				2022-12-01	WOS:000181988900048
J	Flum, DR; Dellinger, EP; Cheadle, A; Chan, L; Koepsell, T				Flum, DR; Dellinger, EP; Cheadle, A; Chan, L; Koepsell, T			Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS FOLLOWING CHOLECYSTECTOMY; BILIARY-TRACT COMPLICATIONS; LAPAROSCOPIC CHOLECYSTECTOMY; OPERATIVE CHOLANGIOGRAPHY; UNITED-STATES; ULTRASONOGRAPHY	Context Intraciperative cholangiography (IOC) may decrease the risk of common bile duct (CBD) injury during cholecystectomy by helping to avoid misidentification of the CBD. Objective To characterize the relationship of IOC use and CBD injury while controlling for patient and surgeon characteristics. Design, Setting, and Patients Retrospective nationwide cohort analysis of Medicare patients undergoing cholecystectomy from January 1, 1992, to December 31, 1999. Patients were identified using Current Procedural Terminology codes from the Medicare Part B depository. Common bile duct injury was defined by a second surgical procedure to repair the CBD injury within 1 year of cholecystectomy. Surgeon demographic features were obtained from matching the Medicare Part B data to the American Medical Association Physician Masterfile database. Main Outcome Measure Frequency of CBD injury in patients who did and did not have IOC performed during cholecystectomy, controlling for patient-level (age, sex, race, and case complexity) and surgeon-level (surgeon's age, sex, race, year of surgical procedure, case order, percentage of IOC use in prior surgical procedures, years in medical practice, board certification, and specialization) factors. Results The database search identified 1570361 cholecystectomies and 7911 CBD injuries (0.5%). Common bile duct injury was found in 2380 (0.39%) of 613 706 patients undergoing cholecystectomy with IOC and in 5531 (0.58%) of 956 655 patients undergoing cholecystectomy without IOC (unadjusted relative risk, 1.49; 95% confidence interval, 1.42-1.57). After controlling for patient-level factors and surgeon-level factors, the risk of injury was increased when IOC was not used (adjusted relative risk, 1.71; 95% confidence interval, 1.38-2.28). While surgeons performing IOCs routinely had a lower rate of CBD injuries than those who did not, this difference disappeared when IOC was not used. Conclusions In this study of Medicare patients undergoing cholecystectomy in the 1990s, the risk of CBD injury was significantly higher when IOC was not used. Although IOCs may not prevent all CBD injuries, this study suggests, that the routine use of IOC may decrease the rate of CBD injury.	Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Robert Wood Johnson Clin Scholars Program, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Ctr Medicare & Medicaid Serv, Div Clin Stand & Qual, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Medicare & Medicaid Services	Flum, DR (corresponding author), Univ Washington, Dept Surg, BB 431,1959 NE Pacific St,Box 356410, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022					Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; ASBUN HJ, 1994, SURG CLIN N AM, V74, P755, DOI 10.1016/S0039-6109(16)46405-4; Baldwin LM, 2002, MED CARE, V40, P82; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birth M, 1996, SURG ENDOSC-ULTRAS, V10, P794, DOI 10.1007/BF00189535; *CDCP NAT CTR HLTH, HOSP CAR STAT BRANCH; Contini S, 1999, J LAPAROENDOSC ADV A, V9, P197, DOI 10.1089/lap.1999.9.197; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fiore NF, 1997, SURGERY, V122, P817, DOI 10.1016/S0039-6060(97)90092-1; Fletcher DR, 1999, ANN SURG, V229, P449, DOI 10.1097/00000658-199904000-00001; Flum DR, 2003, J AM COLL SURGEONS, V196, P385, DOI 10.1016/S1072-7515(02)01806-9; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Gigot JF, 1997, SURG ENDOSC-ULTRAS, V11, P1171, DOI 10.1007/s004649900563; *ING INC, 2000, ICD 9 CM EXP; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Katkhouda N, 2000, SURG ENDOSC-ULTRAS, V14, P88, DOI 10.1007/s004649900020; Ladocsi LT, 1997, AM SURGEON, V63, P150; Machi J, 1999, J AM COLL SURGEONS, V188, P360, DOI 10.1016/S1072-7515(98)00313-5; Mahmud S, 2002, SURG ENDOSC, V16, P581, DOI 10.1007/s00464-001-9094-6; Mirizzi PL, 1937, SURG GYNECOL OBSTET, V65, P702; Moskovitz A H, 2001, Surg Endosc, V15, P1227; *PHYS INS ASS AM, 2000, LAP INJ STUD 2000, P11; *PHYS INS ASS AM, 2000, RISK MAN REV GEN SUR, P15; Podnos YD, 2001, AM J SURG, V182, P663, DOI 10.1016/S0002-9610(01)00808-X; POSTA CG, 1995, SURG LAPAROSC ENDOSC, V5, P412; Roviaro GC, 1997, J ROY COLL SURG EDIN, V42, P324; SOPER NJ, 1994, SURG CLIN N AM, V74, P953, DOI 10.1016/S0039-6109(16)46397-8; TANIGUCHI Y, 1993, AM J GASTROENTEROL, V88, P1258; Taylor B, 1998, CAN MED ASSOC J, V158, P481; Valinsky LJ, 1999, J CLIN EPIDEMIOL, V52, P893, DOI 10.1016/S0895-4356(99)00043-8; Vecchio R, 1998, INT SURG, V83, P215; Vezakis A, 2000, SURG ENDOSC-ULTRAS, V14, P1118, DOI 10.1007/s004640000076; Wherry DC, 1996, ANN SURG, V224, P145, DOI 10.1097/00000658-199608000-00006; WOODS MS, 1994, AM J SURG, V167, P27, DOI 10.1016/0002-9610(94)90050-7; WOODS MS, 1995, SURG ENDOSC-ULTRAS, V9, P1076; Z'graggen K, 1998, SURG ENDOSC-ULTRAS, V12, P1303, DOI 10.1007/s004649900846; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	38	304	317	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1639	1644		10.1001/jama.289.13.1639	http://dx.doi.org/10.1001/jama.289.13.1639			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672731	Bronze			2022-12-01	WOS:000181944500026
J	Read, RC; Cannings, C; Naylor, SC; Timms, JM; Maheswaran, R; Borrow, R; Kaczmarski, EB; Duff, GW				Read, RC; Cannings, C; Naylor, SC; Timms, JM; Maheswaran, R; Borrow, R; Kaczmarski, EB; Duff, GW			Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; PLASMINOGEN-ACTIVATOR-INHIBITOR-1 GENE; CYTOKINE PRODUCTION; ULCERATIVE-COLITIS; INCREASED RISK; ALLELE 2; POLYMORPHISM; ASSOCIATION; SUSCEPTIBILITY; IL-1-BETA	Background: Genetically determined variation in proinflammatory cytokine release influences severity of meningococcal disease and other serious infections. Objective: To ascertain the relative frequencies of single nucleotide polymorphisms within the interleukin-1 gene locus among patients who survived and those who died of meningococcal disease and a control population of blood donors. Design: Association study. Setting: England and Wales. Patients: 1106 consecutively received blood samples from persons with microbiologically confirmed meningococcal disease and 839 samples from blood donors. Measurements: Patient demographic and outcome data, infecting meningococcal serogroups, and genotype at the IL1B(-511) and IL1RN(+2018) loci of patients and blood donor controls. Results: Genotype frequency did not differ between patients with meningococcal disease and blood donor controls. Logistic regression analysis revealed that the likelihood of death was significantly influenced by age but not socioeconomic status and was higher in patients who were infected with serogroup C (odds ratio for survival, 0.50 [95% Cl, 0.33 to 0.78]). Patients carrying the common allele at IL1B(-511) were more likely to survive (odds ratio, 2.01 [Cl, 1.11 to 3.79]). Patients with this allele were less likely to survive if they also carried the rare allele at IL1RN(+2018) (odds ratio, 0.61 [Cl, 0.38 to 0.993]). Conclusion: Genotype at the interleukin-1 gene locus influences likelihood of survival of meningococcal disease but has no effect on susceptibility to the infection. Increasing age and infection with serogroup C also influence the likelihood of death.	Univ Sheffield, Sch Med, Div Genom Med, Sheffield S10 2RX, S Yorkshire, England; Manchester Publ Hlth Lab, Meningococcal Ref Unit England & Wales, Manchester, Lancs, England	University of Sheffield	Read, RC (corresponding author), Univ Sheffield, Sch Med, Div Genom Med, F Floor,Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	r.c.read@sheffield.ac.uk		Read, Robert/0000-0002-4297-6728; Maheswaran, Ravi/0000-0002-3899-4421				Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Carter MJ, 2001, GUT, V48, P461, DOI 10.1136/gut.48.4.461; Cox A, 1999, HUM MOL GENET, V8, P1707, DOI 10.1093/hmg/8.9.1707; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donaldson P, 2001, GUT, V48, P397, DOI 10.1136/gut.48.3.397; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fijen CAP, 2000, CLIN EXP IMMUNOL, V120, P338, DOI 10.1046/j.1365-2249.2000.01208.x; Francis SE, 1999, CIRCULATION, V99, P861, DOI 10.1161/01.CIR.99.7.861; GIRAUD T, 1991, ARCH INTERN MED, V151, P310, DOI 10.1001/archinte.151.2.310; Hefler LA, 2001, FERTIL STERIL, V76, P377, DOI 10.1016/S0015-0282(01)01914-8; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Kondaveeti S, 1999, PEDIATR INFECT DIS J, V18, P893, DOI 10.1097/00006454-199910000-00011; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Makela S, 2001, NEPHROL DIAL TRANSPL, V16, P1368, DOI 10.1093/ndt/16.7.1368; Momiyama Y, 2001, J AM COLL CARDIOL, V38, P712, DOI 10.1016/S0735-1097(01)01438-3; Murphy GM, 2001, NEUROLOGY, V56, P1595, DOI 10.1212/WNL.56.11.1595; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; NICKLIN MJH, 1994, GENOMICS, V19, P382, DOI 10.1006/geno.1994.1076; Niino M, 2001, J NEUROIMMUNOL, V118, P295, DOI 10.1016/S0165-5728(01)00339-3; Read RC, 2000, J INFECT DIS, V182, P1557, DOI 10.1086/315889; RIORDAN FAI, 1995, EUR J PEDIATR, V154, P472; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; TARLOW JK, 1993, HUM GENET, V91, P403; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; Townsend P, 1988, HLTH DEPRIVATION INE; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; vanDeuren M, 1997, BLOOD, V90, P1101, DOI 10.1182/blood.V90.3.1101.1101_1101_1108; Westendorp RGJ, 1999, LANCET, V354, P561, DOI 10.1016/S0140-6736(98)09376-3; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Whyte M, 2000, AM J RESP CRIT CARE, V162, P755, DOI 10.1164/ajrccm.162.2.9909053	37	55	55	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2003	138	7					534	541		10.7326/0003-4819-138-7-200304010-00009	http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BV	12667023				2022-12-01	WOS:000181872100002
J	Gu, LH; Baldocchi, DD; Wofsy, SC; Munger, JW; Michalsky, JJ; Urbanski, SP; Boden, TA				Gu, LH; Baldocchi, DD; Wofsy, SC; Munger, JW; Michalsky, JJ; Urbanski, SP; Boden, TA			Response of a deciduous forest to the Mount Pinatubo eruption: Enhanced photosynthesis	SCIENCE			English	Article							CARBON-DIOXIDE; VOLCANIC SIGNAL; ATMOSPHERIC O-2; CO2; AEROSOLS; EXCHANGE; CLIMATE; CLOUDS; FLUXES; WATER	Volcanic aerosols from the 1991 Mount Pinatubo eruption greatly increased diffuse radiation worldwide for the following 2 years. We estimated that this increase in diffuse radiation alone enhanced noontime photosynthesis of a deciduous forest by 23% in 1992 and 8% in 1993 under cloudless conditions. This finding indicates that the aerosol-induced increase in diffuse radiation by the volcano enhanced the terrestrial carbon sink and contributed to the temporary decline in the growth rate of atmospheric carbon dioxide after the eruption.	Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; SUNY Albany, Atmospher Sci Res Ctr, Albany, NY 12203 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Berkeley; Harvard University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Gu, LH (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, Bldg 1509, Oak Ridge, TN 37831 USA.	lianhong-gu@ornl.gov	Gu, Lianhong/H-8241-2014; Manchun, Kang/D-3194-2011; Munger, J William/H-4502-2013; Baldocchi, Dennis/A-1625-2009	Gu, Lianhong/0000-0001-5756-8738; Munger, J William/0000-0002-1042-8452; Baldocchi, Dennis/0000-0003-3496-4919				Baldocchi D, 1997, PLANT CELL ENVIRON, V20, P1108, DOI 10.1046/j.1365-3040.1997.d01-147.x; Baldocchi DD, 2002, TREE PHYSIOL, V22, P1065, DOI 10.1093/treephys/22.15-16.1065; BARAN AJ, 1994, J GEOPHYS RES-ATMOS, V99, P25673, DOI 10.1029/94JD02044; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; BLUMTHALER M, 1994, TELLUS B, V46, P76, DOI 10.1034/j.1600-0889.1994.00007.x; BLUTH GJS, 1992, GEOPHYS RES LETT, V19, P151, DOI 10.1029/91GL02792; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; DUTTON EG, 1992, GEOPHYS RES LETT, V19, P2313, DOI 10.1029/92GL02495; Freedman JM, 2001, J CLIMATE, V14, P180, DOI 10.1175/1520-0442(2001)013<0180:BLCAVA>2.0.CO;2; GOUDRIAAN J, 1977, P249; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001242; Hansen J, 1996, GEOPHYS RES LETT, V23, P1665, DOI 10.1029/96GL01040; Herber A, 1996, J GEOPHYS RES-ATMOS, V101, P3921, DOI 10.1029/95JD02462; HOLLINGER DY, 1994, ECOLOGY, V75, P134, DOI 10.2307/1939390; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jones CD, 2001, GLOBAL BIOGEOCHEM CY, V15, P453, DOI 10.1029/2000GB001281; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; MCCORMICK MP, 1995, NATURE, V373, P399, DOI 10.1038/373399a0; MICHALSKY JJ, 1994, SOL ENERGY, V52, P205, DOI 10.1016/0038-092X(94)90070-1; MINNIS P, 1993, SCIENCE, V259, P1411, DOI 10.1126/science.259.5100.1411; Molineaux B, 1996, SOL ENERGY, V58, P91, DOI 10.1016/0038-092X(96)00051-5; Olmo FJ, 1996, SOL ENERGY, V57, P433; Parker DE, 1996, INT J CLIMATOL, V16, P487, DOI 10.1002/(SICI)1097-0088(199605)16:5<487::AID-JOC39>3.0.CO;2-J; PRICE DT, 1990, AGR FOREST METEOROL, V50, P139, DOI 10.1016/0168-1923(90)90050-G; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Randel DL, 1996, B AM METEOROL SOC, V77, P1233, DOI 10.1175/1520-0477(1996)077<1233:ANGWVD>2.0.CO;2; ROBOCK A, 1995, J CLIMATE, V8, P1086, DOI 10.1175/1520-0442(1995)008<1086:TVSIST>2.0.CO;2; Robock A, 2002, SCIENCE, V295, P1242, DOI 10.1126/science.1069903; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Schimel DS, 1996, GLOBAL BIOGEOCHEM CY, V10, P677, DOI 10.1029/96GB01524; Song NH, 1996, GEOPHYS RES LETT, V23, P2657, DOI 10.1029/96GL02372; Stenchikov GL, 1998, J GEOPHYS RES-ATMOS, V103, P13837, DOI 10.1029/98JD00693; STOWE LL, 1992, GEOPHYS RES LETT, V19, P159, DOI 10.1029/91GL02958; TREPTE CR, 1993, J GEOPHYS RES-ATMOS, V98, P18563, DOI 10.1029/93JD01362; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314	42	436	485	8	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2035	2038		10.1126/science.1078366	http://dx.doi.org/10.1126/science.1078366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663919				2022-12-01	WOS:000181834200045
J	Xu, J; Bjursell, MK; Himrod, J; Deng, S; Carmichael, LK; Chiang, HC; Hooper, LV; Gordon, JI				Xu, J; Bjursell, MK; Himrod, J; Deng, S; Carmichael, LK; Chiang, HC; Hooper, LV; Gordon, JI			A genomic view of the human-Bacteroides thetaiotaomicron symbiosis	SCIENCE			English	Article							OUTER-MEMBRANE PROTEINS; COMMENSAL; STARCH	The human gut is colonized with a vast community of indigenous microorganisms that help shape our biology. Here, we present the complete genome sequence of the Gram-negative anaerobe Bacteroides thetaiotaomicron, a dominant member of our normal distal intestinal microbiota. Its 4779-member proteome includes an elaborate apparatus for acquiring and hydrolyzing otherwise indigestible dietary polysaccharides and an associated environment-sensing system consisting of a large repertoire of extracytoplasmic function sigma factors and one- and two-component signal transduction systems. These and other expanded paralogous groups shed light on the molecular mechanisms underlying symbiotic host-bacterial relationships in our intestine.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	jgordon@molecool.wustl.edu	Xu, Jian/A-6831-2008; Xu, Jian/G-8430-2012	Xu, Jian/0000-0002-0548-8477	NIDDK NIH HHS [DK30292] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Della JN, 1996, J BACTERIOL, V178, P7180; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; SALYERS AA, 1993, GENETICS MOL BIOL AN, P505; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Whittle G, 2002, J BACTERIOL, V184, P3839, DOI 10.1128/JB.184.14.3839-3847.2002; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4	20	959	1447	3	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2074	2076		10.1126/science.1080029	http://dx.doi.org/10.1126/science.1080029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663928				2022-12-01	WOS:000181834200057
J	Bowers, JE; Chapman, BA; Rong, JK; Paterson, AH				Bowers, JE; Chapman, BA; Rong, JK; Paterson, AH			Unravelling angiosperm genome evolution by phylogenetic analysis of chromosomal duplication events	NATURE			English	Article							NUCLEOTIDE SUBSTITUTION; ARABIDOPSIS; RICE; ORGANIZATION; SEGMENTS; SEQUENCE; SYNTENY; DICOTS; TOMATO; PLANTS	Conservation of gene order in vertebrates is evident after hundreds of millions of years of divergence(1,2), but comparisons of the Arabidopsis thaliana sequence(3) to partial gene orders of other angiosperms (flowering plants) sharing common ancestry, similar to170-235 million years ago(4) yield conflicting results(5-11). This difference may be largely due to the propensity of angiosperms to undergo chromosomal duplication ('polyploidization') and subsequent gene loss(12) ('diploidization'); these evolutionary mechanisms have profound consequences for comparative biology. Here we integrate a phylogenetic approach (relating chromosomal duplications to the tree of life) with a genomic approach (mitigating information lost to diploidization) to show that a genome-wide duplication(3,13-17) post-dates the divergence of Arabidopsis from most dicots. We also show that an inferred ancestral gene order for Arabidopsis reveals more synteny with other dicots (exemplified by cotton), and that additional, more ancient duplication events affect more distant taxonomic comparisons. By using partial sequence data for many diverse taxa to better relate the evolutionary history of completely sequenced genomes to the tree of life, we foster comparative approaches to the study of genome organization, consequences of polyploidy, and the molecular basis of quantitative traits.	Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Bowers, John/AAD-7601-2019; Bowers, John/B-9245-2009	Bowers, John/0000-0001-8984-9796; Chapman, Brad/0000-0002-3026-1856; Bowers, John/0000-0001-5693-2796				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; BENTON MJ, 1993, FOSSIL RECORD, V2; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Eckardt NA, 2001, PLANT CELL, V13, P1699, DOI 10.1105/tpc.13.8.1699; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grant D, 2000, P NATL ACAD SCI USA, V97, P4168, DOI 10.1073/pnas.070430597; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koch M, 1999, PLANT BIOLOGY, V1, P529, DOI 10.1111/j.1438-8677.1999.tb00779.x; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Lee JM, 2001, THEOR APPL GENET, V103, P765, DOI 10.1007/s001220100658; Liu H, 2001, GENOME RES, V11, P2020, DOI 10.1101/gr.194501; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mayer K, 2001, GENOME RES, V11, P1167, DOI 10.1101/gr.GR-1617R; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Rossberg M, 2001, PLANT CELL, V13, P979, DOI 10.1105/tpc.13.4.979; Salse J, 2002, NUCLEIC ACIDS RES, V30, P2316, DOI 10.1093/nar/30.11.2316; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Smith SF, 2002, GENOME RES, V12, P776, DOI 10.1101/gr.221802; Strauss E, 1999, SCIENCE, V283, P1435, DOI 10.1126/science.283.5407.1435; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang CQ, 2000, TEXT CHEM COLOR AM D, V32, P43; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Zhang LQ, 2002, MOL BIOL EVOL, V19, P1464, DOI 10.1093/oxfordjournals.molbev.a004209	30	1140	1198	6	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2003	422	6930					433	438		10.1038/nature01521	http://dx.doi.org/10.1038/nature01521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660784				2022-12-01	WOS:000181801200045
J	Burchard, EG; Ziv, E; Coyle, N; Gomez, SL; Tang, H; Karter, AJ; Mountain, JL; Perez-Stable, EJ; Sheppard, D; Risch, N				Burchard, EG; Ziv, E; Coyle, N; Gomez, SL; Tang, H; Karter, AJ; Mountain, JL; Perez-Stable, EJ; Sheppard, D; Risch, N			The importance of race and ethnic background in biomedical research and clinical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FACTOR-V-LEIDEN; GENETIC-STRUCTURE; AFRICAN-AMERICAN; CROHNS-DISEASE; ADMIXTURE; POPULATIONS; DISPARITIES; ASSOCIATION; PREVALENCE; EVOLUTION		Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Effectiveness Res Ctr Diverse Populat, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; No Calif Canc Ctr, Union City, CA USA; Kaiser Permanente, Div Res, Dept Epidemiol & Hlth Serv Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Stanford University; Stanford University; Stanford University; Stanford University; Kaiser Permanente	Burchard, EG (corresponding author), Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA.		Ziv, Elad/L-5396-2014		NCI NIH HHS [K22 CA109351] Funding Source: Medline; NHLBI NIH HHS [K23 HL004464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA109351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM CIV RIGHTS COA, 2002, RAC PRIV IN; Angier Natalie, 2000, NY TIMES        1107, pF1; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; DEAN M, 1994, AM J HUM GENET, V55, P788; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Gifford AL, 2002, NEW ENGL J MED, V346, P1373, DOI 10.1056/NEJMsa011565; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Institute of Medicine, 2002, UNEQUAL TREATMENT WH; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; LANDER E, 2001, CRACKING CODE LIFE; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; RISCH N, 2002, GENOME BIOL, V3; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Schulman KA, 1999, NEW ENGL J MED, V340, P1130; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shen MC, 1997, THROMB RES, V87, P377, DOI 10.1016/S0049-3848(97)00141-2; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens JC, 2001, SCIENCE, V293, P1048; Williams RC, 2000, AM J HUM GENET, V66, P527, DOI 10.1086/302773; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; YU MC, 1994, J NATL CANCER I, V86, P712, DOI 10.1093/jnci/86.9.712	35	755	783	1	37	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1170	1175		10.1056/NEJMsb025007	http://dx.doi.org/10.1056/NEJMsb025007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646676				2022-12-01	WOS:000181628400015
J	Schulze, ED; Mollicone, D; Achard, F; Matteucci, G; Federici, S; Eva, HD; Valentini, R				Schulze, ED; Mollicone, D; Achard, F; Matteucci, G; Federici, S; Eva, HD; Valentini, R			Climate change - Making deforestation pay under the Kyoto Protocol?	SCIENCE			English	Editorial Material							FORESTS		Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, TP 440, I-21020 Ispra, Italy; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ Tuscia, Dept Forest Environm & Resources, I-01100 Viterbo, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; Max Planck Society; Tuscia University	Achard, F (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, TP 440, I-21020 Ispra, Italy.		Matteucci, Giorgio/AAB-7022-2021; EVA, Hugh D/F-8412-2011; Schulze, Ernst-Detlef/K-9627-2014; Matteucci, Giorgio/N-3526-2015; Valentini, Riccardo/D-1226-2010	Matteucci, Giorgio/0000-0002-4790-9540; Valentini, Riccardo/0000-0002-6756-5634				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; BROWN S, 2000, LAND USE LAND USE CH, pCH5; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schulze ED, 2002, GLOBAL CHANGE BIOL, V8, P505, DOI 10.1046/j.1365-2486.2002.00523.x; Steffen W, 1998, SCIENCE, V280, P1393; *UNFCCC, 2002, ACT IMPL JOINTL LIST; *UNFCCC, 2001, BONN AGR IMPL BUEN A; *UNFCCC, 2002, METH ISS SUBM PART; UNFCCC, 2002, MARR ACC; UNFCCC, 1997, KYOT PROT; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; *WINR INT, 2000, PRACT EXP PIL PROJ N	12	16	16	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1669	1669		10.1126/science.1079024	http://dx.doi.org/10.1126/science.1079024			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637722				2022-12-01	WOS:000181519500021
J	Aebersold, R				Aebersold, R			Constellations in a cellular universe	NATURE			English	Editorial Material									Univ Washington, Dept Biol Mol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Aebersold, R (corresponding author), Univ Washington, Dept Biol Mol, Seattle, WA 98195 USA.								0	74	83	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					115	116		10.1038/422115a	http://dx.doi.org/10.1038/422115a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634755				2022-12-01	WOS:000181488900017
J	Delneri, D; Colson, I; Grammenoudi, S; Roberts, IN; Louis, EJ; Oliver, SG				Delneri, D; Colson, I; Grammenoudi, S; Roberts, IN; Louis, EJ; Oliver, SG			Engineering evolution to study speciation in yeasts	NATURE			English	Article							SENSU-STRICTO COMPLEX; SACCHAROMYCES-CEREVISIAE; REDUNDANCY; GENOME; TRANSLOCATION; STERILITY; BAYANUS; SYSTEM; HYBRID; CELLS	The Saccharomyces 'sensu stricto' yeasts are a group of species that will mate with one another, but interspecific pairings produce sterile hybrids. A retrospective analysis of their genomes revealed that translocations between the chromosomes of these species do not correlate with the group's sequence-based phylogeny(1) (that is, translocations do not drive the process of speciation). However, that analysis was unable to infer what contribution such rearrangements make to reproductive isolation between these organisms. Here, we report experiments that take an interventionist, rather than a retrospective approach to studying speciation, by reconfiguring the Saccharomyces cerevisiae genome so that it is collinear with that of Saccharomyces mikatae. We demonstrate that this imposed genomic collinearity allows the generation of interspecific hybrids that produce a large proportion of spores that are viable, but extensively aneuploid. We obtained similar results in crosses between wild-type S. cerevisiae and the naturally collinear species Saccharomyces paradoxus, but not with non-collinear crosses. This controlled comparison of the effect of chromosomal translocation on species barriers suggests a mechanism for the generation of redundancy in the S. cerevisiae genome(2).	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Leicester	Oliver, SG (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	steve.oliver@man.ac.uk	Oliver, Stephen/AAQ-5992-2021; Louis, Edward/B-7920-2008; Roberts, Ian N/B-9743-2008	Oliver, Stephen/0000-0003-3410-6439; Louis, Edward/0000-0003-1157-3608; Delneri, Daniela/0000-0001-8070-411X				ADAMS A, 1997, METHODS YEAST GENETI, P145; [Anonymous], SACCHAROMYCES GENOME; BENGTSSON BO, 1976, ANN HUM GENET, V40, P253, DOI 10.1111/j.1469-1809.1976.tb00188.x; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Delneri D, 1999, GENETICS, V153, P1591; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; GARDNER DCJ, 1993, YEAST, V9, P1053, DOI 10.1002/yea.320091003; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kielland-Brandt MC, 1983, YEAST GENETICS FUNDA, P421; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; Loidl J, 1998, CHROMOSOMA, V107, P247, DOI 10.1007/s004120050304; Lynch M, 2001, GENETICS, V159, P1789; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Naumov GI, 1997, SYST APPL MICROBIOL, V20, P595, DOI 10.1016/S0723-2020(97)80031-8; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; NAUMOV GI, 1987, EXPANDING REALM YEAS; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ryu SL, 1998, CURR GENET, V33, P345, DOI 10.1007/s002940050346; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Tamai Y, 1998, YEAST, V14, P923, DOI 10.1002/(SICI)1097-0061(199807)14:10<923::AID-YEA298>3.3.CO;2-9; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	26	181	187	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					68	72		10.1038/nature01418	http://dx.doi.org/10.1038/nature01418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621434				2022-12-01	WOS:000181343100038
J	Boffelli, D; McAuliffe, J; Ovcharenko, D; Lewis, KD; Ovcharenko, I; Pachter, L; Rubin, EM				Boffelli, D; McAuliffe, J; Ovcharenko, D; Lewis, KD; Ovcharenko, I; Pachter, L; Rubin, EM			Phylogenetic shadowing of primate sequences to find functional regions of the human genome	SCIENCE			English	Article							CORONARY-HEART-DISEASE; EPSILON-GLOBIN; LIPOPROTEIN(A); APOLIPOPROTEIN(A); GENES; GAMMA	Nonhuman primates represent the most relevant model organisms to understand the biology of Homo sapiens. The recent divergence and associated overall sequence conservation between individual members of this taxon have nonetheless largely precluded the use of primates in comparative sequence studies. We used sequence comparisons of an extensive set of Old World and New World monkeys and hominoids to identify functional regions in the human genome. Analysis of these data enabled the discovery of primate-specific gene regulatory elements and the demarcation of the exons of multiple genes. Much of the information content of the comprehensive primate sequence comparisons could be captured with a small subset of phylogenetically close primates. These results demonstrate the utility of intraprimate sequence comparisons to discover common mammalian as well as primate-specific functional elements in the human genome, which are unattainable through the evaluation of more evolutionarily distant species.	USDA, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rubin, EM (corresponding author), USDA, Joint Genome Inst, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov		Ovcharenko, Dmitriy/0000-0003-1271-1099; Pachter, Lior/0000-0002-9164-6231	NHGRI NIH HHS [R01-HG02362-01] Funding Source: Medline; NHLBI NIH HHS [HL66728] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066728] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002362] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWN RM, 1995, J BIOL CHEM, V270, P24004, DOI 10.1074/jbc.270.41.24004; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; Notredame C, 2001, BIOINFORMATICS, V17, P373, DOI 10.1093/bioinformatics/17.4.373; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; WADE DP, 1994, J BIOL CHEM, V269, P19757; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	14	392	423	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1391	1394		10.1126/science.1081331	http://dx.doi.org/10.1126/science.1081331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610304	Green Submitted			2022-12-01	WOS:000181192300051
J	Mayor, U; Guydosh, NR; Johnson, CM; Grossmann, JG; Sato, S; Jas, GS; Freund, SMV; Alonso, DOV; Daggett, V; Fersht, AR				Mayor, U; Guydosh, NR; Johnson, CM; Grossmann, JG; Sato, S; Jas, GS; Freund, SMV; Alonso, DOV; Daggett, V; Fersht, AR			The complete folding pathway of a protein from nanoseconds to microseconds	NATURE			English	Article							DIFFUSION-COLLISION MODEL; DENATURED STATE; ENERGY; DOMAIN; HELIX	Combining experimental and simulation data to describe all of the structures and the pathways involved in folding a protein is problematical. Transition states can be mapped experimentally by phi values(1,2), but the denatured state(3) is very difficult to analyse under conditions that favour folding. Also computer simulation at atomic resolution is currently limited to about a microsecond or less. Ultrafast-folding proteins fold and unfold on timescales accessible by both approaches(4,5), so here we study the folding pathway of the three-helix bundle protein Engrailed homeodomain(6). Experimentally, the protein collapses in a microsecond to give an intermediate with much native alpha-helical secondary structure, which is the major component of the denatured state under conditions that favour folding. A mutant protein shows this state to be compact and contain dynamic, native-like helices with unstructured side chains. In the transition state between this and the native state, the structure of the helices is nearly fully formed and their docking is in progress, approximating to a classical diffusion-collision model. Molecular dynamics simulations give rate constants and structural details highly consistent with experiment, thereby completing the description of folding at atomic resolution.	MRC, Ctr Prot Engn, Cambridge CB2 2QH, England; CLRC Daresbury Lab, Warrington WA4 4AD, Cheshire, England; NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Cambridge; STFC Daresbury Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle	Fersht, AR (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008; Mayor, Ugo/F-5890-2011	Mayor, Ugo/0000-0003-2812-8287				BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Blanco FJ, 1998, J MOL BIOL, V284, P1153, DOI 10.1006/jmbi.1998.2229; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grossmann JG, 2002, BIOCHEMISTRY-US, V41, P3613, DOI 10.1021/bi015955o; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878; Islam SA, 2002, J MOL BIOL, V318, P199, DOI 10.1016/S0022-2836(02)00029-3; Itzhaki LS, 1997, J MOL BIOL, V270, P89, DOI 10.1006/jmbi.1997.1049; KARPLUS M, 1994, PROTEIN SCI, V3, P650; KIPPEN AD, 1994, BIOCHEMISTRY-US, V33, P10013, DOI 10.1021/bi00199a027; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P2738, DOI 10.1021/bi950967t; Sandstrom J., 1982, DYNAMIC NMR SPECTROS; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Spector S, 1999, BIOPOLYMERS, V49, P29, DOI 10.1002/(SICI)1097-0282(199901)49:1<29::AID-BIP4>3.3.CO;2-Z; Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764; Witty M, 2002, EMBO J, V21, P4207, DOI 10.1093/emboj/cdf417; Zhang Y.Z., 1995, THESIS U PENNSYLVANI	29	414	421	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					863	867		10.1038/nature01428	http://dx.doi.org/10.1038/nature01428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594518				2022-12-01	WOS:000181044700053
J	Scholtz, G; Braband, A; Tolley, L; Reimann, A; Mittmann, B; Lukhaup, C; Steuerwald, F; Vogt, G				Scholtz, G; Braband, A; Tolley, L; Reimann, A; Mittmann, B; Lukhaup, C; Steuerwald, F; Vogt, G			Ecology - Parthenogenesis in an outsider crayfish	NATURE			English	Article							FISH		Humboldt Univ, Inst Biol Vergleichende Zool, D-10115 Berlin, Germany; Heidelberg Univ, Inst Zool, INF 230, D-69120 Heidelberg, Germany	Humboldt University of Berlin; Ruprecht Karls University Heidelberg	Scholtz, G (corresponding author), Humboldt Univ, Inst Biol Vergleichende Zool, D-10115 Berlin, Germany.	gerhard.scholtz@rz.hu-berlin.de						Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Gruner H-E, 1993, LEHRBUCH SPEZIELLEN; LUKHAUP C, 2001, AQUARISTIK AKTUELL, V7, P48; Nam YK, 2000, TRANSGENIC RES, V9, P463, DOI 10.1023/A:1026596422225; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; Scholtz G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P30; Soderhall Kenneth, 1999, Freshwater Crayfish, V12, P11; Vogt G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P53; VRIJENHOEK RC, 1994, ANNU REV ECOL SYST, V25, P71, DOI 10.1146/annurev.es.25.110194.000443	10	152	157	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					806	806		10.1038/421806a	http://dx.doi.org/10.1038/421806a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594502				2022-12-01	WOS:000181044700037
J	Reya, T; Duncan, AW; Ailles, L; Domen, J; Scherer, DC; Willert, K; Hintz, L; Nusse, R; Weissman, IL				Reya, T; Duncan, AW; Ailles, L; Domen, J; Scherer, DC; Willert, K; Hintz, L; Nusse, R; Weissman, IL			A role for Wnt signalling in self-renewal of haematopoietic stem cells	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; AXIS FORMATION; GENE FAMILY; PROLIFERATION; TRANSCRIPTION; EXPANSION; PATHWAY; COMPLEX; MICE	Haematopoietic stem cells (HSCs) have the ability to renew themselves and to give rise to all lineages of the blood; however, the signals that regulate HSC self-renewal remain unclear. Here we show that the Wnt signalling pathway has an important role in this process. Overexpression of activated beta-catenin expands the pool of HSCs in long-term cultures by both phenotype and function. Furthermore, HSCs in their normal microenvironment activate a LEF-1/TCF reporter, which indicates that HCSs respond to Wnt signalling in vivo. To demonstrate the physiological significance of this pathway for HSC proliferation we show that the ectopic expression of axin or a frizzled ligand-binding domain, inhibitors of the Wnt signalling pathway, leads to inhibition of HSC growth in vitro and reduced reconstitution in vivo. Furthermore, activation of Wnt signalling in HSCs induces increased expression of HoxB4 and Notch1, genes previously implicated in self-renewal of HSCs. We conclude that the Wnt signalling pathway is critical for normal HSC homeostasis in vitro and in vivo, and provide insight into a potential molecular hierarchy of regulation of HSC development.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94035 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94035 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94035 USA	Duke University; Stanford University; Stanford University; Duke University; Duke University; Howard Hughes Medical Institute; Stanford University	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu		Duncan, Andrew/0000-0003-4962-4191				Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Audet J, 1998, CURR OPIN BIOTECH, V9, P146, DOI 10.1016/S0958-1669(98)80107-9; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; HING HK, 1994, MECH DEVELOP, V47, P261, DOI 10.1016/0925-4773(94)90044-2; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; INGHAM PW, 1993, DEVELOPMENT, V117, P283; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Maloof JN, 1999, DEVELOPMENT, V126, P37; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; SPANGRUDE GJ, 1989, SCIENCE, V244, P1030; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WILLERT K, 2003, NATURE          0427, DOI DOI 10.1038/NATURE01611; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	44	1620	1765	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					409	414		10.1038/nature01593	http://dx.doi.org/10.1038/nature01593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12717450				2022-12-01	WOS:000183012000034
J	Lee, SS; Kennedy, S; Tolonen, AC; Ruvkun, G				Lee, SS; Kennedy, S; Tolonen, AC; Ruvkun, G			DAF-16 target genes that control C-elegans life-span and metabolism	SCIENCE			English	Article							INSULIN-RECEPTOR; OXIDATIVE STRESS; LONGEVITY; EXPRESSION; RESISTANCE	Signaling from the DAF-2/insulin receptor to the DAF-16/FOXO transcription factor controls longevity, metabolism, and development in disparate phyla. To identify genes that mediate the conserved biological outputs of daf-2/insulin-like signaling, we used comparative genomics to identify 17 orthologous genes from Caenorhabditis and Drosophila, each of which bears a DAF-16 binding site in the promoter region. One-third of these DAF-16 downstream candidate genes were regulated by daf-2/insulin-like signaling in C. elegans, and RNA interference inactivation of the candidates showed that many of these genes mediate distinct aspects of daf-16 function, including longevity, metabolism, and development.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Ruvkun, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Genet, 50 Blossom St, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Kennedy, Scott/0000-0002-7974-8155; Tolonen, Andrew/0000-0001-5907-4504				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; DEAN M, 2002, HUMAN ATP BINDING CA; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gildea JJ, 2000, GENETICS, V156, P645; Guarente L, 2001, TRENDS GENET, V17, P391, DOI 10.1016/S0168-9525(01)02339-3; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee S. A., UNPUB; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	32	503	524	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					644	647		10.1126/science.1083614	http://dx.doi.org/10.1126/science.1083614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12690206				2022-12-01	WOS:000182453700043
J	Royer, S; Pare, D				Royer, S; Pare, D			Conservation of total synaptic weight through balanced synaptic depression and potentiation	NATURE			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL CELLS; PLASTICITY; HIPPOCAMPUS; LTP; NEURONS; CALCIUM; STORES; EFFICACY; RELEASE	Memory is believed to depend on activity-dependent changes in the strength of synapses(1). In part, this view is based on evidence that the efficacy of synapses can be enhanced or depressed depending on the timing of pre- and postsynaptic activity(2-5). However, when such plastic synapses are incorporated into neural network models, stability problems may develop because the potentiation or depression of synapses increases the likelihood that they will be further strengthened or weakened(6). Here we report biological evidence for a homeostatic mechanism that reconciles the apparently opposite requirements of plasticity and stability. We show that, in intercalated neurons of the amygdala, activity-dependent potentiation or depression of particular glutamatergic inputs leads to opposite changes in the strength of inputs ending at other dendritic sites. As a result, little change in total synaptic weight occurs, even though the relative strength of inputs is modified. Furthermore, hetero- but not homosynaptic alterations are blocked by intracellular dialysis of drugs that prevent Ca2+ release from intracellular stores. Thus, in intercalated neurons at least, inverse heterosynaptic plasticity tends to compensate for homosynaptic long-term potentiation and depression, thus stabilizing total synaptic weight.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	pare@axon.rutgers.edu						Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; Arbib MA, 1995, HDB BRAIN THEORY NEU; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Coussens CM, 1996, LEARN MEMORY, V3, P106, DOI 10.1101/lm.3.2-3.106; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; HOLM S, 1979, SCAND J STAT, V6, P65; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; ODonovan MJ, 1997, TRENDS NEUROSCI, V20, P431, DOI 10.1016/S0166-2236(97)01124-7; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Segev C, 1989, METHODS NEURONAL MOD, P9; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680	30	241	245	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					518	522		10.1038/nature01530	http://dx.doi.org/10.1038/nature01530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673250				2022-12-01	WOS:000181965400037
J	Lalloo, F; Varley, J; Ellis, D; Moran, A; O'Dair, L; Pharoah, P; Evans, DGR				Lalloo, F; Varley, J; Ellis, D; Moran, A; O'Dair, L; Pharoah, P; Evans, DGR		Early Onset Breast Canc Study Grp	Prediction of pathogenic mutations in patients with early-onset breast cancer by family history	LANCET			English	Article								We aimed to assess frequency and penetrance of BRCA1, BRCA2, and TP53 mutations in women diagnosed with breast cancer aged 30 years or younger, and then correlate this frequency with family history. 17 of 36 familial cases had a BRCA1, BRCA2, or TP53 mutation, compared with three of 63 non-familial cases. The calculated population frequency of TP53 mutations was one In 5000, substantially greater than previous estimates. This finding underlines the importance of accurate elucidation of a family history from young women diagnosed with breast cancer. Establishment of family history could help with development of patient-specific management and tumour surveillance protocols.	St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; Christie NHS Trust, Canc Res UK Paterson Inst Canc Res, Manchester, Lancs, England; Guys Hosp, London SE1 9RT, England; Univ Manchester, Ctr Canc Epidemiol, Manchester M13 9PL, Lancs, England; Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge CB2 1TN, England	University of Manchester; Cancer Research UK; Christie NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Manchester; University of Cambridge	Lalloo, F (corresponding author), St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England.	Fiona.Lalloo@cmmc.nhs.uk	Evans, D Gareth/AAB-4308-2022; Pharoah, Paul/V-6658-2019; Mathew, Christopher G/G-3434-2015	Evans, D Gareth/0000-0002-8482-5784; Pharoah, Paul/0000-0001-8494-732X; Mathew, Christopher G/0000-0003-4178-1838; Howell, Anthony/0000-0002-6233-719X				BIRCH JM, 1994, CANCER RES, V54, P1298; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301	4	130	132	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 29	2003	361	9363					1101	1102		10.1016/S0140-6736(03)12856-5	http://dx.doi.org/10.1016/S0140-6736(03)12856-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672316				2022-12-01	WOS:000181865200014
J	Nishida, H; Pigg, KB; Rigby, JF				Nishida, H; Pigg, KB; Rigby, JF			Swimming sperm in an extinct Gondwanan plant	NATURE			English	Article									Chuo Univ, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; Queensland Univ Technol, Sch Nat Resource Sci, Brisbane, Qld, Australia; Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA	Chuo University; Queensland University of Technology (QUT); Arizona State University; Arizona State University-Tempe	Nishida, H (corresponding author), Chuo Univ, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.							BLERHORST DW, 1971, MORPHOLOGY VASCULAR; CASS D, 1970, AM J BOT, V57, P2; CHAMBERLAIN CJ, 1935, GYMNOSPERMS; Gifford EM, 1989, MORPHOLOGY EVOLUTION; Gould RE, 1977, ALCHERINGA, V1, P387, DOI 10.1080/03115517708527774; Hirase S., 1896, BOT MAG TOKYO, V10, P325; Ikeno S., 1896, BOT MAG TOKYO, V10, P367, DOI [10.15281/jplantres1887.10.115_61, DOI 10.15281/JPLANTRES1887.10.115_61]; LI Y, 1989, PROTOPLASMA, V149, P57, DOI 10.1007/BF01623983; NORSTOG KJ, 1986, BOT GAZ, V147, P40, DOI 10.1086/337566; Pigg KB, 1997, REV PALAEOBOT PALYNO, V97, P339, DOI 10.1016/S0034-6667(97)00007-9; RETALIACK G, 1988, PALEOBIOLOGY, V7, P54; ROTHWELL GW, 2001, BOT 2001, P25; STEWART WN, 1951, AM MIDL NAT, V46, P717, DOI 10.2307/2421812	13	29	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					396	397		10.1038/422396a	http://dx.doi.org/10.1038/422396a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660772				2022-12-01	WOS:000181801200033
J	Hassall, O; Bedu-Addo, G; Adarkwa, M; Danso, K; Bates, I				Hassall, O; Bedu-Addo, G; Adarkwa, M; Danso, K; Bates, I			Umbilical-cord blood for transfusion in children with severe anaemia in under-resourced countries	LANCET			English	Article								Shortage of blood for transfusion contributes substantially to mortality of children with severe anaemia in sub-Saharan Africa. Umbilical-cord blood could be an additional and readily available source of blood. We aimed to show whether it is possible to gather cord blood in a busy Ghanaian labour ward. Mean volume of each blood sample obtained from the umbilical cord was 85 mL (SID 28.0). This amount of blood is sufficient to raise the haemoglobin concentrations of 28 (21%) of 131 children needing transfusions in the same hospital, by 30 g/L. Further work is needed to improve the sterility of cord blood and to establish the resource and logistical implications of scaling-up for sub-Saharan Africa transfusion services.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Komfo Anokye Teaching Hosp, Kumasi, Ghana	Liverpool School of Tropical Medicine; University of Liverpool; Kwame Nkrumah University Science & Technology	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.			bates, imelda/0000-0002-0862-8199				English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; INSLEY J, 1996, PAEDIAT VADE MECUM; Lackritz EM, 1997, AIDS, V11, P1487, DOI 10.1097/00002030-199712000-00013; *WHO, 1999, CLIN US BLOOD HDB	4	29	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					678	679		10.1016/S0140-6736(03)12565-2	http://dx.doi.org/10.1016/S0140-6736(03)12565-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606183				2022-12-01	WOS:000181129500021
J	Burgess, SA; Walker, ML; Sakakibara, H; Knight, PJ; Oiwa, K				Burgess, SA; Walker, ML; Sakakibara, H; Knight, PJ; Oiwa, K			Dynein structure and power stroke	NATURE			English	Article							HEAVY-CHAIN; ADENOSINE-TRIPHOSPHATASE; CYTOPLASMIC DYNEIN; NUCLEOTIDE-BINDING; MYOSIN; ATP; ACTIVATION; PROTEINS; FLAGELLA; FAMILY	Dynein ATPases are microtubule motors that are critical to diverse processes such as vesicle transport and the beating of sperm tails; however, their mechanism of force generation is unknown. Each dynein comprises a head, from which a stalk and a stem emerge. Here we use electron microscopy and image processing to reveal new structural details of dynein c, an isoform from Chlamydomonas reinhardtii flagella, at the start and end of its power stroke. Both stem and stalk are flexible, and the stem connects to the head by means of a linker approximately 10 nm long that we propose lies across the head. With both ADP and vanadate bound, the stem and stalk emerge from the head 10 nm apart. However, without nucleotide they emerge much closer together owing to a change in linker orientation, and the coiled-coil stalk becomes stiffer. The net result is a shortening of the molecule coupled to an approximately 15-nm displacement of the tip of the stalk. These changes indicate a mechanism for the dynein power stroke.	Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Commun Res Labs, Kansai Adv Res Ctr, Kobe, Hyogo 6512492, Japan	University of Leeds; University of Leeds; National Institute of Information & Communications Technology (NICT) - Japan	Burgess, SA (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.a.burgess@leeds.ac.uk	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X				Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; BURGESS SA, 1995, J MOL BIOL, V250, P52, DOI 10.1006/jmbi.1995.0357; Burgess SA, 1997, J CELL BIOL, V139, P675, DOI 10.1083/jcb.139.3.675; DiBella LM, 2001, INT REV CYTOL, V210, P227; ELLIOTT A, 1976, PROC R SOC SER B-BIO, V193, P45, DOI 10.1098/rspb.1976.0030; Fan J, 2001, J MOL BIOL, V307, P1317, DOI 10.1006/jmbi.2001.4566; Frank J., 1996, 3 DIMENSIONAL ELECT; Gee M, 1998, EUR BIOPHYS J BIOPHY, V27, P466, DOI 10.1007/s002490050157; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GIBBONS IR, 1991, METHOD ENZYMOL, V196, P428; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; Goodenough U.W., 1989, CELL MOVEMENT, V1, P121; GOODENOUGH UW, 1982, J CELL BIOL, V95, P798, DOI 10.1083/jcb.95.3.798; GOODENOUGH UW, 1987, J MOL BIOL, V194, P481, DOI 10.1016/0022-2836(87)90676-0; JOHNSON JG, 1988, CANADIAN SOC PETROLE, V14, P161; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 2000, J CELL SCI, V113, P2521; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Mocz G, 1996, BIOCHEMISTRY-US, V35, P9204, DOI 10.1021/bi960662u; Neuwald AF, 1999, GENOME RES, V9, P27; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; OKUNO M, 1980, J CELL BIOL, V85, P712, DOI 10.1083/jcb.85.3.712; OMOTO CK, 1986, BIOCHEMISTRY-US, V25, P419, DOI 10.1021/bi00350a022; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Shiroguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P189, DOI 10.1002/cm.1032; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Vallee RB, 1998, TRENDS CELL BIOL, V8, P490, DOI 10.1016/S0962-8924(98)01379-8; VERNON GG, 1995, EXP CELL RES, V220, P482, DOI 10.1006/excr.1995.1340; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Woolley D, 2000, Essays Biochem, V35, P103; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263	41	390	395	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					715	718		10.1038/nature01377	http://dx.doi.org/10.1038/nature01377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610617	Green Accepted			2022-12-01	WOS:000180938000035
J	Mamdouh, Z; Chen, X; Pierini, LM; Maxfield, FR; Muller, WA				Mamdouh, Z; Chen, X; Pierini, LM; Maxfield, FR; Muller, WA			Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis	NATURE			English	Article							VESICULO-VACUOLAR ORGANELLES; TRANSENDOTHELIAL MIGRATION; CELL-ADHESION; TRANSMIGRATION; MONOCYTES; CADHERIN; LEUKOCYTES	Leukocytes enter sites of inflammation by squeezing through the borders between endothelial cells that line postcapillary venules at that site. This rapid process, called transendothelial migration (TEM) or diapedesis, is completed within 90 s after a leukocyte arrests on the endothelial surface(1-4). In this time, the leukocyte moves in ameboid fashion across the endothelial borders, which remain tightly apposed to it during transit. It is not known how the endothelial cell changes its borders rapidly and reversibly to accommodate the migrating leukocyte. Here we show that there is a membrane network just below the plasmalemma at the cell borders that is connected at intervals to the junctional surface. PECAM-1, an integral membrane protein with an essential role in TEM5-7, is found in this compartment and constitutively recycles evenly along endothelial cell borders. During TEM, however, recycling PECAM is targeted to segments of the junction across which monocytes are in the act of migration. In addition, blockade of TEM with antibodies against PECAM specifically blocks the recruitment of this membrane to the zones of leukocyte migration, without affecting the constitutive membrane trafficking.	Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University; Cornell University	Muller, WA (corresponding author), Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10021 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866				Ali J, 1997, MICROCIRCULATION-LON, V4, P267, DOI 10.3109/10739689709146790; Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; Bamforth SD, 1997, INVEST OPHTH VIS SCI, V38, P25; Berman ME, 1996, J IMMUNOL, V156, P1515; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Feng D, 1996, J EXP MED, V183, P1981, DOI 10.1084/jem.183.5.1981; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; HAMMERSEN F, 1987, PROG APPL MICROCIRC, V12, P1; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; MULLER WA, 1992, J EXP MED, V176, P819, DOI 10.1084/jem.176.3.819; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vasile E, 1999, J HISTOCHEM CYTOCHEM, V47, P159, DOI 10.1177/002215549904700205; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713	21	248	255	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					748	753		10.1038/nature01300	http://dx.doi.org/10.1038/nature01300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610627				2022-12-01	WOS:000180938000045
J	Spruck, CH; de Miguel, MP; Smith, APL; Ryan, A; Stein, P; Schultz, RM; Lincoln, AJ; Donovan, PJ; Reed, SI				Spruck, CH; de Miguel, MP; Smith, APL; Ryan, A; Stein, P; Schultz, RM; Lincoln, AJ; Donovan, PJ; Reed, SI			Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis	SCIENCE			English	Article							CELL-CYCLE; PROTEIN; ARREST; DISRUPTION; XE-P9; MLH1	We generated mice lacking Cks2, one of two mammalian homologs of the yeast Cdk1-binding proteins, Suc1 and Cks1, and found them to be viable but sterile in both sexes. Sterility is due to failure of both male and female germ cells to progress past the first meiotic metaphase. The chromosomal events up through the end of prophase I are normal in both CKS2(-/-) males and females, suggesting that the phenotype is due directly to failure to enter anaphase and not a consequence of a checkpoint-mediated metaphase I arrest.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Scripps Research Institute; Jefferson University; University of California System; University of California San Diego; University of Pennsylvania	Reed, SI (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-7,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sreed@scripps.edu	Stein, Paula/ABE-9388-2020	Stein, Paula/0000-0002-2040-4593; Smith, Adrian/0000-0001-9732-1422	NCI NIH HHS [CA74224] Funding Source: Medline; NICHD NIH HHS [HD38252, HD22681] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022681] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD022681, R01HD038252] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA074224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow C, 1998, DEVELOPMENT, V125, P4007; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hirao Y, 1997, DEVELOPMENT, V124, P5107; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Orr-Weaver TL, 1999, SCIENCE, V285, P344; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; RICHARDSON HE, 1990, GENE DEV, V4, P1332, DOI 10.1101/gad.4.8.1332; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; Watson ML, 1998, P NATL ACAD SCI USA, V95, P14361, DOI 10.1073/pnas.95.24.14361; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395	18	98	100	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					647	650		10.1126/science.1084149	http://dx.doi.org/10.1126/science.1084149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714746				2022-12-01	WOS:000182453700044
J	Schneider, R; Ferrara, A; Salvaterra, R; Omukai, K; Bromm, V				Schneider, R; Ferrara, A; Salvaterra, R; Omukai, K; Bromm, V			Low-mass relics of early star formation	NATURE			English	Article							NUCLEOSYNTHESIS	The earliest stars to form in the Universe were the first sources of light, heat and metals after the Big Bang. The products of their evolution will have had a profound impact on subsequent generations of stars. Recent studies(1-7) of primordial star formation have shown that, in the absence of metals (elements heavier than helium), the formation of stars with masses 100 times that of the Sun would have been strongly favoured, and that low-mass stars could not have formed before a minimum level of metal enrichment had been reached. The value of this minimum level is very uncertain, but is likely to be between 10(-6) and 10(-4) that of the Sun(6,8). Here we show that the recent discovery(9) of the most iron-poor star known indicates the presence of dust in extremely low-metallicity gas, and that this dust is crucial for the formation of lower-mass second-generation stars that could survive until today. The dust provides a pathway for cooling the gas that leads to fragmentation of the precursor molecular cloud into smaller clumps, which become the lower-mass stars.	Osserv Astrofis Arcetri, I-50125 Florence, Italy; Enrico Fermi Ctr, I-00184 Rome, Italy; Scuola Int Super Studi Avanzati, SSISA, I-34100 Trieste, Italy; Natl Astron Observ, Div Theoret Astrophys, Tokyo 1818588, Japan; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Istituto Nazionale Astrofisica (INAF); International School for Advanced Studies (SISSA); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Schneider, R (corresponding author), Osserv Astrofis Arcetri, Largo Enrico Fermi 5, I-50125 Florence, Italy.	raffa@arcetri.astro.it	Schneider, Raffaella/E-4216-2017; Ferrara, Andrea/A-4357-2011	Schneider, Raffaella/0000-0001-9317-2888; Salvaterra, Ruben/0000-0002-9393-8078				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Mackey J, 2003, ASTROPHYS J, V586, P1, DOI 10.1086/367613; Nakamura F, 2002, ASTROPHYS J, V569, P549, DOI 10.1086/339392; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; OMUKAI K, UNPUB ASTROPHYS J; Qian YZ, 2002, ASTROPHYS J, V567, P515, DOI 10.1086/338277; Ripamonti E, 2002, MON NOT R ASTRON SOC, V334, P401, DOI 10.1046/j.1365-8711.2002.05516.x; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Siess L, 2002, ASTROPHYS J, V570, P329, DOI 10.1086/339733; Truran JW, 2002, PUBL ASTRON SOC PAC, V114, P1293, DOI 10.1086/344585	14	203	204	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					869	871		10.1038/nature01579	http://dx.doi.org/10.1038/nature01579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712198	Green Submitted			2022-12-01	WOS:000182432600047
J	Peiris, JSM; Lai, ST; Poon, LLM; Guan, Y; Yam, LYC; Lim, W; Nicholls, J; Yee, WKS; Yan, WW; Cheung, MT; Cheng, VCC; Chan, KH; Tsang, DNC; Yung, RWH; Ng, TK; Yuen, KY				Peiris, JSM; Lai, ST; Poon, LLM; Guan, Y; Yam, LYC; Lim, W; Nicholls, J; Yee, WKS; Yan, WW; Cheung, MT; Cheng, VCC; Chan, KH; Tsang, DNC; Yung, RWH; Ng, TK; Yuen, KY		SARS Study Grp	Coronavirus as a possible cause of severe acute respiratory syndrome	LANCET			English	Article							HUMAN-DISEASE; VIRUS; INFECTIONS; DIAGNOSIS	Background An outbreak of severe acute respiratory syndrome (SARS) has been reported in Hong Kong. We investigated the viral cause and clinical presentation among 50 patients. Methods We analysed case notes and microbiological findings for 50 patients with SARS, representing more than five separate epidemiologically linked transmission clusters. We defined the clinical presentation and risk factors associated with severe disease and investigated the causal agents by chest radiography and laboratory testing of nasopharyngeal aspirates and sera samples. We compared the laboratory findings with those submitted for microbiological investigation of other diseases from patients whose identity was masked. Findings Patients, age ranged from 23 to 74 years. Fever, chills, myalgia, and cough were the most frequent complaints. When compared with chest radiographic changes, respiratory symptoms and auscultatory findings were disproportionally mild. Patients who were household contacts of other infected people and had older age, lymphopenia, and liver dysfunction were associated with severe disease. A virus belonging to the family Coronaviridae was isolated from two patients. By use of serological and reverse-transcriptase PCR specific for this virus, 45 of 50 patients with SARS, but no controls, had evidence of infection with this virus. Interpretation A coronavirus was isolated from patients with SARS that might be the primary agent associated with this disease. Serological and molecular tests specific for the virus permitted a definitive laboratory diagnosis to be made and allowed further investigation to define whether other cofactors play a part in disease progression.	Univ Hong Kong, Queen Mary Hosp, Dept Pathol & Microbiol, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Med Intens Care & Pathol, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Govt Virus Unit, Hong Kong, Hong Kong, Peoples R China; Pamela Youde Nethersole Eastern Hosp, Dept Pathol & Med, Hong Kong, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Dept Pathol, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; Kwong Wah Hospital	Peiris, JSM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Yuen, Kwok Yung/C-4465-2009; Chan, Kwok Hung/ABD-5399-2021; Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Peiris, Joseph Sriyal Malik/C-4380-2009; Nicholls, John Malcolm/C-4375-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Guan, Yi/0000-0001-6057-9243; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Yuen, Kwok-yung/0000-0002-2083-1552; CHENG, Vincent Chi-Chung/0000-0003-1765-7706; Nicholls, John Malcolm/0000-0001-7217-7444	PHS HHS [A195357] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CAUL EO, 1977, ARCH VIROL, V54, P107, DOI 10.1007/BF01314383; Chan KH, 2002, J CLIN MICROBIOL, V40, P1675, DOI 10.1128/JCM.40.5.1675-1680.2002; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; El-Sahly HM, 2000, CLIN INFECT DIS, V31, P96, DOI 10.1086/313937; FOTZ RJ, 1999, CHEST, V115, P901; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Knipe D, 2001, FIELDS VIROLOGY, P1187; McIntosh K., 1974, Current Topics in Microbiology and Immunology, V63, P85; MCINTOSH K, 1970, AM J EPIDEMIOL, V91, P585, DOI 10.1093/oxfordjournals.aje.a121171; TALBOT PJ, IN PRESS ADV EXP MED; WENZEL RP, 1974, AM REV RESPIR DIS, V109, P621; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P86; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P81; Wiedbrauk DL, 1993, MANUAL CLIN VIROLOGY; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	15	2007	2312	6	363	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1319	1325		10.1016/S0140-6736(03)13077-2	http://dx.doi.org/10.1016/S0140-6736(03)13077-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711465	Green Published, Bronze			2022-12-01	WOS:000182346100007
J	Walker, PR; Worobey, M; Rambaut, A; Holmes, EC; Pybus, OG				Walker, PR; Worobey, M; Rambaut, A; Holmes, EC; Pybus, OG			Sexual transmission of HIV in Africa - Other routes of infection are not the dominant contributor to the African epidemic.	NATURE			English	Article							HEPATITIS-C VIRUS		Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Walker, PR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Rambaut, Andrew/B-2481-2009; Holmes, Edward/GVR-9499-2022; Pybus, Oliver G/B-2640-2012; Holmes, Edward/Y-2789-2019	Rambaut, Andrew/0000-0003-4337-3707; Pybus, Oliver G/0000-0002-8797-2667; Holmes, Edward/0000-0001-9596-3552; Walker, Polly/0000-0003-1969-0059				Gisselquist D, 2003, INT J STD AIDS, V14, P162, DOI 10.1258/095646203762869160; Goldmann DA, 2002, J ALLERGY CLIN IMMUN, V110, pS21, DOI 10.1067/mai.2002.125337; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; *UNAIDS, 2002, REP GLOB HIV AIDS EP	5	40	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					679	679		10.1038/422679a	http://dx.doi.org/10.1038/422679a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700750	Bronze			2022-12-01	WOS:000182272300029
J	Dunder, K; Lind, L; Zethelius, B; Berglund, L; Lithell, H				Dunder, K; Lind, L; Zethelius, B; Berglund, L; Lithell, H			Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							DEPENDENT DIABETES-MELLITUS; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; ESSENTIAL-HYPERTENSION; TREATED HYPERTENSION; RISK-FACTORS; FOLLOW-UP; VASODILATION; SENSITIVITY; TOLERANCE	Objective To investigate the impact of an increase in blood glucose on the risk of developing myocardial infarction, with particular emphasis on people taking antihypertensive drugs. Design Prospective population based cohort study. Setting Uppsala, Sweden. Participants 1860 men who had participated in 1970-3 at age 50 in a health survey aimed at identifying risk factors for cardiovascular disease and were re-examined at age 60 and then followed for 17.4 years. Main outcome measure Myocardial infarction after age 60. Results The incidence of myocardial infarction was significantly higher in men treated for hypertension than in those without such treatment (23% v 13.5%, P < 0.0001). Participants who developed,myocardial infarction after the age of 60 (n=253) showed a significantly larger increase in blood glucose between age 50 and 60 than did those without myocardial infarction. In multivariate Cox proportional hazard models increase in blood glucose was an independent risk factor for myocardial infarction (P=0.0001) in men receiving antihypertensive treatment at age 60 (n=291, mainly &beta; blockers and thiazide diuretics) but not in those without such treatment. The impact of increase in blood glucose declined after inclusion of serum proinsulin concentrations at baseline but was still significant. A significant interaction existed between proinsulin concentration (a marker of insulin resistance) at baseline and antihypertensive treatment on increase in blood glucose. Conclusions Increase in blood glucose between the ages of 50 and 60 and baseline proinsulin concentration were important risk factors for myocardial infarction in men receiving antihypertensive treatment, indicating that both an insulin resistant state and the metabolic impact of P blockers and diuretics increase the risk of myocardial infarction.	Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, SE-75125 Uppsala, Sweden; Uppsala Univ, Dept Med Sci, Akad Sjukhuset, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Dunder, K (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, POB 609, SE-75125 Uppsala, Sweden.	kristina.dunder@pubcare.uu.se	Berglund, Lars/AAD-3856-2019; Berglund, Lars/AAA-3188-2019	Berglund, Lars/0000-0002-7437-9047; 				Andersson OK, 1998, BMJ-BRIT MED J, V317, P167, DOI 10.1136/bmj.317.7152.167; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; FULLER JH, 1980, LANCET, V1, P1373; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Haffner SM, 1999, AM J CARDIOL, V84, p11J; HARPER R, 1994, BRIT MED J, V309, P226, DOI 10.1136/bmj.309.6949.226; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; LUNDGREN H, 1988, BRIT MED J, V297, P1512, DOI 10.1136/bmj.297.6662.1512; MCVEIGH GE, 1992, DIABETOLOGIA, V35, P771; MYKKANEN L, 1994, J HYPERTENS, V12, P1425; Mykkanen L, 1999, DIABETOLOGIA, V42, P1060, DOI 10.1007/s001250051271; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; POLLARE T, 1990, METABOLISM, V39, P167, DOI 10.1016/0026-0495(90)90071-J; POLLARE T, 1989, BRIT MED J, V298, P1152, DOI 10.1136/bmj.298.6681.1152; POLLARE T, 1988, DIABETOLOGIA, V31, P415, DOI 10.1007/BF00271585; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; RAMSAY LE, 1992, EUR HEART J, V13, P68, DOI 10.1093/eurheartj/13.suppl_G.68; REAVEN GM, 1991, DIABETES CARE, V14, P33, DOI 10.2337/diacare.14.4.33; Samuelsson O, 1996, BMJ-BRIT MED J, V313, P660; Sarabi M, 1999, J INTERN MED, V246, P265, DOI 10.1046/j.1365-2796.1999.00542.x; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; SOWERS JR, 1991, AM HEART J, V122, P932, DOI 10.1016/0002-8703(91)90814-X; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695	26	89	95	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 29	2003	326	7391					681	684		10.1136/bmj.326.7391.681	http://dx.doi.org/10.1136/bmj.326.7391.681			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663WL	12663403	Green Published, Bronze			2022-12-01	WOS:000182029500014
J	Kirkham, M; Muller-Reichert, T; Oegema, K; Grill, S; Hyman, AA				Kirkham, M; Muller-Reichert, T; Oegema, K; Grill, S; Hyman, AA			SAS-4 is a C-elegans centriolar protein that controls centrosome size	CELL			English	Article							HAMSTER OVARY CELLS; CAENORHABDITIS-ELEGANS; GAMMA-TUBULIN; SPINDLE POLES; CYCLE; MATURATION; DUPLICATION; NEMATODE; EMBRYO; ORGANIZATION	Centrosomes consist of a centriole pair surrounded by pericentriolar material (PCM). Previous work suggested that centrioles are required to organize PCM to form a structurally stable organelle. Here, we characterize SAS-4, a centriole component in Caenorhabditis elegans. Like tubulin, SAS-4 is incorporated into centrioles during their duplication and remains stably associated thereafter. In the absence of SAS-4, centriole duplication falls. Partial depletion of SAS-4 results in structurally defective centrioles that contain reduced levels of SAS-4 and organize proportionally less PCM. Thus, SAS-4 is a centriole-associated component whose amount dictates centrosome size. These results provide novel insight into the poorly understood role of centrioles as centrosomal organizers.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Oegema, K (corresponding author), CMM-E 3080,9500 Gilman Dr, La Jolla, CA 92093 USA.		Grill, Stephan/D-9427-2012; Hyman, Anthony A/B-3917-2017; Kirkham, Matthew/I-5458-2012; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Kirkham, Matthew/0000-0003-0920-5355				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; CALLAINI G, 1990, J CELL SCI, V97, P539; Chapman MJ, 2000, Q REV BIOL, V75, P409, DOI 10.1086/393621; Fry AM, 2000, CURR TOP DEV BIOL, V49, P291; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GOULD RR, 1977, J CELL BIOL, V73, P601, DOI 10.1083/jcb.73.3.601; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lange BMH, 2000, CURR TOP DEV BIOL, V49, P235; Lonsdale JE, 2001, MICROWAVE TECHNIQUES AND PROTOCOLS, P139, DOI 10.1007/978-1-59259-128-2_11; Marshall WF, 2001, CURR BIOL, V11, pR487, DOI 10.1016/S0960-9822(01)00289-5; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Mignot JP, 1996, BIOL CELL, V86, P81, DOI 10.1016/0248-4900(96)84770-8; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Praitis V, 2001, GENETICS, V157, P1217; Preble AM, 2000, CURR TOP DEV BIOL, V49, P207; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; RIEDER CL, 1982, BIOL CELL, V44, P117; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Schnackenberg BJ, 1998, P NATL ACAD SCI USA, V95, P9295, DOI 10.1073/pnas.95.16.9295; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; VOROBJEV IA, 1987, INT REV CYTOL, V106, P227, DOI 10.1016/S0074-7696(08)61714-3; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	39	237	240	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					575	587		10.1016/S0092-8674(03)00117-X	http://dx.doi.org/10.1016/S0092-8674(03)00117-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600319	Bronze			2022-12-01	WOS:000181252600014
J	Oyranoski, D				Oyranoski, D			Critics slam treatment for SARS as ineffective and perhaps dangerous	NATURE			English	News Item																			0	33	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					4	4		10.1038/423004a	http://dx.doi.org/10.1038/423004a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721587	Green Published, Bronze			2022-12-01	WOS:000182561600005
J	Groce, NE				Groce, NE			HIV/AIDS and people with disability	LANCET			English	Editorial Material							HIV; ADULTS; WOMEN		Yale Univ, Yale Sch Publ Hlth, Global Hlth Div, New Haven, CT 06520 USA	Yale University	Groce, NE (corresponding author), Yale Univ, Yale Sch Publ Hlth, Global Hlth Div, New Haven, CT 06520 USA.			Groce, Nora/0000-0002-7885-7042				ALTMAN B, 1997, J DISABIL POLICY STU, V8, P99; Blumberg SJ, 2003, JAIDS, V32, P77, DOI 10.1097/00126334-200301010-00011; Cambridge P, 1997, DISABIL SOC, V12, P427, DOI 10.1080/09687599727272; Chenoweth L., 1996, VIOLENCE AGAINST WOM, V2, P391, DOI [https://doi.org/10.1177/1077801296002004004, DOI 10.1177/1077801296002004004, 10.1177/1077801296002004004]; Collins PY, 2001, J URBAN HEALTH, V78, P162, DOI 10.1093/jurban/78.1.162; COURNOS F, 1990, HOSP COMMUNITY PSYCH, V41, P163; *EC SOC COMM AS PA, 1995, HIDD SIST WOM GIRLS; Gaskins S, 1999, J Assoc Nurses AIDS Care, V10, P75, DOI 10.1016/S1055-3290(06)60301-4; GASKINS S, 1999, J ASS NURSES AIDS CA, V35, P75; Helander E, 1993, PREJUDICE DIGNITY; Lishner DM, 1996, J RURAL HEALTH, V12, P45, DOI 10.1111/j.1748-0361.1996.tb00772.x; McGillivray JA, 1999, J APPL RES INTELLECT, V12, P113, DOI 10.1111/j.1468-3148.1999.tb00070.x; Moores DF, 1998, AM ANN DEAF, V143, P3, DOI 10.1353/aad.2012.0111; Nosek MA, 2001, VIOLENCE AGAINST WOM, V7, P477, DOI 10.1177/10778010122182569; ROBERTSON PE, 1991, J MENT DEFIC RES, V35, P475; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNICEF, 1999, GLOB SURV AD DIS OV; Van Biema D, 1994, Time, V143, P76	18	65	67	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1401	1402		10.1016/S0140-6736(03)13146-7	http://dx.doi.org/10.1016/S0140-6736(03)13146-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	672HZ	12727388				2022-12-01	WOS:000182516300003
J	Saunders, K; Bedford, ID; Yahara, T; Stanley, J				Saunders, K; Bedford, ID; Yahara, T; Stanley, J			The earliest recorded plant virus disease	NATURE			English	Article									John Innes Ctr Plant Sci Res, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Kyushu University	Saunders, K (corresponding author), John Innes Ctr Plant Sci Res, Dept Dis & Stress Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.			Yahara, Tetsukazu/0000-0001-5105-7152; Saunders, Keith/0000-0002-5606-9627				Briddon RW, 2002, MOL BIOTECHNOL, V20, P315, DOI 10.1385/MB:20:3:315; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; INOUYE T, 1980, Annals of the Phytopathological Society of Japan, V46, P49, DOI 10.3186/jjphytopath.46.49; KOCH R, 1884, MITTHEILUNGEN KAISER, V2; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; Onuki Masatoshi, 2000, Journal of General Plant Pathology, V66, P176, DOI 10.1007/PL00012941; OSAKI T, 1979, Annals of the Phytopathological Society of Japan, V45, P62, DOI 10.3186/jjphytopath.45.62; Saunders K, 2001, VIROLOGY, V282, P38, DOI 10.1006/viro.2000.0832; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; SUGA T, 1991, NANYOSHU COMPLETE EN; YAHARA T, 1993, OECOLOGIA, V96, P310, DOI 10.1007/BF00317499	11	84	94	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					831	831		10.1038/422831a	http://dx.doi.org/10.1038/422831a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712190	Bronze			2022-12-01	WOS:000182432600038
J	Lassmann, H				Lassmann, H			Brain damage when multiple sclerosis is diagnosed clinically	LANCET			English	Editorial Material									Univ Vienna, Brain Res Inst, A-1090 Vienna, Austria	University of Vienna	Lassmann, H (corresponding author), Univ Vienna, Brain Res Inst, Waehringer Guertel 18, A-1090 Vienna, Austria.		Lassmann, Hans/Z-2269-2019	Lassmann, Hans/0000-0001-8617-5052				Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Dautry W, 2000, J CEREBR BLOOD F MET, V20, P789, DOI 10.1097/00004647-200005000-00005; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Kornek B, 1999, BRAIN PATHOL, V9, P651; Lassmann H, 1998, MCALPINES MULTIPLE S, P323; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3	8	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1317	1318		10.1016/S0140-6736(03)13088-7	http://dx.doi.org/10.1016/S0140-6736(03)13088-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711464				2022-12-01	WOS:000182346100006
J	Jain, S; Bates, FS				Jain, S; Bates, FS			On the origins of morphological complexity in block copolymer surfactants	SCIENCE			English	Article							MICROEMULSION NETWORKS; PHASE-SEPARATION; DIBLOCK COPOLYMERS; MICELLES; VESICLES; DILUTE; FLUIDS; WATER; MODEL	Amphiphilic compounds such as lipids and surfactants are fundamental building blocks of soft matter. We describe experiments with poly(1,2-butadiene-b-ethylene oxide) (PB-PEO) diblock copolymers, which form Y-junctions and three-dimensional networks in water at weight fractions of PEO intermediate to those associated with vesicle and wormlike micelle morphologies. Fragmentation of the network produces a nonergodic array of complex reticulated particles that have been imaged by cryogenic transmission electron microscopy. Data obtained with two sets of PB-PEO compounds indicate that this type of self-assembly appears above a critical molecular weight. These block copolymers represent versatile amphiphiles, mimicking certain low molecular weight three-component (surfactant/water/oil) microemulsions, without addition of a separate hydrophobe.	Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	bates@cems.umn.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000989] Funding Source: NIH RePORTER; NIBIB NIH HHS [1R21EB00989-01] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alexandridis P., 2000, AMPHIPHILIC BLOCK CO; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Bernheim-Groswasser A, 1999, LANGMUIR, V15, P5448, DOI 10.1021/la990301q; Bernheim-Groswasser A, 2000, LANGMUIR, V16, P4131, DOI 10.1021/la991231q; Burke S, 2000, HIGH PERFORM POLYM, V12, P535, DOI 10.1088/0954-0083/12/4/308; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; DRYE TJ, 1992, J CHEM PHYS, V96, P1367, DOI 10.1063/1.462172; EVANS DF, 1998, COLLOIDAL DOMAIN WHE; Ferry J. D., 1980, VISCOELASTIC PROPERT; Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570; Hillmyer MA, 1996, MACROMOLECULES, V29, P6994, DOI 10.1021/ma960774t; Israelachvili J., 1992, INTERMOLECULAR SURFA; KHATORY A, 1993, LANGMUIR, V9, P1456, DOI 10.1021/la00030a005; Kindt JT, 2002, J PHYS CHEM B, V106, P8223, DOI 10.1021/jp020670m; Krishnan K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.098301; Kwon SY, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258302; Panizza P, 1998, J PHYS-CONDENS MAT, V10, P11659, DOI 10.1088/0953-8984/10/50/006; PORTE G, 1986, J PHYS CHEM-US, V90, P5746, DOI 10.1021/j100280a055; Tlusty T, 2000, J PHYS-CONDENS MAT, V12, pA253, DOI 10.1088/0953-8984/12/8A/332; Tlusty T, 2000, SCIENCE, V290, P1328, DOI 10.1126/science.290.5495.1328; Tlusty T, 2000, PHYS REV LETT, V84, P1244, DOI 10.1103/PhysRevLett.84.1244; Won YY, 2000, J PHYS CHEM B, V104, P9054, DOI 10.1021/jp002934f; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Won YY, 2003, MACROMOLECULES, V36, P953, DOI 10.1021/ma021439+; Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d; Yu K, 1996, LANGMUIR, V12, P5980, DOI 10.1021/la960894u; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728	27	1025	1041	17	602	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					460	464		10.1126/science.1082193	http://dx.doi.org/10.1126/science.1082193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702869				2022-12-01	WOS:000182295900031
J	Walther, TC; Alves, A; Pickersgill, H; Loiodice, I; Hetzer, M; Galy, V; Hulsmann, BB; Kocher, T; Wilm, M; Allen, T; Mattaj, LW; Doye, V				Walther, TC; Alves, A; Pickersgill, H; Loiodice, I; Hetzer, M; Galy, V; Hulsmann, BB; Kocher, T; Wilm, M; Allen, T; Mattaj, LW; Doye, V			The conserved Nup107-160 complex is critical for nuclear pore complex assembly	CELL			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; PROTEOMIC ANALYSIS; PROTEIN; NUCLEOPORINS; ENVELOPE; NUP98; STEPS; RECONSTITUTION; IDENTIFICATION; INTERFERENCE	Nuclear pore complexes (NPCs) are large multiprotein assemblies that allow traffic between the cytoplasm and the nucleus. During mitosis in higher eukaryotes, the Nuclear Envelope (NE) breaks down and NPCs disassemble. How NPCs reassemble and incorporate into the NE upon mitotic exit is poorly understood. We demonstrate a function for the conserved Nup1107-160 complex in this process. Partial in vivo depletion of Nup133 or Nup107 via RNAi in HeLa cells resulted in reduced levels of multiple nucleoporins and decreased NPC density in the NE. Immunodepletion of the entire Nup1107-160 complex from in vitro nuclear assembly reactions produced nuclei with a continuous NE but no NPCs. This phenotype was reversible only if Nup107-160 complex was readded before closed NE formation. Depletion also prevented association of FG-repeat nucleoporins with chromatin. We propose a stepwise model in which postmitotic NPC assembly initiates on chromatin via early recruitment of the Nup107-160 complex.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France; Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC Dept Struct Cell Biol, Manchester M20 9BX, Lancs, England	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Mattaj, LW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	mattaj@embl-heidelberg.de		Koecher, Thomas/0000-0003-0827-1457; Mattaj, Iain/0000-0002-5537-8284; Wilm, Matthias/0000-0002-5461-6834; Walther, Tobias/0000-0003-1442-1327				Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Allen TD, 1998, METHOD CELL BIOL, V53, P125; Bagley S, 2000, J CELL SCI, V113, P3885; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Bodoor K, 1999, J CELL SCI, V112, P2253; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; CORNINGS DE, 1970, EXP CELL RES, V62, P293; COURVALIN JC, 1990, J CLIN INVEST, V86, P279, DOI 10.1172/JCI114696; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DABAUVALLE MC, 1990, CHROMOSOMA, V100, P56, DOI 10.1007/BF00337603; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Drummond SP, 2002, J CELL BIOL, V158, P53, DOI 10.1083/jcb.200108145; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; GOLDBERG MW, 1992, J STRUCT BIOL, V108, P257, DOI 10.1016/1047-8477(92)90026-7; Goldberg MW, 1997, J CELL SCI, V110, P409; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Haraguchi T, 2000, J CELL SCI, V113, P779; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Imreh G, 2000, EXP CELL RES, V259, P180, DOI 10.1006/excr.2000.4935; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MAUL GG, 1977, J CELL BIOL, V74, P492, DOI 10.1083/jcb.74.2.492; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1994, J BIOL CHEM, V269, P17600; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Wiese C, 1997, J CELL SCI, V110, P1489; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598	54	310	315	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					195	206		10.1016/S0092-8674(03)00235-6	http://dx.doi.org/10.1016/S0092-8674(03)00235-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705868	Bronze			2022-12-01	WOS:000182508500009
J	Gandhi, TK; Weingart, SN; Borus, J; Seger, AC; Peterson, J; Burdick, E; Seger, DL; Shu, K; Federico, F; Leape, LL; Bates, DW				Gandhi, TK; Weingart, SN; Borus, J; Seger, AC; Peterson, J; Burdick, E; Seger, DL; Shu, K; Federico, F; Leape, LL; Bates, DW			Adverse drug events in ambulatory care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZED-PATIENTS; RISK-FACTORS; OUTPATIENTS; PREVENTION; COSTS	BACKGROUND: Adverse events related to drugs occur frequently among inpatients, and many of these events are preventable. However, few data are available on adverse drug events among outpatients. We conducted a study to determine the rates, types, severity, and preventability of such events among outpatients and to identify preventive strategies. METHODS: We performed a prospective cohort study, including a survey of patients and a chart review, at four adult primary care practices in Boston (two hospital-based and two community-based), involving a total of 1202 outpatients who received at least one prescription during a four-week period. Prescriptions were computerized at two of the practices and handwritten at the other two. RESULTS: Of the 661 patients who responded to the survey (response rate, 55 percent), 162 had adverse drug events (25 percent; 95 percent confidence interval, 20 to 29 percent), with a total of 181 events (27 per 100 patients). Twenty-four of the events (13 percent) were serious, 51 (28 percent) were ameliorable, and 20 (11 percent) were preventable. Of the 51 ameliorable events, 32 (63 percent) were attributed to the physician's failure to respond to medication-related symptoms and 19 (37 percent) to the patient's failure to inform the physician of the symptoms. The medication classes most frequently involved in adverse drug events were selective serotonin-reuptake inhibitors (10 percent), beta-blockers (9 percent), angiotensin-converting-enzyme inhibitors (8 percent), and nonsteroidal antiinflammatory agents (8 percent). On multivariate analysis, only the number of medications taken was significantly associated with adverse events. CONCLUSIONS: Adverse events related to drugs are common in primary care, and many are preventable or ameliorable. Monitoring for and acting on symptoms are important. Improving communication between outpatients and providers may help prevent adverse events related to drugs.	Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Harvard Risk Management Fdn, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Gandhi, TK (corresponding author), Brigham & Womens Hosp, Div Gen Med, 75 Francis St, Boston, MA 02115 USA.	tgandhi@partners.org						Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; FOLLI HL, 1987, PEDIATRICS, V79, P718; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; HUTCHINSON TA, 1986, J CHRON DIS, V39, P533, DOI 10.1016/0021-9681(86)90198-0; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Li YC, 2001, INT J MED INFORM, V61, P241, DOI 10.1016/S1386-5056(01)00146-0; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; SANDS DZ, 2001, HIMSS P, V3; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	17	908	929	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1556	1564		10.1056/NEJMsa020703	http://dx.doi.org/10.1056/NEJMsa020703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700376				2022-12-01	WOS:000182248900007
J	Emanuel, EJ; Young-Xu, Y; Levinsky, NG; Gazelle, G; Saynina, O; Ash, AS				Emanuel, EJ; Young-Xu, Y; Levinsky, NG; Gazelle, G; Saynina, O; Ash, AS			Chemotherapy use among medicare beneficiaries at the end of life	ANNALS OF INTERNAL MEDICINE			English	Article							CELL LUNG-CANCER; QUALITY-OF-LIFE; RANDOMIZED-TRIAL; EXPECTATIONS; CISPLATIN; ATTITUDES; MITOMYCIN; SURVIVAL	Background: Although many observers believe that cancer chef motherapy is overused at the end of life, there are no published data on this. Objective: To determine the frequency and duration of chemotherapy use in the last 6 months of life stratified by type of cancer, age, and sex. Design: Retrospective cohort Analysis. Setting: Administrative databases from Massachusetts and California. Patients: All Medicare patients Who died of cancer in Massachusetts and 5% of Medicare cancer decedents in California in 1996. Measurements: Use of intravenous chemotherapy agents, chemotherapy administration, or medical evaluation for chemotherapy from Medicare billing data for each patient in 30-day periods from the date of death backward. Results: in Massachusetts, 33% of cancer decedents older than 65 years of age received chemotherapy in the last 6 months of life, 23% in the last 3 months, and 9% in the last month. In California, the percentages were 26%, 20%, and 9%, respectively. Chemotherapy use greatly declined with age. Chemotherapy use was similar for patients with breast, colon, and ovarian cancer and those with cancer generally considered unresponsive to chemotherapy, such as pancreatic, hepatocellular, or renal-cell cancer or melanoma. Patients with types of cancer that are unresponsive to chemotherapy had shorter duration of chemotherapy use. Conclusion: Among patients who died of cancer, chemotherapy was used frequently in the last 3 months of life. The cancer's responsiveness to chemotherapy does not seem to influence whether dying patients receive chemotherapy at the end of life.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Natl Bur Econ Res, Palo Alto, CA USA; Harvard Vanguard Associates, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA	National Institutes of Health (NIH) - USA; National Bureau of Economic Research; Harvard Vanguard Medical Associates; Boston University	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.		Ash, Arlene/AAG-2914-2019	Ash, Arlene/0000-0002-8448-0253	CLINICAL CENTER [Z01CL010508] Funding Source: NIH RePORTER	CLINICAL CENTER		ABELOFF DM, 2000, CLIN ONCOLOGY, P1681; Annas G J, 1992, Health Matrix Clevel, V2, P119; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; Cullen M, 2001, LANCET ONCOL, V2, P173, DOI 10.1016/S1470-2045(00)00260-6; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; DEVITA WT, 2001, CANC PRINCIPLES PRAC, V1126, P1262; Doyle C, 2001, J CLIN ONCOL, V19, P1266, DOI 10.1200/JCO.2001.19.5.1266; Earle CC, 2000, CHEST, V117, P1239, DOI 10.1378/chest.117.5.1239; ELLIS PA, 1995, BRIT J CANCER, V71, P366, DOI 10.1038/bjc.1995.74; FIELD MJ, 1997, APPROACHING DEATH IM, P12; GOUGH IR, 1981, CLIN ONCOL, V7, P5; MCKHANN CF, 1999, TIME DIE, P1; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; SONTAG S, 1978, ILLNES METAPHOR; Wan GJ, 1997, PSYCHO-ONCOL, V6, P1; YELLEN SB, 1995, J CLIN ONCOL, V13, P1255, DOI 10.1200/JCO.1995.13.5.1255; 1997, CANC EC          MAR, P1	20	217	219	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					639	643		10.7326/0003-4819-138-8-200304150-00011	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693886				2022-12-01	WOS:000182173800006
J	Charron, F; Stein, E; Jeong, J; McMahon, AP; Tessier-Lavigne, M				Charron, F; Stein, E; Jeong, J; McMahon, AP; Tessier-Lavigne, M			The morphogen Sonic hedgehog is an axonal chemoattractant that collaborates with Netrin-1 in midline axon guidance	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; FLOOR PLATE; SPINAL-CORD; COMMISSURAL AXONS; GROWTH CONES; C-ELEGANS; CELL FATES; SPECIFICATION; RECEPTOR; GENE	Developing axons are guided to their targets by attractive and repulsive guidance cues. In the embryonic spinal cord, the floor plate chemoattractant Netrin-1 is required to guide commissural neuron axons to the midline. However, genetic evidence suggests that other chemoattractant(s) are also involved. We show that the morphogen Sonic hedgehog (Shh) can mimic the additional chemoattractant activity of the floor plate in vitro and can act directly as a chemoattractant on isolated axons. Cyclopamine-mediated inhibition of the Shh signaling mediator Smoothened (Smo) or conditional inactivation of Smo in commissural neurons indicate that Smo activity is important for the additional chemoattractant activity of the floor plate in vitro and for the normal projection of commissural axons to the floor plate in vivo. These results provide evidence that Shh, acting via Smo, is a midline-derived chemoattractant for commissural axons and show that a morphogen can also act as an axonal chemoattractant.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Stanford University; Harvard University	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.		Charron, Frederic/D-2140-2009; McMahon, Andrew P/ABE-7520-2020; Charron, Frederic/O-8017-2019; Stein, Elke/E-8107-2013	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Stein, Elke/0000-0001-8965-5692	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 33642] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deshpande G, 2001, CELL, V106, P759, DOI 10.1016/S0092-8674(01)00488-3; Ding Q, 1998, DEVELOPMENT, V125, P2533; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Long FX, 2001, DEVELOPMENT, V128, P5099; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Matise MP, 1999, DEVELOPMENT, V126, P3649; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mo R, 1997, DEVELOPMENT, V124, P113; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wang YS, 2002, J NEUROSCI, V22, P8563; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	44	501	527	0	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					11	23		10.1016/S0092-8674(03)00199-5	http://dx.doi.org/10.1016/S0092-8674(03)00199-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679031	Bronze			2022-12-01	WOS:000182282900003
J	Nardi, F; Spinsanti, G; Boore, JL; Carapelli, A; Dallai, R; Frati, F				Nardi, F; Spinsanti, G; Boore, JL; Carapelli, A; Dallai, R; Frati, F			Hexapod origins: Monophyletic or paraphyletic?	SCIENCE			English	Article							MITOCHONDRIAL GENES; PHYLOGENY; ARTHROPODS; INSECTS; CRUSTACEANS; MYRIAPODS; NUCLEAR	Recent morphological and molecular evidence has changed interpretations of arthropod phylogeny and evolution. Here we compare complete mitochondrial genomes to show that Collembola, a wingless group traditionally considered as basal to all insects, appears instead to constitute a separate evolutionary lineage that branched much earlier than the separation of many crustaceans and insects and independently adapted to life on land. Therefore, the taxon Hexapoda, as commonly defined to include all six-legged arthropods, is not monophyletic.	Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Berkeley Lab, Walnut Creek, CA 94598 USA	University of Siena; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Nardi, F (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Aldo Moro 2, I-53100 Siena, Italy.		Carapelli, Antonio/H-9216-2019; Nardi, Francesco/E-5516-2011	Carapelli, Antonio/0000-0002-3165-9620; Nardi, Francesco/0000-0003-0271-9855; Dallai, Romano/0000-0002-2258-8891				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Bitsch C, 2000, ZOOL SCR, V29, P131, DOI 10.1046/j.1463-6409.2000.00036.x; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BRIGGS DEG, 1989, SCIENCE, V246, P241, DOI 10.1126/science.246.4927.241; Carapelli A, 2000, PEDOBIOLOGIA, V44, P361, DOI 10.1078/S0031-4056(04)70055-4; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Dallai R, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P333; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327; EMERSON MJ, 1997, ARTHROPOD RELATIONSH, P67; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Garcia-Machado E, 1999, J MOL EVOL, V49, P142, DOI 10.1007/PL00006527; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Hennig W., 1981, INSECT PHYLOGENY; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Klass KD, 2001, ANN SOC ENTOMOL FR, V37, P265; KRAUS O., 1997, ARTHROPOD RELATIONSH, P295; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SPEARS T, 1997, ARTHROPOD RELATIONSH, P169; Swofford David L., 1996, P407	24	279	306	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1887	1889		10.1126/science.1078607	http://dx.doi.org/10.1126/science.1078607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649480				2022-12-01	WOS:000181669700044
J	Onoa, B; Dumont, S; Liphardt, J; Smith, SB; Tinoco, I; Bustamante, C				Onoa, B; Dumont, S; Liphardt, J; Smith, SB; Tinoco, I; Bustamante, C			Identifying kinetic barriers to mechanical unfolding of the T-thermophila ribozyme	SCIENCE			English	Article							CRYSTAL-STRUCTURE; RNA; STABILITY; DOMAIN	Mechanical unfolding trajectories for single molecules of the Tetrahymena thermophila ribozyme display eight intermediates corresponding to discrete kinetic barriers that oppose mechanical unfolding with lifetimes of seconds and rupture forces between 10 and 30 piconewtons. Barriers are magnesium dependent and correspond to known intra- and interdomain interactions. Several barrier structures are "brittle," breakage requiring high forces but small (1 to 3 nanometers) deformations. Barrier crossing is stochastic, leading to variable unfolding paths. The response of complex RNA structures to locally applied mechanical forces may be analogous to the responses of RNA during translation, messenger RNA export from the nucleus, and viral replication.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Liphardt, Jan/A-5906-2012	Bustamante, Carlos/0000-0002-2970-0073; Liphardt, Jan/0000-0003-2835-5025	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM010840, R01GM010840, R01GM032543, R37GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840, GM-10840, GM-32543] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9; Bockelmann U, 1998, PHYS REV E, V58, P2386, DOI 10.1103/PhysRevE.58.2386; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Gerland U, 2001, BIOPHYS J, V81, P1324, DOI 10.1016/S0006-3495(01)75789-X; GERLAND U, IN PRESS BIOPHYS; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Juneau K, 2001, STRUCTURE, V9, P221, DOI 10.1016/S0969-2126(01)00579-2; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; LIPHARDT J, UNPUB; Ralston CY, 2000, NAT STRUCT BIOL, V7, P371; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Silverman SK, 2000, BIOCHEMISTRY-US, V39, P12465, DOI 10.1021/bi000828y; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Thirumalai D, 2001, ANNU REV PHYS CHEM, V52, P751, DOI 10.1146/annurev.physchem.52.1.751; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Treiber DK, 2001, CURR OPIN STRUC BIOL, V11, P309, DOI 10.1016/S0959-440X(00)00206-2; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	23	205	211	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1892	1895		10.1126/science.1081338	http://dx.doi.org/10.1126/science.1081338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649482	Green Accepted			2022-12-01	WOS:000181669700046
J	Cooper, RS; Kaufman, JS; Ward, R				Cooper, RS; Kaufman, JS; Ward, R			Race and genomics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SOCIOECONOMIC-STATUS; GENETIC-STRUCTURE; HEART-FAILURE; BLACK; WHITE; POLYMORPHISMS; HYPERTENSION; POPULATIONS; PREVALENCE; PATTERNS		Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; Univ Oxford, Dept Biol Anthropol, Oxford, England	Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford	Cooper, RS (corresponding author), Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	rcooper@lumc.edu	Templeton, Alan R./F-5963-2011; Williams, Scott/Q-4812-2019	Williams, Scott/0000-0002-4835-9544; Kaufman, Jay/0000-0003-1606-401X				*ALLHAT OFF COORD, 2000, JAMA-J AM MED ASSOC, V288, P2981; Brancati FL, 1996, ANN EPIDEMIOL, V6, P67, DOI 10.1016/1047-2797(95)00095-X; Brewster LM, 2000, J HYPERTENS, V18, P1537, DOI 10.1097/00004872-200018110-00002; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Chase Allan, 1977, LEGACY MALTHUS SOCIA; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Dries DL, 2002, J AM COLL CARDIOL, V40, P1019; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Franciosa JA, 2002, J CARD FAIL, V8, P128, DOI 10.1054/jcaf.2002.124730; Freedman BI, 2002, NEPHROL DIAL TRANSPL, V17, P198, DOI 10.1093/ndt/17.2.198; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gould S.J., 1996, MISMEASURE MAN; Grim CE, 1996, SEMIN NEPHROL, V16, P83; Hajjar RJ, 2002, NEW ENGL J MED, V347, P1196, DOI 10.1056/NEJMe020105; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Henderson SO, 2000, AM J MED SCI, V320, P18, DOI 10.1097/00000441-200007000-00004; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; MONTAGU A, 1964, CONCEPT RACE; Muntaner C, 1996, AM J EPIDEMIOL, V144, P531; Risch N, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Robbins AS, 2000, AM J EPIDEMIOL, V151, P409; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens JC, 2001, SCIENCE, V293, P1048; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Wade N, 2002, N Y Times Web, pF2; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yancy Clyde W, 2002, Curr Cardiol Rep, V4, P218, DOI 10.1007/s11886-002-0054-0; 2002, NAT GENET, V30, P125	34	452	457	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1166	1170		10.1056/NEJMsb022863	http://dx.doi.org/10.1056/NEJMsb022863			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646675				2022-12-01	WOS:000181628400014
J	Wei, XP; Decker, JM; Wang, SY; Hui, HX; Kappes, JC; Wu, XY; Salazar-Gonzalez, JF; Salazar, MG; Kilby, JM; Saag, MS; Komarova, NL; Nowak, MA; Hahn, BH; Kwong, PD; Shaw, GM				Wei, XP; Decker, JM; Wang, SY; Hui, HX; Kappes, JC; Wu, XY; Salazar-Gonzalez, JF; Salazar, MG; Kilby, JM; Saag, MS; Komarova, NL; Nowak, MA; Hahn, BH; Kwong, PD; Shaw, GM			Antibody neutralization and escape by HIV-1	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; PRIMARY INFECTION; TYPE-1; VARIANTS; GLYCOSYLATION; INDIVIDUALS; EMERGENCE; RESPONSES; RESIDUES	Neutralizing antibodies (Nab) are a principal component of an effective human immune response to many pathogens, yet their role in HIV-1 infection is unclear(1-6). To gain a better understanding of this role, we examined plasma from patients with acute HIV infection. Here we report the detection of autologous Nab as early as 52 days after detection of HIV-specific antibodies. The viral inhibitory activity of Nab resulted in complete replacement of neutralization-sensitive virus by successive populations of resistant virus. Escape virus contained mutations in the env gene that were unexpectedly sparse, did not map generally to known neutralization epitopes, and involved primarily changes in N-linked glycosylation. This pattern of escape, and the exceptional density of HIV-1 envelope glycosylation generally(7,8) led us to postulate an evolving 'glycan shield' mechanism of neutralization escape whereby selected changes in glycan packing prevent Nab binding but not receptor binding. Direct support for this model was obtained by mutational substitution showing that Nab-selected alterations in glycosylation conferred escape from both autologous antibody and epitope-specific monoclonal antibodies. The evolving glycan shield thus represents a new mechanism contributing to HIV-1 persistence in the face of an evolving antibody repertoire.	Univ Alabama, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Inst Adv Study, Princeton, NJ 08540 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Institute for Advanced Study - USA; National Institutes of Health (NIH) - USA	Shaw, GM (corresponding author), Univ Alabama, Howard Hughes Med Inst, 720 S 20th St,KAUL 816, Birmingham, AL 35294 USA.		Nowak, Martin A/A-6977-2008	Hahn, Beatrice/0000-0002-9400-9887; Salazar-Gonzalez, Jesus F./0000-0003-4626-6448; Kilby, J. Michael/0000-0003-3222-1003	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005023, Z01AI005023] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; KUIKEN CL, 2000, HUMAN RETROVIRUSES A; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; MARKOWITZ M, IN PRESS J VIROL; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; MYERS G, 1992, AIDS RES HUM RETROV, V8, P1459, DOI 10.1089/aid.1992.8.1459; Nowak M.A., 2000, VIRAL DYNAMICS; Parren PWHI, 1999, AIDS, V13, pS137; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; RICHMAN DD, IN PRESS P NATL ACAD; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Stewart J. J., 1999, PROFILE QUASISPECIES; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	30	1882	1968	1	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					307	312		10.1038/nature01470	http://dx.doi.org/10.1038/nature01470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646921				2022-12-01	WOS:000181637300039
J	Li, CI; Anderson, BO; Daling, JR; Moe, RE				Li, CI; Anderson, BO; Daling, JR; Moe, RE			Trends in incidence rates of invasive lobular and ductal breast carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN; CANCER; WOMEN; MANAGEMENT; DIAGNOSIS; PROGESTIN; PATTERNS; RISK	Context Research has suggested that use of combined estrogen and progestin hormone replacement therapy (CHRT) increases breast cancer risk and that CHRT use more strongly associated with the risk of invasive lobular breast carcinoma than that invasive ductal carcinoma. Lobular carcinoma is less common than ductal carcinoma can be more difficult to diagnose because of its subtle elusive. infiltrative pattern. Objective To evaluate trends in invasive lobular and ductal carcinoma incidence from 1987 through 1999, during which time use of CHRT increased in the United Design Descriptive epidemiologic study. Setting Nine cancer registries that participate in the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute and that cover Atlanta, Ga; Detroit, Mich; San Francisco-Oakland, Calif; Seattle, Wash; and Connecticut, Hawaii, Iowa, New Mexico, and Utah., Population Women 30 years of age and older residing in the areas covered by the 9 SEER registries. Main Outcome Measures Proportional changes in incidence rates of invasive lobular and ductal carcinoma among women with no prior history of breast cancer. Results A total of 190458 women were included in this analysis who were identified through the registries as having invasive breast cancer; 7682 of the 198140 potentially eligible women (ie, those identified as not having in situ breast cancer) were I excluded from this analysis because stage of cancer was unknown. Invasive breast cancer incidence rates adjusted for age and for SEER historic stage increased 1.04-fold (95% confidence interval [CI], 1.004-1.07) from 1987-1999 (206.7/100000 to 214.1/100000, age-adjusted). However, incidence rates of tumors classified as lobular increased 1.52-fold (95% CI, 1.42-1.63), and those classified as mixed ductal-lobular increased 1.96-fold (95% CI, 1.80-2.14); rates of these types combined increased 1.65-fold (95% CI, 1.55-1.78) (19.8/100000 to 33.4/100000, age-adjusted). In contrast, ductal carcinoma rates remained largely constant (153.8/100000 to 155.3/100000, age-adjusted; proportional change, 1.03 [95% CI, 0.99-1.061). The proportion of breast cancers with a lobular component increased from 9.5% in 1987 to 15.6% in 1999. Conclusions Ductal carcinoma incidence rates remained essentially constant from 1987-1999 while lobular carcinoma rates increased steadily. This increase presents a clinical challenge given that lobular carcinoma is more difficult to detect than ductal carcinoma by both physical examination and mammography.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Li, CI (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MP 381,POB 19024, Seattle, WA 98109 USA.				NCI NIH HHS [R01 CA 85913, T32 CA 09168] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085913, T32CA009168] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brett KM, 1997, AM J EPIDEMIOL, V145, P536; Carr BR, 1996, EUR J OBSTET GYN R B, V64, pS17, DOI 10.1016/0301-2115(95)02351-8; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Daling JR, 2002, CANCER-AM CANCER SOC, V95, P2455, DOI 10.1002/cncr.10984; DAVIS RP, 1979, ARCH SURG-CHICAGO, V114, P485; DIXON JM, 1982, HISTOPATHOLOGY, V6, P149, DOI 10.1111/j.1365-2559.1982.tb02712.x; DUTOIT RS, 1991, EUR J SURG ONCOL, V17, P251; Evans N, 2000, CLIN RADIOL, V55, P261, DOI 10.1053/crad.1999.0291; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; HEMMINKI E, 1988, American Journal of Public Health, V78, P1479, DOI 10.2105/AJPH.78.11.1479; KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; Munot K, 2002, BRIT J SURG, V89, P1296, DOI 10.1046/j.1365-2168.2002.02208.x; *NAT CANC I, SEER DAT QUAL; *NAT CANC I, ABOUT SEER; *NAT CANC I, CHAR SEER POP COMP T; Newcomb PA, 2002, CANCER EPIDEM BIOMAR, V11, P593; Newcomer LM, 1999, AM J EPIDEMIOL, V149, pS79; ROSS RK, 1980, JAMA-J AM MED ASSOC, V243, P1635, DOI 10.1001/jama.243.16.1635; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SILVERSTEIN MJ, 1994, CANCER-AM CANCER SOC, V73, P1673, DOI 10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B; Skaane P, 1999, ACTA RADIOL, V40, P369, DOI 10.3109/02841859909177749; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; Weinstein SP, 2001, AM J ROENTGENOL, V176, P399, DOI 10.2214/ajr.176.2.1760399; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F; YEATMAN TJ, 1995, ANN SURG, V222, P549	28	350	361	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1421	1424		10.1001/jama.289.11.1421	http://dx.doi.org/10.1001/jama.289.11.1421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636465	Bronze			2022-12-01	WOS:000181616200034
J	Schoemaker, HE; Mink, D; Wubbolts, MG				Schoemaker, HE; Mink, D; Wubbolts, MG			Dispelling the myths - Biocatalysis in industrial synthesis	SCIENCE			English	Article							DIRECTED EVOLUTION; ENZYME; ACID; COMBINATORIAL; BIOSYNTHESIS; ALDOLASE	Biocatalysis has emerged as an important tool in the industrial synthesis of bulk chemicals, pharmaceutical and agrochemical intermediates, active pharmaceuticals, and food ingredients. However, the number and diversity of the applications are modest, perhaps in part because of perceived or real limitations of biocatalysts, such as limited enzyme availability, substrate scope, and operational stability. Recent scientific breakthroughs in genomics, directed enzyme evolution, and the exploitation of biodiversity should help to overcome these limitations. As a result, we expect many new industrial applications of biocatalysis to be realized, from single-step enzymatic conversions to customized multistep microbial synthesis by means of metabolic pathway engineering.	DSM Res & Patents, Life Sci Prod, NL-6160 MD Geleen, Netherlands; Univ Amsterdam, Inst Mol Chem, NL-1018 WS Amsterdam, Netherlands; DSM Biotech, D-52428 Julich, Germany	DSM NV; University of Amsterdam	Schoemaker, HE (corresponding author), DSM Res & Patents, Life Sci Prod, POB 18, NL-6160 MD Geleen, Netherlands.	hans.schoemaker@dsm.com						Berry A, 2002, J IND MICROBIOL BIOT, V28, P127, DOI 10.1038/sj/jim/7000228; Bruggink A, 1998, ORG PROCESS RES DEV, V2, P128, DOI 10.1021/op9700643; DeSantis G, 2002, J AM CHEM SOC, V124, P9024, DOI 10.1021/ja0259842; Doekel S, 2001, METAB ENG, V3, P64, DOI 10.1006/mben.2000.0170; DRATHS KM, 1994, J AM CHEM SOC, V116, P399, DOI 10.1021/ja00080a057; Drauz K., 2002, ENZYME CATALYSIS ORG; Effenberger F, 2000, CURR OPIN BIOTECH, V11, P532, DOI 10.1016/S0958-1669(00)00141-5; Fahrenkamp-Uppenbrink J, 2002, SCIENCE, V297, P798; Fong S, 2000, CHEM BIOL, V7, P873, DOI 10.1016/S1074-5521(00)00035-1; Gibson JM, 2001, ANGEW CHEM INT EDIT, V40, P1945, DOI 10.1002/1521-3773(20010518)40:10<1945::AID-ANIE1945>3.3.CO;2-X; Griengl H, 2000, TRENDS BIOTECHNOL, V18, P252, DOI 10.1016/S0167-7799(00)01452-9; Halling PJ, 2000, CURR OPIN CHEM BIOL, V4, P74, DOI 10.1016/S1367-5931(99)00055-1; Jokela J, 2002, ENZYME MICROB TECH, V31, P67, DOI 10.1016/S0141-0229(02)00074-1; Kimura T, 1997, J AM CHEM SOC, V119, P11734, DOI 10.1021/ja9720422; Lee MY, 2002, CURR OPIN BIOTECH, V13, P376, DOI 10.1016/S0958-1669(02)00337-3; Liese A., 2000, IND BIOTRANSFORMATIO; Liu JJ, 2002, ANGEW CHEM INT EDIT, V41, P1404, DOI 10.1002/1521-3773(20020415)41:8<1404::AID-ANIE1404>3.0.CO;2-G; May O, 2000, NAT BIOTECHNOL, V18, P317, DOI 10.1038/73773; Michels PC, 1998, TRENDS BIOTECHNOL, V16, P210, DOI 10.1016/S0167-7799(98)01190-1; OYAMA K, 1992, CHIRALITY IND; Panke S, 2002, CURR OPIN BIOTECH, V13, P111, DOI 10.1016/S0958-1669(02)00302-6; Patel R.N., 2000, STEREOSELECTIVE BIOC, Vfirst; Persson BA, 1999, J AM CHEM SOC, V121, P1645, DOI 10.1021/ja983819+; Petersen M, 1999, GREEN CHEM, V1, P99, DOI 10.1039/a809538h; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P284, DOI 10.1002/1521-3773(20010119)40:2<284::AID-ANIE284>3.3.CO;2-E; Reetz MT, 2002, TETRAHEDRON, V58, P6595, DOI 10.1016/S0040-4020(02)00668-3; Robin J, 2001, APPL MICROBIOL BIOT, V57, P357; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rutjes FPJT, 2000, J CHEM SOC PERK T 1, P4197, DOI 10.1039/b001538p; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Short JM, 1997, NAT BIOTECHNOL, V15, P1322, DOI 10.1038/nbt1297-1322; Stemmer Willem P. C., 2002, Biotechnology and Bioprocess Engineering, V7, P121; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Stewart JD, 2001, CURR OPIN CHEM BIOL, V5, P120, DOI 10.1016/S1367-5931(00)00180-0; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; Thomas SM, 2002, TRENDS BIOTECHNOL, V20, P238, DOI 10.1016/S0167-7799(02)01935-2; Ulijn RV, 2002, BIOTECHNOL BIOENG, V80, P509, DOI 10.1002/bit.10396; Wolf LB, 2001, ADV SYNTH CATAL, V343, P662, DOI 10.1002/1615-4169(200108)343:6/7<662::AID-ADSC662>3.3.CO;2-9; Yamada H, 1996, BIOSCI BIOTECH BIOCH, V60, P1391, DOI 10.1271/bbb.60.1391; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192; Zhu MM, 2002, BIOTECHNOL PROGR, V18, P694, DOI 10.1021/bp020281+	43	612	653	3	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1694	1697		10.1126/science.1079237	http://dx.doi.org/10.1126/science.1079237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637735				2022-12-01	WOS:000181519500034
J	Libby, RT; Smith, RS; Savinova, OV; Zabaleta, A; Martin, JE; Gonzalez, FJ; John, SWM				Libby, RT; Smith, RS; Savinova, OV; Zabaleta, A; Martin, JE; Gonzalez, FJ; John, SWM			Modification of ocular defects in mouse developmental glaucoma models by tyrosinase	SCIENCE			English	Article							PRIMARY CONGENITAL GLAUCOMA; TRANSCRIPTION FACTOR GENE; FETAL DEVELOPMENT; ADRENERGIC CELLS; RETINOIC ACID; NEURAL CREST; PHENOTYPES; PROMOTER; NEURONS; CYP1B1	Mutations in the cytochrome P450 family 1, subfamily B, polypeptide 1 (CYP1B1) gene are a common cause of human primary congenital glaucoma (PCG). Here we show that Cyp1b1(-/-) mice have ocular drainage structure abnormalities resembling those reported in human PCG patients. Using Cyp1b1(-/-) mice, we identified the tyrosinase gene (Tyr) as a modifier of the drainage structure phenotype, with Tyr deficiency increasing the magnitude of dysgenesis. The severe dysgenesis in eyes lacking both CYP1B1 and TYR was alleviated by administration of the tyrosinase product dihydroxyphenylalanine (L-dopa). Tyr also modified the drainage structure dysgenesis in mice with a mutant Foxc1 gene, which is also involved in PCG. These experiments raise the possibility that a tyrosinase/L-dopa pathway modifies human PCG, which could open new therapeutic avenues.	Jackson Lab, Bar Harbor, ME 04609 USA; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; NCI, Lab Metab, Bethesda, MD 20892 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Jackson Laboratory; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Libby, Richard/Q-6720-2019	Libby, Richard/0000-0003-2844-7632	NCI NIH HHS [CA34196] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN L, 1955, ARCH OPHTHALMOL-CHIC, V53, P783, DOI 10.1001/archopht.1955.00930010791002; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; CATALANO RA, 1988, OPHTHALMIC PAED GEN, V9, P5, DOI 10.3109/13816818809031473; Cazorla P, 2000, J NEUROCHEM, V74, P1829, DOI 10.1046/j.1471-4159.2000.0741829.x; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Dellovade TL, 1998, J COMP NEUROL, V402, P402; GENCIK A, 1980, CLIN GENET, V17, P241; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; MAUMENEE EA, 1958, T AM OPHTHAL SOC, V56, P507; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; RITCH R, 1996, GLAUCOMAS CLIN SCI, V2; Rockwood JM, 1996, EXP CELL RES, V223, P250, DOI 10.1006/excr.1996.0079; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; SAVINOVA OV, UNPUB; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; VANDORP DB, 1984, CLIN GENET, V26, P440; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	28	160	173	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1578	1581		10.1126/science.1080095	http://dx.doi.org/10.1126/science.1080095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624268				2022-12-01	WOS:000181367900039
J	Takahashi, T; Svoboda, K; Malinow, R				Takahashi, T; Svoboda, K; Malinow, R			Experience strengthening transmission by driving AMPA receptors into synapses	SCIENCE			English	Article							BARREL FIELD CORTEX; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; IN-VIVO; TRAFFICKING; RAT; POTENTIATION; EXPRESSION; MECHANISM	The mechanisms underlying experience-dependent plasticity in the brain may depend on the AMPA subclass of glutamate receptors (AMPA-Rs). We examined the trafficking of AMPA-Rs into synapses in the developing rat barrel cortex. In vivo gene delivery was combined with in vitro recordings to show that experience drives recombinant GluR1, an AMPA-R subunit, into synapses formed between layer 4 and layer 2/3 neurons. Moreover, expression of the GluR1 cytoplasmic tail, a construct that inhibits synaptic delivery of endogenous AMPA-Rs during long-term potentiation, blocked experience-driven synaptic potentiation. In general, synaptic incorporation of AMPA-Rs in vivo conforms to rules identified in vitro and contributes to plasticity driven by natural stimuli in the mammalian brain.	Cold Spring Harbor Lab, Jones Lab, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Malinow, R (corresponding author), Cold Spring Harbor Lab, Jones Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038259, R01NS032827] Funding Source: NIH RePORTER; NINDS NIH HHS [NS032827, NS038259] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; DURHAM D, 1984, J COMP NEUROL, V223, P424, DOI 10.1002/cne.902230308; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING LIVING NEURO; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Vees AM, 1998, J COMP NEUROL, V400, P110; WINFIELD DA, 1981, BRAIN RES, V206, P166, DOI 10.1016/0006-8993(81)90110-4; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	29	228	233	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1585	1588		10.1126/science.1079886	http://dx.doi.org/10.1126/science.1079886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624270				2022-12-01	WOS:000181367900041
J	Rortveit, G; Daltveit, AK; Hannestad, YS; Hunskaar, S				Rortveit, G; Daltveit, AK; Hannestad, YS; Hunskaar, S		Norwegian EPINCONT Study	Urinary incontinence after vaginal delivery or cesarean section	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIOLOGIC SURVEY; SEVERITY INDEX; RISK-FACTORS; STRESS-INCONTINENCE; NORWEGIAN EPINCONT; WOMEN; PREVALENCE; PRIMIPARAS; COMMUNITY; VALIDITY	Background: It is uncertain whether women who deliver by cesarean section have an increased risk of urinary incontinence as compared with nulliparous women and whether women who deliver vaginally have an even higher risk. Methods: We studied 15,307 women enrolled in the Epidemiology of Incontinence in the County of Nord-Trondelag (EPINCONT) study, which involved a community-based cohort. The data base for this study was linked to data from the Medical Birth Registry of Norway. We included women who answered questions related to urinary incontinence, were younger than 65 years of age, and had had no deliveries, cesarean sections only, or vaginal deliveries only. Results: The prevalence of any incontinence was 10.1 percent in the nulliparous group; age-standardized prevalences were 15.9 percent in the cesarean-section group and 21.0 percent in the vaginal-delivery group. Corresponding figures for moderate or severe incontinence were 3.7 percent, 6.2 percent, and 8.7 percent, respectively; figures for stress incontinence were 4.7 percent, 6.9 percent, and 12.2 percent, respectively; figures for urge incontinence were 1.6 percent, 2.2 percent, and 1.8 percent, respectively; and figures for mixed-type incontinence were 3.1 percent, 5.3 percent, and 6.1 percent, respectively. As compared with nulliparous women, women who had cesarean sections had an adjusted odds ratio for any incontinence of 1.5 (95 percent confidence interval, 1.2 to 1.9) and an adjusted odds ratio for moderate or severe incontinence of 1.4 (95 percent confidence interval, 1.0 to 2.1). Only stress and mixed-type incontinence were significantly associated with cesarean sections. The adjusted odds ratio for any incontinence associated with vaginal deliveries as compared with cesarean sections was 1.7 (95 percent confidence interval, 1.3 to 2.1), and the adjusted odds ratio for moderate or severe incontinence was 2.2 (95 percent confidence interval, 1.5 to 3.1). Only stress incontinence (adjusted odds ratio, 2.4; 95 percent confidence interval, 1.7 to 3.2) was associated with the mode of delivery. Conclusions: The risk of urinary incontinence is higher among women who have had cesarean sections than among nulliparous women and is even higher among women who have had vaginal deliveries. However, these findings should not be used to justify an increase in the use of cesarean sections.	Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, N-5009 Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, EPINCONT, Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Prevent Med, Bergen, Norway; Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Rortveit, G (corresponding author), Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, Ulriksdal 8C, N-5009 Bergen, Norway.							Breslow NE., 1980, IARC SCI PUBLICATION, V32; Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; Hanley J, 2001, BRIT MED J, V322, P1096, DOI 10.1136/bmj.322.7294.1096; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; IOSIF CS, 1982, INT J GYNECOL OBSTET, V20, P87, DOI 10.1016/0020-7292(82)90017-0; JOLLEYS JV, 1988, BRIT MED J, V296, P1300, DOI 10.1136/bmj.296.6632.1300; King JK, 1998, BRIT J OBSTET GYNAEC, V105, P1300, DOI 10.1111/j.1471-0528.1998.tb10009.x; Kuh D, 1999, J EPIDEMIOL COMMUN H, V53, P453, DOI 10.1136/jech.53.8.453; Persson J, 2000, OBSTET GYNECOL, V96, P440, DOI 10.1016/S0029-7844(00)00950-9; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; SANDVIK H, 1995, J CLIN EPIDEMIOL, V48, P339, DOI 10.1016/0895-4356(94)00147-I; SEIM A, 1995, FAM PRACT, V12, P18, DOI 10.1093/fampra/12.1.18; SNOOKS SJ, 1990, BRIT J SURG, V77, P1358, DOI 10.1002/bjs.1800771213; Thom DH, 1998, J AM GERIATR SOC, V46, P1411; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x	21	499	516	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					900	907		10.1056/NEJMoa021788	http://dx.doi.org/10.1056/NEJMoa021788			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621134				2022-12-01	WOS:000181341100005
J	Bowler, JM; Johnston, H; Olley, JM; Prescott, JR; Roberts, RG; Shawcross, W; Spooner, NA				Bowler, JM; Johnston, H; Olley, JM; Prescott, JR; Roberts, RG; Shawcross, W; Spooner, NA			New ages for human occupation and climatic change at Lake Mungo, Australia	NATURE			English	Article							OLDEST HUMAN REMAINS; EXTINCTION; MEGAFAUNA; SKELETON; DATES; SITE	Australia's oldest human remains, found at Lake Mungo, include the world's oldest ritual ochre burial (Mungo III)(1) and the first recorded cremation (Mungo I)(2). Until now, the importance of these finds has been constrained by limited chronologies and palaeoenvironmental information(3). Mungo III, the source of the world's oldest human mitochondrial DNA(4), has been variously estimated at 30 thousand years (kyr) old(1), 42-45 kyr old(5,6) and 62 +/- 6 kyr old(7,8), while radiocarbon estimates placed the Mungo I cremation near 20-26 kyr ago(2,9,10). Here we report a new series of 25 optical ages showing that both burials occurred at 40 +/- 2 kyr ago and that humans were present at Lake Mungo by 50-46 kyr ago, synchronously with, or soon after, initial occupation of northern(11,12) and western Australia(13). Stratigraphic evidence indicates fluctuations between lake-full and drier conditions from 50 to 40 kyr ago, simultaneously with increased dust deposition, human arrival and continent-wide extinction of the megafauna(14),(15). This was followed by sustained aridity between 40 and 30 kyr ago. This new chronology corrects previous estimates for human burials at this important site and provides a new picture of Homo sapiens adapting to deteriorating climate in the world's driest inhabited continent.	Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; NSW Natl Parks & Wildlife Serv, Buronga, NSW 2739, Australia; CSIRO Land & Water, Canberra, ACT 2601, Australia; Univ Adelaide, Dept Phys & Math Phys, Adelaide, SA 5005, Australia; Univ Wollongong, Sch Geosci, Wollongong, NSW 2522, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; University of Wollongong; Australian National University	Bowler, JM (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	j.bowler@earthsci.unimelb.edu.au	Roberts, Richard Graham/B-8245-2013	Roberts, Richard Graham/0000-0002-0128-4119				Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Aitken MJ., 1998, INTRO OPTICAL DATING; BARBETTI M, 1972, NATURE, V239, P327, DOI 10.1038/239327a0; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; BELL WT, 1991, ARCHAEOMETRY, V33, P43, DOI 10.1111/j.1475-4754.1991.tb00684.x; Bowler J.M., 1998, ARCHAEOL OCEAN, V33, P120, DOI DOI 10.1002/J.1834-4453.1998.TB00414.X; Bowler J. M., 1998, ARCHAEOL OCEAN, V33, P156; Bowler J.M., 1976, ORIGIN AUSTR, P127; BOWLER JM, 1970, WORLD ARCHAEOL, V2, P39, DOI 10.1080/00438243.1970.9979463; BOWLER JM, 1972, NATURE, V240, P48, DOI 10.1038/240048a0; Bowler JM, 2000, J HUM EVOL, V38, P719, DOI 10.1006/jhev.1999.0397; Gillespie R, 2000, J HUM EVOL, V38, P727, DOI 10.1006/jhev.1999.0398; Gillespie R, 1997, RADIOCARBON, V39, P239, DOI 10.1017/S0033822200053236; Grun R, 2000, J HUM EVOL, V38, P733, DOI 10.1006/jhev.2000.0399; Hope JH, 1978, ALCHERINGA, V2, P65, DOI 10.1080/03115517808619080; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; HUXTABLE J, 1977, NATURE, V265, P40, DOI 10.1038/265040a0; Ivanovich M., 1992, URANIUM SERIES DISEQ; Laj C, 2000, PHILOS T ROY SOC A, V358, P1009, DOI 10.1098/rsta.2000.0571; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Oyston B, 1996, QUATERNARY SCI REV, V15, P739, DOI 10.1016/0277-3791(96)00025-X; RADCZEWSKI OE, 1960, SPECIAL PUBLICATION, V4, P496; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Shawcross W., 1998, ARCHAEOL OCEAN, V33, P183; Simpson JJ, 1998, QUATERNARY SCI REV, V17, P1009, DOI 10.1016/S0277-3791(97)00088-7; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195	29	453	471	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					837	840		10.1038/nature01383	http://dx.doi.org/10.1038/nature01383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	646QA	12594511				2022-12-01	WOS:000181044700046
J	Giles, J; Knight, J				Giles, J; Knight, J			Dolly's death leaves researchers woolly on clone ageing issue	NATURE			English	News Item																		Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262	2	4	6	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					776	776		10.1038/421776a	http://dx.doi.org/10.1038/421776a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594470	Bronze			2022-12-01	WOS:000181044700010
J	Ren, SX; Gang, F; Jiang, XG; Zeng, R; Miao, YG; Xu, H; Zhang, YX; Xiong, H; Lu, G; Lu, LF; Jiang, HQ; Jia, J; Tu, YF; Jiang, JX; Gu, WY; Zhang, YQ; Cai, Z; Sheng, HH; Yin, HF; Zhang, Y; Zhu, GF; Wan, M; Huang, HL; Qian, Z; Wang, SY; Ma, W; Yao, ZJ; Shen, Y; Qiang, BQ; Xia, QC; Guo, XK; Danchin, A; Saint Girons, I; Somerville, RL; Wen, YM; Shi, MH; Chen, Z; Xu, JG; Zhao, GP				Ren, SX; Gang, F; Jiang, XG; Zeng, R; Miao, YG; Xu, H; Zhang, YX; Xiong, H; Lu, G; Lu, LF; Jiang, HQ; Jia, J; Tu, YF; Jiang, JX; Gu, WY; Zhang, YQ; Cai, Z; Sheng, HH; Yin, HF; Zhang, Y; Zhu, GF; Wan, M; Huang, HL; Qian, Z; Wang, SY; Ma, W; Yao, ZJ; Shen, Y; Qiang, BQ; Xia, QC; Guo, XK; Danchin, A; Saint Girons, I; Somerville, RL; Wen, YM; Shi, MH; Chen, Z; Xu, JG; Zhao, GP			Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing	NATURE			English	Article							PLATELET-ACTIVATING-FACTOR; GENE; MOTILITY; SYNTHASE	Leptospirosis is a widely spread disease of global concern. Infection causes flu-like episodes with frequent severe renal and hepatic damage, such as haemorrhage and jaundice. In more severe cases, massive pulmonary haemorrhages, including fatal sudden haemoptysis, can occur(1). Here we report the complete genomic sequence of a representative virulent serovar type strain (Lai)(2) of Leptospira interrogans serogroup Icterohaemorrhagiae consisting of a 4.33-megabase large chromosome and a 359-kilobase small chromosome, with a total of 4,768 predicted genes. In terms of the genetic determinants of physiological characteristics, the facultatively parasitic L. interrogans differs extensively from two other strictly parasitic pathogenic spirochaetes, Treponema pallidum(3) and Borrelia burgdorferi(4), although similarities exist in the genes that govern their unique morphological features. A comprehensive analysis of the L. interrogans genes for chemotaxis/motility and lipopolysaccharide synthesis provides a basis for in-depth studies of virulence and pathogenesis. The discovery of a series of genes possibly related to adhesion, invasion and the haematological changes that characterize leptospirosis has provided clues about how an environmental organism might evolve into an important human pathogen.	Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Bioinformat Ctr, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Inst Plant Physiol & Ecol, Biotechnol Res Ctr, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, Dept Microbiol & Parasitol, Shanghai 200025, Peoples R China; Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, ICDC, China CDC, Beijing 102206, Peoples R China; Chinese Natl Human Genome Ctr, Beijing 100170, Peoples R China; Fudan Univ, Dept Mol Virol, Med Ctr, Shanghai 200032, Peoples R China; HKU, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; Inst Pasteur, Unite Bacteriol Mol & Med, F-75724 Paris 15, France; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Fudan University; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr Shanghai, 250 Bi Bo Rd,Zhang Jiang High Tech Pk, Shanghai 201203, Peoples R China.	gpzhao@sibs.ac.cn	Ma, Wei/B-5999-2012; Yin, Haifeng/E-8787-2012	Danchin, Antoine/0000-0002-6350-5001; Zhao, Guo-Ping/0000-0002-7621-6620; Guo, Xiao-Kui/0000-0002-1595-9965				Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Bourhy P, 2000, FEMS MICROBIOL LETT, V191, P259, DOI 10.1016/S0378-1097(00)00393-1; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Herter S, 2001, J BACTERIOL, V183, P4305, DOI 10.1128/JB.183.14.4305-4316.2001; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; Kmety E., 1993, CLASSIFICATION SPECI; KOHLHAW G, 1969, J BIOL CHEM, V244, P2218; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olendzenski L, 2000, J MOL EVOL, V51, P587, DOI 10.1007/s002390010122; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Rodrigo L, 2001, BIOCHEM J, V354, P1, DOI 10.1042/0264-6021:3540001; SAIER M, 2001, SPIROCHETES MOL CELL; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Zhang CT, 2000, NUCLEIC ACIDS RES, V28, P2804, DOI 10.1093/nar/28.14.2804	29	423	892	3	72	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					888	893		10.1038/nature01597	http://dx.doi.org/10.1038/nature01597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712204	hybrid			2022-12-01	WOS:000182432600054
J	Rohani, P; Green, CJ; Mantilla-Beniers, NB; Grenfell, BT				Rohani, P; Green, CJ; Mantilla-Beniers, NB; Grenfell, BT			Ecological interference between fatal diseases	NATURE			English	Article							POPULATION; DETERMINANTS; MEASLES; DENGUE	An important issue in population biology is the dynamic interaction between pathogens. Interest has focused mainly on the indirect interaction of pathogen strains, mediated by cross immunity(1-4). However, a mechanism has recently been proposed for 'ecological interference' between pathogens through the removal of individuals from the susceptible pool after an acute infection. To explore this possibility, we have analysed and modelled historical measles and whooping cough records. Here we show that ecological interference is particularly strong when fatal infections permanently remove susceptibles. Disease interference has substantial dynamical consequences, making multi-annual outbreaks of different infections characteristically out of phase. So, when disease prevalence is high and is associated with significant mortality, it might be impossible to understand epidemic patterns by studying pathogens in isolation. This new ecological null model has important consequences for understanding the multi-strain dynamics of pathogens such as dengue and echoviruses.	Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University System of Georgia; University of Georgia; University of Cambridge	Rohani, P (corresponding author), Univ Georgia, Inst Ecol, Athens, GA 30602 USA.	rohani@uga.edu		rohani, pejman/0000-0002-7221-3801				ANDERSON R M, 1991; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BEHRMAN RE, 1998, NELSON ESSENTIALS PE; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; Butler W, 1913, Proc R Soc Med, V6, P120; BUTLER W, 1947, P ROY SOC MED, V40, P384, DOI 10.1177/003591574704000710; Cherry JD, 1998, ANN INTERN MED, V128, P64, DOI 10.7326/0003-4819-128-1-199801010-00010; CREIGHTON C, 1994, HIST EPIDEMICS BRITA; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gomes MGM, 2002, P ROY SOC B-BIOL SCI, V269, P227, DOI 10.1098/rspb.2001.1869; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; Kurane I., 1991, REV MED VIROL, V1, P211; LINNERT L, 1954, STAT REPORT MEASLES; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; Miller E, 1997, DEV BIOLOGICALS, V89, P15; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Rohani P, 1998, P ROY SOC B-BIOL SCI, V265, P2033, DOI 10.1098/rspb.1998.0537; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; WENJIE W, 1997, DENGUE B, V21	30	132	136	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					885	888		10.1038/nature01542	http://dx.doi.org/10.1038/nature01542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712203				2022-12-01	WOS:000182432600053
J	Simerly, C; Dominko, T; Navara, C; Payne, C; Capuano, S; Gosman, G; Chong, KY; Takahashi, D; Chace, C; Compton, D; Hewitson, L; Schatten, G				Simerly, C; Dominko, T; Navara, C; Payne, C; Capuano, S; Gosman, G; Chong, KY; Takahashi, D; Chace, C; Compton, D; Hewitson, L; Schatten, G			Molecular correlates of primate nuclear transfer failures	SCIENCE			English	Article							RHESUS-MONKEYS; FERTILIZATION; SPINDLE; EG5		Univ Pittsburgh, Sch Med, Dept Obstet Gynecol Reprod Sci, Magee Womens Res Inst,Pittsburgh Dev Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol Physiol, Pittsburgh, PA 15213 USA; Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College	Schatten, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol Reprod Sci, Magee Womens Res Inst,Pittsburgh Dev Ctr, Pittsburgh, PA 15213 USA.		Navara, Christopher/C-2813-2011; Schatten, Gerald/B-3253-2009; simerly, Calvin/AAC-9564-2021	Schatten, Gerald/0000-0001-5206-7782; Compton, Duane/0000-0002-4445-9118				Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Dominko T, 1999, Cloning, V1, P143, DOI 10.1089/15204559950019906; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 2002, NAT MED, V8, P215, DOI 10.1038/nm0302-215	10	187	216	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					297	297		10.1126/science.1082091	http://dx.doi.org/10.1126/science.1082091			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690191				2022-12-01	WOS:000182135400047
J	Dalsgaard, T; Canfield, DE; Petersen, J; Thamdrup, B; Acuna-Gonzalez, J				Dalsgaard, T; Canfield, DE; Petersen, J; Thamdrup, B; Acuna-Gonzalez, J			N-2 production by the anammox reaction in the anoxic water column of Golfo Dulce, Costa Rica	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN-DEFICIENT CONDITIONS; SOUTH-PACIFIC OCEAN; MARINE-SEDIMENTS; NITRATE REDUCTION; ARABIAN SEA; DENITRIFICATION; NITROGEN; NITRIFICATION; MANGANESE	In oxygen-depleted zones of the open ocean, and in anoxic basins and fjords, denitrification (the bacterial reduction of nitrate to give N-2) is recognized as the only significant process converting fixed nitrogen to gaseous N-2. Primary production in the oceans is often limited by the availability of fixed nitrogen such as ammonium or nitrate(1), and nitrogen-removal processes consequently affect both ecosystem function and global biogeochemical cycles. It was recently discovered that the anaerobic oxidation of ammonium with nitrite-the 'anammox' reaction, performed by bacteria-was responsible for a significant fraction of N-2 production in some marine sediments(2). Here we show that this reaction is also important in the anoxic waters of Golfo Dulce, a 200-m-deep coastal bay in Costa Rica, where it accounts for 19-35% of the total N-2 formation in the water column. The water-column chemistry in Golfo Dulce is very similar to that in oxygen-depleted zones of the oceans-in which one-half to one-third of the global nitrogen removal is believed to occur(3,4). We therefore expect the anammox reaction to be a globally significant sink for oceanic nitrogen.	Natl Environm Res Inst, Dept Marine Ecol, DK-8600 Silkeborg, Denmark; Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol, CIMAR, San Jose, Costa Rica	Aarhus University; University of Southern Denmark; Universidad Costa Rica	Dalsgaard, T (corresponding author), Natl Environm Res Inst, Dept Marine Ecol, Vejlsovej 25,POB 314, DK-8600 Silkeborg, Denmark.		Dalsgaard, Tage/J-6258-2014; Dalsgaard, Tage/B-5428-2008; Thamdrup, Bo/F-3889-2016; Canfield, Don/C-1735-2012	Dalsgaard, Tage/0000-0003-2604-6499; Dalsgaard, Tage/0000-0003-2604-6499; Thamdrup, Bo/0000-0002-1221-7077; Canfield, Don/0000-0001-7602-8366				Bange HW, 2000, GLOBAL BIOGEOCHEM CY, V14, P1283, DOI 10.1029/1999GB001228; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Dalsgaard T, 2002, APPL ENVIRON MICROB, V68, P3802, DOI 10.1128/AEM.68.8.3802-3808.2002; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Grasshoff K., 1999, METHODS SEAWATER ANA, DOI DOI 10.1002/ANGE.19770890738; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hulth S, 1999, GEOCHIM COSMOCHIM AC, V63, P49, DOI 10.1016/S0016-7037(98)00285-3; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; Luther GW, 1997, GEOCHIM COSMOCHIM AC, V61, P4043, DOI 10.1016/S0016-7037(97)00239-1; MURRAY JW, 1999, ENV DEGRADATION BLAC, P75; NAQVI SWA, 1987, J MAR RES, V45, P1049, DOI 10.1357/002224087788327118; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; RICHARDS FA, 1965, ADV WATER POLLUTION, P215; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 1996, REV BIOL TROP, V44, P19; Van Mooy BAS, 2002, GEOCHIM COSMOCHIM AC, V66, P457, DOI 10.1016/S0016-7037(01)00787-6; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Vargas JA, 1996, REV BIOL TROP, V44, pU1	26	503	590	8	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					606	608		10.1038/nature01526	http://dx.doi.org/10.1038/nature01526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686998				2022-12-01	WOS:000182111400039
J	Phillips, PEM; Stuber, GD; Heien, MLAV; Wightman, RM; Carelli, RM				Phillips, PEM; Stuber, GD; Heien, MLAV; Wightman, RM; Carelli, RM			Subsecond dopamine release promotes cocaine seeking	NATURE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; EXTRACELLULAR DOPAMINE; DRUG-ADDICTION; NEURONS; REWARD; RATS; ACTIVATION; NEUROBIOLOGY; INTEGRATION	The dopamine-containing projection from the ventral tegmental area of the midbrain to the nucleus accumbens is critically involved in mediating the reinforcing properties of cocaine(1,2). Although neurons in this area respond to rewards on a subsecond timescale(3,4), neurochemical studies have only addressed the role of dopamine in drug addiction by examining changes in the tonic (minute-to-minute) levels of extracellular dopamine(5-9). To investigate the role of phasic (subsecond) dopamine signalling(10), we measured dopamine every 100 ms in the nucleus accumbens using electrochemical technology(11). Rapid changes in extracellular dopamine concentration were observed at key aspects of drug-taking behaviour in rats. Before lever presses for cocaine, there was an increase in dopamine that coincided with the initiation of drug-seeking behaviours. Notably, these behaviours could be reproduced by electrically evoking dopamine release on this timescale. After lever presses, there were further increases in dopamine concentration at the concurrent presentation of cocaine-related cues. These cues alone also elicited similar, rapid dopamine signalling, but only in animals where they had previously been paired to cocaine delivery. These findings reveal an unprecedented role for dopamine in the regulation of drug taking in real time.	Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu	Stuber, Garret/E-1160-2011; Heien, Michael/A-4731-2009; Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Heien, Michael/0000-0001-5164-9596; Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026; Stuber, Garret/0000-0003-1730-4855	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS007431] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bradberry CW, 2000, J NEUROSCI, V20, P3874, DOI 10.1523/JNEUROSCI.20-10-03874.2000; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Carelli Regina M, 2002, Behav Cogn Neurosci Rev, V1, P281, DOI 10.1177/1534582302238338; Carelli RM, 2000, SYNAPSE, V35, P238, DOI 10.1002/(SICI)1098-2396(20000301)35:3<238::AID-SYN10>3.0.CO;2-Y; Carelli RM, 2000, J NEUROSCI, V20, P4255; CARELLI RM, 1993, BRAIN RES, V626, P14, DOI 10.1016/0006-8993(93)90557-4; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; EINHORN LC, 1988, J NEUROSCI, V8, P100; Garris PA, 1997, J NEUROCHEM, V68, P152; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ito R, 2000, J NEUROSCI, V20, P7489; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; MARSDEN CA, 1988, NEUROSCIENCE, V25, P389, DOI 10.1016/0306-4522(88)90247-3; MILLAR J, 1985, EUR J PHARMACOL, V109, P341, DOI 10.1016/0014-2999(85)90394-2; MOGENSON GJ, 1987, PROG PSYCHOB PHYSIOL, V12, P117; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Stamford JA, 1996, ANAL CHEM, V68, pA359, DOI 10.1021/ac961943a; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5	30	810	819	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2003	422	6932					614	618		10.1038/nature01566	http://dx.doi.org/10.1038/nature01566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687000				2022-12-01	WOS:000182111400042
J	Schwimmer, JB; Burwinkle, TM; Varni, JW				Schwimmer, JB; Burwinkle, TM; Varni, JW			Health-related quality of life of severely obese children and adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERIC CORE SCALES; BODY-MASS INDEX; PERCEIVED PHYSICAL APPEARANCE; SCHOOL PERFORMANCE; SOCIAL-ADJUSTMENT; PEDSQL(TM); VALIDITY; RELIABILITY; OVERWEIGHT; RESPONSIVENESS	Context One in 7 US children and adolescents is obese, yet little is known about their health-related quality of life (QOL). Objective To examine the health-related QOL of obese children and adolescents compared with children and adolescents who are healthy or those diagnosed as having cancer. Design, Setting, and Participants Cross-sectional study of 106 children and adolescents (57 males) between the ages of 5 and 18 years (mean [SD], 12.1 [3] years), who had been referred to an academic children's hospital for evaluation of obesity between January and June 2002. Children and adolescents had a mean (SD) body mass index (BMI) of 34.7 (9.3) and BMI z score of 2.6 (0.5). Main Outcome Measures Child self-report and parent proxy report using a pediatric QOL inventory generic core scale (range, 0-100). The inventory was administered by an interviewer for children aged 5 through 7 years. Scores were compared with previously published scores for healthy children and adolescents and children and adolescents diagnosed as having cancer. Results Compared with healthy children and adolescents, obese children and adolescents reported significantly (P<.001) lower health-related QOL in all domains (mean [SD] total score, 67 [16.3] for obese children and adolescents; 83 [14.8] for healthy children and adolescents). Obese children and adolescents were more likely to have impaired health-related QOL than healthy children and adolescents (odds ratio [OR], 5.5; 95% confidence interval [CI], 3.4-8.7) and were similar to children and adolescents diagnosed As having cancer (OR, 1.3; 95% CI, 0.8-2.3). Children and adolescents with obstructive sleep apnea reported a significantly lower health-related QOL total score (mean [SD], 53.8 [13.3]) than obese children and adolescents without obstructive sleep apnea (mean [SD], 67.9 [16.2]). For parent proxy report, the child or adolescent's. BMI z score was significantly inversely correlated with total score (r=-0.246; P=.01), physical functioning (r=-0.263; P<.01), social functioning (r=-0.347; P<001), and psychosocial functioning (r=-0.209; P=.03). Conclusions Severely obese children and adolescents have lower health-related QOL than children and adolescents who are healthy and similar QOL as those diagnosed as having cancer. Physicians, parents, and teachers need to be informed of the risk for impaired health-related QOL among obese children and adolescents to target interventions that could enhance health outcomes.	Univ Calif San Diego, Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA; Childrens Hosp & Hlth Ctr, Ctr Child Hlth Outcomes, San Diego, CA USA; Texas A&M Univ, Dept Architecture, College Stn, TX USA; Texas A&M Univ, Dept Med, College Stn, TX USA	University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Schwimmer, JB (corresponding author), Univ Calif San Diego, Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, 200 W Arbor Dr, San Diego, CA 92103 USA.	jschwimmer@ucsd.edu	Fahimifar, Sepideh/M-5303-2019	Schwimmer, Jeffrey/0000-0001-8538-2877	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BANIS HT, 1988, CHILD CARE HLTH DEV, V14, P157, DOI 10.1111/j.1365-2214.1988.tb00572.x; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; *CDC, OV CHILDR AD 6 19 YE; Cohen J., 2013, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923, DOI 10.1001/archpedi.154.9.923; Dietz WH, 1998, PEDIATRICS, V101, P518; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Dietz WH, 1998, J PEDIATR-US, V132, P191; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; EISER C, 2001, QUALITY LIFE CHILD A, P267; Epstein LH, 2000, OBES RES, V8, P575, DOI 10.1038/oby.2000.74; Fontaine KR, 1996, J FAM PRACTICE, V43, P265; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Hollingshead AA, 1975, 4 FACTOR INDEX SOCIA; Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009; Jonides L, 2002, PEDIATRICS, V110, P215; KOLOTKIN RL, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00120.x; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; Mo-Suwan L, 1999, INT J OBESITY, V23, P272, DOI 10.1038/sj.ijo.0800808; *NAT HEART LUNG BL, MORB MORT CHARTB; Nunnally J.C., 1994, PSYCHOMETRIC THEORY; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pedhazur E.J., 1991, MEASUREMENT DESIGN A, V87, P908, DOI 10.2307/2290248; Ravens-Sieberer U, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801702; SPIRITO A, 1991, CLIN PSYCHOL REV, V11, P539, DOI 10.1016/0272-7358(91)90003-D; SPSS, 1998, SPSS VERS 8 0 WIND; Story MT, 2002, PEDIATRICS, V110, P210; SULLIVAN M, 1993, INT J OBESITY, V17, P503; UZARK K, IN PRESS PROGR PEDIA; VARNI JW, 1994, J DEV BEHAV PEDIATR, V15, P20, DOI 10.1097/00004703-199402000-00004; Varni JW, 2002, ARTHRITIS RHEUM-US, V46, P714, DOI 10.1002/art.10095; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; VARNI JW, 1995, J BEHAV MED, V18, P261, DOI 10.1007/BF01857873; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812; VARNI JW, 1989, J DEV BEHAV PEDIATR, V10, P13; Varni JW, 1996, J CLIN CHILD PSYCHOL, V25, P201, DOI 10.1207/s15374424jccp2502_9; VARNI JW, 1992, AM J DIS CHILD, V146, P103, DOI 10.1001/archpedi.1992.02160130105030; Veale D, 2002, QUAL LIFE RES, V11, P389, DOI 10.1023/A:1015599326110; Vetiska J, 2000, DIABETES CARE, V23, P1706, DOI 10.2337/diacare.23.11.1706	46	1061	1078	1	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2003	289	14					1813	1819		10.1001/jama.289.14.1813	http://dx.doi.org/10.1001/jama.289.14.1813			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZJ	12684360	Bronze			2022-12-01	WOS:000182094900027
J	Forkey, JN; Quinlan, ME; Shaw, MA; Corrie, JET; Goldman, YE				Forkey, JN; Quinlan, ME; Shaw, MA; Corrie, JET; Goldman, YE			Three-dimensional structural dynamics of myosin V by single-molecule fluorescence polarization	NATURE			English	Article							MUSCLE-CONTRACTION; KINETIC MECHANISM; ACTIN; MOTOR; FLUOROPHORE; KINESIN; MICROSCOPY; ROTATION; PURIFICATION; PROTEINS	The structural change that generates force and motion in actomyosin motility has been proposed to be tilting of the myosin light chain domain, which serves as a lever arm. Several experimental approaches have provided support for the lever arm hypothesis; however, the extent and timing of tilting motions are not well defined in the motor protein complex of functioning actomyosin. Here we report three-dimensional measurements of the structural dynamics of the light chain domain of brain myosin V using a single-molecule fluorescence polarization technique that determines the orientation of individual protein domains with 20-40-ms time resolution. Single fluorescent calmodulin light chains tilted back and forth between two well-defined angles as the myosin molecule processively translocated along actin. The results provide evidence for lever arm rotation of the calmodulin-binding domain in myosin V, and support a 'hand-over-hand' mechanism for the translocation of double-headed myosin V molecules along actin filaments. The technique is applicable to the study of real-time structural changes in other biological systems.	Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; Natl Inst Med Res, London NW7 1AA, England	University of Pennsylvania; MRC National Institute for Medical Research	Goldman, YE (corresponding author), Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA.							Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; Bopp MA, 1997, P NATL ACAD SCI USA, V94, P10630, DOI 10.1073/pnas.94.20.10630; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Corrie JET, 1998, BIOCONJUGATE CHEM, V9, P160, DOI 10.1021/bc970174e; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dickson RM, 1998, PHYS REV LETT, V81, P5322, DOI 10.1103/PhysRevLett.81.5322; Empedocles SA, 1999, NATURE, V399, P126, DOI 10.1038/20138; Forkey JN, 2000, PROG BIOPHYS MOL BIO, V74, P1, DOI 10.1016/S0079-6107(00)00015-8; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Goldman YE, 1998, CELL, V93, P1, DOI 10.1016/S0092-8674(00)81137-X; Ha T, 1998, PHYS REV LETT, V80, P2093, DOI 10.1103/PhysRevLett.80.2093; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Irving M, 1997, NEWS PHYSIOL SCI, V12, P249; Mehta A, 2001, J CELL SCI, V114, P1981; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MOISESCU DG, 1979, BIOCHIM BIOPHYS ACTA, V546, P64, DOI 10.1016/0005-2728(79)90170-1; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Press W., 1992, NUMERICAL RECIPES, V2nd; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; PUTKEY JA, 1983, J BIOL CHEM, V258, P1864; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; REEDY MK, 1965, NATURE, V207, P1276, DOI 10.1038/2071276a0; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Sosa H, 2001, NAT STRUCT BIOL, V8, P540, DOI 10.1038/88611; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Vale R D, 1990, Adv Biophys, V26, P97, DOI 10.1016/0065-227X(90)90009-I; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Warshaw DM, 1998, P NATL ACAD SCI USA, V95, P8034, DOI 10.1073/pnas.95.14.8034	44	359	364	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					399	404		10.1038/nature01529	http://dx.doi.org/10.1038/nature01529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660775				2022-12-01	WOS:000181801200036
J	Gerlich, D; Beaudouin, J; Kalbfuss, B; Daigle, N; Eils, R; Ellenberg, J				Gerlich, D; Beaudouin, J; Kalbfuss, B; Daigle, N; Eils, R; Ellenberg, J			Global chromosome positions are transmitted through mitosis in mammalian cells	CELL			English	Article							LIVING HUMAN-CELLS; NUCLEAR-ORGANIZATION; PERICENTRIC HETEROCHROMATIN; CENTROMERE SEPARATION; SPATIAL-ORGANIZATION; GENE ACTIVITY; INTERPHASE; CHROMATIN; DYNAMICS; TERRITORIES	We investigated positioning of chromosomes during the cell cycle in live mammalian cells with a combined experimental and computational approach. By non-invasive labeling of chromosome subsets and tracking by 4D imaging, we could show that no global rearrangements occurred in interphase. Using the same assay, we also observed a striking order of chromosomes throughout mitosis. By contrast, our computer simulation based on stochastic movements of individual chromosomes predicted randomization of chromosome order in mitosis. In vivo, a quantitative assay for single chromosome positioning during mitosis revealed strong similarities between daughter and mother cells. These results demonstrate that global chromosome positions are heritable through the cell cycle in mammalian cells. Based on tracking of labeled chromosomes and centromeres during chromosome segregation and experimental perturbations of chromosomal order, we propose that chromosome specific timing of sister chromatid separation transmits chromosomal positions from one cell generation to the next.	German Canc Res Ctr, D-69120 Heidelberg, Germany; European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Biophys Programme, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Eils, R (corresponding author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	r.eils@dkfz.de	Ellenberg, Jan/I-4688-2014; Eils, Roland/B-6121-2009; Gerlich, Daniel Wolfram W/A-6991-2016	Ellenberg, Jan/0000-0001-5909-701X; Eils, Roland/0000-0002-0034-4036; Gerlich, Daniel Wolfram W/0000-0003-1637-3365				Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; AGARD DA, 1983, NATURE, V302, P676, DOI 10.1038/302676a0; ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; BORDEN J, 1988, SCIENCE, V242, P1687, DOI 10.1126/science.3201257; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; CHUNG HMM, 1990, EMBO J, V9, P2611, DOI 10.1002/j.1460-2075.1990.tb07443.x; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Ellenberg J, 1999, TRENDS CELL BIOL, V9, P52, DOI 10.1016/S0962-8924(98)01420-2; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Franklin AE, 1999, PLANT CELL, V11, P523, DOI 10.1105/tpc.11.4.523; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Haaf T, 2000, CYTOGENET CELL GENET, V91, P113, DOI 10.1159/000056830; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Martou G, 2000, EXP CELL RES, V256, P131, DOI 10.1006/excr.1999.4793; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Rabl C., 1885, MORPHOL JB, V10, P214; Sachs RK, 1997, INT J RADIAT BIOL, V71, P1, DOI 10.1080/095530097144364; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Vig BK, 1998, CHROMOSOMA, V107, P417, DOI 10.1007/s004120050325; VIG BK, 1983, CANCER GENET CYTOGEN, V8, P249, DOI 10.1016/0165-4608(83)90142-5; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	53	217	225	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					751	764		10.1016/S0092-8674(03)00189-2	http://dx.doi.org/10.1016/S0092-8674(03)00189-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654243	Bronze			2022-12-01	WOS:000181818500004
J	Chaimanee, Y; Jolly, D; Benammi, M; Tafforeau, P; Duzer, D; Moussa, I; Jaeger, JJ				Chaimanee, Y; Jolly, D; Benammi, M; Tafforeau, P; Duzer, D; Moussa, I; Jaeger, JJ			A Middle Miocene hominoid from Thailand and orangutan origins	NATURE			English	Article							SIVAPITHECUS; PAKISTAN; NEOGENE; LUFENG; CHINA	The origin of orangutans has long been debated. Sivapithecus is considered to be the closest ancestor of orangutans because of its facial-palatal similarities(1), but its dental characteristics 2 and postcranial skeleton(2,3) do not confirm this phylogenetic position. Here we report a new Middle Miocene hominoid, cf. Lufengpithecus chiangmuanensis n. sp. from northern Thailand. Its dental morphology relates it to the Pongo clade, which includes Lufengpithecus(4,5), Sivapithecus(2), Gigantopithecus(6), Ankarapithecus(7) and possibly Griphopithecus(8). Our new species displays striking dental resemblances with living orangutans and appears as a more likely candidate to represent an ancestor of this ape. In addition, it originates from the geographic area of Pleistocene orangutans. But surprisingly, the associated flora shows strong African affinities, demonstrating the existence of a temporary floral and faunal dispersal corridor between southeast Asia and Africa during the Middle Miocene, which may have played a critical role in hominoid dispersion.	Univ Montpellier 2, ISEM, F-34095 Montpellier, France; Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand; Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City 04510, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Department of Mineral Resources - Thailand; Universidad Nacional Autonoma de Mexico	Jaeger, JJ (corresponding author), Univ Montpellier 2, ISEM, CC 064,Pl Eugene Bataillon, F-34095 Montpellier, France.	jaeger@isem.univ-montp2.fr		Tafforeau, Paul/0000-0002-5962-1683; chaimanee, yaowalak/0000-0002-8432-3880				ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; BADGLEY C, 1988, NATL GEOGR RES, V4, P178; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Harrison Terry, 1997, P327; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; JOHNSON NM, 1983, J GEOPHYS RES, V88, P1213, DOI 10.1029/JB088iB02p01213; KAPPELMAN J, IN PRESS GEOLOGY PAL; Kelley J, 1998, J HUM EVOL, V35, P577, DOI 10.1006/jhev.1998.0253; KELLEY J, 1995, J HUM EVOL, V28, P503, DOI 10.1006/jhev.1995.1039; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin L.B., 1983, THESIS U LONDON; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; PAJUNEN H, 1985, P S INT PEAT SOC JAM, P186; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; PILBEAM D, 1990, NATURE, V348, P237, DOI 10.1038/348237a0; Remus D., 1993, J SE ASIAN EARTH SCI, V8, P321, DOI [10. 1016/0743-9547(93)90043-O, DOI 10.1016/0743-9547(93)90043-O]; Schwartz Jeffrey H., 1997, P363; SCHWARTZ JH, 1990, J HUM EVOL, V19, P591, DOI 10.1016/0047-2484(90)90001-R; Simons E. L., 1969, Postilla, VNo. 138, P1; Swarts J.D., 1988, P263; Ward Steve, 1997, P269; WU R, 1987, ACTA ANTHR SIN, V6, P263; WU RK, 1983, NATURE, V306, P258, DOI 10.1038/306258a0	25	100	104	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					61	65		10.1038/nature01449	http://dx.doi.org/10.1038/nature01449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621432				2022-12-01	WOS:000181343100036
J	Klausberger, T; Magill, PJ; Marton, LF; Roberts, JDB; Cobden, PM; Buzsaki, G; Somogyi, P				Klausberger, T; Magill, PJ; Marton, LF; Roberts, JDB; Cobden, PM; Buzsaki, G; Somogyi, P			Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo	NATURE			English	Article							PYRAMIDAL CELLS; RAT HIPPOCAMPUS; THETA-RHYTHM; IN-VIVO; NEURONS	Neural-network oscillations at distinct frequencies have been implicated in the encoding, consolidation and retrieval of information in the hippocampus. Some GABA (gamma-aminobutyric acid)-containing interneurons fire phase-locked to theta oscillations (4-8 Hz) or to sharp-wave-associated ripple oscillations (120-200 Hz), which represent different behavioural states(1-6). Interneurons also entrain pyramidal cells in vitro(7). The large diversity of interneurons(8-10) poses the question of whether they have specific roles in shaping distinct network activities in vivo. Here we report that three distinct interneuron types-basket, axo-axonic and oriens-lacunosum-moleculare cells-visualized and defined by synaptic connectivity as well as by neurochemical markers, contribute differentially to theta and ripple oscillations in anaesthetized rats. The firing patterns of individual cells of the same class are remarkably stereotyped and provide unique signatures for each class. We conclude that the diversity of interneurons, innervating distinct domains of pyramidal cells 11, emerged to coordinate the activity of pyramidal cells in a temporally distinct and brain-state-dependent manner.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	University of Oxford; Rutgers State University Newark; Rutgers State University New Brunswick	Klausberger, T (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	thomas.klausberger@pharm.ox.ac.uk		Magill, Peter/0000-0001-7141-7071; Buzsaki, Gyorgy/0000-0002-3100-4800				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; SIK A, 1995, J NEUROSCI, V15, P6651; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30; Zar JH., 1999, BIOSTAT ANAL	30	939	990	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					844	848		10.1038/nature01374	http://dx.doi.org/10.1038/nature01374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594513				2022-12-01	WOS:000181044700048
J	Scherer, SW; Cheung, J; MacDonald, JR; Osborne, LR; Nakabayashi, K; Herbrick, JA; Carson, AR; Parker-Katiraee, L; Skaug, J; Khaja, R; Zhang, JJ; Hudek, AK; Li, M; Haddad, M; Duggan, GE; Fernandez, BA; Kanematsu, E; Gentles, S; Christopoulos, CC; Choufani, S; Kwasnicka, D; Zheng, XQH; Lai, ZW; Nusskern, D; Zhang, Q; Gu, ZP; Lu, F; Zeesman, S; Nowaczyk, MJ; Teshima, I; Chitayat, D; Shuman, C; Weksberg, R; Zackai, EH; Grebe, TA; Cox, SR; Kirkpatrick, SJ; Rahman, N; Friedman, JM; Heng, HHQ; Pelicci, PG; Lo-Coco, F; Belloni, E; Shaffer, LG; Pober, B; Morton, CC; Gusella, JF; Bruns, GAP; Korf, BR; Quade, BJ; Ligon, AH; Ferguson, H; Higgins, AW; Leach, NT; Herrick, SR; Lemyre, E; Farra, CG; Kim, HG; Summers, AM; Gripp, KW; Roberts, W; Szatmari, P; Winsor, EJT; Grzeschik, KH; Teebi, A; Minassian, BA; Kere, J; Armengol, L; Pujana, MA; Estivill, X; Wilson, MD; Koop, BF; Tosi, S; Moore, GE; Boright, AP; Zlotorynski, E; Kerem, B; Kroisel, PM; Petek, E; Oscier, DG; Mould, SJ; Dohner, H; Dohner, K; Rommens, JM; Vincent, JB; Venter, JC; Li, PW; Mural, RJ; Adams, MD; Tsui, LC				Scherer, SW; Cheung, J; MacDonald, JR; Osborne, LR; Nakabayashi, K; Herbrick, JA; Carson, AR; Parker-Katiraee, L; Skaug, J; Khaja, R; Zhang, JJ; Hudek, AK; Li, M; Haddad, M; Duggan, GE; Fernandez, BA; Kanematsu, E; Gentles, S; Christopoulos, CC; Choufani, S; Kwasnicka, D; Zheng, XQH; Lai, ZW; Nusskern, D; Zhang, Q; Gu, ZP; Lu, F; Zeesman, S; Nowaczyk, MJ; Teshima, I; Chitayat, D; Shuman, C; Weksberg, R; Zackai, EH; Grebe, TA; Cox, SR; Kirkpatrick, SJ; Rahman, N; Friedman, JM; Heng, HHQ; Pelicci, PG; Lo-Coco, F; Belloni, E; Shaffer, LG; Pober, B; Morton, CC; Gusella, JF; Bruns, GAP; Korf, BR; Quade, BJ; Ligon, AH; Ferguson, H; Higgins, AW; Leach, NT; Herrick, SR; Lemyre, E; Farra, CG; Kim, HG; Summers, AM; Gripp, KW; Roberts, W; Szatmari, P; Winsor, EJT; Grzeschik, KH; Teebi, A; Minassian, BA; Kere, J; Armengol, L; Pujana, MA; Estivill, X; Wilson, MD; Koop, BF; Tosi, S; Moore, GE; Boright, AP; Zlotorynski, E; Kerem, B; Kroisel, PM; Petek, E; Oscier, DG; Mould, SJ; Dohner, H; Dohner, K; Rommens, JM; Vincent, JB; Venter, JC; Li, PW; Mural, RJ; Adams, MD; Tsui, LC			Human chromosome 7: DNA sequence and biology	SCIENCE			English	Article							SEGMENTAL DUPLICATIONS; REGION; MAP; LOCALIZATION; SPEECH; GENES	DNA sequence and annotation of the entire human chromosome 7, encompassing nearly 158 million nucleotides of DNA and 1917 gene structures, are presented. To generate a higher order description, additional structural features such as imprinted genes, fragile sites, and segmental duplications were integrated at the level of the DNA sequence with medical genetic data, including 440 chromosome rearrangement breakpoints associated with disease. This approach enabled the discovery of candidate genes for developmental diseases including autism.	Hosp Sick Children, Dept Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Child Dev Ctr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF A1B 3V6, Canada; Celera Genom, Rockville, MD 20850 USA; Hamilton Hlth Sci Ctr, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Phoenix Genet Program, Phoenix, AZ 85016 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; Wayne State Univ, Sch Med, Detroit, MI 48202 USA; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Firc Inst Mol Oncol, Canc Genet Unit, I-20134 Milan, Italy; Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, I-00133 Rome, Italy; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Neurogenet Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; N York Gen Hosp, Dept Genet, Toronto, ON M2K 1E1, Canada; Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE 19899 USA; Univ Toronto, Univ Hlth Network, Prenatal Diag Program, Toronto, ON M5G 1X5, Canada; Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; Univ Marburg, Med Zentrum Humangenet, D-35037 Marburg, Germany; Karolinska Inst, Novum, Dept Biosci, S-14157 Stockholm, Sweden; Huddinge Univ Hosp, Clin Res Ctr, S-14157 Stockholm, Sweden; Ctr Genom Regulat, Program Genes & Dis, Barcelona 08003, Catalonia, Spain; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Reprod & Dev Biol, Dept Fetal & Maternal Med, London W12 0NN, England; Univ Toronto, Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON M5G 2C4, Canada; Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; Karl Franzens Univ Graz, Inst Med Biol & Human Genet, A-8010 Graz, Austria; Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England; Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; Univ Toronto, Clark Inst, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Memorial University Newfoundland; McMaster University; McMaster University; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Wisconsin System; University of Wisconsin Madison; University of London; Institute of Cancer Research - UK; University of British Columbia; Wayne State University; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Rome Tor Vergata; Baylor College of Medicine; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; North York General Hospital; Nemours Alfred I. duPont Hospital for Children; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Philipps University Marburg; Karolinska Institutet; Karolinska Institutet; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Victoria; University of Oxford; Imperial College London; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hebrew University of Jerusalem; University of Graz; Ulm University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Dept Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	steve@genet.sickkids.on.ca	Tsui, Lap-chee/A-1081-2010; Döhner, Hartmut/C-8933-2016; Rahman, Nazneen/B-8890-2012; belloni, elena/H-9909-2013; Choufani, Sanaa/GWC-1820-2022; MacDonald, Jeffrey Robert/GLU-2255-2022; Wilson, Michael D/K-6294-2014; Scherer, Stephen/B-3785-2013; Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012; Moore, Gudrun/A-2092-2009; pujana, Miguel Angel/N-3127-2014; Koop, Ben F./A-8151-2008; Korf, Bruce R/H-4882-2012; Pelicci, Pier Giuseppe/AAL-6572-2020; Kere, Juha/AAX-9117-2021; Rommens, Johanna/AAT-7465-2021; Kere, Juha/A-9179-2008; Tosi, Sabrina/AAA-7199-2022; Rahman, Nazneen/D-2802-2013	Döhner, Hartmut/0000-0003-2116-5536; Choufani, Sanaa/0000-0002-5241-2213; Wilson, Michael D/0000-0002-4015-3066; Scherer, Stephen/0000-0002-8326-1999; Estivill, Xavier/0000-0002-0723-2256; pujana, Miguel Angel/0000-0003-3222-4044; Koop, Ben F./0000-0003-0045-5200; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Tosi, Sabrina/0000-0002-0036-0191; Friedman, Jan/0000-0002-7482-9570; Moore, Gudrun/0000-0002-2099-3420; Cheung, Joseph/0000-0002-1222-7603; Belloni, Elena/0000-0003-3214-0780; MacDonald, Jeffrey/0000-0001-5058-2393; Rahman, Nazneen/0000-0003-4376-0440; Zheng Bradley, Xiangqun/0000-0002-9324-2708	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [38103] Funding Source: Medline; NIGMS NIH HHS [P01 GM061354] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Bouffard GG, 1997, GENOME RES, V7, P59, DOI 10.1101/gr.7.1.59; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; de la Puente A, 1998, CYTOGENET CELL GENET, V83, P176, DOI 10.1159/000015175; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; *FANT CONS, 2002, NATURE, V420, P523; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; HILLIER LW, IN PRESS NATURE; *INT MOL GEN STUD, 1998, HUM MOL GENET, V3, P571; KOBAYASHI K, 1999, ANTURE GENET, V2, P159; KUNZ J, 1994, GENOMICS, V22, P439, DOI 10.1006/geno.1994.1407; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295	31	152	526	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					767	772		10.1126/science.1083423	http://dx.doi.org/10.1126/science.1083423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12690205	Green Accepted			2022-12-01	WOS:000182579800041
J	Tian, D; Traw, MB; Chen, JQ; Kreitman, M; Bergelson, J				Tian, D; Traw, MB; Chen, JQ; Kreitman, M; Bergelson, J			Fitness costs of R-gene-mediated resistance in Arabidopsis thaliana	NATURE			English	Article							NUCLEOTIDE-BINDING SITE; DISEASE-RESISTANCE; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; NATURAL-SELECTION; PLANT-RESISTANCE; PATHOGENS; RPS2; POLYMORPHISM; SPECIFICITY	Resistance genes (R-genes) act as an immune system in plants by recognizing pathogens and inducing defensive pathways. Many R-gene loci are present in plant genomes, presumably reflecting the need to maintain a large repertoire of resistance alleles. These loci also often segregate for resistance and susceptibility alleles that natural selection has maintained as polymorphisms within a species for millions of years(1-5). Given the obvious advantage to an individual of being disease resistant, what prevents these resistance alleles from being driven to fixation by natural selection? A cost of resistance(6) is one potential explanation; most models require a lower fitness of resistant individuals in the absence of pathogens for long-term persistence of susceptibility alleles(7). Here we test for the presence of a cost of resistance at the RPM1 locus of Arabidopsis thaliana. Results of a field experiment comparing the fitness of isogenic strains that differ in the presence or absence of RPM1 and its natural promoter reveal a large cost of RPM1, providing the first evidence that costs contribute to the maintenance of an ancient R-gene polymorphism.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Nanjing Univ, Dept Biol, Nanjing 210093, Peoples R China	University of Chicago; Nanjing University	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	jbergels@midway.uchicago.edu	Traw, Milton Brian/ABD-3275-2020; Bruening, Stefan/B-8505-2011	Traw, Milton Brian/0000-0002-3148-2108; Chen, Jian-Qun/0000-0003-4376-5655; Bergelson, Joy/0000-0001-7893-7387	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057994, R01GM062504] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062504, R01 GM057994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Caicedo AL, 1999, P NATL ACAD SCI USA, V96, P302, DOI 10.1073/pnas.96.1.302; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; GILLESPIE JH, 1975, ECOLOGY, V56, P493, DOI 10.2307/1934983; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; HOWE C, 1995, GENE CLONING MANIPUL; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; JORGENSEN JH, 1990, NORSK LANDBRUKSFOR S, V9, P125; KLEMENT Z, 1963, NATURE, V199, P299, DOI 10.1038/199299b0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mauricio R, 2003, GENETICS, V163, P735; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Moore ERB, 1996, SYST APPL MICROBIOL, V19, P478, DOI 10.1016/S0723-2020(96)80021-X; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; OW DW, 1995, CRIT REV PLANT SCI, V14, P239, DOI 10.1080/713608117; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; REDEI GP, 1975, ANNU REV GENET, V9, P111, DOI 10.1146/annurev.ge.09.120175.000551; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stuiver MH, 2001, NATURE, V411, P865, DOI 10.1038/35081200; Tang XY, 1999, PLANT CELL, V11, P15, DOI 10.1105/tpc.11.1.15; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Traw MB, 2003, MOL ECOL, V12, P1125, DOI 10.1046/j.1365-294X.2003.01815.x; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Wang ZX, 2001, PLANT MOL BIOL, V47, P653, DOI 10.1023/A:1012457113700; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49	36	548	568	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					74	77		10.1038/nature01588	http://dx.doi.org/10.1038/nature01588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721627				2022-12-01	WOS:000182561600041
J	Berger, A				Berger, A			Science commentary: Pertussis immunisation	BRITISH MEDICAL JOURNAL			English	Editorial Material							REACTOGENICITY; VACCINES											Miller E, 1997, VACCINE, V15, P51, DOI 10.1016/S0264-410X(96)00112-0; Miller E, 2001, VACCINE, V19, P3904, DOI 10.1016/S0264-410X(01)00123-2; MILLER E, 1995, VACCINE, V13, P1183, DOI 10.1016/0264-410X(95)00061-5; Van Buynder PG, 1999, EPIDEMIOL INFECT, V123, P403, DOI 10.1017/S0950268899003052	4	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					853	853		10.1136/bmj.326.7394.853	http://dx.doi.org/10.1136/bmj.326.7394.853			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702618	Green Published, Bronze			2022-12-01	WOS:000182386800018
J	Lee, BH; Amon, A				Lee, BH; Amon, A			Role of Polo-like kinase CDC5 in programming meiosis I chromosome segregation	SCIENCE			English	Article							SISTER-CHROMATID SEPARATION; SINGLE-DIVISION MEIOSIS; COHESIN SUBUNIT SCC1; SACCHAROMYCES-CEREVISIAE; PRECOCIOUS SEPARATION; BUDDING YEAST; CELL-CYCLE; ANAPHASE; CENTROMERES; CLEAVAGE	Meiosis is a specialized cell division in which two chromosome segregation phases follow a single DNA replication phase. The budding yeast Polo-like kinase Cdc5 was found to be instrumental in establishing the meiosis I chromosome segregation program. Cdc5 was required to phosphorylate and remove meiotic cohesin from chromosomes. Furthermore, in the absence of CDC5 kinetochores were bioriented during meiosis I, and Mam1, a protein essential for coorientation, failed to associate with kinetochores. Thus, sister-kinetochore coorientation and chromosome segregation during meiosis I are coupled through their dependence on CDC5.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.			Amon, Angelika/0000-0001-9837-0314; Lee, Brian/0000-0003-2497-5139	NIGMS NIH HHS [GM62207] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BUONOMO SB, IN PRESS DEV CELL; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Goshima G, 2001, GENES CELLS, V6, P765, DOI 10.1046/j.1365-2443.2001.00464.x; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Herrmann S, 1998, CHROMOSOMA, V107, P440, DOI 10.1007/PL00013778; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; Lee B.H., UNPUB; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; MARSTON A, IN PRESS DEV CELL; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; SHARON G, 1990, GENETICS, V125, P487; SHARON G, 1990, GENETICS, V125, P475; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831	32	186	192	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					482	486		10.1126/science.1081846	http://dx.doi.org/10.1126/science.1081846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12663816				2022-12-01	WOS:000182295900039
J	Saad, EB; Marrouche, NF; Saad, CP; Ha, E; Bash, D; White, RD; Rhodes, J; Prieto, L; Martin, DO; Saliba, WI; Schweikert, RA; Natale, A				Saad, EB; Marrouche, NF; Saad, CP; Ha, E; Bash, D; White, RD; Rhodes, J; Prieto, L; Martin, DO; Saliba, WI; Schweikert, RA; Natale, A			Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Emergence of a new clinical syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							ECTOPIC BEATS; RADIOFREQUENCY ABLATION; INITIATION; SYSTEM	Background: Pulmonary vein isolation is a new, effective curative procedure for selected patients with atrial fibrillation. Pulmonary vein stenosis is a potential complication and may lead to symptoms that are often underrecognized. Objective: To describe the clinical course and symptoms associated with pulmonary vein stenosis developing after ablation in the pulmonary veins. Design: Retrospective study. Setting: Tertiary care referral center. Patients: 335 patients referred for catheter ablation of drug-refractory atrial fibrillation. Intervention: Pulmonary vein electrical isolation using radiofrequency catheter ablation. Measurements: Three months after ablation, patients underwent routine screening for pulmonary vein stenosis with spiral computed tomography. Screening was considered earlier if symptoms suggestive of stenosis developed and was repeated at 6 and 12 months if any pulmonary vein narrowing was observed. Pulmonary vein angiography and dilatation were offered to patients with severe (>70%) stenosis. Results: Severe pulmonary vein stenosis was detected in 18 patients (5% [95% Cl, 3.2% to 8.4%]) a mean (+SD) of 5.2 +/- 2.6 months after ablation. Eight of these 18 patients (44%) were asymptomatic, but 8 (44%) reported shortness of breath, 7 (39%) reported cough, and 5 (28%) reported hemoptysis. Radiologic abnormalities were present in 9 patients (50%) and led to diagnoses of pneumonia (4 patients), lung cancer (1 patient), and pulmonary embolism (2 patients). Pulmonary vein stenosis was not considered in any patient during the initial work-up. Dilatation of the affected vein was performed in 12 patients. Postintervention lung perfusion scans revealed significant improvement in lung flow. Conclusions: Severe pulmonary vein stenosis after catheter ablation of atrial fibrillation is associated with respiritory symptoms that frequently mimic more common diseases, often leading to erroneous diagnostic and therapeutic procedures. Awareness of this syndrome is important for proper and prompt management.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Natale, A (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave,Desk F15, Cleveland, OH 44195 USA.	natalea@cce.org		White, Richard D./0000-0002-1133-7819				Chen SA, 2000, J CARDIOVASC ELECTR, V11, P218; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Cole CR, 2001, CIRCULATION, V104, P567; Cooper JM, 2001, CIRCULATION, V104, P3010, DOI 10.1161/hc5001.101503; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kanagaratnam L, 2001, PACE, V24, P1774, DOI 10.1046/j.1460-9592.2001.01774.x; Lin WS, 2000, CIRCULATION, V101, P1274, DOI 10.1161/01.CIR.101.11.1274; Marrouche NF, 2002, J AM COLL CARDIOL, V40, P464, DOI 10.1016/S0735-1097(02)01972-1; Natale A, 2000, CIRCULATION, V102, P1879, DOI 10.1161/01.CIR.102.16.1879; Natale A, 1999, PACE, V22, P1634, DOI 10.1111/j.1540-8159.1999.tb00383.x; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Robbins IM, 1998, CIRCULATION, V98, P1769, DOI 10.1161/01.CIR.98.17.1769; Scanavacca MI, 2000, J CARDIOVASC ELECTR, V11, P677, DOI 10.1111/j.1540-8167.2000.tb00030.x; Yang M, 2001, J COMPUT ASSIST TOMO, V25, P34, DOI 10.1097/00004728-200101000-00006; Yu WC, 2001, J CARDIOVASC ELECTR, V12, P887, DOI 10.1046/j.1540-8167.2001.00887.x	16	167	177	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					634	638		10.7326/0003-4819-138-8-200304150-00010	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693885				2022-12-01	WOS:000182173800005
J	Foell, D; Ichida, F; Vogl, T; Yu, XY; Chen, R; Miyawaki, T; Sorg, C; Roth, J				Foell, D; Ichida, F; Vogl, T; Yu, XY; Chen, R; Miyawaki, T; Sorg, C; Roth, J			S100A12 (EN-RAGE) in monitoring Kawasaki disease	LANCET			English	Article							RECEPTOR	The calcium-binding protein S100A12 causes inflammation through interaction with the multiligand receptor for advanced glycation end products (RAGE). Blocking of S100A12 showed promising therapeutic effects in mice. We investigated 31 individuals with Kawasaki disease, and recorded an association between expression of S100A12 and activity of Kawasaki disease. Serum concentrations of S100A12 decreased quickly in 28 patients who responded to treatment with gammaglobulin (from 463 mug/L [SD 316] to 184 mug/L [147] within 24 h, p<0.0001). Since the interaction of S100A12 with multiligand receptors has a key role in inflammatory responses, this protein could serve as a novel target for future therapeutic interventions in inflammatory disorders.	Univ Hosp Munster, Dept Paediat, D-48149 Munster, Germany; Univ Hosp Munster, Inst Expt Dermatol, D-48149 Munster, Germany; Toyama Med & Pharmaceut Univ, Dept Paediat, Toyama, Japan	University of Munster; University of Munster; University of Toyama	Foell, D (corresponding author), Univ Hosp Munster, Dept Paediat, Von Esmarch Str 58, D-48149 Munster, Germany.							Brogan PA, 2002, ARCH DIS CHILD, V86, P286, DOI 10.1136/adc.86.4.286; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Vogl T, 1999, J BIOL CHEM, V274, P25291, DOI 10.1074/jbc.274.36.25291	4	108	116	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1270	1272		10.1016/S0140-6736(03)12986-8	http://dx.doi.org/10.1016/S0140-6736(03)12986-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699958				2022-12-01	WOS:000182161600014
J	Blake, WJ; Kaern, M; Cantor, CR; Collins, JJ				Blake, WJ; Kaern, M; Cantor, CR; Collins, JJ			Noise in eukaryotic gene expression	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; SINGLE-CELL; DIFFERENTIATION; STOCHASTICITY; REINITIATION; PROBABILITY; RECRUITMENT; INITIATION	Transcription in eukaryotic cells has been described as quantal(1), with pulses of messenger RNA produced in a probabilistic manner(2,3). This description reflects the inherently stochastic nature(4-9) of gene expression, known to be a major factor in the heterogeneous response of individual cells within a clonal population to an inducing stimulus(10-16). Here we show in Saccharomyces cerevisiae that stochasticity (noise) arising from transcription contributes significantly to the level of heterogeneity within a eukaryotic clonal population, in contrast to observations in prokaryotes(15), and that such noise can be modulated at the translational level. We use a stochastic model of transcription initiation specific to eukaryotes to show that pulsatile mRNA production, through reinitiation, is crucial for the dependence of noise on transcriptional efficiency, highlighting a key difference between eukaryotic and prokaryotic sources of noise. Furthermore, we explore the propagation of noise in a gene cascade network and demonstrate experimentally that increased noise in the transcription of a regulatory protein leads to increased cell-cell variability in the target gene output, resulting in prolonged bistable expression states. This result has implications for the role of noise in phenotypic variation and cellular differentiation.	Boston Univ, Ctr Biodynam, Boston, MA 02215 USA; Boston Univ, Ctr Adv Biotechnol, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, 44 Cummington St, Boston, MA 02215 USA.		Kaern, Mads/GVU-6867-2022	Kaern, Mads/0000-0002-9371-666X				Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stewart JJ, 2001, J BIOL CHEM, V276, P30078, DOI 10.1074/jbc.M105276200; Struhl K, 1996, CELL, V84, P179, DOI 10.1016/S0092-8674(00)80970-8; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; VANROON MA, 1989, DEV BIOL, V136, P508, DOI 10.1016/0012-1606(89)90276-5; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Yean D, 1997, MOL CELL BIOL, V17, P3809, DOI 10.1128/MCB.17.7.3809	30	1212	1242	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					633	637		10.1038/nature01546	http://dx.doi.org/10.1038/nature01546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687005				2022-12-01	WOS:000182111400047
J	Scorrano, L; Oakes, SA; Opferman, JT; Cheng, EH; Sorcinelli, MD; Pozzan, T; Korsmeyer, SJ				Scorrano, L; Oakes, SA; Opferman, JT; Cheng, EH; Sorcinelli, MD; Pozzan, T; Korsmeyer, SJ			BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis	SCIENCE			English	Article							CYTOCHROME-C; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PERMEABILITY TRANSITION; BCL-2; CALCIUM; EXPRESSION; ACTIVATION; MOLECULES; CHANNELS	BAX and BAK are "multidomain" proapoptotic proteins that initiate mitochondrial dysfunction but also localize to the endoplasmic reticulum (ER). Mouse embryonic. broblasts deficient for BAX and BAK (DKO cells) were found to have a reduced resting concentration of calcium in the ER ([Ca2+](er)) that results in decreased uptake of Ca2+ by mitochondria after Ca2+ release from the ER. Expression of SERCA (sarcoplasmic-endoplasmic reticulum Ca2+ adenosine triphosphatase) corrected [Ca2+](er) and mitochondrial Ca2+ uptake in DKO cells, restoring apoptotic death in response to agents that release Ca2+ from intracellular stores (such as arachidonic acid, C-2-ceramide, and oxidative stress). In contrast, targeting of BAX to mitochondria selectively restored apoptosis to "BH3-only" signals. A third set of stimuli, including many intrinsic signals, required both ER-released Ca2+ and the presence of mitochondrial BAX or BAK to fully restore apoptosis. Thus, BAX and BAK operate in both the ER and mitochondria as an essential gateway for selected apoptotic signals.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA; Venetian Inst Mol Med, I-35121 Padua, Italy; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Veneto Institute Molecular Medicine; University of Padua	Korsmeyer, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Scorrano, Luca/A-6652-2008; Opferman, Joseph T/M-5331-2018; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Opferman, Joseph T/0000-0002-1147-5621; Scorrano, Luca/0000-0002-8515-8928	NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA50239] Funding Source: Medline; NHLBI NIH HHS [T32HL07627] Funding Source: Medline; Telethon [TCP02016] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Decaudin D, 1997, CANCER RES, V57, P62; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gajkowska B, 2001, CELL BIOL INT, V25, P725, DOI 10.1006/cbir.2001.0768; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; OAKES SA, UNPUB; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2	31	1153	1207	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					135	139		10.1126/science.1081208	http://dx.doi.org/10.1126/science.1081208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12624178				2022-12-01	WOS:000181988900050
J	Harris, LH; Paltrow, L				Harris, LH; Paltrow, L			The status of pregnant women and fetuses in US criminal law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRENATAL COCAINE EXPOSURE; PERINATAL ETHICS		Univ Michigan, Ann Arbor, MI 48109 USA; Natl Advocates Pregnant Women, New York, NY USA	University of Michigan System; University of Michigan	Harris, LH (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							*AM MED ASS, 2002, MOT AM MED ASS LEAV; ANNAS GJ, 1990, HASTINGS CENT REP, V20, P27, DOI 10.2307/3562763; Chavkin W, 2001, JAMA-J AM MED ASSOC, V285, P1626, DOI 10.1001/jama.285.12.1626; CHERVENAK FA, 1985, OBSTET GYNECOL, V66, P442; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; Harris LH, 2000, OBSTET GYNECOL, V96, P786, DOI 10.1016/S0029-7844(00)01021-8; HODGE JG, 1999, AM LAW REPORTS, V70, P461; Humphries Drew, 1999, CRACK MOTHERS PREGNA; Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1149, DOI 10.1001/jama.279.15.1149; NELSON IJ, 1998, ETHICAL LEGAL ANAL 3; PALTROW L, 2000, GOVT RESPONSES PREGN; POLAND ML, 1993, DRUG ALCOHOL DEPEN, V31, P199, DOI 10.1016/0376-8716(93)90001-7; Rose-Jacobs R, 2002, J DEV BEHAV PEDIATR, V23, P340, DOI 10.1097/00004703-200210000-00007; *US DEP HHS, 1993, US DEP HHS PUBL; 2002, FED REG, V67, P61955	15	19	19	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1697	1699		10.1001/jama.289.13.1697	http://dx.doi.org/10.1001/jama.289.13.1697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	662JX	12672741	Bronze			2022-12-01	WOS:000181944500036
J	Li, YY; Cunin, F; Link, JR; Gao, T; Betts, RE; Reiver, SH; Chin, V; Bhatia, SN; Sailor, MJ				Li, YY; Cunin, F; Link, JR; Gao, T; Betts, RE; Reiver, SH; Chin, V; Bhatia, SN; Sailor, MJ			Polymer replicas of photonic porous silicon for sensing and drug delivery applications	SCIENCE			English	Article							OPTICAL-PROPERTIES; FILTERS	Elaborate one-dimensional photonic crystals are constructed from a variety of organic and biopolymers, which can be dissolved or melted, by templating the solution-cast or injection-molded materials in porous silicon or porous silicon dioxide multilayer (rugate dielectric mirror) structures. After the removal of the template by chemical dissolution, the polymer castings replicate the photonic features and the nanostructure of the master. We demonstrate that these castings can be used as vapor sensors, as deformable and tunable optical filters, and as self-reporting, bioresorbable materials.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Li, YY (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,Dept 0358, La Jolla, CA 92093 USA.		Sailor, Michael J/H-9044-2017; Li, Yang Yang/J-9243-2012	Sailor, Michael J/0000-0002-4809-9826; LI, Yang Yang/0000-0003-4153-9558				Allcock P, 2001, J APPL PHYS, V90, P5052, DOI 10.1063/1.1412268; Berger MG, 1997, THIN SOLID FILMS, V297, P237, DOI 10.1016/S0040-6090(96)09361-3; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Gao J, 2002, LANGMUIR, V18, P2229, DOI 10.1021/la015568f; HALIMAOUI A, 1997, PROPERTIES POROUS SI, P12; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h; Lehmann V, 2001, APPL PHYS LETT, V78, P589, DOI 10.1063/1.1334943; Matthias S, 2002, ADV MATER, V14, P1618, DOI 10.1002/1521-4095(20021118)14:22<1618::AID-ADMA1618>3.0.CO;2-A; Moller K, 1998, CHEM MATER, V10, P2950, DOI 10.1021/cm980243e; Pavesi L, 1997, SEMICOND SCI TECH, V12, P570, DOI 10.1088/0268-1242/12/5/009; Polarz S, 2002, CHEM COMMUN, P2593, DOI 10.1039/b205708p; Reese CE, 2001, ANAL CHEM, V73, P5038, DOI 10.1021/ac010667j; Schmedake TA, 2002, ADV MATER, V14, P1270, DOI 10.1002/1521-4095(20020916)14:18<1270::AID-ADMA1270>3.0.CO;2-R; Snow PA, 1999, J APPL PHYS, V86, P1781, DOI 10.1063/1.370968; Thonissen M., 1997, PROPERTIES POROUS SI, V18, P30; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; VINCENT G, 1994, APPL PHYS LETT, V64, P2367, DOI 10.1063/1.111982; Wirtz M, 2002, CHEM-EUR J, V8, P3573; Xu XL, 2002, J AM CHEM SOC, V124, P13864, DOI 10.1021/ja026901k; Zangooie S, 1997, SENSOR ACTUAT B-CHEM, V43, P168, DOI 10.1016/S0925-4005(97)00148-2	21	341	395	3	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2045	2047		10.1126/science.1081298	http://dx.doi.org/10.1126/science.1081298			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663921				2022-12-01	WOS:000181834200047
J	Iizuka, N; Oka, M; Yamada-Okabe, H; Nishida, M; Maeda, Y; Mori, N; Takao, T; Tamesa, T; Tangoku, A; Tabuchi, H; Hamada, K; Nakayama, H; Ishitsuka, H; Miyamoto, T; Hirabayashi, A; Uchimura, S; Hamamoto, Y				Iizuka, N; Oka, M; Yamada-Okabe, H; Nishida, M; Maeda, Y; Mori, N; Takao, T; Tamesa, T; Tangoku, A; Tabuchi, H; Hamada, K; Nakayama, H; Ishitsuka, H; Miyamoto, T; Hirabayashi, A; Uchimura, S; Hamamoto, Y			Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection	LANCET			English	Article							GENE-EXPRESSION PATTERNS; CDNA MICROARRAY; CANCER; CLASSIFICATION; IDENTIFICATION	Background Hepatocellular carcinoma has a poor prognosis because of the high intrahepatic recurrence rate. There are technological limitations to traditional methods such as TNM staging for accurate prediction of recurrence, suggesting that new techniques are needed. Methods We investigated mRNA expression profiles in tissue specimens from a training set, comprising 33 patients with hepatocellular carcinoma, with high-density oligonucleotide microarrays representing about 6000 genes. We used this training set in a supervised learning manner to construct a predictive system, consisting of 12 genes, with the Fisher linear classifier. We then compared the predictive performance of our system with that of a predictive system with a support vector machine (SVM-based system) on a blinded set of samples from 27 newly enrolled patients. Findings Early intrahepatic recurrence within 1 year after curative surgery occurred in 12 (36%) and eight (30%) patients in the training and blinded sets, respectively. Our system correctly predicted early intrahepatic recurrence or non-recurrence in 25 (93%) of 27 samples in the blinded set and had a positive predictive value of 88% and a negative predictive value of 95%. By contrast, the SVM-based system predicted early intrahepatic recurrence or non-recurrence correctly in only 16 (60%) individuals in the blinded set, and the result yielded a positive predictive value of only 38% and a negative predictive value of 79%. Interpretation Our system predicted early intrahepatic recurrence or non-recurrence for patients with hepatocellular carcinoma much more accurately than the SVM-based system, suggesting that our system could serve as a new method for characterising the metastatic potential of hepatocellular carcinoma.	Yamaguchi Univ, Sch Med, Dept Surg 2, Yamaguchi 7558505, Japan; Yamaguchi Univ, Sch Med, Dept Bioregulatory Funct, Yamaguchi 7558505, Japan; Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Yamaguchi 7558505, Japan; Nippon Roche Res Ctr, Dept Oncol, Kanagawa, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Roche Holding	Oka, M (corresponding author), Yamaguchi Univ, Sch Med, Dept Surg 2, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; CABRERA T, 1995, SCAND J IMMUNOL, V41, P398, DOI 10.1111/j.1365-3083.1995.tb03584.x; DeRisi J, 1996, NAT GENET, V14, P457; Duda RO, 2001, PATTERN CLASSIFICATI, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evron E, 2001, CANCER RES, V61, P2782; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; HSU HC, 1993, CANCER RES, V53, P4691; IIZUKA N, 1995, CANCER RES, V55, P652; Iizuka N, 2002, CANCER RES, V62, P3939; IZUMI R, 1994, GASTROENTEROLOGY, V106, P720, DOI 10.1016/0016-5085(94)90707-2; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kell DB, 2000, TRENDS BIOTECHNOL, V18, P93, DOI 10.1016/S0167-7799(99)01407-9; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Luo J, 2001, CANCER RES, V61, P4683; Mathew J, 1996, J PATHOL, V179, P74; Okabe H, 2001, CANCER RES, V61, P2129; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shirota Y, 2001, HEPATOLOGY, V33, P832, DOI 10.1053/jhep.2001.23003; Sobin L, 2002, TNM CLASSIFICATION M, P81; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Xu L, 2001, CANCER RES, V61, P3176	31	413	448	1	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					923	929		10.1016/S0140-6736(03)12775-4	http://dx.doi.org/10.1016/S0140-6736(03)12775-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648972				2022-12-01	WOS:000181741600011
J	Acharya, U; Patel, S; Koundakjian, E; Nagashima, K; Han, X; Acharya, JK				Acharya, U; Patel, S; Koundakjian, E; Nagashima, K; Han, X; Acharya, JK			Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration	SCIENCE			English	Article							VISUAL-SYSTEM; DROSOPHILA; ARRESTIN; PROTEIN; ENDOCYTOSIS; RHODOPSIN; TRANSDUCTION; APOPTOSIS; DYNAMIN; ROLES	Mutations in proteins of the Drosophila phototransduction cascade, a prototypic guanine nucleotide-binding protein-coupled receptor signaling system, lead to retinal degeneration and have been used as models to understand human degenerative disorders. Here, modulating the sphingolipid biosynthetic pathway rescued retinal degeneration in Drosophila mutants. Targeted expression of Drosophila neutral ceramidase rescued retinal degeneration in arrestin and phospholipase C mutants. Decreasing flux through the de novo sphingolipid biosynthetic pathway also suppressed degeneration in these mutants. Both genetic backgrounds modulated the endocytic machinery because they suppressed defects in a dynamin mutant. Suppression of degeneration in arrestin mutant flies expressing ceramidase correlated with a decrease in ceramide levels. Thus, enzymes of sphingolipid metabolism may be suitable targets in the therapeutic management of retinal degeneration.	NCI, Regulat Cell Growth Lab, Frederick, MD 21702 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Sci Applicat Int Corp, Electron Microscopy Facil Image Anal Lab, Frederick, MD 21702 USA; Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of California System; University of California San Diego; Science Applications International Corporation (SAIC); Washington University (WUSTL)	Acharya, JK (corresponding author), NCI, Regulat Cell Growth Lab, Frederick, MD 21702 USA.			Acharya, Jairaj/0000-0001-7366-4228	NATIONAL CANCER INSTITUTE [ZIABC010331, Z01BC010331] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P194; Orem NR, 2002, VISION RES, V42, P497, DOI 10.1016/S0042-6989(01)00229-2; OTOUSA JE, 1997, PROGR RETINAL EYE RE, P691; POODRY CA, 1990, DEV BIOL, V138, P464, DOI 10.1016/0012-1606(90)90212-2; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; ZERR DM, 1990, J NEUROSCI, V10, P2749	23	110	112	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1740	1743		10.1126/science.1080549	http://dx.doi.org/10.1126/science.1080549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637747				2022-12-01	WOS:000181519500048
J	Gregg, EW; Gerzoff, RB; Thompson, TJ; Williamson, DF				Gregg, EW; Gerzoff, RB; Thompson, TJ; Williamson, DF			Intentional weight loss and death in overweight and obese US adults 35 years of age and older	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ALL-CAUSE MORTALITY; BODY-WEIGHT; LIFE-STYLE; WOMEN; DIET; MEN; INTERVENTION; VARIABILITY; TRIAL	Background: Although weight loss improves risk factors for cardiovascular and metabolic disease, it is unclear whether intentional weight loss reduces mortality rates. Objective: To examine the relationships among intention to lose weight, weight loss, and all-cause mortality. Design: Prospective cohort study using a probability sample of the U.S. population. Setting: Interviewer-administered survey. Participants: 6391 overweight and obese persons (body mass index greater than or equal to 25 kg/m(2)) who were at least 35 years of age. Measurements: Intention to lose weight and weight change during the past year were assessed by self-report in 1989. Vital status was followed for 9 years. Hazard rate ratios (HRRs) were adjusted for age, sex, ethnicity, education, smoking, health status, health care utilization, and initial body mass index. Results: Compared with persons not trying to lose weight and reporting no weight change, those reporting intentional weight loss had a 24% lower mortality rate (HRR, 0.76 [95% CI, 0.60 to 0.97]) and those with unintentional weight loss had a 31% higher mortality rate (HRR, 1.31 [CI, 1.01 to 1.70]). However, mortality rates were lower in persons who reported trying to lose weight than those in not trying to lose weight, independent of actual weight change. Compared with persons not trying to lose weight and reporting no weight change, persons trying to lose weight had the following HRRs: no weight change, 0.80 (CI, 0.65 to 0.99); gained weight, 0.94 (CI, 0.65 to 1.37); and lost weight, 0.76 (CI, 0.60 to 0.97). Conclusions: Attempted weight loss is associated with lower all-cause mortality, independent of weight change. Self-reported intentional weight loss is associated with lower mortality rates, and weight loss is associated with higher mortality rates only if it is unintentional.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov		Gregg, Edward/0000-0003-2381-6822				ANDRES R, 1993, ANN INTERN MED, V119, P737, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00022; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; FRENCH SA, 1995, INT J OBESITY, V19, P22; French SA, 1999, AM J EPIDEMIOL, V149, P504, DOI 10.1093/oxfordjournals.aje.a009844; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lee IM, 1996, NUTR REV, V54, pS116; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; MELTZER AA, 1995, AM J EPIDEMIOL, V142, P1039, DOI 10.1093/oxfordjournals.aje.a117557; Meltzer AA, 1996, OBES RES, V4, P479, DOI 10.1002/j.1550-8528.1996.tb00257.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *NAT CTR HLTH STAT, 1993, NAT CTR HLTH STAT 10, V3; *NAT CTR HLTH STAT, 1999, NAT HLTH INT SURV MU; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P731, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00021; Williamson DF, 1999, AM J EPIDEMIOL, V149, P491, DOI 10.1093/oxfordjournals.aje.a009843; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	29	169	175	5	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					383	389		10.7326/0003-4819-138-5-200303040-00007	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614090				2022-12-01	WOS:000181257300003
J	Molinari, M; Calanca, V; Galli, C; Lucca, P; Paganetti, P				Molinari, M; Calanca, V; Galli, C; Lucca, P; Paganetti, P			Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle	SCIENCE			English	Article							MANNOSIDASE-LIKE PROTEIN; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; QUALITY-CONTROL; DEGRADATION; DEFICIENT; YEAST	The mechanisms that determine how folding attempts are interrupted to target folding-incompetent proteins for endoplasmic reticulum-associated degradation (ERAD) are poorly defined. Here the alpha-mannosidase I-like protein EDEM was shown to extract misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle. EDEM overexpression resulted in faster release of folding-incompetent proteins from the calnexin cycle and earlier onset of degradation, whereas EDEM down-regulation prolonged folding attempts and delayed ERAD. Up-regulation of EDEM during ER stress may promote cell recovery by clearing the calnexin cycle and by accelerating ERAD of terminally misfolded polypeptides.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Novartis Pharma AG, Nervous Syst, CH-4002 Basel, Switzerland	Universita della Svizzera Italiana; Novartis	Molinari, M (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.		Paganetti, Paolo/AAF-8039-2020; Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829; Paganetti, Paolo/0000-0003-1896-6324				Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 2001, EMBO REP, V2, P423; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; ORA A, 1995, J BIOL CHEM, V270, P26060, DOI 10.1074/jbc.270.44.26060; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; RAY MK, 1991, J BIOL CHEM, V266, P22818	13	359	380	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1397	1400		10.1126/science.1079474	http://dx.doi.org/10.1126/science.1079474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610306				2022-12-01	WOS:000181192300053
J	Horrobin, DF				Horrobin, DF			Are large clinical trials in rapidly lethal diseases usually unethical?	LANCET			English	Editorial Material							MANTLE CELL LYMPHOMA; TRANSLATION INITIATION; INHIBITION		Laxdale Ltd, Stirling FK7 9JQ, Scotland		Horrobin, DF (corresponding author), Laxdale Ltd, Kings Pk House,Laurethill Business Pk, Stirling FK7 9JQ, Scotland.							Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Dreyling MH, 1997, CANCER RES, V57, P4608; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; HORROBIN DF, 2002, BRIT MED J, V325, pA491; HORROBIN DF, IN PRESS MED HYPOTH; Hughes JR, 2002, JAMA-J AM MED ASSOC, V288, P2118; Janosky JE, 2002, JAMA-J AM MED ASSOC, V288, P2118, DOI 10.1001/jama.288.17.2118; Lilford RJ, 2002, JAMA-J AM MED ASSOC, V288, P2118; Oka K, 1996, LEUKEMIA LYMPHOMA, V21, P37, DOI 10.3109/10428199609067577; Palakurthi SS, 2000, CANCER RES, V60, P2919; Palakurthi SS, 2001, CANCER RES, V61, P6213; RIMOKH R, 1994, BLOOD, V83, P3689	14	41	42	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					695	697		10.1016/S0140-6736(03)12571-8	http://dx.doi.org/10.1016/S0140-6736(03)12571-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611394				2022-12-01	WOS:000181129500026
J	Greene, MJ; Gordon, DM				Greene, MJ; Gordon, DM			Social insects - Cuticular hydrocarbons inform task decisions	NATURE			English	Article							HARVESTER ANTS; COLONIES; DIVISION; DYNAMICS; LABOR		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Greene, MJ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	greene@ants.stanford.edu						Gordon D. M., 2000, ANTS WORK INSECT SOC; GORDON DM, 1989, ANIM BEHAV, V38, P194, DOI 10.1016/S0003-3472(89)80082-X; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; GORDON DM, 1987, ANIM BEHAV, V35, P833, DOI 10.1016/S0003-3472(87)80119-7; Gordon DM, 1999, BEHAV ECOL SOCIOBIOL, V45, P370, DOI 10.1007/s002650050573; Holldobler B., 1990, pi; NELSON DR, 1995, BIOCH WAXES, pCH1; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; WINSTON ML, 1985, CAN J ZOOL, V63, P777, DOI 10.1139/z85-113	13	224	232	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					32	32		10.1038/423032a	http://dx.doi.org/10.1038/423032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721617				2022-12-01	WOS:000182561600031
J	Ben-Yosef, T; Ness, SL; Madeo, AC; Bar-Lev, A; Wolfman, JH; Ahmed, ZM; Desnick, RJ; Willner, JP; Avraham, KB; Ostrer, H; Oddoux, C; Griffith, AJ; Friedman, TB				Ben-Yosef, T; Ness, SL; Madeo, AC; Bar-Lev, A; Wolfman, JH; Ahmed, ZM; Desnick, RJ; Willner, JP; Avraham, KB; Ostrer, H; Oddoux, C; Griffith, AJ; Friedman, TB			Brief report - A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECESSIVE DEAFNESS; GENE; POPULATION; FREQUENCY; FAMILIES; PROFILE; DISEASE; CDH23; GJB2		NIDCD, Mol Genet Lab, NIH, Rockville, MD 20850 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; NYU, Sch Med, Human Genet Program, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Sackler Faculty of Medicine; New York University	Friedman, TB (corresponding author), NIDCD, Mol Genet Lab, NIH, 5 Res Ct,Rm 2A15, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Madeo, Anne C/AAA-6186-2022; Madeo, Anne/K-2880-2012	MADEO, ANNE/0000-0003-2048-9491; Avraham, Karen B/0000-0002-4913-251X	NCRR NIH HHS [RR-M01-00071] Funding Source: Medline; NIDCD NIH HHS [1 Z01 DC00060-01, 1 Z01 DC 00039-06] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, Z01DC000064, Z01DC000060] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO;2-0; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; HINDERINK JB, 1994, ANN OTO RHINOL LARYN, V103, P285, DOI 10.1177/000348949410300405; KRONN D, 1995, AM J HUM GENET, V57, P1250; Liebreich, 1861, DTSCH ARCH KLIN MED, V13, P53; LITTLE S, 1998, CURRENT PORTOCOLS HU, V2; MATOTH Y, 1987, AM J MED GENET, V27, P561; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 2002, HUM GENET, V110, P348, DOI 10.1007/s00439-002-0690-x; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Sobe T, 1999, AM J MED GENET, V86, P499, DOI 10.1002/(SICI)1096-8628(19991029)86:5<499::AID-AJMG19>3.3.CO;2-F; VERNON M, 1969, J CHRON DIS, V22, P133, DOI 10.1016/0021-9681(69)90055-1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Young N M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P342; Zlotogora J, 2000, MOL GENET METAB, V69, P169, DOI 10.1006/mgme.2000.2969	27	70	74	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1664	1670		10.1056/NEJMoa021502	http://dx.doi.org/10.1056/NEJMoa021502			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711741				2022-12-01	WOS:000182416300006
J	Lipshultz, SE; Sleeper, LA; Towbin, JA; Lowe, AM; Orav, EJ; Cox, GF; Lurie, PR; McCoy, KL; McDonald, MA; Messere, JE; Colan, SD				Lipshultz, SE; Sleeper, LA; Towbin, JA; Lowe, AM; Orav, EJ; Cox, GF; Lurie, PR; McCoy, KL; McDonald, MA; Messere, JE; Colan, SD			The incidence of pediatric cardiomyopathy in two regions of the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CLINICAL PROFILE; NATURAL-HISTORY; FEMALE SEX; CHILDREN; INFANTS; HEART; EPIDEMIOLOGY; MORTALITY	Background: Population-based data on the incidence of pediatric cardiomyopathy are rare because of the lack of large, prospective studies. Methods: Since 1996 the Pediatric Cardiomyopathy Registry sponsored by the National Heart, Lung, and Blood Institute has collected data on all children with newly diagnosed cardiomyopathy in New England and the Central Southwest region (Texas, Oklahoma, and Arkansas) of the United States. We report on all children in these regions who received this diagnosis between 1996 and 1999. Results: We identified 467 cases of cardiomyopathy, for an overall annual incidence of 1.13 per 100,000 children (95 percent confidence interval, 1.03 to 1.23). The incidence was significantly higher among infants younger than 1 year old than among children and adolescents who were 1 to 18 years old (8.34 vs. 0.70 per 100,000, P<0.001). The annual incidence of cardiomyopathy was lower among white children (upper-bound estimate, 1.06 cases per 100,000) than among black children (lower-bound estimate, 1.47 per 100,000; P=0.02) and higher among boys than among girls (1.32 vs. 0.92 per 100,000, P<0.001). The incidence also varied significantly by region: 1.44 cases per 100,000 in New England and 0.98 per 100,000 in the Central Southwest region (P<0.001). When categorized according to type, dilated cardiomyopathy made up 51 percent of the cases, hypertrophic cardiomyopathy 42 percent, and restrictive or other types 3 percent; 4 percent were unspecified. There was no significant difference in the incidence rates according to the year. Conclusions: The estimated incidence of pediatric cardiomyopathy in two large regions of the United States is 1.13 cases per 100,000 children. Most cases are identified at an early age, and the incidence varies according to sex, region, and racial or ethnic origin.	Univ Rochester, Med Ctr, Div Pediat Cardiol, Rochester, NY 14642 USA; Golisano Childrens Hosp Strong, Div Pediat Cardiol, Rochester, NY USA; Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; New England Res Inst, Watertown, MA 02172 USA; Texas Childrens Hosp, Dept Pediat Cardiol Mol & Human Genet & Cardiovas, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Genzyme Corp, Cambridge, MA USA; Albany Med Coll, Dept Pediat, Albany, NY 12208 USA	University of Rochester; University of Rochester; University of Rochester; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; HealthCore, Inc; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Sanofi-Aventis; Genzyme Corporation; Albany Medical College	Lipshultz, SE (corresponding author), Univ Rochester, Med Ctr, Div Pediat Cardiol, 601 Elmwood Ave,Box 631, Rochester, NY 14642 USA.		Towbin, Jeffrey A./J-5595-2019; Colan, Steven/ABB-4580-2020	Towbin, Jeffrey A./0000-0002-6585-714X; 	NCI NIH HHS [CA79060, CA68484, CA55576] Funding Source: Medline; NHLBI NIH HHS [HL53392] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079060, P01CA068484, R29CA055576, R01CA055576] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053392] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; Arola A, 1998, PEDIATRICS, V101, P369, DOI 10.1542/peds.101.3.369; BILGIC A, 1990, JPN HEART J, V31, P789; Boneva RS, 2001, CIRCULATION, V103, P2376; Boucek MM, 2001, J HEART LUNG TRANSPL, V20, P39, DOI 10.1016/S1053-2498(00)00243-6; CANNAN CR, 1995, CIRCULATION, V92, P2488, DOI 10.1161/01.CIR.92.9.2488; CARVALHO JS, 2002, PAEDIAT CARDIOLOGY, P1595; *CENS BUR, 1999, EST POP STAT AG SEX; Chang RKR, 2002, CIRCULATION, V106, P1514, DOI 10.1161/01.CIR.0000029104.94858.6F; CHEN SC, 1990, J AM COLL CARDIOL, V15, P189, DOI 10.1016/0735-1097(90)90199-Y; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; CORREAVILLASENOR A, 1991, AM J EPIDEMIOL, V134, P393, DOI 10.1093/oxfordjournals.aje.a116101; COUGHLIN SS, 1993, J CLIN EPIDEMIOL, V46, P1003, DOI 10.1016/0895-4356(93)90167-Y; Cox GF, 2001, CIRCULATION, V104, P588; Evans Roger W, 1982, Heart Transplant, V1, P243; FERENCZ C, 1992, PEDIATR CARDIOL, V13, P65, DOI 10.1007/BF00798206; GILLUM RF, 1986, AM HEART J, V111, P752, DOI 10.1016/0002-8703(86)90111-0; GREENWOOD RD, 1976, AM HEART J, V92, P549, DOI 10.1016/S0002-8703(76)80074-9; Grenier MA, 2000, AM HEART J, V139, pS86, DOI 10.1067/mhj.2000.103933; GRIFFIN ML, 1988, J AM COLL CARDIOL, V11, P139, DOI 10.1016/0735-1097(88)90179-9; KUMAR K, IN PRESS INT J CARDI; Lipshultz, 2000, Prog Pediatr Cardiol, V12, P1, DOI 10.1016/S1058-9813(00)00076-X; Lipshultz SE, 2002, LANCET, V360, P368, DOI 10.1016/S0140-6736(02)09607-1; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MARON BJ, 1981, PEDIAT CARDIOVASCULA, V11, P35; MARON BJ, 2001, MOSS ADAMS HEART DIS, V2, P1167; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; PONGPANIGH B, 1985, JAP HEART J, V27, P11; SCHMALTZ AA, 1987, EUR HEART J, V8, P100, DOI 10.1093/oxfordjournals.eurheartj.a062236; Schwartz ML, 1996, CIRCULATION, V94, P2021, DOI 10.1161/01.CIR.94.8.2021; Simbre VC, 2002, PEDIATR RES, V51, p37A; STEIN H, 1964, ARCH DIS CHILD, V39, P610, DOI 10.1136/adc.39.208.610; TALIERCIO CP, 1985, J AM COLL CARDIOL, V6, P1126, DOI 10.1016/S0735-1097(85)80319-3; Towbin JA, 1999, CURR OPIN CARDIOL, V14, P250, DOI 10.1097/00001573-199905000-00010; TOWBIN JA, 2000, PEDIAT CARDIOVASCULA, P753; Tsirka AE, 2000, CIRCULATION, V102, P406	38	509	546	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1647	1655		10.1056/NEJMoa021715	http://dx.doi.org/10.1056/NEJMoa021715			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711739				2022-12-01	WOS:000182416300004
J	Takemaru, KI; Yamaguchi, S; Lee, YS; Zhang, Y; Carthew, RW; Moon, RT				Takemaru, KI; Yamaguchi, S; Lee, YS; Zhang, Y; Carthew, RW; Moon, RT			Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway	NATURE			English	Article							MAMMALIAN-CELLS; WINGLESS SIGNAL; XENOPUS EMBRYOS; DROSOPHILA; GENE; ARMADILLO; EXPRESSION; PROTEIN; LEF-1; INTERFERENCE	Inappropriate activation of downstream target genes by the oncoprotein beta-catenin is implicated in development of numerous human cancers(1,2). beta-catenin and its fruitfly counterpart Armadillo act as a coactivator in the canonical Wnt/Wingless pathway by binding to Tcf/Lef transcription factors(3-6). Here we report a conserved nuclear protein, named Chibby, which was identified in a screen for proteins that directly interact with the C-terminal region of beta-catenin. In mammalian cultured cells we demonstrate that Chibby inhibits beta-catenin-mediated transcriptional activation by competing with Lef-1 to bind to beta-catenin. Inhibition of Drosophila Chibby by RNA interference results in segment polarity defects that mimick a wingless gain-of-function phenotype, and overexpression of the wingless target genes engrailed and Ultrabithorax. In addition, epistasis experiments indicate that chibby acts downstream of wingless and upstream of armadillo.	Univ Washington, Ctr Dev Biol, Sch Med, Seattle, WA 98195 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Washington; University of Washington Seattle; Northwestern University	Moon, RT (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Sch Med, Room K536C,Hlth Sci Bldg,Campus Box 357750, Seattle, WA 98195 USA.		Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARTHEW RW, 2003, GENE SILENCING; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fukuchi T, 1998, CANCER RES, V58, P3526; Garcia-Rostan G, 2001, AM J PATHOL, V158, P987, DOI 10.1016/S0002-9440(10)64045-X; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEE YS, IN PRESS METHODS; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Polakis P, 2000, GENE DEV, V14, P1837; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 1996, DEVELOPMENT, V122, P849; Yu X, 1998, EMBO J, V17, P7021, DOI 10.1093/emboj/17.23.7021	29	227	253	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					905	909		10.1038/nature01570	http://dx.doi.org/10.1038/nature01570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712206				2022-12-01	WOS:000182432600058
J	Fry, SN; Sayaman, R; Dickinson, MH				Fry, SN; Sayaman, R; Dickinson, MH			The aerodynamics of free-flight maneuvers in Drosophila	SCIENCE			English	Article							MUSCA-DOMESTICA; VISUAL CONTROL; FLY; ORIENTATION; BEHAVIOR	Using three-dimensional infrared high-speed video, we captured the wing and body kinematics of free-flying fruitflies as they performed rapid flight maneuvers. We then "replayed" the wing kinematics on a dynamically scaled robotic model to measure the aerodynamic forces produced by the wings. The results show that fly generates rapid turns with surprisingly subtle modifications in wing motion, which nonetheless generate sufficient torque for the fly to rotate its body through each turn. The magnitude and time course of the torque and body motion during rapid turns indicate that inertia, not friction, dominates the flight dynamics of insects.	CALTECH, Pasadena, CA 91125 USA; Univ Zurich, ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland	California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Dickinson, MH (corresponding author), CALTECH, Pasadena, CA 91125 USA.		Sikandar, Usama/F-6586-2016	Sayaman, Rosalyn/0000-0003-1343-0619				COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; REICHARDT W, 1973, NATURWISSENSCHAFTEN, V60, P122, DOI 10.1007/BF00594781; REICHARDT W, 1976, Q REV BIOPHYS, V9, P311, DOI 10.1017/S0033583500002523; Sane SP, 2001, J EXP BIOL, V204, P2607; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Schilstra C, 1999, J EXP BIOL, V202, P1481; Tammero LF, 2002, J EXP BIOL, V205, P327; VOGEL S, 1966, J EXP BIOL, V44, P567; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P527, DOI 10.1098/rstb.1986.0017	11	386	404	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					495	498		10.1126/science.1081944	http://dx.doi.org/10.1126/science.1081944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702878				2022-12-01	WOS:000182295900043
J	Iglehart, JK				Iglehart, JK			Medicare and drug pricing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRENDS											ALBERT H, 2001, COMMUNICATION   0620; *AM SOC CLIN ONC, 2002, AN WAYS MEANS STAFF; American Society of Clinical Oncology, 2001, REF MED PAYM METH CA; BURTON TM, 2002, WALL STREET J   0313, pB1; CLOUD DJ, 2000, WALL STREET J   0927, pB1; *CTR MED MED SERV, 2003, DMEPOS COMP BIDD DEM; *DEP HLTH HUM SERV, 2000, OEI030000311 DEP HLT; *DEP HLTH HUM SERV, 2001, OEI030000310 DEP HLT; *DEP HLTH HUM SERV, 2000, OEI030000020 DEP HLT; *DEP HLTH HUM SERV, 1997, OEI039700290 DEP HLT; *DEP HLTH HUM SERV, 1998, OEI039700510 DEP HLT; *DEP HLTH HUM SERV, 1996, OEI039500420 DEP HLT; FREUDENHEIM M, 2002, NY TIMES        0513, pC5; FUHRMANS V, 2001, WALL STREET J   1213, pB4; FUHRMANS V, 2002, WALL STREET J   0607, P1; Gabel J, 2002, HEALTH AFFAIR, V21, P143, DOI 10.1377/hlthaff.21.5.143; *GEN ACC OFF, 2001, GAO0253; Gencarelli DM, 2002, AVERAGE WHOLESALE PR; General Accounting Office, 2001, GAO011118; Iglehart JK, 2002, NEW ENGL J MED, V347, P956, DOI 10.1056/NEJMhpr022143; Iglehart JK, 2002, NEW ENGL J MED, V346, P1924, DOI 10.1056/NEJMhpr020324; JAPSEN B, 2001, CHICAGO TRIBUNE 1122; KOWALCZYK L, 2001, BOSTON GLOBE    1221; Levit K, 2003, HEALTH AFFAIR, V22, P154, DOI 10.1377/hlthaff.22.1.154; MCGINLEY L, 2000, WALL STREET J   0602, pB6; NAIK G, 2002, WALL STREET J   1226, pA8; NICOLA TJ, 2001, REGULATORY LEGISLATI; Pear Robert, 2003, N Y Times Web, pA15; Pear Robert, 2002, NY TIMES        0517, pA1; STRUNK BC, 2001, HLTH AFFAIRS    0926; TAUZIN B, 2001, COMMUNICATION   1114; 2002, FED REG, V67, P79973	32	19	19	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1590	1597		10.1056/NEJMhpr035135	http://dx.doi.org/10.1056/NEJMhpr035135			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700381				2022-12-01	WOS:000182248900012
J	Joy, DA; Feng, XR; Mu, JB; Furuya, T; Chotivanich, K; Krettli, AU; Ho, M; Wang, A; White, NJ; Suh, E; Beerli, P; Su, XZ				Joy, DA; Feng, XR; Mu, JB; Furuya, T; Chotivanich, K; Krettli, AU; Ho, M; Wang, A; White, NJ; Suh, E; Beerli, P; Su, XZ			Early origin and recent expansion of Plasmodium falciparum	SCIENCE			English	Article							POPULATION-GROWTH; STATISTICAL TESTS; GENE TREES; MALARIA; DNA; NEUTRALITY; DIVERSITY; INFERENCE; EVOLUTION; HISTORY	The emergence of virulent Plasmodium falciparum in Africa within the past 6000 years as a result of a cascade of changes in human behavior and mosquito transmission has recently been hypothesized. Here, we provide genetic evidence for a sudden increase in the African malaria parasite population about 10,000 years ago, followed by migration to other regions on the basis of variation in 100 worldwide mitochondrial DNA sequences. However, both the world and some regional populations appear to be older (50,000 to 100,000 years old), suggesting an earlier wave of migration out of Africa, perhaps during the Pleistocene migration of human beings.	NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; Mahidol Univ, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok 10400, Thailand; Fiocruz MS, Ctr Pesquisas Rene Rachou, Malaria Lab, BR-30190002 Belo Horizonte, MG, Brazil; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 1N4, Canada; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Florida State Univ, Dirac Sci Lib, Sch Computat Sci & Informat Technol, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; Fundacao Oswaldo Cruz; University of Calgary; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); State University System of Florida; Florida State University	Joy, DA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	djoy@niaid.nih.gov	Beerli, Peter/A-3638-2009; Furuya, Tetsuya/J-5916-2013; feng, xiaorong/G-4811-2010; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Beerli, Peter/HDN-6405-2022	Beerli, Peter/0000-0003-0947-5451; Furuya, Tetsuya/0000-0003-3979-7072; feng, xiaorong/0000-0001-8410-3020; White, Nick/0000-0002-1897-1978; Su, Xinzhuan/0000-0003-3246-3248	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000200, ZIHCT000200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, Z01AI000892] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kuhner MK, 1998, GENETICS, V149, P429; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pybus OG, 2000, GENETICS, V155, P1429; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SCHNEIDER S, 2000, ARLEQUIN SOFTWARE; TAJIMA F, 1989, GENETICS, V123, P585; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	27	280	291	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					318	321		10.1126/science.1081449	http://dx.doi.org/10.1126/science.1081449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690197				2022-12-01	WOS:000182135400054
J	Blount, JD; Metcalfe, NB; Birkhead, TR; Surai, PF				Blount, JD; Metcalfe, NB; Birkhead, TR; Surai, PF			Carotenoid modulation of immune function and sexual attractiveness in zebra finches	SCIENCE			English	Article							BEAK COLOR; SIGNALS; IMMUNOCOMPETENCE; PIGMENTATION; EXPRESSION; FITNESS	One hypothesis for why females in many animal species frequently prefer to mate with the most elaborately ornamented males predicts that availability of carotenoid pigments is a potentially limiting factor for both ornament expression and immune function. An implicit assumption of this hypothesis is that males that can afford to produce more elaborate carotenoid-dependent displays must be healthier individuals with superior immunocompetence. However, whether variation in circulating carotenoid levels causes variation in both immune function and sexual attractiveness has not been determined in any species. In this study, we show that manipulation of dietary carotenoid supply invokes parallel changes in cell-mediated immune function and sexual attractiveness in male zebra finches (Taeniopygia guttata).	Univ Glasgow, Inst Biomed & Life Sci, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Scottish Agr Coll, Avian Sci Res Ctr, Auchincruive KA6 5HW, Ayr, Scotland	University of Glasgow; University of Sheffield; Scottish Agricultural College	Blount, JD (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	j.blount@bio.gla.ac.uk	Blount, Jonathan D/K-7695-2012; Surai, Peter/T-6183-2019; Metcalfe, Neil B./C-5997-2009	Blount, Jonathan D/0000-0002-0016-0130; Metcalfe, Neil B./0000-0002-1970-9349; Surai, Peter/0000-0002-5012-8681				Andersson Malte, 1994; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; BURLEY N, 1987, ETHOLOGY, V76, P133; Chew BP, 1996, ANIM FEED SCI TECH, V59, P103, DOI 10.1016/0377-8401(95)00891-8; Collins SA, 1996, ANIM BEHAV, V52, P105, DOI 10.1006/anbe.1996.0156; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; HILL GE, 1992, AUK, V109, P1; Hill GE, 1999, AM NAT, V154, P589, DOI 10.1086/303264; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; HUDON J, 1994, AUK, V111, P218, DOI 10.2307/4088529; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; MCCORKLE F, 1980, POULTRY SCI, V59, P616, DOI 10.3382/ps.0590616; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2002, COMP BIOCHEM PHYS B, V132, P811, DOI 10.1016/S1096-4959(02)00100-8; McGraw KJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P843, DOI 10.1086/323797; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Stahl W., 1999, ANTIOXIDANT FOOD SUP, P183; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	26	520	527	1	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					125	127		10.1126/science.1082142	http://dx.doi.org/10.1126/science.1082142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677066				2022-12-01	WOS:000181988900047
J	Meier, P; Genoud, N; Prinz, M; Maissen, M; Rulicke, T; Zurbriggen, A; Raeber, AJ; Aguzzi, A				Meier, P; Genoud, N; Prinz, M; Maissen, M; Rulicke, T; Zurbriggen, A; Raeber, AJ; Aguzzi, A			Soluble dimeric prion protein binds PrPSc in vivo and antagonizes prion disease	CELL			English	Article							MICE; RESISTANT; PROPAGATION; FORM; REPLICATION; INFECTIVITY; CONVERSION; VARIANT; STRAIN; DOMAIN	Conversion of cellular prion protein (PrPc) into a pathological conformer (PrPSc) is thought to be promoted by PrPSc in a poorly understood process. Here, we report that in wild-type mice, the expression of PrPC rendered soluble and dimeric by fusion to immunoglobulin Fcgamma (PrP-Fc(2)) delays PrPSc accumulation, agent replication, and onset of disease following inoculation with infective prions. In infected PrP-expressing brains, PrP-Fc(2) relocates to lipid rafts and associates with PrPSc without acquiring protease resistance, indicating that PrP-Fc(2) resists conversion. Accordingly, mice expressing PrP-Fc(2) but lacking endogenous PrPc are resistant to scrapie, do not accumulate PrP-Fc(2)(Sc), and do not transmit disease to others. These results indicate that various PrP isoforms engage in a complex in vivo, whose distortion by PrP-Fc(2) affects prion propagation and scrapie pathogenesis. The unique properties of PrP-Fc(2) suggest that soluble PrP derivatives may represent a new class of prion replication antagonists.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland; Univ Bern, Inst Anim Neurol, CH-3012 Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Bern	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; AGUZZI A, 2003, IN PRESS ADV IMMUNOL; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gatti JL, 2002, BIOL REPROD, V67, P393, DOI 10.1095/biolreprod67.2.393; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LANSBURY PT, 1994, SCIENCE, V265, P1510, DOI 10.1126/science.8079159; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; LUND J, 1991, J IMMUNOL, V147, P2657; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Perini F, 1996, BIOCHEM BIOPH RES CO, V223, P572, DOI 10.1006/bbrc.1996.0936; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P2793, DOI 10.1073/pnas.90.7.2793; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WEISSMANN C, 1991, NATURE, V349, P569, DOI 10.1038/349569a0	46	105	113	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					49	60		10.1016/S0092-8674(03)00201-0	http://dx.doi.org/10.1016/S0092-8674(03)00201-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679034	Bronze			2022-12-01	WOS:000182282900006
J	Azam, M; Latek, RR; Daley, GQ				Azam, M; Latek, RR; Daley, GQ			Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE; C-ABL; CLINICAL RESISTANCE; BLAST CRISIS; SH3 DOMAINS; INTRAMOLECULAR INTERACTIONS; REGULATORY DOMAINS	The Bcr-Abl fusion protein kinase causes chronic myeloid leukemia and is targeted by the signal transduction inhibitor STI-571/Gleevec/imatinib (STI-571). Sequencing of the BCR-ABL gene in patients who have relapsed after STI-571 chemotherapy has revealed a limited set of kinase domain mutations that mediate drug resistance. To obtain a more comprehensive survey of the amino acid substitutions that confer STI-571 resistance, we performed an in vitro screen of randomly mutagenized BCR-ABL and recovered all of the major mutations previously identified in patients and numerous others that illuminate novel mechanisms of acquired drug resistance. Structural modeling implies that a novel class of variants acts allosterically to destabilize the autoinhibited conformation of the ABL kinase to which STI-571 preferentially binds' This screening strategy is a paradigm applicable to a growing list of target-directed anti-cancer agents and provides a means of anticipating the drug-resistant amino acid substitutions that are likely to be clinically problematic.	Whitehead Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Daley, GQ (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	daley@wi.mit.edu			NATIONAL CANCER INSTITUTE [R01CA086991, R29CA076418] Funding Source: NIH RePORTER; NCI NIH HHS [CA76418, CA86991] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Bradshaw JM, 2000, J MOL BIOL, V299, P521; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Brasher BB, 2001, ONCOGENE, V20, P7744, DOI 10.1038/sj.onc.1204978; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Corbin AS, 2002, J BIOL CHEM, V277, P32214, DOI 10.1074/jbc.M111525200; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Emini EA, 1995, ADV EXP MED BIOL, V390, P187; FAINSTEIN E, 1989, ONCOGENE, V4, P1477; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hochhaus A, 2001, SCIENCE, V293, P2163; Hofmann WK, 2002, BLOOD, V99, P1860, DOI 10.1182/blood.V99.5.1860; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KANTARJIAN HM, 2002, BLOOD, V29, P29; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Panni S, 2002, J BIOL CHEM, V277, P21666, DOI 10.1074/jbc.M109788200; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANETTEN RA, 1995, ONCOGENE, V10, P1977; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wisniewski D, 2002, CANCER RES, V62, P4244; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	47	516	540	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					831	843		10.1016/S0092-8674(03)00190-9	http://dx.doi.org/10.1016/S0092-8674(03)00190-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654249	Bronze			2022-12-01	WOS:000181818500010
J	Vermeer, PD; Einwalter, LA; Moniger, TO; Rokhlina, T; Kern, JA; Zabner, J; Welsh, MJ				Vermeer, PD; Einwalter, LA; Moniger, TO; Rokhlina, T; Kern, JA; Zabner, J; Welsh, MJ			Segregation of receptor and ligand regulates activation of epithelial growth factor receptor	NATURE			English	Article							CELL POLARITY; EXPRESSION; LUNG; PRECURSOR	Interactions between ligands and receptors are central to communication between cells and tissues. Human airway epithelia constitutively produce both a ligand, the growth factor heregulin, and its receptors-erbB2, erbB3 and erbB4 (refs 1-3). Although heregulin binding initiates cellular proliferation and differentiation(8), airway epithelia have a low rate of cell division(8). This raises the question of how ligand-receptor interactions are controlled in epithelia. Here we show that in differentiated human airway epithelia, heregulin-alpha is present exclusively in the apical membrane and the overlying airway surface liquid, physically separated from erbB2-4, which segregate to the basolateral membrane. This physical arrangement creates a ligand-receptor pair poised for activation whenever epithelial integrity is disrupted. Indeed, immediately following a mechanical injury, heregulin-alpha activates erbB2 in cells at the edge of the wound, and this process hastens restoration of epithelial integrity. Likewise, when epithelial cells are not separated into apical and basolateral membranes ('polarized'), or when tight Junctions between adjacent cells are opened, heregulin-alpha activates its receptor. This mechanism of ligand-receptor segregation on either side of epithelial tight junctions may be vital for rapid restoration of integrity following injury, and hence critical for survival. This model also suggests a mechanism for abnormal receptor activation in diseases with increased epithelial permeability.	Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Roy J & Lucille A Carver Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; University Hospitals of Cleveland	Zabner, J (corresponding author), Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu; michael-weish@uiowa.edu	Vermeer, Paola D/O-2572-2013	Kern, Jeffrey/0000-0001-9709-9622; Welsh, Michael/0000-0002-1646-6206; Zabner, Joseph/0000-0002-9606-1339				Aguilar Z, 2001, J BIOL CHEM, V276, P44099, DOI 10.1074/jbc.M103442200; AIDA S, 1994, RESPIRATION, V61, P161; Al Moustafa AE, 1999, ANTICANCER RES, V19, P481; Campiglio M, 1999, J CELL BIOCHEM, V73, P522, DOI 10.1002/(SICI)1097-4644(19990615)73:4<522::AID-JCB10>3.0.CO;2-4; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KENNEDY SM, 1984, AM REV RESPIR DIS, V129, P143; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Walker RA, 1998, J PATHOL, V185, P234, DOI 10.1002/(SICI)1096-9896(199807)185:3<234::AID-PATH128>3.0.CO;2-8; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang GS, 1998, J VIROL, V72, P9818, DOI 10.1128/JVI.72.12.9818-9826.1998; Wodarz A, 2000, CURR BIOL, V10, pR624, DOI 10.1016/S0960-9822(00)00658-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	19	286	303	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					322	326		10.1038/nature01440	http://dx.doi.org/10.1038/nature01440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646923				2022-12-01	WOS:000181637300042
J	Vasan, RS; Beiser, A; D'Agostino, RB; Levy, D; Selhub, J; Jacques, PF; Rosenberg, IH; Wilson, PWF				Vasan, RS; Beiser, A; D'Agostino, RB; Levy, D; Selhub, J; Jacques, PF; Rosenberg, IH; Wilson, PWF			Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; FOLIC-ACID; CORONARY; HYPERHOMOCYSTEINEMIA; POPULATION; CLASSIFICATION; DETERMINANTS; FOLATE; SERUM	Context Elevated plasma homocysteine levels are associated with increased risk of vascular disease. It is unclear whether elevated homocysteine levels are a risk factor for congestive heart failure (CHF). Objective To study prospectively the-association between nonfasting plasma homocysteine and incidence of CHF. Design, Setting, and Participants Community-based prospective cohort study of 2491 adults (mean age 72 years, 1547 women) who participated in the Framingham Heart Study during the 1979-1982 and 1986-1990 examinations and were free of CHIF or prior myocardial infarction (recognized or unrecognized) at baseline. Main Outcome Measure incidence of a first episode of CHIF during an 8-year follow-up period. Results During follow-up, 156 subjects (88 women) developed CHF. In multivariable analyses controlling for established risk factors for CHF including the occurrence of myocardial infarction (recognized or unrecognized) during follow-up, plasma homocysteine levels higher than the sex-specific median value were associated with an adjusted hazards ratio,for heart failure of 1.93 in women (95% confidence interval, 1.19-3.14)and 1.84 in men (95% confidence interval, 1.06-3.17). The relation of plasma homocysteine levels to CHF risk was more continuous in women than in men. In analyses restricted to participants without any manifestation of coronary heart disease at baseline, the association of plasma homocysteine levels with risk of CHF was maintained in men and women. Conclusions An increased plasma homocysteine level independently predicts risk of the development of CHF in adults without prior myocardial infarction. Additional investigations are warranted to confirm these findings.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA; Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Site 2, Framingham, MA 01702 USA.	vasan@fram.nhlbi.nih.gov	Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Wilson, Peter W.F./J-2455-2016	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Beiser, Alexa/0000-0001-8551-7778	NHLBI NIH HHS [1K24 HL04334, R01 HL71039, N01-HC-25195] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL071039] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Obaidi MK, 2000, J AM COLL CARDIOL, V36, P1217, DOI 10.1016/S0735-1097(00)00820-2; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; *AM HEART ASS, 2000, 2001 HEART STROK STA, P19; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Blacher J, 1999, J NEPHROL, V12, P248; Bostom AG, 1999, CIRCULATION, V99, P2361, DOI 10.1161/01.CIR.99.18.2361; Chao CL, 1999, ATHEROSCLEROSIS, V147, P379, DOI 10.1016/S0021-9150(99)00208-7; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chilian WM, 1997, CIRCULATION, V95, P522; Clarke R, 2001, J CARDIOVASC RISK, V8, P363, DOI 10.1097/00043798-200112000-00005; Cooke GE, 2000, J AM COLL CARDIOL, V36, P509, DOI 10.1016/S0735-1097(00)00756-7; Cowie MR, 1997, EUR HEART J, V18, P208; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kannel W., 1987, SOME RISK FACTORS RE; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lentz SR, 1997, LIFE SCI, V61, P1205, DOI 10.1016/S0024-3205(97)00392-5; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 1998, EUR HEART J, V19, pP9; Miller A, 2002, AM J HYPERTENS, V15, P157, DOI 10.1016/S0895-7061(01)02286-5; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; Nurk E, 2001, J NUTR, V131, P1214, DOI 10.1093/jn/131.4.1214; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; *SAS I INC, 1997, PHREG PROC CHANG ENH; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Symons JD, 2002, ARTERIOSCL THROM VAS, V22, P772, DOI 10.1161/01.ATV.0000014588.71807.0A; UELAND PM, 1993, CLIN CHEM, V39, P1764; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Ventura P, 2001, METABOLISM, V50, P1466, DOI 10.1053/meta.2001.28079; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Whincup PH, 1999, HEART, V82, P448, DOI 10.1136/hrt.82.4.448; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; 1997, ARCH INTERN MED, V157, P2413; 1996, FED REG, V61, P8781	41	161	177	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1251	1257		10.1001/jama.289.10.1251	http://dx.doi.org/10.1001/jama.289.10.1251			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633186	Bronze			2022-12-01	WOS:000181466500026
J	Acevedo-Whitehouse, K; Gulland, F; Greig, D; Amos, W				Acevedo-Whitehouse, K; Gulland, F; Greig, D; Amos, W			Disease susceptibility in California sea lions	NATURE			English	Article							ZALOPHUS-CALIFORNIANUS; MICROSATELLITES		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Marine Mammal Ctr, Sausalito, CA 94965 USA	University of Cambridge	Acevedo-Whitehouse, K (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	w.amos@zoo.cam.ac.uk		Greig, Denise/0000-0003-0783-1002				Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Buchanan FC, 1998, MOL ECOL, V7, P1083; Coltman DW, 1996, MOL ECOL, V5, P161, DOI 10.1111/j.1365-294X.1996.tb00303.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI 10.1111/j.1558-5646.1999.tb04538.x; Frankham R., 2010, INTRO CONSERVATION G; GAGE LJ, 1993, J ZOO WILDLIFE MED, V24, P41; Goldstein T., 1999, Aquatic Mammals, V25, P43; Gulland FMD, 2002, VET REC, V150, P475; Hoelzel AR, 2001, P ROY SOC B-BIOL SCI, V268, P325; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lipscomb TP, 2000, VET PATHOL, V37, P609, DOI 10.1354/vp.37-6-609; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499	13	266	272	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					35	35		10.1038/422035a	http://dx.doi.org/10.1038/422035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621424	Bronze			2022-12-01	WOS:000181343100027
J	Shaw, SL; Kamyar, R; Ehrhardt, DW				Shaw, SL; Kamyar, R; Ehrhardt, DW			Sustained microtubule treadmilling in Arabidopsis cortical arrays	SCIENCE			English	Article							LIVING PLANT-CELLS; DYNAMIC INSTABILITY; GROWTH; TUBULIN; ORIENTATION; TURNOVER; SITES	Plant cells create highly structured microtubule arrays at the cell cortex without a central organizing center to anchor the microtubule ends. In vivo imaging of individual microtubules in Arabidopsis plants revealed that new microtubules are initiated at the cell cortex and exhibit dynamics at both ends. Polymerization-biased dynamic instability at one end and slow depolymerization at the other end result in sustained microtubule migration across the cell cortex by a hybrid treadmilling mechanism. This motility causes widespread microtubule repositioning and contributes to changes in array organization through microtubule reorientation and bundling.	Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Ehrhardt, DW (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	ehrhardt@andrew2.stanford.edu		Shaw, Sidney/0000-0001-9195-6128				Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; CLAYTON L, 1985, J CELL BIOL, V101, P319, DOI 10.1083/jcb.101.1.319; CYR RJ, 1994, ANNU REV CELL BIOL, V10, P153, DOI 10.1146/annurev.cb.10.110194.001101; Erhardt M, 2002, J CELL SCI, V115, P2423; Granger CL, 2001, PROTOPLASMA, V216, P201, DOI 10.1007/BF02673872; GREEN PB, 1965, J CELL BIOL, V27, P343, DOI 10.1083/jcb.27.2.343; GUNNING BES, 1985, J CELL SCI, P157, DOI 10.1242/jcs.1985.Supplement_2.9; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; HUSH JM, 1994, J CELL SCI, V107, P775; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Lloyd C, 2002, PLANT CELL, V14, P2319, DOI 10.1105/tpc.141030; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SHIBAOKA H, 1991, CYTOSKELETAL BASIS P, P159; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Vorobjev IA, 1999, J CELL SCI, V112, P2277; Wasteneys GO, 2002, J CELL SCI, V115, P1345; WatermanStorer CM, 1997, CURR BIOL, V7, pR369, DOI 10.1016/S0960-9822(06)00177-1; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; WICK SM, 1985, CELL BIOL INT REP, V9, P357, DOI 10.1016/0309-1651(85)90031-1; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050; Yvon AMC, 1997, J CELL SCI, V110, P2391	27	346	353	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1715	1718		10.1126/science.1083529	http://dx.doi.org/10.1126/science.1083529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12714675				2022-12-01	WOS:000183459700042
J	Ksiazek, TG; Erdman, D; Goldsmith, CS; Zaki, SR; Peret, T; Emery, S; Tong, SX; Urbani, C; Comer, JA; Lim, W; Rollin, PE; Dowell, SF; Ling, AE; Humphrey, CD; Shieh, WJ; Guarner, J; Paddock, CD; Rota, P; Fields, B; DeRisi, J; Yang, JY; Cox, N; Hughes, JM; LeDuc, JW; Bellini, WJ; Anderson, LJ				Ksiazek, TG; Erdman, D; Goldsmith, CS; Zaki, SR; Peret, T; Emery, S; Tong, SX; Urbani, C; Comer, JA; Lim, W; Rollin, PE; Dowell, SF; Ling, AE; Humphrey, CD; Shieh, WJ; Guarner, J; Paddock, CD; Rota, P; Fields, B; DeRisi, J; Yang, JY; Cox, N; Hughes, JM; LeDuc, JW; Bellini, WJ; Anderson, LJ		SARS Working Grp	A novel coronavirus associated with severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORCINE EPIDEMIC DIARRHEA; ANTIGENIC RELATIONSHIPS; VIRUS-INFECTION; NIPAH VIRUS; PATHOGENESIS; PROPAGATION; ADAPTATION; DIAGNOSIS; GROWTH; FEVER	BACKGROUND A worldwide outbreak of severe acute respiratory syndrome (SARS) has been associated with exposures originating from a single ill health care worker from Guangdong Province, China. We conducted studies to identify the etiologic agent of this outbreak. METHODS We received clinical specimens from patients in seven countries and tested them, using virus-isolation techniques, electron-microscopical and histologic studies, and molecular and serologic assays, in an attempt to identify a wide range of potential pathogens. RESULTS None of the previously described respiratory pathogens were consistently identified. However, a novel coronavirus was isolated from patients who met the case definition of SARS. Cytopathological features were noted in Vero E6 cells inoculated with a throat-swab specimen. Electron-microscopical examination revealed ultrastructural features characteristic of coronaviruses. Immunohistochemical and immunofluorescence staining revealed reactivity with group I coronavirus polyclonal antibodies. Consensus coronavirus primers designed to amplify a fragment of the polymerase gene by reverse transcription-polymerase chain reaction (RT-PCR) were used to obtain a sequence that clearly identified the isolate as a unique coronavirus only distantly related to previously sequenced coronaviruses. With specific diagnostic RT-PCR primers we identified several identical nucleotide sequences in 12 patients from several locations, a finding consistent with a point-source outbreak. Indirect fluorescence antibody tests and enzyme-linked immunosorbent assays made with the new isolate have been used to demonstrate a virus-specific serologic response. This virus may never before have circulated in the U.S. population. CONCLUSIONS A novel coronavirus is associated with this outbreak, and the evidence indicates that this virus has an etiologic role in SARS. Because of the death of Dr. Carlo Urbani, we propose that our first isolate be named the Urbani strain of SARS-associated coronavirus.	Ctr Dis Control & Prevent, Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Resp & Enter Virus Brach, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Infect Dis Pathol Act, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Influenza Branch, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Off Director, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; WHO, Hanoi, Vietnam; Queen Mary Hosp, Govt Virus Unit, Hong Kong, Hong Kong, Peoples R China; Int Emerging Infect Dis Program, Bangkok, Thailand; Univ Calif San Francisco, San Francisco, CA 94143 USA; Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; Ctr Dis Control, Dept Hlth, Taipei, Taiwan	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization; University of Hong Kong; University of California System; University of California San Francisco; Singapore General Hospital; Centers For Disease Control - Taiwan	Ksiazek, TG (corresponding author), Ctr Dis Control & Prevent, Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.		Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541; Rollin, Pierre/0000-0002-4608-2641; Osborne, Jane/0000-0001-9529-7748				Becker W B, 1967, J Virol, V1, P1019; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; BRADBURNE AF, 1970, ARCH GES VIRUSFORSCH, V31, P352, DOI 10.1007/BF01253769; BRADBURNE AF, 1972, J HYG-CAMB, V70, P235, DOI 10.1017/S0022172400022294; BRUCKOVA M, 1970, P SOC EXP BIOL MED, V135, P431; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Guarner J, 2000, AM J CLIN PATHOL, V114, P227, DOI 10.1309/HV74-N24T-2K2C-3E8Q; Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; JOHNSON KM, 1977, LANCET, V1, P569; Jonassen CM, 1998, J GEN VIROL, V79, P715, DOI 10.1099/0022-1317-79-4-715; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313; Lavi E, 1996, VIROLOGY, V221, P325, DOI 10.1006/viro.1996.0382; Lederberg J., 2003, MICROBIAL THREATS HL; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Luby JP, 1999, J CLIN VIROL, V12, P43, DOI 10.1016/S0928-0197(98)00067-1; MCINTOSH K, 1969, J IMMUNOL, V102, P1109; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; OSHIRO LS, 1971, J GEN VIROL, V12, P161, DOI 10.1099/0022-1317-12-2-161; PATTERSON S, 1982, J GEN VIROL, V60, P307, DOI 10.1099/0022-1317-60-2-307; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; *WHO, 2003, AC RESP SYNDR CHIN U; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; WULFF H, 1975, B WORLD HEALTH ORGAN, V52, P429; ZAKI SR, 1995, AM J PATHOL, V146, P552; 2003, MMWR MORB MORTAL WKL, V52, P241	33	2896	3369	8	796	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1953	1966		10.1056/NEJMoa030781	http://dx.doi.org/10.1056/NEJMoa030781			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12690092	Bronze			2022-12-01	WOS:000182823400004
J	Galagan, JE; Calvo, SE; Borkovich, KA; Selker, EU; Read, ND; Jaffe, D; FitzHugh, W; Ma, LJ; Smirnov, S; Purcell, S; Rehman, B; Elkins, T; Engels, R; Wang, SG; Nielsen, CB; Butler, J; Endrizzi, M; Qui, DY; Ianakiev, P; Pedersen, DB; Nelson, MA; Werner-Washburne, M; Selitrennikoff, CP; Kinsey, JA; Braun, EL; Zelter, A; Schulte, U; Kothe, GO; Jedd, G; Mewes, W; Staben, C; Marcotte, E; Greenberg, D; Roy, A; Foley, K; Naylor, J; Stabge-Thomann, N; Barrett, R; Gnerre, S; Kamal, M; Kamvysselis, M; Mauceli, E; Bielke, C; Rudd, S; Frishman, D; Krystofova, S; Rasmussen, C; Metzenberg, RL; Perkins, DD; Kroken, S; Cogoni, C; Macino, G; Catcheside, D; Li, WX; Pratt, RJ; Osmani, SA; DeSouza, CPC; Glass, L; Orbach, MJ; Berglund, JA; Voelker, R; Yarden, O; Plamann, M; Seiler, S; Dunlap, J; Radford, A; Aramayo, R; Natvig, DO; Alex, LA; Mannhaupt, G; Ebbole, DJ; Freitag, M; Paulsen, I; Sachs, MS; Lander, ES; Nusbaum, C; Birren, B				Galagan, JE; Calvo, SE; Borkovich, KA; Selker, EU; Read, ND; Jaffe, D; FitzHugh, W; Ma, LJ; Smirnov, S; Purcell, S; Rehman, B; Elkins, T; Engels, R; Wang, SG; Nielsen, CB; Butler, J; Endrizzi, M; Qui, DY; Ianakiev, P; Pedersen, DB; Nelson, MA; Werner-Washburne, M; Selitrennikoff, CP; Kinsey, JA; Braun, EL; Zelter, A; Schulte, U; Kothe, GO; Jedd, G; Mewes, W; Staben, C; Marcotte, E; Greenberg, D; Roy, A; Foley, K; Naylor, J; Stabge-Thomann, N; Barrett, R; Gnerre, S; Kamal, M; Kamvysselis, M; Mauceli, E; Bielke, C; Rudd, S; Frishman, D; Krystofova, S; Rasmussen, C; Metzenberg, RL; Perkins, DD; Kroken, S; Cogoni, C; Macino, G; Catcheside, D; Li, WX; Pratt, RJ; Osmani, SA; DeSouza, CPC; Glass, L; Orbach, MJ; Berglund, JA; Voelker, R; Yarden, O; Plamann, M; Seiler, S; Dunlap, J; Radford, A; Aramayo, R; Natvig, DO; Alex, LA; Mannhaupt, G; Ebbole, DJ; Freitag, M; Paulsen, I; Sachs, MS; Lander, ES; Nusbaum, C; Birren, B			The genome sequence of the filamentous fungus Neurospora crassa	NATURE			English	Article							INDUCED POINT MUTATION; YEAST SACCHAROMYCES-CEREVISIAE; DNA METHYLATION; MELANIN BIOSYNTHESIS; COLLETOTRICHUM-LAGENARIUM; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; SMALL RNAS; GENE; RIP	Neurospora crassa is a central organism in the history of twentieth-century genetics, biochemistry and molecular biology. Here, we report a high-quality draft sequence of the N. crassa genome. The approximately 40-megabase genome encodes about 10,000 protein-coding genes-more than twice as many as in the fission yeast Schizosaccharomyces pombe and only about 25% fewer than in the fruitfly Drosophila melanogaster. Analysis of the gene set yields insights into unexpected aspects of Neurospora biology including the identification of genes potentially associated with red light photobiology, genes implicated in secondary metabolism, and important differences in Ca2+ signalling as compared with plants and animals. Neurospora possesses the widest array of genome defence mechanisms known for any eukaryotic organism, including a process unique to fungi called repeat-induced point mutation (RIP). Genome analysis suggests that RIP has had a profound impact on genome evolution, greatly slowing the creation of new genes through genomic duplication and resulting in a genome with an unusually low proportion of closely related genes.	Whitehead Inst, Ctr Genome Res, Cambridge, MA 02141 USA; Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland; Celara Genom, Rockville, MD 20850 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Colorado, Hlth Sci Ctr, Dept Cellular & Struct Biol, Denver, CO 80262 USA; Univ Kansas, Sch Med, Dept Microbiol, Kansas City, KS 66160 USA; Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, D-85350 Freising Weihenstephan, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Bioinformat, D-85764 Neuherberg, Germany; Univ Kentucky, TH Morgan Sch Biol Sci, Lexington, KY 40506 USA; Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Inst Genom Res, Rockville, MD 20878 USA; Univ Calif Berkeley, Dept Plant & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy; Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Univ Arizona, Dept Plant Pathol, Tucson, AZ 85721 USA; Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; Calif State Polytech Univ Pomona, Dept Chem, Pomona, CA 91768 USA; Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Oregon Hlth & Sci Univ, Dept Environm & Biomol Syst, OGI Sch Sci & Engn, Beaverton, OR 97006 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43211 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Riverside; University of Oregon; University of Edinburgh; Texas A&M University System; Texas A&M University College Station; University of New Mexico; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Kansas; University of Kansas Medical Center; State University System of Florida; University of Florida; Hebrew University of Jerusalem; Heinrich Heine University Dusseldorf; Rockefeller University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kentucky; University of Texas System; University of Texas Austin; J. Craig Venter Institute; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Sapienza University Rome; Flinders University South Australia; University System of Ohio; Ohio State University; University of Arizona; University of Missouri System; University of Missouri Kansas City; Dartmouth College; University of Leeds; California State University System; California State Polytechnic University Pomona; Texas A&M University System; Texas A&M University College Station; Oregon Health & Science University; Massachusetts Institute of Technology (MIT); University System of Ohio; Ohio State University	Galagan, JE (corresponding author), Whitehead Inst, Ctr Genome Res, 320 Charles St, Cambridge, MA 02141 USA.	jgalag@mit.edu; bwb@genome.wi.mit.edu	krystofova, svetlana/AAU-8726-2020; Osmani, Stephen A./AAS-3904-2021; Ma, Li-Jun/AAG-2359-2020; Bell-Pedersen, Deborah/H-8012-2016; Paulsen, Ian T/K-3832-2012; Frishman, Dmitrij/AAT-7815-2020; Yarden, Oded/J-5988-2012; Kellis, Manolis/ABE-7385-2020; Staben, Charles/C-1562-2013; Berglund, Andrew/AAS-1065-2021; Rudd, Stephen A/A-6434-2013; Mewes, Hans-Werner/A-8204-2019	Bell-Pedersen, Deborah/0000-0002-1639-8215; Paulsen, Ian T/0000-0001-9015-9418; Kellis, Manolis/0000-0001-7113-9630; Rudd, Stephen A/0000-0002-0344-7487; Ma, Li-Jun/0000-0002-2733-3708; Sachs, Matthew/0000-0001-9891-9223; Aramayo, Rodolfo/0000-0001-9702-6204; , Oded/0000-0002-4722-535X; Read, Nick/0000-0002-2286-2862; Marcotte, Edward/0000-0001-8808-180X; Jedd, Gregory/0000-0002-5428-3873; Engels, Reinhard/0000-0003-0921-0736; Braun, Edward/0000-0003-1643-5212; Catcheside, David/0000-0002-7101-6849; Galagan, James/0000-0003-0542-3291; Mewes, Hans-Werner/0000-0002-9713-6398; krystofova, svetlana/0000-0001-7631-2439	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058770] Funding Source: Medline; NINDS NIH HHS [P01 NS039546] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Aign V, 2001, GENETICS, V157, P1015; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; CAMBARERI EB, 1991, GENETICS, V127, P699; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; CORNELIUS G, 1989, BIOCHEM BIOPH RES CO, V162, P852, DOI 10.1016/0006-291X(89)92388-7; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Davis RH, 2000, NEUROSPORA CONTRIBUT; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Feng B, 2001, INFECT IMMUN, V69, P1781, DOI 10.1128/IAI.69.3.1781-1794.2001; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; FREE SJ, 1979, J BACTERIOL, V137, P1219, DOI 10.1128/JB.137.3.1219-1226.1979; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Gadd G. M, 1994, GROWING FUNGUS, P183; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Graia F, 2001, MOL MICROBIOL, V40, P586, DOI 10.1046/j.1365-2958.2001.02367.x; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; IRELAN JT, 1994, GENETICS, V138, P1093; Ivey FD, 1999, FUNGAL GENET BIOL, V26, P48, DOI 10.1006/fgbi.1998.1101; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Josefsson LG, 1997, EUR J BIOCHEM, V249, P415, DOI 10.1111/j.1432-1033.1997.t01-1-00415.x; Kelkar HS, 2001, GENETICS, V157, P979; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; LAKINTHOMAS PL, 1993, BIOCHEM J, V292, P805, DOI 10.1042/bj2920805; LEE DW, IN PRESS GENETICS; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lindegren CC, 1936, J GENET, V32, P243, DOI 10.1007/BF02982680; Linden H, 1999, ADV GENET, V41, P35, DOI 10.1016/S0065-2660(08)60150-9; LU SW, 2001, FUNGAL GENET NEWS, V48, pA246; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Margolin BS, 1998, GENETICS, V149, P1787; Nelson MA, 1997, FUNGAL GENET BIOL, V21, P348, DOI 10.1006/fgbi.1997.0986; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Payen A., 1843, ANN CHIM PHYS, V9, P5; Perkins DD, 1997, GENETICS, V147, P125; PERKINS DD, 2001, NEUROSPORA COMPENDIU; Pickford A, 2003, CURR GENET, V42, P220, DOI 10.1007/s00294-002-0351-6; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; RUSSELL PJ, 1987, J BACTERIOL, V169, P2902, DOI 10.1128/jb.169.6.2902-2905.1987; Schulte U, 2002, J BIOTECHNOL, V94, P3, DOI 10.1016/S0168-1656(01)00415-1; SELKER EU, 1981, CELL, V24, P819, DOI 10.1016/0092-8674(81)90107-0; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3; SELKER EU, 1993, SCIENCE, V262, P1724, DOI 10.1126/science.8259516; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Shear CL, 1927, J AGRIC RES, V34, P1019; Shiu PKT, 2002, GENETICS, V161, P1483; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Silverman-Gavrila LB, 2001, EUR J CELL BIOL, V80, P379, DOI 10.1078/0171-9335-00175; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; TAKANO Y, 1995, MOL GEN GENET, V249, P162, DOI 10.1007/BF00290362; Takano Y, 1997, FUNGAL GENET BIOL, V21, P131, DOI 10.1006/fgbi.1997.0963; *TIDR, 2003, MICR DAT; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIGFUSSON NV, 1974, NATURE, V249, P383, DOI 10.1038/249383a0; Watters MK, 1999, GENETICS, V153, P705; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yuan WM, 2001, J BACTERIOL, V183, P4040, DOI 10.1128/JB.183.13.4040-4051.2001; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; 2002, FUNGAL GENOME INITIA	72	1214	2170	1	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					859	868		10.1038/nature01554	http://dx.doi.org/10.1038/nature01554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712197	Green Submitted, hybrid			2022-12-01	WOS:000182432600046
J	Grant, CC; Roberts, M; Scragg, R; Stewart, J; Lennon, D; Kivell, D; Ford, R; Menzies, R				Grant, CC; Roberts, M; Scragg, R; Stewart, J; Lennon, D; Kivell, D; Ford, R; Menzies, R			Delayed immunisation and risk of pertussis in infants: unmatched case-control study	BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZATION		Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Auckland 1, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand; S Auckland Hlth, Auckland, New Zealand; Canterbury Dist Hlth Board, Christchurch, New Zealand; Auckland Dist Hlth Board, Auckland, New Zealand	University of Auckland; University of Auckland; Auckland District Health Board	Grant, CC (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Private Bag 92019, Auckland 1, New Zealand.			Grant, Cameron/0000-0002-4032-7230; Scragg, Robert/0000-0003-0013-2620				CRAMPTON P, 1998, NZ PUBLIC HLTH REPOR, V5, P81; DIETZ VJ, 1993, PEDIATR INFECT DIS J, V12, P353, DOI 10.1097/00006454-199304000-00022; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; POLLOCK TM, 1984, ARCH DIS CHILD, V59, P162, DOI 10.1136/adc.59.2.162; REID S, 1994, NEW ZEAL MED J, V107, P460	5	77	77	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					852	853		10.1136/bmj.326.7394.852	http://dx.doi.org/10.1136/bmj.326.7394.852			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702617	Bronze, Green Published			2022-12-01	WOS:000182386800017
J	Frank, SA; Nowak, MA				Frank, SA; Nowak, MA			Developmental predisposition to cancer	NATURE			English	Article									Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Inst Adv Study, Princeton, NJ 08540 USA	University of California System; University of California Irvine; Institute for Advanced Study - USA	Frank, SA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	safrank@uci.edu	Nowak, Martin A/A-6977-2008	Frank, Steven/0000-0001-7348-7794				CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; PREHN RT, 1975, SCIENCE, V190, P1095, DOI 10.1126/science.1188386; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0	7	70	73	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					494	494		10.1038/422494a	http://dx.doi.org/10.1038/422494a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673242				2022-12-01	WOS:000181965400029
J	Hutchinson, JR; Famini, D; Lair, R; Kram, R				Hutchinson, JR; Famini, D; Lair, R; Kram, R			Are fast-moving elephants really running?	NATURE			English	Article							LOCOMOTION; MAMMALS; SPEED		Stanford Univ, Biomech Engn Div, Stanford, CA 94305 USA; Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; Thai Elephant Conservat Ctr, Lampang 52000, Thailand; Univ Colorado, Dept Kinesiol & Appl Physiol, Boulder, CO 80309 USA	Stanford University; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder	Hutchinson, JR (corresponding author), Stanford Univ, Biomech Engn Div, Stanford, CA 94305 USA.	jrhutch@stanford.edu	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038				ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1979, J ZOOL, V189, P135, DOI 10.1111/j.1469-7998.1979.tb03956.x; Cavagna G. A., 1977, SCALE EFFECTS ANIMAL, P111; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; FARLEY CT, 1991, SCIENCE, V253, P306, DOI 10.1126/science.1857965; Gambaryan P. P., 1974, MAMMALS RUN; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; HEGLUND NC, 1982, J EXP BIOL, V97, P41; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Howell A. B, 1944, SPEED IN ANIMALS; MCMAHON TA, 1987, J APPL PHYSIOL, V62, P2326, DOI 10.1152/jappl.1987.62.6.2326; Muybridge E., 1957, ANIMALS MOTION	12	94	94	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					493	494		10.1038/422493a	http://dx.doi.org/10.1038/422493a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673241				2022-12-01	WOS:000181965400028
J	Shishehbor, MH; Aviles, RJ; Brennan, ML; Fu, XM; Goormastic, M; Pearce, GL; Gokce, N; Keaney, JF; Penn, MS; Sprecher, DL; Vita, JA; Hazen, SL				Shishehbor, MH; Aviles, RJ; Brennan, ML; Fu, XM; Goormastic, M; Pearce, GL; Gokce, N; Keaney, JF; Penn, MS; Sprecher, DL; Vita, JA; Hazen, SL			Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; ACUTE CORONARY SYNDROMES; NITRIC-OXIDE SYNTHASE; IN-VIVO; ENDOTHELIAL DYSFUNCTION; LIPOPROTEIN OXIDATION; SUPEROXIDE PRODUCTION; HUMAN ATHEROSCLEROSIS; ARTERY DISEASE; MYELOPEROXIDASE	Context Formation of nitric oxide-derived oxidants may serve as a mechanism linking inflammation to development of atherosclerosis. Nitrotyrosine, a specific marker for protein modification by nitric oxide-derived oxidants, is enriched in human atherosclerotic lesions and low-density lipoprotein (LDL) recovered from human atheroma. Objectives To determine whether systemic levels of nitrotyrosine. are associated with the prevalence of coronary artery disease (CAD) and are modulated by hydroxymethylglutaryl coenzyme-A reductase inhibitor (statin) therapy. Design, Setting, and Patients A case-control and interventional study at 2 urban tertiary-care referral centers; recruitment for each was from June 1, 2001, until January 1, 2002. For the case-control study, 100 case-patients with established CAD and 108 patients with no clinically evident CAD were recruited consecutively. In the interventional study, participants aged 21 years or older with hypercholesterolemia (LDL cholesterol greater than or equal to130 mg/dL [greater than or equal to3.5 mmol/L]) underwent nutrition and exercise counseling. Those whose levels did not decrease with 6 to 8 weeks were enrolled in the study (n=35). For 12 weeks, they received 10 mg/d of oral atorvastatin therapy. Main Outcome Measures In the case-control study, the association between systemic levels of protein-bound nitrotyrosine, CAD risk, and presence of CAD. In the interventional study, the change in nitrotyrosine, lipoprotein, and C-reactive protein (CRP) levels. Results Nitrotyrosine levels were significantly higher among patients with CAD (median 9.1 mumol/mol [interquartile range, 4.8-13.8 mumol/mol] tyrosine vs 5.2 mumol/mol [interquartile range, 2.2-8.4 mumol/mol]; P<.001). Patients in the upper quartile of nitrotyrosine (29%; P<.001) had a higher odds of CAD compared with those in the lowest quartile (unadjusted odds ratio, 6.1; 95% confidence interval, 2.6-14.0; P<.001). In multivariate models adjusting for Framingham Global Risk Score and CRP, upper quartiles of nitrotyrosine remained associated with CAD (odds ratio, 4.4; 95% confidence interval, 1.8-10.6; P<.001). Statin therapy reduced nitrotyrosine levels significantly (25%; P<.02) with a magnitude similar to reductions in total cholesterol levels (25%; P<.001) and LDL particle number (29%; P<.001) yet were independent of alterations in lipoproteins and inflammatory markers like CRP. Conclusions The findings from this preliminary study indicate that nitrotyrosine levels are associated with the presence of CAD and appear to be modulated by statin therapy. These results suggest a potential role for nitric oxide-derived oxidants as inflammatory mediators in CAD and may have implications for atherosclerosis risk assessment and monitoring of anti-inflammatory actions of statins.	Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Boston University	Hazen, SL (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Gokce, Noyan/0000-0003-2920-3445; Keaney, John/0000-0002-0866-1837; Vita, Joseph/0000-0001-5607-1797	NHLBI NIH HHS [HL70621, HL62526, HL61878, HL60886] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060886, R01HL061878, R01HL070621, R01HL062526] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Abu-Soud Husam M., 2000, Nitric Oxide, V4, P179; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Freedman JE, 1998, CIRCULATION, V98, P1481, DOI 10.1161/01.CIR.98.15.1481; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hazen SL, 1999, CIRC RES, V85, P950; Heinecke JW, 2001, ARTERIOSCL THROM VAS, V21, P1261, DOI 10.1161/hq0801.095084; Ignarro LJ, 2002, CIRC RES, V90, P21, DOI 10.1161/hh0102.102330; Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Moncada S, 1999, J ROY SOC MED, V92, P164, DOI 10.1177/014107689909200402; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; Pannala AS, 1999, METHOD ENZYMOL, V301, P319; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Ridker P M, 2000, Curr Cardiol Rep, V2, P269, DOI 10.1007/s11886-000-0080-8; Ridker PM, 2001, CIRCULATION, V103, P1191; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Rifai N, 1999, CLIN CHEM, V45, P2136; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Stroes E, 1998, FEBS LETT, V438, P161, DOI 10.1016/S0014-5793(98)01292-7; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	40	364	395	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1675	1680		10.1001/jama.289.13.1675	http://dx.doi.org/10.1001/jama.289.13.1675			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672736	Bronze			2022-12-01	WOS:000181944500031
J	Rolland-Lagan, AG; Bangham, JA; Coen, E				Rolland-Lagan, AG; Bangham, JA; Coen, E			Growth dynamics underlying petal shape and asymmetry	NATURE			English	Article							CELL LINEAGE PATTERNS; LEAF DEVELOPMENT; CLONAL ANALYSIS; TOBACCO; PARAMETERS	Development commonly involves the generation of complex shapes from simpler ones. One way of following this process is to use landmarks to track the fate of particular points in a developing organ(1-7), but this is limited by the time over which it can be monitored. Here we use an alternative method, clonal analysis', whereby dividing cells are genetically marked and their descendants identified visually, to observe the development of Antirrhinum (snapdragon) petals. Clonal analysis has previously been used to estimate growth parameters of leaves(9-11) and Drosophila wings(12-14) but these results were not integrated within a dynamic growth model. Here we develop such a model and use it to show that a key aspect of shape-petal asymmetry-in the petal lobe of Antirrhinum depends on the direction of growth rather than regional differences in growth rate. The direction of growth is maintained parallel to the proximodistal axis of the flower, irrespective of changes in shape, implying that long-range signals orient growth along the petal as a whole. Such signals may provide a general mechanism for orienting growth in other growing structures.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Informat Syst, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk Colney, Norwich NR4 7UH, Norfolk, England.	Enrico.Coen@bbsrc.ac.uk						Almeida J, 1997, DEVELOPMENT, V124, P1387; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Dolan L, 1998, AM J BOT, V85, P315, DOI 10.2307/2446322; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Efremova N, 2001, DEVELOPMENT, V128, P2661; ERICKSON RO, 1976, ANNU REV PLANT PHYS, V27, P407, DOI 10.1146/annurev.pp.27.060176.002203; ERICKSON RO, 1966, J EXP BOT, V17, P390, DOI 10.1093/jxb/17.2.390; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; HARRISON BJ, 1964, HEREDITY, V19, P237, DOI 10.1038/hdy.1964.28; HERNANDEZ LF, 1991, PLANTA, V185, P139, DOI 10.1007/BF00194054; LLOYD CW, 1988, DEVELOPMENT, V102, P211; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; MAKSYMOWYCH R, 1973, DEV CELL BIOL SERIES, V1; Perbal MC, 1996, DEVELOPMENT, V122, P3433; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1987, AM J BOT, V74, P581, DOI 10.2307/2443838; POETHIG RS, 1995, MAYDICA, V40, P67; Resino J, 2002, P NATL ACAD SCI USA, V99, P7502, DOI 10.1073/pnas.072208199; Richards OW, 1943, AM NAT, V77, P385, DOI 10.1086/281140; Sachs T., 1991, PATTERN FORMATION PL; SUBTELNY S, 1978, CLONAL BASIS DEV; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Thompson DW, 1942, GROWTH FORM, V2; TILNEYBASSET RAE, 1986, PLANT CHIMERAS; Vincent CA, 2003, PLANT J, V33, P765, DOI 10.1046/j.1365-313X.2003.01666.x; Vincent CA, 1995, CURR BIOL, V5, P1449, DOI 10.1016/S0960-9822(95)00282-X; WOLF S, 1986, SILICON PROCESSING V, V1, P73	30	123	128	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					161	163		10.1038/nature01443	http://dx.doi.org/10.1038/nature01443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634785				2022-12-01	WOS:000181488900044
J	Karst, SM; Wobus, CE; Lay, M; Davidson, J; Virgin, HW				Karst, SM; Wobus, CE; Lay, M; Davidson, J; Virgin, HW			STAT1-dependent innate immunity to a Norwalk-like virus	SCIENCE			English	Article							MICE; GASTROENTERITIS	Norwalk-like caliciviruses (Noroviruses) cause over 90% of nonbacterial epidemic gastroenteritis worldwide, but the pathogenesis of norovirus infection is poorly understood because these viruses do not grow in cultured cells and there is no small animal model. Here, we report a previously unknown murine norovirus. Analysis of Murine Norovirus 1 infection revealed that signal transducer and activator of transcription 1-dependent innate immunity, but not T and B cell-dependent adaptive immunity, is essential for norovirus resistance. The identification of host molecules essential for murine norovirus resistance may provide targets for prevention or control of an important human disease.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Virgin@immunology.wustl.edu	Lay, Margarita/AAW-6352-2021	Lay, Margarita/0000-0002-4081-7977	NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049286] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09547] Funding Source: Medline; NIAID NIH HHS [R01 AI49286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; GREEN KY, 2001, FIELDS VIROLOGY, V1, pCH27; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; KARST S, UNPUB; MACMICKING, 1995, CELL, V81, pU17; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pastorian K, 2000, ANAL BIOCHEM, V283, P89, DOI 10.1006/abio.2000.4622; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TREANOR J, 1995, PRINCIPLES PRACTICE, pCH153; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	19	604	639	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1575	1578		10.1126/science.1077905	http://dx.doi.org/10.1126/science.1077905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624267				2022-12-01	WOS:000181367900038
J	Kondoh, M				Kondoh, M			Foraging adaptation and the relationship between food-web complexity and stability	SCIENCE			English	Article							CAPITA INTERACTION STRENGTH; TEMPORAL VARIATION; RAPID EVOLUTION; COMMUNITIES; RESOLUTION; NETWORKS; STREAM; MODEL; FISH	Ecological theory suggests that complex food webs should not persist because of their inherent instability. "Real" ecosystems often support a large number of interacting species. A mathematical model shows that fluctuating short-term selection on trophic links, arising from a consumer's adaptive food choice, is a key to the long-term stability of complex communities. Without adaptive foragers, food-web complexity destabilizes community composition; whereas in their presence, complexity may enhance community persistence through facilitation of dynamical food-web reconstruction that buffers environmental fluctuations. The model predicts a linkage pattern consistent with field observations.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Kyoto University	Kondoh, M (corresponding author), Cardiff Univ, Cardiff Business Sch, POB 915, Cardiff CF10 3TL, S Glam, Wales.	kondohm@cf.ac.uk	rahim, sharul kamal abdul/K-6346-2012; rahim, sharul kamal abdul/I-1584-2014; Seman, Norhudah/L-9662-2016; Kondoh, Michio/AAE-4332-2019	rahim, sharul kamal abdul/0000-0003-4511-1989; rahim, sharul kamal abdul/0000-0003-4511-1989; Seman, Norhudah/0000-0003-3881-271X; 				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Abrams Peter A., 1996, P113; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Chen X, 2001, J THEOR BIOL, V212, P223, DOI 10.1006/jtbi.2001.2370; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Cohen J., 1990, COMMUNITY FOOD WEBS; DEANGELIS DL, 1975, ECOLOGY, V56, P238; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Egas M, 2001, ECOL LETT, V4, P190, DOI 10.1046/j.1461-0248.2001.00219.x; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; HUMPHREYS WF, 1979, J ANIM ECOL, V48, P427, DOI 10.2307/4171; Joshi A, 1997, EVOLUTION, V51, P846, DOI 10.1111/j.1558-5646.1997.tb03666.x; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Matsuda H, 1996, EVOL ECOL, V10, P13, DOI 10.1007/BF01239343; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis Gary A., 1996, P275; Raffaelli David G., 1996, P185; Robbins C.T., 1983, WILDLIFE FEEDING NUT; SCHOENLY K, 1991, ECOL MONOGR, V61, P267, DOI 10.2307/2937109; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stephens DW, 1987, FORAGING THEORY; TavaresCromar AF, 1996, ECOL MONOGR, V66, P91, DOI 10.2307/2963482; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	34	429	445	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1388	1391		10.1126/science.1079154	http://dx.doi.org/10.1126/science.1079154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610303				2022-12-01	WOS:000181192300050
J	De Sandre-Giovannoli, A; Bernard, R; Cau, P; Navarro, C; Amiel, J; Boccaccio, I; Lyonnet, S; Stewart, CL; Munnich, A; Le Merrer, M; Levy, N				De Sandre-Giovannoli, A; Bernard, R; Cau, P; Navarro, C; Amiel, J; Boccaccio, I; Lyonnet, S; Stewart, CL; Munnich, A; Le Merrer, M; Levy, N			Lamin A truncation in Hutchinson-Gilford progeria	SCIENCE			English	Article							DISEASE		Fac Med Timone, INSERM, U491, Marseille, France; Hop La Timone, Dept Med Genet, Marseille, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Hop Conception, Biol Cellulaire Lab, Marseille, France; NCI, Can & Dev Biol Lab, Frederick, MD 21702 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levy, N (corresponding author), Fac Med Timone, INSERM, U491, Marseille, France.		LEVY, Nicolas/J-1632-2014; amiel, jeanne/AGX-1124-2022; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/H-3501-2017; Cau, Pierre/M-3541-2016; De Sandre-Giovannoli, Annachiara/AAJ-6992-2020; Navarro, Claire/V-8774-2017; De Sandre-Giovannoli, Annachiara/L-5759-2016	LEVY, Nicolas/0000-0001-5171-6365; Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; De Sandre-Giovannoli, Annachiara/0000-0002-2324-2462; Navarro, Claire/0000-0001-9490-2643; De Sandre-Giovannoli, Annachiara/0000-0002-2324-2462	NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7	3	1000	1037	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2055	2055		10.1126/science.1084125	http://dx.doi.org/10.1126/science.1084125			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12702809				2022-12-01	WOS:000183774900035
J	Lee, N; Hui, D; Wu, A; Chan, P; Cameron, P; Joynt, GM; Ahuja, A; Yung, MY; Leung, CB; To, KF; Lui, SF; Szeto, CC; Chung, S; Sung, JJY				Lee, N; Hui, D; Wu, A; Chan, P; Cameron, P; Joynt, GM; Ahuja, A; Yung, MY; Leung, CB; To, KF; Lui, SF; Szeto, CC; Chung, S; Sung, JJY			A major outbreak of severe acute respiratory syndrome in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBLITERANS ORGANIZING PNEUMONIA; BRONCHIOLITIS	BACKGROUND There has been an outbreak of the severe acute respiratory syndrome (SARS) worldwide. We report the clinical, laboratory, and radiologic features of 138 cases of suspected SARS during a hospital outbreak in Hong Kong. METHODS From March 11 to 25, 2003, all patients with suspected SARS after exposure to an index patient or ward were admitted to the isolation wards of the Prince of Wales Hospital. Their demographic, clinical, laboratory, and radiologic characteristics were analyzed. Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed. RESULTS There were 66 male patients and 72 female patients in this cohort, 69 of whom were health care workers. The most common symptoms included fever (in 100 percent of the patients); chills, rigors, or both (73.2 percent); and myalgia (60.9 percent). Cough and headache were also reported in more than 50 percent of the patients. Other common findings were lymphopenia (in 69.6 percent), thrombocytopenia (44.8 percent), and elevated lactate dehydrogenase and creatine kinase levels (71.0 percent and 32.1 percent, respectively). Peripheral air-space consolidation was commonly observed on thoracic computed tomographic scanning. A total of 32 patients (23.2 percent) were admitted to the intensive care unit; 5 patients died, all of whom had coexisting conditions. In a multivariate analysis, the independent predictors of an adverse outcome were advanced age (odds ratio per decade of life, 1.80; 95 percent confidence interval, 1.16 to 2.81; P=0.009), a high peak lactate dehydrogenase level (odds ratio per 100 U per liter, 2.09; 95 percent confidence interval, 1.28 to 3.42; P=0.003), and an absolute neutrophil count that exceeded the upper limit of the normal range on presentation (odds ratio, 1.60; 95 percent confidence interval, 1.03 to 2.50; P=0.04). CONCLUSIONS SARS is a serious respiratory illness that led to significant morbidity and mortality in our cohort.	Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Emergency Med, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Anesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Diagnost Radiol & Organ Imaging, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sung, JJY (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Szeto, Cheuk Chun/N-4954-2015; Sung, Joseph J. Y./R-3203-2018; Ahuja, Anil T/H-4031-2017; Hui, David Shu-Cheong/O-2754-2015; Joynt, Gavin M/C-7606-2009; Lee, Nelson/B-6418-2008; Chan, Paul KS/J-9360-2013	Szeto, Cheuk Chun/0000-0002-8898-8505; Sung, Joseph J. Y./0000-0003-3125-5199; Ahuja, Anil T/0000-0002-0726-5402; Hui, David Shu-Cheong/0000-0003-4382-2445; Joynt, Gavin M/0000-0002-5823-3435; Lee, Nelson/0000-0002-0783-6607; Chan, Paul KS/0000-0002-6360-4608; Cameron, Peter/0000-0002-1443-557X				Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; *CDCP, UPD INT DOM INF CONT; Centers for Disease Control and Prevention, SEV AC RESP SYNDR SA; Epler GR, 2001, ARCH INTERN MED, V161, P158, DOI 10.1001/archinte.161.2.158; MULLER NL, 1990, AM J ROENTGENOL, V154, P983; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; *WHO, 2003, CUM NUMB REP CAS SAR; 2003, MMWR MORB MORTAL WKL, V52, P255; 2003, MMWR MORB MORTAL WKL, V52, P241	9	1568	1826	4	134	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1986	1994		10.1056/NEJMoa030685	http://dx.doi.org/10.1056/NEJMoa030685			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12682352	Bronze			2022-12-01	WOS:000182823400007
J	Crespo, M; Bosch, F; Villamor, N; Bellosillo, B; Colomer, D; Rozman, M; Marce, S; Lopez-Guillermo, A; Campo, E; Montserrat, E				Crespo, M; Bosch, F; Villamor, N; Bellosillo, B; Colomer, D; Rozman, M; Marce, S; Lopez-Guillermo, A; Campo, E; Montserrat, E			ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							70-KDA TYROSINE PHOSPHOPROTEIN; V-H GENES; CD38 EXPRESSION; GENOMIC ABERRATIONS; ZETA-CHAIN; B-CELLS; REPERTOIRE; PHENOTYPE; PATHOGENESIS; SURVIVAL	BACKGROUND: The mutational status of immunoglobulin heavy-chain variable-region (IgV(sub H)) genes in the leukemic cells of chronic lymphocytic leukemia (CLL) is an important prognostic factor in the disease. We investigated whether the expression of ZAP-70 by CLL cells correlated with the IgV(sub H) mutational status, disease progression, and survival. METHODS: The expression of ZAP-70 was analyzed in T-cell and B-cell lines and in peripheral-blood samples from 56 patients with CLL with the use of flow cytometry, Western blotting, and immunohistochemistry. The results were correlated with the IgV(sub H) mutational status and clinical outcome. RESULTS: ZAP-70 was detected by flow-cytometric analysis in cells of T-cell lineage and in leukemic cells from 32 of 56 patients with CLL. In all patients in whom at least 20 percent of the leukemic cells were positive for ZAP-70, IgV(sub H) was unmutated, whereas IgV(sub H) mutations were found in 21 of 24 patients in whom less than 20 percent of the leukemic cells were positive for ZAP-70 (P<0.001). Concordant results were obtained when ZAP-70 expression was assessed by immunohistochemistry or Western blotting. The level of ZAP-70 expression did not change over time (median, 37 months) in sequential samples from 30 patients with CLL. Patients with Binet stage A CLL who had at least 20 percent ZAP-70-positive leukemic cells had more rapid progression and poorer survival than those with less than 20 percent ZAP-70-positive cells. CONCLUSIONS: Among patients with CLL, expression of ZAP-70, as detected by flow-cytometric analysis, correlated with IgV(sub H) mutational status, disease progression, and survival.	Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Dept Hematol, E-08036 Barcelona, Spain; Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Hematopathol Unit, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, F (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Dept Hematol, Villarroel 170, E-08036 Barcelona, Spain.	fbosch@clinic.ub.es	MARCE, Silvia/J-6651-2017; COLOMER, DOLORS/ABG-6894-2020; Campo, Elias/AAC-5593-2019; Bosch, Francesc/AAE-7052-2019	MARCE, Silvia/0000-0001-9128-6822; Campo, Elias/0000-0001-9850-9793; Bosch, Francesc/0000-0001-9241-2886; Crespo, Marta/0000-0002-7732-7808; Rozman, Maria/0000-0002-2641-1110; COLOMER, DOLORS/0000-0001-7486-8484				Bellosillo B, 2002, BLOOD, V100, P1810, DOI 10.1182/blood-2001-12-0327; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; CAMPBELL MJ, 1992, MOL IMMUNOL, V29, P193, DOI 10.1016/0161-5890(92)90100-C; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; DEANE M, 1990, EUR J IMMUNOL, V20, P2209, DOI 10.1002/eji.1830201009; Del Poeta G, 2001, BLOOD, V98, P2633, DOI 10.1182/blood.V98.9.2633; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Hamblin BJ, 2000, BLOOD, V95, P2455, DOI 10.1182/blood.V95.7.2455.007a43c_2455_2457; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Ibrahim S, 2001, BLOOD, V98, P181, DOI 10.1182/blood.V98.1.181; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Lin K, 2002, BLOOD, V100, P2291; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montserrat Emili, 2002, Hematol J, V3, P7; Muller-Hermelink, 2001, PATHOLOGY GENETICS T, P168; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Oscier DG, 1997, BLOOD, V89, P4153, DOI 10.1182/blood.V89.11.4153; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; ROZMAN C, 1995, NEW ENGL J MED, V333, P1515; SCHROEDER HW, 1994, IMMUNOL TODAY, V15, P288, DOI 10.1016/0167-5699(94)90009-4; *SPSS, 1999, SPSS ADV STAT VERS 1; Stilgenbauer S, 2002, LEUKEMIA, V16, P993, DOI 10.1038/sj.leu.2402537; VIVIER E, 1993, EUR J IMMUNOL, V23, P1872, DOI 10.1002/eji.1830230821; ZWEIG MH, 1993, CLIN CHEM, V39, P1589	35	1017	1065	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1764	1775		10.1056/NEJMoa023143	http://dx.doi.org/10.1056/NEJMoa023143			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724482				2022-12-01	WOS:000182543500005
J	Hirotsune, S; Yoshida, N; Chen, A; Garrett, L; Sugiyama, F; Takahashi, S; Yagami, K; Wynshaw-Boris, A; Yoshiki, A				Hirotsune, S; Yoshida, N; Chen, A; Garrett, L; Sugiyama, F; Takahashi, S; Yagami, K; Wynshaw-Boris, A; Yoshiki, A			An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene	NATURE			English	Article								A pseudogene is a gene copy that does not produce a functional, full-length protein(1). The human genome is estimated to contain up to 20,000 pseudogenes(2,3). Although much effort has been devoted to understanding the function of pseudogenes, their biological roles remain largely unknown. Here we report the role of an expressed pseudogene-regulation of messenger-RNA stability-in a transgene-insertion mouse mutant exhibiting polycystic kidneys and bone deformity. The transgene was integrated into the vicinity of the expressing pseudogene of Makorin1, called Makorin1-p1. This insertion reduced transcription of Makorin1-p1, resulting in destabilization of Makorin1 mRNA in trans by way of a cis-acting RNA decay element within the 5' region of Makorin1 that is homologous between Makorin1 and Makorin1-p1. Either Makorin1 or Makorin1-p1 transgenes could rescue these phenotypes. Our findings demonstrate a specific regulatory role of an expressed pseudogene, and point to the functional significance of non-coding RNAs.	Saitama Med Sch, Res Ctr Genom Med, Div Neurosci, Hidaka, Saitama 3501241, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama, Japan; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; Univ Calif San Diego, Sch Med, Ctr Canc, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, Dept Med, La Jolla, CA 92093 USA; RIKEN Tsukuba Inst, Bioresource Ctr, Dept Biol Syst, Expt Anim Div, Tsukuba, Ibaraki 3050074, Japan	Saitama Medical University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Tsukuba; University of Tsukuba; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Hirotsune, S (corresponding author), Saitama Med Sch, Res Ctr Genom Med, Div Neurosci, Yamane 1397-1, Hidaka, Saitama 3501241, Japan.		Yoshiki, Atsushi/O-6162-2019	Yoshiki, Atsushi/0000-0002-9450-5151				Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GRAY TA, 2000, GENOMICS, V25, P14430; Greally JM, 1999, P NATL ACAD SCI USA, V96, P14430, DOI 10.1073/pnas.96.25.14430; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Nagai Y, 1998, J BONE MINER RES, V13, P664, DOI 10.1359/jbmr.1998.13.4.664; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253	8	320	354	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					91	96		10.1038/nature01535	http://dx.doi.org/10.1038/nature01535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721631				2022-12-01	WOS:000182561600045
J	Selker, EU; Tountas, NA; Cross, SH; Margolin, BS; Murphy, JG; Bird, AP; Freitag, M				Selker, EU; Tountas, NA; Cross, SH; Margolin, BS; Murphy, JG; Bird, AP; Freitag, M			The methylated component of the Neurospora crassa genome	NATURE			English	Article							INDUCED POINT MUTATION; DNA METHYLATION; CYTOSINE METHYLATION; GENE; TRANSPOSONS; ELEMENT; RETROTRANSPOSON; PROTEIN; ISLANDS; REGION	Cytosine methylation is common, but not ubiquitous, in eukaryotes. Mammals(1) and the fungus Neurospora crassa(2,3) have about 2-3% of cytosines methylated. In mammals, methylation is almost exclusively in the under-represented CpG dinucleotides, and most CpGs are methylated(1) whereas in Neurospora, methylation is not preferentially in CpG dinucleotides and the bulk of the genome is unmethylated(4). DNA methylation is essential in mammals(5) but is dispensable in Neurospora(3,6), making this simple eukaryote a favoured organism in which to study methylation. Recent studies indicate that DNA methylation in Neurospora depends on one DNA methyltransferase, DIM-2 (ref. 6), directed by a histone H3 methyltransferase, DIM-5 (ref. 7), but little is known about its cellular and evolutionary functions. As only four methylated sequences have been reported previously in N. crassa, we used methyl-binding-domain agarose chromatography(8) to isolate the methylated component of the genome. DNA sequence analysis shows that the methylated component of the genome consists almost exclusively of relics of transposons that were subject to repeat-induced point mutation-a genome defence system that mutates duplicated sequences(9).	Univ Oregon, Dept Biol, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Oregon; University of Oregon; University of Edinburgh	Selker, EU (corresponding author), Univ Oregon, Dept Biol, Eugene, OR 97403 USA.		Murphy, Jonathan/AAD-6655-2019	Murphy, Jonathan/0000-0001-6485-5727; Cross, Sally/0000-0001-6518-6449; Bird, Adrian/0000-0002-8600-0372				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bibbins M, 1998, MOL GEN GENET, V258, P431, DOI 10.1007/s004380050752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; CAMBARERI EB, 1994, MOL GEN GENET, V242, P658, DOI 10.1007/BF00283420; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Foss HM, 1998, MOL GEN GENET, V259, P60, DOI 10.1007/s004380050789; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; KRUMLAUF R, 1980, J BIOL CHEM, V255, P1138; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Margolin BS, 1998, GENETICS, V149, P1787; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; METZENBERG RL, 1985, P NATL ACAD SCI USA, V82, P2067, DOI 10.1073/pnas.82.7.2067; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; RUSSELL PJ, 1985, MOL GENETICS FILAMEN, P321; SELKER EU, 1993, SCIENCE, V262, P1724, DOI 10.1126/science.8259516; Selker EU, 2002, ADV GENET, V46, P439; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhou Y, 2001, MOL GENET GENOMICS, V265, P748, DOI 10.1007/s004380100472	30	170	181	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					893	897		10.1038/nature01564	http://dx.doi.org/10.1038/nature01564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712205	Green Published			2022-12-01	WOS:000182432600055
J	Selevan, SG; Rice, DC; Hogan, KA; Euling, SY; Pfahles-Hutchens, A; Bethel, J				Selevan, SG; Rice, DC; Hogan, KA; Euling, SY; Pfahles-Hutchens, A; Bethel, J			Blood lead concentration and delayed puberty in girls	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ETHNIC-DIFFERENCES; POSTMENARCHEAL PERIOD; AFRICAN-AMERICAN; GROWTH; EXPOSURE; RAT; MATURATION; MENARCHE	BACKGROUND: Environmental lead exposure has been linked to alterations in growth and endocrine function. It is not known whether such exposure affects pubertal development. METHODS: We analyzed the relations between blood lead concentration and pubertal development among girls (defined as females 8 to 18 years of age) who were enrolled in a cross-sectional study (the third National Health and Nutrition Examination Survey) in which race was self-reported or proxy-reported: 600 were non-Hispanic white, 805 were non-Hispanic African-American, and 781 were Mexican-American girls. Puberty was measured on the basis of the age at menarche and Tanner stage for pubic-hair and breast development. RESULTS: Geometric mean lead concentrations were less than 3 microg per deciliter (0.144 micromol per liter) in all three groups. As compared with concentrations of 1 microg per deciliter (0.048 micromol per liter), lead concentrations of 3 microg per deciliter were associated with decreased height (P<0.001), after adjustment for age, race, and other factors, but not with body-mass index or weight. Blood lead concentrations of 3 microg per deciliter were associated with significant delays in breast and pubic-hair development in African-American and Mexican-American girls. The delays were most marked among African-American girls; in this group, the delays in reaching Tanner stages 2, 3, 4, and 5 associated with a lead concentration of 3 microg per deciliter as compared with 1 microg per deciliter were 3.8, 5.3, 5.8, and 2.1 months, respectively, for breast development and 4.0, 5.5, 6.0, and 2.2 months, respectively, for pubic-hair development; the associated delay in age at menarche was 3.6 months. In white girls, there were nonsignificant delays in all pubertal measures in association with a lead concentration of 3 microg per deciliter. CONCLUSIONS: These data suggest that environmental exposure to lead may delay growth and pubertal development in girls, although confirmation is warranted in prospective studies.	US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Washington, DC 20460 USA; US EPA, Off Pollut Prevent Pesticides & Tox Subst, Washington, DC 20460 USA; WESTAT Corp, Rockville, MD 20850 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; Westat	Selevan, SG (corresponding author), US EPA, Natl Ctr Environm Assessment, Off Res & Dev, 8623D, Washington, DC 20460 USA.							Agency for Toxic Substances and Disease Registry, 1999, TOX PROF LEAD; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P1; Ballew C, 1999, J PEDIATR-US, V134, P623, DOI 10.1016/S0022-3476(99)70250-7; BELLINGER D, 1991, ENVIRON RES, V54, P151, DOI 10.1016/S0013-9351(05)80097-0; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Blanck HM, 2000, EPIDEMIOLOGY, V11, P641, DOI 10.1097/00001648-200011000-00005; *CDC, 1991, PREV LEAD POIS YOUNG; Dearth RK, 2002, REPROD TOXICOL, V16, P343, DOI 10.1016/S0890-6238(02)00037-0; Den Hond E, 2002, ENVIRON HEALTH PERSP, V110, P771, DOI 10.1289/ehp.02110771; *ENV PROT AG, 1997, EXP FACT HDB, V1, P4; FRISANCHO AR, 1991, AM J CLIN NUTR, V54, P516, DOI 10.1093/ajcn/54.3.516; Harlow SD, 1997, AM J EPIDEMIOL, V146, P572; Harlow SD, 1996, AM J EPIDEMIOL, V144, P980; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Kim D, 2000, BRAIN BEHAV IMMUN, V14, P305, DOI 10.1006/brbi.2000.0609; KIMMEL CA, 1980, TOXICOL APPL PHARM, V56, P28, DOI 10.1016/0041-008X(80)90129-5; Krstevska-Konstantinova M, 2001, HUM REPROD, V16, P1020, DOI 10.1093/humrep/16.5.1020; Magarey AM, 1999, ACTA PAEDIATR, V88, P139, DOI 10.1080/08035259950170286; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Mood AM., 1950, INTRO THEORY STAT; *NAT HLTH NUTR EX, 1997, NHANE 3 SERIES 1A, V2; National Center for Health Statistics, 1994, VIT HLTH STAT, V94-1308; PATTERSON CC, 1983, LEAD VERSUS HLTH, P17; POUNDS JG, 1991, ENVIRON HEALTH PERSP, V91, P17, DOI 10.2307/3430978; Prikle JL, 1994, JAMA-J AM MED ASSOC, V272, P284; Ronis MJJ, 1998, J TOXICOL ENV HEAL A, V54, P101, DOI 10.1080/009841098158944; Ronis MJJ, 1998, J TOXICOL ENV HEAL A, V53, P327, DOI 10.1080/009841098159312; Ronis MJJ, 1998, J TOXICOL ENV HEAL A, V54, P77, DOI 10.1080/009841098158935; RUBIN K, 1993, J PEDIATR-US, V123, P863, DOI 10.1016/S0022-3476(05)80381-6; Russell DL, 2001, J PEDIATR-US, V139, P844, DOI 10.1067/mpd.2001.119446; SCHWARTZ J, 1986, PEDIATRICS, V77, P281; SELVIN S, 1991, STAT ANAL EPIDEMIOLO; SHUKLA R, 1991, PEDIATRICS, V88, P886; Vizmanos B, 2000, EUR J CLIN NUTR, V54, P203, DOI 10.1038/sj.ejcn.1600920; Wattigney Wendy A., 1999, Ethnicity and Disease, V9, P181; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; Yanovski JA, 2000, J CLIN ENDOCR METAB, V85, P2660, DOI 10.1210/jc.85.8.2660	38	185	190	0	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1527	1536		10.1056/NEJMoa020880	http://dx.doi.org/10.1056/NEJMoa020880			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700372				2022-12-01	WOS:000182248900003
J	Kagey, MH; Melhuish, TA; Wotton, D				Kagey, MH; Melhuish, TA; Wotton, D			The polycomb protein Pc2 is a SUMO E3	CELL			English	Article							UBIQUITIN-LIKE PROTEIN; HISTONE METHYLTRANSFERASE ACTIVITY; TRITHORAX GROUP PROTEINS; CELLULAR PHOSPHOPROTEIN; PROMYELOCYTIC LEUKEMIA; MULTIPROTEIN COMPLEX; NEGATIVE MODULATION; CONJUGATING ENZYME; NUCLEAR-BODIES; HUMAN HOMOLOG	Polycomb group (PcG) proteins form large multimeric complexes (PcG bodies) which are involved in the stable repression of gene expression. The human PcG protein, Pc2, has been shown to recruit the transcriptional corepressor, CtBP, to PcG bodies. We show that CtBP is sumoylated at a single lysine. In vitro, CtBP sumoylation minimally requires the SUMO E1 and E2 (Ubc9) and SUMO-1. However, Pc2 dramatically enhances CtBP sumoylation. In vivo, this is likely due to the ability of Pc2 to recruit both CtBP and Ubc9 to PcG bodies, thereby bringing together substrate and E2, and stimulating the transfer of SUMO to CtBP. These results demonstrate that Pc2 is a SUMO E3, and suggest that PcG bodies may be sumoylation centers.	Univ Virginia, Ctr Cell Signaling, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Wotton, D (corresponding author), Univ Virginia, Ctr Cell Signaling, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	dw2p@virginia.edu		Wotton, David/0000-0002-4652-5350	NICHD NIH HHS [HD 39926] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boddy MN, 1996, ONCOGENE, V13, P971; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; Gunster MJ, 2001, J CELL BIOCHEM, P129, DOI 10.1002/jcb.1093; Gunster MJ, 1997, MOL CELL BIOL, V17, P2326, DOI 10.1128/MCB.17.4.2326; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; Mannen H, 1996, BIOCHEM BIOPH RES CO, V222, P178, DOI 10.1006/bbrc.1996.0717; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mayer RJ, 1998, FOLD DES, V3, pR97, DOI 10.1016/S1359-0278(98)00047-9; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; MULLER J, 1995, EMBO J, V14, P1209, DOI 10.1002/j.1460-2075.1995.tb07104.x; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Okura T, 1996, J IMMUNOL, V157, P4277; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Poux S, 2001, DEVELOPMENT, V128, P75; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209	71	442	465	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					127	137		10.1016/S0092-8674(03)00159-4	http://dx.doi.org/10.1016/S0092-8674(03)00159-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679040	Bronze			2022-12-01	WOS:000182282900012
J	Gao, KQ; Shubin, NH				Gao, KQ; Shubin, NH			Earliest known crown-group salamanders	NATURE			English	Article								Salamanders are a model system for studying the rates and patterns of the evolution of new anatomical structures(1-4). Recent discoveries of abundant Late Jurassic and Early Cretaceous salamanders are helping to address these issues(5-8). Here we report the discovery of well-preserved Middle Jurassic salamanders from China, which constitutes the earliest known record of crown-group urodeles (living salamanders and their closest relatives). The new specimens are from the volcanic deposits of the Jiulongshan Formation (Bathonian)(9-13), Inner Mongolia, China, and represent basal members of the Cryptobranchidae, a family that includes the endangered Asian giant salamander (Andrias) and the North American hellbender (Cryptobranchus). These fossils document a Mesozoic record of the Cryptobranchidae, predating the previous record of the group by some 100 million years(14-17). This discovery provides evidence to support the hypothesis that the divergence of the Cryptobranchidae from the Hynobiidae had taken place in Asia before the Middle Jurassic period.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China	University of Chicago; Peking University	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 E 57th St, Chicago, IL 60637 USA.							Dong Zhiming, 1998, Vertebrata Palasiatica, V36, P159; Duellman W. E., 1994, BIOL AMPHIBIANS; Estes R., 1981, HDB PALAOHERPETOLO 2; Evans SE, 1996, PHILOS T R SOC B, V351, P627, DOI 10.1098/rstb.1996.0061; EVANS SE, 1988, GEOBIOS-LYON, V21, P539, DOI 10.1016/S0016-6995(88)80069-X; GAO K, 1998, GEOL CHINA, V248, P40; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; GUBIN YM, 1991, PALEONTOLOG J, P91; HARLAND BW, 1990, GEOLOGIC TIME SCALE; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; [季强 Ji Qiang], 2002, [地质论评, Geological Review], V48, P221; KRZEMISKI W, 2002, POL PIS ENTOMOL, V71, P127; Larson Allan, 1993, Herpetological Monographs, V7, P77, DOI 10.2307/1466953; Milner A. R., 1983, EVOLUTION TIME SPACE, P431; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; NAYLOR BG, 1981, COPEIA, P76, DOI 10.2307/1444042; NESSOV L A, 1988, Acta Zoologica Cracoviensia, V31, P475; Nessov LA, 1996, VESTNIK SANKT PETERS, V7, P3; REN D, 2002, STUTTGART BEIT NAT B, V33, P1; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Scotese CR., 2001, ATLAS EARTH HIST, V1; SHUBIN N, 1995, EVOLUTION, V49, P874, DOI 10.1111/j.1558-5646.1995.tb02323.x; Shubin N, 1996, AM ZOOL, V36, P51; VENCZEL M, 1987, 3 WORLD C HERP, P218; WAKE DB, 1987, SCIENCE, V238, P42, DOI 10.1126/science.238.4823.42; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; Wang S. E., 2000, STRATIGRAPHICAL LEXI; Wang Yuan, 2000, Vertebrata Palasiatica, V38, P100	29	237	276	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					424	428		10.1038/nature01491	http://dx.doi.org/10.1038/nature01491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660782	Green Published			2022-12-01	WOS:000181801200043
J	Oppo, DW; McManus, JF; Cullen, JL				Oppo, DW; McManus, JF; Cullen, JL			Palaeo-oceanography: Deepwater variability in the Holocene epoch	NATURE			English	Article							NORTH-ATLANTIC CLIMATE; CIRCULATION		Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02540 USA; Salem State Coll, Dept Geol Sci, Salem, MA 01970 USA	Woods Hole Oceanographic Institution; Massachusetts System of Public Higher Education; Salem State University	Oppo, DW (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02540 USA.	doppo@whoi.edu						Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Chapman MR, 2000, HOLOCENE, V10, P287, DOI 10.1191/095968300671253196; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; Keigwin LD, 2000, P NATL ACAD SCI USA, V97, P1343, DOI 10.1073/pnas.97.4.1343; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; STUIVER M, 1993, RADIOCARBON, V35, P137	13	197	204	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					277	278		10.1038/422277b	http://dx.doi.org/10.1038/422277b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646912				2022-12-01	WOS:000181637300030
J	Itoh, Y; Kawamata, Y; Harada, M; Kobayashi, M; Fujii, R; Fukusumi, S; Ogi, K; Hosoya, M; Tanaka, Y; Uejima, H; Tanaka, H; Maruyama, M; Satoh, R; Okubo, S; Kizawa, H; Komatsu, H; Matsumura, F; Noguchi, Y; Shinobara, T; Hinuma, S; Fujisawa, Y; Fujino, M				Itoh, Y; Kawamata, Y; Harada, M; Kobayashi, M; Fujii, R; Fukusumi, S; Ogi, K; Hosoya, M; Tanaka, Y; Uejima, H; Tanaka, H; Maruyama, M; Satoh, R; Okubo, S; Kizawa, H; Komatsu, H; Matsumura, F; Noguchi, Y; Shinobara, T; Hinuma, S; Fujisawa, Y; Fujino, M			Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40	NATURE			English	Article							SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; RECEPTOR; GLUCOSE; RAT; EXPRESSION; SUBTYPE	Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue(1,2). Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion(3). Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion(4,5). Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood(6). Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.	Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan	Takeda Chemical Industries	Hinuma, S (corresponding author), Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.			Kawamata, Yuji/0000-0001-5652-4899; Maruyama, Minoru/0000-0002-1478-9415; Komatsu, Hidetoshi/0000-0003-1630-0537				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; BRAUN T, 1987, BIOCHEM BIOPH RES CO, V149, P125, DOI 10.1016/0006-291X(87)91613-5; BRISCOE CP, 2002, J BIOL CHEM     1219; BRUNO JF, 1993, ENDOCRINOLOGY, V133, P2561, DOI 10.1210/en.133.6.2561; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Gadsby R, 2002, ADV DRUG DELIVER REV, V54, P1165, DOI 10.1016/S0169-409X(02)00094-7; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hinuma S, 1999, J MOL MED, V77, P495, DOI 10.1007/s001090050403; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Jovanovic L, 1999, ANN CLIN LAB SCI, V29, P33; KAWAMATA Y, 2003, J BIOL CHEM     0110; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LANKATBUTTGEREIT B, 1994, EXP CLIN ENDOCRINOL, V102, P341, DOI 10.1055/s-0029-1211301; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nunez EA, 1997, PROSTAG LEUKOTR ESS, V57, P107, DOI 10.1016/S0952-3278(97)90500-7; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; SPECTOR AA, 1975, SCIENCE, V190, P490, DOI 10.1126/science.1166323; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WOLHEIM CB, 1986, ANN NY ACAD SCI, V488, P317	26	1176	1295	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					173	176		10.1038/nature01478	http://dx.doi.org/10.1038/nature01478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12629551				2022-12-01	WOS:000181488900047
J	Milner-Gulland, EJ; Bukreevea, OM; Coulson, T; Lushchekina, AA; Kholodova, MV; Bekenov, AB; Grachev, IA				Milner-Gulland, EJ; Bukreevea, OM; Coulson, T; Lushchekina, AA; Kholodova, MV; Bekenov, AB; Grachev, IA			Conservation - Reproductive collapse in saiga antelope harems	NATURE			English	Article							POPULATIONS; DYNAMICS		Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, London SW7 2AZ, England; Dept Hunting Management, Elista 358000, Republic Kalmyk, Russia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; AN Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; Minist Educ, Inst Zool, Almaty 480032, Kazakhstan	Imperial College London; University of Cambridge; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Institute of Zoology in Kazakhstan	Milner-Gulland, EJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, S Kensington Campus, London SW7 2AZ, England.		Coulson, Tim/AAL-8148-2021; Grachev, Yuriy/AAY-9102-2020; Lushchekina, Anna/C-3945-2014; Kholodova, Marina/V-3628-2019	Coulson, Tim/0000-0001-9371-9003; Lushchekina, Anna/0000-0003-1915-7430; grachev, yuriy/0000-0003-3311-2079; Milner-Gulland, E.J./0000-0003-0324-2710				Bekenov AB, 1998, MAMMAL REV, V28, P1, DOI 10.1046/j.1365-2907.1998.281024.x; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Hudson RJ., 1993, FARMING WAPITI RED D; Milner-Gulland EJ, 2001, ORYX, V35, P340, DOI 10.1017/S0030605300032105; MILNERGULLAND EJ, 1995, NATURE, V377, P488, DOI 10.1038/377488a0; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Robinson Sarah., 2000, PASTORALISM LAND DEG; Sharp R, 2002, ORYX, V36, P323, DOI 10.1017/S0030605302000625; Sokolov V. E., 1998, SAIGA FILOGENY TAXON; [No title captured]	10	177	189	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					135	135		10.1038/422135a	http://dx.doi.org/10.1038/422135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634775				2022-12-01	WOS:000181488900034
J	Parish, WL; Laumann, EO; Cohen, MS; Pan, SM; Zheng, HY; Hoffman, I; Wang, TF; Ng, KH				Parish, WL; Laumann, EO; Cohen, MS; Pan, SM; Zheng, HY; Hoffman, I; Wang, TF; Ng, KH			Population-based study of chlamydial infection in China - A hidden epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; REPUBLIC-OF-CHINA; TRACHOMATIS INFECTIONS; UNITED-STATES; RISK-FACTORS; SEX WORKERS; PREVALENCE; HIV; AIDS; WOMEN	Context Sexually transmitted diseases are increasing rapidly in China. Surveillance data imperfectly indicate current prevalence and risk factors, Objectives To estimate the prevalence of genital chlamydial and gonococcal infections and to describe patterns of infection by subgroup and behavioral patterns. Design, Setting, and Participants A national stratified probability sample of 3426 Chinese individuals (1738 women and 1688 men) aged 20 to 64 years, who were interviewed between August 1999 and August 2000, completed a computer-administered survey, and provided a urine specimen (69% total participation rate). Main Outcome Measure Positive-test result for chlamydial or gonococcal infections. Results The overall prevalence per 100 population of chlamydial infection was 2.6 (95% confidence interval [CI], 1.6-4.1) for women and 2.1 (95% CI, 1.3-3.3) for men. For gonococcal infection, the overall prevalence per 100 population was 0.08 (95% CI, 0.02-0.4) for women and 0.02 (95% CI, 0.005-0.1) for men. Risk factors for chlamydial infection among men aged 20 to 44 years were unprotected sex with a commercial sex worker (odds ratio [OR], 8.24; 95% CI, 3.51-19.35), less education (OR, 7.20; 95% CI, 2.31-22.37), and recent sex with their spouse or other steady partner (OR, 7.73; 95% CI, 2.70-22.10). Among women aged 20 to 44 years, risk factors for chlamydial infection were having less education (OR, 2.82; 95% CI, 1.01-7.91) and living in a city (OR, 3.46; 95% CI, 1.67-7.18) or along the southern coast (OR, 2.16; 95% CI, 1.29-3.63) and having a spouse or other steady sexual partner who earned a high income (OR, 2.85; 95% CI, 1.11-7.29), who socialized often (OR, 2.79; 95% CI, 1.08-7.19), or who traveled less than 1 week per year (OR, 5.40; 95% CI, 1.44-20.3). Conclusions The prevalence of chlamydial infection in China is substantial. The patterns of infection suggest potential avenues for intervention.	Univ Chicago, Natl Opin Res Ctr, Populat Res Ctr, Chicago, IL 60637 USA; Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; Renmin Univ, Sociol Sexual Inst, Beijing, Peoples R China; Peking Union Med Coll, Dermatol Venerol Div, Beijing, Peoples R China	University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Renmin University of China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Parish, WL (corresponding author), 1126 E 59th St, Chicago, IL 60637 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD018288, R01HD034157] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U19AI031496] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW01039] Funding Source: Medline; NIAID NIH HHS [P30 AI50410, U19 AI31496] Funding Source: Medline; NICHD NIH HHS [R01 HD34157, P30 HD18288] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALI MM, 2001, AIDS BEHAV, V5, P343, DOI DOI 10.1023/A:1013186806939; Belsley D. A., 2005, REGRESSION DIAGNOSTI; CARAEL M, 1995, SEXUAL BEHAV AIDS DE; *CDCP, 2003, CHLM US; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Cheng YM, 2002, CONTRACEPTION, V66, P179, DOI 10.1016/S0010-7824(02)00350-5; *CHIN CTR DIS CONT, YEAR 2001 NAT SEX TR; *CHIN NAT CENS OFF, 1997, 1995 NAT 1 PERC POP; Chinese Population Census Office under the State Council and Department of Population Social Science and Technology Statistics of the National Bureau of Statistics of China, 2002, TAB 2000 POP CENS PE; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; DOLCINI MM, 2000, AIDS BEHAV, V4, P297; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Fonck K, 2000, SEX TRANSM DIS, V27, P417, DOI 10.1097/00007435-200008000-00007; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Gielen A, 2001, AIDS BEHAV, V5, P193; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Hee Choi Kyung, 2000, AIDS BEHAV, V4, P111; Hershatter Gail, 1997, DANGEROUS PLEASURES; Howell MR, 1998, ANN INTERN MED, V128, P277, DOI 10.7326/0003-4819-128-4-199802150-00005; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; Klouman E, 2002, INT J STD AIDS, V13, P234, DOI 10.1258/0956462021925027; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Laumann E.O., 2000, SOCIAL ORG SEXUALITY; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lim L. L., 1998, SEX SECTOR EC SOCIAL; Long J. S., 1997, REGRESSION MODELS CA, V7, P34; Morre SA, 1999, J CLIN MICROBIOL, V37, P3092; PARISH WL, 2003, CHINESE HLTH FAMILY; Paxton LA, 1998, SEX TRANSM INFECT, V74, P421, DOI 10.1136/sti.74.6.421; Pierpoint T, 2000, SEX TRANSM INFECT, V76, P273, DOI 10.1136/sti.76.4.273; Plafker T, 2001, BRIT MED J, V323, P714, DOI 10.1136/bmj.323.7315.714; Pulerwitz J, 2001, AM J PUBLIC HEALTH, V91, P1650, DOI 10.2105/AJPH.91.10.1650; Radcliffe KW, 2001, SEX TRANSM INFECT, V77, P265, DOI 10.1136/sti.77.4.265; Skinner C, 1989, ANAL COMPLEX SURVEYS; Solomon S, 1998, INT J STD AIDS, V9, P98, DOI 10.1258/0956462981921756; *STAT STAT BUR, 1999, CHIN POP STAT YB 199; *STATA CORP, 2001, STATA REF MAN REL 7, V4; SUN S, 2002, CHINA DAILY     0309; Tarantola DJM, 2001, AIDS PATIENT CARE ST, V15, P439, DOI 10.1089/108729101316914476; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; *UNAIDS CHIN OFF, OBS CHIN YEAR 2000 A; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Van Duynhoven YTHP, 1997, INT J EPIDEMIOL, V26, P1373, DOI 10.1093/ije/26.6.1373; van Valkengoed IGM, 2000, SEX TRANSM INFECT, V76, P375, DOI 10.1136/sti.76.5.375; Wang JC, 2001, SEX TRANSM DIS, V28, P171, DOI 10.1097/00007435-200103000-00009; WEN C, NO CONDOMS PLEASE CH; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZHANG L, 2000, REDRAWING BOUNDARIES, P171; [No title captured]	52	213	224	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1265	1273		10.1001/jama.289.10.1265	http://dx.doi.org/10.1001/jama.289.10.1265			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633188	Bronze			2022-12-01	WOS:000181466500028
J	Ford, N; Cantau, N; Jeanmart, H				Ford, N; Cantau, N; Jeanmart, H			Homelessness and hardship in Moscow	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England; Med Sans Frontieres, Moscow 12310, Russia	Doctors Without Borders; Doctors Without Borders	Cantau, N (corresponding author), Med Sans Frontieres, Shmitovskij Proezd Dom 3, Moscow 12310, Russia.							WHO, 2002, GLOB TUB CONTR	1	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					875	875		10.1016/S0140-6736(03)12717-1	http://dx.doi.org/10.1016/S0140-6736(03)12717-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642069				2022-12-01	WOS:000181466600030
J	Tomasz, A				Tomasz, A			"Intelligence coup" for drug designers: crystal structure of Staphylococcus aureus beta-lactam resistance protein PBP2A	LANCET			English	Editorial Material							BINDING		Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Rockefeller University	Tomasz, A (corresponding author), Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA.	tomasz@mail.rockefeller.edu	Tomasz, Alexander/B-9939-2011	Tomasz, Alexander/0000-0003-1520-1983				Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; *PUBL HLTH DISP, 2002, MMWR-MORBID MORTAL W, V51, P902; Sieradzki K, 1999, NEW ENGL J MED, V340, P517, DOI 10.1056/NEJM199902183400704; Toney JH, 1998, ANAL BIOCHEM, V255, P113, DOI 10.1006/abio.1997.2458; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001	13	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2003	361	9360					795	796		10.1016/S0140-6736(03)12719-5	http://dx.doi.org/10.1016/S0140-6736(03)12719-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642041				2022-12-01	WOS:000181466600003
J	Foster, SE; Vaughan, RD; Foster, WH; Califano, JA				Foster, SE; Vaughan, RD; Foster, WH; Califano, JA			Alcohol consumption and expenditures for underage drinking and adult excessive drinking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RELATIVE RISK; DRIVER AGE; PREVALENCE; YOUTH; IMPACT	Context Although estimates of the amount and proportion of alcohol consumed by underage and adult drinkers have been reported, more accurate estimates are possible and the economic impact has not been explored. Objectives To provide accurate estimates of underage and adult excessive drinking and to describe consumer expenditures linked to underage and adult excessive drinking. Design and Setting Information was obtained from national data sets, including 1999 versions of the National Household Survey of Drug Abuse, the Youth Risk Behavior Survey (YRBS), the Behavior Risk Factor Surveillance System (BRFSS), 2000 US Census, and national data on consumption and consumer expenditures for alcohol, published by Adams Business Research. Participants A total of 217192 persons aged 12 years or older across 3 data sources. Main Outcome Measures Amount as a proportion of total alcohol consumed and proportion of consumer expenditures on alcohol among underage (12-20 years) and adult excessive (greater than or equal to21 years) drinkers. Results The proportion of 12- to 20-year-olds who drink was estimated to be 50.0% using data from the YRBS; the proportion of adults aged 21 or older who drink was estimated to be 52.8% using data from the BRFSS. The estimated total number of drinks consumed per month was 4.21 billion; underage drinkers consumed 19.7% of this total. The amount of adult drinking that was excessive (>2 drinks per day) was 30.4%. Consumer expenditure on alcohol in the United States in 1999 was $116.2 billion; of that, $22.5 billion was attributed to underage drinking and $34.4 billion was attributed to adult excessive drinking. Conclusion These data Suggest that underage drinkers and adult excessive drinkers are responsible for 50.1% of alcohol consumption and, 48.9% of consumer expenditure.	Columbia Univ, Natl Ctr Addict & Subst Abuse, New York, NY 10017 USA; Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA; Columbia Univ, Dept Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University	Foster, SE (corresponding author), Columbia Univ, Natl Ctr Addict & Subst Abuse, 633 3rd Ave, New York, NY 10017 USA.							*AD BUS RES, 2001, AD BEER HDB; *AD BUS RES, 2001, AD LIQ HDB; *AD BUS RES, 2001, AD WIN HDB; [Anonymous], 2000, ALCOHOL RES HEALTH, V24, P5; *CDCP, 1999, BEH RISK FACT SURV S; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P969; Center for Disease Control and Prevention, 1999, YOUTH RISK BEH SURV; Center on Alcohol Marketing and Youth, 2002, OV YOUTH TARG ALC AD; COOK PJ, 1984, ALCOHOLISM RELATED P, P56; Cowan CD, 2001, J DRUG ISSUES, V31, P599, DOI 10.1177/002204260103100302; *CTR SCI PUBL INT, 1996, STAT ALC TAX HLTH CI; *CTR SCI PUBL INT, 1996, AD RESP TEL BEER ADV; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; EIGEN LD, 1996, DRINK AG 21 PROBL SO; EMBREE BG, 1993, J STUD ALCOHOL, V54, P334, DOI 10.15288/jsa.1993.54.334; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Fendrich M, 2001, J DRUG ISSUES, V31, P615, DOI 10.1177/002204260103100303; Fowler FJ, 2001, J DRUG ISSUES, V31, P643, DOI 10.1177/002204260103100304; Gerstein D, 1981, ALCOHOL PUBLIC POLIC, P182; Gfroerer J, 1997, DRUG ALCOHOL DEPEN, V47, P19, DOI 10.1016/S0376-8716(97)00063-X; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78; GRUNBAUM JA, 2002, MMWR-MORBID MORTAL W, V51, P62; Harrison LD, 2001, J DRUG ISSUES, V31, P665, DOI 10.1177/002204260103100305; Hingson RW, 1999, ALCOHOL RES HEALTH, V23, P31; Jacobson JL, 1999, ALCOHOL RES HEALTH, V23, P25; JOHNSTON LD, 2000, MONITORING FUTURE CO; LAIXUTHAI A, 1993, CONTEMP POLICY ISSUE, V11, P70, DOI 10.1111/j.1465-7287.1993.tb00402.x; LEVY DT, 1999, COSTS UNDERAGE DRINK; *NAT CTR ADD SUBST, 2002, TEEN TIPPL AM UND DR; *NAT CTR ADD SUBST, 1998, BARS SUBST AB AM PRI; *NAT I ALC AB ALC, 2002, FAQS ALC AB ALC; *NAT I ALC AB ALC, 2000, C ALC HLTH HIGHL CUR; *OFF APPL STUD, 2001, NAT HOUS SURV DRUG A; *PAC I RES EV, 1999, REG STRAT PREV YOUTH; *PAC I RES EV, 1999, STRAT RED UND ALC US; Rogers JD, 1999, J STUD ALCOHOL, V60, P732, DOI 10.15288/jsa.1999.60.732; Schuman H., 1981, QUESTIONS ANSWERS AT; *SUBST AB MENT HLT, 1999, NAT HOUS SURV DRUG A; *SUBST AB MENT HLT, 2002, STAT SUBST AB MENT H; *US DEP COMM, 2002, PROF GEN DEM CHAR; *US DEP HHS, 2002, RES 2001 NAT HOUS SU, V1; *USDA, 2000, NUTR YOUR HLTH DIET; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	46	67	69	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					989	995		10.1001/jama.289.8.989	http://dx.doi.org/10.1001/jama.289.8.989			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597750	Bronze			2022-12-01	WOS:000181129800024
J	Kim, UK; Jorgenson, E; Coon, H; Leppert, M; Risch, N; Drayna, D				Kim, UK; Jorgenson, E; Coon, H; Leppert, M; Risch, N; Drayna, D			Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide	SCIENCE			English	Article							RECEPTOR; FAMILY; LOCALIZATION; PERCEPTION; GENES	The ability to taste the substance phenylthiocarbamide (PTC) has been widely used for genetic and anthropological studies, but genetic studies have produced conflicting results and demonstrated complex inheritance for this trait. We have identified a small region on chromosome 7q that shows strong linkage disequilibrium between single-nucleotide polymorphism (SNP) markers and PTC taste sensitivity in unrelated subjects. This region contains a single gene that encodes a member of the TAS2R bitter taste receptor family. We identified three coding SNPs giving rise to five haplotypes in this gene worldwide. These haplotypes completely explain the bimodal distribution of PTC taste sensitivity, thus accounting for the inheritance of the classically defined taste insensitivity and for 55 to 85% of the variance in PTC sensitivity. Distinct phenotypes were associated with specific haplotypes, which demonstrates that this gene has a direct influence on PTC taste sensitivity and that sequence variants at different sites interact with each other within the encoded gene product.	Natl Inst Deafness & Other Commun Disorders, NIH, Rockville, MD 20850 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Utah, Med Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Med Ctr, Red Butte Hlth Ctr, Dept Psychiat, Salt Lake City, UT 84112 USA; Kaiser Permanente, Div Res, Oakland, CA 94612 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Stanford University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Kaiser Permanente	Drayna, D (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH, 5 Res Court, Rockville, MD 20850 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [T32 HG00044] Funding Source: Medline; PHS HHS [Z01-000046-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Blakeslee AF, 1932, P NATL ACAD SCI USA, V18, P120, DOI 10.1073/pnas.18.1.120; Blakfslee AF, 1935, P NATL ACAD SCI USA, V21, P84, DOI 10.1073/pnas.21.2.84; BOYD WC, 1950, GENETICS RACES MAN I, P276; BRANDTZAEG MERTON B, 1958, Acta Genet Stat Med, V8, P114; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHAUTARD.EA, 1974, ANN HUM GENET, V38, P191, DOI 10.1111/j.1469-1809.1974.tb01950.x; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DRAYNA D, IN PRESS HUM GENET; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FALCONER DS, 1946, ANN EUGEN, V13, P211; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guo SW, 2001, ANN HUM BIOL, V28, P111; GUYER M, 1992, SCIENCE, V258, P67; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; KALMUS H, 1958, ANN HUM GENET, V22, P222, DOI 10.1111/j.1469-1809.1958.tb01416.x; LEE B. F., 1934, OHIO JOUR SCI, V34, P337; Levit SG, 1935, J GENET, V30, P389, DOI 10.1007/BF02982247; NABHAN C, 1995, BIOCHEM BIOPH RES CO, V212, P1015, DOI 10.1006/bbrc.1995.2071; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Prodi DA, 2002, AM J HUM GENET, V71, P464; REDDY BM, 1989, GENET EPIDEMIOL, V6, P413, DOI 10.1002/gepi.1370060304; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; SPENCE MA, 1984, HUM GENET, V67, P183; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; TILLS D, 1983, DISTRIBUTION HUMAN B; Ueda T, 2001, BIOCHEM BIOPH RES CO, V285, P147, DOI 10.1006/bbrc.2001.5136; 1931, SCIENCE S, V73, P14	33	626	649	2	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1221	1225		10.1126/science.1080190	http://dx.doi.org/10.1126/science.1080190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595690				2022-12-01	WOS:000181065500037
J	Smith, MM; Johanson, Z				Smith, MM; Johanson, Z			Separate evolutionary origins of teeth from evidence in fossil jawed vertebrates	SCIENCE			English	Article								Placoderms are extinct jawed fishes of the class Placodermi and are basal among jawed vertebrates. It is generally thought that teeth are absent in placoderms and that the phylogenetic origin of teeth occurred after the evolution of jaws. However, we now report the presence of tooth rows in more derived placoderms, the arthrodires. New teeth are composed of gnathostome-type dentine and develop at specific locations. Hence, it appears that these placoderm teeth develop and are regulated as in other jawed vertebrates. Because tooth development occurs only in derived forms of placoderms, we suggest that teeth evolved at least twice, through a mechanism of convergent evolution.	Kings Coll London, Inst Dent, London SE1 9RT, England; Australian Museum, Sydney, NSW 2010, Australia	University of London; King's College London; Australian Museum	Smith, MM (corresponding author), Kings Coll London, Inst Dent, Guys Campus,London Bridge, London SE1 9RT, England.	moya.smith@kcl.ac.uk	Self, Casey J/B-6871-2011	Meredith Smith, Moya/0000-0002-3397-873X; Johanson, Zerina/0000-0002-8444-6776				Denison R., 1978, HDB PALEOICHTHYOLOGY; DENNERLINE J, 1995, INT HIST REV, V17, P127; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; McCollum M, 2001, J ANAT, V199, P153, DOI 10.1046/j.1469-7580.2001.19910153.x; ORVIG T, 1980, ZOOL SCR, V9, P141, DOI 10.1111/j.1463-6409.1980.tb00660.x; REIF WE, 1982, EVOL BIOL, V15, P287; Reisz RR, 2001, NATURE, V411, P548, DOI 10.1038/35079187; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; SMITH MM, 1993, EVOL BIOL, V27, P387; Smith MM, 2001, J ANAT, V199, P161; SMITH MM, IN PRESS EVOL DEV; Williams ME, 2001, J VERTEBR PALEONTOL, V21, P214, DOI 10.1671/0272-4634(2001)021[0214:TRICSW]2.0.CO;2; Wilson Mark V. H., 1999, Journal of Vertebrate Paleontology, V19, p85A; Young GC, 2001, J VERTEBR PALEONTOL, V21, P670, DOI 10.1671/0272-4634(2001)021[0670:PJSIAA]2.0.CO;2	15	79	86	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1235	1236		10.1126/science.1079623	http://dx.doi.org/10.1126/science.1079623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595693				2022-12-01	WOS:000181065500041
J	Zubieta, JK; Heitzeg, MM; Smith, YR; Bueller, JA; Xu, K; Xu, YJ; Koeppe, RA; Stohler, CS; Goldman, D				Zubieta, JK; Heitzeg, MM; Smith, YR; Bueller, JA; Xu, K; Xu, YJ; Koeppe, RA; Stohler, CS; Goldman, D			COMT val(158)met genotype affects mu-opioid neurotransmitter responses to a pain stressor	SCIENCE			English	Article							CATECHOL-O-METHYLTRANSFERASE; AFFECTIVE DIMENSIONS; ANTERIOR CINGULATE; NOREPINEPHRINE; MODULATION; RECEPTORS; STRIATUM; BEHAVIOR; AMYGDALA; ORGANIZATION	Responses to pain and other stressors are regulated by interactions between multiple brain areas and neurochemical systems. We examined the influence of a common functional genetic polymorphism affecting the metabolism of catecholamines on the modulation of responses to sustained pain in humans. Individuals homozygous for the met(158) allele of the catechol-O-methyttransferase (COMT) polymorphism (val(158)met) showed diminished regional mu-opioid system responses to pain compared with heterozygotes. These effects were accompanied by higher sensory and affective ratings of pain and a more negative internal affective state. Opposite effects were observed in val(158) homozygotes. The COMT val(158)met polymorphism thus influences the human experience of pain and may underlie interindividual differences in the adaptation and responses to pain and other stressful stimuli.	Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Natl Inst Alcohol & Alcoholism, Neurogenet Lab, Rockville, MD 20852 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Zubieta, JK (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA.		Zubieta, Jon-Kar/AAB-5565-2022; Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010; STOHLER, CHRISTIAN/AAQ-7539-2020; Xu, Ke/V-5941-2019; Heitzeg, Mary/M-7154-2017	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Xu, Ke/0000-0002-6472-7052; Stohler, Christian S/0000-0003-0443-6146; Heitzeg, Mary/0000-0002-6737-2971	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012743, R01DE012059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000302, Z01AA000303, Z01AA000298] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 12059, R01 DE 12743] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; CUMMING P, 1992, J NEUROCHEM, V59, P1905, DOI 10.1111/j.1471-4159.1992.tb11026.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; ENOCH MA, IN PRESS PSYCHOL GEN; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; GEORGE SR, 1987, PEPTIDES, V8, P487, DOI 10.1016/0196-9781(87)90014-3; HELMSTETTER FJ, 1995, J PHARMACOL EXP THER, V275, P381; Johnson PI, 1997, NEUROSCIENCE, V77, P187, DOI 10.1016/S0306-4522(96)00482-4; KALIN NH, 1988, BRAIN RES, V440, P285, DOI 10.1016/0006-8993(88)90997-3; Kalivas PW, 1999, ANN NY ACAD SCI, V877, P64, DOI 10.1111/j.1749-6632.1999.tb09261.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; LI PP, 1984, J NEUROCHEM, V43, P1425, DOI 10.1111/j.1471-4159.1984.tb05404.x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; MCALONAN GM, 1993, NEUROSCIENCE, V52, P605, DOI 10.1016/0306-4522(93)90410-H; Melzack R, 2000, HDB PAIN ASSESSMENT, P152; MOGENSON GJ, 1991, ADV EXP MED BIOL, V295, P267; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Napier TC, 1999, ANN NY ACAD SCI, V877, P176, DOI 10.1111/j.1749-6632.1999.tb09268.x; Nestler EJ, 2001, J NEUROSCI, V21, P8324, DOI 10.1523/JNEUROSCI.21-21-08324.2001; Oke AF, 1997, BRAIN RES, V763, P69, DOI 10.1016/S0006-8993(97)00404-6; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Stohler CS, 1999, PAIN, V79, P165, DOI 10.1016/S0304-3959(98)00171-7; Tiihonen J, 1999, MOL PSYCHIATR, V4, P286, DOI 10.1038/sj.mp.4000509; UNTERWALD EM, 1994, NEUROREPORT, V5, P1613, DOI 10.1097/00001756-199408150-00018; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.3.CO;2-5; VOGT BA, 1995, EXP NEUROL, V135, P83, DOI 10.1006/exnr.1995.1069; WATKINS LR, 1982, SCIENCE, V216, P1185, DOI 10.1126/science.6281891; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Zubieta JK, 2002, J NEUROSCI, V22, P5100, DOI 10.1523/JNEUROSCI.22-12-05100.2002; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	39	841	871	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1240	1243		10.1126/science.1078546	http://dx.doi.org/10.1126/science.1078546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595695				2022-12-01	WOS:000181065500043
J	Yoder, AD; Burns, MM; Zehr, S; Delefosse, T; Veron, G; Goodman, SM; Flynn, JJ				Yoder, AD; Burns, MM; Zehr, S; Delefosse, T; Veron, G; Goodman, SM; Flynn, JJ			Single origin of Malagasy Carnivora from an African ancestor	NATURE			English	Article							MADAGASCAR; PHYLOGENY; RADIATION; DISPERSAL; ANCIENT; LEMURS; INDIA	The Carnivora are one of only four orders of terrestrial mammals living in Madagascar today. All four (carnivorans, primates, rodents and lipotyphlan insectivores) are placental mammals with limited means for dispersal, yet they occur on a large island that has been surrounded by a formidable oceanic barrier for at least(88) million years(1,2), predating the age of origin for any of these groups(3,4). Even so, as many as four colonizations of Madagascar have been proposed for the Carnivora alone(5). The mystery of the island's mammalian origins is confounded by its poor Tertiary fossil record, which leaves us with no direct means for estimating dates of initial diversification. Here we use a multi-gene phylogenetic analysis to show that Malagasy carnivorans are monophyletic and thus the product of a single colonization of Madagascar by an African ancestor. Furthermore, a bayesian analysis(6) of divergence ages for Malagasy carnivorans and lemuriforms indicates that their respective colonizations were temporally separated by tens of millions of years. We therefore conclude that a single event, such as vicariance or common dispersal, cannot explain the presence of both groups in Madagascar.	Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06551 USA; Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Museum Natl Hist Nat, Lab Zool Mammiferes & Oiseaux, F-75231 Paris, France; WWF, Antananarivo 101, Madagascar	Yale University; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Museum National d'Histoire Naturelle (MNHN); World Wildlife Fund	Yoder, AD (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06551 USA.	anne.yoder@yale.edu	Veron, Geraldine/P-8163-2019	Veron, Geraldine/0000-0003-4247-3976				ALBIGNAC R, 1973, FAUNE MADAGASCAR, V36, P206; Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; COFFIN MF, 1992, AAPG MEMOIR, V53, P207; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; GOODMAN SM, IN PRESS NATURAL HIS; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Krause D.W., 1999, GSA TODAY, V9, P1; Krause David W., 1997, P3; Krause DW, 2001, NATURE, V412, P497, DOI 10.1038/35087649; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Novacek MJ, 2001, CURR BIOL, V11, pR573, DOI 10.1016/S0960-9822(01)00347-5; OLSON LE, 1999, THESIS U CHICAGO, P349; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; SCHMID J, IN PRESS NATURAL HIS; SIMPSON GG, 1952, B AM MUS NAT HIST, V99, P163; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Veron G, 1995, MAMMALIA, V59, P551, DOI 10.1515/mamm.1995.59.4.551; Veron Geraldine, 1993, Journal of Mammalian Evolution, V1, P169, DOI 10.1007/BF01024706; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 1996, COLLOQ SEMI, P245	30	224	257	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					734	737		10.1038/nature01303	http://dx.doi.org/10.1038/nature01303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610623				2022-12-01	WOS:000180938000041
J	Burns, KH; Viveiros, MM; Ren, YS; Wang, P; DeMayo, FJ; Frail, DE; Eppig, JJ; Matzuk, MM				Burns, KH; Viveiros, MM; Ren, YS; Wang, P; DeMayo, FJ; Frail, DE; Eppig, JJ; Matzuk, MM			Roles of NPM2 in chromatin and nucleolar organization in oocytes and embryos	SCIENCE			English	Article							SPERM NUCLEI; EGG CYTOPLASM; NUCLEOPLASMIN; MOUSE; GENE; DECONDENSATION; SEQUENCE; NUCLEOPHOSMIN; ACQUISITION; EXPRESSION	Upon fertilization, remodeling of condensed maternal and paternal gamete DNA occurs to form the diploid genome. In Xenopus laevis, nucleoplasmin 2 (NPM2) decondenses sperm DNA in vitro. To study chromatin remodeling in vivo, we isolated mammalian NPM2 orthologs. Mouse NPM2 accumulates in oocyte nuclei and persists in preimplantation embryos. Npm2 knockout females have fertility defects owing to failed preimplantation embryo development. Although sperm DNA decondensation proceeds without NPM2, abnormalities are evident in oocyte and early embryonic nuclei. These defects include an absence of coalesced nucleolar structures and loss of heterochromatin and deacetylated histone H3 that normally circumscribe nucleoli in oocytes and early embryos, respectively. Thus, Npm2 is a maternal effect gene critical for nuclear and nucleolar organization and embryonic development.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wyeth Ayerst Res, Collegeville, PA 19426 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Jackson Laboratory; Pfizer	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu	Burns, Kathleen/A-3360-2011; DeMayo, Francesco/C-6255-2019; Viveiros, Maria/P-4120-2015	DeMayo, Francesco/0000-0002-9480-7336; Burns, Kathleen/0000-0003-1620-3761; Wang, Pei/0000-0003-2373-7315	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033438] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD033438, P30HD007495, R01HD042500, R37HD021970, U01HD021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07495, HD21970, HD42500, HD33438] Funding Source: Medline; NIGMS NIH HHS [T32GM07330] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; BURGLIN TR, 1987, GENE DEV, V1, P97, DOI 10.1101/gad.1.1.97; CAPECCHI MR, 1994, SCI AM, V270, P52, DOI 10.1038/scientificamerican0394-52; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; Gurtu VE, 2002, GENETICS, V160, P271; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; MacArthur CA, 1997, GENOMICS, V42, P137, DOI 10.1006/geno.1997.4353; Maeda Y, 1998, ZYGOTE, V6, P39, DOI 10.1017/S0967199400005062; MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Meric F, 1997, J BIOL CHEM, V272, P12840, DOI 10.1074/jbc.272.19.12840; OHSUMI K, 1991, DEV BIOL, V148, P295, DOI 10.1016/0012-1606(91)90338-4; PERREAULT SD, 1992, MUTAT RES, V296, P43, DOI 10.1016/0165-1110(92)90031-4; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; SCHMIDTZACHMANN MS, 1988, CHROMOSOMA, V96, P417, DOI 10.1007/BF00303035; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; USUI N, 1976, J ULTRA MOL STRUCT R, V57, P276, DOI 10.1016/S0022-5320(76)80117-7; WICKRAMASINGHE D, 1991, DEV BIOL, V143, P162, DOI 10.1016/0012-1606(91)90063-9; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Zuccotti M, 1998, BIOL REPROD, V58, P700, DOI 10.1095/biolreprod58.3.700	28	276	290	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					633	636		10.1126/science.1081813	http://dx.doi.org/10.1126/science.1081813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714744				2022-12-01	WOS:000182453700040
J	Gaudet, F; Hodgson, JG; Eden, A; Jackson-Grusby, L; Dausman, J; Gray, JW; Leonhardt, H; Jaenisch, R				Gaudet, F; Hodgson, JG; Eden, A; Jackson-Grusby, L; Dausman, J; Gray, JW; Leonhardt, H; Jaenisch, R			Induction of tumors in mice by genomic hypomethylation	SCIENCE			English	Article							GERM-LINE; 5-METHYLCYTOSINE CONTENT; RETROVIRAL GENOMES; DNA METHYLATION; C-MYC; EXPRESSION; INSTABILITY; CANCER; TRANSMISSION; INTEGRATION	Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 (Dnmt1) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Munich, Dept Biol 2, D-80336 Munich, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	jia, xu/A-8386-2016; Leonhardt, Heinrich/B-2791-2014		NATIONAL CANCER INSTITUTE [R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [CA87869] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cory S, 1999, CANCER RES, V59, p1685S; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gaudet F, 1998, J BIOL CHEM, V273, P32725, DOI 10.1074/jbc.273.49.32725; GAUDET F, UNPUB; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; JAHNER D, 1980, NATURE, V287, P456, DOI 10.1038/287456a0; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LAPEYRE JN, 1979, BIOCHEM BIOPH RES CO, V87, P698, DOI 10.1016/0006-291X(79)92015-1; Lei H, 1996, DEVELOPMENT, V122, P3195; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Muto M, 1996, JPN J CANCER RES, V87, P247, DOI 10.1111/j.1349-7006.1996.tb00213.x; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; SELTEN G, 1984, EMBO J, V3, P3215, DOI 10.1002/j.1460-2075.1984.tb02281.x; STEWART C, 1983, SCIENCE, V221, P760, DOI 10.1126/science.6683871; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; WAINFAN E, 1992, CANCER RES, V52, pS2071; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WIRSCHUBSKY Z, 1986, INT J CANCER, V38, P739, DOI 10.1002/ijc.2910380518; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; ZAGONEL V, 1993, LEUKEMIA, V7, P30	35	1132	1192	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2003	300	5618					489	492		10.1126/science.1083558	http://dx.doi.org/10.1126/science.1083558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702876				2022-12-01	WOS:000182295900041
J	Kljuic, A; Bazzi, H; Sundberg, JP; Martinez-Mir, A; O'Shaughnessy, R; Mahoney, MG; Levy, M; Montagutelli, X; Ahmad, W; Alta, VM; Gordon, D; Uitto, J; Whiting, D; Ott, J; Fischer, S; Gilliam, TC; Jahoda, CAB; Morris, RJ; Panteleyev, AA; Nguyen, VT; Christiano, AM				Kljuic, A; Bazzi, H; Sundberg, JP; Martinez-Mir, A; O'Shaughnessy, R; Mahoney, MG; Levy, M; Montagutelli, X; Ahmad, W; Alta, VM; Gordon, D; Uitto, J; Whiting, D; Ott, J; Fischer, S; Gilliam, TC; Jahoda, CAB; Morris, RJ; Panteleyev, AA; Nguyen, VT; Christiano, AM			Desmoglein 4 in hair follicle differentiation and epidermal adhesion: Evidence from inherited hypotrichosis and acquired pemphigus vulgaris	CELL			English	Article							SUPRABASAL INTEGRIN EXPRESSION; PALMOPLANTAR KERATODERMA; DESMOSOMAL CADHERINS; CELL-ADHESION; GROWTH-FACTOR; WOOLLY HAIR; KERATINOCYTE; PHENOTYPE; MUTATION; DISEASE	Cell adhesion and communication are interdependent aspects of cell behavior that are critical for morphogenesis and tissue architecture. In the skin, epidermal adhesion is mediated in part by specialized cell-cell junctions known as desmosomes, which are characterized by the presence of desmosomal cadherins, known as desmogleins and desmocollins. We identified a cadherin family member, desmoglein 4, which is expressed in the suprabasal epidermis and hair follicle. The essential role of desmoglein 4 in skin was established by identifying mutations in families with inherited hypotrichosis, as well as in the lanceolate hair mouse. We also show that DSG4 is an autoantigen in pemphigus vulgaris. Characterization of the phenotype of naturally occurring mutant mice revealed disruption of desmosomal adhesion and perturbations in keratinocyte behavior. We provide evidence that desmoglein 4 is a key mediator of keratinocyte cell adhesion in the hair follicle, where it coordinates the transition from proliferation to differentiation.	Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Dermatol, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Baylor Coll Med, Houston, TX 77030 USA; Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; Dallas associated Dermatologists, Dallas, TX 75246 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Univ Durham, Durham DH1 3LE, England; Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA	Columbia University; Columbia University; Columbia University; Jackson Laboratory; Jefferson University; Baylor College of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; Durham University; University of California System; University of California Davis	Christiano, AM (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.		Ahmad, Wasim/E-9713-2015; Mahoney, My/A-2716-2009; Ahmad, Wasim/GSD-8904-2022; IBIS, NEUROGENETICA/P-2947-2015; Panteleyev, Andrey A/R-9151-2016; Bazzi, Hisham/AAA-6584-2021; Martinez-Mir, Amalia/K-7715-2018	Panteleyev, Andrey A/0000-0002-8733-9183; Bazzi, Hisham/0000-0001-8388-4005; Martinez-Mir, Amalia/0000-0002-1628-8972; Nguyen, Vu/0000-0002-1142-6352; O'Shaughnessy, Ryan/0000-0002-3701-0267; Jahoda, Colin/0000-0002-1762-1220	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047938, P01AR038923] Funding Source: NIH RePORTER; NCRR NIH HHS [K26-RR173] Funding Source: Medline; NIAMS NIH HHS [P01 AR38923, R03 AR47938] Funding Source: Medline; PHS HHS [R01-44924] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; AUBER L., 1952, TRANS ROY SOC EDINBURGH, V62, P191; BULLOUGH W. S., 1958, BIOLOGY HAIR GROWTH, P171; BUXTON RS, 1993, J CELL BIOL, V121, P481, DOI 10.1083/jcb.121.3.481; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; FRESHNEY RI, 1987, ANIMAL CELLS MANUAL; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; GRINNELL F, 1990, J TRAUMA, V30, pS144; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARLOW E, 1998, USING ANTIBODIES LAB; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Hunt DM, 2001, EUR J HUM GENET, V9, P197, DOI 10.1038/sj.ejhg.5200605; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Kljuic A, 2003, EXP DERMATOL, V12, P20, DOI 10.1034/j.1600-0625.2003.120103.x; KLJUIC A, IN PRESS EXP DERMATO; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Kurose K, 2000, J DERMATOL SCI, V24, P184, DOI 10.1016/S0923-1811(00)00100-6; Kurzen H, 1998, DIFFERENTIATION, V63, P295, DOI 10.1007/s002580050254; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; McMillan JR, 2001, J DERMATOL, V28, P291, DOI 10.1111/j.1346-8138.2001.tb00136.x; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Montagutelli X, 1997, J INVEST DERMATOL, V109, P324, DOI 10.1111/1523-1747.ep12335844; Montagutelli X, 1996, J INVEST DERMATOL, V107, P20, DOI 10.1111/1523-1747.ep12297438; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Orwin D F, 1979, Int Rev Cytol, V60, P331, DOI 10.1016/S0074-7696(08)61266-8; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pulkkinen L, 2003, EXP DERMATOL, V12, P11, DOI 10.1034/j.1600-0625.2003.120102.x; Pulkkinen L, 2002, J INVEST DERMATOL, V119, P1237, DOI 10.1046/j.1523-1747.2002.19645.x; Rikimaru K, 1997, EXP DERMATOL, V6, P214, DOI 10.1111/j.1600-0625.1997.tb00165.x; ROTH SI, 1964, J ULTRA MOL STRUCT R, V11, P33, DOI 10.1016/S0022-5320(64)80091-5; Sambrook J., 1989, MOL CLONING LAB MANU; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sundberg JP, 2000, EXP DERMATOL, V9, P206, DOI 10.1034/j.1600-0625.2000.009003206.x; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Tong XM, 2003, TRENDS MOL MED, V9, P79, DOI 10.1016/S1471-4914(02)00025-4; VANSCOTT EJ, 1963, J INVEST DERMATOL, V41, P269, DOI 10.1038/jid.1963.110	49	242	252	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					249	260		10.1016/S0092-8674(03)00273-3	http://dx.doi.org/10.1016/S0092-8674(03)00273-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705872	Bronze			2022-12-01	WOS:000182508500013
J	Alberio, R; Campbell, KHS				Alberio, R; Campbell, KHS			Epigenetics and nuclear transfer	LANCET			English	Editorial Material							CLONED MICE; SOMATIC-CELLS		Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	University of Nottingham	Campbell, KHS (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.		Alberio, Ramiro/G-5955-2011	Alberio, Ramiro/0000-0001-6560-3919				Alberio R., 2003, Theriogenology, V59, P318; Bordignon V, 2001, DEV BIOL, V233, P192, DOI 10.1006/dbio.2001.0215; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lanza RP, 2001, SCIENCE, V294, P1893, DOI 10.1126/science.1063440; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ogura A, 2003, THERIOGENOLOGY, V59, P87, DOI 10.1016/S0093-691X(02)01276-1; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262	10	9	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1239	1240		10.1016/S0140-6736(03)13029-2	http://dx.doi.org/10.1016/S0140-6736(03)13029-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699948				2022-12-01	WOS:000182161600005
J	Navarro, A; Barton, NH				Navarro, A; Barton, NH			Chromosomal speciation and molecular divergence - Accelerated evolution in rearranged chromosomes	SCIENCE			English	Article							UPPER MIOCENE; GENES; RECOMBINATION; SELECTION; HISTORY; HOMINID; HUMANS; RATES	Humans and their closest evolutionary relatives, the chimpanzees, differ in similar to1.24% of their genomic DNA sequences. The fraction of these changes accumulated during the speciation processes that have separated the two lineages may be of special relevance in understanding the basis of their differences. We analyzed human and chimpanzee sequence data to search for the patterns of divergence and polymorphism predicted by a theoretical model of speciation. According to the model, positively selected changes should accumulate in chromosomes that present. fixed structural differences, such as inversions, between the two species. Protein evolution was more than 2.2 times faster in chromosomes that had undergone structural rearrangements compared with colinear chromosomes. Also, nucleotide variability is slightly lower in rearranged chromosomes. These patterns of divergence and polymorphism may be, at least in part, the molecular footprint of speciation events in the human and chimpanzee lineages.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Catalonia, Spain; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Pompeu Fabra University; University of Edinburgh	Navarro, A (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.	arcadi.navarro@cexs.upf.es	Navarro, Arcadi/F-1592-2011	Navarro, Arcadi/0000-0003-2162-8246				Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Castresana J, 2002, NUCLEIC ACIDS RES, V30, P1751, DOI 10.1093/nar/30.8.1751; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Consigliere S, 1996, CHROMOSOME RES, V4, P264, DOI 10.1007/BF02263675; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; FITCH WM, 1971, BIOCHEM GENET, V5, P231, DOI 10.1007/BF00485794; Haig D, 1999, PHILOS T R SOC B, V354, P1447, DOI 10.1098/rstb.1999.0490; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JANCZEWSKI DN, 1990, J HERED, V81, P375; Johnson T, 2002, GENETICS, V162, P395; Kimura M., 1983, NEUTRAL THEORY MOL E; KING M, 1993, SPECIES EVOLUTION; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Orr HA, 1996, GENETICS, V144, P1331; Ortiz-Barrientos D, 2002, GENETICA, V116, P167, DOI 10.1023/A:1021296829109; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Spirito F, 1998, ENDLESS FORMS, P320; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Van Doorn GS, 2001, P ROY SOC B-BIOL SCI, V268, P2155, DOI 10.1098/rspb.2001.1780; Vieira J, 2001, GENETICS, V158, P279; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wallis M, 2001, J MOL EVOL, V53, P10, DOI 10.1007/s002390010187; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; Williams EJB, 2002, MOL BIOL EVOL, V19, P1395, DOI 10.1093/oxfordjournals.molbev.a004202; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YANG Z, 2002, PHYLOGENETIC ANAL MA; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	39	302	312	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					321	324		10.1126/science.1080600	http://dx.doi.org/10.1126/science.1080600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690198	Green Submitted			2022-12-01	WOS:000182135400055
J	Verheyen, E; Salzburger, W; Snoeks, J; Meyer, A				Verheyen, E; Salzburger, W; Snoeks, J; Meyer, A			Origin of the superflock of cichlid fishes from Lake Victoria, East Africa	SCIENCE			English	Article							LATE PLEISTOCENE DESICCATION; HAPLOCHROMINE FISHES; SPECIES FLOCK; EVOLUTION; TANGANYIKA; PHYLOGENY; LINEAGE; HISTORY; AGE	Lake Victoria harbors a unique species-rich flock of more than 500 endemic haplochromine cichlid fishes. The origin, age, and mechanism of diversification of this extraordinary radiation are still debated. Geological evidence suggests that the lake dried out completely about 14,700 years ago. On the basis of phylogenetic analyses of almost 300 DNA sequences of the mitochondrial control region of East African cichlids, we find that the Lake Victoria cichlid flock is derived from the geologically older Lake Kivu. We suggest that the two seeding lineages may have already been lake-adapted when they colonized Lake Victoria. A haplotype analysis further shows that the most recent desiccation of Lake Victoria did not lead to a complete extinction of its endemic cichlid fauna and that the major lineage diversification took place about 100,000 years ago.	Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78457 Constance, Germany; Royal Belgian Inst Nat Sci, Vertebrate Dept, B-1000 Brussels, Belgium; Royal Museum Cent Africa, Vertebrate Sect, B-3080 Tervuren, Belgium	University of Konstanz; Royal Belgian Institute of Natural Sciences; Royal Museum for Central Africa	Meyer, A (corresponding author), Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, Univ Str 10, D-78457 Constance, Germany.	axel.meyer@uni-konstanz.de	Meyer, Axel/C-9826-2009; VERHEYEN, ERIK K/E-5550-2013; Salzburger, Walter/G-1598-2011	Meyer, Axel/0000-0002-0888-8193; VERHEYEN, ERIK K/0000-0001-7157-1474; Salzburger, Walter/0000-0002-9988-1674				Beadle L.C., 1974, INLAND WATERS TROPIC, DOI [10.4319/lo.1977.22.5.0972b, DOI 10.4319/LO.1977.22.5.0972B]; Booton GC, 1999, MOL PHYLOGENET EVOL, V11, P273, DOI 10.1006/mpev.1998.0576; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EBINGER CJ, 1989, GEOL SOC AM BULL, V101, P885, DOI 10.1130/0016-7606(1989)101<0885:TDOTWB>2.3.CO;2; Fryer G, 1997, HYDROBIOLOGIA, V354, P177, DOI 10.1023/A:1003183432203; Fryer G, 2001, P ROY SOC B-BIOL SCI, V268, P1147, DOI 10.1098/rspb.2001.1601; Greenwood P.H., 1980, Bulletin of the British Museum (Natural History) Zoology, V39, P1; GREENWOOD P H, 1973, Bulletin of the British Museum (Natural History) Zoology, V25, P139; Greenwood P. H., 1981, HAPLOCHROMINE FISHES; Johnson TC, 2000, AMBIO, V29, P2, DOI 10.1639/0044-7447(2000)029[0002:THHOLV]2.0.CO;2; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Kaufman LS, 1997, ENDEAVOUR, V21, P23, DOI 10.1016/S0160-9327(96)10034-X; LEE WJ, 1995, J MOL EVOL, V41, P54; Lippitsch E, 1997, J FISH BIOL, V51, P284; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Meyer Axel, 1999, P141; MOEYERSONS J, 1979, MUS R AFR CENTR TERV, P127; Nagl S, 2000, P ROY SOC B-BIOL SCI, V267, P1049, DOI 10.1098/rspb.2000.1109; POUCLET A, 1978, MUS R AFR CENTR DEP, P145; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Schmidt U, 2001, PALAEOECO A, V27, P51; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Seehausen O, 2002, P ROY SOC B-BIOL SCI, V269, P491, DOI 10.1098/rspb.2001.1906; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; Snoeks J, 1997, S AFR J SCI, V93, P579; Snoeks Jos, 2001, Journal of Aquariculture & Aquatic Sciences, V9, P150; Stiassny Melanie L. J., 1994, V50, P235; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; STIASSNY MLJ, 1992, NETH J ZOOL, V42, P260, DOI 10.1163/156854291X00324; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; STURMBAUER C, 1994, MOL BIOL EVOL, V11, P691; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; STURMBAUER C, 1992, NATURE, V358, P578, DOI 10.1038/358578a0; SWOFFORD DL, 2000, PAUP STAR PHYLOGENET; 1953, ANN REPORT E AFRICAN, V41	35	311	331	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					325	329		10.1126/science.1080699	http://dx.doi.org/10.1126/science.1080699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12649486	Green Submitted			2022-12-01	WOS:000182135400056
J	Takada, S; Kelkar, A; Theurkauf, WE				Takada, S; Kelkar, A; Theurkauf, WE			Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity	CELL			English	Article							TOPOISOMERASE-II; DNA-DAMAGE; MITOTIC CATASTROPHE; GAMMA-TUBULIN; CLEAVAGE; CELLS; GENE; CHK2; ATM; INHIBITION	In syncytial Drosophila embryos, damaged or incompletely replicated DNA triggers centrosome disruption in mitosis, leading to defects in spindle assembly and anaphase chromosome segregation. The damaged nuclei drop from the cortex and are not incorporated into the cells that form the embryo proper. A null mutation in the Drosophila checkpoint kinase 2 tumor suppressor homolog [DmChk2) blocks this mitotic response to DNA lesions and also prevents loss of defective nuclei from the cortex. In addition, DNA damage leads to increased DmChk2 localization to the centrosome and spindle microtubules. DmChk2 is therefore essential for a "mitotic catastrophe" signal that disrupts centrosome function in response to genotoxic stress and ensures that mutant and aneuploid nuclei are eliminated from the embryonic precursor pool.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	william.theurkauf@umassmed.edu		Theurkauf, William/0000-0001-7342-1912; Kelkar, Anju/0000-0001-7956-8210	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050898] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50898] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andreassen PR, 2001, CANCER RES, V61, P7660; Brodsky MH, 2000, GENE DEV, V14, P666; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Foe Victoria E., 1993, P149; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HUT HMJ, 2003, IN PRESS MOL BIOL CE; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; KROSS J, 1982, BIOCHEMISTRY-US, V21, P4310, DOI 10.1021/bi00261a021; LONG BH, 1985, CANCER RES, V45, P3106; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Oishi I, 1998, MECH DEVELOP, V71, P49, DOI 10.1016/S0925-4773(97)00200-1; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; POMMIER Y, 1991, NUCLEIC ACIDS RES, V19, P5973, DOI 10.1093/nar/19.21.5973; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; ROBERGE M, 1990, J CELL BIOL, V111, P1753, DOI 10.1083/jcb.111.5.1753; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Takai H, 2000, GENE DEV, V14, P1439; TANABE K, 1991, CANCER RES, V51, P4903; THEURKAUF WE, 1994, DROSOPHILA MELANOGAS; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vahteristo P, 2001, CANCER RES, V61, P5718; Xu JH, 2001, FEBS LETT, V508, P394, DOI 10.1016/S0014-5793(01)03103-9; Yu KR, 2000, NAT CELL BIOL, V2, P609, DOI 10.1038/35023555; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	168	170	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					87	99		10.1016/S0092-8674(03)00202-2	http://dx.doi.org/10.1016/S0092-8674(03)00202-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679037	Bronze			2022-12-01	WOS:000182282900009
J	Kaplan, MJ; McCune, WJ				Kaplan, MJ; McCune, WJ			New evidence for vascular disease in patients with early rheumatoid arthritis	LANCET			English	Editorial Material							IMPROVES ENDOTHELIAL FUNCTION; ATHEROSCLEROSIS; MORTALITY; INFLAMMATION		Univ Michigan, Sch Med, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kaplan, MJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.	makaplan@med.umich.edu						Bergholm R, 2002, ARTERIOSCL THROM VAS, V22, P1637, DOI 10.1161/01.ATV.0000033516.73864.4E; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Goodson NJ, 2002, ARTHRITIS RHEUM-US, V46, P2010, DOI 10.1002/art.10419; Greaves DR, 2002, TRENDS IMMUNOL, V23, P535, DOI 10.1016/S1471-4906(02)02331-1; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Kumeda Y, 2002, ARTHRITIS RHEUM-US, V46, P1489, DOI 10.1002/art.10269; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Park YB, 2002, ARTHRITIS RHEUM, V46, P1714, DOI 10.1002/art.10359; Pasceri V, 1999, CIRCULATION, V100, P2124, DOI 10.1161/01.CIR.100.21.2124; Sanada M, 2002, J CLIN ENDOCR METAB, V87, P4634, DOI 10.1210/jc.2001-011223; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; Wallberg-Jonsson S, 2002, J RHEUMATOL, V29, P875; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Woo KS, 2002, AM J MED, V112, P535, DOI 10.1016/S0002-9343(02)01075-6	17	27	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2003	361	9363					1068	1069		10.1016/S0140-6736(03)12901-7	http://dx.doi.org/10.1016/S0140-6736(03)12901-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	660ZD	12672306				2022-12-01	WOS:000181865200004
J	Zhang, HL; Yang, ZR; Shen, Y; Tong, L				Zhang, HL; Yang, ZR; Shen, Y; Tong, L			Crystal structure of the carboxyltransferase domain of acetyl-coenzyme a carboxylase	SCIENCE			English	Article							COA CARBOXYLASE; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; ARYLOXYPHENOXYPROPIONATE; INHIBITORS	Acetyl-coenzyme A carboxylases (ACCs) are required for the biosynthesis and oxidation of long-chain fatty acids. They are targets for therapeutics against obesity and diabetes, and several herbicides function by inhibiting their carboxyltransferase (CT) domain. We determined the crystal structure of the free enzyme and the coenzyme A complex of yeast CT at 2.7 angstrom resolution and found that it comprises two domains, both belonging to the crotonase/ClpP superfamily. The active site is at the interface of a dimer. Mutagenesis and kinetic studies reveal the functional roles of conserved residues here. The herbicides target the active site of CT, providing a lead for inhibitor development against human ACCs.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Tong, Liang/0000-0002-0563-6468				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ALBERTS AW, 1972, ENZYMES, V6, P37; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jelenska J, 2002, J BIOL CHEM, V277, P23208, DOI 10.1074/jbc.M200455200; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Lenhard JM, 2002, ADV DRUG DELIVER REV, V54, P1199, DOI 10.1016/S0169-409X(02)00092-3; Levert KL, 2002, J BIOL CHEM, V277, P16347, DOI 10.1074/jbc.C200113200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; POLAKIS SE, 1974, J BIOL CHEM, V249, P6657; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; Weaver LH, 2001, PROTEIN SCI, V10, P2618, DOI 10.1110/ps.ps.32701; Zagnitko O, 2001, P NATL ACAD SCI USA, V98, P6617, DOI 10.1073/pnas.121172798	22	149	169	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2064	2067		10.1126/science.1081366	http://dx.doi.org/10.1126/science.1081366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663926				2022-12-01	WOS:000181834200054
J	Pearson, H				Pearson, H			Mystery virus slow to yield its identity as patient numbers rise	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					364	364		10.1038/422364b	http://dx.doi.org/10.1038/422364b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660744	Green Published, Bronze			2022-12-01	WOS:000181801200009
J	Seiffert, ER; Simons, EL; Attia, Y				Seiffert, ER; Simons, EL; Attia, Y			Fossil evidence for an ancient divergence of lorises and galagos	NATURE			English	Article							OLIGOCENE; DISCOVERY; EVOLUTION; PRIMATES; AGE	Morphological, molecular, and biogeographic data bearing on early primate evolution suggest that the clade containing extant (or 'crown') strepsirrhine primates (lemurs, lorises and galagos) arose in Afro-Arabia during the early Palaeogene(1), but over a century of palaeontological exploration on that landmass has failed to uncover any conclusive support for that hypothesis(2). Here we describe the first demonstrable crown strepsirrhines from the Afro-Arabian Palaeogene-a galagid and a possible lorisid from the late middle Eocene of Egypt, the latter of which provides the earliest fossil evidence for the distinctive strepsirrhine toothcomb. These discoveries approximately double the previous temporal range of undoubted lorisiforms and lend the first strong palaeontological support to the hypothesis of an ancient Afro-Arabian origin for crown Strepsirrhini and an Eocene divergence of extant lorisiform families(1,3).	Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27705 USA; Duke Primate Ctr, Div Fossil Primates, Durham, NC 27705 USA; Egyptian Geol Museum, Cairo, Egypt	Duke University; Duke University	Seiffert, ER (corresponding author), Duke Univ, Dept Biol Anthropol & Anat, 1013 Broad St, Durham, NC 27705 USA.	erik.seiffert@duke.edu						Beadnell HJL, 1905, TOPOGRAPHY GEOLOGY F; Bown T.M., 1988, US GEOL SURV PROF PA, V1452, P1; CHARLESD.P, 1970, NATURE, V227, P257, DOI 10.1038/227257a0; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; GHEERBRANT E, 1995, CR ACAD SCI II A, V321, P425; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Godinot Marc, 1994, P235; Holroyd Patricia A., 1996, Palaeovertebrata (Montpellier), V25, P175; KAPPELMAN J, 1992, J GEOL, V100, P647, DOI 10.1086/629619; MacLatchy L, 2002, AM J PHYS ANTHROPOL, P104; Maier W., 1980, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; Marivaux L, 2001, SCIENCE, V294, P587, DOI 10.1126/science.1065257; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Phillips EM, 2002, CAM S BIO EVOL ANTHR, V33, P83; Porter CA, 1997, INT J PRIMATOL, V18, P261, DOI 10.1023/A:1026328804319; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rasmussen DT, 1998, FOLIA PRIMATOL, V69, P250; ROSE KD, 1981, NATURE, V289, P583, DOI 10.1038/289583a0; Rose Kenneth D., 1994, P1; Simons EL, 1997, P NATL ACAD SCI USA, V94, P180, DOI 10.1073/pnas.94.1.180; SIMONS EL, 1986, J HUM EVOL, V15, P431, DOI 10.1016/S0047-2484(86)80026-4; Simons Elwyn L., 1994, P179; SIMPSON G G, 1967, Bulletin of the Museum of Comparative Zoology, V136, P39; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/106351501300318003; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	30	131	138	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2003	422	6930					421	424		10.1038/nature01489	http://dx.doi.org/10.1038/nature01489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660781	Green Published			2022-12-01	WOS:000181801200042
J	Williams, PM; Fowler, SB; Best, RB; Toca-Herrera, JL; Scott, KA; Steward, A; Clarke, J				Williams, PM; Fowler, SB; Best, RB; Toca-Herrera, JL; Scott, KA; Steward, A; Clarke, J			Hidden complexity in the mechanical properties of titin	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATION; ATOMIC-FORCE MICROSCOPY; MUSCLE PROTEIN TITIN; IMMUNOGLOBULIN DOMAINS; I-BAND; ELASTICITY; MODULES; EXTENSIBILITY; PATHWAY; DETAIL	Individual molecules of the giant protein titin span the A-bands and I-bands that make up striated muscle. The I-band region of titin is responsible for passive elasticity in such muscle(1-4), and contains tandem arrays of immunoglobulin domains. One such domain (I27) has been investigated extensively, using dynamic force spectroscopy and simulation(5-12). However, the relevance of these studies to the behaviour of the protein under physiological conditions was not established. Force studies reveal a lengthening of I27 without complete unfolding, forming a stable intermediate that has been suggested to be an important component of titin elasticity(6). To develop a more complete picture of the forced unfolding pathway, we use mutant titins-certain mutations allow the role of the partly unfolded intermediate to be investigated in more depth. Here we show that, under physiological forces, the partly unfolded intermediate does not contribute to mechanical strength. We also propose a unified forced unfolding model of all I27 analogues studied, and conclude that I27 can withstand higher forces in muscle than was predicted previously.	Univ Cambridge, Chem Lab, MRC, Ctr Prot Engn, Cambridge CB2 1EW, England; Univ Nottingham, Sch Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England	University of Cambridge; University of Nottingham	Clarke, J (corresponding author), Univ Cambridge, Chem Lab, MRC, Ctr Prot Engn, Lensfield Rd, Cambridge CB2 1EW, England.		Williams, Philip M/C-6947-2009; Toca-Herrera, Jose L./AAX-7366-2021; Best, Robert/H-7588-2016	Williams, Philip M/0000-0002-1822-2133; Toca-Herrera, Jose L./0000-0001-8951-2616; Best, Robert/0000-0002-7893-3543; Scott, Kathryn/0000-0003-3395-9210				Best RB, 2002, P NATL ACAD SCI USA, V99, P12143, DOI 10.1073/pnas.192351899; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Brockwell DJ, 2002, BIOPHYS J, V83, P458, DOI 10.1016/S0006-3495(02)75182-5; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Gautel M, 1996, J MUSCLE RES CELL M, V17, P449, DOI 10.1007/BF00123361; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1998, J CELL SCI, V111, P1567; Linke WA, 1998, BIOPHYS J, V75, P2613, DOI 10.1016/S0006-3495(98)77706-9; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Press W., 1992, NUMERICAL RECIPES, V2nd; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Trinick J, 1996, CURR BIOL, V6, P258, DOI 10.1016/S0960-9822(02)00472-4; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tskhovrebova L, 1997, J MOL BIOL, V265, P100, DOI 10.1006/jmbi.1996.0717; Tskhovrebova L, 2001, J MOL BIOL, V310, P755, DOI 10.1006/jmbi.2001.4700	30	225	230	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2003	422	6930					446	449		10.1038/nature01517	http://dx.doi.org/10.1038/nature01517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660787				2022-12-01	WOS:000181801200048
J	Abbott, A				Abbott, A			Chicken flu races through Dutch poultry farms	NATURE			English	News Item																		2003, NATURE, V422, P6	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					247	247		10.1038/422247b	http://dx.doi.org/10.1038/422247b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646883	Bronze			2022-12-01	WOS:000181637300006
J	Branson, R; Potoczna, N; Kral, JG; Lentes, K; Hoehe, MR; Horber, FF				Branson, R; Potoczna, N; Kral, JG; Lentes, K; Hoehe, MR; Horber, FF			Binge eating as a major phenotype of melanocortin 4 receptor gene mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-FAT DISTRIBUTION; EARLY-ONSET OBESITY; MORBID-OBESITY; FRAMESHIFT MUTATION; MISSENSE MUTATION; LEPTIN RECEPTOR; WEIGHT-LOSS; DISORDER; HUMANS; MC4R	Background: Obesity, a multifactorial disease caused by the interaction of genetic factors with the environment, is largely polygenic. A few mutations in these genes, such as in the leptin receptor (LEPR) gene and melanocortin 4 receptor (MC4R) gene, have been identified as causes of monogenic obesity. Methods: We sequenced the complete MC4R coding region, the region of the proopiomelanocortin gene (POMC) encoding the alpha melanocyte-stimulating hormone, and the leptin-binding domain of LEPR in 469 severely obese white subjects (370 women and 99 men; mean [+/-SE] age, 41.0+/-0.5 years; body-mass index [the weight in kilograms divided by the square of the height in meters], 44.1+/-2.0). Fifteen women and 10 men without a history of dieting or a family history of obesity served as normal-weight controls (age, 47.7+/-2.0 years; body-mass index, 21.6+/-0.4). Detailed phenotypic data, including information on body fat, resting energy expenditure, diet-induced thermogenesis, serum concentrations of leptin, and eating behavior, were collected. Results: Twenty-four obese subjects (5.1 percent) and one control subject (4 percent) had MC4R mutations, including five novel variants. Twenty of the 24 obese subjects with an MC4R mutation were matched for age, sex, and body-mass index with 120 of the 445 obese subjects without an MC4R mutation. All mutation carriers reported binge eating, as compared with 14.2 percent of obese subjects without mutations (P<0.001) and 0 percent of the normal-weight subjects without mutations. The prevalence of binge eating was similar among carriers of mutations in the leptin-binding domain of LEPR and noncarriers. No mutations were found in the region of POMC encoding (alpha) melanocyte-stimulating hormone. Conclusions: Binge eating is a major phenotypic characteristic of subjects with a mutation in MC4R, a candidate gene for the control of eating behavior.	Klin Hirslanden, CH-8008 Zurich, Switzerland; SUNY Downstate Med Ctr, Brooklyn, NY 11203 USA; Bioscientia, Ingelheim, Germany; Max Planck Inst Mol Genet, Berlin, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Max Planck Society	Horber, FF (corresponding author), Klin Hirslanden, Witellikerstr 40, CH-8008 Zurich, Switzerland.		horber, Fritz/AAL-5419-2020	Lentes, Klaus-Ulrich/0000-0002-1605-4332				*AM PSYCH ASS, 1994, DSM 4 CRIT SETS AX P, P703; Chen DL, 1999, J LIPID RES, V40, P1735; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; DEVLIN MJ, 1992, INT J EAT DISORDER, V11, P333, DOI 10.1002/1098-108X(199205)11:4&lt;333::AID-EAT2260110407&gt;3.0.CO;2-K; Dubern B, 2001, J PEDIATR-US, V139, P204, DOI 10.1067/mpd.2001.116284; Eriksson J, 1999, HORM METAB RES, V31, P616, DOI 10.1055/s-2007-978807; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Guss JL, 2002, OBES RES, V10, P1021, DOI 10.1038/oby.2002.139; Hamilton BS, 2002, OBES RES, V10, P182, DOI 10.1038/oby.2002.28; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2; Hsu LKG, 2002, INT J OBESITY, V26, P1398, DOI 10.1038/sj.ijo.0802081; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JACOBSEN P, 2002, J CLIN ENDOCR METAB, V84, P4442; Kalarchian MA, 2002, OBES SURG, V12, P270, DOI 10.1381/096089202762552494; Kobayashi H, 2002, DIABETES, V51, P243, DOI 10.2337/diabetes.51.1.243; Kral JG, 2001, SURG CLIN N AM, V81, P1039, DOI 10.1016/S0039-6109(05)70183-3; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Laederach-Hofmann K, 1999, INT J EAT DISORDER, V26, P231, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;231::AID-EAT1&gt;3.0.CO;2-6; Lahlou N, 2000, DIABETES, V49, P1347, DOI 10.2337/diabetes.49.8.1347; Lahlou N, 2002, DIABETES, V51, P1980, DOI 10.2337/diabetes.51.6.1980; Mergen M, 2001, J CLIN ENDOCR METAB, V86, P3448, DOI 10.1210/jc.86.7.3448; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Rankinen T, 2002, OBES RES, V10, P196, DOI 10.1038/oby.2002.30; Rosmond R, 2001, DIABETOLOGIA, V44, P1335, DOI 10.1007/s001250100649; Sina M, 1999, AM J HUM GENET, V65, P1501, DOI 10.1086/302660; SPITZER RL, 1993, INT J EAT DISORDER, V13, P137, DOI 10.1002/1098-108X(199303)13:2&lt;161::AID-EAT2260130204&gt;3.0.CO;2-R; SPITZER RL, 1992, INT J EAT DISORDER, V11, P191, DOI 10.1002/1098-108X(199204)11:3&lt;191::AID-EAT2260110302&gt;3.0.CO;2-S; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; TATARANNI PA, 1995, AM J CLIN NUTR, V62, P730, DOI 10.1093/ajcn/62.4.730; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wauters M, 1998, Eat Weight Disord, V3, P124; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; 1999, WHO TECH REP SER, V894, P1	43	246	260	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1096	1103		10.1056/NEJMoa021971	http://dx.doi.org/10.1056/NEJMoa021971			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	656UY	12646666	Bronze			2022-12-01	WOS:000181628400005
J	Gillett, NP; Zwiers, FW; Weaver, AJ; Stott, PA				Gillett, NP; Zwiers, FW; Weaver, AJ; Stott, PA			Detection of human influence on sea-level pressure	NATURE			English	Article							ANTHROPOGENIC CLIMATE-CHANGE; MODEL	Greenhouse gases and tropospheric sulphate aerosols-the main human influences on climate-have been shown to have had a detectable effect on surface air temperature(1-3), the temperature of the free troposphere and stratosphere(2,4) and ocean temperature(5,6) Nevertheless, the question remains as to whether human influence is detectable in any variable other than temperature. Here we detect an influence of anthropogenic greenhouse gases and sulphate aerosols in observations of winter sea-level pressure (December to February), using combined simulations from four climate models. We find increases in sea-level pressure over the subtropical North Atlantic Ocean, southern Europe and North Africa, and decreases in the polar regions and the North Pacific Ocean, in response to human influence. Our analysis also indicates that the climate models substantially underestimate the magnitude of the sea-level pressure response. This discrepancy suggests that the upward trend in the North Atlantic Oscillation index(7) (corresponding to strengthened westerlies in the North Atlantic region), as simulated in a number of global warming scenarios(8-10), may be too small, leading to an underestimation of the impacts of anthropogenic climate change on European climate.	Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Meteorol Serv Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC V8W 2Y2, Canada; Hadley Ctr Climate Predict & Res, Met Off, Bracknell RG12 2SY, Berks, England	University of Victoria; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Meteorological Service of Canada; Met Office - UK; Hadley Centre	Gillett, NP (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055, Victoria, BC V8W 3P6, Canada.		Scott, Peter/GYA-5335-2022; Weaver, Andrew J/E-7590-2011; Stott, Peter/N-1228-2016	Weaver, Andrew J/0000-0001-8919-3598; Stott, Peter/0000-0003-4853-7686				Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; ALLEN MR, IN PRESS SURV GEOPHY; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Fyfe JC, 1999, GEOPHYS RES LETT, V26, P1601, DOI 10.1029/1999GL900317; Gillett NP, 2000, GEOPHYS RES LETT, V27, P993, DOI 10.1029/1999GL010981; Gillett NP, 2002, GEOPHYS RES LETT; GILLETT NP, 2002, J GEOPHYS RES; GILLETT NP, 2003, N ATLANTIC OSCILLATI, pCH9; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Krishnamurti TN, 1999, SCIENCE, V285, P1548, DOI 10.1126/science.285.5433.1548; Lambert SJ, 2001, CLIM DYNAM, V17, P83, DOI 10.1007/PL00013736; MITCHELL JFB, 2001, CLIMATE CHANGE 2001, pCH12; Osborn TJ, 1999, CLIM DYNAM, V15, P685, DOI 10.1007/s003820050310; REICHERT BK, 2002, GEOPHYS RES LETT; Shindell DT, 1999, NATURE, V399, P452, DOI 10.1038/20905; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Tett SFB, 1996, SCIENCE, V274, P1170, DOI 10.1126/science.274.5290.1170; Thomas JM, 2000, TOP CATAL, V11, P1; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; TRENBERTH KE, 1980, MON WEATHER REV, V108, P855, DOI 10.1175/1520-0493(1980)108<0855:TNHSLP>2.0.CO;2; [No title captured]	21	168	174	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					292	294		10.1038/nature01487	http://dx.doi.org/10.1038/nature01487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646917				2022-12-01	WOS:000181637300035
J	Knight, EL; Stampfer, MJ; Hankinson, SE; Spiegelman, D; Curhan, GC				Knight, EL; Stampfer, MJ; Hankinson, SE; Spiegelman, D; Curhan, GC			The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; FOOD FREQUENCY QUESTIONNAIRE; CREATININE CLEARANCE; DIETARY-PROTEIN; MEASUREMENT ERROR; HEALTHY-SUBJECTS; CONFIDENCE-INTERVALS; PHOSPHORUS INTAKE; SERUM CREATININE; BLOOD-PRESSURE	Background: In individuals with moderate to severe renal insufficiency, low protein intake may slow renal function decline. However, the long-term impact of protein intake on renal function in persons with normal renal function or mild renal insufficiency is unknown. Objective: To determine whether protein intake influences the rate of renal function change in women over an 11-year period. Design: Prospective cohort study. Setting: Nurses' Health Study. Participants: 1624 women enrolled in the Nurses' Health Study who were 42 to 68 years of age in 1989 and gave blood samples in 1989 and 2000. Ninety-eight percent of women were white, and 1% were African American. Measurements: Protein intake was measured in 1990 and 1994 by using a semi-quantitative food-frequency questionnaire. Creatinine concentration was used to estimate glomerular filtration rate (GFR) and creatinine clearance. Results: In multivariate linear regression analyses, high protein intake was not significantly associated with change in estimated GFR in women with normal renal function (defined as an estimated GFR greater than or equal to 80 mL/min per 1.73 m(2)). Change in estimated GFR in this subgroup over the 11-year period was 0.25 mL/min per 1.73 m(2) (95% Cl, -0.78 to 1.28 mL/min per 1.73 m(2)) per 10-g increase in protein intake; the change in estimated GFR was 1.14 mL/min per 1.73 m(2) (Cl, -3.63 to 5.92 mL/min per 1.73 m(2)) after measurement-error adjustment for protein intake. In women with mild renal insufficiency (defined as an estimated GFR > 55 mL/min per 1.73 m(2) but <80 mL/min per 1.73 m(2)), protein intake was significantly associated with a change in estimated GFR of -1.69 mL/min per 1.73 m(2) (Cl, -2.93 to -0.45 mL/min per 1.73 m 2) per 10-g increase in protein intake. After measurement-error adjustment, the change in estimated GFR was -7.72 mL/min per 1.73 m(2) (Cl, -15.52 to 0.08 mL/min per 1.73 m(2)) per 10-g increase in protein intake, an association of borderline statistical significance. High intake of nondairy animal protein in women with mild renal insufficiency was associated with a significantly greater change in estimated GFR (-1.21 mL/min per 1.73 M2 [Cl, -2.34 to -0.33 mL/min per 1.73 m(2)] per 10-g increase in nondairy animal protein intake). Conclusions: High protein intake was not associated with renal function decline in women with normal renal function. However, high total protein intake, particularly high intake of nondairy animal protein, may accelerate renal function decline in women with mild renal insufficiency.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital	Knight, EL (corresponding author), Channing Labs, Nurses Hlth Study, 3rd Floor,181 Longwood Ave, Boston, MA 02115 USA.	elknight@partners.org			NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052866, T32DK007791] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG BG, 1989, STAT MED, V8, P1151, DOI 10.1002/sim.4780080916; Barsotti G, 1996, NEPHRON, V74, P390, DOI 10.1159/000189341; BARSOTTI G, 1984, CLIN NEPHROL, V21, P54; Blackburn GL, 2001, CLEV CLIN J MED, V68, P761, DOI 10.3949/ccjm.68.9.761; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; BROWN SA, 1991, J AM SOC NEPHROL, V1, P1169; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; DAMICO G, 1994, NEPHROL DIAL TRANSPL, V9, P1590; Dworkin LD, 2001, CURR OPIN NEPHROL HY, V10, P551, DOI 10.1097/00041552-200109000-00001; FOUQUE D, 2000, COCHRANE DATABASE SY; Fuiano G, 1996, NEPHRON, V73, P430; GENTILE MG, 1993, CLIN NEPHROL, V40, P315; Grimm M, 2001, EUR J CLIN NUTR, V55, P153, DOI 10.1038/sj.ejcn.1601131; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; IHLE BU, 1989, NEW ENGL J MED, V321, P1773, DOI 10.1056/NEJM198912283212601; JIBANI MM, 1991, DIABETIC MED, V8, P949, DOI 10.1111/j.1464-5491.1991.tb01535.x; JONES MG, 1987, CLIN NEPHROL, V27, P71; Kasiske BL, 1998, AM J KIDNEY DIS, V31, P954, DOI 10.1053/ajkd.1998.v31.pm9631839; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KONTESSIS PS, 1995, DIABETES CARE, V18, P1233, DOI 10.2337/diacare.18.9.1233; Krauss RM, 2000, STROKE, V31, P2751, DOI 10.1161/01.STR.31.11.2751; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEW SQ, 1991, J AM SOC NEPHROL, V2, P856; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; LOCATELLI F, 1991, LANCET, V337, P1299, DOI 10.1016/0140-6736(91)92977-A; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; McDowell M A, 1994, Adv Data, P1; NICOLL SR, 1991, NEPHRON, V59, P621, DOI 10.1159/000186654; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Rodriguez-Porcel M, 2001, HYPERTENSION, V37, P774, DOI 10.1161/01.HYP.37.2.774; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SALAZAR DE, 1988, AM J MED, V84, P1053, DOI 10.1016/0002-9343(88)90310-5; SOKOLL LJ, 1994, CLIN CHEM, V40, P2276; Soroka N, 1998, NEPHRON, V79, P173, DOI 10.1159/000045021; Spiegelman D, 1997, AM J CLIN NUTR, V65, P1179; Stein K, 2000, J AM DIET ASSOC, V100, P760, DOI 10.1016/S0002-8223(00)00219-4; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 2002, AM J KIDNEY DIS S2, V39, pS1	44	257	268	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2003	138	6					460	467		10.7326/0003-4819-138-6-200303180-00009	http://dx.doi.org/10.7326/0003-4819-138-6-200303180-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655PV	12639078	Green Published			2022-12-01	WOS:000181562400003
J	Thrall, PH; Burdon, JJ				Thrall, PH; Burdon, JJ			Evolution of virulence in a plant host-pathogen metapopulation	SCIENCE			English	Article							MELAMPSORA-LINI; INFECTIOUS-DISEASES; LOCAL ADAPTATION; PARASITE COEVOLUTION; RACIAL STRUCTURE; RESISTANCE; MARGINALE; POPULATION; SELECTION; MIGRATION	In a wild plant-pathogen system, host resistance and pathogen virulence varied markedly among local populations. Broadly virulent pathogens occurred more frequently in highly resistant host populations, whereas avirulent pathogens dominated susceptible populations. Experimental inoculations indicated a negative trade-off between spore production and virulence. The nonrandom spatial distribution of pathogens, maintained through time despite high pathogen mobility, implies that selection favors virulent strains of Melampsora lini in resistant Linum marginale populations and avirulent strains in susceptible populations. These results are consistent with gene-for-gene models of host-pathogen coevolution that require trade-offs to prevent pathogen virulence increasing until host resistance becomes selectively neutral.	CSIRO Plant Ind, Ctr Plant Biodivers Res, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Thrall, PH (corresponding author), CSIRO Plant Ind, Ctr Plant Biodivers Res, Gen POB 1600, Canberra, ACT 2601, Australia.		Burdon, Jeremy J/B-9913-2009					BLACK FL, 1995, EXP CLIN IMMUNOGENET, V12, P206; BURDON JJ, 1994, EVOLUTION, V48, P1564, DOI [10.2307/2410248, 10.1111/j.1558-5646.1994.tb02196.x]; BURDON JJ, 1992, PLANT PATHOL, V41, P165, DOI 10.1111/j.1365-3059.1992.tb02335.x; Burdon JJ, 1999, EVOLUTION, V53, P704, DOI [10.1111/j.1558-5646.1999.tb05365.x, 10.2307/2640711]; CHIN KM, 1984, PLANT PATHOL, V33, P535, DOI 10.1111/j.1365-3059.1984.tb02878.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI 10.1111/j.1558-5646.1999.tb04538.x; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Heyndrickx L, 2000, AIDS, V14, P1862, DOI 10.1097/00002030-200008180-00028; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; JAROSZ AM, 1991, EVOLUTION, V45, P1618, DOI [10.2307/2409783, 10.1111/j.1558-5646.1991.tb02667.x]; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; LIPSITCH M, 1995, EVOLUTION, V49, P743, DOI 10.1111/j.1558-5646.1995.tb02310.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2002, EVOL ECOL RES, V4, P219; Meagher S, 1999, EVOLUTION, V53, P1318, DOI 10.1111/j.1558-5646.1999.tb04547.x; Messenger SL, 1999, P ROY SOC B-BIOL SCI, V266, P397, DOI 10.1098/rspb.1999.0651; Musser JM, 1996, EMERG INFECT DIS, V2, P1, DOI 10.3201/eid0201.960101; Parrish CR, 1999, VET MICROBIOL, V69, P29, DOI 10.1016/S0378-1135(99)00084-X; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Thrall PH, 2002, EVOLUTION, V56, P1340; Thrall PH, 2000, PLANT PATHOL, V49, P767, DOI 10.1046/j.1365-3059.2000.00523.x; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; THRALL PH, IN PRESS PLANT PATHO	27	311	322	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1735	1737		10.1126/science.1080070	http://dx.doi.org/10.1126/science.1080070			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12637745				2022-12-01	WOS:000181519500046
J	Dalton, R				Dalton, R			Auction of DNA archive cancelled	NATURE			English	News Item																		KLUG A, 2003, NATURE, V421, P564	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					102	102		10.1038/422102b	http://dx.doi.org/10.1038/422102b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634743	Bronze			2022-12-01	WOS:000181488900006
J	Cramer, T; Yamanishi, Y; Clausen, BE; Forster, I; Pawlinski, R; Mackman, N; Haase, VH; Jaenisch, R; Corr, M; Nizet, V; Firestein, GS; Gerber, HP; Ferrara, N; Johnson, RS				Cramer, T; Yamanishi, Y; Clausen, BE; Forster, I; Pawlinski, R; Mackman, N; Haase, VH; Jaenisch, R; Corr, M; Nizet, V; Firestein, GS; Gerber, HP; Ferrara, N; Johnson, RS			HIF-1 alpha is essential for myeloid cell-mediated inflammation	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; CUTANEOUS INFLAMMATION; ALVEOLAR MACROPHAGES; OXYGEN HOMEOSTASIS; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; OXIDATIVE STRESS; TUMOR HYPOXIA; T-CELL; EXPRESSION	Granulocytes and monocytes/macrophages of the myeloid lineage are the chief cellular agents of innate immunity. Here, we have examined the inflammatory response in mice with conditional knockouts of the hypoxia responsive transcription factor HIF-1alpha, its negative regulator VHL, and a known downstream target, VEGF. We find that activation of HIF-1alpha is essential for myeloid cell infiltration and activation in vivo through a mechanism independent of VEGF. Loss of VHL leads to a large increase in acute inflammatory responses. Our results show that HIF-1alpha is essential for the regulation of glycolytic capacity in myeloid cells: when HIF-1alpha is absent, the cellular ATP pool is drastically reduced. The metabolic defect results in profound impairment of myeloid cell aggregation, motility, invasiveness, and bacterial killing. This role for HIF-1alpha demonstrates its direct regulation of survival and function in the inflammatory microenvironment.	Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Rheumatol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; Scripps Res Inst, Dept Immunol, San Diego, CA 92037 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich; Scripps Research Institute; University of Pennsylvania; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech	Johnson, RS (corresponding author), Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.		Nizet, Victor/AAF-3190-2019; CLAUSEN, Björn E./A-8229-2010; PAwlinski, Rafal/AAD-6090-2022; Förster, Irmgard/P-8545-2016; Haase, Volker Hans/AAJ-5061-2021; Haase, Volker Hans/A-6758-2013; Johnson, Randall/AAM-1189-2021; Cramer, Thorsten/S-2479-2016	CLAUSEN, Björn E./0000-0002-2484-7842; Förster, Irmgard/0000-0002-7644-5642; Haase, Volker Hans/0000-0002-7051-8994; Johnson, Randall/0000-0002-4084-6639; Cramer, Thorsten/0000-0002-6462-239X; Nizet, Victor/0000-0003-3847-0422	NCI NIH HHS [CA82515, R01 CA100787, R01 CA082515] Funding Source: Medline; NIDDK NIH HHS [K08 DK002668] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082515, R01CA100787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD F, 1987, BRIT J EXP PATHOL, V68, P569; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BAKKER A., 1927, KLIN WOCHENSCHR, V6, P252, DOI 10.1007/BF01710710; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; BOXER LA, 1977, J CELL PHYSIOL, V91, P89, DOI 10.1002/jcp.1040910110; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Buttgereit F, 2000, IMMUNOL TODAY, V21, P192; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Denko NC, 2001, CANCER RES, V61, P795; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Fleischmann W, 1927, BIOCHEM Z, V181, P395; Grunstein J, 1999, CANCER RES, V59, P1592; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hempel SL, 1996, AM J RESP CELL MOL, V14, P170, DOI 10.1165/ajrcmb.14.2.8630267; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; KALBHEN DA, 1967, MED PHARMACOL EXP, V16, P425; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KAY NE, 1980, J RETICULOENDOTH SOC, V28, P367; KELLETT DN, 1965, J PHARM PHARMACOL, V18, P199; Kempner W, 1939, J CLIN INVEST, V18, P291, DOI 10.1172/JCI101045; KITTLICK PD, 1986, EXP PATHOL-JENA, V30, P1; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Levene PA, 1912, J BIOL CHEM, V11, P361; Levene PA, 1912, J BIOL CHEM, V12, P265; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; MANJUNATH N, 1993, J IMMUNOL, V151, P1528; MANNS G, 1967, EXP INT J EXP MED, V17, P557; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MICHL J, 1976, J EXP MED, V144, P1484, DOI 10.1084/jem.144.6.1484; NAJAFIPOUR H, 1995, EXP PHYSIOL, V80, P209, DOI 10.1113/expphysiol.1995.sp003841; NAKADATE T, 1985, JPN J PHARMACOL, V38, P161, DOI 10.1254/jjp.38.161; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; OFLAHERTY JT, 1977, J IMMUNOL, V119, P1751; Ott A, 1987, Adv Exp Med Biol, V220, P79; RAICK AN, 1973, CANCER RES, V33, P269; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Roos D, 1979, Adv Exp Med Biol, V121, P29; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; SAWYER RG, 1991, ANN SURG, V213, P253, DOI 10.1097/00000658-199103000-00013; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Schor H, 2000, Dev Immunol, V7, P227, DOI 10.1155/2000/51902; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; SIMCHOWITZ L, 1979, ARTHRITIS RHEUM, V22, P755, DOI 10.1002/art.1780220711; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thepen T, 2000, NAT BIOTECHNOL, V18, P48, DOI 10.1038/71908; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; VANOTTEREN GM, 1995, AM J RESP CELL MOL, V13, P399, DOI 10.1165/ajrcmb.13.4.7546769; WEISDORF DJ, 1982, BLOOD, V60, P888; WEISDORF DJ, 1982, INFLAMMATION, V6, P245, DOI 10.1007/BF00916406	65	1515	1603	6	149	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					645	657		10.1016/S0092-8674(03)00154-5	http://dx.doi.org/10.1016/S0092-8674(03)00154-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628185	Green Accepted, Bronze			2022-12-01	WOS:000181443600008
J	Dalal, HM; Evans, PH				Dalal, HM; Evans, PH			Achieving national service framework standards for cardiac rehabilitation and secondary prevention	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PRIMARY-CARE	Problem Integrated care for patients who survive a myocardial infarction is lacking. Many patients are not offered cardiac rehabilitation, and secondary prevention is not optimal. Design 12 month audit of 106 patients who survived an acute myocardial infarction. Background and setting Carrick Primary Care Trust in Cornwall (population 98 500) and one district general hospital. Key measures for improvement Proportion of patients who complete a cardiac rehabilitation programme after a myocardial infarction. Proportion of patients with optimal secondary prevention, as measured by smoking status, body mass index, cholesterol < 5.0 mmol/l, and blood pressure < 140/85 mm Hg. Strategies for change We set up a novel, integrated, and seamless system for cardiac rehabilitation. We employed a cardiac liaison nurse to identify and assess in hospital all patients with suspected acute myocardial infarction. The nurse offered patients the choice of home based rehabilitation with the Heart Manual or hospital based rehabilitation. The nurse gave discharge details to the patient's general practice; these were to be included on a practice based register of coronary heart disease. Effects of change All 106 eligible patients were offered cardiac rehabilitation and were included in a practice based register of coronary heart disease to facilitate long term follow up in primary care. 47 (44%) patients chose home based rehabilitation with the Heart Manual, and 41 (87%) of these completed the programme; 35 (33%) patients chose hospital based rehabilitation, and 17 (49%) of these completed the programme. The numbers of patients achieving secondary prevention targets improved significantly: those with serum cholesterol < 5.0 mmol/l at discharge increased from 28% at baseline to 75% at 12 months. Optimal care (at least 80-90% uptake of an intervention) was seen with antiplatelet and statin treatments and with smoking cessation. Significantly more patients were prescribed statins at follow up than at baseline (77/106 v 80/91, P=0.005). Lessons learnt National service framework targets for cardiac rehabilitation and secondary prevention can be achieved in patients who survive a myocardial infarction by integrating rehabilitation services (home and hospital) with secondary prevention clinics in primary care. Nurse led clinics in primary care facilitate long term structured care and optimal secondary prevention.	Royal Cornwall Hosp, Truro TR1 3LJ, Cornwall, England; Postgrad Med Ctr, Peninsula Med Sch, Somerset & N & E Devon Primary Care Res Network, Exeter EX2 5DW, Devon, England	Royal Cornwall Hospital; University of Exeter	Dalal, HM (corresponding author), Lower Lemon St Surg, Truro TR1 2LZ, Cornwall, England.			Evans, Philip/0000-0002-5277-3545				Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Bethell H J, 2001, J Cardiopulm Rehabil, V21, P111, DOI 10.1097/00008483-200103000-00008; Campbell NC, 1998, HEART, V80, P447, DOI 10.1136/hrt.80.5.447; *CORNW ISL SCILL H, 1998, HLTH POP 1998 ANN RE; Dalal HM, 1999, BRIT MED J, V319, P853, DOI 10.1136/bmj.319.7213.853a; de Bono DP, 1998, BRIT MED J, V316, P1329, DOI 10.1136/bmj.316.7141.1329; *DEP HLTH, 2000, NAT SERV FRAM COR HE; JOLLIFFE JA, 2002, COCHRANE LIB, V2, DOI UNSP AB001800; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin RJP, 1998, BRIT MED J, V316, P1354, DOI 10.1136/bmj.316.7141.1354; Mayou R, 1996, BRIT MED J, V313, P1498, DOI 10.1136/bmj.313.7071.1498; Scottish Intercollegiate Guidelines Network 57, 2002, CARD REH NAT CLIN GU; Wood D, 1998, HEART, V80, pS1; 1998, EFFECTIVE HLTH CARE, V4	15	51	51	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					481	484		10.1136/bmj.326.7387.481	http://dx.doi.org/10.1136/bmj.326.7387.481			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609946	Green Published			2022-12-01	WOS:000181421400020
J	Filippone, M; Sartor, M; Zacchello, F; Baraldi, E				Filippone, M; Sartor, M; Zacchello, F; Baraldi, E			Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age	LANCET			English	Article							SEQUELAE	Bronchopulmonary dysplasia is associated with abnormalities in lung function during infancy, yet many infants recover with no respiratory problems in the long term. We therefore did a longitudinal study of pulmonary function in 18 children with moderate to severe bronchopulmonary dysplasia. Forced expiratory volume in 1 s (FEV1) and forced mid-expiratory flow (FEF25-75) at school age were lower than normal in 15 of IS children, and both showed a significant positive correlation with the maximal flow at functional residual capacity (Vmax(FRC)) at 24 months of age (r=0.68 and 0.85, respectively). Our results suggest that assessment of respiratory function during infancy can help to identify children with bronchopulmonary dysplasia at risk of incomplete recovery of respiratory function during childhood.	Univ Padua, Sch Med, Dept Paediat, I-35128 Padua, Italy	University of Padua	Baraldi, E (corresponding author), Univ Padua, Sch Med, Dept Paediat, Via Giustiniani 3, I-35128 Padua, Italy.		baraldi, eugenio/AAC-5233-2022	BARALDI, EUGENIO/0000-0002-1829-3652				Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603	5	95	99	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					753	754		10.1016/S0140-6736(03)12633-5	http://dx.doi.org/10.1016/S0140-6736(03)12633-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620742				2022-12-01	WOS:000181232000013
J	Blumenschine, RJ; Peters, CR; Masao, FT; Clarke, RJ; Deino, AL; Hay, RL; Swisher, CC; Stanistreet, IG; Ashley, GM; McHenry, LJ; Sikes, NE; van der Merwe, NJ; Tactikos, JC; Cushing, AE; Deocampo, DM; Njau, JK; Ebert, JI				Blumenschine, RJ; Peters, CR; Masao, FT; Clarke, RJ; Deino, AL; Hay, RL; Swisher, CC; Stanistreet, IG; Ashley, GM; McHenry, LJ; Sikes, NE; van der Merwe, NJ; Tactikos, JC; Cushing, AE; Deocampo, DM; Njau, JK; Ebert, JI			Late pliocene Homo and hominid land use from western Olduvai Gorge, Tanzania	SCIENCE			English	Article							PLEISTOCENE HOMINIDS; ZINJANTHROPUS; BASIN	Excavation in the previously little-explored western portion of Olduvai Gorge indicates that hominid land use of the eastern pateobasin extended at least episodically to the west. Finds included a dentally complete Homo maxilla (OH 65) with lower face, Oldowan stone artifacts, and butchery-marked bones dated to be between 1.84 and 1.79 million years old. The hominid shows strong affinities to the KNM ER 1470 cranium from Kenya (Homo rudolfensis), a morphotype previously unrecognized at Olduvai. ER 1470 and OH 65 can be accommodated in the H. habilis holotype, casting doubt on H. rudolfensis as a biologically valid taxon.	Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, New Brunswick, NJ 08901 USA; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Paleocultural & Environm Res, Dar Es Salaam, Tanzania; Univ Witwatersrand, Sch Med, Sch Anat Sci, ZA-2193 Johannesburg, South Africa; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85718 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Univ Liverpool, Dept Earth Sci, Liverpool L69 3BX, Merseyside, England; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Univ Cape Town, Dept Archaeol, ZA-7700 Rondebosch, Cape Town, South Africa; Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, MRC 119, Washington, DC 20560 USA; Ebert & Associates, Albuquerque, NM 87107 USA	Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Witwatersrand; Berkeley Geochronolgy Center; University of Arizona; Rutgers State University New Brunswick; University of Liverpool; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Cape Town; Smithsonian Institution; Smithsonian National Museum of Natural History	Blumenschine, RJ (corresponding author), Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, 131 George St, New Brunswick, NJ 08901 USA.		McHenry, Lindsay Jean/ABP-7150-2022	McHenry, Lindsay Jean/0000-0003-1805-1941				BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1998, J HUM EVOL, V34, P565, DOI 10.1006/jhev.1998.0216; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Curtis G.H., 1972, CALIBRATION HOMINOID, P289; Groves C., 1989, THEORY HUMAN PRIMATE; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Leakey L. S. B., 1965, OLDUVAI GORGE 1951 1; LEAKEY LSB, 1964, NATURE, V202, P5, DOI 10.1038/202005a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; LEETHORP JA, 1987, S AFR J SCI, V83, P712; McMahon R.F., 1983, P505; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; PETERS CR, 1996, 4000000 YEARS HOMINI, P175; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Stringer C.B., 1986, P266; TOBIAS PV, 1966, NATURE, V209, P953, DOI 10.1038/209953a0; Tobias PV, 1991, OLDUVAI GORGE, V4; Walker A., 1981, HOMO ERECTUS PAPERS, P193; Walter R. C., 1992, QUATERN INT, V13-14, P37, DOI DOI 10.1016/1040-6182(92)90008-P; WALTER RC, 1991, NATURE, V354, P145, DOI 10.1038/354145a0; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood Bernard, 1993, P485; [No title captured]	29	173	177	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1217	1221		10.1126/science.1075374	http://dx.doi.org/10.1126/science.1075374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	646YY	12595689				2022-12-01	WOS:000181065500036
J	Check, E				Check, E			BSE in human tissue fires debate on patient disclosure	NATURE			English	News Item																		Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; 2000, NATURE, V405, P7	2	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					326	326		10.1038/419326a	http://dx.doi.org/10.1038/419326a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12645536	Bronze			2022-12-01	WOS:000178195400005
J	Jiang, YX; Lee, A; Chen, JY; Ruta, V; Cadene, M; Chait, BT; MacKinnon, R				Jiang, YX; Lee, A; Chen, JY; Ruta, V; Cadene, M; Chait, BT; MacKinnon, R			X-ray structure of a voltage-dependent K+ channel	NATURE			English	Article							POTASSIUM CHANNEL; GATING CHARGE; TRANSMEMBRANE MOVEMENT; S4 SEGMENT; PERSPECTIVE; SEQUENCE; PROTEIN; ACTIVATION; CONDUCTION; HANATOXIN	Voltage-dependent K+ channels are members of the family of voltage-dependent cation (K+, Na+ and Ca2+) channels that open and allow ion conduction in response to changes in cell membrane voltage. This form of gating underlies the generation of nerve and muscle action potentials, among other processes. Here we present the structure of KvAP, a voltage-dependent K+ channel from Aeropyrum pernix. We have determined a crystal structure of the full-length channel at a resolution of 3.2 Angstrom, and of the isolated voltage-sensor domain at 1.9 Angstrom, both in complex with monoclonal Fab fragments. The channel contains a central ion-conduction pore surrounded by voltage sensors, which form what we call 'voltage-sensor paddles'-hydrophobic, cationic, helix-turn-helix structures on the channel's outer perimeter. Flexible hinges suggest that the voltage-sensor paddles move in response to membrane voltage changes, carrying their positive charge across the membrane.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, Lab Mass Spectrometry & Gaseous Ion Chem, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu		Cadene, Martine/0000-0003-4936-2662; Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; BRUNGER AT, 1991, J MOL BIOL, V221, P239, DOI 10.1016/0022-2836(91)90817-P; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Harlow E., 1989, ANTIBODIES LAB MANUA; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	1527	1601	6	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					33	41		10.1038/nature01580	http://dx.doi.org/10.1038/nature01580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721618				2022-12-01	WOS:000182561600032
J	Maller, JL				Maller, JL			Fishing at the cell surface	SCIENCE			English	Editorial Material							PROGESTERONE-RECEPTOR; OOCYTE; PROTEIN; MATURATION; ARREST		Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA.							Bayaa M, 2000, P NATL ACAD SCI USA, V97, P12607, DOI 10.1073/pnas.220302597; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Maller JL, 2001, P NATL ACAD SCI USA, V98, P8, DOI 10.1073/pnas.98.1.8; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Schmitt A, 2002, P NATL ACAD SCI USA, V99, P4361, DOI 10.1073/pnas.022056399; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; Tian JD, 2000, P NATL ACAD SCI USA, V97, P14358, DOI 10.1073/pnas.250492197; YONG Z, 2003, P NATL ACAD SCI USA, V100, P2237; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	11	36	37	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					594	595		10.1126/science.1083725	http://dx.doi.org/10.1126/science.1083725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714732				2022-12-01	WOS:000182453700028
J	Savic, R; Luo, LB; Eisenberg, A; Maysinger, D				Savic, R; Luo, LB; Eisenberg, A; Maysinger, D			Micellar nanocontainers distribute to defined cytoplasmic organelles	SCIENCE			English	Article							BLOCK-COPOLYMER MICELLES; DRUG-DELIVERY; CELLS; NANOPARTICLES; DIBLOCK; TARGET; NERVE	Block copolymer micelles are water-soluble biocompatible nanocontainers with great potential for delivering hydrophobic drugs. An understanding of their cellular distribution is essential to achieving selective delivery of drugs at the subcellular level. Triple-labeling confocal microscopy in live cells revealed the localization of micelles in several cytoplasmic organelles, including mitochondria, but not in the nucleus. Moreover, micelles change the cellular distribution of and increase the amount of the agent delivered to the cells. These micelles may thus be worth exploring for their potential to selectively deliver drugs to specified subcellular targets.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada	McGill University; McGill University	Maysinger, D (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Maysinger, Dusica/GYU-6332-2022; Eisenberg, Adi/B-8676-2008					Allen C, 2000, DRUG DELIV, V7, P139; De Jaeghere F, 2000, J DRUG TARGET, V8, P143, DOI 10.3109/10611860008996860; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haughland R.P., 1996, HDB FLUORESCENT PROB; Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10; Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Liaw J, 1999, PHARM RES-DORDR, V16, P213, DOI 10.1023/A:1012157906528; Liu JQ, 2001, BIOMACROMOLECULES, V2, P362, DOI 10.1021/bm015515c; Luo LB, 2002, BIOCONJUGATE CHEM, V13, P1259, DOI 10.1021/bc025524y; MAYSINGER D, 2002, POLYM BIOMATERIALS, pCH42; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Rapoport N, 2002, J PHARM SCI, V91, P157, DOI 10.1002/jps.10006; Saltzman, 2001, DRUG DELIVERY ENG PR; Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8; Torchilin VP, 2002, ADV DRUG DELIVER REV, V54, P235, DOI 10.1016/S0169-409X(02)00019-4; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Webb RH, 1999, METHOD ENZYMOL, V307, P3; YOKOYAMA M, 1998, BIORELATED POLYM GEL, pCH6; Zhang LF, 1996, SCIENCE, V272, P1777, DOI 10.1126/science.272.5269.1777	23	976	1024	7	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					615	618		10.1126/science.1078192	http://dx.doi.org/10.1126/science.1078192			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714738				2022-12-01	WOS:000182453700034
J	Bonifacio, P; Limongi, M; Chieffi, A				Bonifacio, P; Limongi, M; Chieffi, A			How did the metals in a giant star originate?	NATURE			English	Article							CHEMICAL-COMPOSITION; POOR STARS; SUPERNOVAE		Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy; Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Rome, Italy; CNR, Ist Astrofis Spaziale, I-00133 Rome, Italy	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF)	Bonifacio, P (corresponding author), Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy.	bonifaci@ts.astro.it						Aoki W, 2002, ASTROPHYS J, V576, pL141, DOI 10.1086/343761; Chieffi A, 2002, ASTROPHYS J, V577, P281, DOI 10.1086/342170; Chieffi A, 2002, ASTROPHYS SPACE SC L, V274, P47; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Depagne E, 2002, ASTRON ASTROPHYS, V390, P187, DOI 10.1051/0004-6361:20020687	5	19	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					834	834		10.1038/422834a	http://dx.doi.org/10.1038/422834a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712194	Bronze, Green Submitted			2022-12-01	WOS:000182432600042
J	Chan-Yeung, M; Yu, WC				Chan-Yeung, M; Yu, WC			Outbreak of severe acute respiratory syndrome in Hong kong special administrative region: case report	BRITISH MEDICAL JOURNAL			English	Article								Objective To describe the outbreak of severe acute respiratory syndrome in Hong Kong. Design Descriptive case series. Setting Hong Kong, Special Administrative Region, China Results The outbreak started with a visitor from southern China on 21 February At the hospitals where the first cases were treated the disease spread quickly among healthcare workers, and then out into the community as family members became infected. By 1 April, 685 cases had been reported with 16 deaths. Symptoms include high fever and one or more respiratory symptoms (including cough, shortness of breath, and difficulty breathing,). Changes in lung tissue suggest that part of the lung damage is due to cytokines induced by the microbial agent, which has led to empirical treatment with corticosteroids, broad spectrum antiviral agent, and antibacterial cover. There is strong evidence that a novel coronavirus is the pathogen. Precautions for droplet infection should be instituted, including the wearing of masks and rigorous disinfection and hygiene procedures. On 27 March the Department of Health announced drastic measures, including vigorous contact tracing and examination, quarantine of contacts in their homes, and closure of all schools and universities. Conclusion The rapidity of the spread of the disease and the morbidity indicate that the agent responsible is highly infectious and virulent. Strict infection control measures for droplet and contact transmission by healthcare workers, a vigilant healthcare profession, and public education are essential for disease prevention.	Univ Hong Kong, Queen Mary Hosp, Div Resp & Crit Care Med, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan-Yeung, M (corresponding author), Univ Hong Kong, Queen Mary Hosp, Div Resp & Crit Care Med, 4-F,Professorial Block, Hong Kong, Hong Kong, Peoples R China.							Centers for Disease Control and Prevention, SEV AC RESP SYNDR SA; *GOV HONG KONG SPE, ATYP PNEUM; *HOSP AUTH, 2003, SEV AC RESP SYNDR CL; LEE N, 2003, N ENGL J MED, V7; PERIRIS JSM, 2003, LANCET, V8; TSANG KW, 2003, N ENGL J MED    0401; *WHO, 2003, SEV AC RESP SYNDR	7	79	95	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					850	+		10.1136/bmj.326.7394.850	http://dx.doi.org/10.1136/bmj.326.7394.850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702616	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000182386800016
J	Chang, EF; Merzenich, MM				Chang, EF; Merzenich, MM			Environmental noise retards auditory cortical development	SCIENCE			English	Article							PLASTICITY; CORTEX; MATURATION; EXPERIENCE; CATS; SENSITIVITY; PERIODS; RAT; MAP	The mammalian auditory cortex normally undergoes rapid and progressive functional maturation. Here we show that rearing infant rat pups in continuous, moderate-level noise delayed the emergence of adultlike topographic representational order and the refinement of response selectivity in the primary auditory cortex (A1) long beyond normal developmental benchmarks. When those noise-reared adult rats were subsequently exposed to a pulsed pure-tone stimulus, A1 rapidly reorganized, demonstrating that exposure-driven plasticity characteristic of the critical period was still ongoing. These results demonstrate that A1 organization is shaped by a young animal's exposure to salient, structured acoustic inputs-and implicate noise as a risk factor for abnormal child development.	Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chang, EF (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	echang@itsa.ucsf.edu			NINDS NIH HHS [NS-38416, NS-10414] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; Ehret G, 2000, HEARING RES, V141, P107, DOI 10.1016/S0378-5955(99)00213-0; Etzel RA, 1997, PEDIATRICS, V100, P724; Hanover JL, 1999, J NEUROSCI, V19, part. no.; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; MARLER P, 1973, P NATL ACAD SCI USA, V70, P1393, DOI 10.1073/pnas.70.5.1393; MOORE DR, 1985, ACTA OTO-LARYNGOL, P19; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; PHILBIN MK, 1994, DEV PSYCHOBIOL, V27, P11; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Ponton CW, 1996, NEUROREPORT, V8, P61, DOI 10.1097/00001756-199612200-00013; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Shepherd RK, 1997, ACTA OTO-LARYNGOL, P28; Stanton SG, 1996, AUDIT NEUROSCI, V2, P97; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	29	382	391	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2003	300	5618					498	502		10.1126/science.1082163	http://dx.doi.org/10.1126/science.1082163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702879				2022-12-01	WOS:000182295900044
J	Inoue, M; Chang, L; Hwang, J; Chiang, SH; Saltiel, AR				Inoue, M; Chang, L; Hwang, J; Chiang, SH; Saltiel, AR			The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin	NATURE			English	Article							3T3-L1 ADIPOCYTES; 3T3L1 ADIPOCYTES; RHO; TRANSLOCATION; GLUCOSE; TRANSPORT; PROTEINS; TC10; RAB4; GLUCOSE-TRANSPORTER-4	Insulin stimulates glucose transport by promoting exocytosis of the glucose transporter Glut4 (refs 1, 2). The dynamic processes involved in the trafficking of Glut4-containing vesicles, and in their targeting, docking and fusion at the plasma membrane, as well as the signalling processes that govern these events, are not well understood. We recently described tyrosine-phosphorylation events restricted to subdomains of the plasma membrane that result in activation of the G protein TC10 (refs 3, 4). Here we show that TC10 interacts with one of the components of the exocyst complex, Exo70. Exo70 translocates to the plasma membrane in response to insulin through the activation of TC10, where it assembles a multiprotein complex that includes Sec6 and Sec8. Overexpression of an Exo70 mutant blocked insulin-stimulated glucose uptake, but not the trafficking of Glut4 to the plasma membrane. However, this mutant did block the extracellular exposure of the Glut4 protein. So, the exocyst might have a crucial role in the targeting of the Glut4 vesicle to the plasma membrane, perhaps directing the vesicle to the precise site of fusion.	Univ Michigan, Med Ctr, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Inst Life Sci, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.		Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828; Chang, Louise/0000-0001-5501-4774				Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cormont M, 1996, MOL CELL BIOL, V16, P6879; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hwang JB, 1999, J BIOL CHEM, V274, P22813, DOI 10.1074/jbc.274.32.22813; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sherman LA, 1996, ENDOCRINOLOGY, V137, P266, DOI 10.1210/en.137.1.266; Shisheva A, 1997, BIOCHEMISTRY-US, V36, P6564, DOI 10.1021/bi970202g; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; TING AE, 1995, P NATL ACAD SCI USA, V92, P9613, DOI 10.1073/pnas.92.21.9613; VAN AL, 1997, GENE DEV, V11, P2295; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	29	264	279	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					629	633		10.1038/nature01533	http://dx.doi.org/10.1038/nature01533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687004	Green Published			2022-12-01	WOS:000182111400046
J	Serdula, MK; Khan, LK; Dietz, WH				Serdula, MK; Khan, LK; Dietz, WH			Weight-loss Counseling revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									CDCP, Div Nutr & Phys Act, Chron Dis Nutr Branch, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Serdula, MK (corresponding author), CDCP, Div Nutr & Phys Act, Chron Dis Nutr Branch, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K26, Atlanta, GA 30341 USA.	mks1@cdc.gov						Anderson DA, 1999, ARCH FAM MED, V8, P156, DOI 10.1001/archfami.8.2.156; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Fiore MC., 2000, TREATING TOBACCO USE; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; *NIH, 2003, PRACT GUID ID EV TRE; *PARTN HLTH WEIGH, 2003, VOL GUID PROV WEIGHT; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Simkin-Silverman LR, 1997, OBES RES, V5, P603, DOI 10.1002/j.1550-8528.1997.tb00582.x; SIMKINSILVERMAN LR, 2002, OBES RES, V346, P591; Thomas PR, 1995, COMMITTEE DEV CRITER, DOI 10.1037/10510-000; Wadden T, 1993, OBESITY THEORY THERA, P197; Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/j.psc.2004.09.008; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Yanovski S Z, 1993, Arch Fam Med, V2, P309, DOI 10.1001/archfami.2.3.309; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586; [No title captured]	20	73	77	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2003	289	14					1747	1750		10.1001/jama.289.14.1747	http://dx.doi.org/10.1001/jama.289.14.1747			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZJ	12684339				2022-12-01	WOS:000182094900001
J	Davies, M; Bruce, C; Bewley, K; Outlaw, M; Mioulet, V; Lloyd, G; Clegg, C				Davies, M; Bruce, C; Bewley, K; Outlaw, M; Mioulet, V; Lloyd, G; Clegg, C			Pollovirus type 1 in working stocks of typed human rhinoviruses	LANCET			English	Article							WILD	After eradication of circulating polioviruses, reintroduction might arise from cultured laboratory stocks, or from collections of patients' or environmental samples. In an example of a further class of risk, we recorded poliovirus type 1 in at least four working stocks of what had been identified as various serotypes; of human rhinovirus. This finding emphasises the need to urgently assess the possibility of presence of poliovirus, even in apparently well-characterised stocks of other viruses, to screen for the virus where necessary, and to destroy materials in which risk outweighs potential benefit.	Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Natl Collect Pathogen Viruses, Salisbury SP4 0JG, Wilts, England		Clegg, C (corresponding author), Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Natl Collect Pathogen Viruses, Porton Down, Salisbury SP4 0JG, Wilts, England.			Bewley, Kevin/0000-0002-9078-6734				Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; Minor PD, 2001, LANCET, V358, P166, DOI 10.1016/S0140-6736(01)05399-5; MULDERS MN, 1995, J INFECT DIS, V171, P1399, DOI 10.1093/infdis/171.6.1399; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; *WHO DEP VACC BIOL, 1999, WHOVB9932 DEP VACC B	5	15	17	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1187	1188		10.1016/S0140-6736(03)12919-4	http://dx.doi.org/10.1016/S0140-6736(03)12919-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686044				2022-12-01	WOS:000182094600015
J	Roper, C; Pearce, R; Bredenkamp, B; Gumede, J; Drakeley, C; Mosha, F; Chandramohan, D; Sharp, B				Roper, C; Pearce, R; Bredenkamp, B; Gumede, J; Drakeley, C; Mosha, F; Chandramohan, D; Sharp, B			Antifolate antimalarial resistance in southeast Africa: a population-based analysis	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; SULFADOXINE-PYRIMETHAMINE; POINT MUTATION; SYNTHETASE; FAILURE; MARKERS	Background Sulfadoxine-pyrimethamine was first introduced for treatment of malaria in Africa during the early 1980s for cases when chloroquine treatment failed, and has since become the first-line treatment in many countries. Resistance to sulfadoxine-pyrimethamine is now increasing, especially in southeast Africa. Methods We characterised genetic change in dhfr and dhps genes in the Plasmodium falciparum population of KwaZulu-Natal, South Africa, during 1995-99, a period of rapid deterioration of the effectiveness of sulfadoxine-pyrimethamine. We assessed the evolutionary origin of the resistance by analysing polymorphic microsatellite repeats in the flanking region of the dhfr and dhps genes, which show whether resistance alleles originated through shared or independent ancestral mutation events. We then assessed the current extent of dispersal of dhfr and dhps resistance alleles by doing the same analysis in P falciparum sampled from communities in the Kilimanjaro region of northern Tanzania in 2001. Findings The large genetic change during 1995-99 in KwaZulu-Natal, South Africa, in both the health facility and the wider community surveys, was at the dhps locus, apparently because resistance at dhfr was established before 1995. The allelic determinants of resistance in this province share a common evolutionary origin with those found in Kilimanjaro, Tanzania, even though the two sites are 4000 km apart. Interpretation Three resistant dhfr alleles, and one resistant dhps allele, each derived from independent ancestral lineages, have been driven through through southeast Africa. The movement by the dhfr alleles (pyrimethamine resistance) preceded that of the dhps allele (sulfadoxine resistance). Our findings emphasise that gene flow rather than new mutations has been the most common originator of resistance in African countries.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; MRC, Malaria Res Lead Programme, ZA-4067 Durban, South Africa; Dept Hlth, Malaria Control Programme, Kwa Zulu, South Africa; Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; Kilimanjaro Christian Medical Centre	Roper, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, Keppel St, London WC1E 7HT, England.	Cally.Roper@lshtm.ac.uk	Roper, Cally/K-2989-2013	Roper, Cally/0000-0002-6545-309X				Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Bredenkamp BLF, 2001, SAMJ S AFR MED J, V91, P970; Clyde David F, 1967, MALARIA TANZANIA; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Curtis J, 1998, J INFECT DIS, V177, P1429, DOI 10.1086/517831; HARTL DL, 1997, PRINCIPLES POPULATIO, P430; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; JONES AS, 1958, T R SOC TROP MED HYG, V52, P547; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Mberu EK, 2000, AM J TROP MED HYG, V62, P396, DOI 10.4269/ajtmh.2000.62.396; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0; Paget-McNicol S, 2001, PARASITOLOGY, V122, P497, DOI 10.1017/S0031182001007739; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Sims P, 1998, PARASITOL TODAY, V14, P136, DOI 10.1016/S0169-4758(97)01203-9; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	29	243	244	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2003	361	9364					1174	1181		10.1016/S0140-6736(03)12951-0	http://dx.doi.org/10.1016/S0140-6736(03)12951-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686039				2022-12-01	WOS:000182094600010
J	Allan, DW; St Pierre, SE; Miguel-Aliaga, I; Thor, S				Allan, DW; St Pierre, SE; Miguel-Aliaga, I; Thor, S			Specification of neuropeptide cell identity by the integration of retrograde BMP signaling and a combinatorial transcription factor code	CELL			English	Article							BONE MORPHOGENETIC PROTEINS; GROWTH CONE GUIDANCE; ZINC-FINGER PROTEIN; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; SYMPATHETIC NEURONS; PATHWAY SELECTION; NERVOUS-SYSTEM; GENE; EXPRESSION	Individual neurons express only one or a few of the many identified neurotransmitters; and neuropeptides, but the molecular mechanisms controlling their selection are poorly understood. In the Drosophila ventral nerve cord, the six Tv neurons express the neuropeptide gene FMRFamide. Each Tv neuron resides within a neuronal cell group specified by the LIM-homeodomain gene apterous. We find that the zinc-finger gene squeeze acts in Tv cells to promote their unique axon pathfinding to a peripheral target. There, the BMP ligand Glass bottom boat activates the Wishful thinking receptor, initiating a retrograde BMP signal in the Tv neuron. This signal acts together with apterous and squeeze to activate FMRFamide expression. Reconstituting this "code," by combined BMP activation and apterous/squeeze misexpression, triggers ectopic FMRFamide expression in peptidergic neurons. Thus, an intrinsic transcription factor code integrates with an extrinsic retrograde signal to select a specific neuropeptide identity within peptidergic cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Thor, S (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X; Miguel-Aliaga, Irene/0000-0002-1082-5108	NIMH NIH HHS [TG T32MH20017] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ai XB, 1999, MOL CELL NEUROSCI, V14, P506, DOI 10.1006/mcne.1999.0798; Allen MJ, 1999, J NEUROSCI, V19, P9374; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; DOCTOR JS, 1992, DEV BIOL, V151, P491, DOI 10.1016/0012-1606(92)90188-M; Dorfman R, 2001, DEVELOPMENT, V128, P965; Duggan Anne, 1995, Current Opinion in Neurobiology, V5, P6, DOI 10.1016/0959-4388(95)80080-8; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Ernsberger U, 1999, CELL TISSUE RES, V297, P339, DOI 10.1007/s004410051363; Finley KD, 1998, NEURON, V21, P1363, DOI 10.1016/S0896-6273(00)80655-8; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hall AK, 2002, J NEUROBIOL, V52, P52, DOI 10.1002/neu.10068; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Jarecki J, 1995, J NEUROSCI, V15, P8177; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Koo SJ, 2002, NEURON, V35, P823, DOI 10.1016/S0896-6273(02)00870-X; Landis SC, 1996, PERSPECT DEV NEUROBI, V4, P53; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Massague J, 2000, GENE DEV, V14, P627; Nakamoto T, 2000, MOL CELL BIOL, V20, P1649, DOI 10.1128/MCB.20.5.1649-1658.2000; Nassel DR, 1996, CURR OPIN NEUROBIOL, V6, P842, DOI 10.1016/S0959-4388(96)80036-5; Nassel DR, 1996, PROG NEUROBIOL, V48, P325, DOI 10.1016/0301-0082(95)00048-8; NASSEL DR, 1988, J COMP NEUROL, V267, P343, DOI 10.1002/cne.902670305; O'Brien MA, 1998, J EXP BIOL, V201, P193; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; OLSON PF, 1990, EMBO J, V9, P1219, DOI 10.1002/j.1460-2075.1990.tb08229.x; PANGANIBAN GEF, 1990, DEVELOPMENT, V110, P1041; PEARSE AGE, 1980, CLIN ENDOCRINOL META, V9, P211, DOI 10.1016/S0300-595X(80)80030-2; Perrimon N, 1996, GENETICS, V144, P1681; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; SCHNEIDER LE, 1993, J COMP NEUROL, V337, P446, DOI 10.1002/cne.903370308; SCHNEIDER LE, 1993, NEURON, V10, P279, DOI 10.1016/0896-6273(93)90318-L; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Spradling AC, 1999, GENETICS, V153, P135; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; Taghert PH, 1999, MICROSC RES TECHNIQ, V45, P80, DOI 10.1002/(SICI)1097-0029(19990415)45:2<80::AID-JEMT3>3.0.CO;2-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Zhao HJ, 2000, DEVELOPMENT, V127, P1253	52	131	135	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					73	86		10.1016/S0092-8674(03)00204-6	http://dx.doi.org/10.1016/S0092-8674(03)00204-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679036	Bronze			2022-12-01	WOS:000182282900008
J	Nichol, KL; Nordin, J; Mullooly, J; Lask, R; Fillbrandt, K; Iwane, M				Nichol, KL; Nordin, J; Mullooly, J; Lask, R; Fillbrandt, K; Iwane, M			Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXCESS MORTALITY; RISK-FACTOR; PREVENTING HOSPITALIZATION; PRECEDING INFECTION; COST-EFFECTIVENESS; BRAIN INFARCTION; REDUCED RISK; ASSOCIATION; EPIDEMIC; ADMISSIONS	BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.	Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN USA; HealthPartners Res Fdn, Minneapolis, MN USA; Kaiser Permanente NW, Portland, OR USA; Oxford Hlth Plan, New York, NY USA; Ctr Dis Control & Prevent, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research; Kaiser Permanente; UnitedHealth Group Incorporated; Centers for Disease Control & Prevention - USA	Nichol, KL (corresponding author), Vet Affairs Med Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	nicho014@umn.edu		Nordin, James/0000-0002-3359-5843				*ADV COMM IMM PRAC, 2002, MMWR-MORBID MORTAL W, V51, P1; AHMED AEH, 1995, LANCET, V346, P591, DOI 10.1016/S0140-6736(95)91434-X; Ahmed AH, 1997, EPIDEMIOL INFECT, V118, P27, DOI 10.1017/S0950268896007121; ALLING DW, 1981, AM J EPIDEMIOL, V113, P30, DOI 10.1093/oxfordjournals.aje.a113063; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; BAINTON D, 1978, INT J EPIDEMIOL, V7, P231, DOI 10.1093/ije/7.3.231; Becher H, 2000, J Epidemiol Biostat, V5, P277; Bova IY, 1996, STROKE, V27, P2204, DOI 10.1161/01.STR.27.12.2204; *CDCP, 2002, EARL REL SEL EST NAT; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P374; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P375; COLLINS S. D., 1932, Public Health Reports, V47, P2159, DOI 10.2307/4580606; COOK RJ, 1995, BRIT MED J, V310, P1056; Crocetti E, 2001, EUR J EPIDEMIOL, V17, P163, DOI 10.1023/A:1017978420601; *DEP HLTH HUM SERV, 2000, HLTH PEOPL 2010, V1; EICKHOFF TC, 1961, JAMA-J AM MED ASSOC, V176, P776, DOI 10.1001/jama.1961.03040220024005; EPSEIN SE, 1999, CIRCULATION, V100, pE20; FEDSON DS, 1994, JAMA-J AM MED ASSOC, V271, P1578; Fleming DM, 1995, EPIDEMIOL INFECT, V115, P581, DOI 10.1017/S095026880005874X; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Gurfinkel EP, 2002, CIRCULATION, V105, P2143, DOI 10.1161/01.CIR.0000016182.85461.F4; Hak E, 2002, CLIN INFECT DIS, V35, P370, DOI 10.1086/341403; HOUSWORTH J, 1974, AM J EPIDEMIOL, V100, P40, DOI 10.1093/oxfordjournals.aje.a112007; Jackson LA, 2002, AM J EPIDEMIOL, V156, P634, DOI 10.1093/aje/kwf073; Jakovljevic D, 1996, STROKE, V27, P1774, DOI 10.1161/01.STR.27.10.1774; Lavallee P, 2002, STROKE, V33, P1172; Lavallee P, 2002, STROKE, V33, P513, DOI 10.1161/hs0202.102328; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Macko RF, 1996, STROKE, V27, P1999, DOI 10.1161/01.STR.27.11.1999; MATTILA KJ, 1989, J INTERN MED, V225, P293, DOI 10.1111/j.1365-2796.1989.tb00084.x; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Naghavi M, 2000, CIRCULATION, V102, P3039; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; NICHOL KL, 1998, TXB INFLUENZA, P358; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohmit SE, 1995, INT J EPIDEMIOL, V24, P1240, DOI 10.1093/ije/24.6.1240; PuigBarbera J, 1997, J EPIDEMIOL COMMUN H, V51, P526, DOI 10.1136/jech.51.5.526; Siscovick DS, 2000, AM J EPIDEMIOL, V152, P674, DOI 10.1093/aje/152.7.674; SPODICK DH, 1984, AM J CARDIOL, V53, P481, DOI 10.1016/0002-9149(84)90016-X; Stamboulian D, 1999, VACCINE, V17, pS53, DOI 10.1016/S0264-410X(99)00106-1; SYRJANEN J, 1988, BRIT MED J, V296, P1156, DOI 10.1136/bmj.296.6630.1156; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; VALTONEN VV, 1991, ANN MED, V23, P539, DOI 10.3109/07853899109150515; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5	47	561	595	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2003	348	14					1322	1332		10.1056/NEJMoa025028	http://dx.doi.org/10.1056/NEJMoa025028			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662LW	12672859				2022-12-01	WOS:000181949100003
J	McCarthy, HD; Ellis, SM; Cole, TJ				McCarthy, HD; Ellis, SM; Cole, TJ			Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; CHILDREN; ADOLESCENTS; PREVALENCE	Objective To compare changes over time in waist circumference (a measure of central fatness) and body mass index (a measure of overall obesity) in British youth. Design Representative cross sectional surveys in 1977, 1987, and 1997. Setting Great Britain. Participants Young people aged 11-16 years Surveyed in 1977 (boys) and 1987 (girls) for the British Standards Institute (n=3784) and in 1997 (both sexes) for the national diet and nutrition survey (n=776). Main outcome measures Waist Circumference, expressed as a standard deviation score using the first survey as reference, and body mass index (weight(kg)/height(m)(2)), expressed as a standard deviation score against the British 1990 revised reference. Overweight and obesity were defined as the measurement exceeding the 91st and 98th centile, respectively. Results Waist circumference increased sharply over the period between surveys (mean increases for boys and girls, 6.9 and 6.2 cm, or 0.84 and 1.02 SD score units, P <0.0001). In centile terms, waist circumference increased more in girls than in boys. Increases in body mass index were smaller and similar by sex (means 1.5 and 1.6, or 0.47 and 0.53 SD score units, P < 0.0001). Waist circumference in 1997 exceeded the 91st centile in 28% (n=110) of boys and 38% (n=147) of girls (against 9% for both sexes in 1977-87, P < 0.0001), whereas 14% (n=54) and 17% (n=68), respectively, exceeded the 98th centile (3% in 1977-87, P < 0.0001). The corresponding rates for body mass index in 1997 were 21% (n=80) of boys and 17% (n=67) of girls exceeding the 91st centile (8% and 6% in 1977-87) and 10% (n=39) and 8% (n=32) exceeding the 98th centile (3% and 2% in 1977-87). Conclusions Trends in waist circumference during the past 10-20 years have greatly exceeded those in body mass index, particularly in girls, showing that body mass index is a poor proxy for central fatness. Body mass index has therefore systematically underestimated the prevalence of obesity in young people.	London Metropolitan Univ, Dept Hlth & Human Sci, London N7 8DB, England; Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	London Metropolitan University; University of London; University College London	McCarthy, HD (corresponding author), London Metropolitan Univ, Dept Hlth & Human Sci, London N7 8DB, England.	d.mccarthy@londonmet.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Medical Research Council [G9827821, G9827821(62595)] Funding Source: Medline; MRC [G9827821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bates CJ, 2000, NATL DIET NUTR SURVE; BRAMBILLA P, 1994, INT J OBESITY, V18, P795; *BRIT STAND I, 1990, BS7321; *BRIT STAND I, 1990, BOD MEAS BOYS GIRLS; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2000, AM J EPIDEMIOL, V152, P1179, DOI 10.1093/aje/152.12.1179; FLODMARK CE, 1994, ACTA PAEDIATR, V83, P941, DOI 10.1111/j.1651-2227.1994.tb13177.x; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gregory JR, 1995, NATL DIET NUTR SURVE; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Moreno LA, 1998, J PEDIATR GASTR NUTR, V27, P176, DOI 10.1097/00005176-199808000-00009; Moreno LA, 2001, INT J OBESITY, V25, P1656, DOI 10.1038/sj.ijo.0801803; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Wells JCK, 2002, INT J OBESITY, V26, P1323, DOI 10.1038/sj.ijo.0802077; WHO, 1995, PHYS STAT US INT ANT	21	306	334	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2003	326	7390					624	626		10.1136/bmj.326.7390.624	http://dx.doi.org/10.1136/bmj.326.7390.624			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BF	12649234	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000181870800014
J	Bloor, K; Freemantle, N; Khadjesari, Z; Maynard, A				Bloor, K; Freemantle, N; Khadjesari, Z; Maynard, A			Impact of NICE guidance on laparoscopic surgery for inguinal hernias: analysis of interrupted time series	BRITISH MEDICAL JOURNAL			English	Article									Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of York - UK; University of Birmingham	Bloor, K (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.			Bloor, Karen/0000-0003-4852-9854; Freemantle, Nick/0000-0001-5807-5740; Khadjesari, Zarnie/0000-0002-2958-9555				DEVLIN HB, 1998, MANAGEMENT ABDOMINAL; Motson RW, 2002, BRIT MED J, V324, P1092, DOI 10.1136/bmj.324.7345.1092; National Institute for Clinical Excellence, 2001, GUID US LAP SURG ING	3	36	36	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2003	326	7389					578	578		10.1136/bmj.326.7389.578	http://dx.doi.org/10.1136/bmj.326.7389.578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657ZF	12637402	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000181696600018
J	Boelaert, K; Franklyn, JA				Boelaert, K; Franklyn, JA			Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers?	LANCET			English	Editorial Material							EXPRESSION; GENE; THERAPY; TRANSPORTER; CLONING		Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Franklyn, JA (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.							Boland A, 2000, CANCER RES, V60, P3484; Cho JY, 2000, GENE THER, V7, P740, DOI 10.1038/sj.gt.3301170; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; ESKIN BA, 1970, T NEW YORK ACAD SCI, V32, P911, DOI 10.1111/j.2164-0947.1970.tb02988.x; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Mandell RB, 1999, CANCER RES, V59, P661; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Spitzweg C, 2000, CANCER RES, V60, P6526; Spitzweg C, 1999, CANCER RES, V59, P2136; Spitzweg C, 2001, J CLIN ENDOCR METAB, V86, P3327, DOI 10.1210/jc.86.7.3327; SPITZWEG C, 2002, P 74 ANN M AM THYR A, P128; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630	12	28	33	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					796	797		10.1016/S0140-6736(03)12720-1	http://dx.doi.org/10.1016/S0140-6736(03)12720-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642042				2022-12-01	WOS:000181466600004
J	Mercer, JM; Roth, VL				Mercer, JM; Roth, VL			The effects of Cenozoic global change on squirrel phylogeny	SCIENCE			English	Article							FLYING SQUIRRELS; EVOLUTION	By modifying habitats and creating bridges and barriers between landmasses, climate change and tectonic events are believed to have important consequences for diversification of terrestrial organisms. Such consequences should be most evident in phylogenetic histories of groups that are ancient, widespread, and diverse. The squirrel family (Sciuridae) is one of very few mammalian families endemic to Eurasia, Africa, and North and South America and is idea[ for examining these issues. Through phylogenetic and molecular-clock analyses, we infer that arrival and diversification of squirrels in Africa, on Sunda Shelf islands, across Beringea, and across the Panamanian isthmus coincide in timing and location with multiple well-documented sea-level, tectonic, and paleontological events. These precise correspondences point to an important role for global change in the diversification of a major group of mammals.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Mercer, JM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.							BERGGREN WA, 1992, EOCENE OLIGOCENE CLI, P1; Butlin R. K., 1998, P355; Coates Anthony G., 1996, P21; Corbet G. B., 1992, MAMMALS INDOMALAYAN; de Bruijn Hans, 1999, P271; DEBRUIJN H, 1989, PAPERS FOSSIL RODENT, P139; DEGRACIANSKY PC, 1998, SOC EC PALEONTOL MIN, V60; Emry R.J., 1984, P23; Emry RJ, 1996, J VERTEBR PALEONTOL, V16, P775, DOI 10.1080/02724634.1996.10011366; Emry RJ, 2001, J VERTEBR PALEONTOL, V21, P400, DOI 10.1671/0272-4634(2001)021[0400:DNNFDE]2.0.CO;2; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hoffman Robert S., 1993, P419; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Lavocat R., 1978, P69; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; MARSHALL LG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P329; MERCER JL, UNPUB; MILLER JR. G. S., 1901, P BIOL SOC WASH, V14, P23; MOORE JOSEPH CURTIS, 1959, BULL AMER MUS NAT HIST, V118, P153; Moss Steve J., 1998, P133; Nowack R.M., 1999, WALKERS MAMMALS WORL; Sanders WJ, 2002, J VERTEBR PALEONTOL, V22, P388, DOI 10.1671/0272-4634(2002)022[0388:NPFTEM]2.0.CO;2; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; THORINGTON RW, 1984, SCIENCE, V225, P1048, DOI 10.1126/science.225.4666.1048; Thorington RW, 1996, J MAMMAL, V77, P69, DOI 10.2307/1382710; VIANEYLIAUD M, 1984, EVOLUTIONARY RELATIO, P277; Welcomme JL, 2001, GEOL MAG, V138, P397, DOI 10.1017/S0016756801005428; Wilson DE, 1993, MAMMAL SPECIES WORLD; Wing Scott L., 1998, P37	30	225	243	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1568	1572		10.1126/science.1079705	http://dx.doi.org/10.1126/science.1079705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12595609				2022-12-01	WOS:000181367900036
J	Min, JR; Feng, Q; Li, ZZ; Zhang, Y; Xu, RM				Min, JR; Feng, Q; Li, ZZ; Zhang, Y; Xu, RM			Structure of the catalytic domain of human DOT1L, a Non-SET domain nucleosomal histone methyltransferase	CELL			English	Article							CRYSTAL-STRUCTURE; LYSINE METHYLTRANSFERASE; SILENCING PROTEIN; DIFFRACTION DATA; CORE PARTICLE; METHYLATION; H3; CHROMATIN; UBIQUITINATION; YEAST	Dot1 is an evolutionarily conserved histone methyltransferase that methylates lysine-79 of histone H3 in the core domain. Unlike other histone methyltransferases, Dot1 does not contain a SET domain, and it specifically methylates nucleosomal histone H3. We have solved a 2.5 Angstrom resolution structure of the catalytic domain of human Dot1, hDOT1L, in complex with S-adenosyl-L-methionine (SAM). The structure reveals a unique organization of a mainly alpha-helical N-terminal domain and a central open alpha/beta structure, an active site consisting of a SAM binding pocket, and a potential lysine binding channel. We also show that a flexible, positively charged region at the C terminus of the catalytic domain is critical for nucleosome binding and enzymatic activity. These structural and biochemical analyses, combined with molecular modeling, provide mechanistic insights into the catalytic mechanism and nucleosomal specificity of Dot1 proteins.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Xu, RM (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Zhang, Yi/0000-0002-2789-0811	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063716] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63716, GM63070] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Singer MS, 1998, GENETICS, V150, P613; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	45	290	311	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					711	723		10.1016/S0092-8674(03)00114-4	http://dx.doi.org/10.1016/S0092-8674(03)00114-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628190	Bronze			2022-12-01	WOS:000181443600013
J	Niemeier, M; Crawford, JD; Tweed, DB				Niemeier, M; Crawford, JD; Tweed, DB			Optimal transsaccadic integration explains distorted spatial perception	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; APPARENT POSITION; DISPLACEMENT; SUPPRESSION; MOTION; COMPRESSION; SIGNALS; VISION; SPACE	We scan our surroundings with quick eye movements called saccades, and from the resulting sequence of images we build a unified percept by a process known as transsaccadic integration. This integration is often said to be flawed, because around the time of saccades, our perception is distorted(1-6) and we show saccadic suppression of displacement (SSD): we fail to notice if objects change location during the eye movement(7,8). Here we show that transsaccadic integration works by optimal inference. We simulated a visuomotor system with realistic saccades, retinal acuity, motion detectors and eye-position sense, and programmed it to make optimal use of these imperfect data when interpreting scenes. This optimized model showed human-like SSD and distortions of spatial perception. It made new predictions, including tight correlations between perception and motor action (for example, more SSD in people with less-precise eye control) and a graded contraction of perceived jumps; we verified these predictions experimentally. Our results suggest that the brain constructs its evolving picture of the world by optimally integrating each new piece of sensory or motor information.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Canadian Inst Hlth Res, Grp Act & Percept, Ottawa, ON, Canada; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada	University of Toronto; University of Toronto; Institute for Work & Health; York University - Canada	Tweed, DB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.			Crawford, Doug/0000-0003-2288-1286				BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; CARPENTER RHS, 1991, VISION VISUAL DYSFUN, P1; CHOUDHURY BP, 1981, PHYSIOL BEHAV, V26, P125, DOI 10.1016/0031-9384(81)90087-1; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Gysen V, 2002, VISION RES, V42, P379, DOI 10.1016/S0042-6989(01)00296-6; Honda H, 1997, EXP BRAIN RES, V113, P327, DOI 10.1007/BF02450330; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; ILG UJ, 1993, VISION RES, V33, P211, DOI 10.1016/0042-6989(93)90159-T; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LI WX, 1990, PERCEPT PSYCHOPHYS, V48, P453, DOI 10.3758/BF03211589; Li WX, 1997, VISION RES, V37, P1779, DOI 10.1016/S0042-6989(96)00301-X; MACK A, 1970, PERCEPT PSYCHOPHYS, V8, P291, DOI 10.3758/BF03212596; MACKAY DM, 1973, HDB SENSORY PHYSIOLO, V7, P307; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Morrone MC, 1997, J NEUROSCI, V17, P7941; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; TYNAN PD, 1982, VISION RES, V22, P61, DOI 10.1016/0042-6989(82)90167-5; VANOPSTAL AJ, 1989, VISION RES, V29, P1183, DOI 10.1016/0042-6989(89)90064-3; vonHelmholtz HL, 1910, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WESTHEIMER G, 1984, ANNU REV PSYCHOL, V35, P201, DOI 10.1146/annurev.psych.35.1.201	30	134	135	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					76	80		10.1038/nature01439	http://dx.doi.org/10.1038/nature01439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621435				2022-12-01	WOS:000181343100040
J	Goldberg, M; Stucki, M; Falck, J; D'Amours, D; Rahman, D; Pappin, D; Bartek, J; Jackson, SP				Goldberg, M; Stucki, M; Falck, J; D'Amours, D; Rahman, D; Pappin, D; Bartek, J; Jackson, SP			MDC1 is required for the intra-S-phase DNA damage checkpoint	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSE; HISTONE H2AX; NUCLEAR FOCI; REPAIR; GENE; ATM; DISORDERS	MRE11, RAD50 and NBS1 form a highly conserved protein complex (the MRE11 complex) that is involved in the detection, signalling and repair of DNA damage(1). We identify MDC1 (KIAA0170/NFBD1), a protein that contains a forkhead-associated (FHA) domain and two BRCA1 carboxy-terminal (BRCT) domains, as a binding partner for the MRE11 complex. We show that, in response to ionizing radiation, MDC1 is hyperphosphorylated in an ATM-dependent manner, and rapidly relocalizes to nuclear foci that also contain the MRE11 complex, phosphorylated histone H2AX and 53BP1. Downregulation of MDC1 expression by small interfering RNA yields a radioresistant DNA synthesis (RDS) phenotype and prevents ionizing radiation-induced focus formation by the MRE11 complex. However, downregulation of MDC1 does not abolish the ionizing radiation-induced phosphorylation of NBS1, CHK2 and SMC1, or the degradation of CDC25A. Furthermore, we show that overexpression of the MDC1 FHA domain interferes with focus formation by MDC1 itself and by the MRE11 complex, and induces an RDS phenotype. These findings reveal that MDC1-mediated focus formation by the MRE11 complex at sites of DNA damage is crucial for the efficient activation of the intra-S-phase checkpoint.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Imperial Coll Sch Med, Dept Proteom, London W12 0NN, England	University of Cambridge; University of Cambridge; Danish Cancer Society; Imperial College London	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England.		Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Stucki, Manuel/H-4739-2017; Bartek, Jiri/G-5870-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Pappin, Darryl/0000-0002-8981-8401; Goldberg, Michal/0000-0001-9397-2383				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Michelson RJ, 2000, BIOESSAYS, V22, P966, DOI 10.1002/1521-1878(200011)22:11<966::AID-BIES2>3.3.CO;2-C; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	30	400	431	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					952	956		10.1038/nature01445	http://dx.doi.org/10.1038/nature01445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607003				2022-12-01	WOS:000181186900051
J	Mora, C; Chittaro, PM; Sale, PF; Kritzer, JP; Ludsin, SA				Mora, C; Chittaro, PM; Sale, PF; Kritzer, JP; Ludsin, SA			Patterns and processes in reef fish diversity	NATURE			English	Article							BIODIVERSITY HOTSPOTS; CORAL; CONSERVATION; DURATION; PACIFIC	A central aim of ecology is to explain the heterogeneous distribution of biodiversity on earth. As expectations of diversity loss grow(1-5), this understanding is also critical for effective management and conservation. Although explanations for biodiversity patterns are still a matter for intense debate(5), they have often been considered to be scale-dependent(6,7). At large geographical scales, biogeographers have suggested that variation in species richness results from factors such as area, temperature, environmental stability, and geological processes, among many others(5,7-14). From the species pools generated by these large-scale processes, community ecologists have suggested that local-scale assembly of communities is achieved through processes such as competition, predation, recruitment, disturbances and immigration(5-8,15,16). Here we analyse hypotheses on speciation and dispersal for reef fish from the Indian and Pacific oceans and show how dispersal from a major centre of origination can simultaneously account for both large-scale gradients in species richness and the structure of local communities.	Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada	University of Windsor	Mora, C (corresponding author), Univ Windsor, Dept Biol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	moracamilo@hotmail.com	Ludsin, Stuart/F-2925-2010	Ludsin, Stuart/0000-0002-3866-2216; Chittaro, Paul/0000-0001-9310-7314				Allen G.R., 1994, Atoll Research Bulletin, V412, P1; [Anonymous], 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237.001; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonhomme F, 2000, ENVIRON BIOL FISH, V59, P365, DOI 10.1023/A:1026508715631; Caley MJ, 1997, ECOLOGY, V78, P70; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cornell HV, 2000, CORAL REEFS, V19, P37, DOI 10.1007/s003380050224; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Grove JS, 1997, FISHES GALAPAGOS ISL; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Karlson RH, 1998, ECOL MONOGR, V68, P259, DOI 10.1890/0012-9615(1998)068[0259:SDVILV]2.0.CO;2; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SPRINGER VG, 1982, SMITHSON CONTRIB ZOO, V177, P1; THOMSON DA, 1999, REEF FISHES SEA CORT; Veron J.E.N., 2022, CORALS WORLD; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; VICTOR BC, 1986, MAR BIOL, V90, P317, DOI 10.1007/BF00428555; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; ZAPATA F, 1998, P 8 INT COR REEF S, V1, P1029	27	247	258	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					933	936		10.1038/nature01393	http://dx.doi.org/10.1038/nature01393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606998				2022-12-01	WOS:000181186900046
J	Rees, WE				Rees, WE			A blot on the land	NATURE			English	Article									Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC V6T 1Z2, Canada	University of British Columbia	Rees, WE (corresponding author), Univ British Columbia, Sch Community & Reg Planning, 6333 Mem Rd, Vancouver, BC V6T 1Z2, Canada.							Rees W., 1992, ENVIRON URBAN, V4, P121, DOI DOI 10.1177/095624789200400212; Rees W.E., 2002, B SCI TECHNOL SOC, V22, P249, DOI [DOI 10.1177/0270467602022004001, 10.1177/]; TAINTER JA, 1995, FUTURES, V27, P397, DOI 10.1016/0016-3287(95)00016-P; *WORLDW FUND NAT, 2002, LIV PLAN REP 2002	4	24	26	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					898	898		10.1038/421898a	http://dx.doi.org/10.1038/421898a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649BK	12606978	Bronze			2022-12-01	WOS:000181186900023
J	Wu, LZ; de Bruin, A; Saavedra, HI; Starovic, M; Trimboli, A; Yang, Y; Opavska, J; Wilson, P; Thompson, JC; Ostrowski, MC; Rosol, TJ; Woollett, LA; Weinstein, M; Cross, JC; Robinson, ML; Leone, G				Wu, LZ; de Bruin, A; Saavedra, HI; Starovic, M; Trimboli, A; Yang, Y; Opavska, J; Wilson, P; Thompson, JC; Ostrowski, MC; Rosol, TJ; Woollett, LA; Weinstein, M; Cross, JC; Robinson, ML; Leone, G			Extra-embryonic function of Rb is essential for embryonic development and viability	NATURE			English	Article							RETINOBLASTOMA GENE; MOUSE PLACENTA; CHIMERIC MICE; CELLS; PROLIFERATION; MUTATION; PROTEIN; DIFFERENTIATION; EXPRESSION; APOPTOSIS	The retinoblastoma (Rb) gene was the first tumour suppressor identified(1). Inactivation of Rb in mice results in unscheduled cell proliferation, apoptosis and widespread developmental defects, leading to embryonic death by day 14.5 (refs 2-4). However, the actual cause of the embryonic lethality has not been fully investigated. Here we show that loss of Rb leads to excessive proliferation of trophoblast cells and a severe disruption of the normal labyrinth architecture in the placenta. This is accompanied by a decrease in vascularization and a reduction in placental transport function. We used two complementary techniques-tetraploid aggregation and conditional knockout strategies-to demonstrate that Rb-deficient embryos supplied with a wild-type placenta can be carried to term, but die soon after birth. Most of the neurological and erythroid abnormalities thought to be responsible for the embryonic lethality of Rb-null animals were virtually absent in rescued Rb-null pups. These findings identify and define a key function of Rb in extra-embryonic cell lineages that is required for embryonic development and viability, and provide a mechanism for the cell autonomous versus non-cell autonomous roles of Rb in development.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Childrens Res Inst, Div Mol & Human Genet, Columbus, OH 43205 USA; Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Calgary; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; University of Cincinnati	Leone, G (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA.		Wenzel, Pamela/AAJ-1944-2021; Wenzel, Pamela/A-2992-2010; Rosol, Thomas/G-9585-2011; Cross, James/F-4814-2011; Thompson, Jessica/GXW-0323-2022; Cross, James/AAU-2973-2020; de Bruin, Alain/AAL-9195-2020; Ostrowski, Michael/H-3108-2011	Wenzel, Pamela/0000-0002-4530-015X; Rosol, Thomas/0000-0003-3737-1190; Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378; Ostrowski, Michael/0000-0003-2948-6297; de Bruin, Alain/0000-0001-8579-2649				Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; Hogan B., 2014, MANIPULATING MOUSE E; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Kurz H, 1999, ANAT EMBRYOL, V200, P335, DOI 10.1007/s004290050284; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; LINZER DIH, 1985, P NATL ACAD SCI USA, V82, P4356, DOI 10.1073/pnas.82.13.4356; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Marino S, 2000, GENE DEV, V14, P994; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	29	305	311	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					942	947		10.1038/nature01417	http://dx.doi.org/10.1038/nature01417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607001				2022-12-01	WOS:000181186900049
J	Smith, GCS; Pell, JP; Walsh, D				Smith, GCS; Pell, JP; Walsh, D			Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FACTOR-V-LEIDEN		Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh EH5 3SE, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Box 223, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Walsh, David/0000-0002-3390-5039; Pell, Jill/0000-0002-8898-7035				NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Souza SS, 1999, HUM REPROD, V14, P2448, DOI 10.1093/humrep/14.10.2448; Vaarala O, 1998, LUPUS, V7, pS132, DOI 10.1177/096120339800700229	5	45	45	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					423	424		10.1136/bmj.326.7386.423	http://dx.doi.org/10.1136/bmj.326.7386.423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595381	Green Published, Bronze			2022-12-01	WOS:000181318000018
J	Tanaka, K; Tengeiji, A; Kato, T; Toyama, N; Shionoya, M				Tanaka, K; Tengeiji, A; Kato, T; Toyama, N; Shionoya, M			A discrete self-assembled metal array in artificial DNA	SCIENCE			English	Article							BASE-PAIR; COMPLEXES	DNA has a structural basis to array functionalized building blocks. Here we report the synthesis of a series of artificial oligonucleotides, d(5'-GH(n)C-3') (n = 1 to 5), with hydroxypyridone nucleobases (H) as flat bidentate ligands. Right-handed double helices of the oligonucleotides, nCu(2+).d(5'-GHnC-3'), (n = 1 to 5), were quantitatively formed through copper ion (Cu2+)-mediated alternative base pairing (H-Cu2+-H), where the Cu2+ ions incorporated into each complex were aligned along the helix axes inside the duplexes with the Cu2+-Cu2+ distance of 3.7 +/- 0.1 angstroms. The Cu2+ ions were coupled ferromagnetically with one another through unpaired d electrons to form magnetic chains.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Shionoya, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		Tanaka, Kentaro/I-7056-2014					Atwell S, 2001, J AM CHEM SOC, V123, P12364, DOI 10.1021/ja011822e; BERGSTROM DE, 2001, CURRENT PROTOCOLS NU; Finniss GM, 1996, ANGEW CHEM INT EDIT, V35, P2772, DOI 10.1002/anie.199627721; Kool ET, 2002, ACCOUNTS CHEM RES, V35, P936, DOI 10.1021/ar000183u; Lai SY, 1999, J AM CHEM SOC, V121, P250, DOI 10.1021/ja982065w; Meggers E, 2000, J AM CHEM SOC, V122, P10714, DOI 10.1021/ja0025806; Palmans R, 1996, J AM CHEM SOC, V118, P12647, DOI 10.1021/ja962491m; Tanaka K, 1999, J ORG CHEM, V64, P5002, DOI 10.1021/jo990326u; Tanaka K, 2002, J AM CHEM SOC, V124, P8802, DOI 10.1021/ja020510o; Tanaka K, 2002, J AM CHEM SOC, V124, P12494, DOI 10.1021/ja027175o; Weizman H, 2001, J AM CHEM SOC, V123, P3375, DOI 10.1021/ja005785n	11	451	455	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1212	1213		10.1126/science.1080587	http://dx.doi.org/10.1126/science.1080587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595687				2022-12-01	WOS:000181065500034
J	Butler, D				Butler, D			Ministers back gene-crop advisers	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					775	775		10.1038/421775b	http://dx.doi.org/10.1038/421775b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594469	Bronze			2022-12-01	WOS:000181044700009
J	Sausville, EA				Sausville, EA			Imatinib for chronic myelogenous leukaemia: a 9 or 24 carat gold standard?	LANCET			English	Editorial Material							ABL TYROSINE KINASE; CHRONIC MYELOID-LEUKEMIA; PHILADELPHIA-CHROMOSOME; INHIBITOR; APOPTOSIS; MESYLATE; PATIENT; STI571; CELLS		NCI, Dev Therapeut Program, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sausville, EA (corresponding author), NCI, Dev Therapeut Program, Rockville, MD 20852 USA.							Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HURON DR, IN PRESS CLIN CANC R; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kantarjian HM, 2002, CLIN CANCER RES, V8, P2167; Mow BMF, 2002, BLOOD, V99, P664, DOI 10.1182/blood.V99.2.664; Nimmanapalli R, 2001, CANCER RES, V61, P1799; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Peggs K, 2003, NEW ENGL J MED, V348, P1048, DOI 10.1056/NEJMe030009; Rubin BP, 2002, J CLIN ONCOL, V20, P3586, DOI 10.1200/JCO.2002.01.027; SILVER R, 2000, CANC MED, P1971; Yu CR, 2002, CLIN CANCER RES, V8, P2976	15	6	8	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1400	1401		10.1016/S0140-6736(03)13145-5	http://dx.doi.org/10.1016/S0140-6736(03)13145-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727387				2022-12-01	WOS:000182516300002
J	Nugent, AW; Daubeney, PEF; Chondros, P; Carlin, JB; Cheung, M; Wilkinson, LC; Davis, AM; Kahler, SG; Chow, CW; Wilkinson, JL; Weintraub, RG				Nugent, AW; Daubeney, PEF; Chondros, P; Carlin, JB; Cheung, M; Wilkinson, LC; Davis, AM; Kahler, SG; Chow, CW; Wilkinson, JL; Weintraub, RG		Natl Australian Childhood Cardiomy	The epidemiology of childhood cardiomyopathy in Australia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; INTERNATIONAL-SOCIETY; SUDDEN-DEATH; CHILDREN; MYOCARDITIS; HEART; DETERMINANTS; CARDIOLOGY	Background: The incidence and age distribution of primary cardiomyopathy in children are not well defined. We undertook a population-based, retrospective cohort study in Australia to document the epidemiology of childhood cardiomyopathy. Methods: We analyzed all cases of primary cardiomyopathy in children who presented between 1987 and 1996 and who were younger than 10 years of age. Children were recruited from multiple sources, and cases of cardiomyopathy were classified according to World Health Organization guidelines. Results: Over the 10-year period, 314 new cases of primary cardiomyopathy were identified, for an annual incidence of 1.24 per 100,000 children younger than 10 years of age (95 percent confidence interval, 1.11 to 1.38). Dilated cardiomyopathy made up 58.6 percent of cases, hypertrophic cardiomyopathy 25.5 percent, restrictive cardiomyopathy 2.5 percent, and left ventricular noncompaction 9.2 percent of cases. The incidence of all types of cardiomyopathy except restrictive declined rapidly after infancy. In 11 cases (3.5 percent), sudden death was the first symptom. There was a male predominance among children with hypertrophic and unclassified cardiomyopathy. Indigenous children had a higher incidence of dilated cardiomyopathy than nonindigenous children (relative risk, 2.67; 95 percent confidence interval, 1.42 to 4.63) and a higher rate of death as the presenting symptom (16.7 percent vs. 2.6 percent, P=0.02). Lymphocytic myocarditis was present in 25 of 62 children with dilated cardiomyopathy (40.3 percent) who underwent cardiac histologic examination within two months after presentation. Conclusions: Lymphocytic myocarditis and left ventricular noncompaction are important causes of childhood cardiomyopathy in Australia. The timing and severity of presentation in children with cardiomyopathy are related to the type of cardiomyopathy, as well as to genetic and ethnic factors. .	Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia; Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Weintraub, RG (corresponding author), Royal Childrens Hosp, Dept Cardiol, Flemington Rd, Parkville, Vic 3052, Australia.		Carlin, John/AAG-4332-2020; Chondros, Patty/AAT-6426-2020; Carlin, John B/B-3492-2012	Carlin, John/0000-0002-2694-9463; Carlin, John B/0000-0002-2694-9463; Chondros, Patty/0000-0003-0393-8734; Davis, Andrew/0000-0003-2826-8562				ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; *AUSTR BUR STAT, 1994, 32300 AUSTR BUR STAT; *AUSTR BUR STAT, 1997, 32010 AUSTR BUR STAT; *AUSTR BUR STAT, 1993, 32010 AUSTR BUR STAT; *AUSTR BUR STAT, 1998, 32300 AUSTR BUR STAT; Boucek MM, 2001, J HEART LUNG TRANSPL, V20, P39, DOI 10.1016/S1053-2498(00)00243-6; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; BURCH M, 1994, BRIT HEART J, V72, P246; Carapetis JR, 1999, AUST NZ J PUBL HEAL, V23, P159, DOI 10.1111/j.1467-842X.1999.tb01227.x; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; FERENCZ C, 1992, PEDIATR CARDIOL, V13, P65, DOI 10.1007/BF00798206; Grenier MA, 2000, AM HEART J, V139, pS86, DOI 10.1067/mhj.2000.103933; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARTIN AB, 1994, CIRCULATION, V90, P330, DOI 10.1161/01.CIR.90.1.330; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; MATITIAU A, 1994, CIRCULATION, V90, P1310, DOI 10.1161/01.CIR.90.3.1310; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Nugent AW, 2001, J HEART LUNG TRANSPL, V20, P1152, DOI 10.1016/S1053-2498(01)00334-5; Olson TM, 2002, CIRCULATION, V105, P2337, DOI 10.1161/01.CIR.0000018444.47798.94; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rivenes SM, 2000, CIRCULATION, V102, P876; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; *STAT CORP, 1999, STAT STAT SOFTW REL; Venugopalan P, 2001, INT J CARDIOL, V78, P135, DOI 10.1016/S0167-5273(00)00480-0; WILES HB, 1991, AM J CARDIOL, V68, P1372, DOI 10.1016/0002-9149(91)90248-J; Yetman AT, 1998, J AM COLL CARDIOL, V32, P1943, DOI 10.1016/S0735-1097(98)00493-8	32	473	529	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1639	1646		10.1056/NEJMoa021737	http://dx.doi.org/10.1056/NEJMoa021737			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711738				2022-12-01	WOS:000182416300003
J	Wang, X; Willenbring, H; Akkari, Y; Torimaru, Y; Foster, M; Al-Dhalimy, M; Lagasse, E; Finegold, M; Olson, S; Grompe, M				Wang, X; Willenbring, H; Akkari, Y; Torimaru, Y; Foster, M; Al-Dhalimy, M; Lagasse, E; Finegold, M; Olson, S; Grompe, M			Cell fusion is the principal source of bone-marrow-derived hepatocytes	NATURE			English	Article							FUMARYLACETOACETATE HYDROLASE; HEPATIC-DYSFUNCTION; GENE-THERAPY; MURINE MODEL; STEM-CELLS; LIVER; MICE; REPOPULATION; PHENOTYPE; VIVO	Evidence suggests that haematopoietic stem cells might have unexpected developmental plasticity, highlighting therapeutic potential. For example, bone-marrow-derived hepatocytes can repopulate the liver of mice with fumarylacetoacetate hydrolase deficiency and correct their liver disease(1). To determine the underlying mechanism in this murine model, we performed serial transplantation of bone-marrow-derived hepatocytes. Here we show by Southern blot analysis that the repopulating hepatocytes in the liver were heterozygous for alleles unique to the donor marrow, in contrast to the original homozygous donor cells. Furthermore, cytogenetic analysis of hepatocytes transplanted from female donor mice into male recipients demonstrated 80,XXXY (diploid to diploid fusion) and 120,XXXXYY (diploid to tetraploid fusion) karyotypes, indicative of fusion between donor and host cells. We conclude that hepatocytes derived form bone marrow arise from cell fusion and not by differentiation of haematopoietic stem cells.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; Stem Cells Inc, Palo Alto, CA 94304 USA; Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Oregon Health & Science University; Baylor College of Medicine	Grompe, M (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	grompem@ohsu.edu		Grompe, Markus/0000-0002-6616-4345				Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; FAKTOR VM, 1975, TSITOLOGIYA+, V17, P909; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LABELLE Y, 1993, BIOCHIM BIOPHYS ACTA, V1180, P250, DOI 10.1016/0925-4439(93)90046-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MARTIN G M, 1970, Experimental Cell Research, V63, P466, DOI 10.1016/0014-4827(70)90241-7; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mitchell GA, 2001, METABOLIC MOL BASES, P1777; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Overturf K, 1998, HUM GENE THER, V9, P295, DOI 10.1089/hum.1998.9.3-295; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Overturf K, 1997, AM J PATHOL, V151, P1273; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PEREIRA RF, 1997, SCIENCE, V276, P71; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pira GL, 1998, HUM IMMUNOL, V59, P137, DOI 10.1016/S0198-8859(98)00004-4; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Whitney MA, 1996, BLOOD, V88, P49; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	30	1242	1363	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					897	901		10.1038/nature01531	http://dx.doi.org/10.1038/nature01531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12665832				2022-12-01	WOS:000182432600056
J	Pedulla, ML; Ford, ME; Houtz, JM; Karthikeyan, T; Wadsworth, C; Lewis, JA; Jacobs-Sera, D; Falbo, J; Gross, J; Pannunzio, NR; Brucker, W; Kumar, V; Kandasamy, J; Keenan, L; Bardarov, S; Kriakov, J; Lawrence, JG; Jacobs, WR; Hendrix, RW; Hatfull, GF				Pedulla, ML; Ford, ME; Houtz, JM; Karthikeyan, T; Wadsworth, C; Lewis, JA; Jacobs-Sera, D; Falbo, J; Gross, J; Pannunzio, NR; Brucker, W; Kumar, V; Kandasamy, J; Keenan, L; Bardarov, S; Kriakov, J; Lawrence, JG; Jacobs, WR; Hendrix, RW; Hatfull, GF			Origins of highly mosaic mycobacteriophage genomes	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EVOLUTIONARY RELATIONSHIPS; NUCLEOTIDE-SEQUENCE; PHAGE GENOMICS; BACTERIOPHAGE; TUBERCULOSIS; PROTEIN; TAXONOMY; VIRUSES; RO	Bacteriophages are the most abundant organisms in the biosphere and play major roles in the ecological balance of microbial life. The genomic sequences of ten newly isolated mycobacteriophages suggest that the bacteriophage population as a whole is amazingly diverse and may represent the largest unexplored reservoir of sequence information in the biosphere. Genomic comparison of these mycobacteriophages contributes to our understanding of the mechanisms of viral evolution and provides compelling evidence for the role of illegitimate recombination in horizontal genetic exchange. The promiscuity of these recombination events results in the inclusion of many unexpected genes including those implicated in mycobacterial latency, the cellular and immune responses to mycobacterial infections, and autoimmune diseases such as human lupus. While the role of phages as vehicles of toxin genes is well established, these observations suggest a much broader involvement of phages in bacterial virulence and the host response to bacterial infections.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Greater Latrobe High Sch, Latrobe, PA 15650 USA; ICMR, TB Res Ctr, Madras 600031, Tamil Nadu, India; Pelham Mem High Sch, Pelham, NY 10803 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, Bronx, NY 10461 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		Pannunzio, Nick/0000-0002-8290-8236; Jacobs, William/0000-0003-3321-3080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R22AI026170, R01AI028927, R29AI028927, R01AI026170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051975] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28927, AI26170] Funding Source: Medline; NIGMS NIH HHS [GM5197508] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; ACKERMANN HW, 1987, MICROBIOL SCI, V4, P214; Bibb LA, 2002, MOL MICROBIOL, V45, P1515, DOI 10.1046/j.1365-2958.2002.03130.x; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; Chen XG, 2000, GENE DEV, V14, P777; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobrindt U, 2000, INT J MED MICROBIOL, V290, P519; DOKE S, 1960, J KUMAMOTO MED SOC, V34, P1360; Eltringham IJ, 1999, J CLIN MICROBIOL, V37, P3528, DOI 10.1128/JCM.37.11.3528-3532.1999; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Ford M. E., 1998, Tubercle and Lung Disease, V79, P63, DOI 10.1054/tuld.1998.0007; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; FROMAN S, 1954, AM J PUBLIC HEALTH, V44, P1326, DOI 10.2105/AJPH.44.10.1326; Garza DR, 1998, MICROB ECOL, V36, P281, DOI 10.1007/s002489900115; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HARLEY JB, 1992, RHEUM DIS CLIN N AM, V18, P337; Hatfull GF, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P37; HATFULL GF, 1993, MOL MICROBIOL, V7, P395, DOI 10.1111/j.1365-2958.1993.tb01131.x; Hatfull Graham F., 1994, P165; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JONES WD, 1990, AM REV RESPIR DIS, V142, P1000, DOI 10.1164/ajrccm/142.5.1000; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kell DB, 2000, CURR OPIN MICROBIOL, V3, P238, DOI 10.1016/S1369-5274(00)00082-5; LAAL S, 1991, P NATL ACAD SCI USA, V88, P1054, DOI 10.1073/pnas.88.3.1054; Labbe JC, 2000, P NATL ACAD SCI USA, V97, P13233, DOI 10.1073/pnas.230284297; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; LEVIN ME, 1993, J MOL BIOL, V234, P124, DOI 10.1006/jmbi.1993.1568; MCCAULIFFE DP, 1989, J AUTOIMMUN, V2, P375, DOI 10.1016/0896-8411(89)90166-2; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; NESBIT CE, 1995, MOL MICROBIOL, V17, P1045, DOI 10.1111/j.1365-2958.1995.mmi_17061045.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Recktenwald J, 2002, INFECT IMMUN, V70, P1896, DOI 10.1128/IAI.70.4.1896-1908.2002; ROESSNER CA, 1984, J BACTERIOL, V157, P165, DOI 10.1128/JB.157.1.165-170.1984; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Shi H, 1996, RNA, V2, P769; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Short SM, 1999, HYDROBIOLOGIA, V401, P19, DOI 10.1023/A:1003711115967; SIMON MN, 1971, BACTERIOPHAGE LAMBDA, P313; Smith MCM, 1999, NUCLEIC ACIDS RES, V27, P2145, DOI 10.1093/nar/27.10.2145; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; TIMME TL, 1984, J GEN MICROBIOL, V130, P2059; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; WESTMORELAND BC, 1969, SCIENCE, V163, P1343, DOI 10.1126/science.163.3873.1343; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; XU J, 2000, THESIS U PITTSBURGH	61	469	500	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					171	182		10.1016/S0092-8674(03)00233-2	http://dx.doi.org/10.1016/S0092-8674(03)00233-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705866	Bronze			2022-12-01	WOS:000182508500007
J	Tracey, WD; Wilson, RI; Laurent, G; Benzer, S				Tracey, WD; Wilson, RI; Laurent, G; Benzer, S			painless, a Drosophila gene essential for nociception	CELL			English	Article							CAPSAICIN-RECEPTOR; MECHANOSENSORY TRANSDUCTION; CATION CHANNEL; PROTEIN; IDENTIFICATION; MELANOGASTER; EXPRESSION; ELEGANS; THRESHOLD; NEURONS	We describe a paradigm for nociception in Drosophila. In response to the touch of a probe heated above 38degreesC, Drosophila larvae produce a stereotypical rolling behavior, unlike the response to an unheated probe. In a genetic screen for mutants defective in this noxious heat response, we identified the painless gene. Recordings from wild-type larval nerves identified neurons that initiated strong spiking above 38degreesC, and this activity was absent in the painless mutant. The painless mRNA encodes a protein of the transient receptor potential ion channel family. Painless is required for both thermal and mechanical nociception, but not for sensing light touch painless is expressed in peripheral neurons that extend multiple branched dendrites beneath the larval epidermis, similar to vertebrate pain receptors. An antibody to Painless binds to localized dendritic structures that we hypothesize are involved in nociceptive signaling.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Tracey, WD (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	tracey@caltech.edu; benzer@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Wilson, Rachel/0000-0001-8573-9266; Tracey, W. Daniel/0000-0003-4666-8199				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BECK PW, 1974, BRAIN RES, V67, P373, DOI 10.1016/0006-8993(74)90488-0; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2000, LEARN MEMORY, V7, P104, DOI 10.1101/lm.7.2.104; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colbert HA, 1997, J NEUROSCI, V17, P8259; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Grueber WB, 2002, DEVELOPMENT, V129, P2867; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; MARIATH HA, 1985, J INSECT PHYSIOL, V31, P779, DOI 10.1016/0022-1910(85)90071-X; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rorth P, 1998, DEVELOPMENT, V125, P1049; Sepp KJ, 1999, GENETICS, V151, P1093; Sherrington CS., 1906, INTEGRATIVE ACTION N; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; SUN BH, 1995, J NEUROCHEM, V65, P434, DOI 10.1046/j.1471-4159.1995.65010434.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VANHEES J, 1981, J NEUROL NEUROSUR PS, V44, P600, DOI 10.1136/jnnp.44.7.600; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; 2002, BDGP	42	497	521	5	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					261	273		10.1016/S0092-8674(03)00272-1	http://dx.doi.org/10.1016/S0092-8674(03)00272-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705873	Bronze			2022-12-01	WOS:000182508500014
J	Boucher, P; Gotthardt, M; Li, WP; Anderson, RGW; Herz, J				Boucher, P; Gotthardt, M; Li, WP; Anderson, RGW; Herz, J			LRP: Role in vascular wall integrity and protection from atherosclerosis	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN; MUSCLE CELL-MIGRATION; APOLIPOPROTEIN-E; IN-VIVO; GENE; INACTIVATION; PROGRESSION; MICE	Vascular smooth muscle cell (SMC) proliferation and migration are important events in the development of atherosclerosis. The low-density lipoprotein receptor-related protein (LRP1) mediates suppression of SMC migration induced by platelet-derived growth factor (PDGF). Here we show that LRP1 forms a complex with the PDGF receptor (PDGFR). Inactivation of LRP1 in vascular SMCs of mice causes PDGFR overexpression and abnormal activation of PDGFR signaling, resulting in disruption of the elastic layer, SMC proliferation, aneurysm formation, and marked susceptibility to cholesterol-induced atherosclerosis. The development of these abnormalities was reduced by treatment with Gleevec, an inhibitor of PDGF signaling. Thus, LRP1 has a pivotal role in protecting vascular wall integrity and preventing atherosclerosis by controlling PDGFR activation.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Gotthardt, Michael/ABE-8274-2021	Gotthardt, Michael/0000-0003-1788-3172; Boucher, Philippe/0000-0002-3928-9812	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, P01HL020948, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762, HL20948, HL63762] Funding Source: Medline; NIGMS NIH HHS [GM 52016] Funding Source: Medline; NINDS NIH HHS [NS43408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; Goodall S, 2001, CIRCULATION, V104, P304, DOI 10.1161/01.CIR.104.3.304; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI13992; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Lee RT, 2000, ANN MED, V32, P233, DOI 10.3109/07853890009011765; Lijnen HR, 2002, BIOCHEM SOC T, V30, P163, DOI 10.1042/bst0300163; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; ROSS R, 1993, TRANSPLANT P, V25, P2041; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; Swertfeger DK, 2001, FRONT BIOSCI-LANDMRK, V6, pD526, DOI 10.2741/Swertfeg; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	22	449	477	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					329	332		10.1126/science.1082095	http://dx.doi.org/10.1126/science.1082095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690199				2022-12-01	WOS:000182135400057
J	Gewin, V				Gewin, V			Biosphere owner sues sponsor	NATURE			English	News Item																		Rosenstiel TN, 2003, NATURE, V421, P256, DOI 10.1038/nature01312; 2003, NATURE, V421, P466	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					461	461		10.1038/422461b	http://dx.doi.org/10.1038/422461b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673218	Bronze			2022-12-01	WOS:000181965400009
J	Salzman, NH; Ghosh, D; Huttner, KM; Paterson, Y; Bevins, CL				Salzman, NH; Ghosh, D; Huttner, KM; Paterson, Y; Bevins, CL			Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin	NATURE			English	Article							INNATE HOST-DEFENSE; PANETH CELL; ANTIMICROBIAL PEPTIDE; EPITHELIAL-CELLS; ALPHA-DEFENSINS; GENE; LOCALIZATION; MACROPHAGES; SECRETION; GROWTH	Genetically encoded antibiotic peptides are evolutionarily ancient and widespread effector molecules of immune defence(1-3). Mammalian defensins, one subset of such peptides, have been implicated in the antimicrobial defence capacity of phagocytic leukocytes and various epithelial cells(4), but direct evidence of the magnitude of their in vivo effects have not been clearly demonstrated. Paneth cells, specialized epithelia of the small intestinal crypt, secrete abundant alpha-defensins and other antimicrobial polypeptides(5,6) including human defensin 5 (HD-5; also known as DEFA5)(7-9). Although antibiotic activity of HD-5 has been demonstrated in vitro(9,10), functional studies of HD-5 biology have been limited by the lack of in vivo models. To study the in vivo role of HD-5, we developed a transgenic mouse model using a 2.9-kilobase HD-5 minigene containing two HD-5 exons and 1.4 kilobases of 5'-flanking sequence. Here we show that HD-5 expression in these mice is specific to Paneth cells and reflects endogenous enteric defensin gene expression. The storage and processing of transgenic HD-5 also matches that observed in humans. HD-5 transgenic mice were markedly resistant to oral challenge with virulent Salmonella typhimurium. These findings provide support for a critical in vivo role of epithelial-derived defensins in mammalian host defence.	Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; Med Coll Wisconsin, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neonatol, Boston, MA 02114 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; Medical College of Wisconsin; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bevins, CL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bevinsc@ccf.org	Bevins, Charles L/P-4438-2015	Bevins, Charles L/0000-0003-2725-2622; Salzman, Nita/0000-0003-0939-6139; Paterson, Yvonne/0000-0002-9406-4958	NIAID NIH HHS [K08 AI001525-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001525] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Bevins CL, 1996, GENOMICS, V31, P95, DOI 10.1006/geno.1996.0014; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Cole AM, 2000, BIOTECHNIQUES, V29, P822, DOI 10.2144/00294rv01; COUTO MA, 1994, INFECT IMMUN, V62, P2375, DOI 10.1128/IAI.62.6.2375-2378.1994; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; HARPER ME, 1982, AM J HUM GENET, V34, P227; IWABUCHI Y, 1994, ARCH INT PHARMACOD T, V328, P315; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; LEHRER RI, 1998, MUCOSAL IMMUNOLOGY, P89; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Meister M, 2000, CURR TOP MICROBIOL, V248, P17; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1999, DEV GASTROINTESTINAL, P147; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Wang MSC, 1997, ANAL BIOCHEM, V253, P225, DOI 10.1006/abio.1997.2347; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	30	583	617	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					522	526		10.1038/nature01520	http://dx.doi.org/10.1038/nature01520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12660734				2022-12-01	WOS:000181965400038
J	La Scola, B; Audic, S; Robert, C; Jungang, L; de Lamballerie, X; Drancourt, M; Birtles, R; Claverie, JM; Raoult, D				La Scola, B; Audic, S; Robert, C; Jungang, L; de Lamballerie, X; Drancourt, M; Birtles, R; Claverie, JM; Raoult, D			A giant virus in amoebae	SCIENCE			English	Article									CNRS, UPR 2589, Struct & Genom Informat Lab, Marseille, France; Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies, F-13385 Marseille, France; Univ Mediterranee, UVE, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Claverie, JM (corresponding author), CNRS, UPR 2589, Struct & Genom Informat Lab, Marseille, France.		RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; Claverie, Jean-Michel/0000-0003-1424-0315; Audic, Stephane/0000-0001-6193-4374; Birtles, Richard/0000-0002-4216-5044				Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; HUTSON MS, 1995, BIOPOLYMERS, V35, P297, DOI 10.1002/bip.360350305; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Sandaa RA, 2001, VIROLOGY, V290, P272, DOI 10.1006/viro.2001.1161; van Regenmortel M.H.V., 2000, VIRUS TAXONOMY 7 REP	6	562	579	5	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2033	2033						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663918				2022-12-01	WOS:000181834200044
J	Paulsen, IT; Banerjei, L; Myers, GSA; Nelson, KE; Seshadri, R; Read, TD; Fouts, DE; Eisen, JA; Gill, SR; Heidelberg, JF; Tettelin, H; Dodson, RJ; Umayam, L; Brinkac, L; Beanan, M; Daugherty, S; DeBoy, RT; Durkin, S; Kolonay, J; Madupu, R; Nelson, W; Vamathevan, J; Tran, B; Upton, J; Hansen, T; Shetty, J; Khouri, H; Utterback, T; Radune, D; Ketchum, KA; Dougherty, BA; Fraser, CM				Paulsen, IT; Banerjei, L; Myers, GSA; Nelson, KE; Seshadri, R; Read, TD; Fouts, DE; Eisen, JA; Gill, SR; Heidelberg, JF; Tettelin, H; Dodson, RJ; Umayam, L; Brinkac, L; Beanan, M; Daugherty, S; DeBoy, RT; Durkin, S; Kolonay, J; Madupu, R; Nelson, W; Vamathevan, J; Tran, B; Upton, J; Hansen, T; Shetty, J; Khouri, H; Utterback, T; Radune, D; Ketchum, KA; Dougherty, BA; Fraser, CM			Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis	SCIENCE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PLASMID PAD1; VIRULENCE; PRECURSORS; TOLERANCE	The complete genome sequence of Enterococcusfaecalis V583, a vancomycin-resistant clinical isolate, revealed that more than a quarter of the genome consists of probable mobile or foreign DNA. One of the predicted mobile elements is a previously unknown vanB vancomycin-resistance conjugative transposon. Three plasmids were identified, including two pheromone-sensing conjugative plasmids, one encoding a previously undescribed pheromone inhibitor. The apparent propensity for the incorporation of mobile elements probably contributed to the rapid acquisition and dissemination of drug resistance in the enterococci.	Inst Genom Res, Rockville, MD 20850 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; George Washington Univ, Sch Med, Dept Pharmacol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Microbiol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Trop Med, Washington, DC 20037 USA	J. Craig Venter Institute; Johns Hopkins University; George Washington University; George Washington University; George Washington University	Paulsen, IT (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Paulsen, Ian T/K-3832-2012; Read, Timothy/E-6240-2011; Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016; Myers, Garry/E-7708-2011	Paulsen, Ian T/0000-0001-9015-9418; Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224; Vamathevan, Jessica/0000-0003-2016-9754; Fraser, Claire/0000-0003-1462-2428; Read, Timothy/0000-0001-8966-9680; Myers, Garry/0000-0002-4756-4810	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040963] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40963-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHUR M, 1992, ANTIMICROB AGENTS CH, V36, P867, DOI 10.1128/AAC.36.4.867; Bensing BA, 2001, INFECT IMMUN, V69, P6186, DOI 10.1128/IAI.69.10.6186-6192.2001; Clewell DB, 2000, MOL MICROBIOL, V35, P246, DOI 10.1046/j.1365-2958.2000.01687.x; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; Garnier F, 2000, MICROBIOL-UK, V146, P1481, DOI 10.1099/00221287-146-6-1481; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; Klare I, 2001, Contrib Microbiol, V8, P108; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; PONTIUS LT, 1991, PLASMID, V26, P172, DOI 10.1016/0147-619X(91)90041-T; Robertson GT, 2002, J BACTERIOL, V184, P6987, DOI 10.1128/JB.184.24.6987-7000.2002; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; TAILOR SAN, 1993, ANN PHARMACOTHER, V27, P1231, DOI 10.1177/106002809302701014; WELLS CL, 1990, J INFECT DIS, V162, P82, DOI 10.1093/infdis/162.1.82; [No title captured]	18	700	1206	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2071	2074		10.1126/science.1080613	http://dx.doi.org/10.1126/science.1080613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663927				2022-12-01	WOS:000181834200056
J	Foreman, J; Demidchik, V; Bothwell, JHF; Mylona, P; Miedema, H; Torres, MA; Linstead, P; Costa, S; Brownlee, C; Jones, JDG; Davies, JM; Dolan, L				Foreman, J; Demidchik, V; Bothwell, JHF; Mylona, P; Miedema, H; Torres, MA; Linstead, P; Costa, S; Brownlee, C; Jones, JDG; Davies, JM; Dolan, L			Reactive oxygen species produced by NADPH oxidase regulate plant cell growth	NATURE			English	Article							ROOT HAIRS; CALCIUM-CHANNELS; ARABIDOPSIS; CA2+; GENERATION; HOMOLOGS; DEFENSE; PROTEIN; TIP	Cell expansion is a central process in plant morphogenesis, and the elongation of roots and root hairs is essential for uptake of minerals and water from the soil. Ca2+ influx from the extracellular store is required for ( and sets the rates of) cell elongation in roots(1). Arabidopsis thaliana rhd2 mutants are defective in Ca2+ uptake and consequently cell expansion is compromised rhd2 mutants have short root hairs(2,3) and stunted roots. To determine the regulation of Ca2+ acquisition in growing root cells we show here that RHD2 is an NADPH oxidase, a protein that transfers electrons from NADPH to an electron acceptor leading to the formation of reactive oxygen species (ROS). We show that ROS accumulate in growing wild-type (WT) root hairs but their levels are markedly decreased in rhd2 mutants. Blocking the activity of the NADPH oxidase with diphenylene iodonium (DPI) inhibits ROS formation and phenocopies Rhd2(-). Treatment of rhd2 roots with ROS partly suppresses the mutant phenotype and stimulates the activity of plasma membrane hyperpolarization-activated Ca2+ channels, the predominant root Ca2+ acquisition system. This indicates that NADPH oxidases control development by making ROS that regulate plant cell expansion through the activation of Ca2+ channels.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Marine Biol Assoc UK, Plymouth PL1 2PB, Devon, England; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Cambridge; Marine Biological Association United Kingdom; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Demidchik, Vadim/N-9314-2019; Jones, Jonathan DG/J-5129-2012; Lacruz, Miguel Angel Torres/H-6969-2015	Demidchik, Vadim/0000-0003-3765-8386; Jones, Jonathan DG/0000-0002-4953-261X; Lacruz, Miguel Angel Torres/0000-0002-0435-1786; Dolan, Liam/0000-0003-1206-7096; Bothwell, John/0000-0003-2964-5980; Costa, Silvia/0000-0001-9931-3493	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; Carroll AD, 1998, PLANT CELL, V10, P1267, DOI 10.1105/tpc.10.8.1267; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cramer GR, 1996, PLANT CELL ENVIRON, V19, P1291, DOI 10.1111/j.1365-3040.1996.tb00007.x; Demidchik V, 2002, PLANT J, V32, P799, DOI 10.1046/j.1365-313X.2002.01467.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Felle HH, 1997, PLANT PHYSIOL, V114, P39, DOI 10.1104/pp.114.1.39; Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kiegle E, 2000, PLANT J, V21, P225, DOI 10.1046/j.1365-313x.2000.00659.x; KISS T, 1994, PHARMACOL REV, V46, P245; Miedema H, 2001, TRENDS PLANT SCI, V6, P514, DOI 10.1016/S1360-1385(01)02124-0; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Very AA, 2000, P NATL ACAD SCI USA, V97, P9801, DOI 10.1073/pnas.160250397; WILLIAMS AJ, 1981, THORAX, V36, P866, DOI 10.1136/thx.36.11.866; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x	29	1608	1737	23	427	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 27	2003	422	6930					442	446		10.1038/nature01485	http://dx.doi.org/10.1038/nature01485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659WV	12660786				2022-12-01	WOS:000181801200047
J	Schwab, JM; Schluesener, HJ; Laufer, S				Schwab, JM; Schluesener, HJ; Laufer, S			COX-3: just another COX or the solitary elusive target of paracetamol?	LANCET			English	Editorial Material							EXPRESSION; TRANSCRIPT; MICE		Sch Med, Inst Brain Res, D-72076 Tubingen, Germany; Univ Tubingen, Inst Pharm, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schwab, JM (corresponding author), Sch Med, Inst Brain Res, D-72076 Tubingen, Germany.			Laufer, Stefan/0000-0001-6952-1486; Schwab, Jan/0000-0001-6784-4919				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Botting RM, 2000, CLIN INFECT DIS, V31, pS202, DOI 10.1086/317520; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Hla T, 1996, PROSTAG OTH LIPID M, V51, P81, DOI 10.1016/0090-6980(95)00158-1; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Laulederkind SJF, 2002, LAB INVEST, V82, P919, DOI 10.1097/01.LAB.0000020407.98665.98; Mazario J, 2001, NEUROPHARMACOLOGY, V40, P937, DOI 10.1016/S0028-3908(01)00020-X; Plant MH, 1999, BIOCHEM J, V344, P677, DOI 10.1042/0264-6021:3440677; VANE JR, 1971, NATURE, V23, P232; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2	12	68	74	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 22	2003	361	9362					981	982		10.1016/S0140-6736(03)12841-3	http://dx.doi.org/10.1016/S0140-6736(03)12841-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658AP	12660052				2022-12-01	WOS:000181699700005
J	Fassin, D; Schneider, H				Fassin, D; Schneider, H			The politics of AIDS in South Africa: beyond the controversies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VIOLENCE	At the beginning of 2000 Thabo Mbeki sent a letter to world leaders expressing his doubt that HIV was the exclusive cause of AIDS and arguing for a consideration of socioeconomic causes. He subsequently invited scientists who shared his view to sit with orthodox experts on AIDS on a presidential panel to advise him on appropriate responses to the epidemic in South Africa. Until April 2002, when Mbeki formally distanced himself from the AIDS "dissidents," the international scientific community's interest in South African policies on AIDS was almost exclusively focused on the polemic raised by the president. His statements questioning the AIDS statistics, on poverty as a cause of immune deficiency, and on the dangers of antiretrovirals, together with government stalling on the roll out of nevirapine to prevent transmission of HIV from pregnant mothers to their babies, dominated the debate.(1-3) However, the July 2002 Constitutional Court judgment ordering the government to make nevirapine universally available to pregnant women infected with HIV, followed in October by a cabinet statement supporting wider access to antiretrovirals, may have finally ushered in a new era. It should now be possible to discuss the reality of AIDS in South Africa without reducing the argument to simple dualisms (such as being for or against a viral cause of AIDS, for or against the president). We propose an approach to discussing AIDS in South Africa that is rooted in political economy and political anthropology. Such an approach will shed light not only on the objective determinants of the epidemic, especially social inequalities, but also on subjective responses, such as those of Mbeki.	Univ Paris 13, INSERM, Ctr Rech Enjeux Contemporains Sante Publ, F-93017 Bobigny, France; Univ Witwatersrand, Sch Publ Hlth, Ctr Hlth Policy, ZA-2000 Johannesburg, South Africa	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; University of Witwatersrand	Fassin, D (corresponding author), Univ Paris 13, INSERM, Ctr Rech Enjeux Contemporains Sante Publ, 74 Rue Marcel Cachin, F-93017 Bobigny, France.	dfassin@ehess.fr						Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7; Cottereau Alain., 1999, EXPERIENCE DENI, P159; *DEP HLTH, 2000, NAT HIV SYPH SER PRE; Dorrington R. E., 2001, IMPACT HIV AIDS ADUL; Farmer P., 1999, INFECT INEQUALITIES; Farmer P., 2006, AIDS ACCUSATION HAIT; FASSIN D., 2002, TEMPS MODERNES, V620, P429; Fassin Didier, 2002, Afr J AIDS Res, V1, P63, DOI 10.2989/16085906.2002.9626545; GOULD C, 2000, SUNDAY INDEPEND 1008, P7; JOHNSON L, 2002, HIV RISK FACTORS REV; Lurie M, 2000, S AFR J SCI, V96, P343; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; Packard Randall M., 1990, WHITE PLAGUE BLACK L; Schneider H, 2002, AIDS, V16, pS45, DOI 10.1097/00002030-200216004-00007; Schneider H, 2002, AFRICAN STUDIES, V61, P145, DOI DOI 10.1080/00020180220140118; Seidman G, 1999, ANNU REV SOCIOL, V25, P419, DOI 10.1146/annurev.soc.25.1.419; Sidley, 2000, BMJ, V320, P1016, DOI 10.1136/bmj.320.7240.1016; SWANSON MW, 1977, J AFR HIST, V18, P387, DOI 10.1017/S0021853700027328; Taylor Charles, 1992, POLITICS RECOGNITION; van der Vliet V, 2001, DAEDALUS, V130, P151; WILLIAMS BG, 2000, NATURAL HIST HIV AID; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4	24	81	82	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					495	497		10.1136/bmj.326.7387.495	http://dx.doi.org/10.1136/bmj.326.7387.495			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653EC	12609950	Green Published			2022-12-01	WOS:000181421400026
J	James, LC; Roversi, P; Tawfik, DS				James, LC; Roversi, P; Tawfik, DS			Antibody multispecificity mediated by conformational diversity	SCIENCE			English	Article							PEPTIDE LIBRARIES; MOLECULAR-BASIS; ANTIGEN; BINDING; SITE; TRANSITION; CATALYSIS; INSIGHTS; LIGANDS; MIMICRY	A single antibody was shown to adopt different binding-site conformations and thereby bind unrelated antigens. Analysis by both x-ray crystallography and pre-steady-state kinetics revealed an equilibrium between different preexisting isomers, one of which possessed a promiscuous, low-affinity binding site for aromatic ligands, including the immunizing hapten. A subsequent induced-fit isomerization led to high-affinity complexes with a deep and narrow binding site. A protein antigen identified by repertoire selection made use of an unrelated antibody isomer with a wide, shallow binding site. Conformational diversity, whereby one sequence adopts multiple structures and multiple functions, can increase the effective size of the antibody repertoire but may also lead to autoimmunity and allergy.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; MRC, Ctr Prot Engn, Cambridge CB2 2HQ, England; Global Phasing Ltd, Cambridge, England	Weizmann Institute of Science; University of Cambridge; Global Phasing Limited	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Roversi, Pietro/AAK-4241-2021; Roversi, Pietro/F-8925-2011	Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437				AREVALO JH, 1994, J MOL BIOL, V241, P663, DOI 10.1006/jmbi.1994.1543; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; CHRISTIAN RB, 1992, J MOL BIOL, V227, P711, DOI 10.1016/0022-2836(92)90219-A; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; EHRLICH P, 1901, BERL KLIN WOCHENSCHR, V38, P569; ESHHAR Z, 1980, J IMMUNOL, V124, P775; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Hitchens TK, 2001, BIOCHEMISTRY-US, V40, P11660, DOI 10.1021/bi010909+; JAMES L, UNPUB; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KAPLAN MH, 1962, LANCET, V1, P706; Kramer A, 1997, CELL, V91, P799, DOI 10.1016/S0092-8674(00)80468-7; LANCET D, 1976, P NATL ACAD SCI USA, V73, P3549, DOI 10.1073/pnas.73.10.3549; LANDSTEINER K, 1897, WIEN KLIN WOCHENSCHR, V10, P439; Lindner AB, 1999, J MOL BIOL, V285, P421, DOI 10.1006/jmbi.1998.2309; LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; NOBLE MEM, UNPUB; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; Santiago ML, 1998, INT ARCH ALLERGY IMM, V117, P94, DOI 10.1159/000023995; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; VARGA JM, 1991, MOL IMMUNOL, V28, P641, DOI 10.1016/0161-5890(91)90133-5; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	37	590	610	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1362	1367		10.1126/science.1079731	http://dx.doi.org/10.1126/science.1079731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610298				2022-12-01	WOS:000181192300043
J	Shu, DG; Morris, SC; Zhang, ZF; Liu, JN; Han, J; Chen, L; Zhang, XL; Yasui, K; Li, Y				Shu, DG; Morris, SC; Zhang, ZF; Liu, JN; Han, J; Chen, L; Zhang, XL; Yasui, K; Li, Y			A new species of yunnanozoan with implications for deuterostome evolution	SCIENCE			English	Article							CHORDATE; VERTEBRATES; INSIGHTS; CHINA	Yunnanozoans are a distinctive clade of Lower Cambrian metazoans. Although widely accepted as deuterostomes, their exact placement within this super-phylum is controversial. Here we describe a new species of Haikouella (H. jianshanensis) from the Chengjiang Lagerstatte (Yunnan, China) with exceptional preservation of a number of features. These include external gills, which suggest that the origin of the pharyngeal clefts was independent of the gills. The diagnostic branchial arches of chordates may, therefore, be composite structures. No evidence was found for the chorwdate-like structures that have been described in other yunnanozoans. We propose that yunnanozoans are stem-group deuterostomes, allied to the vetulicolians.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Kumamoto Univ, Dept Dev & Biohist, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Changan Univ, Coll Earth Sci & Land Resources, Xian 710054, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Kumamoto University; Chang'an University	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.		Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				BABCOCK L. E., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011<0004:TCBROT>2.0.CO;2; BRIGGS DEG, 1994, LETHAIA, V26, P275, DOI DOI 10.1111/J.1502-3931.1993.TB01532.X); Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; Dzik Jerzy, 1995, Acta Palaeontologica Polonica, V40, P341; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; HOU XG, 1991, ZOOL SCR, V20, P395; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	15	80	95	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1380	1384		10.1126/science.1079846	http://dx.doi.org/10.1126/science.1079846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610301				2022-12-01	WOS:000181192300048
J	Kramer, C; Loros, JJ; Dunlap, JC; Crosthwaite, SK				Kramer, C; Loros, JJ; Dunlap, JC; Crosthwaite, SK			Role for antisense RNA in regulating circadian clock function in Neurospora crassa	NATURE			English	Article							GENE-FREQUENCY; ANTHERAEA-PERNYI; FEEDBACK LOOP; LIGHT INPUT; PERIOD; RHYTHMICITY; INITIATION; SILKMOTH; DEFINES; WC-2	The prevalence of antisense RNA in eukaryotes is not known and only a few naturally occurring antisense transcripts have been assigned a function(1-4). However, the recent identification of a large number of putative antisense transcripts(5) strengthens the view that antisense RNAs might affect a wider variety of processes than previously thought. Here we show that in the model organism Neurospora crassa entrainment of the circadian clock, which is critical for the correct temporal expression of genes and their products, is controlled partly by an antisense RNA arising from a clock component locus. In a wild-type strain, levels of antisense frequency (frq) transcripts cycle in antiphase to sense frq transcripts in the dark, and are inducible by light. In mutant strains in which the induction of antisense frq RNA by light is abolished, the time of the internal clock is delayed relative to the wild-type strain, and resetting of the clock by light is altered. These data provide an unexpected link between antisense RNA and circadian timing and provide a new example of a eukaryotic cellular process regulated by naturally occurring antisense RNA.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	University of Manchester; Dartmouth College; Dartmouth College	Crosthwaite, SK (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.		Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457				Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Collett MA, 2001, MOL CELL BIOL, V21, P2619, DOI 10.1128/MCB.21.8.2619-2628.2001; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gotter AL, 1999, NEURON, V24, P953, DOI 10.1016/S0896-6273(00)81042-9; Hastings MH, 2000, NAT REV NEUROSCI, V1, P143, DOI 10.1038/35039080; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; JOHNSON KA, 1993, THESIS DARTMOUTH COL; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; MERROW MW, 1994, EMBO J, V13, P2257, DOI 10.1002/j.1460-2075.1994.tb06507.x; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a	30	127	137	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					948	952		10.1038/nature01427	http://dx.doi.org/10.1038/nature01427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607002				2022-12-01	WOS:000181186900050
J	Stewart, GS; Wang, B; Bignell, CR; Taylor, AMR; Elledge, SJ				Stewart, GS; Wang, B; Bignell, CR; Taylor, AMR; Elledge, SJ			MDC1 is a mediator of the mammalian DNA damage checkpoint	NATURE			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST RAD9; BRCT DOMAIN; IN-VIVO; PROTEIN; REPAIR; KINASE; 53BP1; ATM	To counteract the continuous exposure of cells to agents that damage DNA, cells have evolved complex regulatory networks called checkpoints to sense DNA damage and coordinate DNA replication, cell-cycle arrest and DNA repair(1). It has recently been shown that the histone H2A variant H2AX specifically controls the recruitment of DNA repair proteins to the sites of DNA damage(2-4). Here we identify a novel BRCA1 carboxy-terminal (BRCT) and forkhead-associated (FHA) domain-containing protein, MDC1 (mediator of DNA damage checkpoint protein 1), which works with H2AX to promote recruitment of repair proteins to the sites of DNA breaks and which, in addition, controls damage-induced cell-cycle arrest checkpoints. MDC1 forms foci that co-localize extensively with gamma-H2AX foci within minutes after exposure to ionizing radiation. H2AX is required for MDC1 foci formation, and MDC1 forms complexes with phosphorylated H2AX. Furthermore, this interaction is phosphorylation dependent as peptides containing the phosphorylated site on H2AX bind MDC1 in a phosphorylation-dependent manner. We have shown by using small interfering RNA (siRNA) that cells lacking MDC1 are sensitive to ionizing radiation, and that MDC1 controls the formation of damage-induced 53BP1, BRCA1 and MRN foci, in part by promoting efficient H2AX phosphorylation. In addition, cells lacking MDC1 also fail to activate the intra-S phase and G2/M phase cell-cycle checkpoints properly after exposure to ionizing radiation, which was associated with an inability to regulate Chk1 properly. These results highlight a crucial role for MDC1 in mediating transduction of the DNA damage signal.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Birmingham, CRC Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Birmingham	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Stewart, Grant/0000-0002-0960-3241				Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HUANG M, 2000, COLD SPRING HARB SYM, V65, P1; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Liu QH, 2000, GENE DEV, V14, P1448; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Takai H, 2000, GENE DEV, V14, P1439; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Venkitaraman AR, 2001, J CELL SCI, V114, P3591; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang Y, 2000, GENE DEV, V14, P927; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	663	706	6	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					961	966		10.1038/nature01446	http://dx.doi.org/10.1038/nature01446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607005				2022-12-01	WOS:000181186900053
J	Antoine, C; Muller, S; Cant, A; Cavazzana-Calvo, M; Veys, P; Vossen, J; Fasth, A; Heilmann, C; Wulffraat, N; Seger, R; Blanche, S; Friedrich, W; Abinun, M; Davies, G; Bredius, R; Schulz, A; Landais, P; Fischer, A				Antoine, C; Muller, S; Cant, A; Cavazzana-Calvo, M; Veys, P; Vossen, J; Fasth, A; Heilmann, C; Wulffraat, N; Seger, R; Blanche, S; Friedrich, W; Abinun, M; Davies, G; Bredius, R; Schulz, A; Landais, P; Fischer, A		European Grp Blood Marrow Transpla	Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99	LANCET			English	Article							BONE-MARROW TRANSPLANTATION; T-CELL; DEFICIENCY	Background Transplantation of allogeneic haemopoietic stem cells can cure several primary immunodeficiencies. This European report focuses on the long-term results of such procedures done between 1968 and December, 1999, for primary immunodeficiencies. Methods The report includes data from 37 centres in 18 countries, which participated in a European registry for stem-cell transplantation in severe combined immunodeficiencies (SCID) and in other immunodeficiency disorders (non-SCID). 1082 transplants in 919 patients were studied (566 in 475 SCID patients, 512 in 444 non-SCID patients; four procedures excluded owing to insufficient data). Minimum follow-up of 6 months was required. Findings In SCID, 3-year survival with sustained engraftment was significantly better after HLA-identical than after mismatched transplantation (77% vs 54%; p=0.002) and survival improved over time. In HLA-mismatched stem-cell transplantation, B(-) SCID had poorer prognosis than B(+) SCID. However, improvement with time occurred in both SCID phenotypes. In non-SCID, 3-year survival after genotypically HLA-matched, phenotypically HLA-matched, HLA-mismatched related, and unrelated-donor transplantation was 71%, 42%, 42%, and 59%, respectively (p=0.0006). Acute graft versus host disease predicted poor prognosis whatever the donor origin except in related HLA-identical transplantation in SCID. Interpretation The improvement in survival over time indicates more effective prevention and treatment of disease-related and procedure-related complications-eg, infections and graft versus host disease. An important factor is better prevention of graft versus host disease in the HLA-non-identical setting by use of more efficient methods of T-cell depletion. For non-SCID, stem-cell transplantation can provide a cure, and grafts from unrelated donors are almost as beneficial as those from genetically HLA-identical relatives.	Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, F-75743 Paris, France; Hop Necker Enfants Malad, Serv Biostat, Paris, France; Univ Ulm, Kinderklin, Ulm, Germany; Newcastle Gen Hosp, Dept Paediat Immunol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Great Ormond St Hosp Sick Children, Dept Immunol, London, England; Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London, England; Acad Hosp Leiden, Dept Paediat, Leiden, Netherlands; Queen Silvia Childrens Hosp, Gothenburg, Sweden; Rigshosp, Dept Paediat, DK-2100 Copenhagen, Denmark; Wilhelmina Childrens Hosp, Utrecht, Netherlands; Univ Childrens Hosp, Div Immunol Haematol, Zurich, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulm University; Newcastle General Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Queen Silvia Children's Hospital; Rigshospitalet; University of Copenhagen; Wilhelmina Kinderziekenhuis; University Children's Hospital Zurich	Fischer, A (corresponding author), Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, 149 Rue Sevres, F-75743 Paris, France.		Bredius, Robbert/AAF-2592-2019; Fasth, Anders/I-1109-2019; Wulffraat, Nico M/AAE-8929-2020	Wulffraat, Nico M/0000-0001-9548-5562; Bredius, Robbert/0000-0001-8151-1539; Fasth, Anders/0000-0002-0033-740X; Cavazzana, Marina/0000-0002-0264-0891				Bertrand Y, 1999, J PEDIATR-US, V134, P740, DOI 10.1016/S0022-3476(99)70291-X; Buckley RH, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P459; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; FISCHER A, 1986, LANCET, V2, P1080; FISCHER A, 1990, LANCET, V336, P850, DOI 10.1016/0140-6736(90)92348-L; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; FISCHER A, 1994, BLOOD, V83, P1149; GENTLEMAN R, 1997, INTERFACE FDN N AM; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Haddad E, 1998, BLOOD, V91, P3646; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; KLEIN C, 1995, BLOOD, V85, P580; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; PETER HH, 1983, J IMMUNOL, V131, P2332; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; REISNER Y, 1983, BLOOD, V61, P341	19	399	415	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					553	560		10.1016/S0140-6736(03)12513-5	http://dx.doi.org/10.1016/S0140-6736(03)12513-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598139				2022-12-01	WOS:000181033400007
J	Sharma, S; tenOever, BR; Grandvaux, N; Zhou, GP; Lin, RT; Hiscott, J				Sharma, S; tenOever, BR; Grandvaux, N; Zhou, GP; Lin, RT; Hiscott, J			Triggering the interferon antiviral response through an IKK-related pathway	SCIENCE			English	Article							KAPPA-B KINASE; REGULATORY FACTOR-3; TRANSCRIPTION FACTORS; VIRUS-INFECTION; ACTIVATION; PHOSPHORYLATION; DISTINCT; COMPLEX; IRF-3; ASSOCIATION	Rapid induction of type I interferon expression, a central event in establishing the innate antiviral response, requires cooperative activation of numerous transcription factors. Although signaling pathways that activate the transcription factors nuclear factor kappaB and ATF-2/c-Jun have been well characterized, activation of the interferon regulatory factors IRF-3 and IRF-7 has remained a critical missing link in understanding interferon signaling. We report here that the IkappaB kinase (IKK)-related kinases IKKepsilon and TANK-binding kinase 1 are components of the virus-activated kinase that phosphorylate IRF-3 and IRF-7. These studies illustrate an essential role for an IKK-related kinase pathway in triggering the host antiviral response to viral infection.	McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Lin, RT (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Microbiol & Immunol, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.		Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Nomura F, 2000, GENES CELLS, V5, P191; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Peters RT, 2001, BBA-REV CANCER, V1471, pM57, DOI 10.1016/S0304-419X(00)00024-X; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	24	1292	1358	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1148	1151		10.1126/science.1081315	http://dx.doi.org/10.1126/science.1081315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12702806				2022-12-01	WOS:000182886500047
J	Parham, P				Parham, P			The unsung heroes	NATURE			English	Editorial Material							CELLS		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Parham, P (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.							Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Parham P, 1999, IMMUNOL REV, V167, P5, DOI 10.1111/j.1600-065X.1999.tb01378.x; Scalzo AA, 2002, TRENDS MICROBIOL, V10, P470, DOI 10.1016/S0966-842X(02)02441-1	4	40	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					20	20		10.1038/423020a	http://dx.doi.org/10.1038/423020a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721604	Bronze			2022-12-01	WOS:000182561600020
J	Woo, HA; Chae, HZ; Hwang, SC; Yang, KS; Kang, SW; Kim, K; Rhee, SG				Woo, HA; Chae, HZ; Hwang, SC; Yang, KS; Kang, SW; Kim, K; Rhee, SG			Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation	SCIENCE			English	Article							THIOL-SPECIFIC ANTIOXIDANT; THIOREDOXIN PEROXIDASE; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; OXIDATION; PROTEINS; ACTIVATION; REDUCTASE; CATALYSIS	The active-site cysteine of peroxiredoxins is selectively oxidized to cysteine sulfinic acid during catalysis, which leads to inactivation of peroxidase activity. This oxidation was thought to be irreversible. However, by metabolic labeling of mammalian cells with S-35, we show that the sulfinic form of peroxiredoxin I, produced during the exposure of cells to H2O2, is rapidly reduced to the catalytically active thiol form. The mammalian cells' ability to reduce protein sulfinic acid might serve as a mechanism to repair oxidatively damaged proteins or represent a new type of cyclic modification by which the function of various proteins is regulated.	NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ewha Womans University; Ewha Womans University	Rhee, SG (corresponding author), NHLBI, Lab Cell Signaling, NIH, Bldg 10, Bethesda, MD 20892 USA.		Woo, Hyun Ae/AAT-9586-2021	Hwang, Sung Chul/0000-0003-2401-619X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005506] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Hamann M, 2002, METHOD ENZYMOL, V348, P146, DOI 10.1016/S0076-6879(02)48634-X; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee S.G., 2000, SCI STKE; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Shen HM, 2002, FREE RADICAL BIO MED, V33, P552, DOI 10.1016/S0891-5849(02)00918-8; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; YANG KC, UNPUB; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	26	445	466	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					653	656		10.1126/science.1080273	http://dx.doi.org/10.1126/science.1080273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714748				2022-12-01	WOS:000182453700046
J	Wilson, JF				Wilson, JF			Advancing the war on malaria	ANNALS OF INTERNAL MEDICINE			English	News Item													Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					693	696		10.7326/0003-4819-138-8-200304150-00039	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00039			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693913				2022-12-01	WOS:000182173800032
J	Prandoni, P; Bilora, F; Marchiori, A; Bernardi, E; Petrobelli, F; Lensing, AWA; Prins, MH; Girolami, A				Prandoni, P; Bilora, F; Marchiori, A; Bernardi, E; Petrobelli, F; Lensing, AWA; Prins, MH; Girolami, A			An association between atherosclerosis and venous thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; RISK-FACTORS; PULMONARY-EMBOLISM; D-DIMER; CAROTID ATHEROSCLEROSIS; GENERAL-POPULATION; THROMBOEMBOLISM; DISEASE; THROMBOPHILIA; MECHANISMS	BACKGROUND: In about a third of patients with venous thromboembolism, the cause of the disorder is unexplained. In patients with atherosclerosis, activation of both platelets and blood coagulation and an increase in fibrin turnover are detectable, which may lead to thrombotic complications. Whether atherosclerosis is associated with an increased risk of venous thrombosis is unknown. METHODS: We performed ultrasonography of the carotid arteries in 299 unselected patients who had deep venous thrombosis of the legs without symptomatic atherosclerosis and in 150 control subjects. Patients with spontaneous thrombosis, patients with secondary thrombosis from acquired risk factors, and control subjects were assessed for plaques. RESULTS: At least one carotid plaque was detected in 72 of the 153 patients with spontaneous thrombosis (47.1 percent; 95 percent confidence interval, 39.1 to 55.0), 40 of the 146 with secondary thrombosis (27.4 percent; 95 percent confidence interval, 20.2 to 34.6), and 48 of the 150 control subjects (32.0 percent; 95 percent confidence interval, 24.5 to 39.5). The odds ratios for carotid plaques in patients with spontaneous thrombosis, as compared with patients with secondary thrombosis and with controls, were 2.3 (95 percent confidence interval, 1.4 to 3.7) and 1.8 (95 percent confidence interval, 1.1 to 2.9), respectively. In a multivariate analysis that accounted for risk factors for atherosclerosis, the strength of this association did not change. CONCLUSIONS: There is an association between atherosclerotic disease and spontaneous venous thrombosis. Atherosclerosis may induce venous thrombosis, or the two conditions may share common risk factors.	Univ Padua, Chair Internal Med 2, Dept Med & Surg Sci, Sch Med, I-35128 Padua, Italy; Univ Amsterdam, Acad Med Ctr, Ctr Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Maastricht, Dept Clin Epidemiol, Maastricht, Netherlands	University of Padua; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Prandoni, P (corresponding author), Univ Padua, Chair Internal Med 2, Dept Med & Surg Sci, Sch Med, Via Osped Civile 105, I-35128 Padua, Italy.	paoprand@tin.it						ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Andreescu ACM, 2002, THROMB HAEMOSTASIS, V87, P47, DOI 10.1055/s-0037-1612942; Bauer KA, 2001, ANN INTERN MED, V135, P367, DOI 10.7326/0003-4819-135-5-200109040-00013; BERNSTEIN EF, 1993, CEREBRAL REVASCULARI, P73; Binaghi F, 1998, Minerva Cardioangiol, V46, P217; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; Drouet L, 1998, ARCH MAL COEUR VAISS, V91, P41; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; EIKELBOOM BC, 1993, CEREBRAL REVASCULARI, P451; FitzGerald GA, 1997, THROMB HAEMOSTASIS, V78, P280; Foley P W, 1997, Cardiovasc Surg, V5, P157; Gaustadnes M, 1999, BLOOD COAGUL FIBRIN, V10, P251, DOI 10.1097/00001721-199907000-00006; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Heit JA, 2002, SEMIN THROMB HEMOST, V28, P3, DOI 10.1055/s-2002-32312; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Holvoet P, 1997, CURR OPIN LIPIDOL, V8, P320, DOI 10.1097/00041433-199710000-00012; Joakimsen O, 1999, ARTERIOSCL THROM VAS, V19, P3007, DOI 10.1161/01.ATV.19.12.3007; Kearon C, 2000, HEMOSTASIS THROMBOSI, V4th, P1153; Koenig W, 2001, ARTERIOSCL THROM VAS, V21, P1701, DOI 10.1161/hq1001.097020; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Libby P, 2000, CLIN CARDIOL, V23, P3, DOI 10.1002/clc.4960231103; Libby P, 2000, HEMOSTASIS THROMBOSI, P743; Libertiny G, 1999, BRIT J SURG, V86, P907, DOI 10.1046/j.1365-2168.1999.01129.x; MARDER VJ, 2000, HEMOSTASIS THROMBOSI, P1243; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; PRANDONI P, 1999, PULMONARY EMBOLISM, P2; PRATI P, 1992, STROKE, V23, P1705, DOI 10.1161/01.STR.23.12.1705; PRINS MH, 1991, ARCH INTERN MED, V151, P1721, DOI 10.1001/archinte.151.9.1721; Ray JG, 2001, CURR CONTR TRIALS C, V2, P165, DOI 10.1186/CVM-2-4-165; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simioni P, 1996, THROMB HAEMOSTASIS, V76, P187; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Simioni P, 1996, THROMB HAEMOSTASIS, V76, P883; Simioni P, 2000, BLOOD, V96, P3329; Sueishi K, 1998, SEMIN THROMB HEMOST, V24, P255, DOI 10.1055/s-2007-995851; Tierney L. M., 2000, CURRENT MED DIAGNOSI, V39th; TRIPLETT DA, 2001, HEMOSTASIS NEWS, V6, P1; Vaya A, 2002, BRIT J HAEMATOL, V118, P255, DOI 10.1046/j.1365-2141.2002.03563.x; ZIERLER RE, 1993, VASCULAR DIAGNOSIS, P328	47	482	505	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2003	348	15					1435	1441		10.1056/NEJMoa022157	http://dx.doi.org/10.1056/NEJMoa022157			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665CU	12686699	Bronze, Green Published			2022-12-01	WOS:000182102700003
J	Tu, YZ; Wu, S; Shi, XH; Chen, K; Wu, CY				Tu, YZ; Wu, S; Shi, XH; Chen, K; Wu, CY			Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation	CELL			English	Article							ONLY PROTEIN PINCH; CAENORHABDITIS-ELEGANS; INTEGRIN ADHESION; BINDING PROTEIN; TRANSMEMBRANE LINKAGE; EXTRACELLULAR-MATRIX; CYTOPLASMIC DOMAIN; TARGETS FILAMIN; PLASMA-MEMBRANE; ADAPTER PROTEIN	Cell-extracellular matrix adhesion is an important determinant of cell morphology. We show here that migfilin, a LIM-containing protein, localizes to cell-matrix adhesions, associates with actin filaments, and is essential for cell shape modulation. Migfilin interacts with the cell-matrix adhesion protein Mig-2 (mitogen inducible gene-2), a mammalian homolog of UNC-112, and the actin binding protein filamin through its C- and N-terminal domains, respectively. Loss of Mig-2 or migfilin impairs cell shape modulation. Mig-2 recruits migfilin to cell-matrix adhesions, while the interaction with filamin mediates the association of migfilin with actin filaments. Migfilin therefore functions as an important scaffold at cell-matrix adhesions. Together, Mig-2, migfilin and filamin define a connection between cell matrix adhesions and the actin cytoskeleton and participate in the orchestration of actin assembly and cell shape modulation.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54639] Funding Source: Medline; NIGMS NIH HHS [GM65188] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hudson DF, 2002, TRENDS CELL BIOL, V12, P281, DOI 10.1016/S0962-8924(02)02281-X; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cb.11.110195.002115; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Li FG, 1999, J CELL SCI, V112, P4589; Liu SC, 2000, J CELL SCI, V113, P3563; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Olski TM, 2001, J CELL SCI, V114, P525; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; WICK M, 1994, J CELL SCI, V107, P227; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zamir E, 2001, J CELL SCI, V114, P3583; Zervas CG, 2002, CURR BIOL, V12, pR350, DOI 10.1016/S0960-9822(02)00856-4; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200	50	296	312	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					37	47		10.1016/S0092-8674(03)00163-6	http://dx.doi.org/10.1016/S0092-8674(03)00163-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679033	Bronze			2022-12-01	WOS:000182282900005
J	Abbott, A				Abbott, A			Axeing of website article sparks row at Max Planck	NATURE			English	News Item																		Gura T, 2002, NATURE, V416, P250, DOI 10.1038/416250a	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					460	460		10.1038/422460b	http://dx.doi.org/10.1038/422460b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673216	Bronze			2022-12-01	WOS:000181965400007
J	Lahiri, SD; Zhang, GF; Dunaway-Mariano, D; Allen, KN				Lahiri, SD; Zhang, GF; Dunaway-Mariano, D; Allen, KN			The pentacovalent phosphorus intermediate of a phosphoryl transfer reaction	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ENZYME; PHOSPHOGLUCOMUTASE; MECHANISM; PHOSPHATE; COVALENT; STATE; CATALYSIS; PATHWAY; LACTIS	Enzymes provide enormous rate enhancements, unmatched by any other type of catalyst. The stabilization of high-energy states along the reaction coordinate is the crux of the catalytic power of enzymes. We report the atomic-resolution structure of a high-energy reaction intermediate stabilized in the active site of an enzyme. Crystallization of phosphorylated beta-phosphoglucomutase in the presence of the Mg(II) cofactor and either of the substrates glucose 1-phosphate or glucose 6-phosphate produced crystals of the enzyme-Mg(II)-glucose 1,6(bis)phosphate complex, which diffracted x-rays to 1.2 and 1.4 angstroms, respectively. The structure reveals a stabilized pentacovatent phosphorane formed in the phosphoryl transfer from the C(1)O of glucose 1,6-(bis)phosphate to the nucleophilic Asp8 carboxylate.	Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of New Mexico; Boston University	Dunaway-Mariano, D (corresponding author), Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA.	dd39@unm.edu; allen@med-xtal.bu.edu	Allen, Karen N./J-7045-2019	Allen, Karen N./0000-0001-7296-0551	NCRR NIH HHS [RR07707] Funding Source: Medline; NIGMS NIH HHS [GM16099] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Allison RD, 2002, METHOD ENZYMOL, V354, P455; Brubaker MJ, 1996, BIOCHEMISTRY-US, V35, P2854, DOI 10.1021/bi951105v; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Bruice TC, 1999, ACCOUNTS CHEM RES, V32, P127, DOI 10.1021/ar960131y; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; CLELAND WW, 1995, METHOD ENZYMOL, V249, P341; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Corbridge D. E. C., 1974, STRUCTURAL CHEM PHOS; DAI JB, 1992, J BIOL CHEM, V267, P6322; Dunaway-Mariano D, 1999, METHOD ENZYMOL, V308, P149; Gross JW, 2002, METHOD ENZYMOL, V354, P27; Hanes RE, 2002, ORG LETT, V4, P201, DOI 10.1021/ol016941d; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hu QY, 2002, J AM CHEM SOC, V124, P14858, DOI 10.1021/ja027976r; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kack H, 1998, P NATL ACAD SCI USA, V95, P5495, DOI 10.1073/pnas.95.10.5495; KEMP G, 1976, TETRAHEDRON LETT, P4381; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Li YF, 1998, J BIOL CHEM, V273, P15035, DOI 10.1074/jbc.273.24.15035; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muller S, 2002, J MOL BIOL, V315, P141, DOI 10.1006/jmbi.2001.5168; Naught LE, 2001, ARCH BIOCHEM BIOPHYS, V396, P111, DOI 10.1006/abbi.2001.2618; Pauling L, 1960, NATURE CHEM BOND, V3rd, P255; Petsko GA, 2000, CURR OPIN CHEM BIOL, V4, P89, DOI 10.1016/S1367-5931(99)00057-5; Qian N, 1997, MICROBIOL-SGM, V143, P855, DOI 10.1099/00221287-143-3-855; QIAN N, 1994, J BACTERIOL, V176, P5304, DOI 10.1128/JB.176.17.5304-5311.1994; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; RAMIREZ F, 1979, J AM CHEM SOC, V101, P1460, DOI 10.1021/ja00500a016; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Ridder IS, 1999, J BIOL CHEM, V274, P30672, DOI 10.1074/jbc.274.43.30672; RUDNICK G, 1975, BIOCHEMISTRY-US, V14, P4515, DOI 10.1021/bi00691a028; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Schramm VL, 2001, CURR OPIN CHEM BIOL, V5, P556, DOI 10.1016/S1367-5931(00)00246-5; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; WESTHEIMER FH, 1968, ACCOUNTS CHEM RES, V1, P70, DOI 10.1021/ar50003a002; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; [No title captured]	44	290	295	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2003	299	5615					2067	2071		10.1126/science.1082710	http://dx.doi.org/10.1126/science.1082710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12637673				2022-12-01	WOS:000181834200055
J	Gaffikin, L; Blumenthal, PD; Emerson, M; Limpaphayom, K; Lumbiganon, P; Ringers, P; Srisupundit, S; Warakamin, S; Lewis, R; Chumworathayee, B; Kanavacharakul, S				Gaffikin, L; Blumenthal, PD; Emerson, M; Limpaphayom, K; Lumbiganon, P; Ringers, P; Srisupundit, S; Warakamin, S; Lewis, R; Chumworathayee, B; Kanavacharakul, S		RTCOG; JHPIEGO Corp Cervical Canc Grp	Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project	LANCET			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; ACETIC-ACID; DEVELOPING-COUNTRIES; VISUAL INSPECTION; NEOPLASIA; MANAGEMENT; PRECURSORS; CARCINOMA; TRIAL	Background To increase screening and treatment coverage, innovative approaches to cervical-cancer prevention are being investigated in rural Thailand. We assessed the value of a single-visit approach combining visual inspection of the cervix with acetic acid wash (VIA) and cryotherapy. Methods 12 trained nurses provided services in mobile (village health centre-based) and static (hospital-based) teams in four districts of Roi-et Province, Thailand. Over 7 months, 5999 women were tested by VIA. If they tested positive, after counselling about the benefits, potential risks, and probable side-effects they were offered cryotherapy. Data measuring safety, acceptability, feasibility, and effort to implement the programme were gathered. Findings The VIA test-positive rate was 13.3% (798/5999), and 98.5% (609/618) of those eligible accepted immediate treatment. Overall, 756 women received cryotherapy, 629 (83.2%) of whom returned for their first follow-up visit. No major complications were recorded, and 33 (4.4%) of those treated returned for a perceived problem. Only 17 (2.2%) of the treated women needed clinical management other than reassurance about side-effects. Both VIA and cryotherapy were highly acceptable to the patients (over 95% expressed satisfaction with their experience). At their 1-year visit, the squamocolumnar junction was visible to the nurses, and the VIA test-negative rate was 94.3%. Interpretation A single-visit approach with VIA and cryotherapy seems to be safe, acceptable, and feasible in rural Thailand, and is a potentially efficient method of cervical-cancer prevention in such settings.	JHPIEGO Corp, Cerv Canc Prevent Programme, Baltimore, MD 21231 USA	Jhpiego	Gaffikin, L (corresponding author), JHPIEGO Corp, Cerv Canc Prevent Programme, 1615 Thames St,Suite 200, Baltimore, MD 21231 USA.		Chumworathayi, Bandit/J-9927-2019	Chumworathayi, Bandit/0000-0003-1214-1962				ABWAO S, 1998, P REG M NAIR KEN 199; ANDERSEN ES, 1992, GYNECOL ONCOL, V45, P240, DOI 10.1016/0090-8258(92)90297-V; Belinson JL, 2001, OBSTET GYNECOL, V98, P441, DOI 10.1016/S0029-7844(01)01454-5; Blumenthal P D, 2001, Medscape Womens Health, V6, P1; CECCHINI S, 1993, TUMORI, V79, P22, DOI 10.1177/030089169307900104; Cox JT, 1999, LANCET, V353, P857, DOI 10.1016/S0140-6736(98)00392-4; CULLINS VE, 1999, REPROD HEALTH MATTER, V1, P134; Gaffikin L, 1999, LANCET, V353, P869; GAFFIKIN L, 1997, WORKSH P ALT CERV CA; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Holschneider CH, 1999, CANCER-AM CANCER SOC, V86, P2659, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2659::AID-CNCR10>3.3.CO;2-J; Kitchener HC, 1999, LANCET, V353, P856, DOI 10.1016/S0140-6736(98)00417-6; LIMPAPHAYOM K, 1997, BRIT J OBSTET GYNAEC, V23, P3107; Londhe M., 1997, Indian Journal of Cancer, V34, P88; MANDELBLATT JS, 2002, J NATL CANCER I, V94, P1; Megevand E, 1996, OBSTET GYNECOL, V88, P383, DOI 10.1016/0029-7844(96)00189-5; Mitchell MF, 1998, OBSTET GYNECOL, V92, P737, DOI 10.1097/00006250-199811000-00001; MORRIS DL, 1996, NURSE PRACTITIONER, V23, P101; Nuovo J, 2000, INT J GYNECOL OBSTET, V68, P25, DOI 10.1016/S0020-7292(99)00162-9; *REPR HLTH OUTL, 2003, CERV CANC PREV; Sankaranarayanan R, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P411; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0; Sankaranarayanan R, 1999, INT J CANCER, V80, P161, DOI 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.3.CO;2-#; Santos C, 1996, GYNECOL ONCOL, V61, P11, DOI 10.1006/gyno.1996.0088; Soler, 2000, Prim Care Update Ob Gyns, V7, P118, DOI 10.1016/S1068-607X(00)00032-9; *UNFPA, UPD 1998 1999 MATERN; [No title captured]	28	180	184	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 8	2003	361	9360					814	820						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZH	12642047				2022-12-01	WOS:000181466600009
J	Fu, XD; Harberd, NP				Fu, XD; Harberd, NP			Auxin promotes Arabidopsis root growth by modulating gibberellin response	NATURE			English	Article							GAI; DEGRADATION; TRANSPORT; GENE; DEREPRESSION; EXPRESSION; REDUCTION; REGULATOR; DEFINES; PROTEIN	The growth of plant organs is influenced by a stream of the phytohormone auxin that flows from the shoot apex to the tip of the root(1). However, until now it has not been known how auxin regulates the cell proliferation and enlargement that characterizes organ growth. Here we show that auxin controls the growth of roots by modulating cellular responses to the phytohormone gibberellin (GA). GA promotes the growth of plants by opposing the effects of nuclear DELLA protein growth repressors(2-8), one of which is Arabidopsis RGA (for repressor of gal-3)(9,10). GA opposes the action of several DELLA proteins by destabilizing them, reducing both the concentration of detectable DELLA proteins and their growth-restraining effects(9-14). We also show that auxin is necessary for GA-mediated control of root growth, and that attenuation of auxin transport or signalling delays the GA-induced disappearance of RGA from root cell nuclei. Our observations indicate that the shoot apex exerts long-distance control on the growth of plant organs through the effect of auxin on GA-mediated DELLA protein destabilization.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Harberd, NP (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	nicholas.harberd@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council [BBS/E/J/00000583] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BRIAN P. W., 1958, Annals of Botany, V22, P1; Chansang H., 1982, Proceedings of the International Coral Reef Symposium, P129; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fu XD, 2001, PLANT CELL, V13, P1791, DOI 10.1105/tpc.13.8.1791; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; King KE, 2001, GENETICS, V159, P767; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Lomax Terri L., 1995, P509; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Rogg LE, 2001, DEV CELL, V1, P595, DOI 10.1016/S1534-5807(01)00077-6; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	30	556	639	4	212	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					740	743		10.1038/nature01387	http://dx.doi.org/10.1038/nature01387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610625				2022-12-01	WOS:000180938000043
J	Calle, EE; Rodriguez, C; Walker-Thurmond, K; Thun, MJ				Calle, EE; Rodriguez, C; Walker-Thurmond, K; Thun, MJ			Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; OVARIAN-CANCER; RISK-FACTORS; BREAST-CANCER; GALLBLADDER CANCER; PANCREATIC-CANCER; PHYSICAL-ACTIVITY; PROSTATE-CANCER; GASTRIC CARDIA; WEIGHT	Background: The influence of excess body weight on the risk of death from cancer has not been fully characterized. Methods: In a prospectively studied population of more than 900,000 U.S. adults (404,576 men and 495,477 women) who were free of cancer at enrollment in 1982, there were 57,145 deaths from cancer during 16 years of follow-up. We examined the relation in men and women between the body-mass index in 1982 and the risk of death from all cancers and from cancers at individual sites, while controlling for other risk factors in multivariate proportional-hazards models. We calculated the proportion of all deaths from cancer that was attributable to overweight and obesity in the U.S. population on the basis of risk estimates from the current study and national estimates of the prevalence of overweight and obesity in the U.S. adult population. Results: The heaviest members of this cohort (those with a body-mass index [the weight in kilograms divided by the square of the height in meters] of at least 40) had death rates from all cancers combined that were 52 percent higher (for men) and 62 percent higher (for women) than the rates in men and women of normal weight. For men, the relative risk of death was 1.52 (95 percent confidence interval, 1.13 to 2.05); for women, the relative risk was 1.62 (95 percent confidence interval, 1.40 to 1.87). In both men and women, body-mass index was also significantly associated with higher rates of death due to cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney; the same was true for death due to non-Hodgkin's lymphoma and multiple myeloma. Significant trends of increasing risk with higher body-mass-index values were observed for death from cancers of the stomach and prostate in men and for death from cancers of the breast, uterus, cervix, and ovary in women. On the basis of associations observed in this study, we estimate that current patterns of overweight and obesity in the United States could account for 14 percent of all deaths from cancer in men and 20 percent of those in women. Conclusions: Increased body weight was associated with increased death rates for all cancers combined and for cancers at multiple specific sites.	Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA	American Cancer Society	Calle, EE (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.	jcalle@cancer.org						Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Andersson SO, 1997, JNCI-J NATL CANCER I, V89, P385, DOI 10.1093/jnci/89.5.385; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Bergstrom A, 2001, INT J CANCER, V92, P927, DOI 10.1002/ijc.1285; BOYD NF, 1981, JNCI-J NATL CANCER I, V67, P785; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Calle EE, 2000, AM J EPIDEMIOL, V151, P550, DOI 10.1093/oxfordjournals.aje.a010242; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2002, NAT HLTH NUTR EX SUR; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1984, ANAL SURVIVAL DATA; CRAMER DW, 1984, OBSTET GYNECOL, V63, P833; FARROW DC, 1989, AM J EPIDEMIOL, V129, P1300, DOI 10.1093/oxfordjournals.aje.a115249; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FLANDERS WD, 1984, J CHRON DIS, V37, P449, DOI 10.1016/0021-9681(84)90028-6; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Giovannucci E, 1997, CANCER EPIDEM BIOMAR, V6, P557; Henley SJ, 2002, EPIDEMIOLOGY, V13, P268, DOI 10.1097/00001648-200205000-00006; Hill HA, 1996, CANCER CAUSE CONTROL, V7, P19, DOI 10.1007/BF00115635; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; Hunter DJ, 1996, CANCER CAUSE CONTROL, V7, P56, DOI 10.1007/BF00115638; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V6; Ji BT, 1997, CANCER EPIDEM BIOMAR, V6, P481; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P163; Kolonel LN, 1996, CANCER CAUSE CONTROL, V7, P83, DOI 10.1007/BF00115640; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Lindsted KD, 1998, INT J OBESITY, V22, P544, DOI 10.1038/sj.ijo.0800623; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Mink PJ, 1996, EPIDEMIOLOGY, V7, P38, DOI 10.1097/00001648-199601000-00008; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Nomura AM, 2001, EPIDEMIOL REV, V23, P126, DOI 10.1093/oxfordjournals.epirev.a000777; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Petrelli JM, 2002, CANCER CAUSE CONTROL, V13, P325, DOI 10.1023/A:1015288615472; Potter JD, 1996, CANCER CAUSE CONTROL, V7, P127, DOI 10.1007/BF00115644; Purdie DM, 2001, CANCER CAUSE CONTROL, V12, P855, DOI 10.1023/A:1012267619561; Reeves MJ, 1996, CANCER, V77, P301, DOI 10.1002/(SICI)1097-0142(19960115)77:2<301::AID-CNCR12>3.0.CO;2-5; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; SLATTERY ML, 1989, AM J EPIDEMIOL, V130, P497, DOI 10.1093/oxfordjournals.aje.a115363; STELLMAN SD, 1986, JNCI-J NATL CANCER I, V76, P1057; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; STROM BL, 1995, CANCER, V76, P1747, DOI 10.1002/1097-0142(19951115)76:10<1747::AID-CNCR2820761011>3.0.CO;2-L; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; *WHO, 1977, INT CLASS DIS MAN IN, V1; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wolk A, 1996, CANCER CAUSE CONTROL, V7, P5, DOI 10.1007/BF00115634; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund, 1997, FOOD NUTR PREV CANC, P371; Zatonski WA, 1997, JNCI-J NATL CANCER I, V89, P1132, DOI 10.1093/jnci/89.15.1132	65	5273	5425	22	572	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1625	1638		10.1056/NEJMoa021423	http://dx.doi.org/10.1056/NEJMoa021423			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711737				2022-12-01	WOS:000182416300002
J	Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, AL; Martino, G				Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, AL; Martino, G			Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; TRANSPLANTATION; REMYELINATION; ENCEPHALOMYELITIS; REGENERATION; PROGENITORS; ANTIBODIES; LESIONS; REPAIR	Widespread demyelination and axonal loss are the pathological hallmarks of multiple sclerosis. The multifocal nature of this chronic inflammatory disease of the central nervous system complicates cellular therapy and puts emphasis on both the donor cell origin and the route of cell transplantation. We established syngenic adult neural stem cell cultures and injected them into an animal model of multiple sclerosis-experimental autoimmune encephalomyelitis (EAE) in the mouse-either intravenously or intracerebroventricularly. In both cases, significant numbers of donor cells entered into demyelinating areas of the central nervous system and differentiated into mature brain cells. Within these areas, oligodendrocyte progenitors markedly increased, with many of them being of donor origin and actively remyelinating axons. Furthermore, a significant reduction of astrogliosis and a marked decrease in the extent of demyelination and axonal loss were observed in transplanted animals. The functional impairment caused by EAE was almost abolished in transplanted mice, both clinically and neurophysiologically. Thus, adult neural precursor cells promote multifocal remyelination and functional recovery after intravenous or intrathecal injection in a chronic model of multiple sclerosis.	Hosp San Raffaele, DIBIT, Neuroimmunol Unit, I-20132 Milan, Italy; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Hosp San Raffaele, Dept Neurol & Neurophysiol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Martino, G (corresponding author), Hosp San Raffaele, DIBIT, Neuroimmunol Unit, Via Olgettina 58, I-20132 Milan, Italy.	vescovi@tin.it; martino.gianvito@hsr.it	Del Carro, Ubaldo/AAO-3457-2020; Galli, Rossella/AAI-8028-2020; Messier, Claude/A-2322-2008; martino, gianvito/AAL-2682-2020; Pluchino, Stefano/AAE-9037-2019; dina, giorgia/AAN-3770-2020; Vescovi, Angelo Luigi/A-4919-2015; BRAMBILLA, ELENA/AAN-3742-2020; Gritti, Angela/K-2729-2016; Quattrini, Angelo/J-8373-2018	Del Carro, Ubaldo/0000-0003-3301-5412; Galli, Rossella/0000-0001-9023-7033; Messier, Claude/0000-0002-4791-1763; martino, gianvito/0000-0003-1295-9131; Pluchino, Stefano/0000-0002-6267-9472; dina, giorgia/0000-0002-9684-2143; Vescovi, Angelo Luigi/0000-0002-1742-4112; BRAMBILLA, ELENA/0000-0003-1399-2128; Gritti, Angela/0000-0002-9845-0370; Quattrini, Angelo/0000-0002-8226-8320				Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; DECKERTSCHLUTER M, 1994, J NEUROPATH EXP NEUR, V53, P457, DOI 10.1097/00005072-199409000-00005; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Franklin RJM, 1997, MULT SCLER, V3, P84, DOI 10.1177/135245859700300205; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Galli R, 2002, DEVELOPMENT, V129, P1633; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gritti A, 1999, J NEUROSCI, V19, P3287; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949, DOI 10.1038/79432; Jefferson S, 1997, MULT SCLER, V3, P162, DOI 10.1177/135245859700300220; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Learish RD, 1999, ANN NEUROL, V46, P716, DOI 10.1002/1531-8249(199911)46:5<716::AID-ANA6>3.3.CO;2-D; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899	32	849	922	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					688	694		10.1038/nature01552	http://dx.doi.org/10.1038/nature01552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700753				2022-12-01	WOS:000182272300032
J	Kuypers, MMM; Sliekers, AO; Lavik, G; Schmid, M; Jorgensen, BB; Kuenen, JG; Damste, JSS; Strous, M; Jetten, MSM				Kuypers, MMM; Sliekers, AO; Lavik, G; Schmid, M; Jorgensen, BB; Kuenen, JG; Damste, JSS; Strous, M; Jetten, MSM			Anaerobic ammonium oxidation by anammox bacteria in the Black Sea	NATURE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; IN-SITU DETECTION; OXIDIZING BACTERIA; MARINE-SEDIMENTS; DIVERSITY; NITROGEN; OCEAN	The availability of fixed inorganic nitrogen (nitrate, nitrite and ammonium) limits primary productivity in many oceanic regions(1). The conversion of nitrate to N(2) by heterotrophic bacteria (denitrification) is believed to be the only important sink for fixed inorganic nitrogen in the ocean(2). Here we provide evidence for bacteria that anaerobically oxidize ammonium with nitrite to N(2) in the world's largest anoxic basin, the Black Sea. Phylogenetic analysis of 16S ribosomal RNA gene sequences shows that these bacteria are related to members of the order Planctomycetales performing the anammox (anaerobic ammonium oxidation) process in ammonium-removing bioreactors(3). Nutrient profiles, fluorescently labelled RNA probes, (15)N tracer experiments and the distribution of specific 'ladderane' membrane lipids(4) indicate that ammonium diffusing upwards from the anoxic deep water is consumed by anammox bacteria below the oxic zone. This is the first time that anammox bacteria have been identified and directly linked to the removal of fixed inorganic nitrogen in the environment. The widespread occurrence of ammonium consumption in suboxic marine settings(5-7) indicates that anammox might be important in the oceanic nitrogen cycle.	Max Planck Inst Marine Microbiol, Dept Biogeochem, D-28359 Bremen, Germany; Delft Univ Technol, Dept Microbiol, NL-2628 BC Delft, Netherlands; Royal Netherlands Inst Sea Res NIOZ, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Univ Nijmegen, Dept Microbiol, NL-6526 ED Nijmegen, Netherlands	Max Planck Society; Delft University of Technology; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Radboud University Nijmegen	Kuypers, MMM (corresponding author), Max Planck Inst Marine Microbiol, Dept Biogeochem, Celsiusstr 1, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de	Jetten, Mike/B-8834-2011; Jorgensen, Bo B/C-2214-2013; Damste, Jaap S Sinninghe/F-6128-2011; Strous, Marc/B-4064-2017; Schmid, Markus C/D-2669-2012; Lavik, Gaute/F-6578-2013	Jetten, Mike/0000-0002-4691-7039; Jorgensen, Bo B/0000-0001-9398-8027; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Strous, Marc/0000-0001-9600-3828; Sliekers, Olav/0000-0002-8109-2431				AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BENDER M, 1989, GEOCHIM COSMOCHIM AC, V53, P685, DOI 10.1016/0016-7037(89)90011-2; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Codispoti L.A., 1991, DEEP-SEA RES, V38, P691, DOI 10.1016/S0198-0149(10)80004-4; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Dalsgaard T, 2002, APPL ENVIRON MICROB, V68, P3802, DOI 10.1128/AEM.68.8.3802-3808.2002; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Kuenen JG, 2001, ASM NEWS, V67, P456; LEWIS BL, 1991, DEEP SEA RES S2, V38, P773; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1111/j.1574-6941.1995.tb00281.x; MURRAY JW, 1995, ADV CHEM SER, V244, P157, DOI 10.1021/ba-1995-0244.ch007; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Oguz T, 2001, DEEP-SEA RES PT I, V48, P761, DOI 10.1016/S0967-0637(00)00054-6; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Redfield AC., 1963, SEA, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Richards F.A., 1965, CHEM OCEANOGRAPHY, P611; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Sorokin YI., 2002, BIO INL WAT; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; WARD BB, 1991, NATO ADV SCI I C-MAT, V351, P111; [No title captured]	26	878	1030	30	804	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					608	611		10.1038/nature01472	http://dx.doi.org/10.1038/nature01472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686999				2022-12-01	WOS:000182111400040
J	DeCoursey, TE; Morgan, D; Cherny, VV				DeCoursey, TE; Morgan, D; Cherny, VV			The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels	NATURE			English	Article							HYDROGEN-ION CURRENTS; HUMAN-NEUTROPHILS; ELECTRON CURRENTS; HUMAN EOSINOPHILS; SNAIL NEURONS; HUMAN BLOOD; H+ CHANNEL; ACTIVATION; PH; MEMBRANE	The enzyme NADPH oxidase in phagocytes is important in the body's defence against microbes: it produces superoxide anions (O-2(-), precursors to bactericidal reactive oxygen species(1)). Electrons move from intracellular NADPH, across a chain comprising FAD ( flavin adenine dinucleotide) and two haems, to reduce extracellular O-2 to O-2(-). NADPH oxidase is electrogenic(2), generating electron current (I-e) that is measurable under voltage-clamp conditions(3,4). Here we report the complete current-voltage relationship of NADPH oxidase, the first such measurement of a plasma membrane electron transporter. We find that Ie is voltage-independent from -100 mV to >0 mV, but is steeply inhibited by further depolarization, and is abolished at about +190 mV. It was proposed that H+ efflux(2) mediated by voltage-gated proton channels(5,6) compensates I-e, because Zn2+ and Cd2+ inhibit both H+ currents(7-9) and O-2(-) production(10). Here we show that COS-7 cells transfected with four NADPH oxidase components(11), but lacking H+ channels(12), produce O-2(-) in the presence of Zn2+ concentrations that inhibit O-2(-) production in neutrophils and eosinophils. Zn2+ does not inhibit NADPH oxidase directly, but through effects on H+ channels. H+ channels optimize NADPH oxidase function by preventing membrane depolarization to inhibitory voltages.	Rush Presbyterian St Lukes Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Rush University	DeCoursey, TE (corresponding author), Rush Presbyterian St Lukes Med Ctr, Dept Mol Biophys & Physiol, 1750 W Harrison, Chicago, IL 60612 USA.	tdecours@rush.edu	DeCoursey, Thomas/A-6820-2009	DeCoursey, Thomas/0000-0002-4263-180X	NHLBI NIH HHS [R01 HL061437] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061437] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; BURTON K, 1953, BIOCHEM J, V54, P86, DOI 10.1042/bj0540086; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Cherny VV, 2001, J PHYSIOL-LONDON, V535, P783, DOI 10.1111/j.1469-7793.2001.00783.x; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; Gordienko DV, 1996, J PHYSIOL-LONDON, V496, P299, DOI 10.1113/jphysiol.1996.sp021686; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; KAPUS A, 1992, BIOCHEM J, V281, P697, DOI 10.1042/bj2810697; Koshkin V, 1997, BBA-BIOENERGETICS, V1319, P139, DOI 10.1016/S0005-2728(96)00154-5; Lauger P., 1991, ELECTROGENIC ION PUM; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; MAHAUTSMITH MP, 1989, J EXP BIOL, V145, P455; MARTIN MA, 1988, J IMMUNOL, V140, P3928; Morgan D, 2002, J GEN PHYSIOL, V119, P571, DOI 10.1085/jgp.20018544; MUIRWOOD P, 1974, FEBS LETT, V44, P22, DOI 10.1016/0014-5793(74)80297-8; NANDA A, 1991, P NATL ACAD SCI USA, V88, P10816, DOI 10.1073/pnas.88.23.10816; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; Tare M, 1998, J PHYSIOL-LONDON, V506, P303, DOI 10.1111/j.1469-7793.1998.303bw.x; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0	30	246	250	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					531	534		10.1038/nature01523	http://dx.doi.org/10.1038/nature01523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673252				2022-12-01	WOS:000181965400040
J	Steinman, MA; Gonzales, R; Linder, JA; Landefeld, CS				Steinman, MA; Gonzales, R; Linder, JA; Landefeld, CS			Changing use of antibiotics in community-based outpatient practice, 1991-1999	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-TRACT INFECTIONS; ACUTE OTITIS-MEDIA; ANTIMICROBIAL RESISTANCE; JUDICIOUS USE; PHARMACEUTICAL-INDUSTRY; UNITED-STATES; PRIMARY-CARE; INCREASING PREVALENCE; PHYSICIANS BEHAVIOR	Background: Judicious use of antibiotics can slow the spread of antimicrobial resistance. However, overall patterns of antibiotic use among ambulatory patients are not well understood. Objective: To study patterns of outpatient antibiotic use in the United States, focusing on broad-spectrum antibiotics. Design: Cross-sectional survey in three 2-year periods (1991-1992, 1994-1995, and 1998-1999). Setting: The National Ambulatory Medical Care Survey, a nationally representative sample of community-based outpatient visits. Patients: Patients visiting community-based outpatient clinics. Measurements: Rates of overall antibiotic use and use of broad-spectrum antibiotics (azithromycin and clarithromycin, quinolones, amoxicillin-clavulanate, and second- and third-generation cephalosporins). All comparisons were made between the first study period (1991-1992) and the final study period (1998-1999). Results: Between 1991-1992 and 1998-1999, antibiotics were used less frequently to treat acute respiratory tract infections, such as the common cold and pharyngitis. However, use of broad-spectrum agents increased from 24% to 48% of antibiotic prescriptions in adults (P < 0.001) and from 23% to 40% in children (P < 0.001). Use of broad-spectrum antibiotics increased across many conditions, increasing two- to threefold as a percentage of total antibiotic use for a variety of diagnoses in both adults and children. By 1998-1999, 22% of adult and 14% of pediatric prescriptions for broad-spectrum antibiotics were for the common cold, unspecified upper respiratory tract infections, and acute bronchitis, conditions that are primarily viral. Conclusions: Antibiotic use in ambulatory patients is decreasing in the United States. However, physicians are increasingly turning to expensive, broad-spectrum agents, even when there is little clinical rationale for their use.	Univ Calif San Francisco, Vet Adm Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Steinman, MA (corresponding author), Univ Calif San Francisco, Vet Adm Med Ctr, Div Geriatr, Box 18-G,4150 Clement St, San Francisco, CA 94121 USA.	mstein@itsa.ucsf.edu	Linder, Jeffrey/AAF-3424-2021	Linder, Jeffrey/0000-0003-2217-184X	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; BHP HRSA HHS [5T32PE11001-12] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		Appelbaum PC, 2000, CLIN INFECT DIS, V31, pS29, DOI 10.1086/314057; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bloom BS, 2001, BMJ-BRIT MED J, V323, P647, DOI 10.1136/bmj.323.7314.647; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; ClavoSanchez AJ, 1997, CLIN INFECT DIS, V24, P1052, DOI 10.1086/513628; Doern GV, 2001, CLIN INFECT DIS, V33, pS187, DOI 10.1086/321847; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; GONZALES R, 1995, LANCET, V345, P665, DOI 10.1016/S0140-6736(95)90861-7; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Hamm RM, 1996, J FAM PRACTICE, V43, P56; HEMMINKI E, 1975, SOC SCI MED, V9, P111, DOI 10.1016/0037-7856(75)90103-1; Huang ES, 2002, ARCH INTERN MED, V162, P41, DOI 10.1001/archinte.162.1.41; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ioannidis JPA, 2001, J ANTIMICROB CHEMOTH, V48, P677, DOI 10.1093/jac/48.5.677; Jain A, 1999, BRIT MED J, V318, P1596, DOI 10.1136/bmj.318.7198.1596; Jernigan DB, 1996, JAMA-J AM MED ASSOC, V275, P206, DOI 10.1001/jama.275.3.206; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Low DE, 2001, CLIN INFECT DIS, V33, pS206, DOI 10.1086/321849; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Marshall WF, 1999, MAYO CLIN PROC, V74, P187, DOI 10.4065/74.2.187; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; *MED EC, 1999, DRUG TOP RED BOOK; *NAT CTR HLTH STAT, 2001, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 1994, PUBL US DAT TAP DOC; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; O'Brien KL, 1998, PEDIATRICS, V101, P178; O'Brien KL, 1998, PEDIATRICS, V101, P174; Piccirillo JF, 2001, JAMA-J AM MED ASSOC, V286, P1849, DOI 10.1001/jama.286.15.1849; *PRACT MAN INF, 1998, INT CLASS DIS; Rosenstein N, 1998, PEDIATRICS, V101, P181; SABLE CA, 1993, GERIATRICS, V48, P41; Sargent J, 2001, Eff Clin Pract, V4, P136; Schwartz B, 1998, PEDIATRICS, V101, P171; SENSAKOVIC JW, 1995, MED CLIN N AM, V79, P695, DOI 10.1016/S0025-7125(16)30033-5; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Snow V, 2001, ANN INTERN MED, V134, P495, DOI 10.7326/0003-4819-134-6-200103200-00016; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; *STAT CORP, 1999, OV SURV EST STAT US, P321; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Takata GS, 2001, PEDIATRICS, V108, P239, DOI 10.1542/peds.108.2.239; Walker S, 2000, CAN MED ASSOC J, V163, P273; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; 2000, RESIDENT POPULATION	63	235	244	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2003	138	7					525	533		10.7326/0003-4819-138-7-200304010-00008	http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661BV	12667022				2022-12-01	WOS:000181872100001
J	Hantschel, O; Nagar, B; Guettler, S; Kretzschmar, J; Dorey, K; Kuriyan, J; Superti-Furga, G				Hantschel, O; Nagar, B; Guettler, S; Kretzschmar, J; Dorey, K; Kuriyan, J; Superti-Furga, G			A myristoyl/phosphotyrosine switch regulates c-Abl	CELL			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; SRC-FAMILY; SH3 DOMAINS; CRYSTAL-STRUCTURES; PROTEIN-KINASES; F-ACTIN; B-CELL; PHOSPHORYLATION; HCK	The c-Abl tyrosine kinase is inhibited by mechanisms that are poorly understood. Disruption of these mechanisms in the Bcr-Abl oncoprotein leads to several forms of human leukemia. We found that like Src kinases, c-Abl 1b is activated by phosphotyrosine ligands. Ligand-activated c-Abl is particularly sensitive to the anti-cancer drug STI-571/Gleevec/imatinib (STI-571). The SH2 domain-phosphorylated tail interaction in Src kinases is functionally replaced in c-Abl by an intramolecular engagement of the N-terminal myristoyl modification with the kinase domain. Functional studies coupled with structural analysis define a myristoyl/phosphotyrosine switch in c-Abl that regulates docking and accessibility of the SH2 domain. This mechanism offers an explanation for the observed cellular activation of c-Abl by tyrosine-phosphorylated proteins, the intracellular mobility of c-Abl, and it provides new insights into the mechanism of action of STI-571.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Cellzome AG, D-69117 Heidelberg, Germany; European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL)	Superti-Furga, G (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA.	kuriyan@uclink.berkeley.edu; superti@embl-heidelberg.de	Superti-Furga, Giulio/F-4755-2015; Hantschel, Oliver D/H-4705-2013; Superti-Furga, Giulio/AAE-5681-2019; Hantschel, Oliver/M-7016-2019; Nagar, Bhushan/C-1297-2010	Superti-Furga, Giulio/0000-0002-0570-1768; Hantschel, Oliver D/0000-0001-8569-8169; Hantschel, Oliver/0000-0001-8569-8169; Guettler, Sebastian/0000-0002-3135-1546; Dorey, Karel/0000-0003-0846-5286				Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brasher BB, 2001, ONCOGENE, V20, P7744, DOI 10.1038/sj.onc.1204978; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; DALEY GQ, 1992, MOL CELL BIOL, V12, P1864, DOI 10.1128/MCB.12.4.1864; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Hardin JD, 1996, ONCOGENE, V12, P2669; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2002, CURR OPIN STRUC BIOL, V12, P735, DOI 10.1016/S0959-440X(02)00383-4; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; LIU XQ, 1993, ONCOGENE, V8, P1119; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Sawyers CL, 2002, CANCER CELL, V1, P13, DOI 10.1016/S1535-6108(02)00022-3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Smith JM, 2002, FRONT BIOSCI, V7, pD31; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Taylor SS, 1997, CURR OPIN CHEM BIOL, V1, P219, DOI 10.1016/S1367-5931(97)80013-0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yano H, 2000, J NEUROSCI RES, V59, P356, DOI 10.1002/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zhou Songyang, 1995, Nature (London), V373, P536; ZHU GC, 1994, ONCOGENE, V9, P1379; Zipfel PA, 2000, J IMMUNOL, V165, P6872, DOI 10.4049/jimmunol.165.12.6872	63	323	333	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2003	112	6					845	857		10.1016/S0092-8674(03)00191-0	http://dx.doi.org/10.1016/S0092-8674(03)00191-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	660DL	12654250	Bronze			2022-12-01	WOS:000181818500011
J	Farooqi, IS; Keogh, JM; Yeo, GSH; Lank, EJ; Cheetham, T; O'Rahilly, S				Farooqi, IS; Keogh, JM; Yeo, GSH; Lank, EJ; Cheetham, T; O'Rahilly, S			Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL LEPTIN DEFICIENCY; BODY-WEIGHT REGULATION; EARLY-ONSET OBESITY; MORBID-OBESITY; ENERGY-EXPENDITURE; HUMANS; MICE; DYSFUNCTION; PROTEIN	Background: Melanocortin 4 receptor (MC4R) deficiency is the commonest monogenic form of obesity. However, the clinical spectrum and mode of inheritance have not been defined, pathophysiological mechanisms leading to obesity are poorly understood, and there is little information regarding genotype-phenotype correlations. Methods: We determined the nucleotide sequence of the MC4R gene in 500 probands with severe childhood obesity. Family studies were undertaken to examine cosegregation of identified mutations with obesity. Subjects with MC4R deficiency underwent metabolic and endocrine evaluation; the results were correlated with the signaling properties of mutant receptors. Results: Twenty-nine probands (5.8 percent) had mutations in MC4R; 23 were heterozygous, and 6 were homozygous. Mutation carriers had severe obesity, increased lean mass, increased linear growth, hyperphagia, and severe hyperinsulinemia; homozygotes were more severely affected than heterozygotes. Subjects with mutations retaining residual signaling capacity had a less severe phenotype. Conclusions: Mutations in MC4R result in a distinct obesity syndrome that is inherited in a codominant manner. Mutations leading to complete loss of function are associated with a more severe phenotype. The correlation between the signaling properties of these mutant receptors and energy intake emphasizes the key role of this receptor in the control of eating behavior in humans.	Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Med, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Cambridge Inst Med Res, Genet Obes Collaborat Grp, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Clin Biochem, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Univ Dept Med, Hills Rd, Cambridge CB2 2QQ, England.		Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; Yeo, Giles See How/0000-0001-8823-3615	Wellcome Trust [068086] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; DeLany JP, 2002, AM J CLIN NUTR, V75, P705, DOI 10.1093/ajcn/75.4.705; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jacobson P, 2002, J CLIN ENDOCR METAB, V87, P4442, DOI 10.1210/jc.2002-020568; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Ohshiro Y, 1999, ANN HUM GENET, V63, P483, DOI 10.1017/S0003480099007782; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PERSANI L, 1993, J ENDOCRINOL INVEST, V16, P511, DOI 10.1007/BF03348894; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; WAHNER HW, 1994, J BONE MINER RES, V9, P951; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	35	1120	1166	0	64	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2003	348	12					1085	1095		10.1056/NEJMoa022050	http://dx.doi.org/10.1056/NEJMoa022050			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656UY	12646665				2022-12-01	WOS:000181628400004
J	Kushiro, T; Nambara, E; McCourt, P				Kushiro, T; Nambara, E; McCourt, P			The key to signalling	NATURE			English	Article									RIKEN, Plant Sci Ctr, Lab Reprod Growth Regulat, Wako, Saitama 35101, Japan; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	RIKEN; University of Toronto	Kushiro, T (corresponding author), RIKEN, Plant Sci Ctr, Lab Reprod Growth Regulat, 2-1 Hirosawa, Wako, Saitama 35101, Japan.		Nambara, Eiji/E-5533-2012	Kushiro, Tetsuo/0000-0002-7598-4791				Bogan AA, 1998, NAT STRUCT BIOL, V5, P679, DOI 10.1038/1372; McCourt P, 2001, MOL CELL, V8, P1157, DOI 10.1016/S1097-2765(01)00420-8; Mussig C, 2001, TRENDS ENDOCRIN MET, V12, P398, DOI 10.1016/S1043-2760(01)00477-5; Ourisson G, 1994, CHEM BIOL, V1, P11, DOI 10.1016/1074-5521(94)90036-1; Szostak JW, 2002, NATURE, V419, P890, DOI 10.1038/419890a	5	35	35	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					122	122		10.1038/422122a	http://dx.doi.org/10.1038/422122a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634761				2022-12-01	WOS:000181488900022
J	Loconto, J; Papes, F; Chang, E; Stowers, L; Jones, EP; Takada, T; Kumanovics, A; Lindahl, KF; Dulac, C				Loconto, J; Papes, F; Chang, E; Stowers, L; Jones, EP; Takada, T; Kumanovics, A; Lindahl, KF; Dulac, C			Functional expression of murine V213 pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules	CELL			English	Article							MULTIGENE FAMILY; AXONAL PROJECTIONS; VOMERONASAL SYSTEM; ODORANT RECEPTORS; CRYSTAL-STRUCTURE; SENSORY NEURONS; H2-M REGION; FC RECEPTOR; MAMMALS; GENES	The vomeronasal organ (VNO) of the mouse has two neuronal compartments expressing distinct families of pheromone receptors, the V1Rs and the V2Rs. We report here that two families of major histocompatibility complex (MHC) class Ib molecules, the M10 and the M1 families, show restricted expression in V2R-expressing neurons. Our data suggest that neurons expressing a given V2R specifically co-express one or a few members of the M10 family. Biochemical and immunocytochemical analysis demonstrates that in VNO sensory dendrites M10s belong to large multi-molecular complexes that include pheromone receptors and beta2-microglobulin (beta2m). In cultured cells, M10s appear to function as escort molecules in transport of V2Rs to the cell surface. Accordingly, beta2m-deficient mice exhibit mislocalization of V2Rs in the VNO and a specific defect in male-male aggressive behavior. The functional characterization of M10 highlights an unexpected role for MHC molecules in pheromone detection by mammalian VNO neurons.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Texas, Ctr Immunol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dallas, TX 75390 USA	Harvard University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Papes, Fabio/E-3774-2013; Stowers, Lisa/K-6137-2015; Takada, Toyoyuki/U-3206-2018	Papes, Fabio/0000-0001-5034-4088; Stowers, Lisa/0000-0002-4403-1269; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037818] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37818] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arepalli SR, 1998, IMMUNOGENETICS, V47, P264, DOI 10.1007/s002510050356; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hotta C, 2000, IMMUNOGENETICS, V51, P624, DOI 10.1007/s002510000195; Houimel M, 2001, INT J CANCER, V92, P748, DOI 10.1002/1097-0215(20010601)92:5<748::AID-IJC1258>3.0.CO;2-1; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jones EP, 1999, IMMUNOGENETICS, V49, P183, DOI 10.1007/s002510050479; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Praetor A, 2002, J CELL SCI, V115, P2389; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TAKADA T, 2003, IN PRESS GENOME RES; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilson IA, 1998, CURR OPIN IMMUNOL, V10, P67, DOI 10.1016/S0952-7915(98)80034-4; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	42	217	225	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					607	618		10.1016/S0092-8674(03)00153-3	http://dx.doi.org/10.1016/S0092-8674(03)00153-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628182	Bronze			2022-12-01	WOS:000181443600005
J	Cox, H; Hargreaves, S				Cox, H; Hargreaves, S			To treat or not to treat? Implementation of DOTS in Central Asia	LANCET			English	Editorial Material							TUBERCULOSIS		Med Sans Frontieres, Tashkent 700000, Uzbekistan		Cox, H (corresponding author), Med Sans Frontieres, POB 333, Tashkent 700000, Uzbekistan.	hom@msfh-tashkent.uz		Cox, Helen/0000-0002-6538-7192; Hargreaves, Sally/0000-0003-2974-4348				Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; ILKHAMOV FA, 2001, EUROPEAN OBSERVATORY, P179; RAVIGLIONE MC, 2002, 33 IUATLD WORLD C LU; Small I, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3455025; Trebucq A, 1999, INT J TUBERC LUNG D, V3, P466; *WHO, 1996, WHO REP TUB EP 1996; World Health Organization, 1998, TUB HDB; World Health Organization, 2002, WHOCDSTB2002295	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					714	715		10.1016/S0140-6736(03)12667-0	http://dx.doi.org/10.1016/S0140-6736(03)12667-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620733				2022-12-01	WOS:000181232000004
J	Simon, AF; Shih, C; Mack, A; Benzer, S				Simon, AF; Shih, C; Mack, A; Benzer, S			Steroid control of longevity in Drosophila melanogaster	SCIENCE			English	Article							ECDYSONE; RECEPTOR; METAMORPHOSIS; MECHANISMS; L(3)3DTS; DEATH; FLIES	Ecdysone, the major steroid hormone of Drosophila melanogaster, is known for its role in development and reproduction. Flies that are heterozygous for mutations of the ecdysone receptor exhibit increases in life-span and resistance to various stresses, with no apparent deficit in fertility or activity. A mutant involved in the biosynthesis of ecdysone displays similar effects, which are suppressed by feeding ecdysone to the flies. These observations demonstrate the importance of the ecdysone hormonal pathway, a new player in regulating longevity.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Benzer, S (corresponding author), CALTECH, Div Biol 156 29, 1201 Calif Blvd, Pasadena, CA 91125 USA.	benzer@caltech.edu	Simon, Anne/J-9199-2015	Simon, Anne/0000-0002-6509-4541	NIA NIH HHS [AG16630] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG016630] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Carney GE, 2000, GENETICS, V154, P1203; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; HOLDEN JJA, 1986, DEV GENET, V6, P153; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Lewis EB., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; LUO Y, 1991, MOL CELL BIOL, V11, P3660, DOI 10.1128/MCB.11.7.3660; MAROY P, COMMUNICATION; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Perry HM, 1999, CLIN CHEM, V45, P1369; Radyuk SN, 2000, ARCH INSECT BIOCHEM, V45, P79, DOI 10.1002/1520-6327(200010)45:2&lt;79::AID-ARCH4&gt;3.0.CO;2-Y; Riddiford LM, 2001, VITAM HORM, V60, P1; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; WALKER VK, 1987, J INSECT PHYSIOL, V33, P137, DOI 10.1016/0022-1910(87)90139-9	21	187	199	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1407	1410		10.1126/science.1080539	http://dx.doi.org/10.1126/science.1080539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610309				2022-12-01	WOS:000181192300056
J	Sieber, OM; Lipton, L; Crabtree, M; Heinimann, K; Fidalgo, P; Phillips, RKS; Bisgaard, M; Orntoft, TF; Aaltonen, LA; Hodgson, SV; Thomas, HJW; Tomlinson, IPM				Sieber, OM; Lipton, L; Crabtree, M; Heinimann, K; Fidalgo, P; Phillips, RKS; Bisgaard, M; Orntoft, TF; Aaltonen, LA; Hodgson, SV; Thomas, HJW; Tomlinson, IPM			Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXIDATIVE DNA-DAMAGE; MUTY HOMOLOG HMYH; ESCHERICHIA-COLI; LUNG-CANCER; 8-HYDROXYGUANINE 7,8-DIHYDRO-8-OXOGUANINE; INTRACELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; REPAIR ENZYME; HOGG1	BACKGROUND Germ-line mutations in the base-excision-repair gene MYH have been associated with recessive inheritance of multiple colorectal adenomas. Tumors from affected persons displayed excess somatic transversions of a guanine-cytosine pair to a thymine-adenine pair (G:C(rightarrow)T:A) in the APC gene. METHODS We screened for germ-line MYH mutations in 152 patients with multiple (3 to 100) colorectal adenomas and 107 APC-mutation-negative probands with classic familial adenomatous polyposis (>100 adenomas). Subgroups were analyzed for changes in the related genes MTH1 and OGG1. Adenomas were tested for somatic APC mutations. RESULTS Six patients with multiple adenomas and eight patients with polyposis had biallelic germline MYH variants. Missense and protein-truncating mutations were found, and the spectrums of mutations were very similar in the two groups of patients. In the tumors of carriers of biallelic mutations, all somatic APC mutations were G:C(rightarrow)T:A transversions. In the group with multiple adenomas, about one third of patients with more than 15 adenomas had biallelic MYH mutations. In the polyposis group, no patient with biallelic MYH mutations had severe disease (>1000 adenomas), but three had extracolonic disease. No clearly pathogenic MTH1 or OGG1 mutations were identified. CONCLUSIONS Germ-line MYH mutations predispose persons to a recessive phenotype, multiple adenomas, or polyposis coli. For patients with about 15 or more colorectal adenomas -- especially if no germ-line APC mutation has been identified and the family history is compatible with recessive inheritance - genetic testing of MYH is indicated for diagnosis and calculation of the level of risk in relatives. Clinical care of patients with biallelic MYH mutations should be similar to that of patients with classic or attenuated familial adenomatous polyposis.	Canc Res UK, Mol & Populat Genet Lab, London Res Inst, London WC2A 3PX, England; St Marks Hosp, Canc Res UK Colorectal Unit, Harrow, Middx, England; St Marks Hosp, Polyposis Registry, Harrow, Middx, England; Guys Hosp, Dept Clin Genet, London, England; Univ Clin, Div Med Genet, Res Grp Human Genet, Basel, Switzerland; Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; Hvidovre Univ Hosp, Dept Gastroenterol, Danish Polyposis Register, DK-2650 Hvidovre, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland	Cancer Research UK; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Portuguese Institute of Oncology; University of Copenhagen; Aarhus University; University of Helsinki	Tomlinson, IPM (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Sieber, Oliver/M-9473-2015; Sieber, Oliver/ABA-9211-2021; Aaltonen, Lauri/A-5375-2010	Sieber, Oliver/0000-0001-9480-0786; Sieber, Oliver/0000-0001-9480-0786; Aaltonen, Lauri/0000-0001-6839-4286; Fidalgo, Paulo/0000-0001-7199-3810				Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Halliwell B, 1996, PATHOL BIOL, V44, P6; Hanaoka T, 2001, CANCER LETT, V170, P53, DOI 10.1016/S0304-3835(01)00565-1; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Lamlum H, 2000, HUM MOL GENET, V9, P2215, DOI 10.1093/oxfordjournals.hmg.a018912; LOTHE RA, 1995, GENE CHROMOSOME CANC, V14, P182, DOI 10.1002/gcc.2870140305; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; LYNCH HT, 1995, SEMIN SURG ONCOL, V11, P406, DOI 10.1002/ssu.2980110607; MALINS DC, 1991, CANCER RES, V51, P5430; McLennan AG, 1999, INT J MOL MED, V4, P79; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; *NAT CANC I, 2003, SURV EP END RES; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Oda H, 1997, J BIOL CHEM, V272, P17843, DOI 10.1074/jbc.272.28.17843; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; OKAMOTO K, 1994, INT J CANCER, V58, P825, DOI 10.1002/ijc.2910580613; OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2; PRAML C, 1995, ONCOGENE, V11, P1357; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shinmura K, 1997, MUTAT RES-DNA REPAIR, V385, P75, DOI 10.1016/S0921-8777(97)00041-4; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; TANAKA K, 1993, ONCOGENE, V8, P2253; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Wikman H, 2000, INT J CANCER, V88, P932, DOI 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P	36	613	647	0	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					791	799		10.1056/NEJMoa025283	http://dx.doi.org/10.1056/NEJMoa025283			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606733	Bronze			2022-12-01	WOS:000181173300005
J	Horak, E; Lanigan, A; Roberts, M; Welsh, L; Wilson, J; Carlin, JB; Olinsky, A; Robertson, CF				Horak, E; Lanigan, A; Roberts, M; Welsh, L; Wilson, J; Carlin, JB; Olinsky, A; Robertson, CF			Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; CAFFEINE INTAKE; FETAL GROWTH; ADULT LIFE; PREGNANCY; RISK; BIRTH; REPRODUCTION; CONSUMPTION; POPULATION	Longitudinal studies have reported that asthma in childhood has a good prognosis. However, most of these studies have not taken into account the severity of childhood symptoms.' The Melbourne Epidemiological Study of Childhood Asthma recruited children at age 7 years and followed them up through adolescence to adulthood.(2-5) This report describes outcome at age 42 years in relation to symptoms in childhood.	Royal Childrens Hosp, Dept Resp Med, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia; Alfred Hosp, Dept Resp Med, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Florey Institute of Neuroscience & Mental Health	Robertson, CF (corresponding author), Royal Childrens Hosp, Dept Resp Med, Flemington Rd, Parkville, Vic 3052, Australia.		Carlin, John/AAG-4332-2020; Carlin, John B/B-3492-2012	Carlin, John/0000-0002-2694-9463; Carlin, John B/0000-0002-2694-9463				Ahmed IH, 1999, LUNG BIOL HEALTH DIS, V126, P41; Andersen K V, 1991, Ugeskr Laeger, V153, P1494; BUNKER ML, 1979, J AM DIET ASSOC, V74, P28; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GILBERT SG, 1988, J PHARMACOL EXP THER, V245, P1048; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Juel K, 1999, DAN MED BULL, V46, P354; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; MCNICOL KN, 1973, BRIT MED J, V4, P7, DOI 10.1136/bmj.4.5883.7; Muhajarine N, 1997, CAN J PUBLIC HEALTH, V88, P375, DOI 10.1007/BF03403909; OSWALD H, 1994, BRIT MED J, V309, P95, DOI 10.1136/bmj.309.6947.95; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; WATKINSON B, 1985, NEUROBEH TOXICOL TER, V7, P9; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55; WILLIAMS H, 1969, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5679.321; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322	23	83	83	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					422	+		10.1136/bmj.326.7386.422	http://dx.doi.org/10.1136/bmj.326.7386.422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595380	Bronze, Green Published			2022-12-01	WOS:000181318000017
J	Luo, MM; Fee, MS; Katz, LC				Luo, MM; Fee, MS; Katz, LC			Encoding pheromonal signats in the accessory olfactory bulb of behaving mice	SCIENCE			English	Article							VOMERONASAL NEURONS; URINARY PROTEINS; RECEPTOR NEURONS; SEXUAL-BEHAVIOR; MALE HAMSTER; ORGANIZATION; PROJECTIONS; ORGAN; RAT; ACTIVATION	Many mammalian species rely on pheromones-semiochemicals produced by other members of the same species-to communicate social status and reproductive readiness. To assess how the central nervous system integrates the complex repertoire of pheromones, we recorded from single neurons in the accessory olfactory bulb, a nucleus that processes pheromonal signals, of mate mice engaged in natural behaviors. Neuronal firing was robustly modulated by physical contact with mate and female conspecifics, with individual neurons activated selectively by specific combinations of the sex and strain of conspecifics. We infer that mammals encode social and reproductive information by integrating vomeronasal sensory activity specific to sex and genetic makeup.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Duke University; Howard Hughes Medical Institute; Duke University; Alcatel-Lucent; Lucent Technologies; AT&T	Luo, MM (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	luo@neuro.duke.edu		Luo, Minmin/0000-0003-3535-6624; Fee, Michale/0000-0001-7539-1745				Albone E.S., 1984, MAMMALIAN SEMIOCHEMI; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; BOOTH WD, 1972, J ENDOCRINOL, V55, P119, DOI 10.1677/joe.0.0550119; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura I, 1999, J PHYSIOL-LONDON, V517, P731, DOI 10.1111/j.1469-7793.1999.0731s.x; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1999, J NEUROPHYSIOL, V81, P345, DOI 10.1152/jn.1999.81.1.345; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Lazar J, 2002, BIOCHEMISTRY-US, V41, P11786, DOI 10.1021/bi0256734; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; MORI K, 1987, PROG NEUROBIOL, V29, P275, DOI 10.1016/0301-0082(87)90024-4; MURPHY MR, 1970, SCIENCE, V167, P302, DOI 10.1126/science.167.3916.302; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; POWERS JB, 1973, PHYSIOL BEHAV, V10, P361; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; REINHARDT W, 1983, NEUROSCIENCE, V10, P131, DOI 10.1016/0306-4522(83)90087-8; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; THIESSEN D, 1976, PSYCHOL BULL, V83, P505, DOI 10.1037/0033-2909.83.4.505; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	48	287	293	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1196	1201		10.1126/science.1082133	http://dx.doi.org/10.1126/science.1082133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595684				2022-12-01	WOS:000181065500030
J	Pasha, O; Del Rosso, J; Mukaka, M; Marsh, D				Pasha, O; Del Rosso, J; Mukaka, M; Marsh, D			The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi	LANCET			English	Article							MALARIA	Malaria is a major cause of death in school-age (5-18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2.2 to 1.44 deaths/1000 student-years and from 1.28 to 0.44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.	Save Children Federat, Int Program, Off Hlth, Westport, CT 06881 USA; Save Children Malawi, Malawi Field Off, Mangochi, Malawi	Save the Children; Save the Children	Del Rosso, J (corresponding author), Save Children Federat, Int Program, Off Hlth, Westport, CT 06881 USA.			Pasha, Omrana/0000-0003-4046-3918				Brooker S, 2000, PARASITOL TODAY, V16, P183, DOI 10.1016/S0169-4758(00)01663-X; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; Magnussen P, 2001, TROP MED INT HEALTH, V6, P273, DOI 10.1046/j.1365-3156.2001.00720.x; MURRAY CJL, 1996, GLOBAL HLTH STAT, P137; OGUTU RO, 1992, E AFR MED J, V69, P298	5	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					577	578		10.1016/S0140-6736(03)12511-1	http://dx.doi.org/10.1016/S0140-6736(03)12511-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598146				2022-12-01	WOS:000181033400014
J	Kasahara, T; Kato, T				Kasahara, T; Kato, T			A new redox-cofactor vitamin for mammals	NATURE			English	Article							PYRROLOQUINOLINE QUINONE; ALPHA-AMINOADIPATE; LYSINE; BIOSYNTHESIS		RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan	RIKEN	Kasahara, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.		Kato, Tadafumi/J-3583-2014; Kasahara, Takaoki/AAJ-5367-2020	Kato, Tadafumi/0000-0001-7856-3952; Kasahara, Takaoki/0000-0002-0953-5146				BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; Ehmann DE, 1999, BIOCHEMISTRY-US, V38, P6171, DOI 10.1021/bi9829940; FLUCKIGER R, 1988, BIOCHEM BIOPH RES CO, V153, P353, DOI 10.1016/S0006-291X(88)81230-0; HIGASHINO K, 1971, ARCH BIOCHEM BIOPHYS, V142, P606, DOI 10.1016/0003-9861(71)90525-X; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; MATHEWS FS, 1995, METHOD ENZYMOL, V258, P191; Praphanphoj V, 2001, MOL GENET METAB, V72, P336, DOI 10.1006/mgme.2000.3138; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744	10	156	187	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					832	832		10.1038/422832a	http://dx.doi.org/10.1038/422832a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712191				2022-12-01	WOS:000182432600039
J	Imai, Y; Parodo, J; Kajikawa, O; de Perrot, M; Fischer, S; Edwards, V; Cutz, E; Liu, MY; Keshavjee, S; Martin, TR; Marshall, JC; Ranieri, VM; Slutsky, AS				Imai, Y; Parodo, J; Kajikawa, O; de Perrot, M; Fischer, S; Edwards, V; Cutz, E; Liu, MY; Keshavjee, S; Martin, TR; Marshall, JC; Ranieri, VM; Slutsky, AS			Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL TUBULAR CELLS; INDUCED LUNG INJURY; SOLUBLE FAS-LIGAND; DEATH; FAILURE; SEPSIS; EXPRESSION; INDUCTION; CYTOKINES; ISCHEMIA	Context Recent clinical trials have demonstrated a decrease in multiple organ dysfunction syndrome (MODS) and mortality in patients with acute respiratory distress syndrome (ARDS) treated with a protective ventilatory strategy. Objective To examine the hypothesis that an injurious ventilatory strategy may lead to end-organ epithelial cell apoptosis and organ dysfunction. Design and Setting In vivo animals: 24 rabbits with acid-aspiration lung injury were ventilated with injurious or noninjurious ventilatory strategies. In vitro:,rabbit epithelial cells were exposed to plasma from in vivo rabbit studies. In vivo human: plasma samples from patients included in a previous randomized controlled trial examining a lung protective strategy were analyzed (lung protection group, n=9 and controls, n=11). Main Outcome Measures In vivo animals: biochemical markers of liver and renal dysfunction; apoptosis in end organs. In vitro: induction of apoptosis in LLC-RK1 renal tubular epithelial cells. In vivo human: correlation of plasma creatinine and soluble Fas ligand. Results The injurious ventilatory strategy led to increased rates of epithelial cell apoptosis in the kidney (mean [SE]: injurious, 10.9% [0.88%]; noninjurious, 1.86% [0.17%]; P<001) and small intestine villi (injurious, 6.7% [0.66%]; noninjurious, 0.97% [0.14%]; P<001), and led to the elevation of biochemical markers indicating renal dysfunction in vivo. Induction of apoptosis was increased in LLC-RK1 cells incubated with plasma from rabbits ventilated with injurious ventilatory strategy at 4 hours (P=.03) and 8 hours (P=.002). The Fas:Ig, a fusion protein that blocks soluble Fas ligand, attenuated induction of apoptosis in vitro. There was a significant correlation between changes in soluble Fas ligand and changes in creatinine in patients with ARDS (R=0.64, P=.002). Conclusions Mechanical ventilation can lead to epithelial cell apoptosis in the kidney and small intestine, Accompanied by biochemical evidence of organ dysfunction. This may partially explain the high rate of MODS observed in patients with ARDS and the decrease in morbidity and mortality in patients treated with a lung protective strategy.	Univ Toronto, St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada; Univ Hlth Network, Res Lab, Toronto, ON, Canada; Seattle Vet Adm Med Ctr, Seattle, WA USA; Hosp Sick Children, Res Inst, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; Univ Turin, Osped S Giovanni Battista, Sez Anestesiol & Rianimaz, Dipartimento Discipline Medicochirurg Div, Turin, Italy	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Slutsky, AS (corresponding author), Univ Toronto, St Michaels Hosp, Dept Crit Care, 30 Bond St,Queen Wing,Room 4-042, Toronto, ON M5B 1W8, Canada.	arthur.slutsky@utoronto.ca	Imai, Yumiko/GXW-1144-2022; Slutsky, Arthur S/A-6013-2008; Ranieri, Marco/AFX-8152-2022; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; de Perrot, Marc/0000-0003-2000-9427; Liu, Mingyao/0000-0002-9188-8417; Keshavjee, Shaf/0000-0003-4547-8094				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 1999, INTENS CARE MED, V25, P1444; BALK RA, 1995, JAMA-J AM MED ASSOC, V274, P127, DOI 10.1001/jama.1995.03530020045021; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Daemen MARC, 2001, TRANSPLANTATION, V71, P1007; de Perrot M, 2002, J THORAC CARDIOV SUR, V124, P1137, DOI 10.1067/mtc.2002.125056; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fink M P, 2000, Minerva Anestesiol, V66, P337; Fischer S, 2000, ANN SURG, V231, P424, DOI 10.1097/00000658-200003000-00016; Fry DE, 2000, AM SURGEON, V66, P126; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P237, DOI 10.1164/ajrccm.161.1.9810007; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hudson LD, 1999, JAMA-J AM MED ASSOC, V282, P77, DOI 10.1001/jama.282.1.77; Imai Y, 2001, J APPL PHYSIOL, V91, P1836, DOI 10.1152/jappl.2001.91.4.1836; Iwama H, 2000, AM J EMERG MED, V18, P348, DOI 10.1016/S0735-6757(00)90141-4; Kajikawa O, 1997, J IMMUNOL METHODS, V205, P135, DOI 10.1016/S0022-1759(97)00066-5; Kajikawa O, 1996, J IMMUNOL METHODS, V197, P19, DOI 10.1016/0022-1759(96)00101-9; Koide N, 1996, FEMS IMMUNOL MED MIC, V16, P205, DOI 10.1016/S0928-8244(96)00084-3; Krammer P H, 1999, Adv Immunol, V71, P163; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, pL328, DOI 10.1152/ajplung.2001.281.2.L328; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OrtizArduan A, 1996, AM J PHYSIOL-RENAL, V271, pF1193; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Perianayagam MC, 2000, J LAB CLIN MED, V136, P320, DOI 10.1067/mlc.2000.109318; Rana A, 2001, APOPTOSIS, V6, P83, DOI 10.1023/A:1009680229931; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; SCHUMER M, 1992, AM J PATHOL, V140, P831; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Tesch GH, 1999, J CLIN INVEST, V103, P73, DOI 10.1172/JCI4876; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Ueda N, 1998, KIDNEY INT, V54, P399, DOI 10.1046/j.1523-1755.1998.00008.x; WARDLE EN, 1994, NEPHROL DIAL TRANSPL, V9, P104; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watson RWG, 1997, J IMMUNOL, V158, P945; Wyncoll DLA, 1999, LANCET, V354, P497, DOI 10.1016/S0140-6736(98)08129-X	51	447	488	2	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2003	289	16					2104	2112		10.1001/jama.289.16.2104	http://dx.doi.org/10.1001/jama.289.16.2104			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669WW	12709468	Bronze			2022-12-01	WOS:000182374300026
J	Ayad, NG; Rankin, S; Murakami, M; Jebanathirajah, J; Gygi, S; Kirschner, MW				Ayad, NG; Rankin, S; Murakami, M; Jebanathirajah, J; Gygi, S; Kirschner, MW			Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC	CELL			English	Article							SISTER-CHROMATID SEPARATION; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; SUBSTRATE RECOGNITION; MITOSIS; KINASE; CDH1; DEGRADATION; PROTEOLYSIS; INHIBITOR	Entry into mitosis requires the activation of cdk1/ cyclin B, while mitotic exit is achieved when the same kinase activity decreases, as cyclin B is degraded. Cyclin B proteolysis is mediated by the anaphase promoting complex, or APC, an E3 ligase that is active at anaphase in mitosis through G1. We have identified a G1 substrate of the APC that we have termed Tome-1, for trigger of mitotic entry. Tome-1 is a cytosolic protein required for proper activation of cdk1/cyclin B and mitotic entry. Tome-1 associates with Skp-1 and is required for degradation of the cdk1 inhibitory tyrosine kinase wee1; Tome-1 therefore appears to be acting as part of an SCF-type E3 for wee1. Degradation of Tome-1 during G1 allows for wee 1 accumulation during interphase, thereby providing a critical link between the APC and SCF pathways in regulation of cclk1/cyclin B activity and thus mitotic entry and exit.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; NCI, Frederick, MD 21702 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA.			Rankin, Susannah/0000-0002-4056-6610	NHGRI NIH HHS [HG00041] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fang CH, 1998, INT J MOL MED, V1, P163; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Kawasaki H, 2001, EMBO J, V20, P4618, DOI 10.1093/emboj/20.16.4618; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Schlosser A, 2001, ANAL CHEM, V73, P170, DOI 10.1021/ac000826j; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SOLOMON MJ, 1991, COLD SH Q B, V56, P427; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	32	141	150	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					101	113		10.1016/S0092-8674(03)00232-0	http://dx.doi.org/10.1016/S0092-8674(03)00232-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679038	Bronze			2022-12-01	WOS:000182282900010
J	Lyon, BE				Lyon, BE			Egg recognition and counting reduce costs of avian conspecific brood parasitism	NATURE			English	Article							NEST PARASITISM; CUCULUS-CANORUS; CLUTCH SIZE; DISCRIMINATION; COEVOLUTION; CUCKOO; COOTS; MODEL	Birds parasitized by interspecific brood parasites often adopt defences based on egg recognition but such behaviours are puzzlingly rare in species parasitized by members of the same species. Here I show that conspecific egg recognition is frequent, accurate and used in three defences that reduce the high costs of conspecific brood parasitism in American coots. Hosts recognized and rejected many parasitic eggs, reducing the fitness costs of parasitism by half. Recognition without rejection also occurred and some hosts banished parasitic eggs to inferior outer incubation positions. Clutch size comparisons revealed that females combine egg recognition and counting to make clutch size decisions - by counting their own eggs, while ignoring distinctive parasitic eggs, females avoid a maladaptive clutch size reduction. This is clear evidence that female birds use visual rather than tactile cues to regulate their clutch sizes, and provides a rare example of the ecological and evolutionary context of counting in animals.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Lyon, BE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	lyon@biology.ucsc.edu	Lyon, Bruce E/E-8491-2011					ANDERSSON M, 1982, AM NAT, V120, P1, DOI 10.1086/283965; Andersson M., 1984, ANIM BEHAV, V33, P1394; ARNOLD TW, 1987, CONDOR, V89, P675, DOI 10.2307/1368662; BERTRAM BCR, 1992, OSTRICH COMMUNAL NES, P109; BROOKE MD, 1988, NATURE, V335, P630; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; Eadie J, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P306; GALLISTEL CR, 1988, BEHAV BRAIN SCI, V11, P585, DOI 10.1017/S0140525X00053504; Hauser MD, 2000, AM SCI, V88, P144, DOI 10.1511/2000.19.863; HAYWOOD S, 1993, Q REV BIOL, V68, P33, DOI 10.1086/417910; Jackson WM, 1998, OX ORN SER, V9, P407; Jamieson IG, 2000, AUK, V117, P250, DOI 10.1642/0004-8038(2000)117[0250:HROCBP]2.0.CO;2; KEMAL RE, 1988, ANIM BEHAV, V36, P175, DOI 10.1016/S0003-3472(88)80261-6; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; Lyon BE, 2002, EVOLUTION, V56, P1253, DOI 10.1111/j.0014-3820.2002.tb01436.x; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; Lyon BE, 1998, NATURE, V392, P380, DOI 10.1038/32878; LYON BE, 1992, ECOLOGY EVOLUTION CO; ROHWER FC, 1989, CAN J ZOOL, V67, P239, DOI 10.1139/z89-035; ROTHSTEIN SI, 1982, AM ZOOL, V22, P547; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; SEIBT U, 1988, BEHAV BRAIN SCI, V11, P597, DOI 10.1017/S0140525X00053644; Sherman Paul W., 1997, P69; Shettleworth, 2010, COGNITION EVOLUTION	26	197	203	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					495	499		10.1038/nature01505	http://dx.doi.org/10.1038/nature01505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673243				2022-12-01	WOS:000181965400030
J	White, T				White, T			Paleoanthropology: Early hominids - Diversity or distortion?	SCIENCE			English	Editorial Material							AFRICA; CHAD		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	White, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.							Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; GOULD SJ, 1976, NAT HIST, V85, P24; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; LI TY, 1992, NATURE, V357, P404; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; MAYR E, 1950, COLD SPRING HARB SYM, V15, P109, DOI 10.1101/SQB.1950.015.01.013; SCHULTZ CB, 1956, B AM MUS NAT HIST, V109, P1; SIMPSON GG, 1963, CLASSIFICATION HUMAN, P4; Spoor F, 1999, NATURE, V397, P572, DOI 10.1038/17505; STEVENS MS, 1996, TERRESTRIAL EOCENE O, pCH25; TATTERSALL I, 2000, EXTINCT HUMANS; WILFORD JN, 2001, NY TIMES        0325; Wood B, 2002, NATURE, V418, P133, DOI 10.1038/418133a	13	81	84	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					1994	+		10.1126/science.1078294	http://dx.doi.org/10.1126/science.1078294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12663903				2022-12-01	WOS:000181834200028
J	Kullander, K; Butt, SJB; Lebret, JM; Lundfald, L; Restrepo, CE; Rydstrom, A; Klein, R; Kiehn, O				Kullander, K; Butt, SJB; Lebret, JM; Lundfald, L; Restrepo, CE; Rydstrom, A; Klein, R; Kiehn, O			Role of EphA4 and EphrinB3 in local neuronal circuits that control walking	SCIENCE			English	Article							CENTRAL PATTERN GENERATOR; VITRO NEONATAL RAT; SPINAL-CORD; IN-VITRO; CORTICOSPINAL TRACT; AXONS; LOCOMOTION; MECHANISMS; RECEPTORS; NETWORKS	Local circuits in the spinal cord that generate locomotion are termed central pattern generators (CPGs). These provide coordinated bilateral control over the normal limb alternation that underlies walking. The molecules that organize the mammalian CPG are unknown. Isolated spinal cords from mice lacking either the EphA4 receptor or its ligand ephrinB3 have lost left-right limb alternation and instead exhibit synchrony. We identified EphA4-positive neurons as an excitatory component of the locomotor CPG. Our study shows that dramatic locomotor changes can occur as a consequence of local genetic rewiring and identifies genes required for the development of normal locomotor behavior.	Univ Gothenburg, Dept Biochem Med, S-40530 Gothenburg, Sweden; AstraZeneca Transgen & Comparat Genom, S-43183 Molndal, Sweden; Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	University of Gothenburg; AstraZeneca; Karolinska Institutet; Max Planck Society	Kullander, K (corresponding author), Univ Gothenburg, Dept Biochem Med, Medicinaregatan 9A, S-40530 Gothenburg, Sweden.	klas.kullander@medkem.gu.se; ole.kiehn@neuro.ki.se	kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021; Kiehn, Ole/C-4679-2008; Butt, Simon/I-2689-2019; Klein, Ruediger/C-6147-2008	Butt, Simon/0000-0002-2399-0102; Klein, Ruediger/0000-0002-3109-0163; Kullander, Klas/0000-0001-6418-5460; Kiehn, Ole/0000-0002-5954-469X				ARSHAVSKY YI, 1993, TRENDS NEUROSCI, V16, P227, DOI 10.1016/0166-2236(93)90161-E; Butt SJB, 2002, BRAIN RES REV, V40, P107, DOI 10.1016/S0165-0173(02)00194-7; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Grillner S, 2011, COMPR PHYSIOL, V26, P1179, DOI [10.1126/science.1245629, DOI 10.1002/CPHY.CP010226]; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; KIEHN O, 1997, NEURONS NETWORKS MOT, P47; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Whelan PJ, 1997, J NEUROPHYSIOL, V78, P1643, DOI 10.1152/jn.1997.78.3.1643; Wickelgren I, 1998, SCIENCE, V279, P319, DOI 10.1126/science.279.5349.319; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	25	257	264	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1889	1892		10.1126/science.1079641	http://dx.doi.org/10.1126/science.1079641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649481				2022-12-01	WOS:000181669700045
J	Murray, M				Murray, M			Anthropology: Overkill and sustainable use	SCIENCE			English	Editorial Material									Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Murray, M (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.			Murray, Martyn/0000-0003-4371-388X				Bleek W.H.I., 1911, SPECIMENS BUSHMEN FO; Bowen-Jones E, 1999, ORYX, V33, P233, DOI 10.1046/j.1365-3008.1999.00066.x; Diamond Jared, 1992, RISE FALL 3 CHIMPANZ; Etnier M. A., 2002, THESIS U WASHINGTON; *IUCN, 2001, STRAT APPR INT BIOD; Jones Brian, 2001, P38; Kay C.E., 2002, WILDERNESS POLITICAL; Krech S, 1999, ECOLOGICAL INDIAN MY; Krech Shepard III, 1981, INDIANS ANIMALS FUR; LISTERKAYE J, 1994, 3 SCOTT NAT HER; Marshall L., 1976, KUNG BUSHMEN NYAENYA, DOI DOI 10.4159/HARVARD.9780674180574; Martin Calvin, 1978, KEEPERS GAME INDIAN; MARTIN PS, 1973, SCIENCE, V179, P969, DOI 10.1126/science.179.4077.969; MARTIN PS, 1966, NATURE, V212, P339, DOI 10.1038/212339a0; Milner-Gulland E.J., 1998, CONSERVATION BIOL RE; MUIR J, 1913, STORY MY BOYHOOD YOU, P161; Robinson J., 2000, HUNTING SUSTAINABILI; Silberbauer GB, 1981, HUNTER HABITAT CENTR; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Stevens S., 1997, CONSERVATION CULTURA; TRENCH CC, 1967, POACHER SQUIRE; *WORLD CONS UN UN, 1991, CAR EARTH STRAT SUST; Worthy T.H., 2002, LOST WORLD MOA PREHI	23	13	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1851	1853		10.1126/science.1079823	http://dx.doi.org/10.1126/science.1079823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649469				2022-12-01	WOS:000181669700030
J	Sasaki, A; Itoh, H; Gomi, K; Ueguchi-Tanaka, M; Ishiyama, K; Kobayashi, M; Jeong, DH; An, G; Kitano, H; Ashikari, M; Matsuoka, M				Sasaki, A; Itoh, H; Gomi, K; Ueguchi-Tanaka, M; Ishiyama, K; Kobayashi, M; Jeong, DH; An, G; Kitano, H; Ashikari, M; Matsuoka, M			Accumulation of phosphorylated repressor for gibberellin signaling in an F-box mutant	SCIENCE			English	Article							RESPONSE MUTANT; GENE; DEGRADATION; RICE; ENCODES; PATHWAY; PROTEIN; ALPHA; SLN1	Gibberellin (GA) regulates growth and development in plants. We isolated and characterized a rice GA-insensitive dwarf mutant, gid2. The GID2 gene encodes a putative F-box protein, which interacted with the rice Skp1 homolog in a yeast two-hybrid assay. In gid2, a repressor for GA signaling, SLR1, was highly accumulated in a phosphorylated form and GA increased its concentration, whereas SLR1 was rapidly degraded by GA through ubiquitination in the wild type. We conclude that GID2 is a positive regulator of GA signaling and that regulated degradation of SLR1 is initiated through GA-dependent phosphorylation and finalized by an SCFGID2-proteasome pathway.	Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan; RIKEN, Bioresources Ctr, Tsukuba, Ibaraki 3050074, Japan; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; RIKEN; Pohang University of Science & Technology (POSTECH); Nagoya University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan.	makoto@agr.nagoya-u.ac.jp	Kobayashi, Masatomo/A-5945-2016	Gomi, Kenji/0000-0002-6736-1113				Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Davies P. J, 1995, PLANT HORMONES; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; SASAKI A, UNPUB; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Steber CM, 1998, GENETICS, V149, P509; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416	24	461	531	5	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2003	299	5614					1896	1898		10.1126/science.1081077	http://dx.doi.org/10.1126/science.1081077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12649483				2022-12-01	WOS:000181669700047
J	Jamora, C; DasGupta, R; Kocieniewski, P; Fuchs, E				Jamora, C; DasGupta, R; Kocieniewski, P; Fuchs, E			Links between signal transduction, transcription and adhesion in epithelial bud development	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; E-CADHERIN; BETA-CATENIN; GENE-EXPRESSION; SONIC HEDGEHOG; FACTOR SNAIL; DIFFERENTIATION	The morphogenesis of organs as diverse as lungs, teeth and hair follicles is initiated by a downgrowth from a layer of epithelial stem cells(1,2). During follicular morphogenesis, stem cells form this bud structure by changing their polarity and cell-cell contacts. Here we show that this process is achieved through simultaneous receipt of two external signals: a Writ protein to stabilize beta-catenin, and a bone morphogenetic protein (BMP) inhibitor to produce Lef1. beta-Catenin then binds to, and activates, Lef1 transcription complexes that appear to act uncharacteristically by downregulating the gene encoding E-cadherin, an important component of polarity and intercellular adhesion. When either signal is missing, functional Lef1 complexes are not made, and E-cadherin downregulation and follicle morphogenesis are impaired. In Drosophila, E-cadherin can influence the plane of cell division and cytoskeletal dynamics(3). Consistent with this notion, we show that forced elevation of E-cadherin levels block invagination and follicle production. Our findings reveal an intricate molecular programme that links two extracellular signalling pathways to the formation of a nuclear transcription factor that acts on target genes to remodel cellular junctions and permit follicle formation.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10021 USA.	fuchs@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Dasgupta, Ramanuj/0000-0001-9015-3729	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR031737, R01 AR031737-24] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan SK, 2002, CELL, V111, P265, DOI 10.1016/S0092-8674(02)01037-1; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; HIRAI Y, 1989, DEVELOPMENT, V105, P271; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	29	455	482	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2003	422	6929					317	322		10.1038/nature01458	http://dx.doi.org/10.1038/nature01458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12646922	Green Accepted			2022-12-01	WOS:000181637300041
J	Sirovich, BE; Schwartz, LM; Woloshin, S				Sirovich, BE; Schwartz, LM; Woloshin, S			Screening men for prostate and colorectal cancer in the United States - Does practice reflect the evidence?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED TRIAL; PRIMARY-CARE PHYSICIANS; PATIENTS SELF-REPORTS; PAP SMEAR; PART I; MORTALITY; ANTIGEN; QUEBEC; VALIDITY	Context The debate about the efficacy of prostate-specific antigen (PSA) screening for prostate cancer has received substantial attention in the medical literature and the media, but the extent to which men are actually screened is unknown. If practice were evidence-based, PSA screening would be less common among men than colorectal cancer screening, a preventive service of broad acceptance and proven efficacy. Objective To compare the prevalences of PSA and colorectal cancer screening among US men. Design, Setting, and Population The 2001 Behavioral Risk Factor Surveillance System, an annual population-based telephone survey of US adults conducted by the Centers for Disease Control and Prevention, was used to gather data on a representative sample of men aged 40 years or older from all 50 states and the District of Columbia (n=49315). Main Outcome Measures Proportions of men ever screened and up to date on screening for prostate cancer (with PSA testing) and colorectal cancer (with fecal occult blood testing, flexible sigmoidoscopy, or colonoscopy). Results Overall, men are more likely to report having ever been screened for prostate cancer than for colorectal cancer; 75% of those aged 50 years or older have had a PSA test vs 63% for any colorectal cancer test (risk ratio [RR], 1.20; 95% confidence interval [CI], 1.18-1.21). Up-to-date PSA screening is also more common than colorectal cancer screening for men of all ages. Among men aged 50 to 69 years (those for whom there is the greatest consensus in favor of screening), 54% reported an up-to-date PSA screen, while 45% reported up-to-date testing for colorectal cancer (RR, 1.19; 95% CI, 1.16-1.21). In state-level analyses of this age group, men were significantly more likely to be up to date on prostate cancer screening compared with colorectal cancer screening in 27 states, while up-to-date colorectal cancer screening was more common in only 1 state. Conclusion Among men in the United States, prostate cancer screening is more common than colorectal cancer screening. Physicians should ensure that men who choose to be screened for cancer are aware of the known mortality benefit of colorectal cancer screening and the uncertain benefits of screening for prostate cancer.	Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center	Sirovich, BE (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, 111B,, White River Jct, VT 05009 USA.				NCI NIH HHS [CA91052-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander FE, 1999, PROSTATE, V40, P135; [Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P162; Baier M, 2000, CANCER EPIDEM BIOMAR, V9, P229; Barry MJ, 2000, J GEN INTERN MED, V15, P749, DOI 10.1046/j.1525-1497.2000.00816.x; Boer R, 1999, PROSTATE, V40, P130; BOWMAN JA, 1991, HEALTH SERV RES, V26, P97; Brawer MK, 1999, CA-CANCER J CLIN, V49, P264, DOI 10.3322/canjclin.49.5.264; Carroll P, 2001, UROLOGY, V57, P217, DOI 10.1016/S0090-4295(00)00993-6; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; *CDCP, 2002, BEH RISK FACT SURV S; *CDCP, 2002, 2001 BEH RISK FACT S; Coley CM, 1997, ANN INTERN MED, V126, P480; Donovan JL, 2001, BMJ-BRIT MED J, V323, P763, DOI 10.1136/bmj.323.7316.763; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; FARRELL MH, 2002, EFF CLIN PRACT, V5, P91; Fowler FJ, 1998, AM J MED, V104, P526, DOI 10.1016/S0002-9343(98)00124-7; Hahn DL, 1999, J FAM PRACTICE, V48, P679; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Hawley ST, 2001, CANCER DETECT PREV, V25, P309; Hoffman RM, 1996, AM J PREV MED, V12, P277, DOI 10.1016/S0749-3797(18)30325-8; Jordan TR, 1999, PREV MED, V28, P297, DOI 10.1006/pmed.1998.0430; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Labrie F, 2000, PROSTATE, V43, P215, DOI 10.1002/(SICI)1097-0045(20000515)43:3<215::AID-PROS7>3.0.CO;2-G; Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B; Labrie F, 1999, PROSTATE, V40, P132; Labrie F, 1999, PROSTATE, V40, P137; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandelson MT, 1999, AM J EPIDEMIOL, V150, P617; McGovern PG, 1998, AM J PREV MED, V14, P201, DOI 10.1016/S0749-3797(97)00076-7; Mettlin C, 1997, PROSTATE, V31, P71; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; *NAT CTR HLTH STAT, 2000, NAT HLTH INT SURV DA; *NAT CTR HLTH STAT, 2002, NCHS DEF ALPH LIST M; *NCI, 2002, SEER INC US MORT STA; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; *POP EST PROGR POP, 2002, ANN POP EST AG GROUP; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Ries LAG, 2002, SEER CANC STAT REV 1; Schroy PC, 2001, PREV MED, V33, P381, DOI 10.1006/pmed.2001.0903; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; Standaert B, 1997, CANCER, V80, P1830; SUAREZ L, 1995, AM J PREV MED, V11, P94, DOI 10.1016/S0749-3797(18)30483-5; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P119; US Preventive Services Task Force United States. Office of Disease Prevention Health Promotion, 1996, GUID CLIN PREV SERV, P89; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Volk RJ, 2002, AM J PREV MED, V22, P56, DOI 10.1016/S0749-3797(01)00397-X; Voss JD, 2001, J GEN INTERN MED, V16, P831, DOI 10.1046/j.1525-1497.2001.10133.x; WHITMAN S, 1993, INT J EPIDEMIOL, V22, P393, DOI 10.1093/ije/22.3.393; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112	54	266	271	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1414	1420		10.1001/jama.289.11.1414	http://dx.doi.org/10.1001/jama.289.11.1414			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636464				2022-12-01	WOS:000181616200033
J	Toma, TP; Hopkinson, NS; Hillier, J; Hansell, DM; Morgan, C; Goldstraw, PG; Polkey, MI; Geddes, DM				Toma, TP; Hopkinson, NS; Hillier, J; Hansell, DM; Morgan, C; Goldstraw, PG; Polkey, MI; Geddes, DM			Bronchoscopic volume reduction with valve implants in patients with severe emphysema.	LANCET			English	Article								Eight patients with severe emphysema entered a pilot study of unilateral volume reduction by endobronchial valve insertion. Five patients had emphysema judged too severe for volume reduction surgery and three refused the operation. After valve insertions, the median forced expiratory volume in 1 s (FEV1) increased from 0.79 L (range 0.61-1.07) to 1.06 L (0.75-1.22) (difference 34%, p=0.028) and the median diffusing capacity (TLco) increased from 3.05 mL/min/mm Hg (2.35-4.71) to 3.92 mL/min/mm Hg (2.89-5.40) (difference 29%, p=0.017). CT scans showed a substantial reduction in regional volume in four of the eight patients. Two patients developed a transient pneumothorax (one requiring drainage) but we recorded no other important adverse effects during follow-up. Lung-volume reduction can be achieved with unilateral bronchoscopically placed valve implants in patients with severe emphysema with acceptable short-term safety and worthwhile functional benefits.	Royal Brompton Hosp, Dept Resp Med, London SW3 6NP, England; Royal Brompton Hosp, Dept Radiol, London SW3 6NP, England; Royal Brompton Hosp, Dept Anaesthesia, London SW3 6NP, England; Royal Brompton Hosp, Dept Thorac Surg, London SW3 6NP, England; Natl Heart & Lung Inst, Dept Thorac Med, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Geddes, DM (corresponding author), Royal Brompton Hosp, Dept Resp Med, London SW3 6NP, England.			Hillier, James/0000-0001-9591-6510				Fishman A, 2001, NEW ENGL J MED, V345, P1075; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Ingenito EP, 2003, AM J RESP CRIT CARE, V167, P771, DOI 10.1164/rccm.200208-842OC; SNELL GI, 2001, ACCP M; Toma TP, 2001, LANCET, V357, P1621, DOI 10.1016/S0140-6736(00)04761-9	5	207	238	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 15	2003	361	9361					931	933		10.1016/S0140-6736(03)12762-6	http://dx.doi.org/10.1016/S0140-6736(03)12762-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VP	12648974				2022-12-01	WOS:000181741600013
J	Huang, CY; Ayliffe, MA; Timmis, JN				Huang, CY; Ayliffe, MA; Timmis, JN			Direct measurement of the transfer rate of chloroplast DNA into the nucleus	NATURE			English	Article							PLASTID GENOME; GENE; TOBACCO; PLANTS; ARABIDOPSIS; EXPRESSION; REVEALS; INSERTION	Gene transfer from the chloroplast to the nucleus has occurred over evolutionary time(1). Functional gene establishment in the nucleus is rare, but DNA transfer without functionality is presumably more frequent. Here, we measured directly the transfer rate of chloroplast DNA (cpDNA) into the nucleus of tobacco plants (Nicotiana tabacum). To visualize this process, a nucleus-specific neomycin phosphotransferase gene (neoSTLS2) was integrated into the chloroplast genome, and the transfer of cpDNA to the nucleus was detected by screening for kanamycin-resistant seedlings in progeny. A screen for kanamycin-resistant seedlings was conducted with about 250,000 progeny produced by fertilization of wild-type females with pollen from plants containing cp-neoSTLS2. Sixteen plants of independent origin were identified and their progenies showed stable inheritance of neoSTLS2, characteristic of nuclear genes. Thus, we provide a quantitative estimate of one transposition event in about 16,000 pollen grains for the frequency of transfer of cpDNA to the nucleus. In addition to its evident role in organellar evolution, transposition of cpDNA to the nucleus in tobacco occurs at a rate that must have significant consequences for existing nuclear genes.	Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia; CSIRO Plant Ind, Canberra, ACT 2601, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Timmis, JN (corresponding author), Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia.	jeremy.timmis@adelaide.edu.au	Ayliffe, Michael A/A-2089-2010					Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Horser C, 2002, GENET ENG P, V24, P239; Huang CY, 2000, PLANT PHYSIOL, V124, P415, DOI 10.1104/pp.124.1.415; Kaneko T, 1996, DNA Res, V3, P109; Maas C, 1997, MOL BREEDING, V3, P15, DOI 10.1023/A:1009602923403; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Scott SE, 1999, NAT BIOTECHNOL, V17, P390, DOI 10.1038/7952; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; TIMMIS JN, 1983, NATURE, V305, P65, DOI 10.1038/305065a0; Whitney SM, 2001, PLANT CELL, V13, P193, DOI 10.1105/tpc.13.1.193; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; ZOUBENKO OV, 1994, NUCLEIC ACIDS RES, V22, P3819, DOI 10.1093/nar/22.19.3819	26	217	234	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					72	76		10.1038/nature01435	http://dx.doi.org/10.1038/nature01435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594458				2022-12-01	WOS:000181343100039
J	Allen, M				Allen, M			Liability for climate change	NATURE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford	Allen, M (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	myles.allen@physics.ox.ac.uk							0	285	286	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					891	892		10.1038/421891a	http://dx.doi.org/10.1038/421891a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606972				2022-12-01	WOS:000181186900017
J	Lou, ZK; Minter-Dykhouse, K; Wu, XL; Chen, JJ				Lou, ZK; Minter-Dykhouse, K; Wu, XL; Chen, JJ			MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways	NATURE			English	Article							ATAXIA-TELANGIECTASIA; FHA DOMAIN; CHECKPOINT; PHOSPHORYLATION; PROTEIN; THREONINE-68; KINASE; ATM; REPAIR; BRCA1	Forkhead-homology-associated (FHA) domains function as protein-protein modules that recognize phosphorylated serine/threonine motifs(1-5). Interactions between FHA domains and phosphorylated proteins are thought to have essential roles in the transduction of DNA damage signals; however, it is unclear how FHA-domain-containing proteins participate in mammalian DNA damage responses. Here we report that a FHA-domain-containing protein-mediator of DNA damage checkpoint protein 1 (MDC1; previously known as KIAA0170)-is involved in DNA damage responses. MDC1 localizes to sites of DNA breaks and associates with CHK2 after DNA damage. This association is mediated by the MDC1 FHA domain and the phosphorylated Thr 68 of CHK2. Furthermore, MDC1 is phosphorylated in an ATM/CHK2-dependent manner after DNA damage, suggesting that MDC1 may function in the ATM-CHK2 pathway. Consistent with this hypothesis, suppression of MDC1 expression results in defective S-phase checkpoint and reduced apoptosis in response to DNA damage, which can be restored by the expression of wildtype MDC1 but not MDC1 with a deleted FHA domain. Suppression of MDC1 expression results in decreased p53 stabilization in response to DNA damage. These results suggest that MDC1 is recruited through its FHA domain to the activated CHK2, and has a critical role in CHK2-mediated DNA damage responses.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	chen.junjie@mayo.edu	Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826				Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Jack MT, 2002, P NATL ACAD SCI USA, V99, P9825, DOI 10.1073/pnas.152053599; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shieh SY, 2000, GENE DEV, V14, P289; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang P, 2000, J MOL BIOL, V302, P927, DOI 10.1006/jmbi.2000.4095; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	30	270	291	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					957	961		10.1038/nature01447	http://dx.doi.org/10.1038/nature01447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607004				2022-12-01	WOS:000181186900052
J	Richardson, DS; Komdeur, J; Burke, T				Richardson, DS; Komdeur, J; Burke, T			Altruism and infidelity among warblers	NATURE			English	Article							ACROCEPHALUS-SECHELLENSIS; SEYCHELLES		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands; Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia	University of Sheffield; Lund University; University of Groningen; University of Melbourne	Richardson, DS (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Burke, Terry/B-3196-2011; Komdeur, Jan/X-1261-2019; Richardson, David S/A-5082-2010	Burke, Terry/0000-0003-3848-1244; Komdeur, Jan/0000-0002-9241-0124; Richardson, David S/0000-0001-7226-9074				EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Komdeur J, 1996, P ROY SOC B-BIOL SCI, V263, P661, DOI 10.1098/rspb.1996.0099; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/s002650050031; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790	10	49	50	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					580	580		10.1038/422580a	http://dx.doi.org/10.1038/422580a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686990	Green Published			2022-12-01	WOS:000182111400029
J	Lusk, C				Lusk, C			Tree-species competition and coexistence	NATURE			English	Article							NEOTROPICAL FOREST; NEW-ZEALAND; HISTORY		Univ Concepcion, Dept Bot, Concepcion, Chile	Universidad de Concepcion	Lusk, C (corresponding author), Univ Concepcion, Dept Bot, Casilla 160-C, Concepcion, Chile.	clusk@udec.cl	Burke, Terry/B-3196-2011; Komdeur, Jan/X-1261-2019; Richardson, David S/A-5082-2010	Burke, Terry/0000-0003-3848-1244; Komdeur, Jan/0000-0002-9241-0124; Richardson, David S/0000-0001-7226-9074				CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harper J. L, 1977, POPULATION BIOL PLAN; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Kelly CK, 2002, NATURE, V417, P437, DOI 10.1038/417437a; LIEBERMAN M, 1995, J TROP ECOL, V11, P161, DOI 10.1017/S0266467400008609; LORIMER CG, 1985, CAN J FOREST RES, V15, P200, DOI 10.1139/x85-038; LUSK C, 1992, J ECOL, V80, P379, DOI 10.2307/2260684; OGDEN J, 1981, J BIOGEOGR, V8, P405, DOI 10.2307/2844759; STEWART GH, 1990, VEGETATIO, V87, P101, DOI 10.1007/BF00042947	10	49	50	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2003	422	6932					580	581		10.1038/422580b	http://dx.doi.org/10.1038/422580b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686990				2022-12-01	WOS:000182111400030
